Citrus Sinensis ID: 020027

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330--
Protein Sequence
MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP
Secondary Structure (PSIPRED)
cccccEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccccccccccHHHHHHHHHccccccccccEEEEcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccccccEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHcHcHHEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEEcccHcHEEEcccccccHccccHHEEEccccccccccccHHHHHHHccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHcccHHHHccHHccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHccccccc
Coil and Loop (DISEMBL)
MSHFEHIAYDCLLAILSLFLIILAIVLIVLCkkkpveseetlpIKLCafayplteidaatdgfshrriigQGRLGTVYAALLSTGklvavkrihprlvlsnagfGFASVIKTLslaqhpnivpilgfsqapgerIIVSEFINMASLDFylhenndgasllDWNRRLRIATGAARGLEylhqgvapniIHGCIKASNILLNEKFCARVCDyglsflapeekrglagyvdddywhekgggnatresdvYGFGVVLLEILsgrrceeglLVKWALPLIKEmrfselldprlaipceikPLVRLAKVALACvgnsrknrpsIVQVATILNNLVGDP
Flexible Loop (DISEMBL)
MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGgnatresdvYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACvgnsrknrpsivqVATILNNLVGDP
Low Complexity Region (SEG)
MSHFEHIAYDCllailslfliilaivlivlCKKKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP
Disordered region (IsUnstruct)
***FEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL****
Disordered Region (DISOPRED)
*****HI**DCLLAILSLFLIILAIVLIV********************AYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHP******A***FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG**
Disordered Region (DISEMBL)
MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP
Disordered Region (DISPRO)
****EHIAYDCLLAILSLFLIILAIVLIVLCKKKP****ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN******
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	332	2.2.26 [Sep-21-2011]
Q9LX29	895	Serine/threonine-protein	no	no	0.849	0.315	0.409	3e-50
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.816	0.265	0.379	1e-46
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.792	0.260	0.377	1e-46
Q9LJF3	1164	Receptor-like protein kin	no	no	0.858	0.244	0.362	5e-45
Q9S7D9	775	Serine/threonine-protein	no	no	0.834	0.357	0.350	1e-44
Q6R2J8	703	Protein STRUBBELIG-RECEPT	no	no	0.855	0.403	0.347	1e-44
O24585	901	Putative receptor protein	N/A	no	0.840	0.309	0.394	1e-44
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.840	0.234	0.368	2e-44
Q94AG2	625	Somatic embryogenesis rec	no	no	0.873	0.464	0.340	8e-43
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.891	0.253	0.339	1e-42

>sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1

 Score =  199 bits (506), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 124/303 (40%), Positives = 168/303 (55%), Gaps = 21/303 (6%)

Query: 48  AFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFA 107
           A  +   E++ A DGF    I+G+G    VY  +L  G  VAVKR             F 
Sbjct: 497 ARVFTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFR 556

Query: 108 SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG-ASLLDWNRRL 166
           + +  LS   H +++ +LG+ +  GER++V EF+   SL  +LH  N      LDW +R+
Sbjct: 557 TELDLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRV 616

Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP--------E 218
            IA  AARG+EYLH    P +IH  IK+SNIL++E+  ARV D+GLS L P        E
Sbjct: 617 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSPLAE 676

Query: 219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-----EEGLLVKWALP 273
              G  GY+D +Y+        T +SDVY FGV+LLEILSGR+      EEG +V+WA+P
Sbjct: 677 LPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVP 733

Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN----NLV 329
           LIK    + LLDP L  P EI+ L R+  VA  CV    K+RPS+ +V T L      L+
Sbjct: 734 LIKAGDINALLDPVLKHPSEIEALKRIVSVACKCVRMRGKDRPSMDKVTTALERALAQLM 793

Query: 330 GDP 332
           G+P
Sbjct: 794 GNP 796

Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  187 bits (474), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 110/290 (37%), Positives = 163/290 (56%), Gaps = 19/290 (6%)

Query: 53   LTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT 112
            L +I  +T  F+   IIG G  G VY A L  G  VA+KR+            F + ++T
Sbjct: 733  LDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLSGDT--GQMDREFQAEVET 790

Query: 113  LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
            LS AQHPN+V +LG+     +++++  +++  SLD++LHE  DG   LDW  RLRIA GA
Sbjct: 791  LSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVDGPPSLDWKTRLRIARGA 850

Query: 173  ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------GLAG 225
            A GL YLHQ   P+I+H  IK+SNILL++ F A + D+GL+  + P +        G  G
Sbjct: 851  AEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLG 910

Query: 226  YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR----CE---EGLLVKWALPLIKEM 278
            Y+  +Y        AT + DVY FGVVLLE+L+GRR    C+      L+ W L +  E 
Sbjct: 911  YIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGRRPMDVCKPRGSRDLISWVLQMKTEK 967

Query: 279  RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
            R SE+ DP +      + ++ + ++A  C+G + K RP+  Q+ + L N+
Sbjct: 968  RESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPTTQQLVSWLENI 1017

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  187 bits (474), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/286 (37%), Positives = 163/286 (56%), Gaps = 23/286 (8%)

Query: 59   ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
            +T+ F    IIG G  G VY A L  GK VA+K++            F + ++TLS AQH
Sbjct: 730  STNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDC--GQIEREFEAEVETLSRAQH 787

Query: 119  PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
            PN+V + GF     +R+++  ++   SLD++LHE NDG +LL W  RLRIA GAA+GL Y
Sbjct: 788  PNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLY 847

Query: 179  LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------GLAGYVDDDY 231
            LH+G  P+I+H  IK+SNILL+E F + + D+GL+  ++P E        G  GY+  +Y
Sbjct: 848  LHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEY 907

Query: 232  WHEKGGGNATRESDVYGFGVVLLEILSGRR---------CEEGLLVKWALPLIKEMRFSE 282
                    AT + DVY FGVVLLE+L+ +R         C +  L+ W + +  E R SE
Sbjct: 908  GQ---ASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRD--LISWVVKMKHESRASE 962

Query: 283  LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
            + DP +      K + R+ ++A  C+  + K RP+  Q+ + L+++
Sbjct: 963  VFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  181 bits (460), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 113/312 (36%), Positives = 170/312 (54%), Gaps = 27/312 (8%)

Query: 40   ETLPIKLCAFAYPLTEID-----AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIH 94
            E L I +  F  PL ++       AT+GFS   +IG G  G VY A L+ G +VA+K++ 
Sbjct: 830  EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLI 889

Query: 95   PRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENN 154
               V       F + ++T+   +H N+VP+LG+ +   ER++V E++   SL+  LHE  
Sbjct: 890  Q--VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKT 947

Query: 155  D-GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL- 212
              G   LDW+ R +IA GAARGL +LH    P+IIH  +K+SN+LL++ F ARV D+G+ 
Sbjct: 948  KKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMA 1007

Query: 213  -------SFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR---- 261
                   + L+     G  GYV  +Y+        T + DVY +GV+LLE+LSG++    
Sbjct: 1008 RLVSALDTHLSVSTLAGTPGYVPPEYYQSF---RCTAKGDVYSYGVILLELLSGKKPIDP 1064

Query: 262  ---CEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK-PLVRLAKVALACVGNSRKNRPS 317
                E+  LV WA  L +E R +E+LDP L         L+   K+A  C+ +    RP+
Sbjct: 1065 EEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPT 1124

Query: 318  IVQVATILNNLV 329
            ++QV T+   LV
Sbjct: 1125 MIQVMTMFKELV 1136

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S7D9|ACCR1_ARATH Serine/threonine-protein kinase-like protein CCR1 OS=Arabidopsis thaliana GN=CCR1 PE=1 SV=1

 Score =  181 bits (458), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 107/305 (35%), Positives = 174/305 (57%), Gaps = 28/305 (9%)

Query: 33  KKPVESEETLP-IKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVK 91
            +P+E+    P +   A  + L+E+  AT+GF     +G+G  G VY A+L+ G+ VAVK
Sbjct: 489 DQPLENVSPAPSVTPFAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVK 548

Query: 92  RIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH 151
           R +   ++      F + ++ L   +H NIV +LG+S   GER++V E++   +L  +LH
Sbjct: 549 RANAATIIHTNTREFETELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLH 608

Query: 152 ENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
               G S L W+ R++IA   A+GLEYLH    P IIHG +K+SN+LL+ ++ ARV D+G
Sbjct: 609 S---GFSPLSWSLRIKIAMQTAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFG 665

Query: 212 LSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR-----CEEGL 266
           L   + E+                   N   + DVY FGVVLLEIL+GR+     C+   
Sbjct: 666 LVTSSNEK-------------------NLDIKRDVYDFGVVLLEILTGRKRYDRDCDPPE 706

Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
           +V+W +P+I+E + + ++D  +A+P  ++PL++LA VA  CV      +P++ ++A  L 
Sbjct: 707 IVEWTVPVIREGKAAAIVDTYIALPRNVEPLLKLADVAELCVREDPNQQPTMSELANWLE 766

Query: 327 NLVGD 331
           ++  D
Sbjct: 767 HVARD 771

Serine/threonine-protein kinase with low activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1

 Score =  180 bits (457), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/296 (34%), Positives = 162/296 (54%), Gaps = 12/296 (4%)

Query: 46  LCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFG 105
           + A  Y ++ +  AT+ FS   IIG+G LG VY A    GK++A+K+I    +       
Sbjct: 378 ITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDN 437

Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           F   +  +S  +HPNIVP+ G+    G+R++V E++   +LD  LH N+D +  L WN R
Sbjct: 438 FLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNAR 497

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
           +++A G A+ LEYLH+   P+I+H   K++NILL+E+    + D GL+ L P  +R ++ 
Sbjct: 498 VKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTERQVST 557

Query: 226 YVDDDYWHEKG----GGNATRESDVYGFGVVLLEILSGRRC-------EEGLLVKWALPL 274
            V   + +        G  T +SDVY FGVV+LE+L+GR+         E  LV+WA P 
Sbjct: 558 QVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQ 617

Query: 275 IKEMR-FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           + ++   S+++DP L      K L R A +   C+    + RP + +V   L  LV
Sbjct: 618 LHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLV 673

Arabidopsis thaliana (taxid: 3702)

>sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1

 Score =  180 bits (457), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 119/302 (39%), Positives = 171/302 (56%), Gaps = 23/302 (7%)

Query: 49  FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFAS 108
           F+Y   E++ AT GFS    +G+G    V+  +L  G +VAVKR      +  +   F +
Sbjct: 493 FSY--EELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHN 550

Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG-ASLLDWNRRLR 167
            +  LS   H +++ +LG+ +   ER++V EF+   SL  +LH  +      L+W RR+ 
Sbjct: 551 ELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVT 610

Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK------- 220
           IA  AARG+EYLH    P +IH  IK+SNIL++E   ARV D+GLS L P +        
Sbjct: 611 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTPLSEL 670

Query: 221 -RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-----EEGLLVKWALPL 274
             G  GY+D +Y+        T +SDVY FGVVLLEILSGR+      EEG +V+WA+PL
Sbjct: 671 PAGTLGYLDPEYYRLH---YLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGNIVEWAVPL 727

Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN----LVG 330
           IK      +LDP L+ P +++ L ++A VA  CV    K+RPS+ +V T L +    L+G
Sbjct: 728 IKAGDIFAILDPVLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTALEHALALLMG 787

Query: 331 DP 332
            P
Sbjct: 788 SP 789

Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  179 bits (455), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 112/304 (36%), Positives = 164/304 (53%), Gaps = 25/304 (8%)

Query: 38   SEETLPIKLCAFAYPLT-----EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKR 92
            S E L I +  F  PL      +I  ATD FS + IIG G  GTVY A L   K VAVK+
Sbjct: 887  SREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKK 946

Query: 93   IHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE 152
            +       N  F   + ++TL   +HPN+V +LG+     E+++V E++   SLD +L  
Sbjct: 947  LSEAKTQGNREF--MAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRN 1004

Query: 153  NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
                  +LDW++RL+IA GAARGL +LH G  P+IIH  IKASNILL+  F  +V D+GL
Sbjct: 1005 QTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGL 1064

Query: 213  SFLAPEEKR-------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG------ 259
            + L    +        G  GY+  +Y        AT + DVY FGV+LLE+++G      
Sbjct: 1065 ARLISACESHVSTVIAGTFGYIPPEYGQS---ARATTKGDVYSFGVILLELVTGKEPTGP 1121

Query: 260  --RRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS 317
              +  E G LV WA+  I + +  +++DP L         +RL ++A+ C+  +   RP+
Sbjct: 1122 DFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPN 1181

Query: 318  IVQV 321
            ++ V
Sbjct: 1182 MLDV 1185

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  174 bits (441), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 108/317 (34%), Positives = 171/317 (53%), Gaps = 27/317 (8%)

Query: 32  KKKP------VESEETLPIKLCAFA-YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLST 84
           ++KP      V +EE   + L     + L E+  A+DGFS++ I+G+G  G VY   L+ 
Sbjct: 264 RRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLAD 323

Query: 85  GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA 144
           G LVAVKR+            F + ++ +S+A H N++ + GF   P ER++V  ++   
Sbjct: 324 GTLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 382

Query: 145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC 204
           S+   L E       LDW  R RIA G+ARGL YLH    P IIH  +KA+NILL+E+F 
Sbjct: 383 SVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 442

Query: 205 ARVCDYGLSFLAPEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL 257
           A V D+GL+ L   +        RG  G++  +Y      G ++ ++DV+G+G++LLE++
Sbjct: 443 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGIMLLELI 499

Query: 258 SGRRC---------EEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACV 308
           +G+R          ++ +L+ W   L+KE +   L+DP L    E + L ++ +VAL C 
Sbjct: 500 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCT 559

Query: 309 GNSRKNRPSIVQVATIL 325
             S   RP + +V  +L
Sbjct: 560 QGSPMERPKMSEVVRML 576

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  173 bits (439), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 110/324 (33%), Positives = 169/324 (52%), Gaps = 28/324 (8%)

Query: 31   CKKKPVESEETLPIKLCAFAYPLTEID-----AATDGFSHRRIIGQGRLGTVYAALLSTG 85
            C  K     E L I +  F  PL ++       AT+GFS   ++G G  G VY A L  G
Sbjct: 822  CSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDG 881

Query: 86   KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMAS 145
             +VA+K++    +       F + ++T+   +H N+VP+LG+ +   ER++V E++   S
Sbjct: 882  SVVAIKKL--IRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGS 939

Query: 146  LDFYLHENND--GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF 203
            L+  LHE +   G   L+W  R +IA GAARGL +LH    P+IIH  +K+SN+LL+E F
Sbjct: 940  LETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDF 999

Query: 204  CARVCDYGL--------SFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLE 255
             ARV D+G+        + L+     G  GYV  +Y+        T + DVY +GV+LLE
Sbjct: 1000 EARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSF---RCTAKGDVYSYGVILLE 1056

Query: 256  ILSGRR-------CEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK-PLVRLAKVALAC 307
            +LSG++        E+  LV WA  L +E R +E+LDP L         L    K+A  C
Sbjct: 1057 LLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQC 1116

Query: 308  VGNSRKNRPSIVQVATILNNLVGD 331
            + +    RP+++Q+  +   +  D
Sbjct: 1117 LDDRPFKRPTMIQLMAMFKEMKAD 1140

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	332
255536711	335	ATP binding protein, putative [Ricinus c	0.987	0.979	0.723	1e-140
359483498	377	PREDICTED: serine/threonine-protein kina	0.981	0.864	0.734	1e-139
356549280	336	PREDICTED: serine/threonine-protein kina	0.987	0.976	0.748	1e-138
147833459	796	hypothetical protein VITISV_029763 [Viti	0.981	0.409	0.734	1e-138
356548662	333	PREDICTED: serine/threonine-protein kina	0.984	0.981	0.695	1e-133
356521414	335	PREDICTED: serine/threonine-protein kina	0.984	0.976	0.690	1e-133
224125434	337	predicted protein [Populus trichocarpa]	0.984	0.970	0.710	1e-131
224079163	336	predicted protein [Populus trichocarpa]	0.984	0.973	0.697	1e-128
357446755	340	Receptor-like protein kinase BRI1-like p	0.987	0.964	0.670	1e-126
297740434	291	unnamed protein product [Vitis vinifera]	0.858	0.979	0.640	1e-113

>gi|255536711|ref|XP_002509422.1| ATP binding protein, putative [Ricinus communis] gi|223549321|gb|EEF50809.1| ATP binding protein, putative [Ricinus communis]

 Score =  504 bits (1297), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 238/329 (72%), Positives = 283/329 (86%), Gaps = 1/329 (0%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAAT 60
           M+  E IAYD +L++L++ L+IL +VLI  C+KKPVESEETL +K+ A  Y LT+IDAAT
Sbjct: 1   MNSAEQIAYDFILSLLAITLVILGLVLIFFCRKKPVESEETLSVKVSAPTYSLTDIDAAT 60

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           DGF+HRRI+G G LGTVYAA +L   +LVAVKRIHP LVLSN GFGF+S++KTLSLAQH 
Sbjct: 61  DGFNHRRIVGTGHLGTVYAAVILPRQQLVAVKRIHPSLVLSNPGFGFSSILKTLSLAQHS 120

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           NIVPILGFSQAPGERIIV+EF+ MASLDFYLHEN+DG SLLDW+RRLRI  GAA G++YL
Sbjct: 121 NIVPILGFSQAPGERIIVTEFVGMASLDFYLHENSDGGSLLDWSRRLRIGAGAASGMQYL 180

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN 239
           H+G+APN++HGC KASN+LL+ KFC RVCDYGL FLAP EKRGLAGYVDD+YW + GGG 
Sbjct: 181 HEGMAPNVVHGCFKASNVLLDVKFCPRVCDYGLYFLAPNEKRGLAGYVDDEYWSQTGGGG 240

Query: 240 ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVR 299
             + SDVYGFGVVLLE+L+GRR E GLLVKWALPLIKEM+FSELLDPRLA+P ++  ++R
Sbjct: 241 PCKASDVYGFGVVLLELLTGRRSEGGLLVKWALPLIKEMKFSELLDPRLALPSDMNQIIR 300

Query: 300 LAKVALACVGNSRKNRPSIVQVATILNNL 328
           L+KVA ACV NSRKNRP+IVQVA ILN+L
Sbjct: 301 LSKVASACVSNSRKNRPTIVQVAAILNSL 329

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483498|ref|XP_002278731.2| PREDICTED: serine/threonine-protein kinase-like protein ACR4 [Vitis vinifera]

 Score =  499 bits (1286), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 241/328 (73%), Positives = 285/328 (86%), Gaps = 2/328 (0%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAAT 60
           MS+ E I+Y  ++A+LS  ++IL ++L +LC+KKPVESEETLPIKLCA A PLT+IDAAT
Sbjct: 1   MSYGEGISYAVVMALLSTSIVILGVLLFILCRKKPVESEETLPIKLCAQACPLTDIDAAT 60

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           D F+HRRIIG+GRLGTVYAAL   G+LVAVKRIHP LVLSNA FGF+S++++LSLAQHPN
Sbjct: 61  DCFNHRRIIGKGRLGTVYAALSGRGELVAVKRIHPGLVLSNACFGFSSILRSLSLAQHPN 120

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           IV I+GFS+ PGERIIV EF  M SLDFYL +N+DGASLLDW RRLRIA GAARGLEYLH
Sbjct: 121 IVSIVGFSEGPGERIIVMEFAGMVSLDFYLQQNSDGASLLDWGRRLRIAAGAARGLEYLH 180

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
           +G+ P+I+HGCIKASNI+++ KFCARVCDYGLSFLAP EKRGL GYVDD+YW E+GG  A
Sbjct: 181 EGMTPHIVHGCIKASNIIIDVKFCARVCDYGLSFLAPHEKRGLVGYVDDEYWAERGG--A 238

Query: 241 TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL 300
           ++ESDVYGFGV+LLE+LSGRR +EGLLV+WALPLIKEM  S LLDPRL IP ++K L+RL
Sbjct: 239 SKESDVYGFGVMLLELLSGRRSDEGLLVEWALPLIKEMNISALLDPRLVIPSDMKHLIRL 298

Query: 301 AKVALACVGNSRKNRPSIVQVATILNNL 328
           AKVA ACVGNSRKNRPSI QV  IL++L
Sbjct: 299 AKVASACVGNSRKNRPSIAQVVAILSSL 326

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356549280|ref|XP_003543022.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Glycine max]

 Score =  498 bits (1283), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 247/330 (74%), Positives = 287/330 (86%), Gaps = 2/330 (0%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAAT 60
           M+H EHIAYD ++  LS+ LI+LAI+L + CKKKPVESEETLP+KLCA A+PL EIDAAT
Sbjct: 1   MNHVEHIAYDMVMITLSMSLIVLAIILFLACKKKPVESEETLPVKLCARAHPLMEIDAAT 60

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
           DGF+ RRIIGQGRLGTVYA  L   K  LVA+KRIHP LVLSNAGFGF+SV+K LSLAQH
Sbjct: 61  DGFNPRRIIGQGRLGTVYAGTLDKEKEQLVALKRIHPFLVLSNAGFGFSSVLKWLSLAQH 120

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PN+VPI+GFS+APGER+IV EF++MASLDFYLH+N DGASLLDWN+R RIA G ARGL+Y
Sbjct: 121 PNVVPIIGFSEAPGERVIVMEFVHMASLDFYLHQNQDGASLLDWNKRFRIAAGVARGLQY 180

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           LH+ VAPNI+HGC+K+SNIL++  FCAR+CDYGL+FLAP EKRG+ GYVDD+YW E+ GG
Sbjct: 181 LHEVVAPNIVHGCVKSSNILIDVNFCARICDYGLNFLAPVEKRGIVGYVDDEYWSERRGG 240

Query: 239 NATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV 298
            AT+ESDVYG GVVLLE+LSG+ CE GLLVKWALPLI+E  FSELLDPRL IP ++KPLV
Sbjct: 241 VATKESDVYGLGVVLLELLSGKGCEGGLLVKWALPLIRETSFSELLDPRLVIPSDMKPLV 300

Query: 299 RLAKVALACVGNSRKNRPSIVQVATILNNL 328
           RLAKV  ACVGNSRK RPS+ QVATILNNL
Sbjct: 301 RLAKVVSACVGNSRKCRPSVAQVATILNNL 330

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147833459|emb|CAN77470.1| hypothetical protein VITISV_029763 [Vitis vinifera]

 Score =  496 bits (1278), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 241/328 (73%), Positives = 285/328 (86%), Gaps = 2/328 (0%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAAT 60
           MS+ E I+Y  ++A+LS  ++IL ++L +LC+KKPVESEETLPIKLCA A PLT+IDAAT
Sbjct: 48  MSYGEGISYAVVMALLSTSIVILGVLLFILCRKKPVESEETLPIKLCAQACPLTDIDAAT 107

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           D F+HRRIIG+GRLGTVYAAL   G+LVAVKRIHP LVLSNA FGF+S++++LSLAQHPN
Sbjct: 108 DCFNHRRIIGKGRLGTVYAALSGRGELVAVKRIHPGLVLSNACFGFSSILRSLSLAQHPN 167

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           IV I+GFS+ PGERIIV EF  M SLDFYL +N+DGASLLDW RRLRIA GAARGLEYLH
Sbjct: 168 IVSIVGFSEGPGERIIVMEFAGMVSLDFYLQQNSDGASLLDWGRRLRIAAGAARGLEYLH 227

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
           +G+ P+I+HGCIKASNI+++ KFCARVCDYGLSFLAP EKRGL GYVDD+YW E+GG  A
Sbjct: 228 EGMTPHIVHGCIKASNIIIDVKFCARVCDYGLSFLAPHEKRGLVGYVDDEYWAERGG--A 285

Query: 241 TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL 300
           ++ESDVYGFGV+LLE+LSGRR +EGLLV+WALPLIKEM  S LLDPRL IP ++K L+RL
Sbjct: 286 SKESDVYGFGVMLLELLSGRRSDEGLLVEWALPLIKEMNISXLLDPRLVIPSDMKHLIRL 345

Query: 301 AKVALACVGNSRKNRPSIVQVATILNNL 328
           AKVA ACVGNSRKNRPSI QV  IL++L
Sbjct: 346 AKVASACVGNSRKNRPSIAQVVAILSSL 373

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356548662|ref|XP_003542719.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Glycine max]

 Score =  482 bits (1240), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 228/328 (69%), Positives = 275/328 (83%), Gaps = 1/328 (0%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAAT 60
           M+H  +IAYD ++  LS+   +LA+VL ++CKKKPVESEETL +K CA AY L +I AAT
Sbjct: 1   MNHGTYIAYDVVMVTLSISFFVLAVVLYLVCKKKPVESEETLAVKHCARAYSLMDIHAAT 60

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           DGF+H RI+G+GR+GTVYA +   G+LVAVKRIH  LVLSNAGFGF+SV+K LS AQHPN
Sbjct: 61  DGFNHSRILGKGRVGTVYAGVQENGELVAVKRIHSVLVLSNAGFGFSSVLKWLSSAQHPN 120

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           IV ILGFS+APGERIIV EF  M SLDFYLH+N +GASLLDWN+R+RIA+GAARG++YLH
Sbjct: 121 IVSILGFSEAPGERIIVMEFGRMVSLDFYLHQNVNGASLLDWNKRIRIASGAARGIQYLH 180

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
           +   PNI+HGC+K+SN+L++  FC R+CDYGL+FLAP EKRGL GYVDD+YW+E+GGG A
Sbjct: 181 EVATPNIVHGCVKSSNVLIDVNFCPRICDYGLNFLAPREKRGLVGYVDDEYWNEEGGG-A 239

Query: 241 TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL 300
            +ESDVYG GV++LE+LSGR CEEGL+ KWALPLIKE  F ELLD RL IP ++KPLVRL
Sbjct: 240 GKESDVYGLGVIMLELLSGRGCEEGLIAKWALPLIKETSFGELLDARLVIPSDMKPLVRL 299

Query: 301 AKVALACVGNSRKNRPSIVQVATILNNL 328
           AKVA ACVGNSRK RPSI QV TILNN+
Sbjct: 300 AKVASACVGNSRKCRPSIAQVTTILNNI 327

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356521414|ref|XP_003529351.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Glycine max]

 Score =  480 bits (1235), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 228/330 (69%), Positives = 275/330 (83%), Gaps = 3/330 (0%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPV--ESEETLPIKLCAFAYPLTEIDA 58
           M+H  +IAYD ++  LS+   +LA+VL ++CKKKPV  ESEETL +K C  AY L +IDA
Sbjct: 1   MNHDTYIAYDVVMVALSISFFVLAVVLYLVCKKKPVNVESEETLALKHCVRAYSLMDIDA 60

Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
           ATDGF H RI+G+GR+GTVYAA+   G+LVAVKRIH  LVLSNAGFGF+SV+K LS A H
Sbjct: 61  ATDGFDHSRIVGKGRVGTVYAAVQENGELVAVKRIHSVLVLSNAGFGFSSVLKWLSSAHH 120

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNIVPI+GFS+APGERIIV EF  M SLDFYLH+N +GASLLDWN+R+RI  GAARG++Y
Sbjct: 121 PNIVPIIGFSEAPGERIIVMEFGRMVSLDFYLHQNVNGASLLDWNKRIRIVAGAARGIQY 180

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           LH+   PNI+HGC+K+SN+L++  FC R+CDYGL+FLAP EKRGL G VDD+YW+E+GGG
Sbjct: 181 LHEVATPNIVHGCVKSSNVLIDVNFCTRICDYGLNFLAPREKRGLVGNVDDEYWNEEGGG 240

Query: 239 NATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV 298
            A++ESDVYG GVV+LE+LSGR CEEGL+ KWA+PLIKEM F ELLD RL IP ++KPLV
Sbjct: 241 -ASKESDVYGLGVVMLELLSGRGCEEGLIAKWAMPLIKEMSFGELLDARLVIPSDMKPLV 299

Query: 299 RLAKVALACVGNSRKNRPSIVQVATILNNL 328
           RLAKVALACVGNSRK RPSI QV TILNN+
Sbjct: 300 RLAKVALACVGNSRKCRPSIAQVTTILNNI 329

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125434|ref|XP_002329804.1| predicted protein [Populus trichocarpa] gi|222870866|gb|EEF07997.1| predicted protein [Populus trichocarpa]

 Score =  474 bits (1219), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 236/332 (71%), Positives = 281/332 (84%), Gaps = 5/332 (1%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKK-KPVESEETLPI-KLCAFAYPLTEIDA 58
           M   + +AY  +L++L+  ++IL +VL + C+K KP+ESEE+LP  K+ A  YPLT+ID 
Sbjct: 1   MKSSQEVAYYFILSLLAASVVILCLVLTIFCRKIKPIESEESLPAAKISAQGYPLTDIDD 60

Query: 59  ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           AT+GF+ RRIIG GRLGTVYAA+L S  K VAVKRIHP LVLSNAGFGF S++KTLS A+
Sbjct: 61  ATEGFNRRRIIGTGRLGTVYAAVLPSDQKPVAVKRIHPSLVLSNAGFGFTSILKTLSSAR 120

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGAS-LLDWNRRLRIATGAARGL 176
           HPNIVPILGFSQAPGERIIV EF++  SLD+YLHEN+DGAS LLDW+RRL IA GAARGL
Sbjct: 121 HPNIVPILGFSQAPGERIIVMEFVSAVSLDYYLHENSDGASSLLDWSRRLSIAAGAARGL 180

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG 236
           EYLH+G+APNI+HGC KASN+LL++K CARV DYGLS LAP EKRGLAGYVDD++W   G
Sbjct: 181 EYLHEGMAPNIVHGCFKASNVLLDDKLCARVSDYGLSSLAPYEKRGLAGYVDDEHWR-NG 239

Query: 237 GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP 296
            G A +E DVYGFGVVLLE+LSGRR EEGLLV+WALPLIK+MRFSELLD RL +P +++P
Sbjct: 240 RGEACKEGDVYGFGVVLLELLSGRRAEEGLLVRWALPLIKQMRFSELLDLRLVMPSDMRP 299

Query: 297 LVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           L+RLAKVA ACV NSRK+RP+IVQVATILNNL
Sbjct: 300 LIRLAKVASACVSNSRKSRPTIVQVATILNNL 331

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224079163|ref|XP_002305775.1| predicted protein [Populus trichocarpa] gi|222848739|gb|EEE86286.1| predicted protein [Populus trichocarpa]

 Score =  464 bits (1193), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 231/331 (69%), Positives = 277/331 (83%), Gaps = 4/331 (1%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPI-KLCAFAYPLTEIDAA 59
           M   + IAY  +L++L+ F++IL +VLI  C+KKPVESEE+LP  ++ A  YP T+IDAA
Sbjct: 1   MKPSQEIAYYFMLSLLAAFVVILCLVLIFFCRKKPVESEESLPAARISAQWYPSTDIDAA 60

Query: 60  TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
           TDGF+HRRIIG GRLGTVYAA+L S  K VAVKRIHP LVLSNA FGF+S++KTLS+AQH
Sbjct: 61  TDGFNHRRIIGTGRLGTVYAAVLPSDQKPVAVKRIHPSLVLSNACFGFSSMVKTLSMAQH 120

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGAS-LLDWNRRLRIATGAARGLE 177
           PN+VPILGFSQAPGERIIV EF++  SL++YLHEN+DGAS +LDW+ RLRIA GAARGLE
Sbjct: 121 PNVVPILGFSQAPGERIIVMEFVSAVSLNYYLHENSDGASSVLDWSWRLRIAAGAARGLE 180

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           YLH G+APNI+HGC KASN+LL++K CARV DYGLS L   EKRGL GYVDD++W   G 
Sbjct: 181 YLHGGMAPNIVHGCFKASNVLLDDKLCARVSDYGLSSLVANEKRGLVGYVDDEFW-SNGR 239

Query: 238 GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL 297
           G A +ESDVYGFGVVLLE+L+GRR EEGLLV+WALPLIKEMR SELLD RLA P + + +
Sbjct: 240 GEACKESDVYGFGVVLLELLTGRRAEEGLLVRWALPLIKEMRLSELLDLRLAKPSDTRAI 299

Query: 298 VRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           +RLAKVA ACV NSRK+RP++ QVATIL+NL
Sbjct: 300 IRLAKVASACVNNSRKSRPTMFQVATILSNL 330

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357446755|ref|XP_003593653.1| Receptor-like protein kinase BRI1-like protein [Medicago truncatula] gi|124360742|gb|ABN08719.1| Protein kinase [Medicago truncatula] gi|355482701|gb|AES63904.1| Receptor-like protein kinase BRI1-like protein [Medicago truncatula]

 Score =  458 bits (1179), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 222/331 (67%), Positives = 270/331 (81%), Gaps = 3/331 (0%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAAT 60
           M+  EHIAYD ++AILS+ LIIL I L   CKKKPVESEETLP+K  A  YPLT ID AT
Sbjct: 1   MNLGEHIAYDTVMAILSISLIILGIFLFFSCKKKPVESEETLPVKQIALLYPLTVIDIAT 60

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           +GF+HRRIIG+GRLGTVYA  L   +LVAVKRIH  LVLSNAGFGF+SV+K LSL+QHPN
Sbjct: 61  NGFNHRRIIGKGRLGTVYAGKLENEELVAVKRIHSVLVLSNAGFGFSSVMKWLSLSQHPN 120

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG--ASLLDWNRRLRIATGAARGLEY 178
           +VPI+GFS+APGER+I+ EF+ MA+L+FYLHEN DG  +SLLDWN+R +IA G A+GL+Y
Sbjct: 121 VVPIIGFSEAPGERVILMEFVRMANLEFYLHENQDGGSSSLLDWNKRFKIAAGVAKGLQY 180

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-GG 237
           LH+ VAPNI+HGC+K+SN+L++  FCA++ DYGLSFL   EKRGL GYVDD+YW+E   G
Sbjct: 181 LHEVVAPNIVHGCVKSSNVLIDVNFCAKISDYGLSFLGGVEKRGLVGYVDDEYWNEGIRG 240

Query: 238 GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL 297
           G+  +E+DVYG GV+LLE+LSGR CE GLLVKW LPLIK+MRFSE+LDPRL IP  +  +
Sbjct: 241 GSVCKENDVYGLGVILLELLSGRGCEGGLLVKWVLPLIKDMRFSEVLDPRLIIPSNMNAI 300

Query: 298 VRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           +RLAKVA ACVGN RK RP +  V  ILN+L
Sbjct: 301 IRLAKVASACVGNPRKCRPCVNHVMNILNDL 331

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740434|emb|CBI30616.3| unnamed protein product [Vitis vinifera]

 Score =  415 bits (1067), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 210/328 (64%), Positives = 246/328 (75%), Gaps = 43/328 (13%)

Query: 1   MSHFEHIAYDCLLAILSLFLIILAIVLIVLCKKKPVESEETLPIKLCAFAYPLTEIDAAT 60
           MS+ E I+Y  ++A+LS  ++IL ++L +LC+KKPVESEETLPIKLCA A PLT+IDAAT
Sbjct: 1   MSYGEGISYAVVMALLSTSIVILGVLLFILCRKKPVESEETLPIKLCAQACPLTDIDAAT 60

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           D F+HRRIIG+GRLGTVYAAL   G+LVAVKRIHP LVLSNA FGF+S++++LSLAQHPN
Sbjct: 61  DCFNHRRIIGKGRLGTVYAALSGRGELVAVKRIHPGLVLSNACFGFSSILRSLSLAQHPN 120

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           IV I+GFS+ PGERIIV EF  M SLDFYL +N+DGASLLDW RRLRIA GAARGLEYLH
Sbjct: 121 IVSIVGFSEGPGERIIVMEFAGMVSLDFYLQQNSDGASLLDWGRRLRIAAGAARGLEYLH 180

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
           +G+ P+I+HGCIKASNI+++ KFCARVCDYGLSFLAP EKRGL GY              
Sbjct: 181 EGMTPHIVHGCIKASNIIIDVKFCARVCDYGLSFLAPHEKRGLVGY-------------- 226

Query: 241 TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL 300
                                        WALPLIKEM  S LLDPRL IP ++K L+RL
Sbjct: 227 -----------------------------WALPLIKEMNISALLDPRLVIPSDMKHLIRL 257

Query: 301 AKVALACVGNSRKNRPSIVQVATILNNL 328
           AKVA ACVGNSRKNRPSI QV  IL++L
Sbjct: 258 AKVASACVGNSRKNRPSIAQVVAILSSL 285

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	332
TAIR|locus:2161373	332	AT5G46080 [Arabidopsis thalian	0.960	0.960	0.553	1.6e-88
TAIR|locus:2081227	895	CR4 "crinkly4" [Arabidopsis th	0.840	0.311	0.413	8.2e-47
TAIR|locus:2036818	389	AT1G61860 [Arabidopsis thalian	0.882	0.753	0.388	4.4e-45
UNIPROTKB|O24585	901	CR4 "Putative receptor protein	0.867	0.319	0.391	1.6e-44
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.798	0.262	0.383	1e-43
TAIR|locus:2120683	703	SRF8 "STRUBBELIG-receptor fami	0.852	0.402	0.350	5.5e-42
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.861	0.239	0.369	6e-42
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.855	0.243	0.361	7.4e-42
TAIR|locus:2162296	359	AT5G42440 [Arabidopsis thalian	0.840	0.777	0.362	5.9e-41
TAIR|locus:2183835	433	AT5G11020 [Arabidopsis thalian	0.807	0.618	0.372	1.2e-40

TAIR|locus:2161373 AT5G46080 [Arabidopsis thaliana (taxid:3702)]

 Score = 884 (316.2 bits), Expect = 1.6e-88, P = 1.6e-88
 Identities = 186/336 (55%), Positives = 234/336 (69%)

Query:     1 MSHFEHIAYDCXXXXXXXXXXXXXXXXXXXCKKKPVESEET--LP-IKLCAFAYPLTEID 57
             M   E IAY                     C+KKP  S++   LP  K    +Y LTE+D
Sbjct:     1 MDKSEKIAYASVLSLLSLSLLLLIIFLFLLCRKKPNRSDDEYLLPETKPAGLSYSLTELD 60

Query:    58 AATDGFSHRRIIGQGRLGTVYAALLSTGK-LVAVKRIHPRLVLSNAGFGFASVIKTLSLA 116
             +ATDGF+ RRIIG GRLGTVYAA++   K LVAVKRIHP LVLS  GFGF++VIK+LS +
Sbjct:    61 SATDGFNQRRIIGSGRLGTVYAAIIPDHKNLVAVKRIHPGLVLSKPGFGFSTVIKSLSSS 120

Query:   117 QHPNIVPILGFSQAPGERIIVSEFINMA-SLDFYLHENNDGASLLD--WNRRLRIATGAA 173
              HPN+V ILGFS+APGERI+V+EF+    SL  +LH  ++ A+ ++  W  R +IA GAA
Sbjct:   121 HHPNVVSILGFSEAPGERIVVTEFVGEGKSLSDHLHGGSNSATAVEFGWKTRFKIAAGAA 180

Query:   174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
             RGLEYLH+   P I+HG   +SN+L++EK  A++CDYG  FL P EK G+ GY+++ Y  
Sbjct:   181 RGLEYLHEIANPRIVHGRFTSSNVLVDEKSTAKICDYGFGFLIPIEKSGIFGYIEEGY-- 238

Query:   234 EKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE 293
                     +ESDVYG+GVVL+EILSGRR E GL+VKWA PLIKE RF+ELLDPR+ +  E
Sbjct:   239 -------CKESDVYGYGVVLMEILSGRRSENGLIVKWATPLIKEQRFAELLDPRIVVQSE 291

Query:   294 IKPLV-RLAKVALACVGNSRKNRPSIVQVATILNNL 328
             IK LV RLAKVALACVGNSR++RPSI +VA ILN+L
Sbjct:   292 IKSLVIRLAKVALACVGNSRRSRPSISEVAAILNSL 327

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)]

 Score = 498 (180.4 bits), Expect = 8.2e-47, P = 8.2e-47
 Identities = 125/302 (41%), Positives = 168/302 (55%)

Query:    49 FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFAS 108
             F Y   E++ A DGF    I+G+G    VY  +L  G  VAVKR             F +
Sbjct:   500 FTYE--ELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFRT 557

Query:   109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGAS-LLDWNRRLR 167
              +  LS   H +++ +LG+ +  GER++V EF+   SL  +LH  N      LDW +R+ 
Sbjct:   558 ELDLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVT 617

Query:   168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP--------EE 219
             IA  AARG+EYLH    P +IH  IK+SNIL++E+  ARV D+GLS L P        E 
Sbjct:   618 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSPLAEL 677

Query:   220 KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-----EEGLLVKWALPL 274
               G  GY+D +Y+        T +SDVY FGV+LLEILSGR+      EEG +V+WA+PL
Sbjct:   678 PAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVPL 734

Query:   275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN----LVG 330
             IK    + LLDP L  P EI+ L R+  VA  CV    K+RPS+ +V T L      L+G
Sbjct:   735 IKAGDINALLDPVLKHPSEIEALKRIVSVACKCVRMRGKDRPSMDKVTTALERALAQLMG 794

Query:   331 DP 332
             +P
Sbjct:   795 NP 796

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0009986 "cell surface" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030139 "endocytic vesicle" evidence=IDA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0009786 "regulation of asymmetric cell division" evidence=IMP

GO:0010311 "lateral root formation" evidence=IMP

GO:0048829 "root cap development" evidence=IMP

GO:0000280 "nuclear division" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007000 "nucleolus organization" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0009640 "photomorphogenesis" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009845 "seed germination" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009933 "meristem structural organization" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010182 "sugar mediated signaling pathway" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0016567 "protein ubiquitination" evidence=RCA

GO:0019915 "lipid storage" evidence=RCA

GO:0048825 "cotyledon development" evidence=RCA

GO:0050826 "response to freezing" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)]

 Score = 474 (171.9 bits), Expect = 4.4e-45, P = 4.4e-45
 Identities = 123/317 (38%), Positives = 176/317 (55%)

Query:    31 CKKKPVESE--ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKL 87
             C++K +  E  +   +K C   +   E+ AATD FS   +IG+G  G VY   L S  ++
Sbjct:    51 CRQKYITEEIKKYGNVKNCGRIFKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQV 110

Query:    88 VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD 147
             VAVKR+    +     F FA V+  LSLAQHPN+V ++G+     +R++V EF+   SL+
Sbjct:   111 VAVKRLDRNGLQGTREF-FAEVM-VLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLE 168

Query:   148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
              +L +  +G+  LDW  R+RI  GAA+GLEYLH    P +I+   KASNILL   F +++
Sbjct:   169 DHLFDLPEGSPSLDWFTRMRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKL 228

Query:   208 CDYGLSFLAPEEKR--------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
              D+GL+ L P E +        G  GY   +Y      G  T +SDVY FGVVLLEI+SG
Sbjct:   229 SDFGLARLGPTEGKDHVSTRVMGTYGYCAPEYAMT---GQLTAKSDVYSFGVVLLEIISG 285

Query:   260 RRC-------EEGLLVKWALPLIKEMR-FSELLDPRLAIPCEIKPLVRLAKVALACVGNS 311
             RR        EE  L+ WA PL+K+ R F++++DP L     +K L +   +A  C+   
Sbjct:   286 RRAIDGDRPTEEQNLISWAEPLLKDRRMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEE 345

Query:   312 RKNRPSIVQVATILNNL 328
              + RP +  V T L  L
Sbjct:   346 AETRPLMGDVVTALEFL 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)]

 Score = 477 (173.0 bits), Expect = 1.6e-44, P = 1.6e-44
 Identities = 122/312 (39%), Positives = 175/312 (56%)

Query:    40 ETLPIKLCA-FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLV 98
             E L I+    F+Y   E++ AT GFS    +G+G    V+  +L  G +VAVKR      
Sbjct:   483 EDLKIRRAQEFSYE--ELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASD 540

Query:    99 LSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGAS 158
             +  +   F + +  LS   H +++ +LG+ +   ER++V EF+   SL  +LH  +    
Sbjct:   541 VKKSSKEFHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLK 600

Query:   159 L-LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP 217
               L+W RR+ IA  AARG+EYLH    P +IH  IK+SNIL++E   ARV D+GLS L P
Sbjct:   601 KRLNWARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGP 660

Query:   218 EEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-----EE 264
              +          G  GY+D +Y+        T +SDVY FGVVLLEILSGR+      EE
Sbjct:   661 ADSGTPLSELPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVVLLEILSGRKAIDMQFEE 717

Query:   265 GLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI 324
             G +V+WA+PLIK      +LDP L+ P +++ L ++A VA  CV    K+RPS+ +V T 
Sbjct:   718 GNIVEWAVPLIKAGDIFAILDPVLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTA 777

Query:   325 LNN----LVGDP 332
             L +    L+G P
Sbjct:   778 LEHALALLMGSP 789

GO:0042803 "protein homodimerization activity" evidence=IDA

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 471 (170.9 bits), Expect = 1.0e-43, P = 1.0e-43
 Identities = 109/284 (38%), Positives = 165/284 (58%)

Query:    59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
             +T+ F    IIG G  G VY A L  GK VA+K++            F + ++TLS AQH
Sbjct:   730 STNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDC--GQIEREFEAEVETLSRAQH 787

Query:   119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
             PN+V + GF     +R+++  ++   SLD++LHE NDG +LL W  RLRIA GAA+GL Y
Sbjct:   788 PNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLY 847

Query:   179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------GLAGYVDDDY 231
             LH+G  P+I+H  IK+SNILL+E F + + D+GL+  ++P E        G  GY+  +Y
Sbjct:   848 LHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEY 907

Query:   232 WHEKGGGNATRESDVYGFGVVLLEILSGRR----CE-EGL--LVKWALPLIKEMRFSELL 284
                     AT + DVY FGVVLLE+L+ +R    C+ +G   L+ W + +  E R SE+ 
Sbjct:   908 GQ---ASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHESRASEVF 964

Query:   285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             DP +      K + R+ ++A  C+  + K RP+  Q+ + L+++
Sbjct:   965 DPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 449 (163.1 bits), Expect = 5.5e-42, P = 5.5e-42
 Identities = 104/297 (35%), Positives = 163/297 (54%)

Query:    46 LCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFG 105
             + A  Y ++ +  AT+ FS   IIG+G LG VY A    GK++A+K+I    +       
Sbjct:   378 ITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDN 437

Query:   106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
             F   +  +S  +HPNIVP+ G+    G+R++V E++   +LD  LH N+D +  L WN R
Sbjct:   438 FLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNAR 497

Query:   166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
             +++A G A+ LEYLH+   P+I+H   K++NILL+E+    + D GL+ L P  +R ++ 
Sbjct:   498 VKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTERQVST 557

Query:   226 YVDDDYWHEKG----GGNATRESDVYGFGVVLLEILSGR--------RCEEGLLVKWALP 273
              V   + +        G  T +SDVY FGVV+LE+L+GR        R E+ L V+WA P
Sbjct:   558 QVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSL-VRWATP 616

Query:   274 LIKEM-RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
              + ++   S+++DP L      K L R A +   C+    + RP + +V   L  LV
Sbjct:   617 QLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLV 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009624 "response to nematode" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 456 (165.6 bits), Expect = 6.0e-42, P = 6.0e-42
 Identities = 115/311 (36%), Positives = 168/311 (54%)

Query:    38 SEETLPIKLCAFAYPLTEI---DA--ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKR 92
             S E L I +  F  PL ++   D   ATD FS + IIG G  GTVY A L   K VAVK+
Sbjct:   887 SREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKK 946

Query:    93 IHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE 152
             +       N  F   + ++TL   +HPN+V +LG+     E+++V E++   SLD +L  
Sbjct:   947 LSEAKTQGNREF--MAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRN 1004

Query:   153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
                   +LDW++RL+IA GAARGL +LH G  P+IIH  IKASNILL+  F  +V D+GL
Sbjct:  1005 QTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGL 1064

Query:   213 SFL--APEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR---- 261
             + L  A E        G  GY+  +Y        AT + DVY FGV+LLE+++G+     
Sbjct:  1065 ARLISACESHVSTVIAGTFGYIPPEYGQS---ARATTKGDVYSFGVILLELVTGKEPTGP 1121

Query:   262 ----CEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS 317
                  E G LV WA+  I + +  +++DP L         +RL ++A+ C+  +   RP+
Sbjct:  1122 DFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPN 1181

Query:   318 IVQVATILNNL 328
             ++ V   L  +
Sbjct:  1182 MLDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 455 (165.2 bits), Expect = 7.4e-42, P = 7.4e-42
 Identities = 113/313 (36%), Positives = 173/313 (55%)

Query:    40 ETLPIKLCAFAYPLTEID-----AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIH 94
             E L I +  F  PL ++       AT+GFS   +IG G  G VY A L+ G +VA+K++ 
Sbjct:   830 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLI 889

Query:    95 PRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENN 154
                V       F + ++T+   +H N+VP+LG+ +   ER++V E++   SL+  LHE  
Sbjct:   890 Q--VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKT 947

Query:   155 D-GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               G   LDW+ R +IA GAARGL +LH    P+IIH  +K+SN+LL++ F ARV D+G++
Sbjct:   948 KKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMA 1007

Query:   214 --------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC--- 262
                      L+     G  GYV  +Y+        T + DVY +GV+LLE+LSG++    
Sbjct:  1008 RLVSALDTHLSVSTLAGTPGYVPPEYYQSF---RCTAKGDVYSYGVILLELLSGKKPIDP 1064

Query:   263 ----EEGLLVKWALPLIKEMRFSELLDPRLAIPC--EIKPLVRLAKVALACVGNSRKNRP 316
                 E+  LV WA  L +E R +E+LDP L      +++ L+   K+A  C+ +    RP
Sbjct:  1065 EEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVE-LLHYLKIASQCLDDRPFKRP 1123

Query:   317 SIVQVATILNNLV 329
             +++QV T+   LV
Sbjct:  1124 TMIQVMTMFKELV 1136

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2162296 AT5G42440 [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 5.9e-41, P = 5.9e-41
 Identities = 111/306 (36%), Positives = 169/306 (55%)

Query:    40 ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRI-HPRLV 98
             E+    +C  +  + E+  AT  FS   I+G G  G VY A LS G +VAVK++ H  L 
Sbjct:    60 ESFDPSICEIS--MAELTIATKNFSSDLIVGDGSFGLVYRAQLSNGVVVAVKKLDHDAL- 116

Query:    99 LSNAGFG-FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGA 157
                 GF  FA+ + TL    HPNIV ILG+  +  +RI++ EF+  +SLD++LHE ++  
Sbjct:   117 ---QGFREFAAEMDTLGRLNHPNIVRILGYCISGSDRILIYEFLEKSSLDYWLHETDEEN 173

Query:   158 SLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP 217
             S L W+ R+ I    A+GL YLH G+   IIH  IK+SN+LL+  F A + D+GL+    
Sbjct:   174 SPLTWSTRVNITRDVAKGLAYLH-GLPKPIIHRDIKSSNVLLDSDFVAHIADFGLARRID 232

Query:   218 EEKR-------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-------- 262
               +        G  GY+  +YW  +G   AT ++DVY FGV++LE+ + RR         
Sbjct:   233 ASRSHVSTQVAGTMGYMPPEYW--EGNTAATVKADVYSFGVLMLELATRRRPNLTVVVDE 290

Query:   263 EEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA 322
             +E  L +WA+ ++++ R  E+LD       E K +    ++A  C+  S + RP++VQV 
Sbjct:   291 KEVGLAQWAVIMVEQNRCYEMLDFGGVCGSE-KGVEEYFRIACLCIKESTRERPTMVQVV 349

Query:   323 TILNNL 328
              +L  L
Sbjct:   350 ELLEEL 355

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)]

 Score = 432 (157.1 bits), Expect = 1.2e-40, P = 1.2e-40
 Identities = 107/287 (37%), Positives = 156/287 (54%)

Query:    56 IDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL 115
             ++  T GF    I+GQG  G VY+A L      AVK++       +A   F S ++ LS 
Sbjct:   134 LEEGTSGFKESNILGQGGFGCVYSATLENNISAAVKKLD--CANEDAAKEFKSEVEILSK 191

Query:   116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
              QHPNI+ +LG+S     R IV E +   SL+ +LH ++ G S + W  R++IA    RG
Sbjct:   192 LQHPNIISLLGYSTNDTARFIVYELMPNVSLESHLHGSSQG-SAITWPMRMKIALDVTRG 250

Query:   176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL-APEEKR----GLAGYVDDD 230
             LEYLH+   P IIH  +K+SNILL+  F A++ D+GL+ +  P+ K     G  GYV  +
Sbjct:   251 LEYLHEHCHPAIIHRDLKSSNILLDSNFNAKISDFGLAVVDGPKNKNHKLSGTVGYVAPE 310

Query:   231 YWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL-------LVKWALPLIKEM-RFSE 282
             Y      G  T +SDVY FGVVLLE+L G++  E L       ++ WA+P + +  +   
Sbjct:   311 YLLN---GQLTEKSDVYAFGVVLLELLLGKKPVEKLAPGECQSIITWAMPYLTDRTKLPS 367

Query:   283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
             ++DP +    ++K L ++A VA+ CV      RP I  V   L  LV
Sbjct:   368 VIDPAIKDTMDLKHLYQVAAVAILCVQPEPSYRPLITDVLHSLIPLV 414

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00003043001 SubName- Full=Chromosome chr10 scaffold_138, whole genome shotgun sequence; (332 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	332
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-35
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-25
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-14
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-09
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-09
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-07
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-06
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-06
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-06
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-05
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-05
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-05
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-05
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-04
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.001
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	0.001
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.001
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.001
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.002
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.002
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	0.002
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.002
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.002
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.002
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.003
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	0.003
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	0.003
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	0.003
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	0.003
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	0.003
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  126 bits (318), Expect = 7e-35
 Identities = 65/194 (33%), Positives = 87/194 (44%), Gaps = 13/194 (6%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G+G  GTVY A    TGK VA+K I      S         I+ L    HPNIV + G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
            +      +V E+    SL   L EN      L  +  LRI      GLEYLH      I
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GI 113

Query: 188 IHGCIKASNILLNEK-FCARVCDYGLSFLAPEEKRGLAGYVDDDYWH--E--KGGGNATR 242
           IH  +K  NILL+      ++ D+GLS L   +K  L   V    +   E   G G  + 
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 243 ESDVYGFGVVLLEI 256
           +SD++  GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  114 bits (287), Expect = 7e-30
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           R +G G  GTVY A    TGK+VAVK +  R   S         I+ L    HPNIV ++
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +      +V E+     L  YL         L  +   +IA    RGLEYLH   + 
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLH---SN 117

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH--E--KGGGNAT 241
            IIH  +K  NILL+E    ++ D+GL+    +    L  +V   ++   E   GG    
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 242 RESDVYGFGVVLLEILSGR 260
            + DV+  GV+L E+L+G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 5e-28
 Identities = 58/219 (26%), Positives = 85/219 (38%), Gaps = 44/219 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFG----FASVIKTLSLAQH 118
           + +G+G  G VY   L         VAVK +       +A       F    + +    H
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-----EDASEEERKDFLKEARVMKKLGH 55

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGA-----SLLDWNRRLRIATGAA 173
           PN+V +LG         +V E++    L  YL ++         S L     L  A   A
Sbjct: 56  PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
           +G+EYL        +H  + A N L+ E    ++ D+GLS            Y DD Y  
Sbjct: 116 KGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD---------VYDDDYYRK 163

Query: 234 EKGG--------------GNATRESDVYGFGVVLLEILS 258
           + GG              G  T +SDV+ FGV+L EI +
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  108 bits (272), Expect = 1e-27
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 51/220 (23%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHP----RLVLSNAGFGF---ASVIKTLS 114
           + +G+G  G VY   L      T   VAVK +                F   AS++K L 
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-----FLEEASIMKKL- 58

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +LG         IV+E++    L  +L ++ +    L     L++A   A+
Sbjct: 59  --SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAK 113

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           G+EYL      N +H  + A N L+ E    ++ D+GLS       R +    +DDY+ +
Sbjct: 114 GMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLS-------RDIY---EDDYYRK 160

Query: 235 KGGGNA---------------TRESDVYGFGVVLLEILSG 259
           +GGG                 T +SDV+ FGV+L EI + 
Sbjct: 161 RGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  103 bits (260), Expect = 6e-26
 Identities = 81/279 (29%), Positives = 113/279 (40%), Gaps = 45/279 (16%)

Query: 67  RIIGQGRLGTVYAALLS-----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           + +G+G  G VY   L          VAVK +            F    + +    HPNI
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPNI 63

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           V +LG        +IV E++    L  YL +N      L  +  L  A   ARG+EYL  
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES 121

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---- 237
               N IH  + A N L+ E    ++ D+GLS       R L    DDDY+  KGG    
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLS-------RDLY---DDDYYKVKGGKLPI 168

Query: 238 ----------GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP 286
                     G  T +SDV+ FGV+L EI + G     G+     L  +K+         
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY------- 221

Query: 287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL 325
           RL  P    P   L K+ L C     ++RP+  ++  IL
Sbjct: 222 RLPKP-PNCPP-ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  102 bits (256), Expect = 2e-25
 Identities = 80/280 (28%), Positives = 112/280 (40%), Gaps = 48/280 (17%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           + +G+G  G VY   L          VAVK +            F    + +    HPN+
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPNV 63

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           V +LG         IV E++    L  YL +N    SL D    L  A   ARG+EYL  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSD---LLSFALQIARGMEYLES 120

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA- 240
               N IH  + A N L+ E    ++ D+GLS       R L    DDDY + K GG   
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLS-------RDLY---DDDY-YRKRGGKLP 166

Query: 241 --------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD 285
                         T +SDV+ FGV+L EI + G +   G+  +  L  +K         
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY------ 220

Query: 286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL 325
            RL  P    P   L  + L C     ++RP+  ++  IL
Sbjct: 221 -RLPQP-PNCPP-ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  101 bits (253), Expect = 5e-25
 Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 41/212 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G+G  G VY A    TGKLVA+K I  + +  +        IK L   +HPNIV + 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIVRLY 63

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +   +  +V E+     L   L +       L  +            LEYLH     
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHS---K 116

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLS-----------------FLAPEEKRGLAGYVD 228
            I+H  +K  NILL+E    ++ D+GL+                 ++APE   G  GY  
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGK-GY-- 173

Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                        +  D++  GV+L E+L+G+
Sbjct: 174 ------------GKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 63/227 (27%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
            ++G+G  G+VY AL   TG+L+AVK +    +  ++     ++   I+ LS  QHPNIV
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIV 62

Query: 123 PILGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA------R 174
              G  +   +    I  E+++  SL          +SLL    +L              
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSL----------SSLLKKFGKLPEPVIRKYTRQILE 112

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------------------F 214
           GL YLH      I+H  IK +NIL++     ++ D+G +                    +
Sbjct: 113 GLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 215 LAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
           +APE  R               G    R +D++  G  ++E+ +G+ 
Sbjct: 170 MAPEVIR---------------GEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 73/299 (24%), Positives = 123/299 (41%), Gaps = 60/299 (20%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           + +G+G  G V          +TG+ VAVK ++           F   I+ L    H NI
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRTLDHENI 68

Query: 122 VPILGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           V   G  + PG R   ++ E++   SL  YL  + D    ++  R L  ++   +G++YL
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYL 125

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN 239
               +   IH  + A NIL+  +   ++ D+GL+ + PE         D DY++ K  G 
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE---------DKDYYYVKEPGE 173

Query: 240 A---------------TRESDVYGFGVVLLEILSGRRCEE-----GLLVKWALPLIKEM- 278
           +               +  SDV+ FGV L E+ +    +         ++       +M 
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT--YGDPSQSPPAEFLRMIGIAQGQMI 231

Query: 279 --RFSELLDP--RL----AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
             R  ELL    RL    + P E+  L++L      C     ++RPS   +  I++ L 
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKL------CWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 94.0 bits (232), Expect = 1e-21
 Identities = 79/278 (28%), Positives = 114/278 (41%), Gaps = 26/278 (9%)

Query: 62  GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL-SNAGFGFASVIKTL-SLAQHP 119
            +   R +G+G  G VY A     KLVA+K +  +L   S     F   I+ L SL   P
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           NIV +  F Q  G   +V E+++  SL+  L +      L + +  L I       LEYL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE-SEALFILAQILSALEYL 117

Query: 180 HQGVAPNIIHGCIKASNILLNEK-FCARVCDYGLSFLAPEEK------------RGLAGY 226
           H      IIH  IK  NILL+      ++ D+GL+ L P+               G  GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP 286
           +  +         A+  SD++  G+ L E+L+G    EG     A     ++   EL  P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI-ILELPTP 233

Query: 287 RLAIPCEIKPLVRLAKVA----LACVGNSRKNRPSIVQ 320
            LA P        ++K A       +    KNR S   
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 43/211 (20%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPR------LVLSNAGFGFASVIKTLSLAQHPNI 121
           IG+G  G VY A    TGK VA+K I          +++         I+ L   +HPNI
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINE--------IQILKKCKHPNI 59

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD-WNRRLR------IATGAAR 174
           V   G      E  IV EF +  SL            LL   N+ L       +     +
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSL----------KDLLKSTNQTLTESQIAYVCKELLK 109

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR----GLAGYVDD 229
           GLEYLH   +  IIH  IKA+NILL      ++ D+GLS  L+  + R    G   ++  
Sbjct: 110 GLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166

Query: 230 DYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           +  + K        +D++  G+  +E+  G+
Sbjct: 167 EVINGKPYDYK---ADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 8e-18
 Identities = 76/285 (26%), Positives = 118/285 (41%), Gaps = 50/285 (17%)

Query: 67  RIIGQGRLGTVYAALLS-TGK---LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           ++IG G  G V    L   GK    VA+K +            F +    +    HPNI+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNII 68

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            + G        +I++E++   SLD +L EN DG       + + +  G A G++YL + 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLREN-DGK--FTVGQLVGMLRGIASGMKYLSE- 124

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG----- 237
              N +H  + A NIL+N     +V D+GLS       R L    +  Y   KGG     
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLS-------RRL-EDSEATY-TTKGGKIPIR 173

Query: 238 ---------GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP---LIKEMRFSELL 284
                       T  SDV+ FG+V+ E++S G R        W +    +IK +     L
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER------PYWDMSNQDVIKAVEDGYRL 227

Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
            P +  P     L +L    L C    R  RP+  Q+ + L+ ++
Sbjct: 228 PPPMDCP---SALYQL---MLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 62/196 (31%), Positives = 92/196 (46%), Gaps = 16/196 (8%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+G  G V       G+ VAVK +      + A    ASV+ TL   +HPN+V +LG  
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL---RHPNLVQLLGVV 69

Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  IV+E++   SL  YL     G +++   ++L  A     G+EYL      N +
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---GNATRESD 245
           H  + A N+L++E   A+V D+G   LA E  +G         W           + +SD
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFG---LAKEASQGQDSGKLPVKWTAPEALREKKFSTKSD 181

Query: 246 VYGFGVVLLEILS-GR 260
           V+ FG++L EI S GR
Sbjct: 182 VWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 58/199 (29%), Positives = 88/199 (44%), Gaps = 15/199 (7%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +IG+G  G VY  L L TG  VA+K+I    +   A       I  L   +HPNIV  +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENND-GASLLDWNRRLRIATGAARGLEYLH-QGVA 184
             +      I+ E+    SL   + +      SL+             +GL YLH QGV 
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYLHEQGV- 120

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GGGNAT 241
              IH  IKA+NIL  +    ++ D+G++    +  +  A  V   YW          A+
Sbjct: 121 ---IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 242 RESDVYGFGVVLLEILSGR 260
             SD++  G  ++E+L+G 
Sbjct: 178 TASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 49/219 (22%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVP 123
             IG+G  G VY A    TG+LVA+K+I  R+     GF   ++  IK L   +HPNIV 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 124 ILGFSQAPGERIIVSEFINMASLDF-YLHENNDGASLLDWNRRLRIATGAAR-------- 174
           +        + I+ S+      + F Y+  ++D   LLD +  ++      +        
Sbjct: 63  L--------KEIVTSKGKGSIYMVFEYM--DHDLTGLLD-SPEVKFTESQIKCYMKQLLE 111

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDY-- 231
           GL+YLH      I+H  IK SNIL+N     ++ D+GL+                 DY  
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA--------DYTN 160

Query: 232 -----WHEK-----GGGNATRESDVYGFGVVLLEILSGR 260
                W+       G      E D++  G +L E+  G+
Sbjct: 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 19/218 (8%)

Query: 108 SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR 167
           S I  +   QHPNIV ++G  ++     ++ E+I   +L   L         L W RR +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRK 784

Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGL-AGY 226
           IA G A+ L +LH   +P ++ G +    I+++ K    +       L  + K  + + Y
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAY 844

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE------GLLVKWALPLIKEMRF 280
           V  +    K   + T +SD+YGFG++L+E+L+G+   +      G +V+WA     +   
Sbjct: 845 VAPETRETK---DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL 901

Query: 281 SELLDPRLAIPCEI--KPLVRLAKVALACVGNSRKNRP 316
              +DP +     +    +V +  +AL C       RP
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939

Length = 968

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 44/220 (20%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIH--PRLVLSNAGFGFASVIKTLSLAQ 117
           D   +   +G G  G V   L   TGK++AVK I       +          +  L    
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ---ILRELDILHKCN 57

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL-RIATGAARGL 176
            P IV   G     G+  I  E+++  SLD  L E           R L +IA    +GL
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE----RILGKIAVAVLKGL 113

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------------FLAPEEK 220
            YLH+     IIH  +K SNIL+N +   ++CD+G+S                ++APE  
Sbjct: 114 TYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERI 171

Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           +G       DY         + +SD++  G+ L+E+ +GR
Sbjct: 172 QGN------DY---------SVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 43/214 (20%)

Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLAQHPNI 121
           +G+G  G+V    Y  L  +TG++VAVK++      S A     F   I+ L   QH NI
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH----STAEHLRDFEREIEILKSLQHDNI 67

Query: 122 VPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           V   G   + G R   +V E++   SL  YL ++ +    LD  + L  A+   +G+EYL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL 124

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN 239
               +   +H  +   NIL+  +   ++ D+GL+ + P++K         +Y+  +  G 
Sbjct: 125 G---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK---------EYYKVREPGE 172

Query: 240 A---------------TRESDVYGFGVVLLEILS 258
           +               +  SDV+ FGVVL E+ +
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 70.3 bits (172), Expect = 7e-14
 Identities = 71/283 (25%), Positives = 115/283 (40%), Gaps = 38/283 (13%)

Query: 67  RIIGQGRLGTVY-----AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           R++G+G  G V       A   TG++VAVK +       N   G+   I  L    H NI
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTS-GWKKEINILKTLYHENI 68

Query: 122 VPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           V   G     G + +  + E++ + SL  YL ++    + L     L  A     G+ YL
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYL 123

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKG 236
           H   + + IH  + A N+LL+     ++ D+GL+   PE         D D   +W+   
Sbjct: 124 H---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 177

Query: 237 GGNATRE------SDVYGFGVVLLEILSGRRCEEGL--------LVKWALPLIKEMRFSE 282
                +E      SDV+ FGV L E+L+   C+           ++      +  +R  E
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT--HCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235

Query: 283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL 325
           LL+  + +PC       +  +   C     K RP+   +  IL
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 69.9 bits (172), Expect = 8e-14
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 49/215 (22%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFG--FASVIKTLSLAQHPNIVPIL 125
           +GQG  G VY      TGK+ A+K+IH   V  +  F       +KTL   + P +V   
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--RIATGAARGLEYLHQGV 183
           G     GE  IV E+++  SL   L        +      +   IA    +GL+YLH   
Sbjct: 66  GAFYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLAG 225
             +IIH  IK SN+L+N K   ++ D+G+S                  +++PE  +G   
Sbjct: 120 --HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG--- 174

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              + Y         +  +D++  G+ LLE   G+
Sbjct: 175 ---ESY---------SYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 60/203 (29%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
             IG+G  G VY  +L     VAVK     L   +    F    + L    HPNIV ++G
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                    IV E +   SL  +L +  +    L   + L+++  AA G+EYL      N
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLES---KN 113

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD-------YWHEKGG-- 237
            IH  + A N L+ E    ++ D+G+S    EE+ G+  Y   D        W       
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMS---REEEGGI--YTVSDGLKQIPIKWTAPEALN 168

Query: 238 -GNATRESDVYGFGVVLLEILSG 259
            G  T ESDV+ +G++L E  S 
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 36/212 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           R +G G+ G V+    +    VAVK + P  +   A    A ++K L   +H  +V +  
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL---RHDKLVQLYA 68

Query: 127 F-SQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
             S+   E I IV+E+++  SL  +L         L   + + +A   A G+ YL     
Sbjct: 69  VCSE--EEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES--- 121

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG------- 237
            N IH  + A NIL+ E    ++ D+GL+ L            DD+Y   +G        
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIE----------DDEYTAREGAKFPIKWT 171

Query: 238 -------GNATRESDVYGFGVVLLEILSGRRC 262
                  G  T +SDV+ FG++L EI++  R 
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.0 bits (166), Expect = 4e-13
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 36/208 (17%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V+    +    VA+K +    +   A    A+++K L   QHP +V +  ++
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL---QHPRLVRL--YA 68

Query: 129 QAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               E I I++E++   SL  +L         L  N+ + +A   A G+ ++ +    N 
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNY 123

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL++E  C ++ D+GL+ L            D++Y   +G           
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLI----------EDNEYTAREGAKFPIKWTAPE 173

Query: 238 ----GNATRESDVYGFGVVLLEILS-GR 260
               G  T +SDV+ FG++L EI++ GR
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 67.3 bits (164), Expect = 6e-13
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)

Query: 68  IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IIG+G  G V      TG+ VAVK I    V + A     +V+  L    H N+V +LG 
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKL---HHKNLVRLLGV 67

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               G  I V E ++  +L  +L     G +L+   + L+ +   A G+EYL    +  +
Sbjct: 68  ILHNGLYI-VMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SKKL 121

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---GNATRES 244
           +H  + A NIL++E   A+V D+G   LA     G+        W           + +S
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFG---LARVGSMGVDNSKLPVKWTAPEALKHKKFSSKS 178

Query: 245 DVYGFGVVLLEILS-GR 260
           DV+ +GV+L E+ S GR
Sbjct: 179 DVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 67.5 bits (165), Expect = 8e-13
 Identities = 57/227 (25%), Positives = 87/227 (38%), Gaps = 54/227 (23%)

Query: 61  DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA--- 116
           +       +G+G  G+V    L +TG + A+K I       N       +++ L +    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI---TTDPNPDLQ-KQILRELEINKSC 56

Query: 117 QHPNIVPILG--FSQAPGERIIVSEFINMASLDFYLHE-----NNDGASLLDWNRRLRIA 169
           + P IV   G    ++     I  E+    SLD    +        G  +L      +IA
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIA 111

Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---------------- 213
               +GL YLH      IIH  IK SNILL  K   ++CD+G+S                
Sbjct: 112 ESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF 168

Query: 214 FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           ++APE  +               G   +  SDV+  G+ LLE+   R
Sbjct: 169 YMAPERIQ---------------GKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 67.1 bits (164), Expect = 9e-13
 Identities = 64/299 (21%), Positives = 125/299 (41%), Gaps = 70/299 (23%)

Query: 66  RRIIGQGRLGTVYAAL----LSTGKL-VAVKRIH---PRLV---LSNAGFGFASVIKTLS 114
            +++G G  GTVY  +        K+ VA+K +           + +  +  ASV     
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV----- 66

Query: 115 LAQHPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENND---GASLLDWNRRLRIAT 170
              HP++V +LG       ++ ++++ + +  L  Y+  + D      LL+W  ++    
Sbjct: 67  --DHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI---- 118

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
             A+G+ YL +     ++H  + A N+L+      ++ D+GL+ L           VD+ 
Sbjct: 119 --AKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---------VDEK 164

Query: 231 YWHEKGG--------------GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLI 275
            +H +GG                 T +SDV+ +GV + E+++ G +  EG+       L+
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Query: 276 KEMRFSELLDPRLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           ++         RL  P  C I   + L K    C     ++RP+  ++    + +  DP
Sbjct: 225 EK-------GERLPQPPICTIDVYMVLVK----CWMIDAESRPTFKELINEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 13/193 (6%)

Query: 69  IGQGRLGTVYAALLST-GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G G+ G VY  +       VAVK +    +        A+V+K +   +HPN+V +LG 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLVQLLGV 70

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
                   I++EF+   +L  YL E N     ++    L +AT  +  +EYL      N 
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE---KKNF 125

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-RGLAGYVDDDYWHEKGG---GNATRE 243
           IH  + A N L+ E    +V D+GLS L   +     AG      W           + +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 244 SDVYGFGVVLLEI 256
           SDV+ FGV+L EI
Sbjct: 186 SDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 34/215 (15%)

Query: 68  IIGQGRLGTVYAALLSTG--KLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVPI 124
           +IG+G  G V  A++     K+ A  ++       N    FA  ++ L  L  HPNI+ +
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLRIATGA 172
           LG  +  G   I  E+    +L  +L ++            +  AS L   + L+ A+  
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY- 231
           A G++YL +      IH  + A N+L+ E   +++ D+GLS       RG   YV     
Sbjct: 129 ATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS-------RGEEVYVKKTMG 178

Query: 232 -----WHEKGGGN---ATRESDVYGFGVVLLEILS 258
                W      N    T +SDV+ FGV+L EI+S
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 41/284 (14%)

Query: 64  SHRRIIGQGRLGTVYAALLST-GK---LVAVKRIHPRLV--LSNAGFGFASVIKTLSLAQ 117
           + +++IG G  G V+  +L   G+    VA+K + P             AS++   S   
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS--- 64

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           H NI+ + G        +I++E++   +LD YL +++   S       LR   G A G++
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA---PEEKRGLAGYVDDDYWHE 234
           YL      N +H  + A NIL+N     +V D+GLS +    PE     +G      W  
Sbjct: 122 YLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 235 KGG---GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP---- 286
                    T  SDV+ FG+V+ E++S G R        W      +M   E++      
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER------PYW------DMSNHEVMKAINDG 226

Query: 287 -RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
            RL  P +    V   ++ L C    R  RP  V +  +L+ L+
Sbjct: 227 FRLPAPMDCPSAVY--QLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 34/215 (15%)

Query: 68  IIGQGRLGTVYAALLSTG--KLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVPI 124
           +IG+G  G V  A +     ++ A  +        +    FA  ++ L  L  HPNI+ +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLRIATGA 172
           LG  +  G   +  E+    +L  +L ++            N  AS L   + L  A   
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY- 231
           ARG++YL Q      IH  + A NIL+ E + A++ D+GLS       RG   YV     
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS-------RGQEVYVKKTMG 171

Query: 232 -----WHEKGGGN---ATRESDVYGFGVVLLEILS 258
                W      N    T  SDV+ +GV+L EI+S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 37/160 (23%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVP 123
            +G+G  G+VY A+   TG++VA+K     +V          +IK +S+ +    P IV 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDL--QEIIKEISILKQCDSPYIVK 62

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW----NRRL---RIAT---GAA 173
             G      +  IV E+                 S+ D     N+ L    IA       
Sbjct: 63  YYGSYFKNTDLWIVMEYC-------------GAGSVSDIMKITNKTLTEEEIAAILYQTL 109

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           +GLEYLH       IH  IKA NILLNE+  A++ D+G+S
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 9/155 (5%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V+ A    TG+ VA+K++  R +           IK L   QHP +V +L  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
                  ++V E++  + L   L +             +R+     +G+ Y+H   A  I
Sbjct: 68  FPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMH---ANGI 120

Query: 188 IHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR 221
           +H  +K +N+L++     ++ D+GL+   + EE R
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 28/220 (12%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVK--RIH---PRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           IG G  G VY A+ L TG+L+AVK  RI    P+ +        A  +K L L +HPN+V
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-----IADEMKVLELLKHPNLV 62

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
              G      +  I  E+ +  +L+  L        +LD +           GL YLH  
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSF-------LAPEEKRGLAG---YVDDDYW 232
               I+H  IK +NI L+     ++ D+G +           EE + LAG   Y+  +  
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 233 HEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL 272
               G    R +D++  G V+LE+ +G+R    L  ++ +
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 19/155 (12%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV------IKTLSLAQHP 119
            ++G G  G+VY  L L  G   AVK +    +  +   G  +V      I  LS  QHP
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEV---SLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 120 NIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           NIV  LG ++   + + I  E +   SL   L +       +      +I      GLEY
Sbjct: 63  NIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLEY 117

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           LH     N +H  IK +NIL++     ++ D+G++
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMA 149

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 65.6 bits (161), Expect = 3e-12
 Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 12/149 (8%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPI 124
            +G+G  G VY A    TG++VA+K+I  RL     G    ++  I  L   +HPNIV +
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
           L       +  +V E+ +M  L  YL +       L  N    I     RGL Y H    
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH-- 117

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS 213
             I+H  +K  NIL+N     ++ D+GL+
Sbjct: 118 -RILHRDLKPQNILINRDGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL---AQHPNIVPI 124
           +G+G  G+VY  L   TG  +A+K I  RL L  + F    +I  L +   A  P IV  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKF--NQIIMELDILHKAVSPYIVDF 64

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G     G   +  E+++  SLD  L+        +  +   RI     +GL++L +   
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGL----------------SFLAPEEKRGLAGYVD 228
            NIIH  +K +N+L+N     ++CD+G+                S++APE  +       
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGG---- 177

Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                       T +SDV+  G+ +LE+  GR
Sbjct: 178 -----PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 49/152 (32%), Positives = 67/152 (44%), Gaps = 21/152 (13%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIVPI 124
           IG G  G VY A  ++TG+LVA+K     ++    G  F  +   I  L   +HPNIV  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA---TGAARGLEYLHQ 181
            G      +  IV E+    SL           S       L+IA       +GL YLH+
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS------ELQIAYVCRETLKGLAYLHE 119

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
                 IH  IK +NILL E    ++ D+G+S
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 43/223 (19%)

Query: 69  IGQGRLGTVYAALL---STGKL--------VAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           +GQG    +Y  +L   S   +        V +K +      S A F  AS    +S   
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETAS---LMSQLS 59

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           H ++V + G      E I+V E++    LD +LH   +  SL  W  +L +A   A  L 
Sbjct: 60  HKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLH-W--KLDVAKQLASALH 115

Query: 178 YLHQGVAPNIIHGCIKASNILL-----NEKF--CARVCD--YGLSFLAPEEKRGLAGYVD 228
           YL       ++HG +   NIL+     NE +    ++ D    ++ L+ EE+      V+
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VE 166

Query: 229 DDYW-----HEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL 266
              W        G  + T  +D + FG  LLEI S    EE L
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS--NGEEPL 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 64/268 (23%), Positives = 107/268 (39%), Gaps = 38/268 (14%)

Query: 63  FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           F+  R +G G  G V+  L      VA+K +    +L    F     ++ L   +H +++
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDF--QKEVQALKRLRHKHLI 65

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLH----ENNDGASLLDWNRRLRIATGAARGLEY 178
            +           I++E +   SL  +L     +    ASL+D      +A   A G+ Y
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID------MACQVAEGMAY 119

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY-----W- 232
           L      N IH  + A NIL+ E    +V D+GL+ L  E+      Y+  D      W 
Sbjct: 120 LE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-----YLSSDKKIPYKWT 171

Query: 233 --HEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA 289
                  G  + +SDV+ FG++L E+ + G+    G+        I           R+ 
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-------GYRMP 224

Query: 290 IPCEIKPLVRLAKVALACVGNSRKNRPS 317
            P +    +   K+ L C     ++RPS
Sbjct: 225 CPAKCPQEIY--KIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 58/294 (19%)

Query: 68  IIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVP 123
           +IG+G  G V  A +    L    A+KR+       +    FA  ++ L  L  HPNI+ 
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLRIATG 171
           +LG  +  G   +  E+    +L  +L ++            N  AS L   + L  A  
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            ARG++YL Q      IH  + A NIL+ E + A++ D+GLS       RG   YV    
Sbjct: 133 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS-------RGQEVYVKKTM 182

Query: 232 ------WHEKGGGN---ATRESDVYGFGVVLLEILS-------GRRCEEGLLVKWALPLI 275
                 W      N    T  SDV+ +GV+L EI+S       G  C E         L 
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 233

Query: 276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +++     L+  L    E+  L+R       C       RPS  Q+   LN ++
Sbjct: 234 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRML 281

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.9 bits (158), Expect = 4e-12
 Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 33/277 (11%)

Query: 68  IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFG------FASVIKTLSLAQHPNI 121
           +IG G  G V    L   KL   + I   +    +G+       F S    +    HPNI
Sbjct: 11  VIGAGEFGEVCRGRL---KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           + + G        +I++EF+   +LD +L +N+   +++     LR   G A G++YL +
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE 124

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLA-----PEEKRGLAGYVDDDYWHEK 235
               N +H  + A NIL+N     +V D+GLS FL      P     L G +   +   +
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 236 GGG--NATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC 292
                  T  SDV+ +G+V+ E++S G R    +  +  +  I++       D RL  P 
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------DYRLPPPM 234

Query: 293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +  P   L ++ L C    R  RP   Q+ + L+ ++
Sbjct: 235 DC-PTA-LHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 59/224 (26%), Positives = 87/224 (38%), Gaps = 49/224 (21%)

Query: 69  IGQGRLGTVYAALL------STGKLVAVK--RIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           +G+G  G VY   L       +   VA+K  + +    +       A ++  L   QHPN
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL---QHPN 69

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYL------------HENNDGASLLDWNRRLRI 168
           IV +LG         ++ E++    L  +L              +    S LD +  L I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   A G+EYL    + + +H  + A N L+ E    ++ D+GLS            Y  
Sbjct: 130 AIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---------IYSA 177

Query: 229 DDY-----------WHEKGG---GNATRESDVYGFGVVLLEILS 258
           D Y           W        G  T ESD++ FGVVL EI S
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 43/220 (19%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASV-------IKTLSLAQH 118
           +IG+G  G VY AL ++TG+++AVK++  P  +          +       I+TL    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR------IATGA 172
            NIV  LGF        I  E++   S+           S L    R             
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSI----------GSCLRTYGRFEEQLVRFFTEQV 117

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAGYV 227
             GL YLH   +  I+H  +KA N+L++     ++ D+G+S         ++   + G V
Sbjct: 118 LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174

Query: 228 DDDYW------HEKGGGNATRESDVYGFGVVLLEILSGRR 261
              +W      H    G + +  D++  G V+LE+ +GRR
Sbjct: 175 ---FWMAPEVIHSYSQGYSAK-VDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 42/211 (19%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG+G  G V       G  VAVK I      + A    ASV+  L   +H N+V +LG
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL---RHSNLVQLLG 66

Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +  G   IV+E++   SL  YL     G S+L  +  L+ +      +EYL    A 
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---AN 121

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLS---------------FLAPEEKRGLAGYVDDD 230
           N +H  + A N+L++E   A+V D+GL+               + APE  R         
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR--------- 172

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILS-GR 260
              EK     + +SDV+ FG++L EI S GR
Sbjct: 173 ---EK---KFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 74/299 (24%), Positives = 122/299 (40%), Gaps = 57/299 (19%)

Query: 56  IDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFASV 109
           IDA+       ++IG G  G V +  L   KL   + I   +    AG+       F S 
Sbjct: 1   IDASC--IKIEKVIGAGEFGEVCSGRL---KLPGKREIPVAIKTLKAGYTEKQRRDFLSE 55

Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
              +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR  
Sbjct: 56  ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-- 113

Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDD 229
            G A G++YL        +H  + A NIL+N     +V D+GLS +  +         D 
Sbjct: 114 -GIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED---------DP 160

Query: 230 DYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP 273
           +  +   GG                 T  SDV+ +G+V+ E++S G R        W + 
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER------PYWEMS 214

Query: 274 ---LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
              +IK +     L   +  P        L ++ L C    R  RP   Q+ +IL+ L+
Sbjct: 215 NQDVIKAIEEGYRLPAPMDCP------AALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 48/219 (21%)

Query: 67  RIIGQGRLGTVYAA----LLSTGKL--VAVKRIHPRLVLSNAGFGFASVIKTLS-LAQHP 119
           + +G G  G V  A    L  +  +  VAVK + P    S       S +K +S L  H 
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE-ALMSELKIMSHLGNHE 99

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           NIV +LG     G  ++++E+     L  +L    +  S L     L  +   A+G+ +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFL 157

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------------------FLAPEE 219
               + N IH  + A N+LL      ++CD+GL+                    ++APE 
Sbjct: 158 ---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 220 KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS 258
                   +  Y         T ESDV+ +G++L EI S
Sbjct: 215 ------IFNCVY---------TFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 33/209 (15%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           R +G G+ G V+  L +    VAVK + P  +        A ++K L   +HP ++ +  
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL---RHPKLIQLYA 68

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                    IV+E +   SL  YL         L   + + +A   A G+ YL    A N
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLE---AQN 123

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY-----------WHEK 235
            IH  + A N+L+ E    +V D+GL+ +            +D Y           W   
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARV----------IKEDIYEAREGAKFPIKWTAP 173

Query: 236 GGGNATR---ESDVYGFGVVLLEILS-GR 260
                 R   +SDV+ FG++L EI++ GR
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 32/206 (15%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + +G G+ G V+    +    VAVK + P  +   A    A+++KTL   QH  +V +  
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL---QHDKLVRLYA 68

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                    I++E++   SL  +L  +  G  LL   + +  +   A G+ Y+ +    N
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIER---KN 123

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------- 237
            IH  ++A+N+L++E    ++ D+GL+ +            D++Y   +G          
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIE----------DNEYTAREGAKFPIKWTAP 173

Query: 238 -----GNATRESDVYGFGVVLLEILS 258
                G+ T +SDV+ FG++L EI++
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 45/275 (16%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  ++  A    A ++K L   +H  +VP+    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL---RHDKLVPLYAVV 70

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+EF+   SL  +L E  DG  L    + + +A   A G+ Y+ +    N 
Sbjct: 71  SEEP--IYIVTEFMGKGSLLDFLKEG-DGKYL-KLPQLVDMAAQIADGMAYIER---MNY 123

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL+ +    ++ D+GL+ L            D++Y   +G           
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 173

Query: 238 ----GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC 292
               G  T +SDV+ FG++L E+++ GR    G++ +  L         E ++    +PC
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---------EQVERGYRMPC 224

Query: 293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
                  L ++   C       RP+   + + L +
Sbjct: 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 45/223 (20%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNIVP 123
           +G+G  G VY A  + TG++VA+K+I    ++ N   GF       IK L   +HPN+VP
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKILKKLKHPNVVP 71

Query: 124 ILG--FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR------- 174
           ++     +    +        M +   Y+  ++D + LL+ N  +++     +       
Sbjct: 72  LIDMAVERPDKSKRKRGSVY-MVT--PYM--DHDLSGLLE-NPSVKLTESQIKCYMLQLL 125

Query: 175 -GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL----APEEKRGLAGYVDD 229
            G+ YLH+    +I+H  IKA+NIL++ +   ++ D+GL+       P  K G  G    
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG-GTR 181

Query: 230 DY-------WHEK-----GGGNATRESDVYGFGVVLLEILSGR 260
            Y       W+       G    T   D++G G V  E+ + R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 9e-11
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 48/215 (22%)

Query: 65  HRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           ++ I+G G  GTVY A  L T +++AVK I P  +         S ++ L     P I+ 
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIG 63

Query: 124 ILGFSQAPGERIIVSEFINMASLDFY--LHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G         I +EF++  SLD Y  + E+  G          RIA    +GL YL  
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG----------RIAVAVVKGLTYLW- 112

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------------FLAPEEKRGLAG 225
             +  I+H  +K SN+L+N +   ++CD+G+S                ++APE   G   
Sbjct: 113 --SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISG--- 167

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              + Y            SDV+  G+  +E+  GR
Sbjct: 168 ---EQY---------GIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 47/216 (21%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRI---HPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
             IG G  GTVY  +   TG+L A+K I   H   V           I+ L    HPN+V
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ----ICREIEILRDVNHPNVV 135

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
                    GE  ++ EF++  SL+       D   L D  R++        G+ YLH+ 
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEG--THIADEQFLADVARQI------LSGIAYLHR- 186

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLA 224
              +I+H  IK SN+L+N     ++ D+G+S                  +++PE      
Sbjct: 187 --RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPER----- 239

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             ++ D  H    G A    D++  GV +LE   GR
Sbjct: 240 --INTDLNHGAYDGYA---GDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 67/279 (24%), Positives = 124/279 (44%), Gaps = 47/279 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + +G G+ G V+ A  +    VAVK + P  +   A    A+V+KTL   QH  +V +  
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL---QHDKLVKL-- 66

Query: 127 FSQAPGERI-IVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            +    E I I++EF+   SL DF   +      L    + +  +   A G+ ++ Q   
Sbjct: 67  HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQ--- 120

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG------- 237
            N IH  ++A+NIL++     ++ D+GL+ +            D++Y   +G        
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE----------DNEYTAREGAKFPIKWT 170

Query: 238 -------GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA 289
                  G+ T +SDV+ FG++L+EI++ GR    G+       +I+ +     +     
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYRMPRPEN 227

Query: 290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
            P E      L  + + C  N  + RP+   + ++L++ 
Sbjct: 228 CPEE------LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 54/208 (25%), Positives = 80/208 (38%), Gaps = 39/208 (18%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V+         VA+K I    +  +     A V+  LS   HPN+V + G  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLS---HPNLVQLYGVC 68

Query: 129 QAPGERIIVSEFINMASLDFYLHENND--GASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                  IV+E++    L  YL E     G   L     L + +     +EYL       
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLESN---G 120

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------- 237
            IH  + A N L+ E    +V D+           GLA YV DD +    G         
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDF-----------GLARYVLDDQYTSSQGTKFPVKWAP 169

Query: 238 ------GNATRESDVYGFGVVLLEILSG 259
                    + +SDV+ FGV++ E+ S 
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 49/225 (21%)

Query: 67  RIIGQGRLGTVYAALLSTGK------LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           R +G+G  G V+       +      LVAVK +      ++A   F    + L+  QH N
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHEN 69

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR----------LRIAT 170
           IV   G        I+V E++    L+ +L  +   A+ L               L+IA 
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
             A G+ YL    + + +H  +   N L+      ++ D+G+S       R +  Y  D 
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-------RDV--YTTDY 177

Query: 231 YWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
           Y   + GG+                  T ESDV+ FGVVL EI +
Sbjct: 178 Y---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 24/156 (15%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPI 124
            IG+G  G VY A   ++G++VA+K++  R+     G   +S+  I  L   +HPNIV +
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKV--RMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR-------LRIATGAARGLE 177
                     ++V + ++   L     E  D ASLLD             +     RGL+
Sbjct: 72  K--------EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           YLH+     IIH  +K SN+LL +K C ++ D+GL+
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.5 bits (145), Expect = 4e-10
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 47/186 (25%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKTLSL 115
            + IG G  G V +A+   TG+ VA+K+I            F  +         IK L  
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV---------FDDLIDAKRILREIKLLRH 55

Query: 116 AQHPNIVPILGFSQAP-----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT 170
            +H NI+ +L   + P      +  IV+E   M +         D   ++   + L    
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTEL--MET---------DLHKVIKSPQPLTDDH 104

Query: 171 GAA------RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAPEEKR 221
                    RGL+YLH     N+IH  +K SNIL+N     ++CD+GL+       +EK 
Sbjct: 105 IQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 222 GLAGYV 227
            L  YV
Sbjct: 162 FLTEYV 167

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 35/211 (16%)

Query: 68  IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           ++G+G  G V+   L     VAVK     L        F S  + L    HPNIV ++G 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
                   IV E +       +L +  D    L   + ++ A  AA G+ YL    + N 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLE---SKNC 114

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  + A N L+ E    ++ D+G+S              +DD  +   G          
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS------------RQEDDGIYSSSGLKQIPIKWTA 162

Query: 238 ------GNATRESDVYGFGVVLLEILSGRRC 262
                 G  + ESDV+ +G++L E  S   C
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVC 193

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 59.1 bits (144), Expect = 4e-10
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 27/202 (13%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G VY A   +TGK VA+K++  R            ++K     +HPNIV     
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC---KHPNIVDYYDS 83

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNR-RL---RIATGAA---RGLEYLH 180
                E  +V E+++  SL            ++  N  R+   +IA       +GLEYLH
Sbjct: 84  YLVGDELWVVMEYMDGGSL----------TDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH--EKGGG 238
                N+IH  IK+ NILL++    ++ D+G +    +EK      V   YW   E    
Sbjct: 134 SQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190

Query: 239 NA-TRESDVYGFGVVLLEILSG 259
                + D++  G++ +E+  G
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 16/199 (8%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           IG+G  G VY A    TG++VA+K+I  R    + G    ++  IK L    HPNI+ +L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +  G+  +V EF++    D Y     D    L  +          +GL + H     
Sbjct: 65  DVFRHKGDLYLVFEFMDT---DLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK----GGGNAT 241
            I+H  +K  N+L+N +   ++ D+GL+       R    YV   ++       G    +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 242 RESDVYGFGVVLLEILSGR 260
              D++  G +  E+LS R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 41/211 (19%)

Query: 69  IGQGRLGTVYAALLSTGKL----VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           +G G  G+V   +          VAVK +    + +     F      ++   HP IV +
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK-EFLREASVMAQLDHPCIVRL 61

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENND--GASLLDWNRRLRIATGAARGLEYLHQG 182
           +G  +     ++V E   +  L  YL +  +   + L +       A   A G+ YL   
Sbjct: 62  IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES- 113

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN--- 239
              + +H  + A N+LL  +  A++ D+G+S       R L      DY+     G    
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMS-------RALG--AGSDYYRATTAGRWPL 162

Query: 240 ------------ATRESDVYGFGVVLLEILS 258
                        + +SDV+ +GV L E  S
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 58/222 (26%), Positives = 86/222 (38%), Gaps = 49/222 (22%)

Query: 87  LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL 146
           LVAVK + P     NA   F   +K LS    PNI  +LG         ++ E++    L
Sbjct: 48  LVAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 147 DFYL--HENNDGASL-----LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL 199
           + +L  H             L ++  L +AT  A G+ YL      N +H  +   N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV 163

Query: 200 NEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY--------------WHEKGGGNATRESD 245
            + +  ++ D+G+S       R L  Y  D Y              W     G  T +SD
Sbjct: 164 GKNYTIKIADFGMS-------RNL--YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214

Query: 246 VYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
           V+ FGV L EIL+               L +E  +  L D +
Sbjct: 215 VWAFGVTLWEILT---------------LCREQPYEHLTDQQ 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 46/169 (27%), Positives = 66/169 (39%), Gaps = 26/169 (15%)

Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
            T  F    +IG+G  G VY A    TG+LVA+K +              ++++  S   
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--N 61

Query: 118 HPNIVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGA-SLLDWNRRLR--- 167
           HPNI    G               +V E     S+        D    L    +RL+   
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-------TDLVKGLRKKGKRLKEEW 114

Query: 168 ---IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
              I     RGL YLH+     +IH  IK  NILL +    ++ D+G+S
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 58.5 bits (141), Expect = 7e-10
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 39/209 (18%)

Query: 69  IGQGRLGTVYAALL-STGKLVAVKRIHPRLV--LSNAGFGFASVIKTLSLAQHPNIVPIL 125
           IG+G  G V++  L +    VAVK     L   L       A ++K  S   HPNIV ++
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS---HPNIVRLI 59

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
           G         IV E +     DF      +G  L      +++   AA G+EYL    + 
Sbjct: 60  GVCTQKQPIYIVMELVQGG--DFLTFLRTEGPRL-KVKELIQMVENAAAGMEYLE---SK 113

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG-------- 237
           + IH  + A N L+ EK   ++ D+G+S    EE+ G+        +   GG        
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMS---REEEDGV--------YASTGGMKQIPVKW 162

Query: 238 --------GNATRESDVYGFGVVLLEILS 258
                   G  + ESDV+ FG++L E  S
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)

Query: 87  LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL 146
           LVAVK +    V   A   F   IK +S  ++PNI+ +LG   +     +++E++    L
Sbjct: 46  LVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 147 DFYLHENNDGASLLDWNR--------RLRIATGAARGLEYLHQGVAPNIIHGCIKASNIL 198
           + +L +    ++    N          L +A   A G++YL    + N +H  +   N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161

Query: 199 LNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY--------------WHEKGGGNATRES 244
           +   +  ++ D+G+S       R L  Y  D Y              W     G  T  S
Sbjct: 162 VGNHYTIKIADFGMS-------RNL--YSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS 212

Query: 245 DVYGFGVVLLEILSGRRCEE 264
           DV+ FGV L E+ +   C+E
Sbjct: 213 DVWAFGVTLWEMFT--LCKE 230

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 57.5 bits (140), Expect = 1e-09
 Identities = 49/216 (22%), Positives = 77/216 (35%), Gaps = 41/216 (18%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVP 123
           + IG+G  G VY     S GKL  +K I   L   +      ++  +K L    HPNI+ 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
                +  G+  IV E+ +   L   + +           + L         L+YLH   
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLAG 225
              I+H  IK  NI L      ++ D+G+S                  +L+PE       
Sbjct: 122 -RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE------- 173

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                    K        SD++  G VL E+ + + 
Sbjct: 174 -----LCQNKPYNYK---SDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 70

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 71  SEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 173

Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 54/221 (24%), Positives = 85/221 (38%), Gaps = 60/221 (27%)

Query: 69  IGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQHPNIVPILG 126
           +G+G  G V       TGKL A+K +  + ++           +  LS   HP IV  L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59

Query: 127 FS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR--------GLE 177
           ++ Q   +  +V E+     L  +L            ++  R +   AR         LE
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL------------SKEGRFSEERARFYAAEIVLALE 107

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEE 219
           YLH      II+  +K  NILL+     ++ D+GL+                  +LAPE 
Sbjct: 108 YLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV 164

Query: 220 KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             G  GY               +  D +  GV+L E+L+G+
Sbjct: 165 LLG-KGY--------------GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 47/235 (20%), Positives = 79/235 (33%), Gaps = 63/235 (26%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT--LSLAQHPNIVP 123
           +IIG+G   TV  A    T K  A+K +  R ++      +  + K     L  HP I+ 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 124 ILGFSQAPGERIIVSEF---------------INMASLDFYLHENNDGASLLDWNRRLRI 168
           +    Q       V E+               ++     FY  E      +L        
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE------ILL------- 113

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
                  LEYLH      IIH  +K  NILL++    ++ D+G + +        +   D
Sbjct: 114 ------ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 229 DDYWHEKGGGNATR-----------------------ESDVYGFGVVLLEILSGR 260
                 +   N  R                        SD++  G ++ ++L+G+
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 54/221 (24%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRI--------HPRLVLSNAGFGFASVIKTLSLAQHP 119
           IG+G  GTV   L   +G ++AVKRI          RL++         V+   S    P
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD------LDVVMRSSDC--P 63

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLD-FYLHENNDGASLLDWNRRLRIATGAARGLEY 178
            IV   G     G+  I  E +++ SLD FY +      S++      +IA    + L Y
Sbjct: 64  YIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-----------------FLAPE--E 219
           L + +   IIH  +K SNILL+     ++CD+G+S                 ++APE  +
Sbjct: 123 LKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180

Query: 220 KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                GY   D             SDV+  G+ L E+ +G+
Sbjct: 181 PSARDGY---DV-----------RSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 61/274 (22%), Positives = 120/274 (43%), Gaps = 43/274 (15%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK + P  +   +    A ++K L   +H  +V +    
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL---RHDKLVQLYAVV 70

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L ++ +G +L      + +A   A G+ Y+ +    N 
Sbjct: 71  SEEP--IYIVTEYMSKGSLLDFL-KDGEGRAL-KLPNLVDMAAQVAAGMAYIER---MNY 123

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++++NIL+ +    ++ D+GL+ L            D++Y   +G           
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 173

Query: 238 ----GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE 293
               G  T +SDV+ FG++L E+++  R           P +      E ++    +PC 
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRV--------PYPGMNNREVLEQVERGYRMPCP 225

Query: 294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
               + L ++ L C     + RP+   + + L +
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 24/206 (11%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFAS-VIKTLSLAQHPNIVPILG 126
           IG G    VYAA+ L   + VA+KRI   L             ++ +S   HPN+V    
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 127 FSQAPGERIIVSEFINMAS-LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH-QGVA 184
                 E  +V  +++  S LD        G   LD      +     +GLEYLH  G  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNG-- 122

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS-FLAP---EEKRGLAGYVDDDYW------HE 234
              IH  IKA NILL E    ++ D+G+S  LA      ++    +V    W       +
Sbjct: 123 --QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 235 KGGGNATRESDVYGFGVVLLEILSGR 260
             G +   ++D++ FG+  +E+ +G 
Sbjct: 181 VHGYDF--KADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.9 bits (135), Expect = 5e-09
 Identities = 59/299 (19%), Positives = 106/299 (35%), Gaps = 74/299 (24%)

Query: 68  IIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
            +G+G  G V+ A            LV VK +       N    F   +       H N+
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNV 70

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL-----LDWNRRLRIATGAARGL 176
           V +LG  +      ++ E+ ++  L  +L              L   +++ + T  A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------------------FLAP 217
           ++L        +H  + A N L++ +   +V    LS                   +LAP
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE 277
           E  +      +DD+         + +SDV+ FGV++ E+ +                  E
Sbjct: 188 EAVQ------EDDF---------STKSDVWSFGVLMWEVFT----------------QGE 216

Query: 278 MRFSELLDP---------RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
           + F  L D          +L +P       RL K+   C   + K+RPS  ++ + L  
Sbjct: 217 LPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           + +   IG+G  G V +A    TG  VA+K+I P     +  F   ++  IK L   +H 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP---FEHQTFCQRTLREIKILRRFKHE 63

Query: 120 NIVPILGFSQAPG-----ERIIVSEFINMASLDFY-----LHENNDGASLLDWNRRLRIA 169
           NI+ IL   + P      +  IV E   M + D Y      H +ND      +       
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQEL--MET-DLYKLIKTQHLSNDHIQYFLYQ------ 114

Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE---KRGLAGY 226
               RGL+Y+H   + N++H  +K SN+LLN     ++CD+GL+ +A  E      L  Y
Sbjct: 115 --ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 227 VDDDYWH-------EKGGGNATRESDVYGFGVVLLEILSGR 260
           V   ++         KG    T+  D++  G +L E+LS R
Sbjct: 170 VATRWYRAPEIMLNSKG---YTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 63  FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F H R++G+G  G V A  + +TGK+ A K++  + +    G   A   K +    +   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 122 VPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           V  L ++    + + +V   +N   L F+++  N G    D  R +  A     GLE L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWHEK 235
           +     I++  +K  NILL+++   R+ D GL+   PE +      G  GY+  +  + +
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE 176

Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
                T   D +G G ++ E++ G+
Sbjct: 177 ---KYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 34/159 (21%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           I +G  G VY A    TG++VA+K++         GF   S+  I  L   QHPNIV + 
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE--GFPITSLREINILLKLQHPNIVTV- 69

Query: 126 GFSQAPGERIIV---SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------R 174
                  + ++V    + I M  +++  H   D  SL++   +                 
Sbjct: 70  -------KEVVVGSNLDKIYMV-MEYVEH---DLKSLME-TMKQPFLQSEVKCLMLQLLS 117

Query: 175 GLEYLHQGVAPN-IIHGCIKASNILLNEKFCARVCDYGL 212
           G+ +LH     N I+H  +K SN+LLN +   ++CD+GL
Sbjct: 118 GVAHLHD----NWILHRDLKTSNLLLNNRGILKICDFGL 152

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---H 118
           R +G+G  G V          +TG+ VAVK + P     + G   A + K + + +   H
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP----ESGGNHIADLKKEIEILRNLYH 65

Query: 119 PNIVPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            NIV   G     G   I  + EF+   SL  YL  N +  +L    ++L+ A    +G+
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL---KQQLKYAVQICKGM 122

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY--VDDD---- 230
           +YL    +   +H  + A N+L+  +   ++ D+GL+     +K     Y  V DD    
Sbjct: 123 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----EYYTVKDDLDSP 175

Query: 231 -YWHEKG---GGNATRESDVYGFGVVLLEILS 258
            +W+             SDV+ FGV L E+L+
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 63  FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F   R++G+G  G V A  + +TGK+ A KR+  + +    G   A   K +    +   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 122 VPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           V  L ++    + + +V   +N   L F+++  N G    +  R L  A     GLE LH
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----EKRGLAGYVDDDYWHEK 235
           +    N ++  +K  NILL++    R+ D GL+   PE      + G  GY+  +  + +
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ 176

Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
                T   D +G G ++ E++ G+
Sbjct: 177 ---RYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 40/223 (17%)

Query: 63  FSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
           F+  R++G+G  G+V  A L     + + VAVK +   +  S+    F      +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 119 PNIVPILGFS--QAPGERI----IVSEFINMASLDFYLHENNDGASLLDWNRR--LRIAT 170
           PN++ ++G S       R+    ++  F+    L  +L  +  G        +  +R   
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
             A G+EYL    + N IH  + A N +LNE     V D+GLS      K+  +G    D
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLS------KKIYSG----D 167

Query: 231 YWH--------------EKGGGNA-TRESDVYGFGVVLLEILS 258
           Y+               E    N  T  SDV+ FGV + EI++
Sbjct: 168 YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 19/157 (12%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFA-----SVIKTLSLAQHPNI 121
            IG+G  GTVY A  L+TG+ VA+K++  R+ LS  G   +     +++K L   +HPNI
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 122 VPILGFSQAP-GERII----VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           V +L     P  +R +    V E ++   L  YL  +      L       +     RG+
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKDLMRQLLRGV 120

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           ++LH   +  I+H  +K  NIL+      ++ D+GL+
Sbjct: 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 15/206 (7%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           R++G+G  G V+     +  KLV +K+I    +  +      +  + L L  HPNI+   
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
                    +IV E+    +L  Y+       SLLD +  L         L ++H     
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHT---K 120

Query: 186 NIIHGCIKASNILLNE-KFCARVCDYGLS-FLAPEEKR----GLAGYVDDDYWHEKGGGN 239
            I+H  +K  NILL++ K   ++ D+G+S  L+ + K     G   Y+  +    K    
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK---P 177

Query: 240 ATRESDVYGFGVVLLEILSGRRCEEG 265
             ++SD++  G VL E+ S +R  E 
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 55/283 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLA---QHPNI 121
           + +G G   + Y A  + TG L+AVK++ + R   S       ++ K + L     HP+I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           + +LG +       +  E++   S+   L     GA        +       RGL YLH+
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGA--FKEAVIINYTEQLLRGLSYLHE 121

Query: 182 GVAPNIIHGCIKASNILLNEK-FCARVCDYG----------------------LSFLAPE 218
                IIH  +K +N+L++      R+ D+G                      ++F+APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM 278
             RG           E+ G    R  DV+  G V++E+ + +           L LI ++
Sbjct: 179 VLRG-----------EQYG----RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223

Query: 279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
             S    P  +IP  + P +R   V L C+    ++RP   ++
Sbjct: 224 A-SATTAP--SIPEHLSPGLR--DVTLRCLELQPEDRPPSREL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 55/204 (26%), Positives = 85/204 (41%), Gaps = 26/204 (12%)

Query: 75  GTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLAQHPNIVPILGFSQAPG 132
           G +Y   +   +LVA+K +     ++N      F      ++   HPNIV +LG      
Sbjct: 24  GHLYLPGMDHAQLVAIKTLKD---INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80

Query: 133 ERIIVSEFINMASLDFYL-----------HENNDGA--SLLDWNRRLRIATGAARGLEYL 179
              ++ E++N   L  +L             + DG   S LD    L IA   A G+EYL
Sbjct: 81  PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAGYVDDDYWHEKGG 237
                   +H  + A NIL+ E+   ++ D GLS    + +  R     +    W     
Sbjct: 141 SSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA 197

Query: 238 ---GNATRESDVYGFGVVLLEILS 258
              G  + +SD++ FGVVL EI S
Sbjct: 198 IMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLAQH 118
           R +GQG  G VY  L            VA+K ++    +         ASV+K  +    
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC--- 68

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLLDWNRRLRIATGA 172
            ++V +LG        ++V E +    L  YL       ENN G       + +++A   
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A G+ YL    A   +H  + A N ++ E    ++ D+G++    E           DY+
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET----------DYY 175

Query: 233 HEKGG---------------GNATRESDVYGFGVVLLEILS 258
            + G                G  T +SDV+ FGVVL E+ +
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 35/181 (19%)

Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQ 117
           D F     IG+G  G VY A    TG+LVA+K++  RL     GF   ++  IK L    
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLN 64

Query: 118 HPNIVPI----------LGFSQAPGERIIVSEFIN---MASLDFYLHENNDGASLLDWNR 164
           H NIV +          L F +  G   +V E+++   M  L+         + L+ ++ 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE---------SGLVHFSE 115

Query: 165 RLRIATGAAR---GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEK 220
              I +   +   GL Y H+    N +H  IK SNILLN K   ++ D+GL+     EE 
Sbjct: 116 D-HIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Query: 221 R 221
           R
Sbjct: 172 R 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 41/165 (24%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
             IG G  G V +A+   +GK VA+K+I H   V + A       +K L   +H NI+ I
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE-LKILRHFKHDNIIAI 69

Query: 125 LGFSQAPGERIIVSEFIN-------MAS-LDFYLHENNDGA---------SLLDWNRRLR 167
               + PG     ++F +       M S L   +H +              LL       
Sbjct: 70  RDILRPPG-----ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL------- 117

Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
                 RGL+Y+H   + N+IH  +K SN+L+NE    R+ D+G+
Sbjct: 118 ------RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGM 153

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 53/160 (33%), Positives = 73/160 (45%), Gaps = 27/160 (16%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRI-----------HPRLVLSNAGFGFASVIKTLSL 115
           +IG G  G+VY  +  S+G+L+AVK++             R +L       A  I  L  
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLD----ALAREIALLKE 62

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGA--SLLDWNRRLRIATGAA 173
            QH NIV  LG S       I  E++   S+   L  NN GA    L  N   +I  G  
Sbjct: 63  LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKG-- 118

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
             L YLH      IIH  IK +NIL++ K   ++ D+G+S
Sbjct: 119 --LNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 35/209 (16%)

Query: 69  IGQGRLGTVYAA--LLSTGKL--VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           +G G  G V       S GK+  VAVK +     LS+    F      +    H N++ +
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-KLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G        ++V+E   + SL   L ++  G  L+  +     A   A G+ YL     
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLES--- 115

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW----HEK----- 235
              IH  + A NILL      ++ D+GL        R L    ++D++    H K     
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLM-------RALP--QNEDHYVMEEHLKVPFAW 166

Query: 236 ------GGGNATRESDVYGFGVVLLEILS 258
                      +  SDV+ FGV L E+ +
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 15/199 (7%)

Query: 69  IGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQHPNIVPILG 126
           +G+G  G V A  + +TGK+ A K++  + +    G   A   K  L       IV +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
             +   +  +V   +N   L ++++  N G       R +  A     GLE+LHQ     
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIY--NVGEPGFPEARAIFYAAQIICGLEHLHQ---RR 115

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWHEKGGGNAT 241
           I++  +K  N+LL++    R+ D GL+      K+     G  GY+  +      G    
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ---GEVYD 172

Query: 242 RESDVYGFGVVLLEILSGR 260
              D +  G  L E+++GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 61/230 (26%)

Query: 87  LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL 146
           LVAVK + P     NA   F   +K LS  + PNI+ +LG         +++E++    L
Sbjct: 48  LVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106

Query: 147 DFYL--HENNDGAS-------------LLDWNRRLRIATGAARGLEYLHQGVAPNIIHGC 191
           + +L  H  +D                 + ++  L +A   A G++YL    + N +H  
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163

Query: 192 IKASNILLNEKFCARVCDYGLSFLAPEEKRGL-AGYVDDDYWHEKGG------------- 237
           +   N L+ E    ++ D+G+S       R L AG    DY+  +G              
Sbjct: 164 LATRNCLVGENLTIKIADFGMS-------RNLYAG----DYYRIQGRAVLPIRWMAWECI 212

Query: 238 --GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD 285
             G  T  SDV+ FGV L EIL                L KE  + EL D
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILM---------------LCKEQPYGELTD 247

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 50/288 (17%)

Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +++G G  GTVY  +      T K+    +I        A   F      ++   HP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGAS---LLDWNRRLRIATGAARGLEYL 179
            +LG   +P  ++ V++ +    L  Y+HE+ D      LL+W  ++      A+G+ YL
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG- 238
            +     ++H  + A N+L+      ++ D+GL+       R L G  D+  ++  GG  
Sbjct: 126 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLA-------RLLEG--DEKEYNADGGKM 173

Query: 239 -------------NATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL 284
                          T +SDV+ +GV + E+++ G +  +G         I      +LL
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG---------IPTREIPDLL 224

Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           +    +P      + +  V + C      +RP   ++A   + +  DP
Sbjct: 225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 55/266 (20%)

Query: 69  IGQGRLGTVYAA----LL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +G+G  G V+ A    LL      LVAVK +  +    +A   F    + L++ QH +IV
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIV 70

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNR-----------RLRIATG 171
              G        ++V E++    L+ +L  +   A +L                L IA+ 
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            A G+ YL    + + +H  +   N L+ +    ++ D+G+S       R +  Y  D Y
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS-------RDI--YSTDYY 178

Query: 232 WHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP 273
              + GG                   T ESD++ FGVVL EI + G++    L    A+ 
Sbjct: 179 ---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235

Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVR 299
            I + R  EL  PR   P E+  +++
Sbjct: 236 CITQGR--ELERPR-TCPPEVYAIMQ 258

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 42/219 (19%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQ 117
           T+ +   + +G G  G V +A    TG+ VA+K+I  P      A   +   +K L   +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKLLKHLR 67

Query: 118 HPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLR------IAT 170
           H NI+ +     +P E I  V+E +             D   LL  +R L          
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLG-----------TDLHRLLT-SRPLEKQFIQYFLY 115

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
              RGL+Y+H   +  ++H  +K SNIL+NE    ++CD+GL+    ++ + + GYV   
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA--RIQDPQ-MTGYVSTR 169

Query: 231 Y---------WHEKGGGNATRESDVYGFGVVLLEILSGR 260
           Y         W +        E D++  G +  E+L G+
Sbjct: 170 YYRAPEIMLTWQKYD-----VEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 52.6 bits (126), Expect = 6e-08
 Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 37/206 (17%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG-- 126
           IG G+ G V+       + VA+K I    +        A V+  LS   HP +V + G  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS---HPKLVQLYGVC 68

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
             ++P    +V EF+    L  YL               L +      G+ YL      N
Sbjct: 69  TERSP--ICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---N 120

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------- 237
           +IH  + A N L+ E    +V D+G++             +DD Y    G          
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFV----------LDDQYTSSTGTKFPVKWSSP 170

Query: 238 -----GNATRESDVYGFGVVLLEILS 258
                   + +SDV+ FGV++ E+ S
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 52.8 bits (126), Expect = 7e-08
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 26/201 (12%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIH----PRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           IGQG  GTVY A+ ++TG+ VA+K+++    P+  L        + I  +   ++PNIV 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL------IINEILVMRENKNPNIVN 80

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
            L       E  +V E++   SL   + E     + +D  +   +     + L++LH   
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN- 134

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRE 243
              +IH  IK+ NILL      ++ D+G       E+   +  V   YW        TR+
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW--MAPEVVTRK 190

Query: 244 S-----DVYGFGVVLLEILSG 259
           +     D++  G++ +E++ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 26/201 (12%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIH----PRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           IGQG  GTVY A+ ++TG+ VA+K+++    P+  L        + I  +   +HPNIV 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL------IINEILVMRENKHPNIVN 80

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
            L       E  +V E++   SL   + E     + +D  +   +     + LE+LH   
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH--- 132

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRE 243
           +  +IH  IK+ NILL      ++ D+G       E+   +  V   YW        TR+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW--MAPEVVTRK 190

Query: 244 S-----DVYGFGVVLLEILSG 259
           +     D++  G++ +E++ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.4 bits (125), Expect = 8e-08
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 26/201 (12%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIH----PRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           IGQG  GTVY A+ ++TG+ VA+++++    P+  L        + I  +   ++PNIV 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL------IINEILVMRENKNPNIVN 81

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
            L       E  +V E++   SL   + E     + +D  +   +     + LE+LH   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN- 135

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRE 243
              +IH  IK+ NILL      ++ D+G       E+   +  V   YW        TR+
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW--MAPEVVTRK 191

Query: 244 S-----DVYGFGVVLLEILSG 259
           +     D++  G++ +E++ G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 45/290 (15%)

Query: 57  DAATDGFSHRRIIGQGRLGTVYAALLSTGKL-------VAVKRIHP------RLVLSNAG 103
           + A +  +  R +GQG  G VY  + + G +       VA+K ++       R+   N  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNE- 59

Query: 104 FGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGA 157
              ASV+K  +   H  +V +LG        +++ E +    L  YL       ENN   
Sbjct: 60  ---ASVMKEFN-CHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ 113

Query: 158 SLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---F 214
           +     + +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G++   +
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 170

Query: 215 LAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWA 271
                ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +G+  +  
Sbjct: 171 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230

Query: 272 LPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
           L  + E     LLD     P  +  L+R+      C   + K RPS +++
Sbjct: 231 LRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 43/176 (24%)

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           ARG+E+L    +   IH  + A NILL+E    ++CD+GL+       R +  Y D DY 
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA-------RDI--YKDPDYV 231

Query: 233 HEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
            +   G+A                 T +SDV+ FGV+L EI S G     G+        
Sbjct: 232 RK---GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV-------Q 281

Query: 275 IKEMRFSELLD-PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           I E     L D  R+  P    P +   ++ LAC     K RP+   +  IL +L+
Sbjct: 282 INEEFCQRLKDGTRMRAPENATPEIY--RIMLACWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 23/204 (11%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQHPN 120
           F+  R IG G  G VY A  + T ++VA+K++      SN  +      +K L   +HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 121 IVPILGFSQAPGERIIVSEF-INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            +   G         +V E+ +  AS    +H+       L       I  GA +GL YL
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYL 141

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYG-LSFLAPEEKRGLAGYVDDDYWHEK--- 235
           H   + N+IH  IKA NILL E    ++ D+G  S  +P        +V   YW      
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVI 193

Query: 236 ---GGGNATRESDVYGFGVVLLEI 256
                G    + DV+  G+  +E+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 20/224 (8%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +IG+G  G V +A+   TG+ VA+K+I+      +        IK L L +HP+IV I  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 127 FSQAPGERIIVSEFINMASLDFYLHE----NNDGASLLDWNRRLRIATGAARGLEYLHQG 182
               P  R     ++    ++  LH+    N+D   L   + +  +     R L+Y+H  
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHHQFFLYQ-LLRALKYIH-- 120

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD--DDYWH---EKGG 237
              N+ H  +K  NIL N     ++CD+GL+ +A  +      + D     W+   E  G
Sbjct: 121 -TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 238 GNATRES---DVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM 278
              ++ +   D++  G +  E+L+G+    G  V   L LI ++
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 35/205 (17%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLS---HEKLVQLYGVC 68

Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  IV+E+++   L  YL E+         ++ L +      G+ YL    +   I
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKR---FQPSQLLEMCKDVCEGMAYLE---SKQFI 122

Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYV-DDDYWHEKGGGNATR----- 242
           H  + A N L++++ C +V D+GLS            YV DD+Y    G     R     
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLS-----------RYVLDDEYTSSVGSKFPVRWSPPE 171

Query: 243 ---------ESDVYGFGVVLLEILS 258
                    +SDV+ FGV++ E+ S
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 51.3 bits (122), Expect = 2e-07
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 26/201 (12%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIH----PRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           IGQG  GTV+ A+ ++TG+ VA+K+I+    P+  L        + I  +   ++PNIV 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL------IINEILVMKELKNPNIVN 80

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
            L       E  +V E++   SL   + E     + +D  +   +     + LE+LH   
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLH--- 132

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRE 243
           A  +IH  IK+ N+LL      ++ D+G       E+   +  V   YW        TR+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW--MAPEVVTRK 190

Query: 244 S-----DVYGFGVVLLEILSG 259
           +     D++  G++ +E++ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 23/210 (10%)

Query: 62  GFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            F   + +G+G  G+VY    LS  +  A+K +    +         + I+ L+   HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 121 IVPILGFSQA--PGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           I+    + +A   G ++ IV E+     L   + +      L+      RI     RGL+
Sbjct: 61  II---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG-------YVDDD 230
            LH      I+H  +K++NILL      ++ D G+S +    K+ +A        Y+  +
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPE 171

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            W    G   + +SD++  G +L E+ +  
Sbjct: 172 VWK---GRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 40/219 (18%)

Query: 67  RIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +I+G+G  G+V    LS    +   VAVK +   +   +    F S    +    HPN++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 123 PILGFS------QAPGERIIVSEFINMASLDFYLHENN--DGASLLDWNRRLRIATGAAR 174
            ++G        Q   + +++  F+    L  +L  +        L     L+     A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH- 233
           G+EYL      N IH  + A N +L E     V D+GLS      K+  +G    DY+  
Sbjct: 125 GMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLS------KKIYSG----DYYRQ 171

Query: 234 -------------EKGGGNA-TRESDVYGFGVVLLEILS 258
                        E       T +SDV+ FGV + EI +
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 44/215 (20%)

Query: 69  IGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G+G  G V A  + +TGKL A K+++ + +    G+  A V K +    H   +  L +
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 128 S-QAPGERIIVSEFINMASLDFYLH---ENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           + Q   +  +V   +N   L ++++   E N G       R          GLE+LHQ  
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLEHLHQR- 116

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLAG 225
              II+  +K  N+LL+     R+ D GL+                  F+APE  +G   
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG--- 171

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             + D+             D +  GV L E+++ R
Sbjct: 172 -EEYDF-----------SVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 35/207 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + +G G+ G V+         VA+K I+   +        A V+  LS   HP +V + G
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLS---HPKLVQLYG 66

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                    IV+EF+    L  YL +       L  +  L +      G+EYL +    +
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---S 120

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYV-DDDYWHEKGG-------- 237
            IH  + A N L++     +V D+           G+  YV DD+Y    G         
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDF-----------GMTRYVLDDEYTSSSGAKFPVKWSP 169

Query: 238 ------GNATRESDVYGFGVVLLEILS 258
                    + +SDV+ FGV++ E+ +
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 40/216 (18%)

Query: 68  IIGQGRLGTVYAALLSTGKLVAVKRI--HPRLVLSNAG--FGFASVIKTLSLAQHPNIVP 123
           ++G+G  GTVY  L + G+L+AVK++      VL+           +  L   +H NIV 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGA----SLLDWNRRLRIATGAARGLEYL 179
            LG         I  EF+   S+   L  N  G         + +++        G+ YL
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQI------LDGVAYL 118

Query: 180 HQGVAPNIIHGCIKASNILLNEK--------FCA-RVCDYGLSFLAPEEKRGLAGYVDDD 230
           H      ++H  IK +N++L            CA R+   GL        + + G     
Sbjct: 119 HNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG---TP 172

Query: 231 YW------HEKGGGNATRESDVYGFGVVLLEILSGR 260
           YW      +E G G   R+SD++  G  + E+ +G+
Sbjct: 173 YWMAPEVINESGYG---RKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 20/150 (13%)

Query: 118 HPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGAS---LLDWNRRLRIATGAA 173
           H  IV +LG    PG  + +V++   + SL  ++ ++ D      LL+W  ++      A
Sbjct: 68  HAYIVRLLGI--CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------A 119

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDY- 231
           +G+ YL +     ++H  + A NILL      ++ D+G++  L P++K+           
Sbjct: 120 KGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 232 WHEKGG---GNATRESDVYGFGVVLLEILS 258
           W        G  T +SDV+ +GV + E++S
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 37/160 (23%)

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           + P IV   G         +  EF++  SLD    +       +      +IA     GL
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGL 116

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------------FLAPEEK 220
            YL+      I+H  IK SNIL+N +   ++CD+G+S                +++PE  
Sbjct: 117 TYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERI 174

Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           +               GG  T +SDV+  G+ ++E+  G+
Sbjct: 175 Q---------------GGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 47/222 (21%)

Query: 67  RIIGQGRLGTVYAAL---LSTGKL---VAVKRIHPRLVLSN--AGFGFASVIKTLSLAQH 118
           R +GQG  G VY      +  G+    VAVK ++    L         ASV+K  +   H
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHH 70

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLLDWNRRLRIATGA 172
             +V +LG        ++V E +    L  YL       ENN G         +++A   
Sbjct: 71  --VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A G+ YL+   A   +H  + A N ++   F  ++ D+G++       R +    + DY+
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT-------RDI---YETDYY 175

Query: 233 HEKGG----------------GNATRESDVYGFGVVLLEILS 258
             KGG                G  T  SD++ FGVVL EI S
Sbjct: 176 -RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---H 118
           FS  R IG G  G VY A  +   ++VA+K++      SN  +    +IK +   Q   H
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW--QDIIKEVRFLQKLRH 74

Query: 119 PNIVPILGFSQAPGERIIVSEF-INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           PN +   G         +V E+ +  AS    +H+       L       +  GA +GL 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLA 129

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG-LSFLAPEEKRGLAGYVDDDYWHEK- 235
           YLH   + N+IH  +KA NILL+E    ++ D+G  S +AP        +V   YW    
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPE 181

Query: 236 -----GGGNATRESDVYGFGVVLLEI 256
                  G    + DV+  G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 30/114 (26%), Positives = 52/114 (45%), Gaps = 36/114 (31%)

Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------- 213
           +IA    + LEYLH  +  ++IH  +K SN+L+N     ++CD+G+S             
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 214 ----FLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               ++APE    +    GY                +SDV+  G+ ++E+ +GR
Sbjct: 165 GCKPYMAPERINPELNQKGY--------------DVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 40/172 (23%)

Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHEN---NDGASLLDW-------- 162
            + +H NI+ +LG     G   +V E+    +L  +L       + AS  D         
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 163 NRRL-RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
            + L   A   ARG+E+L        IH  + A N+L+ E    ++ D+GL+       R
Sbjct: 131 QKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLA-------R 180

Query: 222 GLAGYVDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS 258
            +      DY+ +   G                 T +SDV+ FGV+L EI +
Sbjct: 181 DIH---HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.0 bits (117), Expect = 9e-07
 Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 44/214 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAG--FGFASVIKTLSLAQHPN 120
           R IG+G+ G VY  +  + +     VAVK        S        A +++      HP+
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF---DHPH 68

Query: 121 IVPILGF-SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           IV ++G  ++ P    IV E   +  L  YL  N     L      +  +   +  L YL
Sbjct: 69  IVKLIGVITENP--VWIVMELAPLGELRSYLQVNKYSLDLA---SLILYSYQLSTALAYL 123

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD-YWHEKGGG 238
               +   +H  I A N+L++   C ++ D+GLS            Y++D+ Y+    G 
Sbjct: 124 E---SKRFVHRDIAARNVLVSSPDCVKLGDFGLS-----------RYLEDESYYKASKGK 169

Query: 239 --------------NATRESDVYGFGVVLLEILS 258
                           T  SDV+ FGV + EIL 
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 70/278 (25%)

Query: 87  LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL 146
           LVAVK +       NA   F   IK +S  + PNI+ +L          +++E++    L
Sbjct: 48  LVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 147 DFYL--HE-----NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL 199
           + +L  HE            + ++  + +AT  A G++YL    + N +H  +   N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV 163

Query: 200 NEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY--------------WHEKGGGNATRESD 245
            + +  ++ D+G+S       R L  Y  D Y              W     G  T  SD
Sbjct: 164 GKNYTIKIADFGMS-------RNL--YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASD 214

Query: 246 VYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA---------------I 290
           V+ FGV L EIL+               L KE  +S+L D ++                +
Sbjct: 215 VWAFGVTLWEILT---------------LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYL 259

Query: 291 PCEIKPLV---RLAKVALACVGNSRKNRPSIVQVATIL 325
           P   KP +    L K+ L+C   + K RPS  ++   L
Sbjct: 260 P---KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 62/217 (28%), Positives = 82/217 (37%), Gaps = 37/217 (17%)

Query: 67  RIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           R +G G  G VY  L            VAVK + P          F      +S   H N
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQN 70

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLE 177
           IV ++G S     R I+ E +    L  +L EN    +  S L     L  A   A+G +
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           YL +    + IH  I A N LL  K   RV       +A +  R         Y+  KGG
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA-------SYY-RKGG 179

Query: 238 ----------------GNATRESDVYGFGVVLLEILS 258
                           G  T ++DV+ FGV+L EI S
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 31/207 (14%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKR--------IHPRLVLSNAGFGFASVIKTLSLAQHP 119
           +G+G  G V      +TG++VA+K+           +  L          +K L   +H 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALRE--------VKVLRQLRHE 60

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           NIV +    +  G   +V E++    L+  L  +  G   L  +          + + Y 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGG---LPPDAVRSYIWQLLQAIAYC 116

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK--- 235
           H     NIIH  IK  NIL++E    ++CD+G +  L       L  YV    W+     
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-WYRAPEL 172

Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
             G  N  +  DV+  G ++ E+L G 
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)

Query: 63  FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F   R++G+G  G V A  + +TGK+ A K++  + +    G   A   K +    +   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 122 VPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           V  L ++    + + +V   +N   L F+++   +     +  R +  A     GLE LH
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWHEK 235
           Q     I++  +K  NILL++    R+ D GL+   PE +      G  GY+  +    +
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 176

Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
                T   D +  G +L E+++G+
Sbjct: 177 ---RYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 15/205 (7%)

Query: 63  FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQHPN 120
           F H R++G+G  G V A  + +TGK+ A K++  + +    G   A   K  L       
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +V +    +      +V   +N   L F+++  N G    D  R +  A     GLE LH
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLH 119

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWHEK 235
           +     I++  +K  NILL++    R+ D GL+   PE +      G  GY+  +    +
Sbjct: 120 R---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176

Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
                T   D +G G ++ E++ G+
Sbjct: 177 ---RYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 31/158 (19%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPI 124
           IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +   HPNIV +
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKELNHPNIVKL 64

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL--EYLHQ- 181
           L       +  +V EF++   L  ++    D + L          +G    L   YL Q 
Sbjct: 65  LDVIHTENKLYLVFEFLHQ-DLKKFM----DASPL----------SGIPLPLIKSYLFQL 109

Query: 182 --GVA----PNIIHGCIKASNILLNEKFCARVCDYGLS 213
             G+A      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 22/155 (14%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV---------IKTLSLAQH 118
           IG+G  G V +A  S T + VA+K+I       NA   F +          IK L    H
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA------NA---FDNRIDAKRTLREIKLLRHLDH 63

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
            N++ I      P        +I    +D  LH+    +  L  +          RGL+Y
Sbjct: 64  ENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           +H   + N++H  +K SN+LLN     ++CD+GL+
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 46/215 (21%)

Query: 68  IIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSN----AGFGFASVIKTLSLAQHPNIV 122
           ++G+G  G V  A    TG+L A+K +    +++     +      + +T +  +HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            +    Q       V E+     L  ++H +     +    R +  A     GL+YLH+ 
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN 120

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLA 224
               I++  +K  N+LL+ +   ++ D+GL                   FLAPE      
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV----- 172

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
              +  Y         TR  D +G GV++ E+L G
Sbjct: 173 -LTETSY---------TRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 26/200 (13%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIVPI 124
           IG G  G VY A  ++TG+L A+K I         G  FA V   I  +   +H NIV  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIK-----LEPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G      +  I  EF    SL    H        L  ++   ++    +GL YLH   +
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLH---S 124

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--------HEKG 236
              +H  IK +NILL +    ++ D+G+S            ++   YW          KG
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184

Query: 237 GGNATRESDVYGFGVVLLEI 256
           G N  +  D++  G+  +E+
Sbjct: 185 GYN--QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 69/293 (23%), Positives = 116/293 (39%), Gaps = 45/293 (15%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLS-TGK---LVAVKRIHPRLVLSNAGFGFASVI 110
           E+D  +      RI+G GR G +    L    K    VA+  +           GF +  
Sbjct: 1   ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEA 57

Query: 111 KTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYL--HENNDGASLLDWNRRLRI 168
            TL    H NIV + G        +IV+E+++  +LD +L  HE    A  L     + +
Sbjct: 58  LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGM 112

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------- 220
             G A G++YL +      +H  + A  +L+N     ++  +       E+K        
Sbjct: 113 LPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTM 166

Query: 221 --RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKE 277
             +    +   +        + +  SDV+ FG+V+ E++S G R        W +     
Sbjct: 167 SGKSPVLWAAPEAIQY---HHFSSASDVWSFGIVMWEVMSYGER------PYWDMSGQDV 217

Query: 278 MRFSELLDP-RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           ++  E  D  RL  P     L  L ++ L C    R  RP   Q+ +IL+ +V
Sbjct: 218 IKAVE--DGFRLPAPRNCPNL--LHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 16/153 (10%)

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL-RIATGAARG 175
            HPN++  LG        ++V EF  +  L  YL  N    + +     L R+A   A G
Sbjct: 53  NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK------------RGL 223
           L +LHQ    + IH  +   N  L      ++ DYGL+     E             R L
Sbjct: 113 LLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEI 256
           A  + +    +    + T++S+++  GV + E+
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 47/183 (25%)

Query: 100 SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL 159
           S + F  AS++  LS   H ++V   G      E I+V E++   SLD YL +N +  ++
Sbjct: 43  SESFFEAASMMSQLS---HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI 99

Query: 160 LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---------NEKFCARVCDY 210
             W  +L +A   A  L +L       + HG + A N+LL         N  F  ++ D 
Sbjct: 100 S-W--KLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDP 152

Query: 211 GLS--------------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEI 256
           G+S              ++ PE        +++         N +  +D + FG  L EI
Sbjct: 153 GISITVLPKEILLERIPWVPPE-------CIENPQ-------NLSLAADKWSFGTTLWEI 198

Query: 257 LSG 259
            SG
Sbjct: 199 FSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 47/218 (21%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA------QHPN 120
           R+IG+G  G VY   L        ++IH  +   N       V + L          HPN
Sbjct: 1   RVIGKGHFGCVYHGTLIDS---DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 121 IVPILGFSQAP-GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG--AARGLE 177
           ++ +LG      G  ++V  ++    L  ++       ++ D      I  G   A+G+E
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGME 112

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEK 235
           YL        +H  + A N +L+E F  +V D+GL+       R +    D +Y+  H  
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLA-------RDI---YDKEYYSVHNH 159

Query: 236 GGGNA---------------TRESDVYGFGVVLLEILS 258
            G                  T +SDV+ FGV+L E+++
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 39/216 (18%)

Query: 67  RIIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           + +G+G  G+V    L+       VAVK +   +   +    F S    +    HPN++ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 124 ILGFSQAPGER------IIVSEFINMASLDFYLHEN--NDGASLLDWNRRLRIATGAARG 175
           ++G      E       +++  F+    L  +L  +   D    L     ++  T  A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK 235
           +EYL    + + IH  + A N +LNE     V D+GLS      K+   G    DY+ + 
Sbjct: 125 MEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS------KKIYNG----DYYRQG 171

Query: 236 GGGNA---------------TRESDVYGFGVVLLEI 256
                               T +SDV+ FGV + EI
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 76/296 (25%), Positives = 119/296 (40%), Gaps = 59/296 (19%)

Query: 66  RRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           +R +G+G  G V+ A            LVAVK +  +    NA   F    + L+  QH 
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTNLQHE 67

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL---------LDWNRRLRIAT 170
           +IV   G        I+V E++    L+ +L  +   A L         L  ++ L IA 
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
             A G+ YL    + + +H  +   N L+ E    ++ D+G+S       R +  Y  D 
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS-------RDV--YSTDY 175

Query: 231 YWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
           Y   + GG+                  T ESDV+  GVVL EI + G++    L     +
Sbjct: 176 Y---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232

Query: 273 PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             I + R   L  PR   P E+  L+      L C       R +I ++ ++L NL
Sbjct: 233 ECITQGRV--LQRPR-TCPKEVYDLM------LGCWQREPHMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 43/176 (24%)

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           ARG+E+L    +   IH  + A NILL+E    ++CD+GL+       R +  Y D DY 
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA-------RDI--YKDPDYV 230

Query: 233 HEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
            +   G+A                 T +SDV+ FGV+L EI S G     G+        
Sbjct: 231 RK---GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV-------Q 280

Query: 275 IKEMRFSELLD-PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           I E     L +  R+  P    P   +  + L C  N+ ++RP+  ++  IL +L+
Sbjct: 281 IDEEFCRRLKEGTRMRAPEYATP--EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 29/208 (13%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH---PRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +++GQG  G VY    + TG+ +AVK++                   I+ L   QH  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
              G  +      I  E++   S+   L     GA  L      +       G+EYLH  
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAY--GA--LTETVTRKYTRQILEGVEYLHSN 123

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLAGYVDDDYWH 233
               I+H  IK +NIL +     ++ D+G S      KR         G+       YW 
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGAS------KRLQTICSSGTGMKSVTGTPYWM 174

Query: 234 EK---GGGNATRESDVYGFGVVLLEILS 258
                 G    R++DV+  G  ++E+L+
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 39/218 (17%)

Query: 62  GFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ--- 117
            F   R+IG+G  G V       T K+ A+K ++ +  +        +V+    + Q   
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELN 58

Query: 118 HPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR-- 174
           HP +V  L +S    E + +V + +    L ++L            +++++ +    +  
Sbjct: 59  HPFLVN-LWYSFQDEENMYLVVDLLLGGDLRYHL------------SQKVKFSEEQVKFW 105

Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GL 223
                  LEYLH      IIH  IK  NILL+E+    + D+ ++     +       G 
Sbjct: 106 ICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGT 162

Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
            GY+  +    +G   A    D +  GV   E L G+R
Sbjct: 163 PGYMAPEVLCRQGYSVA---VDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 56/216 (25%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-----HPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           IG+G  G V  A   STG+ VAVK++       R +L N        +  +   QHPNIV
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE-------VVIMRDYQHPNIV 79

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR-----IAT---GAAR 174
            +        E  +V EF+             +G +L D     R     IAT      +
Sbjct: 80  EMYSSYLVGDELWVVMEFL-------------EGGALTDIVTHTRMNEEQIATVCLAVLK 126

Query: 175 GLEYLH-QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE---KRGLAGYVDDD 230
            L +LH QGV    IH  IK+ +ILL      ++ D+G      +E   ++ L G     
Sbjct: 127 ALSFLHAQGV----IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG---TP 179

Query: 231 YW-------HEKGGGNATRESDVYGFGVVLLEILSG 259
           YW           G     E D++  G++++E++ G
Sbjct: 180 YWMAPEVISRLPYG----TEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 43/214 (20%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLA-QHPNIVP 123
           R++G+G  G V  A L  +G+L AVK +   ++L +         K  LSLA  HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +    Q P     V EF+N   L F++ ++       D  R    A      L +LH   
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHD-- 114

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLAG 225
              II+  +K  N+LL+ +   ++ D+G+                   ++APE  + +  
Sbjct: 115 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
               D+W                 GV+L E+L G
Sbjct: 174 GPSVDWW---------------AMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 26/204 (12%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           ++G+G  G V       TG++VA+K+                 I+ L   +H N+V ++ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
             +      +V EF++   LD  L +  +G   LD +R  +      RG+E+ H     N
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLD-DLEKYPNG---LDESRVRKYLFQILRGIEFCHSH---N 120

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLA--GYVDDDY----WHEK----- 235
           IIH  IK  NIL+++    ++CD+G +       R LA  G V  DY    W+       
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFA-------RTLAAPGEVYTDYVATRWYRAPELLV 173

Query: 236 GGGNATRESDVYGFGVVLLEILSG 259
           G     R  D++  G ++ E+L+G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 30/162 (18%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNIV 122
            IGQG  G V+ A    T ++VA+K++    ++ N   GF       IK L L +H N+V
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVV 74

Query: 123 PILGFSQA---PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR----- 174
            ++   +    P  R   S ++     +F  H   D A LL  N+ ++      +     
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVF---EFCEH---DLAGLLS-NKNVKFTLSEIKKVMKM 127

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
              GL Y+H+     I+H  +KA+NIL+ +    ++ D+GL+
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 46/215 (21%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNA----GFGFASVIKTLSLAQHPNIVP 123
           IG+G  G VY      T ++ A+K +  + +++        G  +++    L + P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 124 ILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            L FS Q   +  +V+++  M+  + + H   +G    +   +  IA      LE+LH+ 
Sbjct: 61  -LKFSFQTDSDLYLVTDY--MSGGELFWHLQKEG-RFSEDRAKFYIAE-LVLALEHLHKY 115

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLA 224
              +I++  +K  NILL+      +CD+GLS                  +LAPE      
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
           GY              T+  D +  GV++ E+  G
Sbjct: 173 GY--------------TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 13/200 (6%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLA-QHPNIVP 123
           +++G+G  G V+ A L  T +  A+K +   +VL +       V K  LSLA +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +    Q       V E++N   L F++   +      D  R    A     GL++LH   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLH--- 113

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGL---SFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
           +  I++  +K  NILL+     ++ D+G+   + L   +     G  D        G   
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 241 TRESDVYGFGVVLLEILSGR 260
               D + FGV+L E+L G+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 53/217 (24%)

Query: 69  IGQGRLGTV---YAALLSTGKLVAVKRIHPRLVLSNAG---------FGFASVIKTLSLA 116
           +G G  GTV      +  + K VAVK      +L N              A+V++ L   
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK------ILKNDNNDPALKDELLREANVMQQLD-- 54

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            +P IV ++G  +A    ++V E   +  L+ +L +N     + + N    +    + G+
Sbjct: 55  -NPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKH---VTEKNI-TELVHQVSMGM 108

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG 236
           +YL +    N +H  + A N+LL  +  A++ D+GLS       + L    D++Y+  K 
Sbjct: 109 KYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS-------KALGA--DENYYKAKT 156

Query: 237 GG---------------NATRESDVYGFGVVLLEILS 258
            G                 + +SDV+ FGV++ E  S
Sbjct: 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 34/158 (21%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAG---FGFASVIKTLSLAQHPNIVPI 124
           IG+G  G VY A+   T ++VA+K I     L  A          I+ LS  + P I   
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 125 LGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RG 175
            G S   G ++ I+ E+               G S LD  +  ++              G
Sbjct: 65  YG-SFLKGSKLWIIMEYC-------------GGGSCLDLLKPGKLDETYIAFILREVLLG 110

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           LEYLH+      IH  IKA+NILL+E+   ++ D+G+S
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 46.8 bits (112), Expect = 7e-06
 Identities = 63/230 (27%), Positives = 94/230 (40%), Gaps = 66/230 (28%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-----------FASVIKTL 113
            + +G+G  G V+ A+   T ++VA+K+I          F            F  ++   
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIMFLQ 61

Query: 114 SLAQHPNIVPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATG 171
            L  HPNIV +L   +A  ++ I  V E++     +  LH       L D ++R  I   
Sbjct: 62  ELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQ 115

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL--SFLAPEEKRG---LAGY 226
             + L+Y+H G   N+IH  +K SNILLN     ++ D+GL  S    EE      L  Y
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 227 VDDDYWHEKGGGNATR---------ESDVYGFGV-------VLLEILSGR 260
           V            ATR          S  Y  GV       +L E+L G+
Sbjct: 173 V------------ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 46.4 bits (111), Expect = 8e-06
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 33/168 (19%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHP-RLVLSNAGFGFASV--IKTLSLAQHPNIVPI 124
           +G+G    VY A    TG++VA+K+I       +  G  F ++  IK L   +HPNI+ +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 125 LG-FSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG--------AAR 174
           L  F       I +V EF  M +         D   ++  ++ + +             R
Sbjct: 68  LDVFGH--KSNINLVFEF--MET---------DLEKVIK-DKSIVLTPADIKSYMLMTLR 113

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL--SFLAPEEK 220
           GLEYLH      I+H  +K +N+L+      ++ D+GL  SF +P  K
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 8e-06
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 31/206 (15%)

Query: 69  IGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ--HPNIVPIL 125
           I +G  G+VY A   STG   A+K +    +++          + + + Q   P +  + 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLL--------DWNRRLRIATGAARGLE 177
              Q+     +V E++N            D ASL+        DW ++         G+E
Sbjct: 64  YSFQSKDYLYLVMEYLN----------GGDCASLIKTLGGLPEDWAKQY--IAEVVLGVE 111

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR--GLAGYVDDDYWHEK 235
            LHQ     IIH  IK  N+L+++    ++ D+GLS    E K+  G   Y+  +     
Sbjct: 112 DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGV 168

Query: 236 GGGNATRESDVYGFGVVLLEILSGRR 261
           G     + SD +  G V+ E L G  
Sbjct: 169 GD---DKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 37/158 (23%)

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           P IV   G   + GE  I  E ++  SLD  L +    A  +  N   +I+    RGL Y
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTY 114

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL----------------SFLAPEEKRG 222
           L +     I+H  +K SNIL+N +   ++CD+G+                S+++PE  + 
Sbjct: 115 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ- 171

Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                         G + T +SD++  G+ L+E+  GR
Sbjct: 172 --------------GTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 58/226 (25%), Positives = 88/226 (38%), Gaps = 25/226 (11%)

Query: 110 IKTLSLAQHPNIVPILGF----SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           IK L      NI+ I GF            ++ E+     L   L +  D    L +  +
Sbjct: 69  IKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTK 124

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL--SFLAPEEKR-G 222
           L +A    +GL  L++    N  +  + + + L+ E +  ++  +GL     +P  K   
Sbjct: 125 LDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182

Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE 282
              Y      ++      T + D+Y  GVVL EI +G+   E L  K    LI     S 
Sbjct: 183 FMVYFSYKMLNDIFS-EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241

Query: 283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
            L   L  P EIK +V       AC  +    RP+I     IL NL
Sbjct: 242 KLP--LDCPLEIKCIVE------ACTSHDSIKRPNI---KEILYNL 276

Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 23/198 (11%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQHPNIVPILG 126
           IG G  G VY A  S T ++VAVK++      +N  +      +K L   +HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 127 FSQAPGERIIVSEF-INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
                    +V E+ +  AS    +H+       L       I  GA +GL YLH   + 
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLH---SH 140

Query: 186 NIIHGCIKASNILLNEKFCARVCDYG-LSFLAPEEKRGLAGYVDDDYWHEK------GGG 238
           N+IH  IKA NILL E    ++ D+G  S  +P        +V   YW           G
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPEVILAMDEG 195

Query: 239 NATRESDVYGFGVVLLEI 256
               + DV+  G+  +E+
Sbjct: 196 QYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 46/191 (24%), Positives = 80/191 (41%), Gaps = 41/191 (21%)

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENN--------DGASL----LDW 162
           + +H NI+ +LG     G   ++ E+    +L  +L            D   +    L +
Sbjct: 74  IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +  A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       RG
Sbjct: 134 KDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA-------RG 183

Query: 223 LAGYVDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGL 266
           +    D DY+ +   G                 T +SDV+ FG+++ EI + G     G+
Sbjct: 184 VH---DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240

Query: 267 LVKWALPLIKE 277
            V+    L++E
Sbjct: 241 PVEELFKLLRE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 51/196 (26%)

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGA------------SLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL                     L +
Sbjct: 80  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------- 213
              +  A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+         
Sbjct: 140 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196

Query: 214 -----------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRR 261
                      ++APE         D  Y H+         SDV+ FGV+L EI + G  
Sbjct: 197 KKTTNGRLPVKWMAPE------ALFDRIYTHQ---------SDVWSFGVLLWEIFTLGGS 241

Query: 262 CEEGLLVKWALPLIKE 277
              G+ V+    L+KE
Sbjct: 242 PYPGVPVEELFKLLKE 257

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 45/216 (20%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLA-QHPNIVP 123
           +++G+G  G V  A L  T +L AVK +   ++L +         K  L+LA +HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +    Q       V E++N   L F++  +       D  R    A     GL++LH+  
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHE-- 114

Query: 184 APNIIHGCIKASNILLN-EKFCARVCDYGLS------------------FLAPEEKRGLA 224
              II+  +K  N+LL+ E    ++ D+G+                   ++APE      
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHI-KIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-- 170

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                 Y             D +  GV+L E+L+G+
Sbjct: 171 ----QPY---------GPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 17/201 (8%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G G  G VY A    TG   A K I  ++        F   I  LS  +HPNIV +   
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
                +  I+ EF +  +LD  + E   G   L   +   +       L +LH   +  +
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLH---SHKV 124

Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH-------EKGGGNA 240
           IH  +KA NILL      ++ D+G+S       +    ++   YW        E    N 
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 241 -TRESDVYGFGVVLLEILSGR 260
              ++D++  G+ L+E+    
Sbjct: 185 YDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 65/217 (29%), Positives = 93/217 (42%), Gaps = 54/217 (24%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS----LAQ--HPNI 121
           IG+G  G V       T ++ A+K I    ++S +      V  TL+    LAQ   P I
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-----EVTHTLAERTVLAQVNCPFI 55

Query: 122 VPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           VP L FS Q+P +  +V  FIN   L F+ H   +G    D +R           LE LH
Sbjct: 56  VP-LKFSFQSPEKLYLVLAFINGGEL-FH-HLQREGR--FDLSRARFYTAELLCALENLH 110

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRG 222
           +    N+I+  +K  NILL+ +    +CD+GL                   +LAPE   G
Sbjct: 111 KF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167

Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
             GY              T+  D +  GV+L E+L+G
Sbjct: 168 H-GY--------------TKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 37/167 (22%)

Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
           ++ L     P IV   G   + GE  I  E ++  SLD  L E    A  +      +++
Sbjct: 54  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVS 109

Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL----------------S 213
               RGL YL +     I+H  +K SNIL+N +   ++CD+G+                S
Sbjct: 110 IAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Query: 214 FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           +++PE  +G                + + +SD++  G+ L+E+  GR
Sbjct: 168 YMSPERLQGT---------------HYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 72/242 (29%), Positives = 105/242 (43%), Gaps = 45/242 (18%)

Query: 102 AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD 161
           A F  AS++  +S   H ++  + G      E I+V EF+    LD  L +   G   + 
Sbjct: 62  AFFETASLMSQVS---HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVA 117

Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA-------RVCDYGLSF 214
           W  ++ +A   A  L YL      N++HG + A NILL     A       ++ D G+SF
Sbjct: 118 W--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF 172

Query: 215 --LAPEEKRGLAGYVDDDYWHE----KGGGNATRESDVYGFGVVLLEILSGRRCEEG-LL 267
             L+ EE+      V+   W       GG + +  +D + FG  LLEI     C +G + 
Sbjct: 173 TALSREER------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGEVP 221

Query: 268 VKWALPLIKEMRFSELLDPRLAIP-CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
           +K   P  KE RF E    RL  P C+      LA +   C+      RPS     TIL 
Sbjct: 222 LKERTPSEKE-RFYE-KKHRLPEPSCK-----ELATLISQCLTYEPTQRPSF---RTILR 271

Query: 327 NL 328
           +L
Sbjct: 272 DL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 20/202 (9%)

Query: 68  IIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFA----SVIKTLSLAQHPNIV 122
           IIG+G  G VY    + TGK+ A+K +  + +    G   A     ++  +S    P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI-ATGAARGLEYLHQ 181
            +      P +   + + +N   L ++L ++   +      + +R  AT    GLE++H 
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE-----KEMRFYATEIILGLEHMHN 115

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGL----SFLAPEEKRGLAGYVDDDYWHEKGG 237
                +++  +K +NILL+E    R+ D GL    S   P    G  GY+  +   +  G
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK--G 170

Query: 238 GNATRESDVYGFGVVLLEILSG 259
                 +D +  G +L ++L G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 45/197 (22%), Positives = 86/197 (43%), Gaps = 41/197 (20%)

Query: 152 ENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
           E+ + +  LD +  LR ++  A+G+++L    + N IH  + A N+LL +   A++CD+G
Sbjct: 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFG 257

Query: 212 LSFLAPEEKRGLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLL 254
           L+       R +    D +Y  +   GNA                 T +SDV+ +G++L 
Sbjct: 258 LA-------RDIMN--DSNYVVK---GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 305

Query: 255 EILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRK 313
           EI S G+    G+LV          +F +++     +         +  +   C      
Sbjct: 306 EIFSLGKSPYPGILV--------NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPT 357

Query: 314 NRPSIVQVATILNNLVG 330
            RP+  Q++ ++   +G
Sbjct: 358 ERPTFSQISQLIQRQLG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 35/230 (15%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS-NAGFGFA 107
           EI+ +T  F     +G+ R G VY   L         + VA+K +  +        F   
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 108 SVIKTLSLAQHPNIVPILG-----------FSQAPGERIIVSEFINMASLDFYLHENNDG 156
           ++++  S  QHPNIV +LG           FS      +   EF+ M S    +   +D 
Sbjct: 59  AMMR--SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL--HEFLVMRSPHSDVGSTDDD 114

Query: 157 ---ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL- 212
               S L+    + I T  A G+E+L    + +++H  +   N+L+ +K   ++ D GL 
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLF 171

Query: 213 -SFLAPEEKRGLAGYVDDDYWHEKGG---GNATRESDVYGFGVVLLEILS 258
               A +  + +   +    W        G  + +SD++ +GVVL E+ S
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 26/156 (16%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA---QHPNIVPI 124
           IG+G  G VY      TG++VA+K+I  RL     G   ++ I+ +SL    QHPNIV +
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI--RLESEEEGVP-STAIREISLLKELQHPNIVCL 64

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ--- 181
                      ++ EF++M  L  YL     G  +            A     YL+Q   
Sbjct: 65  QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYM-----------DAELVKSYLYQILQ 112

Query: 182 GV----APNIIHGCIKASNILLNEKFCARVCDYGLS 213
           G+    +  ++H  +K  N+L++ K   ++ D+GL+
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 8/92 (8%)

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL-APEEKRGLAGYVDDDYW 232
           RGL+YLH   +  I+H  IK  N+L+N     ++CD+GL+ +  P+E + +   V   Y+
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 233 HEK----GGGNATRESDVYGFGVVLLEILSGR 260
                  G  + T   D++  G +  E+L  R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 41/212 (19%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFA------SVIKTLSLAQHPN 120
           +IG+G  G VY    + TG++VA+K I+    L       +      +++  L  +Q PN
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 121 IVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA------ 173
           I    G + + P   II         +++      +G S+    +   IA          
Sbjct: 64  ITKYYGSYLKGPRLWII---------MEYA-----EGGSVRTLMKAGPIAEKYISVIIRE 109

Query: 174 --RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
               L+Y+H+     +IH  IKA+NIL+      ++CD+G++ L  +     + +V   Y
Sbjct: 110 VLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY 166

Query: 232 WHE----KGGGNATRESDVYGFGVVLLEILSG 259
           W        G     ++D++  G+ + E+ +G
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)

Query: 66  RRIIGQGRLGTVYAAL---LSTGK---LVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQH 118
           +R +G+G  G V+ A    LS  K   LVAVK +  P L    A   F    + L+  QH
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQH 66

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENN-------DGASL-----LDWNRRL 166
            +IV   G        I+V E++    L+ +L  +        DG        L  ++ L
Sbjct: 67  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            IA+  A G+ YL    + + +H  +   N L+      ++ D+G+S       R +  Y
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS-------RDV--Y 174

Query: 227 VDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
             D Y   + GG+                  T ESDV+ FGV+L EI +
Sbjct: 175 STDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 32/103 (31%)

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A+G+E+L    +   IH  + A NILL+E    ++CD+GL+       R +  Y D DY 
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA-------RDI--YKDPDYV 236

Query: 233 HEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
            +   G+A                 T +SDV+ FGV+L EI S
Sbjct: 237 RK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 47/182 (25%)

Query: 67  RIIGQGRLGTVYAALLS-TGKLVAVKR--------IHPRLVLSNAGFGFASVIKTLSLAQ 117
             +G G  G V +A  + TG+ VA+K+        IH +             ++ L    
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRE--------LRLLKHMD 72

Query: 118 HPNIVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR--------- 167
           H N++ +L  F+  P     + +F      D YL  +  GA L   N  ++         
Sbjct: 73  HENVIGLLDVFT--PASS--LEDF-----QDVYLVTHLMGADL---NNIVKCQKLSDDHI 120

Query: 168 --IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
             +     RGL+Y+H   +  IIH  +K SNI +NE    ++ D+GL+    +E   + G
Sbjct: 121 QFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTG 174

Query: 226 YV 227
           YV
Sbjct: 175 YV 176

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 25/238 (10%)

Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A + S+GKLVAVK++  R         F  V+  +   QH N+V +   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVV-IMRDYQHENVVEMYNS 85

Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                E  +V EF+   +L D   H      + ++  +   +     + L  LH   A  
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQG 136

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR---- 242
           +IH  IK+ +ILL      ++ D+G      +E       V   YW        +R    
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW--MAPELISRLPYG 194

Query: 243 -ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVR 299
            E D++  G++++E++ G   E     +  L  +K +R  + L P+L    ++ P ++
Sbjct: 195 PEVDIWSLGIMVIEMVDG---EPPYFNEPPLKAMKMIR--DNLPPKLKNLHKVSPSLK 247

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 58/226 (25%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGK----LVAVKRIH----PRL---VLSNAGFGFASVI 110
           F   +++G G  GTVY  L +  G+     VA+K +     P+    +L  A +  ASV 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASV- 66

Query: 111 KTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRLR 167
                  +P++  +LG       ++I ++ +    L  Y+ E+ D      LL+W  ++ 
Sbjct: 67  ------DNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI- 118

Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGY 226
                A+G+ YL +     ++H  + A N+L+      ++ D+GL+  L  +EK      
Sbjct: 119 -----AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE----- 165

Query: 227 VDDDYWHEKGGG--------------NATRESDVYGFGVVLLEILS 258
                +H +GG                 T +SDV+ +GV + E+++
Sbjct: 166 -----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 40/217 (18%)

Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
            IG+G  GTV      S GK++  K I    +         S +  L   +HPNIV    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY- 65

Query: 127 FSQAPGERIIVSEFINMASLDFYLH----ENNDGASLLDWNRR----------LRIATGA 172
                 +RII     + ++   Y+     E  D A L+   ++           RI T  
Sbjct: 66  ------DRII-----DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 173 ARGLEYLHQGVAPN--IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
              L   H    P   ++H  +K +NI L+     ++ D+GL+ +   +      YV   
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP 174

Query: 231 YW-------HEKGGGNATRESDVYGFGVVLLEILSGR 260
           Y+       H         +SD++  G ++ E+ +  
Sbjct: 175 YYMSPEQLNHMS----YDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 45.1 bits (106), Expect = 2e-05
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 42/214 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPNIVPI 124
           +++G+G  G V      ++GK  A+K +   ++++        +  + L   +HP +  +
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               Q       V E++N   L F+L        +   +R           L+YLH G  
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG-- 114

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLAGY 226
             I++  +K  N++L++    ++ D+GL                   +LAPE        
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE----- 168

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            D+DY          R  D +G GVV+ E++ GR
Sbjct: 169 -DNDY---------GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 50/159 (31%), Positives = 70/159 (44%), Gaps = 25/159 (15%)

Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---H 118
           F+  R IG G  G VY A    T ++VA+K++      SN  +    +IK +   Q   H
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW--QDIIKEVRFLQQLRH 74

Query: 119 PNIVPILGFSQAPGERIIVSEF-INMAS--LDFY---LHENNDGASLLDWNRRLRIATGA 172
           PN +   G         +V E+ +  AS  L+ +   L E    A          I  GA
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA----------ICHGA 124

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
            +GL YLH   +   IH  IKA NILL E    ++ D+G
Sbjct: 125 LQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 22/209 (10%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHP-RLVLSNAGFGFASVIKTLSLAQ 117
              F   + IG+G+   VY A+ L  G++VA+K++    ++ + A       I  L    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD----WNRRLRIATGAA 173
           HPN++  L       E  IV E  +   L   +        L+     W   +++     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPE--EKRGLAG---YV 227
             LE++H      I+H  IK +N+ +      ++ D GL  F + +      L G   Y+
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEI 256
             +  HE G      +SD++  G +L E+
Sbjct: 174 SPERIHENG---YNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 43/215 (20%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLA-QHPNIVP 123
           +++G+G  G V  A L   G+  AVK +   +VL +       V K  L+LA ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +    Q       V EF+N   L F++ +        D  R    A     GL++LH   
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR----FDLYRATFYAAEIVCGLQFLH--- 113

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLAG 225
           +  II+  +K  N++L+     ++ D+G+                   ++APE  +GL  
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               D+W                FGV+L E+L G+
Sbjct: 174 TFSVDWW---------------SFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 52/209 (24%), Positives = 83/209 (39%), Gaps = 28/209 (13%)

Query: 69  IGQGRLGTVYAALLSTG---KLVAVKRIHPRLVLSNAG----FGFASVIKTLSLAQHPNI 121
           IG G  G V    +++G     V VK +       +A       F    +     QH N+
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELR-----VSASVQEQMKFLEEAQPYRSLQHSNL 57

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL-RIATGAARGLEYLH 180
           +  LG        ++V EF  +  L  YL        +      L R+A   A GL +LH
Sbjct: 58  LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------FLAPEEK----RGLAGYVD 228
           +    N IH  +   N LL      ++ DYGLS        ++ P++     R +A  + 
Sbjct: 118 KN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEIL 257
           D+        + T+ES+V+  GV + E+ 
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 50/196 (25%), Positives = 79/196 (40%), Gaps = 51/196 (26%)

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENN--------DGASL----LDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL            D   L    L +
Sbjct: 74  IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133

Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------- 213
              +  A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+         
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190

Query: 214 -----------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRR 261
                      ++APE         D  Y H+         SDV+ FGV+L EI + G  
Sbjct: 191 KKTTNGRLPVKWMAPE------ALFDRVYTHQ---------SDVWSFGVLLWEIFTLGGS 235

Query: 262 CEEGLLVKWALPLIKE 277
              G+ V+    L+KE
Sbjct: 236 PYPGIPVEELFKLLKE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 65/263 (24%), Positives = 113/263 (42%), Gaps = 71/263 (26%)

Query: 67  RIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV------IKTLSLAQHP 119
           R +G G  G V++A+ S   K VAVK+I    VL++      SV      IK +    H 
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDP----QSVKHALREIKIIRRLDHD 62

Query: 120 NIVPIL-----GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNR------RLRI 168
           NIV +        S    +   ++E  ++  +  Y+    D A++L+         RL  
Sbjct: 63  NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLSEEHARL-F 119

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYV 227
                RGL+Y+H   + N++H  +K +N+ +N E    ++ D+GL+ +           V
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI-----------V 165

Query: 228 DDDYWHEKG-------------------GGNATRESDVYGFGVVLLEILSGR-------R 261
           D  Y H KG                     N T+  D++  G +  E+L+G+        
Sbjct: 166 DPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224

Query: 262 CEEGLLVKWALPLIKEMRFSELL 284
            E+  L+  ++P+++E   +ELL
Sbjct: 225 LEQMQLILESVPVVREEDRNELL 247

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 43/215 (20%)

Query: 67  RIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTL--SLAQHPNIVP 123
           R+IG+G    V    L  T ++ A+K +   LV  +    +    K +    + HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +    Q       V E++N   L F++        L + + R   A   +  L YLH+  
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAE-ISLALNYLHE-- 114

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLAG 225
              II+  +K  N+LL+ +   ++ DYG+                  +++APE  RG   
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--- 170

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              +DY             D +  GV++ E+++GR
Sbjct: 171 ---EDYGF---------SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 25/210 (11%)

Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRL--VLSNAGFGFASVIKTLSLAQ 117
           D F     +G G  G V+      +G ++A K IH  +   + N       +I+ L +  
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58

Query: 118 HPNIVPILGFSQA---PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
             N   I+GF  A    GE  I  E ++  SLD  L +    A  +      +++    +
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 114

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDD 230
           GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+  +
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 172

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                 G + + +SD++  G+ L+E+  GR
Sbjct: 173 RLQ---GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 52/167 (31%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 60  TDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQ 117
           TD +     IG+G  G VY       G L AVK + P   +S+      +    L SL  
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP---ISDVDEEIEAEYNILQSLPN 77

Query: 118 HPNIVPILG-FSQAP----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR----- 167
           HPN+V   G F +A     G+  +V E  N  S+   +        LL   +RL      
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK------GLLICGQRLDEAMIS 131

Query: 168 -IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            I  GA  GL++LH      IIH  +K +NILL  +   ++ D+G+S
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 43.7 bits (104), Expect = 7e-05
 Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 27/156 (17%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--------IKTL-SLAQH 118
           +G G  G+VY A    TG+LVA+K++  +         F S         +K+L  L +H
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKK---------FYSWEECMNLREVKSLRKLNEH 57

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR-IATGAARGLE 177
           PNIV +    +   E   V E++                        +R I     +GL 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKG---KPFS-ESVIRSIIYQILQGLA 113

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           ++H+       H  +K  N+L++     ++ D+GL+
Sbjct: 114 HIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA 146

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 43.3 bits (102), Expect = 7e-05
 Identities = 63/224 (28%), Positives = 86/224 (38%), Gaps = 48/224 (21%)

Query: 67  RIIGQGRLGTVYAALL------STGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLA--- 116
             +G G  G VY           +G + VAVK +                +K   L    
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE----KKEFLKEAHLMSNF 56

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE---NNDGASLLDWNRRLRIATGAA 173
            HPNIV +LG       + I+ E +    L  YL +      G  LL     L I    A
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEK--FCARVC---DYGLSFLAPEEKRGLAGYVD 228
           +G  YL Q    + IH  + A N L++EK     RV    D+GL+       R +  Y  
Sbjct: 117 KGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA-------RDI--YKS 164

Query: 229 DDYWHEKGG--------------GNATRESDVYGFGVVLLEILS 258
           D Y  E  G              G  T +SDV+ FGV++ EIL+
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 29/156 (18%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRL------VLSNAGFGFASVIKTLSL---AQH 118
           IG+G  G VY A    TG++VA+K+I  RL      V S A       I+ +SL     H
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI--RLETEDEGVPSTA-------IREISLLKELNH 57

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--RIATGAARGL 176
           PNIV +L    +  +  +V EF+++  L  Y+    D + L   +  L         +G+
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM----DSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
            Y H      ++H  +K  N+L++ +   ++ D+GL
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 83

Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 84  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 134

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H   + +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 135 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 188

Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 42.9 bits (102), Expect = 9e-05
 Identities = 50/239 (20%), Positives = 79/239 (33%), Gaps = 85/239 (35%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT------- 112
           D F   + +G G  G V       +GK  A+K +             A ++K        
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS-----------KAKIVKLKQVEHVL 49

Query: 113 -----LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR 167
                L   +HP +V + G  Q      +V E++    L F               +  R
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL-FSHL-----------RKSGR 97

Query: 168 IATGAAR--------GLEYLHQGVAPNIIHGCIKASNILLNEK---------FCARV--- 207
                AR         LEYLH   + +I++  +K  N+LL+           F  RV   
Sbjct: 98  FPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154

Query: 208 -------CDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
                   +Y    LAPE      GY               +  D +  G+++ E+L+G
Sbjct: 155 TYTLCGTPEY----LAPEIILS-KGY--------------GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 51/232 (21%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL 113
           E +   D    R ++G+G  G VYAA  LST   +A+K I  R   S         I   
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALH 59

Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE-----NNDGASLLDWNRRLRI 168
           S  +H NIV  LG     G   I  E +   SL   L        ++  +++ + +++  
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-- 117

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYG---------------- 211
                 GL+YLH      I+H  IK  N+L+N      ++ D+G                
Sbjct: 118 ----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170

Query: 212 --LSFLAPEE-KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             L ++APE   +G  GY          G  A    D++  G  ++E+ +G+
Sbjct: 171 GTLQYMAPEVIDKGPRGY----------GAPA----DIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 42/185 (22%), Positives = 72/185 (38%), Gaps = 46/185 (24%)

Query: 108 SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHEN-------------- 153
           S    L    HP+++ + G     G  +++ E+    SL  +L E+              
Sbjct: 52  SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111

Query: 154 ------NDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
                 N     L     +  A   +RG++YL +     ++H  + A N+L+ E    ++
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKI 168

Query: 208 CDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA--------------TRESDVYGFGVVL 253
            D+GLS       R +  Y +D Y     G                 T +SDV+ FGV+L
Sbjct: 169 SDFGLS-------RDV--YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 219

Query: 254 LEILS 258
            EI++
Sbjct: 220 WEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 37/143 (25%), Positives = 54/143 (37%), Gaps = 26/143 (18%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRI------HPRLVLSNAGFGFASVIKTLSLAQHPN 120
           +      +  +      T  LVAVK+I         L L         +I +  L QHPN
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLL-----QQEIITSRQL-QHPN 60

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHEN-NDGASLLDWNRRLRIA---TGAARGL 176
           I+P +       E  +VS  +   S +  L  +  +G         L IA         L
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNAL 114

Query: 177 EYLHQGVAPNIIHGCIKASNILL 199
           +Y+H       IH  +KAS+ILL
Sbjct: 115 DYIHSK---GFIHRSVKASHILL 134

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 15/168 (8%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G G  G VY A    TG L A K I  +         +   I+ L+   HP IV +LG 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL---RIATGAARGLEYLHQGVA 184
               G+  I+ EF    ++D         A +L+ +R L   +I     + LE L    +
Sbjct: 78  FYWDGKLWIMIEFCPGGAVD---------AIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
             IIH  +KA N+LL      ++ D+G+S    +  +    ++   YW
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYW 176

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 51/213 (23%), Positives = 83/213 (38%), Gaps = 29/213 (13%)

Query: 67  RIIGQGRLG--TVYAALLSTGKLVAVKRIH--------PRLVLSNAGFGFASVIKTLSLA 116
           R++G+G  G  T+Y        LV  K ++         R  L+         I  LSL 
Sbjct: 6   RVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNE--------IVILSLL 56

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARG 175
           QHPNI+            +I  E+ N  +L D  + +      L +    L         
Sbjct: 57  QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSA 113

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK 235
           + Y+H+     I+H  IK  NI L +    ++ D+G+S +   E       V   Y+   
Sbjct: 114 VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSP 170

Query: 236 ---GGGNATRESDVYGFGVVLLEILSGRRCEEG 265
               G     +SD++  G VL E+L+ +R  + 
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 10/113 (8%)

Query: 88  VAVKRIHP-RLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL 146
           V +K + P    +S A F  AS+++ +S   H +IV + G      E I+V EF+    L
Sbjct: 35  VILKVLDPSHRDISLAFFETASMMRQVS---HKHIVLLYGVCVRDVENIMVEEFVEFGPL 91

Query: 147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL 199
           D ++H  +D   +L    + ++A   A  L YL      +++HG +   NILL
Sbjct: 92  DLFMHRKSD---VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 45/199 (22%), Positives = 92/199 (46%), Gaps = 15/199 (7%)

Query: 69  IGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQHPNIVPILG 126
           +G+G  G V A  + +TGK+ A K++  + +   +G   A + K  L     P IV +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
             ++     +V   +N   L ++++  N G   L+  R +  +     G+ +LH     +
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIY--NVGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNAT 241
           I++  +K  N+LL+++   R+ D GL+    +     ++ G  GY+  +   E+     +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE---PYS 172

Query: 242 RESDVYGFGVVLLEILSGR 260
              D +  G  + E+++GR
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 50/245 (20%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPNIVPI 124
           +++G+G  G V      +TG+  A+K +   ++++        +  + L   +HP +  +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               Q       V E+ N   L F+L        +    R           LEYLH   +
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH---S 113

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLAGY 226
            ++++  IK  N++L++    ++ D+GL                   +LAPE        
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE----- 168

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCEEGLLVKWALPLIKEMRFS 281
            D+DY          R  D +G GVV+ E++ GR     +  E L   + L L++E+RF 
Sbjct: 169 -DNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEIRFP 215

Query: 282 ELLDP 286
             L P
Sbjct: 216 RTLSP 220

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 21/216 (9%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPI 124
           +G+G   TV+      T  LVA+K I     L +      + I+ +SL +   H NIV +
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
                      +V E+++   L  Y+   +D  +++  +          RGL Y H+   
Sbjct: 70  HDIVHTDKSLTLVFEYLD-KDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHR--- 122

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-----GGGN 239
             ++H  +K  N+L+NE+   ++ D+GL+       +  +  V    W+       G   
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV-VTLWYRPPDVLLGSSE 181

Query: 240 ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
            + + D++G G +  E+ SGR    G  V+  L LI
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 50/223 (22%), Positives = 89/223 (39%), Gaps = 59/223 (26%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL--SLAQHPNIVP 123
           R+IG+G    V    L  T ++ A+K I   LV  +    +    K +  + + HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR--------G 175
           +    Q       V EF++   L F++             R+ ++    AR         
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQ------------RQRKLPEEHARFYSAEISLA 108

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAP 217
           L +LH+     II+  +K  N+LL+ +   ++ DYG+                  +++AP
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAP 165

Query: 218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           E  RG      +DY             D +  GV++ E+++GR
Sbjct: 166 EILRG------EDY---------GFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 41/191 (21%)

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL                     + +
Sbjct: 77  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136

Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 137 KDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 186

Query: 223 LAGYVDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 187 VNNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243

Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 244 PVEELFKLLKE 254

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 31/160 (19%)

Query: 118 HPNIVPILGFS-QAPGERIIVSEFINMASLDFYL----HENNDGASLLDWNRRLRIATGA 172
           H NI+PIL    +      ++  ++N  +L  +L        +    L   + + +A   
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---F------LAPEEKR-- 221
           A G+ YLH+     +IH  I A N +++E+   ++ D  LS   F      L   E R  
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183

Query: 222 ---GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS 258
               L   V+ +Y         +  SDV+ FGV+L E+++
Sbjct: 184 KWMALESLVNKEY---------SSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 55/245 (22%), Positives = 100/245 (40%), Gaps = 49/245 (20%)

Query: 67  RIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPNIVPI 124
           +++G+G  G V      +TG+  A+K +   ++++        +  + L  ++HP +  +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               Q       V E+ N   L F+L        +   +R           L+YLH    
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--E 114

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLAGY 226
            N+++  +K  N++L++    ++ D+GL                   +LAPE        
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE----- 169

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCEEGLLVKWALPLIKEMRFS 281
            D+DY          R  D +G GVV+ E++ GR     +  E L   + L L++E+RF 
Sbjct: 170 -DNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEEIRFP 216

Query: 282 ELLDP 286
             L P
Sbjct: 217 RTLSP 221

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 25/111 (22%), Positives = 45/111 (40%), Gaps = 30/111 (27%)

Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
           ++     + L YL +     +IH  +K SNILL+     ++CD+G+S           G 
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS-----------GR 164

Query: 227 VDDDYWHEKGGGNATR-----------------ESDVYGFGVVLLEILSGR 260
           + D     +  G A                    +DV+  G+ L+E+ +G+
Sbjct: 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL----AQ 117
           F    ++G G  G VY    + TG+L A+K      V+   G     + + +++    + 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIK------VMDVTGDEEEEIKQEINMLKKYSH 61

Query: 118 HPNIVPILGF---SQAPG---ERIIVSEFINMASLDFYLHENNDGASLLD-WNRRLRIAT 170
           H NI    G       PG   +  +V EF    S+   L +N  G +L + W     I  
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEW--IAYICR 118

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
              RGL +LHQ     +IH  IK  N+LL E    ++ D+G+S            ++   
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175

Query: 231 YW--------HEKGGGNATRESDVYGFGVVLLEILSG 259
           YW         E        +SD++  G+  +E+  G
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 10/91 (10%)

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
           RGL+Y+H   +  IIH  +K SN+ +NE    R+ D+GL+  A +E   + GYV   ++ 
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYR 182

Query: 234 EK----GGGNATRESDVYGFGVVLLEILSGR 260
                    +  +  D++  G ++ E+L G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 21/216 (9%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPI 124
           +G+G   TV+      T  LVA+K I     L +      + I+ +SL +   H NIV +
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
                      +V E+++ + L  YL  +N G  +   N ++ +     RGL Y H+   
Sbjct: 69  HDIIHTERCLTLVFEYLD-SDLKQYL--DNCGNLMSMHNVKIFMFQ-LLRGLSYCHK--- 121

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-----GGGN 239
             I+H  +K  N+L+NEK   ++ D+GL+       +  +  V    W+       G   
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV-VTLWYRPPDVLLGSTE 180

Query: 240 ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
            +   D++G G +L E+ +GR    G  VK  L LI
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 61/233 (26%), Positives = 85/233 (36%), Gaps = 57/233 (24%)

Query: 67  RIIGQGRLGTVYAA----LLSTGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           R IGQG  G V+ A    LL      +VAVK +            F      ++   HPN
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMAEFDHPN 69

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGA--SLLDWNRRLR----------- 167
           IV +LG         ++ E++    L+ +L   +  A  SL       R           
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 168 -----IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
                IA   A G+ YL +      +H  +   N L+ E    ++ D+GLS       R 
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS-------RN 179

Query: 223 LAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
           +  Y  D Y   K   N                  T ESDV+ +GVVL EI S
Sbjct: 180 I--YSADYY---KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 34/116 (29%), Positives = 50/116 (43%), Gaps = 32/116 (27%)

Query: 160 LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE 219
           LD    L  +   A+G+ +L    + N IH  + A NILL      ++CD+GL+     +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RD 263

Query: 220 KRGLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
            R  + YV          GNA                 T ESDV+ +G++L EI S
Sbjct: 264 IRNDSNYVVK--------GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 28/201 (13%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPI 124
           +G G  G VY A  L TG+L AVK     ++    G  F+ + + + + +   H NIV  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVK-----IIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G   +  +  I  E+    SL    H     + L    +   +     +GL YLH   +
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAYLH---S 124

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAGYVDDDYWH-------EK 235
              +H  IK +NILL +    ++ D+G++    A   KR    ++   YW        EK
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEK 182

Query: 236 GGGNATRESDVYGFGVVLLEI 256
            GG   +  D++  G+  +E+
Sbjct: 183 NGG-YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 38/126 (30%)

Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           ++DG+  L     L      ARG+E+L    + N +H  + A N+LL +    ++CD+GL
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGL 283

Query: 213 S--------------------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVV 252
           +                    ++APE         D+ Y         T  SDV+ +G++
Sbjct: 284 ARDIMHDSNYVSKGSTFLPVKWMAPES------IFDNLY---------TTLSDVWSYGIL 328

Query: 253 LLEILS 258
           L EI S
Sbjct: 329 LWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 45/170 (26%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI----------HPRLVLSNAGFGFASV--IKTLSL 115
           +G+G  G V  A    TGK+VA+K++            R ++   G  F ++  +K ++ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 116 AQHPNIVPILGFSQAPGERIIVSE-FIN-----MASLDFYLHENNDGASLLDWNRRLR-- 167
            +H NI+ ++         + V   FIN     MAS         D   ++D   RL   
Sbjct: 77  IKHENIMGLVD--------VYVEGDFINLVMDIMAS---------DLKKVVDRKIRLTES 119

Query: 168 ----IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               I      GL  LH       +H  +  +NI +N K   ++ D+GL+
Sbjct: 120 QVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLA 166

Length = 335

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 37/210 (17%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFAS----VIKTLSLAQHPNIVP 123
           +G G  GTV +AL   TG  VA+K+++ R   S     FA      ++ L   +H N++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSEL---FAKRAYRELRLLKHMKHENVIG 78

Query: 124 ILGFSQAPGERIIVSEFINMASL-DFYLHENNDGASL--------LDWNRRLRIATGAAR 174
           +L          + +  +++    DFYL     G  L        L  +R   +     +
Sbjct: 79  LLD---------VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           GL+Y+H   A  IIH  +K  N+ +NE    ++ D+GL+     E   + GYV   ++  
Sbjct: 130 GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRA 183

Query: 235 K----GGGNATRESDVYGFGVVLLEILSGR 260
                   + T+  D++  G ++ E+L+G+
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 56/214 (26%), Positives = 83/214 (38%), Gaps = 26/214 (12%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-LAQHPN 120
           F    ++G G  G VY    + TG+L A+K +    V  +        I  L   + H N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRN 74

Query: 121 IVPILGF---SQAPG---ERIIVSEFINMASLDFYLHENNDGASLL-DWNRRLRIATGAA 173
           I    G       PG   +  +V EF    S+   L +N  G +L  DW     I     
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT-DLVKNTKGNALKEDW--IAYICREIL 131

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW- 232
           RGL +LH   A  +IH  IK  N+LL E    ++ D+G+S            ++   YW 
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 233 -------HEKGGGNATRESDVYGFGVVLLEILSG 259
                   E         SD++  G+  +E+  G
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 21/216 (9%)

Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPI 124
           +G+G   TVY      T  LVA+K I     L +      + I+ +SL +   H NIV +
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
                      +V E+++   L  YL   +D  + ++ +          RGL Y H+   
Sbjct: 70  HDIIHTEKSLTLVFEYLD-KDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHR--- 122

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-----GGGN 239
             ++H  +K  N+L+NE+   ++ D+GL+       +  +  V    W+       G  +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV-VTLWYRPPDILLGSTD 181

Query: 240 ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
            + + D++G G +  E+ +GR    G  V+  L  I
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 23/157 (14%)

Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFG----FASVIKTLSLAQHPNIVPI 124
           IG G  G V  + + T   VA  R+  + + +NA       F        + QHPNI+  
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVA--RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR-------LRIATGAARGLE 177
           LG        ++V E+  +  L  YL +         W+RR        R+A   A G+ 
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQE-------QWHRRNSQLLLLQRMACEIAAGVT 113

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF 214
           ++H+    N +H  +   N  L      +V DYG+  
Sbjct: 114 HMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGP 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 18/201 (8%)

Query: 68  IIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFA----SVIKTLSLAQHPNIV 122
           IIG+G  G VY    + TGK+ A+K +  + +    G   A     ++  +S    P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            +      P +   + + +N   L ++L ++     +         A     GLE++H  
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGL----SFLAPEEKRGLAGYVDDDYWHEKGGG 238
               +++  +K +NILL+E    R+ D GL    S   P    G  GY+  +   +  G 
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK--GV 171

Query: 239 NATRESDVYGFGVVLLEILSG 259
                +D +  G +L ++L G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 40.4 bits (94), Expect = 6e-04
 Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 35/214 (16%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH-----PRLVLSNAGFGFASVIKTLSLAQHPN 120
           +++GQG  G VY      TG+ +AVK++      P    S         I+ L    H  
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET--SKEVNALECEIQLLKNLLHER 65

Query: 121 IVPILGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           IV   G  + P ER   I  E +   S+   L     GA  L  N   +       G+ Y
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GA--LTENVTRKYTRQILEGVSY 121

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLAGYVDD 229
           LH  +   I+H  IK +NIL +     ++ D+G S      KR         G+      
Sbjct: 122 LHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS------KRLQTICLSGTGMKSVTGT 172

Query: 230 DYWHEK---GGGNATRESDVYGFGVVLLEILSGR 260
            YW       G    R++D++  G  ++E+L+ +
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 39.8 bits (93), Expect = 9e-04
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 43/213 (20%)

Query: 69  IGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ--HPNIVPIL 125
           IG+G  G V+  +  +  ++ A+K+I   L   N      ++ +   LA+     I+   
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
                 G+  IV E+     L   L         L  ++  R       GL +LH   + 
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLH---SK 120

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLAGYV 227
            I+H  IK+ N+ L+     ++ D G++                  +L+PE         
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-------LC 173

Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           +D  ++EK        SDV+  GVVL E  +G+
Sbjct: 174 EDKPYNEK--------SDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 70/312 (22%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRL----VLSNAGFGFASVIKTLSLAQHPNI 121
           R+IG+G +G VY A      + VA+K+I   L    +L      F    K  +   HP I
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR---FLREAKIAADLIHPGI 64

Query: 122 VPI-------------LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
           VP+             + + +    + ++       SL   L E     + L       I
Sbjct: 65  VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL------SI 118

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYV 227
                  +EY+H   +  ++H  +K  NILL       + D+G + F   EE+  L   V
Sbjct: 119 FHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 228 DD------------------DYW-HEKGGGN-ATRESDVYGFGVVLLEILSGR---RCEE 264
           D+                  DY   E+  G  A+  +D+Y  GV+L ++L+     R ++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235

Query: 265 GLLVKWALPLIKEMRFSE-LLDPRLAIPC-EIKPLVRLAKVALACVGNSRKNRPSIVQ-- 320
           G          +++ + + +L P    P  EI P   L+++A+  +      R S VQ  
Sbjct: 236 G----------RKISYRDVILSPIEVAPYREIPPF--LSQIAMKALAVDPAERYSSVQEL 283

Query: 321 VATILNNLVGDP 332
              +  +L G P
Sbjct: 284 KQDLEPHLQGSP 295

Length = 932

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 29/209 (13%)

Query: 63  FSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGF----ASVIKTLSLAQ 117
           F     +G G  G V  A    TG+  A+K +  R +L            S++  LS   
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS--- 76

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHEN----NDGASLLDWNRRLRIATGAA 173
           HP IV ++   Q       + EF+    L  +L +     ND A    ++  L +A    
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF--YHAELVLA---- 130

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG---YVDDD 230
              EYLH     +II+  +K  N+LL+ K   +V D+G +   P+    L G   Y+  +
Sbjct: 131 --FEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPE 185

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSG 259
               KG G A    D +  GV+L E ++G
Sbjct: 186 VIQSKGHGKAV---DWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 7/88 (7%)

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG---LSFLAPEEKRGLAGYVDDD 230
            GL YLH      IIH  +K  NI +N+     + D G      +AP    GLAG V+ +
Sbjct: 168 EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF-LGLAGTVETN 223

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILS 258
                       ++D++  G+VL E+L+
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 11/95 (11%)

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAPEEKRG-LAGYVDD 229
            GL+Y+H   + N++H  +K  N+L+N     ++CD+GL+      P E  G +  YV  
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++          + T+  DV+  G +L E+L  +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 11/91 (12%)

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKR-----GLAGYVD 228
           L++LHQ     II+  IK  NILL+ +    + D+GLS  FLA EE+R     G   Y+ 
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            +      GG+  +  D +  GV+  E+L+G
Sbjct: 175 PEVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 31/171 (18%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF---GFASVIKTLSLA 116
           D +     IG+G  G VY A   +TGKLVA+K+   RL +   G        +     L+
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT--RLEMDEEGIPPTALREISLLQMLS 58

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +   IV +L       +    S ++    LD      +D    +D N R     G  R L
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD------SDLKKFMDSNGR-----GPGRPL 107

Query: 177 E---------YLHQGVAP----NIIHGCIKASNILLN-EKFCARVCDYGLS 213
                      L +GVA      ++H  +K  N+L++ +K   ++ D GL 
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 27/99 (27%)

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           G++YL      N +H  + A N+LL  +  A++ D+GLS       + L    DD Y+  
Sbjct: 107 GMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLS-------KALGA--DDSYYKA 154

Query: 235 KGGG---------------NATRESDVYGFGVVLLEILS 258
           +  G                 +  SDV+ +G+ + E  S
Sbjct: 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 86/263 (32%)

Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ----- 117
           +++G+G  G V   +L    +TGK  A+K +   ++++        V  TL+ ++     
Sbjct: 1   KLLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKD-----EVAHTLTESRVLQNT 52

Query: 118 -HPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT----- 170
            HP +   L +S    +R+  V E+ N   L F+L              R R+ +     
Sbjct: 53  RHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHL-------------SRERVFSEDRAR 98

Query: 171 --GA--ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL-------------- 212
             GA     L YLH     ++++  +K  N++L++    ++ D+GL              
Sbjct: 99  FYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155

Query: 213 ----SFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCE 263
                +LAPE         D+DY          R  D +G GVV+ E++ GR     +  
Sbjct: 156 CGTPEYLAPEVLE------DNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Query: 264 EGLLVKWALPLIKEMRFSELLDP 286
           E L   + L L++E+RF   L P
Sbjct: 201 EKL---FELILMEEIRFPRTLSP 220

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 19/156 (12%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV-----IKTLSLAQHPNIV 122
           IG G  GTVY A    +G  VA+K +  R+  +  G   ++V     +K L    HPNIV
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 123 PILGF-SQAPGER----IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
            ++   + +  +R     +V E ++   L  YL +        +  + L       RGL+
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDL--MRQFLRGLD 122

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           +LH   A  I+H  +K  NIL+      ++ D+GL+
Sbjct: 123 FLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 47/164 (28%), Positives = 65/164 (39%), Gaps = 33/164 (20%)

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMAS----LDFYLHENNDGASLLDWNRRLRIATGA 172
           +HPNI+             ++S F+   S    L  Y  E    A + +      I  GA
Sbjct: 57  RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN------ILFGA 110

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY- 231
            RGL YLHQ      IH  IKAS+IL++      V   GLS L    + G    V  D+ 
Sbjct: 111 LRGLNYLHQN---GYIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFP 165

Query: 232 --------W-------HEKGGGNATRESDVYGFGVVLLEILSGR 260
                   W        +  G N   +SD+Y  G+   E+ +GR
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNV--KSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 46/217 (21%), Positives = 88/217 (40%), Gaps = 49/217 (22%)

Query: 136 IVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCI 192
           +V++ +    L  Y+ EN D      LL+W  ++      A+G+ YL +     ++H  +
Sbjct: 85  LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE---VRLVHRDL 135

Query: 193 KASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG-------------- 238
            A N+L+      ++ D+GL+ L           +D+  +H  GG               
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLD---------IDETEYHADGGKVPIKWMALESILHR 186

Query: 239 NATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP--RLAIPCEIK 295
             T +SDV+ +GV + E+++ G +  +G         I      +LL+   RL  P    
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDG---------IPAREIPDLLEKGERLPQPPICT 237

Query: 296 PLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
             V +  + + C     + RP   ++    + +  DP
Sbjct: 238 IDVYM--IMVKCWMIDSECRPRFRELVDEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 18/197 (9%)

Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A    TGK VAVK++  R         F  V+  +    H N+V +   
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVV-IMRDYHHENVVDMYNS 87

Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLH-QGVAP 185
                E  +V EF+   +L D   H      + ++  +   +     R L YLH QGV  
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGV-- 139

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNAT---R 242
             IH  IK+ +ILL      ++ D+G      +E       V   YW      +      
Sbjct: 140 --IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 243 ESDVYGFGVVLLEILSG 259
           E D++  G++++E++ G
Sbjct: 198 EVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 43/215 (20%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLA-QHPNIVP 123
           +++G+G  G V  A L  T +  A+K +   +VL +       V +  L+LA +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +    Q       V E++N   L F++  +       D  R    A     GL++LH+  
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKK- 115

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRGLAG 225
              II+  +K  N+LL++    ++ D+G+                   ++APE  +G   
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               D+W                FGV+L E+L G+
Sbjct: 174 NESVDWW---------------SFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 44/212 (20%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKR---------IHPRLVLSNAGFGFASVIKTLSLAQH 118
           IG+G  G V+      TG++VA+K+         I  ++ L          I+ L   +H
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALRE--------IRMLKQLKH 59

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PN+V ++   +   +  +V E+ +   L+  L +N  G   +  +   +I     + + +
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRG---VPEHLIKKIIWQTLQAVNF 115

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDD--DY----W 232
            H+    N IH  +K  NIL+ ++   ++CD+G +       R L G  DD  DY    W
Sbjct: 116 CHKH---NCIHRDVKPENILITKQGQIKLCDFGFA-------RILTGPGDDYTDYVATRW 165

Query: 233 HEK-----GGGNATRESDVYGFGVVLLEILSG 259
           +       G        DV+  G V  E+L+G
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 21/205 (10%)

Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQH 118
           F+    IG+G  G V+  + + T K+VA+K I     L  A      +   I  LS    
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCDS 61

Query: 119 PNIVPILGFSQAPGERIIVSEFINMAS-LDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           P +    G      +  I+ E++   S LD            LD  +   I     +GL+
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLD 115

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           YLH   +   IH  IKA+N+LL+E    ++ D+G++    + +     +V   +W     
Sbjct: 116 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 236 -GGGNATRESDVYGFGVVLLEILSG 259
                   ++D++  G+  +E+  G
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 18/151 (11%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           IG+G  GTV+ A    T ++VA+KR+  RL   + G   +++  I  L   +H NIV + 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEYLHQG 182
               +  +  +V E+ +   L  Y    N   D   +  +  +L       +GL + H  
Sbjct: 66  DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS- 117

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
              N++H  +K  N+L+N+    ++ D+GL+
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 37/213 (17%)

Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQH 118
           F+    IG+G  G V+  + + T ++VA+K I     L  A      +   I  LS    
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEITVLSQCDS 61

Query: 119 PNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNR-----RLRIATGA 172
           P +    G S   G ++ I+ E++              G S LD  R       +IAT  
Sbjct: 62  PYVTKYYG-SYLKGTKLWIIMEYLG-------------GGSALDLLRAGPFDEFQIATML 107

Query: 173 A---RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDD 229
               +GL+YLH   +   IH  IKA+N+LL+E+   ++ D+G++    + +     +V  
Sbjct: 108 KEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 230 DYWHEK---GGGNATRESDVYGFGVVLLEILSG 259
            +W             ++D++  G+  +E+  G
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 16/207 (7%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G  G +Y A   S  +   +K I    +           +  L+  +HPNIV   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              Q  G   IV E+ +    D     N     L   ++ L      + GL+++H     
Sbjct: 66  ASFQENGRLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---R 120

Query: 186 NIIHGCIKASNILLNEK-FCARVCDYGLSFL---APEEKRGLAG---YVDDDYWHEKGGG 238
            I+H  IK+ NI L++    A++ D+G++     + E      G   Y+  +    +   
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180

Query: 239 NATRESDVYGFGVVLLEILSGRRCEEG 265
           N T   D++  G VL E+ + +   EG
Sbjct: 181 NKT---DIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	332
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
PRK10345	210	hypothetical protein; Provisional	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
smart00090	237	RIO RIO-like kinase.	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.1
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.91
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.77
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.7
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.7
COG4248	637	Uncharacterized protein with protein kinase and he	98.69
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.59
PRK09902	216	hypothetical protein; Provisional	98.57
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.46
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.4
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.33
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.16
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.07
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.07
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.97
PF01636	239	APH: Phosphotransferase enzyme family This family	97.96
PLN02876	822	acyl-CoA dehydrogenase	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.93
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.89
PRK10593	297	hypothetical protein; Provisional	97.65
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.64
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.58
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.52
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.47
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.45
KOG2270	520	consensus Serine/threonine protein kinase involved	97.23
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.02
PRK05231	319	homoserine kinase; Provisional	96.98
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.96
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.95
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.78
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.72
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.61
PLN02756	418	S-methyl-5-thioribose kinase	96.48
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.46
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.31
PLN02236	344	choline kinase	96.24
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.15
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.87
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.75
COG2334	331	Putative homoserine kinase type II (protein kinase	95.46
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.23
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.15
PRK06148	1013	hypothetical protein; Provisional	94.43
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	94.3
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.29
PRK12396	409	5-methylribose kinase; Reviewed	93.82
PRK11768	325	serine/threonine protein kinase; Provisional	93.22
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	92.51
PTZ00384	383	choline kinase; Provisional	92.09
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	90.39
PRK10271	188	thiK thiamine kinase; Provisional	90.27

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-56  Score=404.90  Aligned_cols=276  Identities=42%  Similarity=0.725  Sum_probs=244.6

Q ss_pred             cccCCChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceee
Q 020027           47 CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG  126 (332)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  126 (332)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+++|..||||++.......  ..+|.+|+.++++++|||+|+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence            345678999999999999999999999999999999999999999887654332  345899999999999999999999


Q ss_pred             eeecCC-ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCce
Q 020027          127 FSQAPG-ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA  205 (332)
Q Consensus       127 ~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  205 (332)
                      ||.+.+ ..+||+||+++|+|.+.+......  .++|.++++|+.++|+||+|||..+.+.|+|||||++|||+|+++++
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            999988 599999999999999999875432  58999999999999999999999988899999999999999999999


Q ss_pred             EEccCCccccCCc-cc------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc-------hhHHHH
Q 020027          206 RVCDYGLSFLAPE-EK------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG-------LLVKWA  271 (332)
Q Consensus       206 kl~dfg~a~~~~~-~~------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~-------~~~~~~  271 (332)
                      ||+|||+|+..+. ..      .||.+|++||+...   +..+.|+||||||++|.|++||+++...       ...+|.
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~---g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST---GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhcc---CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence            9999999987764 22      68999999999987   7899999999999999999999987652       256777


Q ss_pred             HHHhhhcccccccCCcCC-CCCCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          272 LPLIKEMRFSELLDPRLA-IPCEI-KPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ...+.++.+.+++|+++. ...+. ++..++..++.+|++.+|.+||+|.||++.|+.+.
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            788888889999999987 55554 67888999999999999999999999999997765

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-53  Score=380.63  Aligned_cols=261  Identities=30%  Similarity=0.400  Sum_probs=214.6

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-ce
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ER  134 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~  134 (332)
                      .....+++...+.+|+|+||+||+|.+.....||+|.+............|.+|+.+|++++|||||+++|+|..+. ..
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            33444455566679999999999999854444999999876554444557899999999999999999999999887 79


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeecCCCCCCEEeCCCC-ceEEccCCc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN-IIHGCIKASNILLNEKF-CARVCDYGL  212 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Nill~~~~-~~kl~dfg~  212 (332)
                      +|||||+++|+|.+++...  ....+++..++.++.|||.||.|||++   + ||||||||+|+|++.++ ++||+|||+
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            9999999999999999874  122389999999999999999999998   7 99999999999999997 999999999


Q ss_pred             cccCCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          213 SFLAPEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       213 a~~~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ++.....      ..||..|||||.+... ...++.|+||||||+++|||+||+.||.+.........+....      .
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~------~  263 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG------L  263 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------C
Confidence            9765532      3789999999999853 3689999999999999999999999999876644333332221      1


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ++..+  ..+...+..+|.+||+.||+.||+|.+++..|+.+..
T Consensus       264 Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 RPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             CCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            11222  2245578899999999999999999999999997653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-53  Score=382.79  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=219.6

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ...+.+...+.||+|.||.||.|.+.....||+|.++....   ...+|.+|+++|++|+|+|||+++|+|..++.++||
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            33344555688999999999999997777999999986532   233578999999999999999999999999899999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||||+.|+|.+|++...  ...+...+.+.++.|||+||+||.++   ++|||||.++|||++++..+||+|||+|+...
T Consensus       280 tE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999998732  23478899999999999999999999   99999999999999999999999999999644


Q ss_pred             ccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          218 EEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       218 ~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ++.       .-...|.|||.+..   +.++.|||||||||+|||++| |+.||.+....++...+..+         ++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~---~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G---------yR  422 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNY---GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG---------YR  422 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhh---CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc---------Cc
Confidence            332       23568999999987   789999999999999999999 99999998888777766664         56


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .+.+..|+.+++++|..||..+|++||||+.+...|+.+.
T Consensus       423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            7777788889999999999999999999999999888765

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-52  Score=360.16  Aligned_cols=252  Identities=25%  Similarity=0.268  Sum_probs=213.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-----cccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-----GFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ..+.|...+.||+|+||.|-+|. .++|+.||||+++++......     .....+|+++|++++|||||++++++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45667888999999999999998 779999999999876654321     223579999999999999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC---CceEEcc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK---FCARVCD  209 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~d  209 (332)
                      ..|+||||++||+|.+++-.+..    +.+.....++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999999987654    66677788999999999999999   99999999999999766   7899999


Q ss_pred             CCccccCCccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH-HHHHhhhcccccc
Q 020027          210 YGLSFLAPEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW-ALPLIKEMRFSEL  283 (332)
Q Consensus       210 fg~a~~~~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~  283 (332)
                      ||+|+..++..     +||+.|.|||.+...+...+..++|+||+||+||-+++|.+||.+...+. ..+.+..+++.  
T Consensus       323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~--  400 (475)
T KOG0615|consen  323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA--  400 (475)
T ss_pred             cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc--
Confidence            99999886543     89999999999988655555669999999999999999999998875544 44555555432  


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +..+...+-.++..+++.++|..||++|||+.|+++
T Consensus       401 ----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  401 ----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                223444556678999999999999999999999875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-51  Score=370.01  Aligned_cols=243  Identities=25%  Similarity=0.352  Sum_probs=214.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..|...++||+|||+.||+++. .+|+.||+|++.+..... .......+||++.+.|+|||||+++++|++.+..||+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999994 899999999998755433 33446789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |+|++++|..+++....    +++..+..++.||+.||.|||++   +|+|||||..|++++++.++||+|||+|.....
T Consensus        98 ELC~~~sL~el~Krrk~----ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKP----LTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhcCC----CCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999985432    89999999999999999999999   999999999999999999999999999987652


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      .+||+.|+|||.+..   ..++..+||||+||++|-|++|++||......+.+..++...+        ..|.
T Consensus       171 ~~Erk~TlCGTPNYIAPEVl~k---~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--------~~P~  239 (592)
T KOG0575|consen  171 DGERKKTLCGTPNYIAPEVLNK---SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--------SMPS  239 (592)
T ss_pred             cccccceecCCCcccChhHhcc---CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--------cccc
Confidence            2      379999999999986   6789999999999999999999999999988999888877542        2222


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .  -..++.+||.++|+.||.+|||+++|+.
T Consensus       240 ~--ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  240 H--LSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             c--cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2  2236779999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-51  Score=354.22  Aligned_cols=247  Identities=23%  Similarity=0.276  Sum_probs=205.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||+||+|+ .+++..||||.+.+.....+.......|+.+++.++|||||++++++..++..++|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            35678889999999999999999 56789999999987754333334568999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC------CceEEccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK------FCARVCDYG  211 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------~~~kl~dfg  211 (332)
                      ||||.||+|.+|++..+.    +++.++..++.|+|.||++||++   +||||||||.|||++.+      ..+||+|||
T Consensus        88 MEyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            999999999999987654    89999999999999999999999   99999999999999864      568999999


Q ss_pred             ccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          212 LSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       212 ~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      +|+...+.     .+|++-|||||.+..   .+|+.|+|+||.|+++||+++|+.||......+.+.+++.+...     
T Consensus       161 fAR~L~~~~~a~tlcGSplYMAPEV~~~---~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~-----  232 (429)
T KOG0595|consen  161 FARFLQPGSMAETLCGSPLYMAPEVIMS---QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI-----  232 (429)
T ss_pred             hhhhCCchhHHHHhhCCccccCHHHHHh---ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-----
Confidence            99988754     379999999999987   78999999999999999999999999988888887766553211     


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                        ....+......+.+++...++.+|.+|-++.+..
T Consensus       233 --~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  233 --VPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             --cCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence              1111111111233666667777777777766543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-52  Score=344.80  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=213.0

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeee-eecCCc-eeEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF-SQAPGE-RIIV  137 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~-~~~~~~-~~lv  137 (332)
                      .+|.+.+.||+|.||.||++. ..+|..+|.|.++-......+..+...|+.+|++++|||||+++++ +..++. ++|+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457888899999999999999 7899999999998666666666678999999999999999999994 444554 8999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP-NIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ||+|.+|+|.++++........+++.++++++.|++.||..+|+.+.. .|+||||||.||+++.+|.+|++|||++++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999987666666799999999999999999999995322 2999999999999999999999999999887


Q ss_pred             Cccc------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          217 PEEK------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       217 ~~~~------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....      .||+.||+||....   ..|+.+|||||+||++|||+.-.+||.|..-...-..+..+.+..+.+     
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~---~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~-----  250 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHE---SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD-----  250 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhc---CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-----
Confidence            6543      69999999999987   789999999999999999999999999875555545555553322111     


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                         .--...+..++..|+..||+.||+...+++.+..
T Consensus       251 ---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  251 ---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence               2223468889999999999999985555555443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-51  Score=381.24  Aligned_cols=253  Identities=25%  Similarity=0.421  Sum_probs=224.8

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ....+.++||.|.||.|++|+++    ....||||.++... ..++..+|+.|..+|.+++||||+++.|+.......+|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            34456689999999999999953    33589999998654 34556689999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ++|||++|+|+.|++++..+   +++.+...|+.+||.||.||.+.   ++|||||.++|||++.+..+|++|||+++..
T Consensus       708 iTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence            99999999999999987654   78889999999999999999999   9999999999999999999999999999987


Q ss_pred             Cccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          217 PEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       217 ~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      .+..         .....|.|||....   ..+|.+|||||||+++||.++ |.+||.+...+++.+.+.+         
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~---RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~---------  849 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ---------  849 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhh---cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh---------
Confidence            5543         12467999999887   789999999999999999998 9999999988888887766         


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                      .++.|.+.+|+..|..||..||+.|-.+||.|.+|+..|.+++.+|
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            3556667778889999999999999999999999999999999887

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=349.05  Aligned_cols=244  Identities=27%  Similarity=0.346  Sum_probs=204.6

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc-eeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE-RIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  138 (332)
                      ++.+..+.||+|.-|+||+++ ..+++.+|+|.+.... ......++.+|+++++..+||+||.++|.|..++. .+|+|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            356777899999999999999 4689999999995433 23334468999999999999999999999999984 99999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||++|+|+.+++..+.    +++...-+++.++++||.|||+ +   .|+||||||+|+|++.+|++||||||.+....
T Consensus       158 EYMDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             hhcCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            99999999999987543    8899999999999999999996 5   99999999999999999999999999997655


Q ss_pred             c----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch-----hHHHHHHHhhhcccccccCCcC
Q 020027          218 E----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL-----LVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       218 ~----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      +    +..||..||+||...+   ..|+.++||||||+.++|+++|+.|+...     ..-+.+.++..+       +..
T Consensus       231 nS~a~tfvGT~~YMsPERi~g---~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-------ppP  300 (364)
T KOG0581|consen  231 NSIANTFVGTSAYMSPERISG---ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-------PPP  300 (364)
T ss_pred             hhhcccccccccccChhhhcC---CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-------CCC
Confidence            4    3479999999999887   78999999999999999999999998764     222333334332       222


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..|.. ....++.+++..|++.||.+|||+.|+++
T Consensus       301 ~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  301 RLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22222 35568999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2e-51  Score=386.21  Aligned_cols=254  Identities=27%  Similarity=0.404  Sum_probs=219.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ..+....+.||+|+||+||+|+.      ++...||||.++.... .....+|.+|+..++.++|||||+++|.|..++.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            34555668899999999999983      3456899999975543 3345579999999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCC----------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          134 RIIVSEFINMASLDFYLHENNDG----------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      .++++|||..|||.+|+......          +..++..+.+.|+.|||.||.||.++   .+|||||..+|+|+.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence            99999999999999999754321          23378899999999999999999999   999999999999999999


Q ss_pred             ceEEccCCccccCCccc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHH
Q 020027          204 CARVCDYGLSFLAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL  274 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~  274 (332)
                      .|||+|||+++..-...        --..+||+||....   +++|++||||||||+|||++| |+.||.+...+++...
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly---~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY---GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc---CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            99999999997543221        23568999999887   899999999999999999999 9999999999999998


Q ss_pred             hhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +.++.+         .+.+.+|+.++++||..||+.+|.+||||+||.++|+...
T Consensus       718 i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  718 IRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            888653         4556677889999999999999999999999999998764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=354.23  Aligned_cols=264  Identities=25%  Similarity=0.354  Sum_probs=222.2

Q ss_pred             hHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           53 LTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ..++++..+.+.....||+|.||+||+|++.  ..||||.+............|.+|+..+++-+|.||+-+.|+|..++
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            4677777788888899999999999999973  47999999887766666668999999999999999999999999988


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      . .||+.+|+|.+|+.+++.....   ++..+...|+.|||+||.|||.+   +|+|||||..||++.++++|||+|||+
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etk---fdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETK---FDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhh---hhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence            7 8999999999999999876533   88899999999999999999999   999999999999999999999999999


Q ss_pred             cccCC--------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          213 SFLAP--------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       213 a~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      +....        +...|...|||||........+|+++||||||||++|||+||..||.....+.+..++..+-.    
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l----  610 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL----  610 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc----
Confidence            85422        223567789999999877778999999999999999999999999996655555444444321    


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .++.. ....++..++.+|+..||.+++++||+|.+|+..|+.++.
T Consensus       611 ~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  611 MPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             Cccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11111 1123456678899999999999999999999999988764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=371.56  Aligned_cols=255  Identities=25%  Similarity=0.341  Sum_probs=215.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC--CC----CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS--TG----KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      .++.+..+.||+|+||.||+|...  .|    ..||+|.++.... ..+..+|.+|..+|+.++|||||+++|+|.....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            445556688999999999999943  33    2599999875533 3334579999999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          134 RIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      .+|++|||++|+|..|+++...   +...++....+.++.|||+|+.||+++   .+|||||..+|+|++....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999987522   234588899999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCcc-------c-CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccc
Q 020027          211 GLSFLAPEE-------K-RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFS  281 (332)
Q Consensus       211 g~a~~~~~~-------~-~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  281 (332)
                      |+|+.....       . .-...||+||.+..   +.+++|+|||||||++||++| |..||.+....+++..+.++.  
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d---~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD---GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhh---cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            999833221       1 22368999999988   899999999999999999999 999999988888777555542  


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                             +.+.+..|++.++++|.+||+.+|++||+|..|++.+..++.
T Consensus       922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             -------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                   344556777899999999999999999999999998887653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-47  Score=320.05  Aligned_cols=254  Identities=20%  Similarity=0.239  Sum_probs=201.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +.|+....+|+|+||.||+++ ..+|+.||||++...........-.++||+++++++|+|+|.+.++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            457888899999999999999 5689999999997654434334457899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      ||+..-|.+ +....++   ++...+..++.|++.|+.|+|++   +++||||||+|||++.++.+|+||||+|+.....
T Consensus        82 ~~dhTvL~e-Le~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDHTVLHE-LERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecchHHHHH-HHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            998755544 4443332   78899999999999999999999   9999999999999999999999999999987632


Q ss_pred             c------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--ccc-----------
Q 020027          220 K------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--MRF-----------  280 (332)
Q Consensus       220 ~------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~-----------  280 (332)
                      .      ..|.-|.|||.+.+.  .+|++.+||||.||++.||++|.+-|.|..+-+.+..+..  +.+           
T Consensus       155 gd~YTDYVATRWYRaPELLvGD--tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGD--TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             cchhhhhhhhhhccChhhhccc--CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            2      457788999988764  7899999999999999999999998887655444333321  111           


Q ss_pred             ---ccccCCcCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 ---SELLDPRLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ---~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         .-+.-|....+.+     ++-..-+.+++..|++.||++|+|.+|++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               1011111111111     112335779999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=349.73  Aligned_cols=260  Identities=28%  Similarity=0.377  Sum_probs=217.5

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEeC--CC---CEEEEEEeccCc-ccccccccHHHHHHHhccCCCCCccceeee
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALLS--TG---KLVAVKRIHPRL-VLSNAGFGFASVIKTLSLAQHPNIVPILGF  127 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  127 (332)
                      +.++...++....+.||+|+||.||+|++.  ++   ..||+|..+... ....+..++++|.++|++++|||||+++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            344555566666799999999999999943  22   238999987533 344455579999999999999999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEE
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV  207 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  207 (332)
                      +..+...+++||+|.||+|.++++....   .++..+.+.++.+.|.||+|||++   +++||||..+|+|++.++.+||
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence            9999999999999999999999987654   388999999999999999999999   9999999999999999999999


Q ss_pred             ccCCccccCCccc------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccc
Q 020027          208 CDYGLSFLAPEEK------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF  280 (332)
Q Consensus       208 ~dfg~a~~~~~~~------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  280 (332)
                      +|||+++......      .-...|+|||.+..   +.+++++|||||||++||+++ |..||.+....++...+.... 
T Consensus       304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~---~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~-  379 (474)
T KOG0194|consen  304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT---GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG-  379 (474)
T ss_pred             CccccccCCcceeeccccccCcceecChhhhcc---CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC-
Confidence            9999997764211      23468999999988   789999999999999999999 888999988777766663322 


Q ss_pred             ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                             ++.+.+...+..+..++.+||..||++||||.++.+.|+.+..
T Consensus       380 -------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  380 -------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             -------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                   2333333555678889999999999999999999999988764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=337.16  Aligned_cols=254  Identities=21%  Similarity=0.261  Sum_probs=205.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCC-ceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPG-ERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l  136 (332)
                      .++|...+.||.|+||.||+|+ ..+|+.||||+++++...-++. --++|++.+++++ |||||++++.+.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4578888999999999999999 7789999999998776543322 3579999999998 999999999998877 8999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |||||+ .+|+++++...   ..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+||..
T Consensus        88 VfE~Md-~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhh-hhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            999996 79999998763   3489999999999999999999999   9999999999999998999999999999876


Q ss_pred             Cccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--cc----------
Q 020027          217 PEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--MR----------  279 (332)
Q Consensus       217 ~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~----------  279 (332)
                      ....     ..|.-|+|||.+...  +.|+.+.|+||+||+++|+.+-++.|.|...-+....+.+  |.          
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs--~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRS--GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhc--cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            5443     578889999999875  8899999999999999999999998887644333222211  00          


Q ss_pred             ---------cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          280 ---------FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       280 ---------~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                               +.+.....+..-. .....++.+++.+|+++||++|||++|.++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                     0011011111111 1245678899999999999999999998863

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-46  Score=338.35  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeec
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQA  130 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  130 (332)
                      ...++|...+.||+|+||.||+|..      .+++.||+|.++.... ......+.+|+.++..+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            3457899999999999999999973      2456899999874422 22233578999999999 89999999998876


Q ss_pred             C-CceeEEEeccCCCCHHHHhcccCCC-----------------------------------------------------
Q 020027          131 P-GERIIVSEFINMASLDFYLHENNDG-----------------------------------------------------  156 (332)
Q Consensus       131 ~-~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------------------------  156 (332)
                      . +..+++|||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4688999999999999998753210                                                     


Q ss_pred             -----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc--------cCCc
Q 020027          157 -----ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--------KRGL  223 (332)
Q Consensus       157 -----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~  223 (332)
                           ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....        ..++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 12377888899999999999999998   9999999999999999999999999998754221        1345


Q ss_pred             ccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHH-HHHHhhhcccccccCCcCCCCCChHHHHHHH
Q 020027          224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKW-ALPLIKEMRFSELLDPRLAIPCEIKPLVRLA  301 (332)
Q Consensus       224 ~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  301 (332)
                      ..|+|||.+..   ..++.++|||||||++|||++ |..||.+....+ ....+..+.       ....+  ......+.
T Consensus       240 ~~y~aPE~~~~---~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~--~~~~~~l~  307 (338)
T cd05102         240 LKWMAPESIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-------RMRAP--ENATPEIY  307 (338)
T ss_pred             ccccCcHHhhc---CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-------CCCCC--CCCCHHHH
Confidence            67999998875   678999999999999999997 999997654322 222222211       11111  12234688


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          302 KVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       302 ~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      +++.+||+.||++|||+.|+++.|++++..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=323.39  Aligned_cols=240  Identities=22%  Similarity=0.268  Sum_probs=207.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ...++|+..++||+|+||+||.++ ..+++.+|+|++++...... +......|..++..++||.||.++-.+++...+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            456789999999999999999999 67899999999998766544 3335789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +|+||+.||.|...+.+.+.    +++..+.-++..|+.||.|||+.   +||||||||+|||+|.+|.++|+|||+++.
T Consensus       102 lVld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            99999999999999987654    89999999999999999999999   999999999999999999999999999974


Q ss_pred             CC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          216 AP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       216 ~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ..      ...+||+.|||||.+..   ..++..+|.||+|+++|||++|.+||.+.......+.+..++..       .
T Consensus       175 ~~~~~~~t~tfcGT~eYmAPEil~~---~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------~  244 (357)
T KOG0598|consen  175 DLKDGDATRTFCGTPEYMAPEILLG---KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------L  244 (357)
T ss_pred             cccCCCccccccCCccccChHHHhc---CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC-------C
Confidence            32      23479999999999988   68999999999999999999999999998877777766665411       1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCC
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRP  316 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RP  316 (332)
                      .+.  .-..+..+++...++.||++|-
T Consensus       245 ~p~--~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 PPG--YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCc--cCCHHHHHHHHHHhccCHHHhc
Confidence            111  1122677999999999999995

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-46  Score=333.28  Aligned_cols=257  Identities=21%  Similarity=0.263  Sum_probs=205.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--Cce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  134 (332)
                      ...+.|+.++.||+|+||.||+|+ ..+|+.||+|+++.+........-..+||.+|++++||||+++.+.....  +.+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            345678899999999999999999 78999999999987765554444568999999999999999999998766  789


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |+|+|||++ +|.-++....-.   ++..++..++.|++.||.|||++   +|+|||||.+|||+|++|.+||+|||+|+
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vk---ft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVK---FTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcc---cChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence            999999975 787777654322   89999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh-------ccc
Q 020027          215 LAPEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE-------MRF  280 (332)
Q Consensus       215 ~~~~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~-------~~~  280 (332)
                      +.....       .-|.-|.+||.+.+.  ..|++++|+||.||||.||++|++.|.|...-+.+..+-.       ..|
T Consensus       267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~--t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  267 FYTPSGSAPYTSRVVTLWYRPPELLLGA--TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eccCCCCcccccceEEeeccChHHhcCC--cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            654322       357889999999875  8899999999999999999999999998765555443321       011


Q ss_pred             c--c-----ccCCcCCCCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 S--E-----LLDPRLAIPCEI-----KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ~--~-----~~~~~~~~~~~~-----~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .  .     ...+........     .-.....+|+..+|..||++|.|+.+.++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  1     111110000000     11235678899999999999999998875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=335.82  Aligned_cols=258  Identities=24%  Similarity=0.309  Sum_probs=212.8

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      ...+.+.||+|.||.|..+....+..||+|.+++... .+...+|.+|+++|.+++||||++++|.|..++.+++++||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3445578999999999999987889999999987754 334567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc-
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-  220 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~-  220 (332)
                      ++|+|.+|+..+....  ++-....+|+.||+.||+||.+.   ++||||+.++|+|++.++++||+|||+++-+-... 
T Consensus       618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999998764322  44566778999999999999998   99999999999999999999999999998543221 


Q ss_pred             -------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh--CCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          221 -------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS--GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       221 -------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                             .-...|||+|.+..   +++|++||+|+||+.+||+++  ..+||.....+.+......  +..-.....-.+
T Consensus       693 y~vqgr~vlpiRwmawEsill---gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~--~~~~~~~~~~l~  767 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILL---GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE--FFRDQGRQVVLS  767 (807)
T ss_pred             eeeecceeeeeeehhHHHHHh---ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh--hcCCCCcceecc
Confidence                   23468999999887   899999999999999999987  7889988766655433222  211112222334


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .+.-|+.+++++|.+||..|.++||||+++...|++...
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~~  806 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDAL  806 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhcc
Confidence            455677789999999999999999999999999987654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=326.17  Aligned_cols=247  Identities=28%  Similarity=0.368  Sum_probs=196.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC--ceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG--ERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  136 (332)
                      ..++...+.||+|+||.||.+.. ++|+..|||.+.......  ...+.+|+.+|++++|||||+++|......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            34567788999999999999994 569999999987552222  334789999999999999999999844333  6899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCcccc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLSFL  215 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~  215 (332)
                      .|||+++|+|.+++...+.   .+++..+..+..||++||+|||++   |++||||||+|||++. ++.+||+|||++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            9999999999999987653   289999999999999999999999   9999999999999999 79999999998875


Q ss_pred             CCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch-hHHHHHHHhhhcccccccC
Q 020027          216 APE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL-LVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       216 ~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~  285 (332)
                      ...         ...||+.|||||++..  +.....++||||+||++.||+||++||... ......-.+....    ..
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~--g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~----~~  241 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRN--GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED----SL  241 (313)
T ss_pred             cccccccccccccccCCccccCchhhcC--CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC----CC
Confidence            441         2369999999999985  233446999999999999999999999873 2211111111111    11


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      |  ..|..  ...+..+++.+|++.||++|||++++++.
T Consensus       242 P--~ip~~--ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  242 P--EIPDS--LSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             C--CCCcc--cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            1  22222  33467799999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=323.16  Aligned_cols=261  Identities=21%  Similarity=0.253  Sum_probs=213.4

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .....+.|+....||.|..+.||+|+ .++++.||||++..+..... ...+.+|+..|+.++||||++++..|..+..+
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            33557789999999999999999999 67889999999987665444 34678999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |+||.||.+|++.+.++.....+  +++..+..|+.++++||.|||.+   |.+|||+|+.|||++.+|++||+|||.+.
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeee
Confidence            99999999999999998754433  89999999999999999999999   99999999999999999999999999763


Q ss_pred             cCC----------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          215 LAP----------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       215 ~~~----------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      ...          +...||+.|||||.+.+.. ..|+.|+||||||+...||.+|..||....+..++-.-..+......
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~-~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQL-HGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcc-cCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            221          3347899999999954332 56899999999999999999999999988776655444343322211


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+.....-.-...+.+++..|++.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            112222222222336778999999999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.2e-45  Score=322.31  Aligned_cols=249  Identities=20%  Similarity=0.234  Sum_probs=201.1

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeec----CCceeEEE
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQA----PGERIIVS  138 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  138 (332)
                      .....||+|++|.||+|.. +|+.||+|.++........ ...+.+|+.++++++||||++++|++..    ....+++|
T Consensus        23 ~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         23 YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            3346899999999999998 6889999999765332221 2346799999999999999999999866    35678999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++|+|.+++....    .+++...+.++.|++.|+.|||+..  +++||||||+||++++++.+|++|||+++....
T Consensus       102 Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        102 EYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             EeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            9999999999997643    2788999999999999999999731  788999999999999999999999999875433


Q ss_pred             c---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 E---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                      .   ..++..|+|||..... ...++.++|||||||++|||+||+.||.+.........+.....      ++..  +..
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~-~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------~~~~--~~~  246 (283)
T PHA02988        176 PPFKNVNFMVYFSYKMLNDI-FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN------SLKL--PLD  246 (283)
T ss_pred             ccccccCcccccCHHHhhhc-cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC------CCCC--CCc
Confidence            2   3477899999988642 14688999999999999999999999988766555444432211      1111  223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +...+.+++.+||+.||++|||++|+++.|+.+
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            345788999999999999999999999999865

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.2e-45  Score=302.73  Aligned_cols=255  Identities=21%  Similarity=0.237  Sum_probs=208.9

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.+|+|.||.||+|+ .++|+.||||+++.....+.......+||+.++.++|+||+.+.+.+...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999999 7899999999999876655555668999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |++ .+|+..++....   .++..++..++.++++|++|||++   .|+||||||.|+|++.+|.+||+|||+|+.....
T Consensus        82 fm~-tdLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             ecc-ccHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            996 699999986543   378899999999999999999999   9999999999999999999999999999876533


Q ss_pred             c------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh-------cccccc---
Q 020027          220 K------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE-------MRFSEL---  283 (332)
Q Consensus       220 ~------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~---  283 (332)
                      .      .-|.-|.|||.+-+.  ..|+..+||||.||++.||+-|.+.|.|..+-+.+..+-.       ..|.++   
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGs--r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGS--RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CcccccceeeeeccChHHhccc--hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            2      356789999988764  7899999999999999999999998888766555544322       111111   


Q ss_pred             cCC-cCC-CCC------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          284 LDP-RLA-IPC------EIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       284 ~~~-~~~-~~~------~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      -|. .+. .|.      -+.+...+.+++..+|.+||.+|+|++|.++.
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            110 000 111      12234466899999999999999999998753

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-47  Score=340.09  Aligned_cols=239  Identities=24%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .+....++-||.|+.|.||.|++. ++.||||+++.-.         ..+|+-|++|+|+||+.+.|+|.....++|+||
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            334455677999999999999984 5799999886221         567889999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      ||..|.|...++....    ++.........+||.||.|||.+   .|+|||||.-|||++.+..+||+|||-++...+.
T Consensus       193 fCa~GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             ccccccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            9999999999986543    77788889999999999999999   9999999999999999999999999998776543


Q ss_pred             c-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 K-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 ~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      .     .||..|||||.+..   .+.+.|+|||||||+||||+||..||.+.....+...+..        ..+..+.+.
T Consensus       266 STkMSFaGTVaWMAPEvIrn---ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--------NsL~LpvPs  334 (904)
T KOG4721|consen  266 STKMSFAGTVAWMAPEVIRN---EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--------NSLHLPVPS  334 (904)
T ss_pred             hhhhhhhhhHhhhCHHHhhc---CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--------CcccccCcc
Confidence            3     68999999999987   7899999999999999999999999977543322222222        345566677


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .|++-+.-|+.+||+-.|.+||||++|+..|.
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            77788889999999999999999999998875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=330.94  Aligned_cols=246  Identities=22%  Similarity=0.286  Sum_probs=208.7

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccc-cHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~-~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      ...++|...+.||+|+|++|++|+ ..+++.+|||++.++....+... ....|-..|.+| .||.|++++-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            445789999999999999999999 77999999999988776554443 356788888888 899999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |+++||+++|+|.++|+..+.    +++.-...++.+|+.||+|||++   |||||||||+|||+|.++.+||+|||.|+
T Consensus       150 YFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            999999999999999987654    88888999999999999999999   99999999999999999999999999886


Q ss_pred             cCCc-------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHh
Q 020027          215 LAPE-------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI  275 (332)
Q Consensus       215 ~~~~-------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~  275 (332)
                      ..+.                   +..||..|++||.+..   ...++.+|+|+|||++|+|+.|.+||.+...--.+..+
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~---~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND---SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcC---CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            5421                   1258999999999987   78899999999999999999999999987655454444


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...        .+..+....  ..+.+|+.+.|..||.+|+|.++|-+
T Consensus       300 ~~l--------~y~fp~~fp--~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  300 QAL--------DYEFPEGFP--EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHh--------cccCCCCCC--HHHHHHHHHHHccCccccccHHHHhh
Confidence            332        222222222  36779999999999999999988765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.4e-45  Score=318.97  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=204.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|+..+.||+|+||.||+|..    ..+..||+|.++.... ......+.+|+..++.++||||+++++++..++..+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            45688889999999999999974    2456899999876432 222335789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....   .+++..++.++.|++.|++|||++   +++||||||+||+++.++.++++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999999976432   378999999999999999999998   999999999999999999999999998654


Q ss_pred             CCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCc
Q 020027          216 APEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       216 ~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      ....       ..++..|+|||.+..   ..++.++|||||||++||+++ |..||.+.........+.++.        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~--------  225 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQY---HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------  225 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhh---CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------
Confidence            3211       124567999998876   678999999999999999886 999998766555544443321        


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                       ..+.+..++..+.+++.+||+.+|++|||+.+|.+.|++++
T Consensus       226 -~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         226 -RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence             11122234457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=328.49  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=206.7

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc---cccccHHHHHHHhccCC-CCCccceeeeeecCC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS---NAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPG  132 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  132 (332)
                      ...++|...+.||+|+||+|+.|. ..+++.||+|.+.......   .......+|+.+++.++ ||||++++++.....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            446689999999999999999998 5688999999776642221   12223568999999998 999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccCC
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYG  211 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg  211 (332)
                      ..+++|||+.+|+|.+++...+.    +.+..+..++.|++.|++|||++   +|+||||||+|+|++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            99999999999999999987433    78899999999999999999999   99999999999999999 999999999


Q ss_pred             ccccCC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          212 LSFLAP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       212 ~a~~~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ++....      ...+|++.|+|||.+..... ....++||||+||+||.|++|+.||...........+..+.      
T Consensus       167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~-Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~------  239 (370)
T KOG0583|consen  167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGT-YSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE------  239 (370)
T ss_pred             cccccCCCCCcccCCCCCcccCCHHHhCCCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC------
Confidence            998662      23479999999999987521 33589999999999999999999999866555555444432      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                        +..+.... ..++.+++.+|+..||.+|+|+.+|+
T Consensus       240 --~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 --FKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             --ccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence              23333221 34778999999999999999999998

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=334.77  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=221.8

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ++++....+......||-|.||.||.|.|+ -...||||.++.+.   -+..+|+.|..+|+.++|||+|+++|+|..+.
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            566666667777889999999999999964 56789999997543   23446899999999999999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      .+||++|||.+|+|.+|+++..+.  .++.--.+.|+.||+.||.||..+   +++||||..+|+|+.++..+|++|||+
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999986543  366677889999999999999998   999999999999999999999999999


Q ss_pred             cccCCccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          213 SFLAPEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       213 a~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      +++.....       .-...|.|||.+.-   ..++.|+|||+|||+|||+.| |..||.|.....++..+..       
T Consensus       412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAy---NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-------  481 (1157)
T KOG4278|consen  412 SRLMTGDTYTAHAGAKFPIKWTAPESLAY---NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-------  481 (1157)
T ss_pred             hhhhcCCceecccCccCcccccCcccccc---cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-------
Confidence            98875442       23467999998876   678999999999999999999 9999999877777665554       


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                        .++...+..|+.++++||+.||+++|.+||+|.|+.+.++.+..+
T Consensus       482 --gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  482 --GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             --cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence              345555667777999999999999999999999999999987643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=330.15  Aligned_cols=242  Identities=21%  Similarity=0.271  Sum_probs=208.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.||+|+||.||||+ ..+.+.||+|.+.+....+.+.....+|+++++.++||||+.++++++...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            467778899999999999999 5689999999998876666666678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+.| +|..++.+...    +++..+..++.++..||.|||++   +|.|||+||+|||++.++++|+||||+|+.....
T Consensus        82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9976 99999987655    89999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                            ..||+-|||||....   .+|+..+|+||+||++||+++|++||.........+.+...       +.   ..+
T Consensus       154 t~vltsikGtPlYmAPElv~e---~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-------~v---~~p  220 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEE---QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-------PV---KPP  220 (808)
T ss_pred             ceeeeeccCcccccCHHHHcC---CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-------CC---CCc
Confidence                  379999999999986   79999999999999999999999999876554444444332       11   112


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..-...+..++...+..||.+|.|-.+++.
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            233446778999999999999999888763

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.8e-44  Score=320.48  Aligned_cols=259  Identities=23%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC-----------------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCcc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS-----------------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV  122 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  122 (332)
                      .++|...+.||+|+||.||+|...                 ++..||+|.+..... ......+.+|+.++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCee
Confidence            356888899999999999999742                 234799999875432 22233578999999999999999


Q ss_pred             ceeeeeecCCceeEEEeccCCCCHHHHhcccCC---------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 020027          123 PILGFSQAPGERIIVSEFINMASLDFYLHENND---------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNI  187 (332)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i  187 (332)
                      ++++++...+..+++|||+++++|.+++.....               ....+++.....++.|++.||.|||+.   ++
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            999999999999999999999999999865321               112367888999999999999999998   99


Q ss_pred             eecCCCCCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-
Q 020027          188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-  258 (332)
Q Consensus       188 vH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-  258 (332)
                      +||||||+|||++.++.+||+|||+++.....        ..++..|+|||.+..   ..++.++||||||+++|||++ 
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM---GKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc---CCCCchhhhHHHHHHHHHHHHc
Confidence            99999999999999999999999998754221        134668999998865   678999999999999999987 


Q ss_pred             -CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          259 -GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       259 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                       +..||.+.............. ... ........+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFF-RDQ-GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHh-hhc-cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence             556777654443332221100 000 0000111122334478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=321.36  Aligned_cols=243  Identities=18%  Similarity=0.208  Sum_probs=201.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            4688899999999999999994 578999999987543221 22334688999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++.....++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999976432    78888999999999999999998   999999999999999999999999999876543


Q ss_pred             c---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 E---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                      .   ..|+..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+..+.        ...+... 
T Consensus       154 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--------~~~~~~~-  221 (291)
T cd05612         154 RTWTLCGTPEYLAPEVIQS---KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--------LEFPRHL-  221 (291)
T ss_pred             CcccccCChhhcCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------cCCCccC-
Confidence            2   357889999999876   567899999999999999999999998876655554444332        1111111 


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                       ...+.+++.+||+.||.+||+     ++++++
T Consensus       222 -~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         222 -DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence             236779999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-45  Score=327.62  Aligned_cols=243  Identities=24%  Similarity=0.284  Sum_probs=208.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ..|.....||+|+-|.||.++ ..+++.||||++.......++  -..+|+.+|+..+|+|||.+++.+...+.+|+|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke--LilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE--LLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh--hhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            467777899999999999999 678999999999876544333  35899999999999999999999988899999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++|+|.+.+....     +++.++..|+.++++||+|||.+   +|+|||||..|||++.+|.+||+|||++....+.
T Consensus       351 ym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             ecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            999999999886543     88999999999999999999999   9999999999999999999999999998766543


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                            ..||+.|||||....   ..|++++||||||++++||+-|.+||-...+-.++..+....       .+....+
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtr---k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-------~P~lk~~  492 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTR---KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-------TPKLKNP  492 (550)
T ss_pred             cCccccccCCCCccchhhhhh---cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-------CCCcCCc
Confidence                  269999999999988   789999999999999999999999998665555555554432       2222333


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+.+++.+||+.|+++|||+.|+|+
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            344447889999999999999999999986

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=298.39  Aligned_cols=263  Identities=21%  Similarity=0.277  Sum_probs=219.3

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC----
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP----  131 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  131 (332)
                      .+..++|.+.+.||+|||+.||.++ ..+++.+|+|++.....  ++....++|+...++++|||+++++++...+    
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            3456789999999999999999999 78999999999976542  2233568999999999999999999987433    


Q ss_pred             -CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          132 -GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                       ...||++.|...|+|.+.+......+..+++.+.+.++.++++||.+||+. .+++.||||||.|||+++++.+++.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence             458999999999999999988766666799999999999999999999997 345999999999999999999999999


Q ss_pred             CccccCCcc---------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHh
Q 020027          211 GLSFLAPEE---------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI  275 (332)
Q Consensus       211 g~a~~~~~~---------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~  275 (332)
                      |.+...+-.               ...|..|.|||.|.-+.+...++++|||||||+||+|+.|..||.....       
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------  246 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------  246 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence            998655321               1468899999999988778899999999999999999999999965321       


Q ss_pred             hhccc-ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          276 KEMRF-SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       276 ~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .-+.+ ..+..+.+..|.+..-++.+..++.+|++.||.+||++.+++..+..+.
T Consensus       247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11222 2234445556655556668889999999999999999999999988764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-45  Score=330.00  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=210.4

Q ss_pred             CCCCCceeeccCCeEEEEEEeC---CCC--EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLS---TGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      .....+.||+|.||.||+|.+.   .|+  .||||..+.+...++ ...|+.|..+|++++||||+++.|.|... ..||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            3344578999999999999843   222  699999887665544 45789999999999999999999999765 4789


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |||.++.|.|..|++.+...   ++..+...++.||+.||+|||+.   ++|||||..+|||+..+..+|++|||+++..
T Consensus       468 vmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence            99999999999999887654   78888999999999999999998   9999999999999999999999999999887


Q ss_pred             Cccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          217 PEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       217 ~~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      .+..       .-...||+||...-   .+++++||||-|||++||++. |..||.+-...++...+         ...-
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINf---RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i---------EnGe  609 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINF---RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI---------ENGE  609 (974)
T ss_pred             cccchhhccccccceeecCccccch---hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe---------cCCC
Confidence            6543       22467999998776   789999999999999999998 99999986544433222         3334


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      +.|.+++|+..++.+|.+||++||.+||+|.|+...|+.++.
T Consensus       610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            566777788899999999999999999999999999988764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.4e-44  Score=319.71  Aligned_cols=253  Identities=19%  Similarity=0.360  Sum_probs=201.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCC----EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ..+|+..+.||+|+||.||+|.+ .+++    .||+|.++.... ......+.+|+.+++.++||||++++|++... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            35689999999999999999984 3444    389999864322 22233578899999999999999999999765 46


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++|+|.+++.....   .+++...+.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            799999999999999976432   278889999999999999999998   99999999999999999999999999997


Q ss_pred             cCCccc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ......        ..+..|++||....   ..++.++|||||||++||++| |+.||.+.............       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-------  227 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------  227 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhcc---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-------
Confidence            653221        23457999998876   678999999999999999998 99999876544433322221       


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                        ...+.+..+...+.+++.+||+.||++|||+.+++..|..+..+|
T Consensus       228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence              111112223346889999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-44  Score=322.49  Aligned_cols=242  Identities=21%  Similarity=0.237  Sum_probs=208.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|+.++.||+|+||.||.++ ..+|..+|+|++++....... ......|-.+|...++|+||+++-.|.+...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            46899999999999999999999 679999999999987654433 3357888899999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||++||++..++...+.    +++..+..++.+++.|+.-+|..   |++||||||+|+|||..|.+||+|||++...
T Consensus       219 iMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999976543    88899999999999999999999   9999999999999999999999999987210


Q ss_pred             ---------------------------Cc--------------------------ccCCcccccCcccccccCCCCCCch
Q 020027          217 ---------------------------PE--------------------------EKRGLAGYVDDDYWHEKGGGNATRE  243 (332)
Q Consensus       217 ---------------------------~~--------------------------~~~~~~~~~~pe~~~~~~~~~~~~~  243 (332)
                                                 +.                          +..||+.|+|||++..   ..|+..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~---kgY~~~  368 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG---KGYGKE  368 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc---CCCCcc
Confidence                                       00                          0158999999999988   668999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCC
Q 020027          244 SDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS  317 (332)
Q Consensus       244 ~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs  317 (332)
                      +|.||+|||+|||+.|-+||.+..+.+++..+..-+      ..+..|.......++.++|.+|+. ||++|--
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999999999999999887776532      234445455555789999999999 9999964

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-44  Score=325.37  Aligned_cols=243  Identities=22%  Similarity=0.231  Sum_probs=200.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+. .+++.||+|.+....... .....+.+|+.+++.++||||+++++.+..++..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            46788899999999999999994 578999999987543222 2223578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        97 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999999876432    78888889999999999999998   99999999999999999999999999987654


Q ss_pred             cc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          218 EE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       218 ~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      +.   ..|+..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+..+.        +..+.. 
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--------~~~p~~-  237 (329)
T PTZ00263        170 DRTFTLCGTPEYLAPEVIQS---KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--------LKFPNW-  237 (329)
T ss_pred             CCcceecCChhhcCHHHHcC---CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------cCCCCC-
Confidence            33   357889999999876   567899999999999999999999998766555444444332        112211 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPS-----IVQVA  322 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs-----~~~i~  322 (332)
                       ...++.+++.+||+.||.+||+     +.+++
T Consensus       238 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        238 -FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             -CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence             1236779999999999999997     56665

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.6e-44  Score=328.27  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQ  129 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  129 (332)
                      ....++|...+.||+|+||.||+|..      .++..||+|.++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34456789999999999999999962      3566899999875432 22233578899999999 8999999999999


Q ss_pred             cCCceeEEEeccCCCCHHHHhcccCC------------------------------------------------------
Q 020027          130 APGERIIVSEFINMASLDFYLHENND------------------------------------------------------  155 (332)
Q Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  155 (332)
                      ..+..+++|||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999999864321                                                      


Q ss_pred             -----------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          156 -----------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       156 -----------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                                       ....+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             011367888999999999999999998   999999999999999999999999999875432


Q ss_pred             cc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHH-HHHHHhhhcccccccCCcC
Q 020027          219 EK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVK-WALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       219 ~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~  288 (332)
                      ..        .++..|++||....   ..++.++|||||||++|||+| |..||.+.... .....+..+. .       
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~-------  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-R-------  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcC---CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-c-------
Confidence            21        23456999998876   678999999999999999998 88888765332 2222222221 0       


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                       ...+.....++.+++.+||+.||++|||+.|+++.|++.
T Consensus       336 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 -MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             011111234788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=335.94  Aligned_cols=250  Identities=21%  Similarity=0.384  Sum_probs=214.0

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCC----EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ....++||+|+||+||+|. ...|+    +||+|++..... .+...+++.|...|+.++|||+++++|+|..+. ..|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            3456789999999999998 44454    799998865432 334557899999999999999999999998776 7899


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ++|++.|+|.+|++.++..   +.....+.+..|||+||.|||.+   ++|||||..+|||+.....+||.|||+++...
T Consensus       776 tq~mP~G~LlDyvr~hr~~---igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDN---IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHhcccchHHHHHHHhhcc---ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            9999999999999987654   67788899999999999999999   99999999999999999999999999998765


Q ss_pred             ccc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          218 EEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       218 ~~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ...        .-...|||-|....   ..++.++|||||||.+||++| |..|+.+...+++-+.++.+.         
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~---~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge---------  917 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRI---RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE---------  917 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhc---cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc---------
Confidence            432        22356777777666   789999999999999999999 999999998888877666642         


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                      +.++++-|...++.+|.+||..|++.||+|+++...+.++.+||
T Consensus       918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            35556677789999999999999999999999999999998887

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.8e-44  Score=328.48  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFS  128 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  128 (332)
                      +....++|+..+.||+|+||.||+|..      .++..||+|.++..... .....+.+|+.+++.+ +|+||+++++++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            344556899999999999999999873      23458999999754322 2223578899999999 899999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCC-----------------------------------------------------
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENND-----------------------------------------------------  155 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  155 (332)
                      ...+..+++|||+++|+|.+++.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            999999999999999999999854210                                                     


Q ss_pred             -------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc--
Q 020027          156 -------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK--  220 (332)
Q Consensus       156 -------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~--  220 (332)
                                   ....+++..+++++.|++.||.|||++   +++||||||+||++++++.+||+|||+++......  
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                         011367888999999999999999998   99999999999999999999999999986543221  


Q ss_pred             ------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          221 ------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       221 ------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                            .++..|+|||....   ..++.++|||||||++|||++ |+.||.................        ....+
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~--------~~~~~  337 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--------QMSRP  337 (374)
T ss_pred             eeccCCCCccceeCHHHhcC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc--------CccCC
Confidence                  23457999998865   678999999999999999998 9999976543322211111111        11111


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ...+.++.+++.+||+.||++|||+.++++.|++++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            111236889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.5e-44  Score=316.16  Aligned_cols=248  Identities=21%  Similarity=0.271  Sum_probs=196.2

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .|...+.||+|+||.||++. ..+|+.||+|.+....... .....+.+|+.+++.++|+|++++++.+..++..+++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            36778899999999999999 5689999999987544322 222346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++++|..++.....  ..+++..+..++.|++.|+.|||+.   +++||||||+|||+++++.+||+|||++..... 
T Consensus        81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999888764322  2378999999999999999999998   999999999999999999999999999876432 


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                          ...|+..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+...    ........  +.
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~--~~  226 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINN---EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR----VKEDQEEY--SE  226 (285)
T ss_pred             CeecCCCCCCCccCHhhhcC---CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH----hhcccccC--Cc
Confidence                2357899999999876   67899999999999999999999999764322111111110    00111111  11


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      .....+.+++.+||+.||++||+     ++++++
T Consensus       227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            12336779999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-43  Score=312.82  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC-C-----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS-T-----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ++|+..+.||+|+||.||+|... .     ...||+|.++.... ......+.+|+..++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            46888899999999999999842 2     25799998864432 22223578999999999999999999999998999


Q ss_pred             eEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          135 IIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      +++|||+++++|.+++......            ...+++..++.++.|++.||.|||+.   +++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            9999999999999999754211            13478889999999999999999998   99999999999999999


Q ss_pred             CceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHH
Q 020027          203 FCARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP  273 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~  273 (332)
                      +.+||+|||++.....        ...++..|+|||....   ..++.++|||||||++|||+| |..||.+....+...
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY---GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc---CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999865321        1234677999998866   678899999999999999998 999998876655544


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .+.....         .+.+..++.++.+++.+||+.||++|||++||++.|+++
T Consensus       238 ~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 MIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            4443221         112233445888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-43  Score=307.81  Aligned_cols=245  Identities=21%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      ++|+..+.||+|+||.||++...++..+|+|.+.....   ....+.+|+.++++++||||+++++++..++..+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            45778889999999999999987888999998764322   123578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK  220 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~  220 (332)
                      +++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||+|+||++++++.+|++|||.++......
T Consensus        81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          81 MENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            999999999875432   278999999999999999999998   99999999999999999999999999887543211


Q ss_pred             -------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          221 -------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       221 -------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                             .++..|++||....   ..++.++|+||||+++||+++ |+.||...........+..+..       ...+ 
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-------~~~~-  223 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNF---SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-------LYRP-  223 (256)
T ss_pred             eeccCCCCCchhhCChhhccc---CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------CCCC-
Confidence                   23457999999875   568899999999999999999 8999987655544444433211       0011 


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                       ......+.+++.+||+.||++|||+.++++.|.
T Consensus       224 -~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         224 -KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             112246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-44  Score=313.72  Aligned_cols=242  Identities=31%  Similarity=0.446  Sum_probs=191.7

Q ss_pred             CceeeccCCeEEEEEEeC-----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           66 RRIIGQGRLGTVYAALLS-----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .+.||.|+||.||+|.+.     .+..|+||.++... .......+.+|++.+++++||||++++|++...+..++++||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeecccccccccccccccccccccccccccccccc
Confidence            468999999999999964     35689999996532 222245689999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      +++|+|.+++.....  ..+++..+..++.|++.||.|||++   +++|+||+++||++++++.+||+|||++.....  
T Consensus        83 ~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999987621  2388999999999999999999998   999999999999999999999999999876521  


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                            .......|++||.+..   ..++.++||||||+++||++| |+.||.+.........+.++..         .+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~---~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~---------~~  225 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD---GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR---------LP  225 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH---SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---------TT
T ss_pred             cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccc---------ce
Confidence                  1235668999999877   568999999999999999999 7789887765555555544321         11


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      .+..++..+.+++.+||+.||++|||+.++++.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1222344788999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-43  Score=318.93  Aligned_cols=255  Identities=21%  Similarity=0.258  Sum_probs=200.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||++. ..+|..+|+|.+..... ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            4689999999999999999999 45788999999875422 122235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++....+
T Consensus        83 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999976432    78889999999999999999975  1699999999999999999999999999865432


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccc------c------
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS------E------  282 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~------~------  282 (332)
                          ...++..|+|||.+..   ..++.++|||||||++|||+||+.||......+....+......      .      
T Consensus       157 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         157 SMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             cccccCCCCcCcCCHhHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence                2357889999999875   67899999999999999999999999765443332221110000      0      


Q ss_pred             --------------------------ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          283 --------------------------LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       283 --------------------------~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                                                ................++.+++.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                      000000000011123468899999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.7e-44  Score=321.59  Aligned_cols=237  Identities=19%  Similarity=0.262  Sum_probs=194.7

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      +.||+|+||.||+++ ..+|+.||+|.++...... .....+.+|+.+++.++||||+++++.+...+..+++|||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999998 4688999999997643322 22234678999999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc------
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE------  218 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~------  218 (332)
                      +|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++....      
T Consensus        81 ~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          81 ELFFHLSRERV----FSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            99999875432    78999999999999999999998   999999999999999999999999999865321      


Q ss_pred             ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       219 ~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                      ...|+..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....        ...+.  ....
T Consensus       154 ~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~p~--~~~~  220 (323)
T cd05571         154 TFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------IRFPR--TLSP  220 (323)
T ss_pred             ceecCccccChhhhcC---CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------CCCCC--CCCH
Confidence            2258899999999876   678899999999999999999999998765554444333221        11111  2233


Q ss_pred             HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ++.+++.+||+.||++||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            678999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.7e-43  Score=356.75  Aligned_cols=254  Identities=25%  Similarity=0.439  Sum_probs=203.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ...|...+.||+|+||.||+|.. .++..||+|.+.....      ....|++.+++++||||++++|++..++..++||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            35677888999999999999994 6899999998863221      1245688999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      ||+++++|.++++.       ++|.++..++.|+++||+|||+.+.++++|||+||+||+++.++.+++. ||.+.... 
T Consensus       763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            99999999999952       7899999999999999999997666799999999999999999888875 55543322 


Q ss_pred             -cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch------hHHHHHHHhhhcccccccCCcCCC
Q 020027          218 -EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL------LVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       218 -~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                       ....++..|+|||+...   ..++.++|||||||++|||+||+.||...      ..++..............++.+..
T Consensus       835 ~~~~~~t~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 DTKCFISSAYVAPETRET---KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             CCCccccccccCcccccC---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence             22357789999999876   67899999999999999999999998532      122222222222233344554422


Q ss_pred             --CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          291 --PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       291 --~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                        +.+.++..++.+++.+||+.||++||||+|+++.|+++..
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence              2344566788899999999999999999999999998764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-44  Score=322.23  Aligned_cols=252  Identities=18%  Similarity=0.181  Sum_probs=204.3

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+|+. .+++.||+|.++...... .....+.+|+.++..++||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            3688899999999999999995 578999999997653322 22235788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999975432    78889999999999999999998   999999999999999999999999999876533


Q ss_pred             ---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 ---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                         ...|+..|+|||.+..   ..++.++|||||||++|||++|..||.+....+....+....  ..............
T Consensus       154 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~  228 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRG---KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFN  228 (333)
T ss_pred             ccCCcccCccccChhHhcC---CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccc
Confidence               3468899999999876   578899999999999999999999998776655544443211  11111000000112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ...++.+++.+||+.+|++|||+.++++.
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            24478899999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-44  Score=312.69  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=215.0

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccccc-ccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ....+|++.+.||+|+||+|-++. ...|+.||||.++++...+.+. ..+.+||.+|+.++||||+.++.+|+..+...
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            345678899999999999999998 6899999999999877655443 35789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      |||||..+|.|++|+.+.+.    +++..+.+++.||..|+.|+|.+   +++|||||.+|||+|.|+++||+|||++-.
T Consensus       130 ivMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhh
Confidence            99999999999999987654    89999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....     .+|.+-|.+||...+.  ..-.+.+|.||+|++||.|+.|.-||+|.........+..+.+.+.-.|    
T Consensus       203 y~~~kfLqTFCGSPLYASPEIvNG~--PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~P----  276 (668)
T KOG0611|consen  203 YADKKFLQTFCGSPLYASPEIVNGT--PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETP----  276 (668)
T ss_pred             hccccHHHHhcCCcccCCccccCCC--CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCC----
Confidence            5543     3789999999998763  3346899999999999999999999999988888777777755442111    


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                             .....||++++-.||++|-|+.+|...
T Consensus       277 -------SdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  277 -------SDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             -------chHHHHHHHHHhcCcccchhHHHHhhh
Confidence                   145678999999999999999998763

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-43  Score=309.12  Aligned_cols=250  Identities=20%  Similarity=0.361  Sum_probs=205.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|+..+.||+|+||.||+|...+++.||+|.+.....   ....+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            4567888999999999999999987888999998865322   2235788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....  ..+++.+++.++.|++.|++|||+.   +++||||||+||++++++.++++|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          81 EYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            99999999999975432  2378888999999999999999998   999999999999999999999999999976543


Q ss_pred             cc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 EK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..       .++..|++||+...   ..++.++|||||||++|||+| |..||.+.........+....         ..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------~~  223 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---------RM  223 (261)
T ss_pred             CceeccCCCccceecCCHHHhcc---CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---------CC
Confidence            21       24557999998865   668889999999999999999 999997765544444333221         11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +.....+..+.+++.+||+.||++|||++++.+.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11122334678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-43  Score=308.66  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=203.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..+|...+.||+|+||.||+|. .++++.||+|.+....   .....+.+|+..++.++|+|++++++++..++..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            3457788899999999999999 4578899999886432   12235788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....  ..+++..++.++.|+++||+|||++   +++||||||+||++++++.+|++|||++....+
T Consensus        82 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          82 EFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999875432  2378999999999999999999998   999999999999999999999999999876543


Q ss_pred             cc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 EK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..       ..+..|++||....   ..++.++|||||||++|||+| |..||.+.........+...         ...
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---------~~~  224 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---------YRM  224 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---------CCC
Confidence            21       23457999998765   678899999999999999998 89999876555444433321         111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +.+...+.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11222334788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.2e-43  Score=311.82  Aligned_cols=253  Identities=18%  Similarity=0.196  Sum_probs=196.4

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.||+|+||.||+++. .+++.||+|.++...........+.+|+.+++.++||||+++++++..++..+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4688899999999999999995 578899999997654333333457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |++++++..+....    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99987776554332    1278899999999999999999998   9999999999999999999999999998764321


Q ss_pred             -------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c-----------
Q 020027          220 -------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R-----------  279 (332)
Q Consensus       220 -------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~-----------  279 (332)
                             ..++..|+|||....   ..++.++|||||||++|||++|+.||.+.........+...  .           
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLG---APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccCCcHHHcC---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence                   247888999999865   56889999999999999999999999765432222111110  0           


Q ss_pred             ---cccccCCcCCCCCC------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ---FSELLDPRLAIPCE------IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ---~~~~~~~~~~~~~~------~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         ......+....+..      ......+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00000000000000      012346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-43  Score=312.32  Aligned_cols=254  Identities=23%  Similarity=0.270  Sum_probs=197.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|+ ..+++.||+|.++.... ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            3568899999999999999999 45789999999875432 222234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ ++|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          83 EYLD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eCCC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            9997 489888865432   268888999999999999999998   999999999999999999999999999865322


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------ccc----
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RFS----  281 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~----  281 (332)
                            ...++..|+|||.+...  ..++.++||||+||++|||+||+.||.+....+....+...       .+.    
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             CCccccCceecccccChHHhcCC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence                  22467889999987642  56789999999999999999999999876554443322110       000    


Q ss_pred             -----cccCCcCCCCC----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 -----ELLDPRLAIPC----EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 -----~~~~~~~~~~~----~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           ...-+......    ......++.+++.+|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 00001100000    0112236779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-43  Score=306.85  Aligned_cols=251  Identities=24%  Similarity=0.401  Sum_probs=204.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|+..+.||+|+||.||+|...    +...||+|.++.... ......+.+|+..++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            457889999999999999999853    245899998865432 222345788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....   .+++..++.++.|++.|+.|||++   +++|+||||+||++++++.++++|||++..
T Consensus        82 iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            99999999999999976432   378999999999999999999998   999999999999999999999999999876


Q ss_pred             CCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          216 APEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       216 ~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ....        ..++..|++||....   ..++.++||||||+++||+++ |..||...........+....       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------  225 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------  225 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhcc---CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-------
Confidence            5311        123467999998875   678899999999999999998 999997655544444333221       


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                        ..+.+...+..+.+++.+||+.||++|||++++++.|++++
T Consensus       226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence              11112233447889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-43  Score=308.83  Aligned_cols=252  Identities=25%  Similarity=0.417  Sum_probs=207.9

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ....+|...+.||.|+||.||+|...+++.+|+|.+......  ....+..|+.+++.++|+|++++++++...+..+++
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            345678889999999999999999777999999998754321  223578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....  ..+++.++..++.|++.|+.|||++   +++|+||+|+||++++++.+|++|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          81 TELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999976432  2378999999999999999999998   99999999999999999999999999986543


Q ss_pred             cc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          218 EE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       218 ~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..      ..++..|++||....   ..++.++||||||+++|++++ |+.||.+....+....+...         ...
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---------~~~  223 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASH---GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG---------YRM  223 (261)
T ss_pred             CccccccCCCCceEecCHHHHcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC---------CcC
Confidence            32      134567999998765   678899999999999999998 88999876655554444321         111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +.+......+.+++.+||+.||++|||++++++.|+++
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            22233345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-43  Score=305.48  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|...+.||+|+||.||+|...+++.||+|.++....   ....+.+|+..+++++|+|++++++++...+..+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            4566888899999999999999977778999999875432   2235788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++....  ...+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999999997643  22378999999999999999999998   999999999999999999999999999875542


Q ss_pred             cc----CC---cccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 EK----RG---LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~~----~~---~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..    .+   +..|++||....   ..++.++|+||||+++|||+| |+.||.+.........+....         ..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------~~  223 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY---NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---------RM  223 (261)
T ss_pred             CcccccCCCcCceeccCcccccc---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CC
Confidence            21    12   346999998765   678899999999999999999 999998765554444333211         11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +.+......+.+++.+||+.||++||++.++.+.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            11222334788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.2e-43  Score=308.49  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCC----EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ++|...+.||+|+||.||+|.. .+++    .+++|.+..... .....++..|+..++.++||||+++++++.. ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            4678889999999999999984 4555    477777643211 1122346677788899999999999999864 4567


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +++||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||++++++.+|++|||+++.
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            89999999999999975432   378999999999999999999998   999999999999999999999999999875


Q ss_pred             CCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          216 APEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       216 ~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ....        ..++..|++||....   ..++.++|||||||++||++| |..||.+.........+..+..      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------  229 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILF---GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER------  229 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhcc---CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc------
Confidence            4321        135568999998875   678999999999999999998 9999987655544343333211      


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                       +  +.+..+...+.+++.+||+.||++|||+.|+++.|..+..||
T Consensus       230 -~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         230 -L--AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             -C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence             1  111122346778999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-43  Score=300.97  Aligned_cols=257  Identities=19%  Similarity=0.183  Sum_probs=203.1

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--Cce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  134 (332)
                      .+.++|+..+.|++|+||.||+|+ .++++.||+|+++.+.....-....++||.++.+.+|||||.+..+....  +..
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            455679999999999999999999 67899999999987653333233468999999999999999999988654  579


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |+|||||+ -+|...+....   ..+...++.-++.|++.|++|||.+   .|+|||||++|+|+++.|.+||+|||+|+
T Consensus       153 y~VMe~~E-hDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhh
Confidence            99999997 48988887654   2378888999999999999999999   99999999999999999999999999999


Q ss_pred             cCCccc------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--c-----ccc
Q 020027          215 LAPEEK------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--M-----RFS  281 (332)
Q Consensus       215 ~~~~~~------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--~-----~~~  281 (332)
                      ...+..      .-|.-|.|||.+.+.  ..|+++.|+||+|||+.|++++++.|.|...-+..+.+-.  +     .|.
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~--~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGA--KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCC--cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            876653      357789999999875  7899999999999999999999998887654443333211  1     111


Q ss_pred             cccCCc----C---CCCCC-------h-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ELLDPR----L---AIPCE-------I-KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~~~~~----~---~~~~~-------~-~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......    .   ..+.+       . ...+.-++++...+.+||.+|-|++|.+.
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            100000    0   01110       0 12346779999999999999999998764

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-43  Score=333.87  Aligned_cols=255  Identities=19%  Similarity=0.235  Sum_probs=205.9

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-  132 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  132 (332)
                      +.....++|...+.||+|+||.||+++ ..+|+.||+|.+............+.+|+..+..++|+|++++++.+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            334456789999999999999999998 568999999999765443333445788999999999999999987764322 


Q ss_pred             -------ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCce
Q 020027          133 -------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA  205 (332)
Q Consensus       133 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  205 (332)
                             ..+++|||+++|+|.+++.........+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence                   36799999999999999976543344588999999999999999999998   99999999999999999999


Q ss_pred             EEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh
Q 020027          206 RVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       206 kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~  277 (332)
                      ||+|||+++....        ...||+.|+|||.+..   ..++.++|||||||++|||++|+.||.+............
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~  259 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR---KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA  259 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            9999999865432        2357899999999876   6789999999999999999999999987765555444333


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      +...         +.+.....++.+++.+||+.||++|||+.++++.
T Consensus       260 ~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            2211         1112223478899999999999999999998763

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.5e-43  Score=306.94  Aligned_cols=254  Identities=21%  Similarity=0.266  Sum_probs=203.8

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+|+ ..+++.||+|.++...... .....+.+|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            578899999999999999999 4588999999886533222 22335788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.........++...++.++.|++.||.|||++   +++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998865433333478889999999999999999998   999999999999999999999999999876443


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH--HHHHHHhhhcccccccCCcCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV--KWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                            ...++..|++||.+..   ..++.++|+||||+++|||++|+.||.....  ......+.....     +.   
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~---  227 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-----PP---  227 (267)
T ss_pred             hhHHHhcCCCCccccChhhhcc---CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC-----CC---
Confidence                  2246778999998875   5678899999999999999999999865322  122122211111     11   


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .........+.+++.+||+.+|++|||+.++++.|+++
T Consensus       228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11112334688999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=334.89  Aligned_cols=258  Identities=21%  Similarity=0.235  Sum_probs=214.5

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEeCC-CCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeee-ee---
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALLST-GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGF-SQ---  129 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~---  129 (332)
                      +.+...++.+.+.|.+|||+.||.+.... |..+|+|++...  .........+||.+|++|+ |+|||.+++. ..   
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            34455677888999999999999999544 499999998755  2333445789999999996 9999999993 21   


Q ss_pred             cC---CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          130 AP---GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       130 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                      ..   -+++|.||||++|.|-++++......  +++..+++|+.|+++|+++||.. .++|+|||||.+|||++.++..|
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence            11   35689999999999999998644332  89999999999999999999985 77899999999999999999999


Q ss_pred             EccCCccccCCc---c------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH
Q 020027          207 VCDYGLSFLAPE---E------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA  271 (332)
Q Consensus       207 l~dfg~a~~~~~---~------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~  271 (332)
                      |||||.+.....   .            ...|+.|++||.+.--.+..+++|+|||||||+||.|+....||.+.     
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s-----  261 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES-----  261 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-----
Confidence            999998743211   1            13689999999998777789999999999999999999999999763     


Q ss_pred             HHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          272 LPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                             .-..++...+..|........+.+||..||+.||++||++-+++..+.++..
T Consensus       262 -------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  262 -------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                   1223455667777777888899999999999999999999999999988764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=317.89  Aligned_cols=231  Identities=24%  Similarity=0.247  Sum_probs=189.0

Q ss_pred             eeccCCeEEEEEEe-CCCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           69 IGQGRLGTVYAALL-STGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        69 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      ||+|+||.||+++. .+++.||+|.++..... ......+.+|+.+++.++||||+++++++..++..+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999994 57889999998754322 22223567899999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc------cc
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE------EK  220 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~------~~  220 (332)
                      .+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++....      ..
T Consensus        81 ~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          81 FHHLQREGR----FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             HHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            999976432    78899999999999999999998   999999999999999999999999999875321      22


Q ss_pred             CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHH
Q 020027          221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL  300 (332)
Q Consensus       221 ~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  300 (332)
                      .||..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....        ...+.  .....+
T Consensus       154 ~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~  220 (312)
T cd05585         154 CGTPEYLAPELLLG---HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------LRFPD--GFDRDA  220 (312)
T ss_pred             cCCcccCCHHHHcC---CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--------CCCCC--cCCHHH
Confidence            58899999999876   678999999999999999999999998765554443333221        11111  122367


Q ss_pred             HHHHHHcccCCCCCCCCHH
Q 020027          301 AKVALACVGNSRKNRPSIV  319 (332)
Q Consensus       301 ~~l~~~c~~~dp~~RPs~~  319 (332)
                      .+++.+||+.||++||++.
T Consensus       221 ~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         221 KDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             HHHHHHHcCCCHHHcCCCC
Confidence            7999999999999998643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-44  Score=297.31  Aligned_cols=237  Identities=19%  Similarity=0.240  Sum_probs=205.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|+..+.||.|+||+|..++ ..+|..+|+|++++...-. .+.....+|..+++.+.||.++++++.+.+.+..++
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            45689999999999999999999 5688999999998655432 233346889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||.+||.|..+++..++    +++..+..++.||+.|++|||+.   +|++|||||+|||+|.+|.+||+|||+|+..
T Consensus       122 vmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            9999999999999987655    89999999999999999999999   9999999999999999999999999999876


Q ss_pred             Ccc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          217 PEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       217 ~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                      ...   .+||+.|+|||..+.   ..++.++|.|||||++|||+.|.+||.+..+..++..+.++.        +..|..
T Consensus       195 ~~rT~TlCGTPeYLAPEii~s---k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~--------v~fP~~  263 (355)
T KOG0616|consen  195 SGRTWTLCGTPEYLAPEIIQS---KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK--------VKFPSY  263 (355)
T ss_pred             cCcEEEecCCccccChHHhhc---CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc--------ccCCcc
Confidence            654   389999999999988   789999999999999999999999999887777777776653        233322


Q ss_pred             hHHHHHHHHHHHHcccCCCCCC
Q 020027          294 IKPLVRLAKVALACVGNSRKNR  315 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~R  315 (332)
                      ..  ..+.+|+...++.|-.+|
T Consensus       264 fs--~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  264 FS--SDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cC--HHHHHHHHHHHhhhhHhh
Confidence            22  256688999999998888

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-42  Score=305.31  Aligned_cols=251  Identities=23%  Similarity=0.315  Sum_probs=197.7

Q ss_pred             CCCceeeccCCeEEEEEEeC-CCC--EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------Cce
Q 020027           64 SHRRIIGQGRLGTVYAALLS-TGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------GER  134 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  134 (332)
                      ...+.||+|+||.||+|... ++.  .+|+|.++...........+.+|+.+++.++|+||+++++.+...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45678999999999999954 333  689998876543333344578899999999999999999987432      346


Q ss_pred             eEEEeccCCCCHHHHhcccC--CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          135 IIVSEFINMASLDFYLHENN--DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ++++||+++++|.+++....  .....+++.....++.|++.||+|||++   +++||||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999998874322  1223478999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccc
Q 020027          213 SFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSEL  283 (332)
Q Consensus       213 a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      ++.....        ..++..|++||....   ..++.++||||||+++||+++ |+.||.+.........+..+..   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD---RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR---  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccC---CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            8764322        124567899998765   678999999999999999999 7889987655555454443221   


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                          .  +.+......+.+++.+||+.||++|||+.++++.|++++
T Consensus       233 ----~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         233 ----L--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             ----C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                1  111223346789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-43  Score=316.85  Aligned_cols=237  Identities=20%  Similarity=0.273  Sum_probs=193.6

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      +.||+|+||.||+++ ..+|+.||+|.++...... .....+.+|+.+++.++||||+++++.+...+..+++|||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            469999999999999 4688999999997643322 22234678999999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc------
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE------  218 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~------  218 (332)
                      +|..++.....    +++..+..++.|++.||.|||++   +++||||||+|||+++++.+||+|||++.....      
T Consensus        81 ~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          81 ELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            99988865432    78999999999999999999998   999999999999999999999999998864321      


Q ss_pred             ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       219 ~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                      ...|+..|+|||....   ..++.++|||||||++|||++|+.||.+.........+....        ...+..  ...
T Consensus       154 ~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--------~~~p~~--~~~  220 (323)
T cd05595         154 TFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------IRFPRT--LSP  220 (323)
T ss_pred             cccCCcCcCCcccccC---CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------CCCCCC--CCH
Confidence            2257899999999865   678899999999999999999999998765554444333221        111111  223


Q ss_pred             HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .+.+++.+||+.||++||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            677999999999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.6e-43  Score=308.30  Aligned_cols=254  Identities=21%  Similarity=0.325  Sum_probs=203.0

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      ...++|+..+.||+|+||.||+|...      ++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            35677999999999999999998742      356899998854321 12233578999999999999999999999998


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCC------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCce
Q 020027          132 GERIIVSEFINMASLDFYLHENNDG------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA  205 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  205 (332)
                      +..+++|||+++++|.+++......      ...+++..++.++.|++.|+.|||+.   +++|+||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            9999999999999999998653221      12357888999999999999999998   99999999999999999999


Q ss_pred             EEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhh
Q 020027          206 RVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIK  276 (332)
Q Consensus       206 kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~  276 (332)
                      +++|||+++.....        ..++..|+|||.+..   ..++.++|||||||++|||++ |..||.+.........+.
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhc---CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999998654221        134567999999875   678999999999999999999 788988765555544443


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ......         .+......+.+++.+||+.||++|||+.|+++.|++
T Consensus       236 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            322111         111233478899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-43  Score=317.24  Aligned_cols=237  Identities=19%  Similarity=0.274  Sum_probs=194.3

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      +.||+|+||.||+++ ..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999 5689999999997653322 22235678999999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc------
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE------  218 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~------  218 (332)
                      +|..++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....      
T Consensus        81 ~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          81 ELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             CHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            99988865432    78999999999999999999998   999999999999999999999999999865321      


Q ss_pred             ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       219 ~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                      ...|+..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+....        ...+..  ...
T Consensus       154 ~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~p~~--~~~  220 (328)
T cd05593         154 TFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--------IKFPRT--LSA  220 (328)
T ss_pred             cccCCcCccChhhhcC---CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--------ccCCCC--CCH
Confidence            1257899999999875   678899999999999999999999998765544433332211        111111  223


Q ss_pred             HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ++.+++.+||+.||++||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            677999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.6e-43  Score=318.46  Aligned_cols=258  Identities=25%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAP  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  131 (332)
                      ..++|...+.||+|+||.||+|..      .+++.||+|+++.... ......+..|+.++.++ +|+||+++++++...
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            345789999999999999999962      2457899999874332 22223467899999999 899999999988654


Q ss_pred             -CceeEEEeccCCCCHHHHhcccCCC------------------------------------------------------
Q 020027          132 -GERIIVSEFINMASLDFYLHENNDG------------------------------------------------------  156 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------  156 (332)
                       ...++++||+++++|.+++......                                                      
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             5688999999999999998643210                                                      


Q ss_pred             ---CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc--------cCCccc
Q 020027          157 ---ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAG  225 (332)
Q Consensus       157 ---~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~  225 (332)
                         ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||+++.....        ..++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12478899999999999999999998   9999999999999999999999999998754221        234567


Q ss_pred             ccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHH-HHhhhcccccccCCcCCCCCChHHHHHHHHH
Q 020027          226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKV  303 (332)
Q Consensus       226 ~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  303 (332)
                      |+|||+...   ..++.++|||||||++|||++ |..||.+....+.. ..+.... .        ...+.....++.++
T Consensus       241 y~aPE~~~~---~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~l  308 (337)
T cd05054         241 WMAPESIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-R--------MRAPEYATPEIYSI  308 (337)
T ss_pred             ccCcHHhcC---CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-C--------CCCCccCCHHHHHH
Confidence            999998876   678999999999999999998 99999764433222 2222111 0        01111223478899


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          304 ALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       304 ~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                      +.+||+.+|++|||+.|+++.|++++.++
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~~~  337 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQEN  337 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHhcC
Confidence            99999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-43  Score=319.72  Aligned_cols=245  Identities=20%  Similarity=0.187  Sum_probs=200.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC-C-CCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS-T-GKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ..++|...+.||+|+||.||+|... + +..||+|.+....... .....+.+|+.+++.++||||+++++++..++..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            4567899999999999999999843 3 3689999986543222 22235678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....    +++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999976533    78899999999999999999998   999999999999999999999999999876


Q ss_pred             CCc---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          216 APE---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       216 ~~~---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      ...   ...||+.|+|||.+..   ..++.++|||||||++|||+||..||.+.........+..+..        ..+.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------~~p~  249 (340)
T PTZ00426        181 VDTRTYTLCGTPEYIAPEILLN---VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------YFPK  249 (340)
T ss_pred             cCCCcceecCChhhcCHHHHhC---CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------CCCC
Confidence            543   2358899999999876   5678999999999999999999999988765555444443221        1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .  ....+.+++.+||+.||++|+     |++++++
T Consensus       250 ~--~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        250 F--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             C--CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            1  123567899999999999995     7888764

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-42  Score=302.54  Aligned_cols=240  Identities=22%  Similarity=0.336  Sum_probs=194.3

Q ss_pred             eeeccCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           68 IIGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .||+|+||.||+|.+   .++..+|+|.++...........+.+|+.+++.++|+||+++++++.. +..+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999963   467899999987554333333457889999999999999999999864 4578999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc----
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK----  220 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~----  220 (332)
                      +|.+++....    .+++..+..++.|++.|+.|||++   +++||||||+||++++++.+|++|||++.......    
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999996543    278899999999999999999998   99999999999999999999999999986543221    


Q ss_pred             -----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          221 -----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       221 -----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           .++..|++||....   ..++.++|+|||||++||++| |..||.+.........+..+..         .+.+.
T Consensus       154 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---------~~~~~  221 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNY---YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---------MECPQ  221 (257)
T ss_pred             ecCCCCCCccccCHhHhcc---CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---------CCCCC
Confidence                 12467999998765   567889999999999999998 9999987655555444443211         11112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ....++.+++.+||+.||++|||+++|.+.|++
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            233478899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9e-43  Score=309.40  Aligned_cols=254  Identities=19%  Similarity=0.245  Sum_probs=192.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEe--CCCCEEEEEEeccCcccccccccHHHHHHHhccC---CCCCccceeeeee-----c
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA---QHPNIVPILGFSQ-----A  130 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  130 (332)
                      ++|...+.||+|+||.||+|+.  .+++.||+|.++...........+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999984  3567899999876544333333456677766655   6999999999885     2


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      ....+++|||++ ++|.+++......  .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 6898888654322  378999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc------
Q 020027          211 GLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR------  279 (332)
Q Consensus       211 g~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~------  279 (332)
                      |++.....     ...++..|+|||.+..   ..++.++|||||||++|||++|+.||.+....+....+.+..      
T Consensus       155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~  231 (290)
T cd07862         155 GLARIYSFQMALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  231 (290)
T ss_pred             cceEeccCCcccccccccccccChHHHhC---CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            99875432     2247889999999865   678899999999999999999999998765444333322110      


Q ss_pred             -ccc-------ccCCcCCCC---CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -FSE-------LLDPRLAIP---CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -~~~-------~~~~~~~~~---~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       +..       ...+....+   ........+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence             000       000000000   00012235679999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.6e-43  Score=321.88  Aligned_cols=259  Identities=27%  Similarity=0.386  Sum_probs=204.1

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFS  128 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  128 (332)
                      +....++|...+.||+|+||.||+|...      ++..||+|.++.... ......+.+|+.+++.++ ||||+++++++
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            3345678899999999999999999831      234799999975432 222335789999999996 99999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCC-----------------------------------------------------
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENND-----------------------------------------------------  155 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  155 (332)
                      ...+..+++|||+++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999998865311                                                     


Q ss_pred             ---------------------------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCC
Q 020027          156 ---------------------------------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASN  196 (332)
Q Consensus       156 ---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  196 (332)
                                                             ....+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence                                                   012367888899999999999999998   99999999999


Q ss_pred             EEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchh
Q 020027          197 ILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLL  267 (332)
Q Consensus       197 ill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~  267 (332)
                      |++++++.+|++|||+++.....        ..++..|++||.+..   ..++.++|||||||++|||++ |..||.+..
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD---NLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            99999999999999998754321        134567999998865   678899999999999999997 889987653


Q ss_pred             HHH-HHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          268 VKW-ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       268 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .+. ....+..+         ...+.+......+.+++.+||+.||++|||+.++.+.|+++..
T Consensus       345 ~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         345 VDSTFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             hhHHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            322 22222221         1111122334578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-42  Score=302.83  Aligned_cols=245  Identities=20%  Similarity=0.309  Sum_probs=199.4

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      ++|...+.||+|+||.||.|...++..+|+|.+.....   ....+.+|+.++++++||||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            45777889999999999999977777899999874432   123578999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK  220 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~  220 (332)
                      +++++|.+++.....   .+++..++.++.|++.|+.|||+.   +++|+||||+||++++++.+|++|||.++......
T Consensus        81 ~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          81 MSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            999999999875432   378999999999999999999998   99999999999999999999999999986543221


Q ss_pred             -------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          221 -------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       221 -------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                             .++..|++||....   ..++.++|||||||++|||+| |..||...........+..+..       .  ..
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------~--~~  222 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLY---SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-------L--YR  222 (256)
T ss_pred             eeecCCCccChhhCCHHHHhc---CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-------C--CC
Confidence                   23457999998865   568899999999999999999 9999876554444333333211       0  01


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      +......+.+++.+||+.||++|||+.++++.|+
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1112347889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-42  Score=309.80  Aligned_cols=254  Identities=22%  Similarity=0.267  Sum_probs=193.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|+. .+++.||+|.++.... ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            46799999999999999999994 5789999999875432 222234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ +++.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+||++++++.+||+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          83 EYVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             ECCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9996 678777765432   278888999999999999999998   999999999999999999999999999864321


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-HHHHHHhhh--c-----ccccc-
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-KWALPLIKE--M-----RFSEL-  283 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-~~~~~~~~~--~-----~~~~~-  283 (332)
                            ...++..|+|||.+...  ..++.++||||+||++|||+||..||.+... ......+..  +     .+... 
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence                  23467889999987642  4578899999999999999999999976422 111111100  0     00000 


Q ss_pred             ----cC-CcCC--CCCCh-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 ----LD-PRLA--IPCEI-------KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ----~~-~~~~--~~~~~-------~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          .. ....  .+...       .....+.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                00 0000  00000       01235679999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.3e-43  Score=319.78  Aligned_cols=248  Identities=19%  Similarity=0.241  Sum_probs=195.0

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||+||++. ..+++.||+|.++...... .....+.+|+.++..++|+||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            468889999999999999998 5578999999997543222 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999976432    78999999999999999999998   999999999999999999999999999864321


Q ss_pred             -----------------------------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH
Q 020027          219 -----------------------------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL  257 (332)
Q Consensus       219 -----------------------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~  257 (332)
                                                               ...||..|+|||.+..   ..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ---TGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC---CCCCCchhhhhhHHHHHHHH
Confidence                                                     1258899999999876   67889999999999999999


Q ss_pred             hCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 020027          258 SGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALA--CVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       258 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~dp~~RPs~~~i~~~  324 (332)
                      +|+.||.+....+....+.....      .+..+.......++.+++.+  |...++..||+++|+++.
T Consensus       231 ~G~~Pf~~~~~~~~~~~i~~~~~------~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         231 IGYPPFCSETPQETYKKVMNWKE------TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hCCCCCCCCCHHHHHHHHHcCcC------cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99999988766555544433211      11111111112245566655  333345567999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-43  Score=321.12  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=211.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcc-cccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLV-LSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      +-|...+.||.|+-|.|-.|+ ..+|+.+|||.+.+... .......+.+||-+|+.+.|||++++++.++...++|++.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            346778899999999999999 67999999999987733 3334456899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++|-|.+++-..+.    +++..+.+++.||..|+.|+|..   +|+||||||+|+|+|.++++||+|||+|....+
T Consensus        92 Eyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            99999999999987654    78899999999999999999998   999999999999999999999999999976543


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ..+|.+.|.+||...+.  ...+.++||||.|||||.|+||+.||++......+..++.|.+.        .|..
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~--pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--------MPs~  234 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGR--PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--------MPSN  234 (786)
T ss_pred             CccccccCCCcccCCchhhcCC--CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--------CCCc
Confidence                 45899999999999874  45578999999999999999999999987777776666665432        2322


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .  ..++.+|+.+++..||..|.|++||+.
T Consensus       235 I--s~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  235 I--SSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             C--CHHHHHHHHHHhccCccccccHHHHhh
Confidence            2  226779999999999999999999976

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.3e-43  Score=330.20  Aligned_cols=245  Identities=15%  Similarity=0.185  Sum_probs=198.9

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CC-CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-ST-GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .|...+.||+|+||.||++.. .+ ++.||+|.+....  ......+.+|+.+++.++||||+++++++..++..+++||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            488889999999999999984 34 6788988765332  1222346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++++|.+++.+.......+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999998865433233478889999999999999999998   9999999999999999999999999998754322


Q ss_pred             --------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          220 --------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       220 --------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                              ..||..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+..+...         +
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------~  290 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWER---KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------P  290 (478)
T ss_pred             cccccccccCCCccccCHhHhCC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------C
Confidence                    248899999999876   67899999999999999999999999876555444443332211         1


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+......+.+++.+||+.||++|||+.++++
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11122346889999999999999999999874

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-42  Score=306.83  Aligned_cols=257  Identities=21%  Similarity=0.275  Sum_probs=206.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCC-----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec-C
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLST-----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA-P  131 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~  131 (332)
                      ...++|...+.||+|+||.||+|....     +..|++|.+.... .......+.+|+..++.++|+|++++++++.. +
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            456788899999999999999999644     6889999886432 22233457889999999999999999998765 4


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCC----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEE
Q 020027          132 GERIIVSEFINMASLDFYLHENNDG----ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV  207 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  207 (332)
                      ...++++||+++++|.+++......    ...+++.+++.++.|++.||+|||++   +++|+||||+||++++++.+|+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6789999999999999998764322    13488999999999999999999998   9999999999999999999999


Q ss_pred             ccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhc
Q 020027          208 CDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       208 ~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~  278 (332)
                      +|||+++....        ...++..|++||.+..   ..++.++|||||||++||+++ |+.||.+.........+..+
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  235 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN---KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG  235 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhc---CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence            99999975422        1234667999998865   568899999999999999999 99999876544443333322


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .         ..+.+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       236 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 Y---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             C---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1         111122233478899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-42  Score=314.44  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=197.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|+..+.||+|+||.||++.. .++..+|+|.+..... ......+.+|+++++.++|+||+++++++..++..+++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            346899999999999999999994 4788999998875432 22223578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++.....++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++....
T Consensus        82 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            999999999999975432    78888999999999999999974  169999999999999999999999999986543


Q ss_pred             c----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhh---hcccccc-------
Q 020027          218 E----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK---EMRFSEL-------  283 (332)
Q Consensus       218 ~----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~-------  283 (332)
                      .    ...++..|+|||.+..   ..++.++|+|||||++||+++|+.||...........+.   .+.....       
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         156 DSMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             hhccccCCCCccccCHHHhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence            2    2357889999999875   678899999999999999999999997654332221110   0000000       


Q ss_pred             --------cCC-------------------cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 --------LDP-------------------RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 --------~~~-------------------~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                              ..+                   ....+. .....++.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS-GVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCC-CCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                    000                   000000 011246789999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-42  Score=307.46  Aligned_cols=254  Identities=25%  Similarity=0.325  Sum_probs=204.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      .++|...+.||+|+||.||++..      .++..+|+|.+....  ......+.+|+.++++++|||++++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            46788899999999999999973      234578999886432  2223357899999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCC---------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc
Q 020027          134 RIIVSEFINMASLDFYLHENND---------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC  204 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  204 (332)
                      .++++||+++++|.+++.....         ....+++..++.++.|++.||+|||++   +++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999999875431         123489999999999999999999998   9999999999999999999


Q ss_pred             eEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHh
Q 020027          205 ARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLI  275 (332)
Q Consensus       205 ~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~  275 (332)
                      +|++|||++......        ..++..|+|||.+..   ..++.++|||||||++|||+| |..||.+.........+
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999998754321        123567999998865   678899999999999999999 89998776555544444


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ..+....       .+  ......+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       236 ~~~~~~~-------~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         236 TQGRVLQ-------RP--RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HcCCcCC-------CC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            4432111       11  1122368899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-42  Score=303.60  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=200.2

Q ss_pred             CCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc-----
Q 020027           63 FSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE-----  133 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  133 (332)
                      |...+.||+|+||.||+|...    .+..||+|.++...........+.+|+..++.++|+|++++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            466789999999999999843    24689999987654333333457899999999999999999998865443     


Q ss_pred             -eeEEEeccCCCCHHHHhcccC--CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          134 -RIIVSEFINMASLDFYLHENN--DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       134 -~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                       .++++||+++++|..++....  .....+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             789999999999999885432  1223478999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccc
Q 020027          211 GLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFS  281 (332)
Q Consensus       211 g~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  281 (332)
                      |+++.....        ...+..|++||....   ..++.++|||||||++|||++ |..||.+.........+..+...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  234 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL  234 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            998754322        123567999998765   678899999999999999999 88898776555544444332211


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                             ..  +.....++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       235 -------~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         235 -------KQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             -------CC--CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                   11  1223347889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-43  Score=317.22  Aligned_cols=247  Identities=21%  Similarity=0.265  Sum_probs=212.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc-eeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE-RIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  138 (332)
                      ++|...+++|+|+||.++..+ ..++..+++|.+..............+|+.++++++|||||.+.+.+..++. .+|+|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            578889999999999999998 4577899999998877666666678999999999999999999999998888 99999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      +||+||++.+.+....  ...+++.+++.++.|++.|+.|||++   +|+|||||+.||+++.++.+||+|||+|+...+
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998765  33489999999999999999999988   999999999999999999999999999987765


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      ..||+.|++||.+..   .+|+.|+|||||||++|||++-+++|.+.........+..+.         ..|.
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d---~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---------~~Pl  226 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSD---IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---------YSPL  226 (426)
T ss_pred             chhhhheecCCCcccCHHHhCC---CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---------CCCC
Confidence            4      369999999999988   799999999999999999999999998876554433333322         1222


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      +.....++..++..|++.+|..||++.+++..
T Consensus       227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            23334478889999999999999999999875

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=302.16  Aligned_cols=245  Identities=21%  Similarity=0.321  Sum_probs=200.2

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .+|...+.||+|+||.||+|...++..+|+|.+.....   ....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            35788899999999999999977778899998864322   123468899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK  220 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~  220 (332)
                      +++++|.+++.....   .+++..++.++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++...+..
T Consensus        81 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          81 MANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             CCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            999999999875432   378999999999999999999998   99999999999999999999999999987543321


Q ss_pred             -------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          221 -------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       221 -------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                             .++..|++||....   ..++.++|+||||+++||++| |+.||.+....+....+....         ..+.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------~~~~  222 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDY---SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---------RLYR  222 (256)
T ss_pred             ccccCCCCCCccccCHHHhcc---CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC---------cCCC
Confidence                   12346999998876   678899999999999999999 788987665544444333221         1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      +...+.++.+++.+||+.+|++|||+.|+++.|.
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            1223447889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.8e-43  Score=310.25  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=207.2

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFS  128 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  128 (332)
                      +....++|+..+.||+|+||.||++...      ....+|+|.+..... ......+.+|+.++.++ +|+||+++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3445667888999999999999999842      336899999875432 22223578899999999 799999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccC------------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCC
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENN------------DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASN  196 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  196 (332)
                      ..++..+++|||+++++|..++....            .....+++..++.++.|++.|+.|||+.   +++||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence            99999999999999999999986532            1123478999999999999999999998   99999999999


Q ss_pred             EEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchh
Q 020027          197 ILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLL  267 (332)
Q Consensus       197 ill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~  267 (332)
                      |++++++.+|++|||+++.....        ..++..|++||.+..   ..++.++|||||||++||+++ |..||.+..
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc---CCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            99999999999999998764322        123467999998765   678899999999999999998 999998765


Q ss_pred             HHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .......+....         ....+......+.+++.+||+.||++|||+.++++.|+.++
T Consensus       240 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         240 VEELFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            555544443321         11122233447889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.8e-42  Score=300.00  Aligned_cols=242  Identities=25%  Similarity=0.361  Sum_probs=194.8

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMAS  145 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  145 (332)
                      +.||+|+||.||+|.. .+++.+|+|.+..... ......+.+|+.+++.++||||+++++++...+..+++|||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            3689999999999994 5889999998764321 2223357899999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc-----
Q 020027          146 LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-----  220 (332)
Q Consensus       146 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~-----  220 (332)
                      |.+++....   ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+|++|||++....+..     
T Consensus        80 L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          80 FLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            999986532   2378999999999999999999998   99999999999999999999999999987543221     


Q ss_pred             ---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHH
Q 020027          221 ---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP  296 (332)
Q Consensus       221 ---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                         ..+..|++||....   +.++.++||||||+++||+++ |..||...........+...         ...+.+...
T Consensus       154 ~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~  221 (252)
T cd05084         154 GMKQIPVKWTAPEALNY---GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---------VRLPCPELC  221 (252)
T ss_pred             CCCCCceeecCchhhcC---CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---------CCCCCcccC
Confidence               12346999998865   668899999999999999998 88888765444433333221         111112223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          297 LVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       297 ~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      +..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            4478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-43  Score=287.37  Aligned_cols=247  Identities=23%  Similarity=0.299  Sum_probs=212.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      +.++|+..+.||+|.||.||.|+ .+++..||+|++.+..... .....+.+|+.+-+.|+||||+++++++.++...|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            35789999999999999999999 6688899999997665433 233467899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ++||.++|.+...+......  .+++.....++.|+|.|+.|+|..   +++|||+||+|+|++..+..|++|||.+...
T Consensus       100 ilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999854322  277888889999999999999998   9999999999999999999999999999877


Q ss_pred             Cccc----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          217 PEEK----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       217 ~~~~----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      +...    +||..|.+||...+   ..++..+|+|++|++.||++.|.+||.....++.+..+....+        ..|.
T Consensus       175 p~~kR~tlcgt~dyl~pEmv~~---~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--------~~p~  243 (281)
T KOG0580|consen  175 PSNKRKTLCGTLDYLPPEMVEG---RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--------KFPS  243 (281)
T ss_pred             CCCCceeeecccccCCHhhcCC---CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--------cCCc
Confidence            6443    68999999998877   7789999999999999999999999998888888777766432        2222


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .....+.+++.+|+..+|.+|.+..|++.
T Consensus       244 --~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  244 --TISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             --ccChhHHHHHHHHhccCccccccHHHHhh
Confidence              22236779999999999999999999875

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2e-42  Score=305.44  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=203.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      .++|...+.||+|+||.||+|...      +++.||+|.++..... .....+.+|+++++.++|+|++++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            456888899999999999999852      3578999998754322 123467899999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCC----------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          134 RIIVSEFINMASLDFYLHENND----------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      .+++|||+++++|.+++.....          ....+++..+..++.|++.|+.|||++   +++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence            9999999999999999976432          123378889999999999999999998   999999999999999999


Q ss_pred             ceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHH
Q 020027          204 CARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL  274 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~  274 (332)
                      .+|++|||++.....        ...++..|+|||.+..   ..+++++|||||||++|||++ |..||.+.........
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc---CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999864321        1123567999999876   678999999999999999999 9999977655554444


Q ss_pred             hhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      +..+....         .+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       237 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 ITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            44322111         111223478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-43  Score=321.49  Aligned_cols=246  Identities=18%  Similarity=0.242  Sum_probs=198.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||+++ ..+|+.||+|.+....... .....+.+|+.++..++||||+++++++..++..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            468889999999999999999 4578999999997543222 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKKDT----FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999876432    78999999999999999999998   999999999999999999999999998754221


Q ss_pred             --------------------------------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHH
Q 020027          219 --------------------------------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLL  254 (332)
Q Consensus       219 --------------------------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~  254 (332)
                                                                  ...||+.|+|||.+..   ..++.++|||||||++|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~  230 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ---TGYNKECDWWSLGVIMY  230 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC---CCCCCeeeeecchhHHH
Confidence                                                        1247899999999876   67889999999999999


Q ss_pred             HHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 020027          255 EILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS---IVQVAT  323 (332)
Q Consensus       255 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs---~~~i~~  323 (332)
                      ||++|..||.+.........+....      ..+..+........+.+++.+|+. +|.+|++   +.++++
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999998766554443332211      111222222223467788989996 9999998   877765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=314.38  Aligned_cols=244  Identities=25%  Similarity=0.304  Sum_probs=202.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ...|.....||+|.||.||+|. ..+++.||+|++..+..... ..+..+|+.+++.++++||.+++|.+..+..++++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            3457788999999999999999 67899999999987654332 346789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |||.||++.+.++....    +++..+.-++.++..|+.|||.+   +.+|||||+.|||+..+|.+|++|||++....+
T Consensus        91 ey~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999976432    35666666889999999999999   999999999999999999999999999876544


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                            ...||+.|||||+...   ..|+.|+||||||++.+||++|.+|+...++..++-.+....     .|.+..  
T Consensus       164 ~~~rr~tfvGTPfwMAPEVI~~---~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-----PP~L~~--  233 (467)
T KOG0201|consen  164 TVKRRKTFVGTPFWMAPEVIKQ---SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-----PPRLDG--  233 (467)
T ss_pred             hhhccccccccccccchhhhcc---ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-----CCcccc--
Confidence                  3479999999999985   789999999999999999999999998876533322222211     122222  


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .....+.+++..|++.||+.|||+.++++
T Consensus       234 --~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  234 --DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              22335778999999999999999999986

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-42  Score=303.46  Aligned_cols=251  Identities=24%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC-CCC---EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS-TGK---LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|+..+.||+|+||.||+|+.+ +++   .+|+|.++.... ......+..|+..++.++|+|++++.+++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            457888899999999999999953 333   799998865432 122335788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....   .+++.++..++.|++.|+.|||+.   +++|+||||+||++++++.+|++|||++..
T Consensus        83 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          83 IITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence            99999999999999875432   378999999999999999999998   999999999999999999999999999865


Q ss_pred             CCccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          216 APEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       216 ~~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....         ..+..|++||.+..   ..++.++|||||||++||++| |+.||...........+....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~------  227 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF------  227 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhc---CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC------
Confidence            43221         12346999998865   567899999999999999998 999997665554444443321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                         ..+........+.+++.+||+.||++||++.++++.|++++
T Consensus       228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence               11122223457889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.7e-43  Score=320.94  Aligned_cols=246  Identities=20%  Similarity=0.194  Sum_probs=195.9

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .|...+.||+|+||+||+|+ ..+++.||+|.+....... .....+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            57888999999999999998 5688999999997643322 223357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC--
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP--  217 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~--  217 (332)
                      |+++++|.+++.....    +++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....  
T Consensus        82 ~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRMEV----FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999876432    78888889999999999999998   99999999999999999999999999864210  


Q ss_pred             ---------------------------------------------------cccCCcccccCcccccccCCCCCCchhhh
Q 020027          218 ---------------------------------------------------EEKRGLAGYVDDDYWHEKGGGNATRESDV  246 (332)
Q Consensus       218 ---------------------------------------------------~~~~~~~~~~~pe~~~~~~~~~~~~~~Di  246 (332)
                                                                         ....||..|+|||.+..   ..++.++||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~Di  231 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR---KGYTQLCDW  231 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC---CCCCCccce
Confidence                                                               11258889999999875   568899999


Q ss_pred             HHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHH--cccCCCCCCCCHHHHHH
Q 020027          247 YGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALA--CVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       247 wS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~dp~~RPs~~~i~~  323 (332)
                      |||||++|||+||+.||.+.........+....      ..+..+.......++.+++.+  |+..+|..||++.++++
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWE------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHHHccc------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999999999998765544333222211      111122211222356677776  66777778999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=320.61  Aligned_cols=247  Identities=19%  Similarity=0.215  Sum_probs=201.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+|+. .+|+.||+|.++...... .....+.+|+.++..++|+||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4688899999999999999994 589999999997643322 22335788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999997652    278899999999999999999998   999999999999999999999999999865432


Q ss_pred             c-----------------------------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          219 E-----------------------------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       219 ~-----------------------------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                      .                                   ..||..|+|||.+..   ..++.++|||||||++|||++|+.||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC---CCCCCceeeEecchhhhhhccCCCCC
Confidence            2                                   247889999999876   57899999999999999999999999


Q ss_pred             CchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 020027          264 EGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS-IVQVATI  324 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs-~~~i~~~  324 (332)
                      .+.........+....      .....+........+.+++.+|+. ||.+||+ ++++++.
T Consensus       231 ~~~~~~~~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         231 YSDTLQETYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCHHHHHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            8765544433332210      111111111123467899999998 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.4e-43  Score=300.06  Aligned_cols=259  Identities=20%  Similarity=0.206  Sum_probs=203.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCC-ccceeeeeecCC-----
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN-IVPILGFSQAPG-----  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-----  132 (332)
                      ...|...+.||+|+||+||+|+ ..+|+.||+|+++.....+..-....+|+.+++.++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3456777789999999999999 678999999999877654333335689999999999999 999999998776     


Q ss_pred             -ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          133 -ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       133 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                       ..++++||++ .+|..++.........++...+..++.|++.|++|||++   +|+||||||.|+|++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             7899999995 699999987653223467788999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh-------c
Q 020027          212 LSFLAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE-------M  278 (332)
Q Consensus       212 ~a~~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~-------~  278 (332)
                      +|+...-      ....|.-|.|||.+.+.  ..|++..||||+|||+.||++++..|.|.........+-+       .
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs--~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGS--TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCC--CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9986541      12467889999998874  5799999999999999999999999988765544433321       1


Q ss_pred             ccccc---cCCcCCCC-----CC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          279 RFSEL---LDPRLAIP-----CE-----IKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       279 ~~~~~---~~~~~~~~-----~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .|...   .+.....+     .+     .+......+++.+|++++|.+|.|+...++.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111   11111111     00     0111257789999999999999999998874

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.8e-42  Score=299.51  Aligned_cols=246  Identities=21%  Similarity=0.249  Sum_probs=202.0

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|...+.||+|++|.||+|.. .+++.|++|.+............+.+|+.+++.++|||++++++.+...+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477788999999999999994 5789999999876544444445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999976422  2378899999999999999999998   9999999999999999999999999988754332 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||+...   ..++.++|+||||+++|||+||+.||...........+..+....       .  +.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~--~~  223 (256)
T cd08529         156 NFANTIVGTPYYLSPELCED---KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-------V--SQ  223 (256)
T ss_pred             chhhccccCccccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------C--cc
Confidence                 246778999999876   567899999999999999999999998765444333332221111       1  11


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            223468899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.4e-42  Score=305.79  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             CCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           62 GFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      +|...+.||+|+||.||+|...      ....+++|.+..... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            4677889999999999999842      235788888864432 122235788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCC--------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCC
Q 020027          136 IVSEFINMASLDFYLHENND--------------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  195 (332)
                      +++||+++++|.+++.....                    ....+++..++.++.|++.|+.|||+.   +++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence            99999999999999864321                    112478899999999999999999998   9999999999


Q ss_pred             CEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCch
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGL  266 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~  266 (332)
                      ||++++++.+||+|||+++.....        ..++..|++||....   ..++.++||||||+++|||+| |..||.+.
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc---CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999998653221        134567999998765   568899999999999999999 99999877


Q ss_pred             hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      .............         ..+.+.....++.+++.+||+.||++|||+.++++.|+++...
T Consensus       234 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         234 APERLFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             CHHHHHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            6655554443321         1111222334788999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.6e-42  Score=303.88  Aligned_cols=253  Identities=19%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCC----EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|. ..+|+    .||+|.++.... ......+.+|+..++.++|+||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            4578889999999999999998 44555    489998865432 22233578899999999999999999998754 46


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++|+|.+++.+...   .+++..++.++.|++.||.|||++   +++||||||+||++++++.+||+|||+++
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            789999999999999876432   378999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....        ..++..|++||....   ..++.++|||||||++||++| |..||...........+..+.      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------  228 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILH---RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE------  228 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------
Confidence            65321        123567999998865   678899999999999999998 889987654444333332221      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                         ..+.+......+.+++.+||+.||++|||+.++++.|+++..+|
T Consensus       229 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 ---RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence               11111223447889999999999999999999999999987765

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.8e-42  Score=306.61  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC-CCC--EEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS-TGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      ++|+..+.||+|+||.||+|..+ ++.  .+++|.++... .......+.+|+.+++++ +||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            57888999999999999999853 443  47888776321 122223578899999999 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc
Q 020027          137 VSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC  204 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  204 (332)
                      ++||+++++|.+++.....            ....+++..+..++.|++.|++|||++   +++||||||+||+++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence            9999999999999965321            112478899999999999999999998   9999999999999999999


Q ss_pred             eEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhc
Q 020027          205 ARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       205 ~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~  278 (332)
                      +||+|||++......     ...+..|++||....   ..++.++|||||||++|||+| |..||.+.........+...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~  234 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY---SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  234 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence            999999998643221     122446999998765   668899999999999999998 99999876655544333221


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                               ...+.+......+.+++.+||+.||.+|||++++++.|++++
T Consensus       235 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         235 ---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     111111223346789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-42  Score=312.25  Aligned_cols=240  Identities=21%  Similarity=0.278  Sum_probs=191.7

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHH---hccCCCCCccceeeeeecCCceeEE
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKT---LSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      |...+.||+|+||.||+|. ..+++.||+|.+++...... ....+.+|+.+   ++.++||||+++++++...+..+++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            5667899999999999998 45789999999975432222 22234556554   4567899999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|..++...     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999999888642     278999999999999999999998   99999999999999999999999999986432


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .      ...|+..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+.....        ..+
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--------~~p  221 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--------RYP  221 (324)
T ss_pred             CCCCcccccccCccccCHhHhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCC
Confidence            1      2257889999999876   6788999999999999999999999987765555444433211        111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .  .....+.+++.+||+.||++||     ++.++++
T Consensus       222 ~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         222 R--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             C--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1  1223677999999999999999     4555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.3e-42  Score=303.04  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=203.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||++. ..+++.+|+|.+....... .....+.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            468888999999999999999 5689999999886533222 22335788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.........+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999875333333478999999999999999999998   999999999999999999999999998865432


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH--HHHHHhhhcccccccCCcCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK--WALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .      ..++..|++||....   ..++.++|+||||+++|||++|..||.+...+  .....+....        ...
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~  227 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------YPP  227 (267)
T ss_pred             CCcccccccCCcCccCHHHhcC---CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--------CCC
Confidence            2      256788999998866   56788999999999999999999998754321  1111111110        111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .........+.+++.+||+.||++|||+.+|++.++++
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11112344788999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.5e-42  Score=304.58  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=201.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ++|+..+.||+|+||.||+|..     .++..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            4677889999999999999983     3567899999875332 122235788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          136 IVSEFINMASLDFYLHENND-------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      ++|||+++++|.+++.....             ....+++.+.+.++.|++.||.|||++   +++||||||+||+++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence            99999999999999853221             112378889999999999999999998   99999999999999999


Q ss_pred             CceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHH
Q 020027          203 FCARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP  273 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~  273 (332)
                      +.+|++|||+++....        ...++..|++||....   ..++.++|+||||+++|||++ |..||.+........
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY---GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhcc---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999865422        1234557999998865   568999999999999999999 888997765555444


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      .+.....         .+.+.....++.+++.+||+.||++||++.++.+.|..
T Consensus       238 ~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            4433221         11112233478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-42  Score=314.26  Aligned_cols=253  Identities=24%  Similarity=0.353  Sum_probs=191.6

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Ccee
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GERI  135 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  135 (332)
                      +|...+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            47778999999999999999 56889999999875433333334578999999999999999999987543     2479


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+. ++|.+++.....    +++..+..++.|+++||.|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhccc----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 689888865432    78999999999999999999999   999999999999999999999999999875


Q ss_pred             CCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh---------
Q 020027          216 APE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE---------  277 (332)
Q Consensus       216 ~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~---------  277 (332)
                      ...         ...++..|+|||.+... ...++.++|||||||++|||+||+.||.+.........+.+         
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhcc-ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            321         22578899999987531 14678899999999999999999999976533222111110         


Q ss_pred             ------ccccc---ccCCcCCCCCC---hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 ------MRFSE---LLDPRLAIPCE---IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 ------~~~~~---~~~~~~~~~~~---~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            .....   ........+..   ......+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  00000   00000000000   011235779999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-43  Score=316.95  Aligned_cols=234  Identities=23%  Similarity=0.268  Sum_probs=192.6

Q ss_pred             ceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccC
Q 020027           67 RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      +.||+|+||.||+++.    .+|+.+|+|.+............+..|+.++++++||||+++++++..++..+++|||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999873    478899999997654333333346789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc---
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE---  219 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~---  219 (332)
                      +++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++......   
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            999999986543    278999999999999999999998   9999999999999999999999999998754322   


Q ss_pred             ---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHH
Q 020027          220 ---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP  296 (332)
Q Consensus       220 ---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                         ..|+..|++||.+..   ..++.++|||||||++|||+||+.||.+.........+....        ...+..  .
T Consensus       155 ~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------~~~p~~--~  221 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------LGMPQF--L  221 (318)
T ss_pred             eecccCChhhcCHHHHcC---CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--------CCCCCC--C
Confidence               247889999999876   567889999999999999999999998766555544443321        111111  2


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHH
Q 020027          297 LVRLAKVALACVGNSRKNRPSIVQ  320 (332)
Q Consensus       297 ~~~l~~l~~~c~~~dp~~RPs~~~  320 (332)
                      ...+.+++.+||+.||++|||+.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            236779999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.3e-42  Score=299.39  Aligned_cols=241  Identities=18%  Similarity=0.307  Sum_probs=193.5

Q ss_pred             eeeccCCeEEEEEEeC---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           68 IIGQGRLGTVYAALLS---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .||+|+||.||+|.+.   ++..||+|.+..... ......+.+|+.++++++|+||+++++++.. +..+++|||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999999742   455799999875432 2222357899999999999999999998864 4678999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc----
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK----  220 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~----  220 (332)
                      +|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+|++|||++.......    
T Consensus        80 ~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          80 PLNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99999865322   378999999999999999999998   99999999999999999999999999986443211    


Q ss_pred             -----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          221 -----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       221 -----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           .++..|++||.+..   ..++.++|||||||++||+++ |..||.+.........+..+.         ..+.+.
T Consensus       154 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~  221 (257)
T cd05115         154 ARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK---------RLDCPA  221 (257)
T ss_pred             ccCCCCCCcccCCHHHHcc---CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---------CCCCCC
Confidence                 12467999998865   567889999999999999997 999998766555444443321         111222


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .+..++.+++.+||+.||++||++.+|.+.|+..
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            3345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-42  Score=312.60  Aligned_cols=237  Identities=19%  Similarity=0.248  Sum_probs=192.4

Q ss_pred             ceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccc--cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           67 RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +.||+|+||.||+++.    .+++.||+|.++......  .....+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999984    367899999987543211  1222467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      +++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++....  
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLEREGI----FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999875432    67888888999999999999998   999999999999999999999999999864321  


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                          ...|+..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+..+.        ...+.  
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--------~~~~~--  221 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMR---SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--------LNLPP--  221 (323)
T ss_pred             CcccccCCCccccChhhccC---CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CCCCC--
Confidence                1257889999999876   567889999999999999999999998765554444433321        11111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .....+.+++.+||+.||++||     ++.++++
T Consensus       222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1223678999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.7e-43  Score=315.37  Aligned_cols=237  Identities=19%  Similarity=0.274  Sum_probs=193.5

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      +.||+|+||.||++. ..+|+.||+|.+....... .....+..|+.++..++||||+++.+++..++..+++|||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999998 5689999999997643322 22234678899999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      +|..++....    .+++..+..++.|++.||.|||+ .   +++||||||+|||++.++.+||+|||+++....     
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            9998886543    27899999999999999999997 6   999999999999999999999999999864321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...|+..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....        ...+..  ..
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--------~~~p~~--~~  220 (325)
T cd05594         154 KTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------IRFPRT--LS  220 (325)
T ss_pred             ccccCCcccCCHHHHcc---CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--------CCCCCC--CC
Confidence             1258899999999875   678899999999999999999999998766554444333221        111111  12


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .++.+++.+||+.||++|+     ++.++++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            3677999999999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.5e-42  Score=300.37  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...... .....+.+|+.++++++|+|++++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999954 89999999987533222 22345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|..++.........+++.+++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999875433334478999999999999999999998   999999999999999999999999999865432


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH--HHHHHhhhcccccccCCcCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK--WALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .      ..++..|.+||....   ..++.++|+||||+++|||++|+.||......  .....+..+...       ..
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~  228 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-------PL  228 (267)
T ss_pred             CCcccceecCCccccCHHHhcc---CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC-------CC
Confidence            2      246778999998865   66889999999999999999999998653211  111111111110       01


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      + .......+.+++.+||..+|++|||+.++++.|+++-
T Consensus       229 ~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 P-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             C-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1 1123346789999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-42  Score=312.13  Aligned_cols=232  Identities=24%  Similarity=0.301  Sum_probs=189.6

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|+. .+++.||+|.+.+..... .....+..|..++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999994 578999999987543222 2223456777877766 799999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC------
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP------  217 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~------  217 (332)
                      ++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....      
T Consensus        81 g~L~~~i~~~~~----l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          81 GDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             chHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            999998876432    78899999999999999999998   99999999999999999999999999986432      


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                      ....|+..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+.....        ..+.  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--------~~~~--~~~  220 (320)
T cd05590         154 STFCGTPDYIAPEILQE---MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--------VYPT--WLS  220 (320)
T ss_pred             cccccCccccCHHHHcC---CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--------CCCC--CCC
Confidence            12357899999999875   6788999999999999999999999988766655554433221        1111  122


Q ss_pred             HHHHHHHHHcccCCCCCCCCH
Q 020027          298 VRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      .++.+++.+||+.||++||++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCC
Confidence            367799999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=320.50  Aligned_cols=247  Identities=19%  Similarity=0.231  Sum_probs=196.5

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||++. ..+++.||+|.+....... .....+.+|+.+++.++||||+++++++.+++..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            468889999999999999998 5689999999986543221 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||+++....
T Consensus        81 E~~~gg~L~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKYDT----FSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999875432    78888999999999999999998   999999999999999999999999999852110


Q ss_pred             -----------------------------------------------------ccCCcccccCcccccccCCCCCCchhh
Q 020027          219 -----------------------------------------------------EKRGLAGYVDDDYWHEKGGGNATRESD  245 (332)
Q Consensus       219 -----------------------------------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~D  245 (332)
                                                                           ...||..|+|||.+..   ..++.++|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~D  230 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ---QGYGQECD  230 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc---CCCCCcee
Confidence                                                                 1247889999999876   67889999


Q ss_pred             hHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCC---CCHHHHH
Q 020027          246 VYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNR---PSIVQVA  322 (332)
Q Consensus       246 iwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~R---Ps~~~i~  322 (332)
                      ||||||++|||+||..||.+....+....+....      ..+..+.......++.+++.+|+. +|.+|   ||+.|++
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWR------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999999999998765554444333211      111122221223467789999997 67665   5998887


Q ss_pred             HH
Q 020027          323 TI  324 (332)
Q Consensus       323 ~~  324 (332)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            63

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.5e-42  Score=299.58  Aligned_cols=248  Identities=22%  Similarity=0.380  Sum_probs=202.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|...+.||+|+||.||+|...+++.||+|.+.....   ....+.+|+.+++.++|+|++++++++. .+..+++|
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            4567888999999999999999988889999999874432   2235789999999999999999999874 45689999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....  ..+++.+...++.|++.||+|||+.   +++|+||||+||++++++.++++|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999999865432  2378899999999999999999998   999999999999999999999999999865441


Q ss_pred             c-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 E-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .       ..++..|++||....   ..++.++||||||+++||+++ |+.||.+.........+....         ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------~~  222 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------RM  222 (260)
T ss_pred             CCcccccCCcccccccCHHHhcc---CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC---------CC
Confidence            1       123567999998865   567899999999999999999 999998765544444333221         11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      +.+...+.++.+++.+||+.||++|||++++.+.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1122233478899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=316.36  Aligned_cols=247  Identities=23%  Similarity=0.291  Sum_probs=191.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||+|+ ..+++.||+|.+..... ......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            3567778899999999999999 45789999999864432 122235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|....        ..++..+..++.|++.||.|||++   +++||||||+|||+++++.+||+|||+++....
T Consensus       152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999886432        145677888999999999999998   999999999999999999999999999875432


Q ss_pred             ------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                            ...|+..|++||.+...  .+...+.++|||||||++|||++|+.||...........+.......    .  .
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~--~  294 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----P--P  294 (353)
T ss_pred             ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----C--C
Confidence                  23578899999987542  12344578999999999999999999997432211111111110000    0  1


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ........++.+++.+||+.||++|||+.|+++.
T Consensus       295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112233478899999999999999999999863

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-42  Score=304.49  Aligned_cols=253  Identities=21%  Similarity=0.345  Sum_probs=203.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ..++|...+.||+|+||.||+|...      ++..||+|.+..... ......+.+|+.+++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            4567888999999999999999842      346899999864432 122235788999999999999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCC------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          133 ERIIVSEFINMASLDFYLHENNDG------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                      ..+++|||+++++|.+++......      ...+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            999999999999999998753321      12368889999999999999999998   999999999999999999999


Q ss_pred             EccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhh
Q 020027          207 VCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       207 l~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~  277 (332)
                      |+|||+++.....        ..++..|++||....   ..++.++|||||||++||++| |..||.+.........+..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD---GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhc---CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            9999998653221        234678999998865   568899999999999999998 8999987665555544443


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      +..       ...+  ......+.+++.+||+.+|++|||+.++++.|++
T Consensus       237 ~~~-------~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 GGH-------LDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCC-------CCCC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            211       1111  1224578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-41  Score=295.80  Aligned_cols=241  Identities=26%  Similarity=0.380  Sum_probs=196.7

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      +.||+|+||.||+|...++..+|+|.++.... ......+.+|+..++.++|||++++++++...+..+++|||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999987889999999875432 22223578899999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc------
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK------  220 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~------  220 (332)
                      .+++.....   .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.+|++|||++.......      
T Consensus        80 ~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          80 LSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            999865432   278999999999999999999998   99999999999999999999999999986543221      


Q ss_pred             -CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          221 -RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       221 -~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                       .++..|++||+...   ..++.++||||||+++||+++ |..||.+.........+....       .  ...+...+.
T Consensus       154 ~~~~~~y~aPE~~~~---~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~  221 (250)
T cd05085         154 KQIPIKWTAPEALNY---GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-------R--MSCPQKCPD  221 (250)
T ss_pred             CCCcccccCHHHhcc---CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-------C--CCCCCCCCH
Confidence             23457999998865   678899999999999999998 999998765544433333221       1  111122334


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          299 RLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.2e-43  Score=316.28  Aligned_cols=250  Identities=19%  Similarity=0.227  Sum_probs=200.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+++ ..+|+.||+|.++...... .....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            468889999999999999999 4588999999998654322 22234678899999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999976522   278999999999999999999998   999999999999999999999999999865432


Q ss_pred             c-------cCCcccccCcccccccC---CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          219 E-------KRGLAGYVDDDYWHEKG---GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       219 ~-------~~~~~~~~~pe~~~~~~---~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      .       ..++..|+|||.+....   ...++.++|||||||++|||++|+.||.+.........+....      ...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------~~~  228 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------RFL  228 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC------Ccc
Confidence            2       25788999999886321   2567899999999999999999999998765544433332211      011


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+........+.+++..||+ ||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            122222233467789999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.4e-42  Score=303.21  Aligned_cols=244  Identities=18%  Similarity=0.226  Sum_probs=189.8

Q ss_pred             eeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           69 IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        69 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      ||+|+||.||++. ..+|+.+|+|.+........ .......|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999998 45799999999875433221 122346789999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-----cC
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-----KR  221 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-----~~  221 (332)
                      .+++.....  ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++....+.     ..
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            988865432  2278899999999999999999998   9999999999999999999999999998654332     35


Q ss_pred             CcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHH
Q 020027          222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLA  301 (332)
Q Consensus       222 ~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  301 (332)
                      ++..|++||.+..   ..++.++||||+||++|||++|+.||.+.........+......    ....... .....++.
T Consensus       156 ~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~  227 (277)
T cd05607         156 GTNGYMAPEILKE---EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE----DEVKFEH-QNFTEESK  227 (277)
T ss_pred             CCCCccCHHHHcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc----ccccccc-ccCCHHHH
Confidence            7889999999876   56899999999999999999999999754322111111111111    1111110 11233678


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHH
Q 020027          302 KVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       302 ~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      +++.+||+.||++||++.|+++.+
T Consensus       228 ~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         228 DICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHHHhccCHhhCCCCccchhhh
Confidence            999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.5e-43  Score=319.55  Aligned_cols=252  Identities=18%  Similarity=0.225  Sum_probs=202.4

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ...++|...+.||+|+||.||+++ ..+++.||+|.+....... .....+.+|+.+++.++||||+++++++..++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            345689999999999999999999 4578999999986533222 22223678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++|+|.+++....     ++...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            9999999999999986532     67788888999999999999998   999999999999999999999999999865


Q ss_pred             CCc-------ccCCcccccCcccccccC-CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCc
Q 020027          216 APE-------EKRGLAGYVDDDYWHEKG-GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       216 ~~~-------~~~~~~~~~~pe~~~~~~-~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      ...       ...|++.|+|||.+.... ...++.++|||||||++|||++|+.||.+.........+....      ..
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------~~  265 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK------NS  265 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC------Cc
Confidence            432       235889999999886532 2457899999999999999999999998765544444333221      11


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKN--RPSIVQVAT  323 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~--RPs~~~i~~  323 (332)
                      +..+........+.+++.+|++.+|++  |||+.++++
T Consensus       266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            122222223347789999999999987  999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.5e-42  Score=309.47  Aligned_cols=236  Identities=21%  Similarity=0.272  Sum_probs=188.3

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhcc-CCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSL-AQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|. ..+++.||+|.++...... ........|..++.. .+||||+++++++...+..+++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999 4578899999997643222 122234556666654 4899999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....     
T Consensus        81 g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          81 GDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            999999876432    78889999999999999999998   999999999999999999999999999864321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...||..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+....        ...+  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------~~~~--~~~~  220 (316)
T cd05592         154 STFCGTPDYIAPEILKG---QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--------PHFP--RWIS  220 (316)
T ss_pred             ccccCCccccCHHHHcC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------CCCC--CCCC
Confidence             2357899999999875   568899999999999999999999998876555544433211        1111  1122


Q ss_pred             HHHHHHHHHcccCCCCCCCCHH-HHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIV-QVA  322 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~-~i~  322 (332)
                      .++.+++.+||+.||++||++. +++
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            3677899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-42  Score=304.46  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=196.5

Q ss_pred             CCCceeeccCCeEEEEEE-----eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--CceeE
Q 020027           64 SHRRIIGQGRLGTVYAAL-----LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERII  136 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  136 (332)
                      ...+.||+|+||.||.+.     ..++..||+|.++.... ......+.+|+.+++.++||||+++++++...  ...++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            778999999999998765     24678999999875432 12233578899999999999999999987653  45789


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++....     +++..+..++.|++.|+.|||++   +++|+||||+||++++++.++++|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~~~-----l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999999996532     79999999999999999999998   9999999999999999999999999998765


Q ss_pred             Ccc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH--HHHH----hhhcccc
Q 020027          217 PEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW--ALPL----IKEMRFS  281 (332)
Q Consensus       217 ~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~--~~~~----~~~~~~~  281 (332)
                      ...         ..++..|++||....   ..++.++||||||+++|||+||..|+.......  ....    .....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKE---NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcc---cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            432         124556899998865   578899999999999999999999986432211  0000    0000111


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +..+.....+.+...+.++.+++.+||+.||++|||++++++.|+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111122222223334458889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=301.54  Aligned_cols=254  Identities=23%  Similarity=0.283  Sum_probs=199.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      ...|...+.||+|+||.|..+. ..+|+.||+|++..............+|++.++.++|+||+.+.+.+..+     +.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            4456667899999999999998 67899999999986655555555679999999999999999999988652     46


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .|+|+|+| +.+|...+++...    ++..++..+++|++.||.|+|+.   +++||||||+|++++.+...||+|||+|
T Consensus       101 vYiV~elM-etDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            79999999 5799999987543    78899999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--------
Q 020027          214 FLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--------  277 (332)
Q Consensus       214 ~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--------  277 (332)
                      +...+.        ...|.-|.|||.....  ..|+.+.||||.|||+.||++|++-|.|...-.....+.+        
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~--~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNS--SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhcc--ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            987531        1357778999988653  7899999999999999999999998876533333222211        


Q ss_pred             -------cccccccC---CcCCCCCC---hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 -------MRFSELLD---PRLAIPCE---IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 -------~~~~~~~~---~~~~~~~~---~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                             ......+.   ...+.+..   +.......+++.+++.+||.+|+|++|.++
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                   11111111   01111100   122236779999999999999999999875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.3e-42  Score=315.73  Aligned_cols=252  Identities=21%  Similarity=0.276  Sum_probs=194.3

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-----cee
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-----ERI  135 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  135 (332)
                      +|+..+.||+|+||.||++. ..+|+.||+|.+............+.+|+.+++.++|+||+++++++..++     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            47888999999999999999 468999999998654332223335788999999999999999999998776     789


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +++||+. ++|.+++....    .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 57877775433    278999999999999999999998   999999999999999999999999999875


Q ss_pred             CCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc----c-----
Q 020027          216 APEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM----R-----  279 (332)
Q Consensus       216 ~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~----~-----  279 (332)
                      ....       ..++..|+|||.+...  ..++.++|||||||++|||++|+.||.+.........+.+.    .     
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGS--RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCC--CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            4321       2457789999988652  45789999999999999999999999876544333322110    0     


Q ss_pred             -----ccc-ccCCcCCC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -----FSE-LLDPRLAI-------PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -----~~~-~~~~~~~~-------~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           ... ........       ........++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                 000 00000000       001112346789999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8e-42  Score=299.79  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=202.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CC---CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-ST---GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|...+.||+|+||.||+|.. .+   +..+|+|.++.... ......+.+|+..++.++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            34678889999999999999984 23   33799998865432 222335788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....   .+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||++..
T Consensus        82 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            99999999999999976432   378899999999999999999998   999999999999999999999999999876


Q ss_pred             CCccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          216 APEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       216 ~~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....         .++..|++||.+..   ..++.++|+||||+++||+++ |..||.+.........+....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------  226 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------  226 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhcc---CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC------
Confidence            43321         12356999999875   578899999999999999887 999997765444444333321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                         ..+.+...+..+.+++.+||+.+|++|||+.++++.|.+++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence               11112223346789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.3e-42  Score=309.89  Aligned_cols=237  Identities=22%  Similarity=0.288  Sum_probs=192.1

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|.. .+++.||+|.++...... .....+..|..++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999984 578899999997643222 2223456788888777 799999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|..++.....    +++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++....     
T Consensus        81 ~~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          81 GDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            999998876432    78999999999999999999998   999999999999999999999999999864211     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...++..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....        ...+.  ...
T Consensus       154 ~~~~g~~~y~aPE~~~~---~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--------~~~~~--~~~  220 (318)
T cd05570         154 STFCGTPDYIAPEILSY---QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--------VRYPR--WLS  220 (318)
T ss_pred             cceecCccccCHHHhcC---CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------CCCCC--cCC
Confidence             1247889999999876   678899999999999999999999998766555444333221        11111  123


Q ss_pred             HHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSI-----VQVAT  323 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~-----~~i~~  323 (332)
                      ..+.+++.+||+.||++|||+     .++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            467899999999999999999     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-41  Score=297.61  Aligned_cols=247  Identities=22%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .++|+..+.||+|+||.||+|...++..+|+|.++....   ....+.+|+.++++++|+|++++++++. .+..+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence            456888999999999999999987888899999876432   2235789999999999999999999875 456789999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++++|.+++.....  ..+++.+++.++.|++.|+.|||++   +++||||||+||++++++.++++|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            9999999999975432  2378999999999999999999998   9999999999999999999999999998654322


Q ss_pred             c-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          220 K-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       220 ~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .       .++..|+|||....   ..++.++|+||||+++||+++ |..||.+....+....+...         ...+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---------~~~~  223 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG---------YRMP  223 (260)
T ss_pred             ccccccCCCCCccccChHHHhc---CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------CCCC
Confidence            1       23457999998765   678899999999999999999 88899776554444433221         1111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      .+......+.+++.+||+.||++|||+.++.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            222333478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=304.83  Aligned_cols=248  Identities=21%  Similarity=0.259  Sum_probs=196.7

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +|+..+.||+|+||.||++. ..+++.||+|.+......... ...+.+|+.+++.++||||+++++.+..++..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            47788999999999999999 457899999998754332222 2346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++++|.+++.....  ..+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999988865322  2378999999999999999999998   9999999999999999999999999998764322


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||....   ..++.++||||+||++||+++|+.||.+.........+... ..   ...  ...+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~---~~~--~~~~~  226 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKN---ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VK---EDQ--EEYSE  226 (285)
T ss_pred             CccccccCCCCccCcHHhcC---CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-hh---hcc--cccCc
Confidence                 257889999999865   67889999999999999999999999875443222222111 00   000  11111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .....+.+++.+||+.||++||     +++++++
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            2234678999999999999999     7878754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-42  Score=311.44  Aligned_cols=237  Identities=20%  Similarity=0.257  Sum_probs=191.5

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|+. .+++.||+|.++...... .....+..|..++..+ +||||+++++++..++..+++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999994 578899999987643222 2222456788888765 799999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....     
T Consensus        81 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          81 GDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            999988875432    78889999999999999999999   999999999999999999999999999864321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...|+..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+.....        ..+.  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--------~~p~--~~~  220 (321)
T cd05591         154 TTFCGTPDYIAPEILQE---LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--------LYPV--WLS  220 (321)
T ss_pred             cccccCccccCHHHHcC---CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCCC--CCC
Confidence             2247889999998875   6788999999999999999999999988766555544433221        1111  122


Q ss_pred             HHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRP-------SIVQVAT  323 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RP-------s~~~i~~  323 (332)
                      .++.+++.+||+.||++||       ++.++++
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            3677999999999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.5e-42  Score=307.02  Aligned_cols=255  Identities=26%  Similarity=0.365  Sum_probs=200.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCC--EEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|+..+.||+|+||.||+|.. .++.  .+++|.++... .......+.+|+.++.++ +|+||+++++++...+..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            45788889999999999999995 4554  45777665321 122223567899999999 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          136 IVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      +++||+++++|.+++.....            ....+++.+++.++.|++.|++|||++   +++||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence            99999999999999975431            112478999999999999999999998   999999999999999999


Q ss_pred             ceEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhh
Q 020027          204 CARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~  277 (332)
                      .+||+|||++......     ...+..|++||....   ..++.++|||||||++|||+| |..||.+.........+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhc---cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            9999999998643211     123457999998765   567899999999999999998 9999976655444333322


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ..       .  .+.+......+.+++.+||+.+|++|||+.++++.|++++.
T Consensus       239 ~~-------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         239 GY-------R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             CC-------c--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            10       1  11111223367899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.3e-42  Score=322.31  Aligned_cols=252  Identities=18%  Similarity=0.205  Sum_probs=189.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-------  131 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  131 (332)
                      ..+|...+.||+|+||.||+|.. .+++.||+|.+....      ....+|+.+++.++||||+++++++...       
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            45799999999999999999994 678999999885321      1236799999999999999998876332       


Q ss_pred             -CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEcc
Q 020027          132 -GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCD  209 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~d  209 (332)
                       ...+++|||++ +++.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             24678999997 477777654332333488999999999999999999998   999999999999998654 799999


Q ss_pred             CCccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c---
Q 020027          210 YGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R---  279 (332)
Q Consensus       210 fg~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~---  279 (332)
                      ||+|+....     ...++..|+|||.+...  ..++.++|||||||++|||+||.+||.+.........+...  .   
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999975432     22568889999987642  46899999999999999999999999876443332222110  0   


Q ss_pred             ---------cccccCCc-----CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ---------FSELLDPR-----LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ---------~~~~~~~~-----~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                               +.+..-+.     +....+.....++.+++.+||+.||.+|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                     00000000     000011112347889999999999999999999874

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.4e-42  Score=300.73  Aligned_cols=252  Identities=23%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||+|+ ..+++.||+|.+.....  .....+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            4578999999999999999999 46888999999865432  12224678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++....    .+++..+..++.|++.|+.|||+.   +++|||++|+||++++++.++++|||++.....
T Consensus        86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          86 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            9999999999886543    278899999999999999999998   999999999999999999999999999865432


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                            ...++..|++||.........++.++|+|||||++|||++|+.||...........+....+   ..+....  
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~--  233 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF---QPPKLKD--  233 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC---CCCCCcc--
Confidence                  12467789999987543345678899999999999999999999865432222111111110   0111111  


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      .......+.+++.+||+.||++|||++++++.|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            112234788999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-42  Score=306.48  Aligned_cols=258  Identities=22%  Similarity=0.332  Sum_probs=206.6

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEe--------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGF  127 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  127 (332)
                      ....++|...+.||+|+||.||+++.        .++..||+|.+..... ......+.+|+..++.+ +||||++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            34567788899999999999999973        1345799998864322 22234578899999999 89999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCC
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  195 (332)
                      +...+..+++|||+++++|.+++......            ...+++.+++.++.|++.||.|||++   +++||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence            99999999999999999999999764221            12378888999999999999999998   9999999999


Q ss_pred             CEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCch
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGL  266 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~  266 (332)
                      ||++++++.+|++|||+++.....        ..++..|+|||.+..   ..++.++||||||+++||++| |..||.+.
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999999998754321        123567999998865   568899999999999999999 78888876


Q ss_pred             hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ...+....+.....         ...+..+...+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       244 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         244 PVEELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             CHHHHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            66555554433211         11112334478899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-41  Score=297.62  Aligned_cols=248  Identities=22%  Similarity=0.375  Sum_probs=200.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .++|...+.||+|+||.||+|...++..||+|.++....   ....+.+|+.+++.++|+||+++++.+.. +..+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            456888999999999999999976667899999875332   12357889999999999999999998754 55789999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++++|.+++.+...  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          81 YMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             cCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999975422  2378899999999999999999998   9999999999999999999999999998654322


Q ss_pred             c-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          220 K-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       220 ~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .       .++..|++||....   ..++.++|+||||+++||++| |..||.+.........+....         ..+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---------~~~  223 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------RMP  223 (262)
T ss_pred             ccccccCCcccceecCHhHhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC---------CCC
Confidence            1       24457999998765   678999999999999999999 888887765544443332211         111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2223445788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8e-42  Score=303.61  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=203.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .+|...+.||+|+||.||+|..      .++..+++|.+.....  .....+.+|+..+++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            4577788999999999999973      2455789998764332  2223578999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          135 IIVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      +++|||+++++|.+++.....            ....+++..++.++.|++.|++|||++   +++||||||+||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            999999999999999975431            112378999999999999999999999   99999999999999999


Q ss_pred             CceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHH
Q 020027          203 FCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP  273 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~  273 (332)
                      +.++++|||++......        ..++..|++||....   ..++.++|||||||++|||+| |..||..........
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999998654321        234667999998876   678899999999999999999 999987765555444


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .+..+.....         +...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       237 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            4433322111         11123468899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=304.04  Aligned_cols=255  Identities=27%  Similarity=0.387  Sum_probs=191.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhc--cCCCCCccceeeeeecCC----c
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS--LAQHPNIVPILGFSQAPG----E  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~----~  133 (332)
                      .+..+...++|+|+||.||+|.+. ++.||||++...     +...|..|..+.+  .++|+||+++++.-...+    .
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            455667789999999999999984 589999998633     2234566655554  678999999999876554    7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC------CCCeeecCCCCCCEEeCCCCceEE
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV------APNIIHGCIKASNILLNEKFCARV  207 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~ivH~dlk~~Nill~~~~~~kl  207 (332)
                      ++||+||.+.|+|.+|++.+.     ++|....+|+..+++||+|||+..      .++|+|||||.+|||+.+++++.|
T Consensus       283 ywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            899999999999999998764     799999999999999999999753      568999999999999999999999


Q ss_pred             ccCCccccCCcc--------cCCcccccCcccccccCCCC---CCchhhhHHHHHHHHHHHhCCCC------------CC
Q 020027          208 CDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGN---ATRESDVYGFGVVLLEILSGRRC------------EE  264 (332)
Q Consensus       208 ~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~---~~~~~DiwS~G~il~el~tg~~p------------~~  264 (332)
                      +|||+|......        ..||.+|||||.+++...-+   .-.+.||||+|.+|||++++-..            |.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999765422        26999999999998652222   22468999999999999986432            21


Q ss_pred             ---c--hhHHHHHHHhhhcccccccCCcCCCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          265 ---G--LLVKWALPLIKEMRFSELLDPRLAIPCE-IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       265 ---~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                         |  ...++....+..    +..+|.++-..- -....-+.+.+..||.+||+.|-|+.=+-+++.++.
T Consensus       438 ~evG~hPt~e~mq~~VV~----kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVR----KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHhcCCCCHHHHHHHHHh----hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence               0  112222222222    222222221100 023445778999999999999999988888777654

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4e-42  Score=317.35  Aligned_cols=259  Identities=24%  Similarity=0.331  Sum_probs=204.2

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGF  127 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~  127 (332)
                      ++....++|...+.||+|+||.||+|++.      +++.||+|.++..... .....+.+|+.++..+. ||||++++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            35556677888999999999999999842      3468999999754322 22235788999999997 9999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCC----------------------------------------------------
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENND----------------------------------------------------  155 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------  155 (332)
                      +..++..++++||+++|+|.++++....                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999999965321                                                    


Q ss_pred             ------------------------------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCC
Q 020027          156 ------------------------------------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIK  193 (332)
Q Consensus       156 ------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  193 (332)
                                                                ....+++...+.++.|++.||.|||+.   +++|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence                                                      112367788899999999999999998   99999999


Q ss_pred             CCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 020027          194 ASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEE  264 (332)
Q Consensus       194 ~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~  264 (332)
                      |+|||+++++.+|++|||+++.....        ..++..|++||....   ..++.++||||||+++|||++ |..||.
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN---NLYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC---CCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999998753211        134567999998865   568899999999999999998 888987


Q ss_pred             chhHHHHH-HHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          265 GLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       265 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .....+.. ..+..+         ...+.+.....++.+++.+||..+|.+|||++++++.|++++
T Consensus       344 ~~~~~~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         344 ELPMNEQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCchHHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            64333322 222211         011111222347889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3e-42  Score=305.01  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=200.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .+|...+.||+|+||.||+|...      ++..||+|.++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            34667788999999999999842      357899999874432 11123467899999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          135 IIVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      ++++||+++++|.+++.....            ....+++..++.++.|++.||.|||++   +++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            999999999999999853210            112378888999999999999999998   99999999999999999


Q ss_pred             CceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHH
Q 020027          203 FCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP  273 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~  273 (332)
                      +.+|++|||+++.....        ..++..|++||....   ..++.++|||||||++|||+| |..||.+........
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY---GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE  237 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999998654321        124568999998865   668899999999999999998 888888766555555


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      .+......         +.+..++..+.+++.+||+.||++|||+.+|++.|++
T Consensus       238 ~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            44443211         1122334468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.8e-42  Score=308.52  Aligned_cols=236  Identities=22%  Similarity=0.297  Sum_probs=189.7

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCccc-ccccccHHHHHHHhcc-CCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSL-AQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|.. .+++.||+|.++..... .........|..++.. ++||||+++++++...+..+++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999994 57889999999765321 1222235667777765 4899999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC------
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP------  217 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~------  217 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....      
T Consensus        81 g~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          81 GDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            999999875432    78889999999999999999998   99999999999999999999999999986421      


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                      ....|+..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+....      +.  .+.  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------~~--~~~--~~~  220 (316)
T cd05619         154 CTFCGTPDYIAPEILLG---QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN------PC--YPR--WLT  220 (316)
T ss_pred             eeecCCccccCHHHHcC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CC--CCc--cCC
Confidence            12257889999999875   678999999999999999999999998766555544333221      11  111  122


Q ss_pred             HHHHHHHHHcccCCCCCCCCHH-HHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIV-QVA  322 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~-~i~  322 (332)
                      .++.+++.+||+.||++||++. ++.
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHH
Confidence            3677999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.8e-42  Score=301.88  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      .+++|...+.||+|+||.||+|...      ++..||+|....... ......+.+|+.+++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            3567889999999999999999853      467899998764322 222235788999999999999999999998888


Q ss_pred             ceeEEEeccCCCCHHHHhcccCC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC---ceE
Q 020027          133 ERIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF---CAR  206 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~k  206 (332)
                      ..+++|||+++++|.+++.....   ....+++..++.++.||+.|+.|||++   +++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence            89999999999999999976432   123488999999999999999999998   999999999999998654   689


Q ss_pred             EccCCccccCCccc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhh
Q 020027          207 VCDYGLSFLAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       207 l~dfg~a~~~~~~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~  277 (332)
                      ++|||+++......        ..+..|++||.+..   ..++.++|||||||++|||++ |..||.+.........+..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~  236 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD---GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG  236 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhc---CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999987653211        12357999999865   678999999999999999997 9999987655554444332


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ..       .  ...+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       237 ~~-------~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         237 GG-------R--LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CC-------c--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            21       0  11112223478899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-42  Score=310.02  Aligned_cols=237  Identities=19%  Similarity=0.255  Sum_probs=192.2

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCC-CccceeeeeecCCceeEEE
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHP-NIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  138 (332)
                      +|...+.||+|+||.||+|. ..+++.||+|.+++..... .....+..|..++..++|+ +|+++++++...+..+++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47788999999999999998 4578899999997643222 2223467888888888764 6888999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.... 
T Consensus        81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999999875432    78899999999999999999998   99999999999999999999999999986421 


Q ss_pred             -----cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 -----EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 -----~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                           ....|+..|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+....        ...+.
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------~~~~~  222 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------VSYPK  222 (324)
T ss_pred             CCCceeeecCCccccChhhhcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence                 11257899999999876   678899999999999999999999998776555544443321        11111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                        ....++.+++.+||+.||.+||+.
T Consensus       223 --~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         223 --SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCHHHHHHHHHHhhcCHHHcCCC
Confidence              122367799999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=303.77  Aligned_cols=250  Identities=21%  Similarity=0.252  Sum_probs=203.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-------c-----cccHHHHHHHhccCCCCCcccee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-------A-----GFGFASVIKTLSLAQHPNIVPIL  125 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-------~-----~~~~~~e~~~l~~l~h~niv~~~  125 (332)
                      ..++|...+.||+|.||.|-+|+ ..+++.||+|++.+......       .     .....+||.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            35789999999999999999999 56899999999976432211       1     12478999999999999999999


Q ss_pred             eeeecC--CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          126 GFSQAP--GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       126 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      .+..++  +.+|+|+|||..|.+...-    .....+++.++..++.++..||.|||.+   +|+||||||+|+|++++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            998765  6789999999888764321    1122378999999999999999999999   999999999999999999


Q ss_pred             ceEEccCCccccCCcc-----------cCCcccccCcccccccC-CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH
Q 020027          204 CARVCDYGLSFLAPEE-----------KRGLAGYVDDDYWHEKG-GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA  271 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~~-----------~~~~~~~~~pe~~~~~~-~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~  271 (332)
                      ++||+|||.+...+..           ..||+.|+|||...... ....+.+.||||+||.||=|+.|+.||.+...-+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999998754211           26999999999876632 34457889999999999999999999998776666


Q ss_pred             HHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          272 LPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +..+.+.        .+..|...+....+.+|+.++|..||++|.+..+|..
T Consensus       328 ~~KIvn~--------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  328 FDKIVND--------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             HHHHhcC--------cccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            6656553        3445544445557889999999999999999988753

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-41  Score=297.66  Aligned_cols=251  Identities=26%  Similarity=0.324  Sum_probs=191.3

Q ss_pred             ceeeccCCeEEEEEEeC---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALLS---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|...   ++..+|+|.++..... .....+.+|+.+++.++||||+++++++......+++|||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999853   4457999988755422 2223578899999999999999999999998899999999999


Q ss_pred             CCHHHHhcccCC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc---
Q 020027          144 ASLDFYLHENND-GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE---  219 (332)
Q Consensus       144 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~---  219 (332)
                      ++|.+++..... .....++..++.++.|++.|+.|||+.   +++||||||+||+++.++++|++|||++......   
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999975432 122356778888999999999999998   9999999999999999999999999998643221   


Q ss_pred             -----cCCcccccCcccccccCC----CCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          220 -----KRGLAGYVDDDYWHEKGG----GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~----~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                           ..++..|++||......+    ..++.++|+||||+++|||++ |+.||......+..............++...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence                 235667999998864211    246889999999999999997 9999976544443322222111111122211


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .    .....+.+++.+|| .+|++|||++||++.|+
T Consensus       237 ~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         237 L----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             C----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1    12235778999999 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.6e-42  Score=302.96  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=203.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      ...++|+..+.||+|+||.||+|...      .+..||+|.+..... ......+.+|+..++.++|+||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45678999999999999999999732      345899998764432 12223567899999999999999999999988


Q ss_pred             CceeEEEeccCCCCHHHHhcccCC------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCce
Q 020027          132 GERIIVSEFINMASLDFYLHENND------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA  205 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  205 (332)
                      +..+++|||+++++|.+++.....      .....++..+..++.|++.||.|||++   +++||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999975321      122356778889999999999999998   99999999999999999999


Q ss_pred             EEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhh
Q 020027          206 RVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIK  276 (332)
Q Consensus       206 kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~  276 (332)
                      +++|||+++.....        ..++..|++||.+..   ..++.++|+|||||++||+++ |..||.+.........+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~---~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD---GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhcc---CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999998753221        123567999998876   678899999999999999999 788888765555444433


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .+....       .  +......+.+++.+||+.||++|||+.++++.|++.+
T Consensus       236 ~~~~~~-------~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGGYLD-------Q--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCCCCC-------C--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            322111       1  1122347889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-42  Score=303.79  Aligned_cols=243  Identities=21%  Similarity=0.225  Sum_probs=189.8

Q ss_pred             eeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           69 IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        69 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      ||+|+||+||++. ..+++.+|+|.+........ ....+..|+.+++.++|+||+++.+++...+..+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999998 45889999999875433222 122467899999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc------c
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE------K  220 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~------~  220 (332)
                      ..++.........+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++......      .
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            988754332233488999999999999999999998   9999999999999999999999999998654322      2


Q ss_pred             CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHH
Q 020027          221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL  300 (332)
Q Consensus       221 ~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  300 (332)
                      .++..|++||.+..   ..++.++|||||||++|||++|+.||...............    ........  +......+
T Consensus       158 ~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~  228 (280)
T cd05608         158 AGTPGFMAPELLQG---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----ILNDSVTY--PDKFSPAS  228 (280)
T ss_pred             CCCcCccCHHHhcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh----hcccCCCC--cccCCHHH
Confidence            57889999999876   67889999999999999999999999754221111111111    11111111  12233467


Q ss_pred             HHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          301 AKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       301 ~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .+++.+||+.||++||     |++++++
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         229 KSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            7999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=296.20  Aligned_cols=250  Identities=23%  Similarity=0.381  Sum_probs=205.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ...++|...+.||+|+||.||+|..+++..+|+|.+.....   ....+.+|+..++.++|+|++++++++...+..+++
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            34578899999999999999999987778999999875432   223578999999999999999999999988899999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....  ..+++.++..++.|++.|+.|||++   +++|+||+|+||++++++.+|++|||.+....
T Consensus        80 ~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             EeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence            999999999999976432  2378999999999999999999998   99999999999999999999999999987654


Q ss_pred             cc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          218 EE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       218 ~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      +.       ...+..|++||....   ...+.++|+||||+++||++| |+.||.+.........+....         .
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------~  222 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANY---GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---------R  222 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhcc---CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------C
Confidence            21       123457999998865   668899999999999999999 999998765554444333211         1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      .+.+...+.++.+++.+||+.||++|||++++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11111223478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=303.23  Aligned_cols=259  Identities=21%  Similarity=0.309  Sum_probs=198.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCC---------------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLST---------------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI  124 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  124 (332)
                      .++|...+.||+|+||.||++....               ...||+|.++.... ......+.+|++++++++|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            4578899999999999999987421               23589999875432 2223357899999999999999999


Q ss_pred             eeeeecCCceeEEEeccCCCCHHHHhcccCC--------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCC
Q 020027          125 LGFSQAPGERIIVSEFINMASLDFYLHENND--------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASN  196 (332)
Q Consensus       125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  196 (332)
                      ++++...+..+++|||+++++|.+++.....        ....+++..++.++.|++.|+.|||++   +++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            9999999999999999999999999864321        112367889999999999999999998   99999999999


Q ss_pred             EEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh--CCCCCCch
Q 020027          197 ILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS--GRRCEEGL  266 (332)
Q Consensus       197 ill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t--g~~p~~~~  266 (332)
                      |++++++.+|++|||++......        ..++..|++||....   ..++.++|+|||||++|||++  +..||...
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL---GKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc---CCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999999999998654321        123567999998875   668999999999999999998  56787765


Q ss_pred             hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ............ +... ........+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus       237 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         237 SDEQVIENTGEF-FRNQ-GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ChHHHHHHHHHh-hhhc-cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            443332222110 0000 0000011111223478899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=295.05  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=204.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .++|...+.||.|+||.||+|... |+.||+|.+.....   ....+.+|+.+++.++|+|++++++++...+..+++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            457888999999999999999864 78999999875532   23457899999999999999999999998899999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++++|.+++.....  ..+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.+||+|||.++.....
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          81 YMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            9999999999976432  2378999999999999999999998   9999999999999999999999999998765433


Q ss_pred             c---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          220 K---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       220 ~---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                      .   ..+..|++||....   ..++.++|+||||+++||+++ |..||...........+....       .  ...+..
T Consensus       156 ~~~~~~~~~~~ape~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------~--~~~~~~  223 (256)
T cd05039         156 QDSGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-------R--MEAPEG  223 (256)
T ss_pred             cccCCCcccccCchhhcC---CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-------C--CCCccC
Confidence            2   23457999998865   678889999999999999998 999987765554433333211       0  111112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .+..+.+++.+||+.+|++|||++++++.|+++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            234788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=299.62  Aligned_cols=253  Identities=20%  Similarity=0.364  Sum_probs=203.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCC----EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|.. .+|+    .+|+|....... ......+.+|+..++.++|+|++++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            35678889999999999999984 3343    689998765432 2223357889999999999999999999987 778


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++++|.+++.+...   .+++..++.++.|++.|++|||++   +++||||||+||++++++.+||+|||.++
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            999999999999999976433   278999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCccc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ......        .++..|++||....   ..++.++|+||||+++||++| |+.||.+....+....+..+.      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------  228 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILH---RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE------  228 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhc---CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC------
Confidence            654221        12457999998765   678899999999999999999 999998766555444333321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                         ..+.+..+...+.+++.+||..||++|||+.++++.|.++..+|
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence               11111122346789999999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6e-42  Score=307.95  Aligned_cols=236  Identities=22%  Similarity=0.291  Sum_probs=189.6

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhcc-CCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSL-AQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|+. .+|+.||+|.++...... ........|..++.. .+||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999994 578999999997643221 222235667777764 4899999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC------
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP------  217 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~------  217 (332)
                      ++|..++.....    +++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++...      
T Consensus        81 g~L~~~i~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          81 GDLMFHIQDKGR----FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            999998876432    78889999999999999999998   99999999999999999999999999986421      


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                      ....|+..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+....      +.  .+..  ..
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~------~~--~~~~--~~  220 (316)
T cd05620         154 STFCGTPDYIAPEILQG---LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT------PH--YPRW--IT  220 (316)
T ss_pred             eccCCCcCccCHHHHcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CC--CCCC--CC
Confidence            12357899999999876   678899999999999999999999998766555444433221      11  1111  22


Q ss_pred             HHHHHHHHHcccCCCCCCCCHH-HHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIV-QVA  322 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~-~i~  322 (332)
                      .++.+++.+||+.||++||++. ++.
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            3677999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-41  Score=295.59  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee-cCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ-APGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||++.. .|..+|+|..+...    ....+.+|+..+++++|+|++++++++. ..+..++++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            34688889999999999999986 47889999886432    2235789999999999999999999764 556789999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||++   +++||||||+||++++++.+|++|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             ECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            99999999999876432  2378899999999999999999998   999999999999999999999999999875432


Q ss_pred             c---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          219 E---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       219 ~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      .   ...+..|++||.+..   ..++.++|||||||++|||++ |+.||...........+..+.         ....+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~  222 (256)
T cd05082         155 TQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------KMDAPD  222 (256)
T ss_pred             cCCCCccceeecCHHHHcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------CCCCCC
Confidence            2   234567999998865   678899999999999999998 999987655444433332211         011111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      ..+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            2234788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=298.42  Aligned_cols=248  Identities=27%  Similarity=0.374  Sum_probs=194.8

Q ss_pred             ceeeccCCeEEEEEEe-CCCC--EEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccC
Q 020027           67 RIIGQGRLGTVYAALL-STGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      +.||+|+||.||+|.. +++.  .+++|.++... .......+.+|+.++.++ +||||+++++++...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            3689999999999995 3444  46888876322 122223578899999999 79999999999999999999999999


Q ss_pred             CCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          143 MASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       143 ~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      +++|.+++.....            ....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            9999999875321            112478899999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          211 GLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       211 g~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      |++......     ...+..|++||+...   ..++.++|||||||++|||+| |..||.+.........+....     
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----  228 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----  228 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHcc---CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----
Confidence            998533211     123456999998865   678899999999999999997 999997765444433332211     


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                        .  .+.+......+.+++.+||+.||.+|||+.++++.|++++.
T Consensus       229 --~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         229 --R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             --C--CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence              1  11111223467899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-42  Score=316.41  Aligned_cols=255  Identities=18%  Similarity=0.253  Sum_probs=201.0

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      .....++|...+.||+|+||.||+++. .+++.+|+|.+.+..... .....+.+|+.+++.++||||+++++++..++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            334467899999999999999999994 578899999986532222 222346789999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++....     +++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~-----~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999996532     68888999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCc-------ccCCcccccCcccccccC-CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          214 FLAPE-------EKRGLAGYVDDDYWHEKG-GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       214 ~~~~~-------~~~~~~~~~~pe~~~~~~-~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....       ...||..|+|||.+.... ...++.++||||+||++|||+||+.||.+.........+....      
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~------  263 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK------  263 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Confidence            75432       235899999999986532 2347889999999999999999999998765544444333211      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKN--RPSIVQVATI  324 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~--RPs~~~i~~~  324 (332)
                      ..+..+........+.+++..|++.++..  |||+.|+++.
T Consensus       264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11222222222346678888999755543  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-41  Score=301.82  Aligned_cols=259  Identities=23%  Similarity=0.322  Sum_probs=201.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC-----------------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCcc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS-----------------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV  122 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  122 (332)
                      ..+|...+.||+|+||.||++...                 .+..||+|.+...... .....+.+|+.++++++|||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence            457889999999999999998743                 2246899998755332 2233578899999999999999


Q ss_pred             ceeeeeecCCceeEEEeccCCCCHHHHhcccCCC-------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCC
Q 020027          123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDG-------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  195 (332)
                      ++++++..++..++++|++++++|.+++......       ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence            9999999999999999999999999999765411       12478999999999999999999998   9999999999


Q ss_pred             CEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh--CCCCCCc
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS--GRRCEEG  265 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t--g~~p~~~  265 (332)
                      ||++++++.++++|||+++.....        ..++..|++||....   ..++.++|||||||++|||++  +..||..
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL---GKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc---CCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999999998754221        134567999998875   578999999999999999998  6678866


Q ss_pred             hhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ....+...........  .......+.+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       237 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         237 LTDQQVIENAGHFFRD--DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cChHHHHHHHHhcccc--ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            5444443333221000  00111111122233578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6e-43  Score=300.86  Aligned_cols=250  Identities=22%  Similarity=0.244  Sum_probs=192.5

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--C---cee
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--G---ERI  135 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~---~~~  135 (332)
                      .|...+++|.|+||.||+|. .++++.||||++-.+..    .  -.+|+++|++++|||||++.-++...  +   ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~--knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----Y--KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----c--CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            56778999999999999999 56789999999865432    2  26789999999999999998877433  2   345


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccCCccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYGLSF  214 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a~  214 (332)
                      +||||+| .+|.++++........++...+.-+..|+.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            8999997 589998885332233367777888999999999999998   99999999999999964 999999999998


Q ss_pred             cCCccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh------------
Q 020027          215 LAPEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE------------  277 (332)
Q Consensus       215 ~~~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~------------  277 (332)
                      ......     ..+..|.|||.+.+.  ..|+.+.||||.||++.||+-|++-|.|......+..+..            
T Consensus       175 ~L~~~epniSYicSRyYRaPELifga--~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcCc--cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            764332     346789999998875  8899999999999999999999999988655554433221            


Q ss_pred             ccc--ccccCCcCCCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 MRF--SELLDPRLAIP-----CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 ~~~--~~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +..  .+...+.+...     .......++.+++.++++++|.+|.|+.|+++
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            100  01111111111     11223447889999999999999999998875

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.3e-41  Score=294.70  Aligned_cols=246  Identities=23%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      ++|.....||+|+||.||+|....+..+|+|.+.....   ....+.+|+.+++.++|+|++++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            45778889999999999999977777899998865432   2235688999999999999999999875 4567899999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+...... 
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          82 MGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999975432  2378999999999999999999998   9999999999999999999999999998754322 


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                            ..++..|++||....   ...+.++||||||+++||++| |..||.+.........+....         ..+.
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------~~~~  224 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY---------RMPC  224 (260)
T ss_pred             ccccCCCccchhhCCHHHhcc---CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------CCCC
Confidence                  124567999998765   678899999999999999999 899998765544443332211         1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      +...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            12233478899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.8e-42  Score=305.98  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=204.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC--------CCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS--------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFS  128 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  128 (332)
                      ...++|...+.||+|+||.||+++..        ++..+|+|.++.... ......+..|+.+++.+ +|+||+++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            33567899999999999999999731        235799999875422 22223467899999999 799999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCC
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASN  196 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  196 (332)
                      ...+..+++|||+++++|.+++......            ...+++.+++.++.|++.||+|||++   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            9999999999999999999999764321            12378899999999999999999998   99999999999


Q ss_pred             EEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchh
Q 020027          197 ILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLL  267 (332)
Q Consensus       197 ill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~  267 (332)
                      |+++.++.+|++|||.+......        ..++..|++||....   ..++.++|+|||||++|||++ |..||.+..
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc---CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            99999999999999998654321        123357999998865   568899999999999999998 888887766


Q ss_pred             HHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .......+....       .  .+.+.....++.+++.+||..+|++|||+.++++.|.++..
T Consensus       248 ~~~~~~~~~~~~-------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         248 VEELFKLLKEGH-------R--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             HHHHHHHHHcCC-------C--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            555444443321       1  11112223477899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.6e-42  Score=309.11  Aligned_cols=237  Identities=21%  Similarity=0.261  Sum_probs=192.8

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEE
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      +|...+.||+|+||.||+|+ ..+++.||+|.+++...... .......|..++..+ +|++|+++++++...+..+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47788999999999999998 45788999999976533222 122356677777666 5899999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      ||+++++|..++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++... 
T Consensus        81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999998865432    78899999999999999999998   99999999999999999999999999986432 


Q ss_pred             -----cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 -----EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 -----~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                           ....|+..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....        ...+.
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------~~~p~  222 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------VAYPK  222 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcC---CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------CCCCC
Confidence                 12357899999999876   678999999999999999999999998876665555444322        11111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                        ....++.+++.+|++.||++|++.
T Consensus       223 --~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         223 --SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --cCCHHHHHHHHHHcccCHHhcCCC
Confidence              123367899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-42  Score=318.35  Aligned_cols=246  Identities=20%  Similarity=0.194  Sum_probs=195.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+++ ..+++.||+|.+....... .....+.+|+.+++.++|+||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            368889999999999999999 5678999999986543222 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.... 
T Consensus        81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999997643    278888889999999999999998   99999999999999999999999999874210 


Q ss_pred             ------------------------------------------------cccCCcccccCcccccccCCCCCCchhhhHHH
Q 020027          218 ------------------------------------------------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGF  249 (332)
Q Consensus       218 ------------------------------------------------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~  249 (332)
                                                                      ....||..|+|||.+..   ..++.++|||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSl  230 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR---TGYTQLCDWWSV  230 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC---CCCCcceeeeec
Confidence                                                            01247889999999876   678899999999


Q ss_pred             HHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 020027          250 GVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP---SIVQVAT  323 (332)
Q Consensus       250 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP---s~~~i~~  323 (332)
                      ||++|||++|+.||.+....+....+....      ..+..+........+.+++.+|+ .+|.+|+   |+.++++
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999999999998766554433332211      11111211122335667777776 4999999   8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=304.03  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQ  129 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  129 (332)
                      ....++|...+.||+|+||.||++..      .++..||+|.++.... ......+.+|+.+++++ +|+||+++++++.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            34556799999999999999999973      2345899998875432 22223578899999999 7999999999999


Q ss_pred             cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEcc
Q 020027          130 APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD  209 (332)
Q Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~d  209 (332)
                      ..+..+++|||+++++|.+++.....  ..+++.+...++.|++.|+.|||++   +++|+||||+||+++.++.++++|
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence            99999999999999999999975432  2378999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccc
Q 020027          210 YGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF  280 (332)
Q Consensus       210 fg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  280 (332)
                      ||+++.....        ..++..|++||....   ..++.++|||||||++||++| |..||.+...............
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~  261 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY  261 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhcc---CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence            9998754322        124567999998866   668899999999999999998 9999876544332211111111


Q ss_pred             ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                              ....+.....++.+++.+||+.+|++|||+.|+++.|++++
T Consensus       262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence                    11111112347889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-41  Score=301.83  Aligned_cols=253  Identities=24%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ..++|...+.||+|+||.||++...      ++..+|+|.+..... ......+.+|+.+++.++|||++++++++...+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            3467889999999999999999842      567899999875432 122235788999999999999999999999989


Q ss_pred             ceeEEEeccCCCCHHHHhcccCC------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCC
Q 020027          133 ERIIVSEFINMASLDFYLHENND------------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKA  194 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~  194 (332)
                      ..++++||+++++|.+++.....                  ....+++..++.++.|++.||.|||++   +++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            99999999999999999964321                  112367888999999999999999998   999999999


Q ss_pred             CCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCc
Q 020027          195 SNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEG  265 (332)
Q Consensus       195 ~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~  265 (332)
                      +||++++++.++++|||++......        ...+..|++||....   ..++.++|||||||++|||++ |..||.+
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999998643211        123456999998765   678999999999999999998 8889877


Q ss_pred             hhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ....+....+..+...         +.+.....++.+++.+||+.||++|||+.|+++.|++
T Consensus       236 ~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         236 MAHEEVIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCHHHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            6555554444333211         1111233578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.4e-41  Score=301.28  Aligned_cols=258  Identities=23%  Similarity=0.340  Sum_probs=197.7

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC-----------------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccc
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS-----------------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP  123 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  123 (332)
                      ++|+..+.||+|+||.||++...                 ++..+|+|.+..... ......+.+|+..++.++|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcce
Confidence            46888999999999999998532                 244799998875421 222235789999999999999999


Q ss_pred             eeeeeecCCceeEEEeccCCCCHHHHhcccCCC-------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCC
Q 020027          124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDG-------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASN  196 (332)
Q Consensus       124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  196 (332)
                      +++++..++..+++|||+++++|.+++......       ...+++.++..++.|++.|++|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999998764321       12367889999999999999999998   99999999999


Q ss_pred             EEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh--CCCCCCch
Q 020027          197 ILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS--GRRCEEGL  266 (332)
Q Consensus       197 ill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t--g~~p~~~~  266 (332)
                      |+++.++.++++|||+++.....        ...+..|++||....   ..++.++|+|||||++|||+|  |..||...
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL---GKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc---CCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999998754321        122457899997765   678999999999999999998  67788765


Q ss_pred             hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ............ +... ......+.+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus       238 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         238 SDEQVIENTGEF-FRDQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ChHHHHHHHHHH-Hhhc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            443332211110 0000 0001111122233578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-41  Score=298.12  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             CCCCCceeeccCCeEEEEEEeC-CC---CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLS-TG---KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .|...+.||+|+||.||+|... ++   ..||+|.++.... ......+..|+..++.++||||+++++++..++..+++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            4677889999999999999843 33   3699999875422 22334678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....   .+++.+++.++.|++.|+.|||++   +++|+||||+||+++.++.+|++|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999999876432   378999999999999999999998   99999999999999999999999999986543


Q ss_pred             ccc--------C---CcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          218 EEK--------R---GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       218 ~~~--------~---~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ...        .   .+..|++||....   ..++.++|||||||++||+++ |..||.+.........+...       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-------  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-------  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhcc---CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence            221        1   1236999998875   678899999999999999987 99999776554443333221       


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                        ...+.+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 --YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              11111223344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-42  Score=317.02  Aligned_cols=245  Identities=19%  Similarity=0.189  Sum_probs=192.8

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .|...+.||+|+||.||+|+ ..+++.||+|.+...... ......+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            57888999999999999999 567899999998754322 1223357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC--
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP--  217 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~--  217 (332)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++....  
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999987543    278888899999999999999998   99999999999999999999999999864210  


Q ss_pred             ---------------------------------------------------cccCCcccccCcccccccCCCCCCchhhh
Q 020027          218 ---------------------------------------------------EEKRGLAGYVDDDYWHEKGGGNATRESDV  246 (332)
Q Consensus       218 ---------------------------------------------------~~~~~~~~~~~pe~~~~~~~~~~~~~~Di  246 (332)
                                                                         ....||..|+|||.+..   ..++.++||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~Di  231 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR---TGYTQLCDW  231 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC---CCCCCeeeE
Confidence                                                               01247889999999876   678899999


Q ss_pred             HHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 020027          247 YGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS---IVQVAT  323 (332)
Q Consensus       247 wS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs---~~~i~~  323 (332)
                      ||+||++|||+||+.||.+....+....+....      ..+..+.......++.+++.+++ .||++|++   +.++++
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHHHccC------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999999998765544433332211      11112211122235667776665 49999997   777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-41  Score=312.57  Aligned_cols=245  Identities=20%  Similarity=0.220  Sum_probs=190.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||++. ..+++.||+|....        ..+.+|+.+++.++||||+++++++...+..++++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            4679999999999999999999 56889999996532        23588999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |++. ++|..++.....    +++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       163 e~~~-~~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        163 PRYK-TDLYCYLAAKRN----IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             ecCC-CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            9995 688888865432    78899999999999999999998   999999999999999999999999999864321


Q ss_pred             -------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-------HHHHHHHhhh--cc---
Q 020027          219 -------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL-------VKWALPLIKE--MR---  279 (332)
Q Consensus       219 -------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-------~~~~~~~~~~--~~---  279 (332)
                             ...||..|+|||.+..   ..++.++|||||||++|||+||+.|+.+..       .......+..  +.   
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLAR---DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             ccccccccccCccCCCChhhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence                   1258899999999876   678999999999999999999998764321       0011111100  00   


Q ss_pred             ---------cc-------cc--cCCcCCCC--CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ---------FS-------EL--LDPRLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ---------~~-------~~--~~~~~~~~--~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                               ..       ..  ..+.....  .......++.+++.+||+.||++|||++|+++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                     00       00  00000000  00122346889999999999999999999985

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4e-42  Score=310.08  Aligned_cols=233  Identities=24%  Similarity=0.245  Sum_probs=187.4

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHH-HhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIK-TLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||+||+|+. .+|+.||+|.+........ ....+..|.. .++.++||||+++++.+...+..+++|||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999994 5899999999875432221 2223444544 46788999999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....     
T Consensus        81 g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          81 GELFFHLQRERS----FPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            999998875432    78889999999999999999998   999999999999999999999999999864321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...|+..|++||.+..   ..++.++|||||||++|||++|+.||.+.........+.....        ..+.  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------~~~~--~~~  220 (323)
T cd05575         154 STFCGTPEYLAPEVLRK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--------RLKP--NIS  220 (323)
T ss_pred             ccccCChhhcChhhhcC---CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--------CCCC--CCC
Confidence             1247889999999876   6788999999999999999999999987665554444433211        1111  113


Q ss_pred             HHHHHHHHHcccCCCCCCCCHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIV  319 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~  319 (332)
                      ..+.+++.+||+.||++||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            3678999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-41  Score=294.82  Aligned_cols=242  Identities=20%  Similarity=0.327  Sum_probs=194.4

Q ss_pred             ceeeccCCeEEEEEEe-C---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccC
Q 020027           67 RIIGQGRLGTVYAALL-S---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      +.||+|+||.||+|.. .   ++..+|+|.+...... .....+.+|+++++.++|+|++++++++.. +..+++|||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            4699999999999973 2   2368999998765443 233357889999999999999999998764 45789999999


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc--
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK--  220 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~--  220 (332)
                      +++|.+++....    .+++..++.++.|++.|+.|||+.   +++|+||||+||+++.++.+|++|||+++......  
T Consensus        79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          79 LGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            999999997654    278999999999999999999998   99999999999999999999999999987543221  


Q ss_pred             -------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          221 -------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       221 -------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                             .++..|++||....   ..++.++||||||+++||+++ |..||...........+.....         .+.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---------~~~  219 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINY---GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---------LPR  219 (257)
T ss_pred             cccccCccccccccCHHHhcC---CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---------CCC
Confidence                   12356999998865   678899999999999999998 9999976654444443333211         111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +......+.+++.+||+.||++|||+.++++.|++.-
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            1223347889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-41  Score=300.23  Aligned_cols=253  Identities=20%  Similarity=0.238  Sum_probs=190.4

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC---CCCCccceeeeeec-----CC
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA---QHPNIVPILGFSQA-----PG  132 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  132 (332)
                      +|...+.||+|+||.||+|+ ..+++.||+|.++.............+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47788999999999999998 55889999999876543333233455677666654   79999999998754     24


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..++++|+++ ++|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            5789999997 588888865432  2378999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------cc
Q 020027          213 SFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RF  280 (332)
Q Consensus       213 a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~  280 (332)
                      +......     ..++..|+|||.+..   ..++.++||||+||++|||++|++||.+.........+...       .+
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         155 ARIYSCQMALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             cccccCcccCCCccccccccCchHhhC---CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence            8765322     246788999999875   67899999999999999999999999765443332222110       00


Q ss_pred             ccc-------cCCcCCC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 SEL-------LDPRLAI---PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ~~~-------~~~~~~~---~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...       ..+....   .........+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000       0000000   000122346779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.7e-42  Score=308.28  Aligned_cols=232  Identities=22%  Similarity=0.291  Sum_probs=185.7

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+++ ..+++.||+|.++........ ...+..|..++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            469999999999999 457899999999865432222 22467888888888 799999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC------
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP------  217 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~------  217 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...      
T Consensus        81 g~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          81 GDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            999988865432    88999999999999999999998   99999999999999999999999999986421      


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh---------HHHHHHHhhhcccccccCCcC
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL---------VKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ....|+..|+|||.+..   ..++.++|+|||||++|||+||+.||....         .+.....+..        ...
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~  222 (329)
T cd05588         154 STFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------KQI  222 (329)
T ss_pred             ccccCCccccCHHHHcC---CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--------CCC
Confidence            12357889999999876   678899999999999999999999996321         1111122221        112


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      ..+..  ...++.+++.+||+.||.+|||+
T Consensus       223 ~~p~~--~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         223 RIPRS--LSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCC--CCHHHHHHHHHHhccCHHHcCCC
Confidence            22222  22367899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-42  Score=287.05  Aligned_cols=252  Identities=21%  Similarity=0.267  Sum_probs=210.9

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccccc------ccHHHHHHHhccC-CCCCccceeeeeec
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAG------FGFASVIKTLSLA-QHPNIVPILGFSQA  130 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~  130 (332)
                      .-+.|...+.||.|..+.|-++. ..+|+.+|+|++..........      ..-.+|+.+++++ .||||+.+.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            34578889999999999998887 6789999999997544322211      1346788899988 69999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      +...++|+|.|+.|.|.+++.+.-.    +++....+|+.|+.+|+.|||.+   +||||||||+|||++++.++||+||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~Vt----lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVT----LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhee----ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999976533    88999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCccc-----CCcccccCccccccc---CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          211 GLSFLAPEEK-----RGLAGYVDDDYWHEK---GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       211 g~a~~~~~~~-----~~~~~~~~pe~~~~~---~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      |+|.......     +||++|.|||.+.-.   ....|+..+|+||.|+|+|.|+.|.+||..-..--.+.++.++.+  
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky--  245 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY--  245 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc--
Confidence            9998877653     799999999977432   235689999999999999999999999987666566666666653  


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          .+..+...+-.....+++.+|++.||.+|.|++|.++
T Consensus       246 ----qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 ----QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                2334444455557789999999999999999999875

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-41  Score=300.59  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=195.7

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--CCc
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--PGE  133 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  133 (332)
                      .+|...+.||+|+||.||++..     .++..||+|.+.....  .....+.+|+.+++.++|||++++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            4678889999999999999974     3678999999865422  222357899999999999999999998744  346


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .++++||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            7899999999999999965432   278999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-----
Q 020027          214 FLAPEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-----  279 (332)
Q Consensus       214 ~~~~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-----  279 (332)
                      .......         .++..|++||....   ..++.++||||||+++|||++|..++........ ..+....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~~  231 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQGQMI  231 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhcc---CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccccccc
Confidence            7654321         12335899998865   6788999999999999999998776543321111 1111100     


Q ss_pred             ---cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          280 ---FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       280 ---~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                         +.+.+......+.+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence               0011111112222223345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-41  Score=299.52  Aligned_cols=251  Identities=23%  Similarity=0.294  Sum_probs=199.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ..+|...+.||+|+||.||++..      .++..+|+|.+....  ......+.+|+..++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            34677889999999999999963      245689999876432  2223357899999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCC-----------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          134 RIIVSEFINMASLDFYLHENNDG-----------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      .++++||+++++|.+++......           ...+++..++.++.|++.|++|||+.   +++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence            99999999999999998754311           12378899999999999999999998   99999999999999999


Q ss_pred             CceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHH
Q 020027          203 FCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP  273 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~  273 (332)
                      +.+||+|||++......        ..++..|++||....   ..++.++|||||||++|||++ |..||..........
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY---RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc---CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            99999999998643221        123567999998865   678999999999999999998 889987654444333


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      .+..+..       .  ..+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       236 ~~~~~~~-------~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQGRE-------L--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHcCcc-------C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            3322210       1  1111223467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=294.24  Aligned_cols=246  Identities=21%  Similarity=0.231  Sum_probs=197.9

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc---ccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN---AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ++|...+.||+|++|.||++. ..+++.+|+|.+........   ....+.+|+.++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            578899999999999999998 46789999999875432221   12357889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ++||+++++|.+++.....    +++.....++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999999875432    78888999999999999999998   9999999999999999999999999998643


Q ss_pred             Cc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCc
Q 020027          217 PE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       217 ~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      ..         ...++..|++||....   ..++.++||||||+++||+++|+.||.................      .
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~  225 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISG---EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT------N  225 (263)
T ss_pred             cccccccccccCCCcCccccCcceecc---CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC------C
Confidence            22         1235678999999876   5688999999999999999999999976533322222111110      1


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                        ...+......+.+++.+||+.+|++|||+.++++.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              11112233467899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.7e-41  Score=294.65  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=190.2

Q ss_pred             eeeccCCeEEEEEEeCCC---CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           68 IIGQGRLGTVYAALLSTG---KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .||+|+||.||+|...++   ..+++|.+..... ......+.+|+..++.++|||++++++.+......+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            589999999999984333   3466666654322 122335789999999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-------
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-------  217 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-------  217 (332)
                      +|.+++.+........++.....++.|++.||.|||+.   +++||||||+|||++.++.+|++|||++....       
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999976533333467777889999999999999998   99999999999999999999999999975421       


Q ss_pred             -cccCCcccccCcccccccC----CCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 -EEKRGLAGYVDDDYWHEKG----GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 -~~~~~~~~~~~pe~~~~~~----~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                       ....++..|++||.+....    ...++.++|||||||++|||++ |..||......+....+.........++....+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence             1224667899999875321    2346789999999999999997 566887655544444333322223333333322


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .    ...+.+++..|| .+|++|||++++++.|.
T Consensus       238 ~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         238 Y----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2    236678999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=317.58  Aligned_cols=243  Identities=21%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             CCCceeeccCCeEEEEEEeC--CCC--EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           64 SHRRIIGQGRLGTVYAALLS--TGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ...++||+|.||.|++|.|.  +|+  .||||.++.+.... ...+|++|+..|.+|+|+|++++||...+ ....+|+|
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            34478999999999999964  343  79999998765433 45579999999999999999999999987 66789999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      +++.|+|.+.++...  ...+.......++.|||.||.||-++   ++|||||..+|+|+....++||+|||+.+.++..
T Consensus       191 LaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999998732  23377788889999999999999999   9999999999999999999999999999876644


Q ss_pred             c---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          220 K---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       220 ~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .         .-...|.|||.+..   ..++.+||||+|||.+|||+| |..||.|.....+++.+.++         -.
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh---~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~---------er  333 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRH---RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG---------ER  333 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhcc---ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------cc
Confidence            3         23457999999987   789999999999999999999 88999998777776666543         34


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      .+.+..|...++++|..||+++|.+||||..|.+.+
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            455566777999999999999999999999997443

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.8e-41  Score=302.67  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=195.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.||+|+||.||+|+ ..+++.||+|.++.... ......+.+|+.+++.++||||+++++++..++..+++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            568889999999999999999 45788999999875432 2222346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++ +|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..... 
T Consensus        85 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          85 YLDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            9975 78887765432   268888999999999999999998   999999999999999999999999999865322 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------cccccc--
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RFSELL--  284 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~--  284 (332)
                           ...++..|++||.+...  ..++.++|||||||++|||+||+.||.+....+....+...       .+....  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             ccccccccccccccCCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence                 12467889999987642  46789999999999999999999999865443332222110       000000  


Q ss_pred             ----C---CcCCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 ----D---PRLAI----PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ----~---~~~~~----~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +   +....    ........++.+++.+|++.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                0   00000    000112336779999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-41  Score=295.23  Aligned_cols=238  Identities=21%  Similarity=0.353  Sum_probs=186.1

Q ss_pred             ceeeccCCeEEEEEEeCC-------------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           67 RIIGQGRLGTVYAALLST-------------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      +.||+|+||.||+|+..+             ...|++|.+.....  .....+.+|+..++.++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999998432             22588888765432  223356888899999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc-------eE
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC-------AR  206 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------~k  206 (332)
                      .+++|||+++++|..++.....   .+++..++.++.|+++||+|||++   +++||||||+|||++.++.       ++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999998865322   378899999999999999999998   9999999999999986654       89


Q ss_pred             EccCCccccCCc--ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH-hCCCCCCchhHHHHHHHhhhcccccc
Q 020027          207 VCDYGLSFLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL-SGRRCEEGLLVKWALPLIKEMRFSEL  283 (332)
Q Consensus       207 l~dfg~a~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      ++|||++.....  ...++..|+|||.+...  ..++.++|||||||++|||+ +|..|+.+....+..... ...    
T Consensus       153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~----  225 (262)
T cd05077         153 LSDPGIPITVLSRQECVERIPWIAPECVEDS--KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQ----  225 (262)
T ss_pred             eCCCCCCccccCcccccccccccChhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcC----
Confidence            999999865432  23567889999987632  56789999999999999998 488888765433322211 111    


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                          .....+  ...++.+++.+||+.||++||++.+|++.+
T Consensus       226 ----~~~~~~--~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 ----CMLVTP--SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ----ccCCCC--ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                111111  123678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.9e-41  Score=293.39  Aligned_cols=246  Identities=20%  Similarity=0.242  Sum_probs=203.6

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||.||.++ ..+++.+++|.+............+.+|+.++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47888999999999999998 56789999999876554444445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+|++|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999976432  2378899999999999999999998   9999999999999999999999999998654322 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|.+||....   ...+.++|+||||+++|||++|..||.+....+....+..+....         ...
T Consensus       156 ~~~~~~~~~~~y~ape~~~~---~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------~~~  223 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQG---VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---------VVS  223 (256)
T ss_pred             ccccccCCCccccCHhhcCC---CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------Ccc
Confidence                 347889999998875   567889999999999999999999998765554444333322111         111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ....++.+++.+||+.||++|||+.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            223467899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.5e-41  Score=294.00  Aligned_cols=245  Identities=22%  Similarity=0.315  Sum_probs=189.7

Q ss_pred             ceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee-cCCceeEEEecc
Q 020027           67 RIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ-APGERIIVSEFI  141 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  141 (332)
                      +.||+|+||.||+|...    ++..+|+|.+..... ......+.+|+.+++.++|||++++++++. .++..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999842    345799998753221 122335678999999999999999999875 456688999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc---
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE---  218 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~---  218 (332)
                      ++++|.+++......   .++...+.++.|++.|+.|||+.   +++||||||+||++++++.+|++|||+++....   
T Consensus        80 ~~~~L~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          80 KHGDLRNFIRSETHN---PTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999999754322   56777889999999999999998   999999999999999999999999999864322   


Q ss_pred             -------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhC-CCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 -------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG-RRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 -------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                             ...++..|++||.+..   ..++.++|||||||++|||++| ..||...........+..+.       ....
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  223 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-------RLLQ  223 (262)
T ss_pred             eeecccccCcCCccccChhHhcc---CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-------CCCC
Confidence                   1134567999998876   6788999999999999999995 55666544333333222211       1111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                        +...+..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       224 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         224 --PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             --CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence              11123468899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-41  Score=303.72  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=204.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe--------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFS  128 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  128 (332)
                      ...++|...+.||+|+||.||++..        .....+|+|.++.... ......+..|+.+++.+ +||||+++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3456788899999999999999973        1345799998874422 22233577899999998 699999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCC
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASN  196 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  196 (332)
                      ...+..+++|||+++++|.+++.....            ....+++.+++.++.|++.||.|||++   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            998999999999999999999975321            112478899999999999999999998   99999999999


Q ss_pred             EEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchh
Q 020027          197 ILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLL  267 (332)
Q Consensus       197 ill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~  267 (332)
                      |+++.++.+|++|||+++.....        ..++..|++||.+..   ..++.++||||||+++||+++ |..||.+..
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD---RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc---CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999754321        123356999998865   678899999999999999999 888998766


Q ss_pred             HHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .......+.....         ...+..+..++.+++.+||+.||++|||+.++++.|+++.
T Consensus       242 ~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         242 VEELFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            6555554433211         1111223346779999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=314.81  Aligned_cols=241  Identities=21%  Similarity=0.270  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccccc-ccHHHHHHHhccC-CCCCccceeeeeecCCc
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSLA-QHPNIVPILGFSQAPGE  133 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  133 (332)
                      ....++|...++||+|+||+|+.+. ..+++.+|||.++++....++. ...+.|..++... +||-++.++..+.+.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            4456789999999999999999999 5688999999999887655443 3567888877766 59999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      +++||||+.||++..+.+..     .+++.++..++..|+.||.|||++   +|++||||.+|||+|.+|.+||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence            99999999999944333321     289999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCc
Q 020027          214 FLAP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       214 ~~~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      +..-      ...+||+.|+|||.+..   ..|+.++|.|||||+||||+.|..||.|...++..+.+....        
T Consensus       516 Ke~m~~g~~TsTfCGTpey~aPEil~e---~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--------  584 (694)
T KOG0694|consen  516 KEGMGQGDRTSTFCGTPEFLAPEVLTE---QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--------  584 (694)
T ss_pred             cccCCCCCccccccCChhhcChhhhcc---CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------
Confidence            7532      23479999999999988   789999999999999999999999999999999988887642        


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                        ..++...+.+...+|++.+..||++|--+
T Consensus       585 --~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 --VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              22333445578899999999999999754

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.3e-42  Score=313.02  Aligned_cols=257  Identities=18%  Similarity=0.231  Sum_probs=201.5

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      ..+....++|...+.||+|+||.||+++ ..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            4455567899999999999999999999 4578899999986432211 2222467889999999999999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      +..+++|||+++++|.+++....     ++...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999986532     67888889999999999999999   99999999999999999999999999


Q ss_pred             ccccCCc-------ccCCcccccCcccccccC-CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccc
Q 020027          212 LSFLAPE-------EKRGLAGYVDDDYWHEKG-GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSEL  283 (332)
Q Consensus       212 ~a~~~~~-------~~~~~~~~~~pe~~~~~~-~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      ++.....       ...||..|+|||.+.... ...++.++|||||||++|||++|+.||.+.........+....    
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----  263 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK----  263 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----
Confidence            9865432       235889999999987532 2347899999999999999999999998765544444433211    


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKN--RPSIVQVATI  324 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~--RPs~~~i~~~  324 (332)
                        ..+..+........+.+++.+|++.++.+  ||++.++++.
T Consensus       264 --~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 --NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             --CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence              11112222223346778999999843332  7788888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-41  Score=307.42  Aligned_cols=232  Identities=22%  Similarity=0.299  Sum_probs=184.4

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+++ ..+++.||+|.+++....... ...+..|+.++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999999 457889999999865432222 22356788877766 899999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC------
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP------  217 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~------  217 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...      
T Consensus        81 ~~L~~~~~~~~~----l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          81 GDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            999988865432    78999999999999999999998   99999999999999999999999999986532      


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh---------HHHHHHHhhhcccccccCCcC
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL---------VKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ....|+..|+|||.+..   ..++.++|||||||++|||+||+.||....         .......+..        ...
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------~~~  222 (329)
T cd05618         154 STFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------KQI  222 (329)
T ss_pred             ccccCCccccCHHHHcC---CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--------CCC
Confidence            12357899999999876   678899999999999999999999995211         1111111111        112


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      ..+..  ...++.+++.+||+.||++|||+
T Consensus       223 ~~p~~--~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRS--LSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCC--CCHHHHHHHHHHhcCCHHHcCCC
Confidence            22222  22367799999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-41  Score=301.45  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=199.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCC----EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|.. .+|+    .+|+|.+..... ......+.+|+.+++.++||||+++++++..+ ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            45678889999999999999984 4554    478888764432 12223578899999999999999999998764 46


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++|+|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||++++++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            789999999999999876432   278889999999999999999998   99999999999999999999999999987


Q ss_pred             cCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....        ..++..|++||....   ..++.++||||||+++||+++ |+.||.+.........+....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------  228 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHY---RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE------  228 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhcc---CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC------
Confidence            54321        123567999998765   678899999999999999998 889997754444433332211      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                       .+  +.+..+...+.+++.+||..||++|||++++++.|+.+..+
T Consensus       229 -~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         229 -RL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -CC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             11  11112234678999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.4e-41  Score=294.79  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=189.5

Q ss_pred             ceeeccCCeEEEEEEeC---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALLS---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|...   ....+++|.+.... .......+.+|+..++.++|+||+++++.+...+..+++|||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            35899999999999743   33468888775432 122223568899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccCCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc----
Q 020027          144 ASLDFYLHENNDG-ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~----  218 (332)
                      ++|.+++...... ....++...+.++.|++.|++|||++   +++||||||+||++++++++|++|||++.....    
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            9999999765321 12246778889999999999999998   999999999999999999999999999864321    


Q ss_pred             ----ccCCcccccCccccccc----CCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          219 ----EKRGLAGYVDDDYWHEK----GGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~----~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                          ...++..|++||.+...    ....++.++|||||||++|||++ |..||......+...............+...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence                11345679999987542    12467889999999999999999 7788876654444333322221122222211


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                          ......+.+++..|| .||++|||+++|++.|.
T Consensus       237 ----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         237 ----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                122235667888999 49999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.9e-41  Score=299.96  Aligned_cols=244  Identities=22%  Similarity=0.270  Sum_probs=197.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..+|+..+.||+|+||.||+|. ..+++.||+|.+......  ....+.+|+.+++.++|+|++++++.+..++..+++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            3578888999999999999998 568899999998754432  2234688999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++....     +++.+...++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        97 e~~~~~~L~~~~~~~~-----~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          97 EYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cccCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999986432     68889999999999999999998   999999999999999999999999998865432


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                            ...++..|++||.+..   ..++.++|||||||++|||++|+.||...............       .....+.
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~  238 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-------GTPELQN  238 (296)
T ss_pred             cccccCcccCCccccCHHHHcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-------CCCCCCC
Confidence                  1256788999998875   56789999999999999999999999765443322211111       1111111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +......+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            1222346779999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.8e-41  Score=292.98  Aligned_cols=242  Identities=23%  Similarity=0.290  Sum_probs=195.7

Q ss_pred             ceeeccCCeEEEEEEeC--CC--CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccC
Q 020027           67 RIIGQGRLGTVYAALLS--TG--KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      +.||+|++|.||+|...  ++  ..||+|.+...... .....+.+|+..+++++||||+++++.+.. +..++++||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            36899999999999853  23  36999998766543 333467899999999999999999999988 88999999999


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc----
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE----  218 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~----  218 (332)
                      +++|.+++.+...  ..+++.....++.|++.||.|||++   +++|+||+|+||+++.++.+|++|||++.....    
T Consensus        79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            9999999976542  2478999999999999999999998   999999999999999999999999999875533    


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                           ...++..|++||+...   ..++.++|||||||++|||+| |..||......+....+....      ....  .
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~~~--~  222 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRT---RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------ERLE--R  222 (257)
T ss_pred             eecccCCCCCceecCHHHhcc---cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------CcCC--C
Confidence                 1235678999998876   578899999999999999999 999997655444433332211      1111  1


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1122347889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.9e-42  Score=309.66  Aligned_cols=243  Identities=19%  Similarity=0.206  Sum_probs=191.0

Q ss_pred             CCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccc--cccccHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           62 GFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      +|+..+.||+|+||.||+++.    .+++.||+|.+.......  .....+..|+.+++.+ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999874    468899999987543221  1122467889999999 599999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            999999999999999875432    78899999999999999999998   99999999999999999999999999986


Q ss_pred             cCCc-------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH----HHHHHHhhhcccccc
Q 020027          215 LAPE-------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV----KWALPLIKEMRFSEL  283 (332)
Q Consensus       215 ~~~~-------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~  283 (332)
                      ....       ...||..|+|||.+...  ..++.++|||||||++|||+||+.||.....    ......+..      
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------  225 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------  225 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCC--CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------
Confidence            5321       12578999999998652  3478899999999999999999999964321    111111111      


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .++.+  +  ......+.+++.+||+.||++||     +++++++
T Consensus       226 ~~~~~--~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 CDPPF--P--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCC--C--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111  1  11223677999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.3e-42  Score=307.93  Aligned_cols=239  Identities=23%  Similarity=0.210  Sum_probs=189.0

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHH-HhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIK-TLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|+. .+++.||+|.+........ ....+..|.. .++.++|+||+++++++...+..+++|||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999994 5778999999875432211 1223344443 46788999999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|.+++.....    ++...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....     
T Consensus        81 ~~L~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          81 GELFYHLQRERC----FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            999999875432    67788888999999999999998   999999999999999999999999999864321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...|+..|+|||.+..   ..++.++|||||||++|||++|..||.+.........+.....        ..+  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--------~~~--~~~~  220 (325)
T cd05602         154 STFCGTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------QLK--PNIT  220 (325)
T ss_pred             ccccCCccccCHHHHcC---CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--------CCC--CCCC
Confidence             2258899999999876   6788999999999999999999999987665554444433211        111  1122


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      ..+.+++.+||+.||.+||++.+.+..+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            3677899999999999999987654443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.8e-41  Score=293.35  Aligned_cols=245  Identities=20%  Similarity=0.255  Sum_probs=199.1

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||.||++. ..+++.+|+|.++.... ......+.+|+.+++.++|+|++++++.+..++..++++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            47778999999999999998 45789999999864432 22233567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.....  ..++....+.++.|++.||.|||++   +++|+||||+||++++++.++++|||.+...... 
T Consensus        80 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          80 CDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999998865332  2368889999999999999999998   9999999999999999999999999998654321 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||.+..   ..++.++|+||||+++|+|++|..||...........+..+....       .  +.
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~--~~  222 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWEN---MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-------L--PS  222 (255)
T ss_pred             cccccccCCccccCHHHHcc---CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-------C--Cc
Confidence                 246778999999876   568899999999999999999999998765444433332222111       1  11


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .....+.+++.+||+.||++|||+.++++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            223367799999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.3e-41  Score=304.63  Aligned_cols=253  Identities=20%  Similarity=0.213  Sum_probs=191.6

Q ss_pred             CCceeecc--CCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           65 HRRIIGQG--RLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        65 ~~~~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      ..++||+|  +|++||++. ..+|+.||+|.++...........+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35679999  788999998 568999999999765433333334678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC----
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP----  217 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~----  217 (332)
                      ++++|.+++..+...  .+++..++.++.|++.||.|||++   +++||||||+||+++.++.++++||+......    
T Consensus        82 ~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999999754322  278999999999999999999998   99999999999999999999999998643221    


Q ss_pred             ---------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCc-
Q 020027          218 ---------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR-  287 (332)
Q Consensus       218 ---------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  287 (332)
                               ....++..|++||.+... ...++.++|||||||++|||++|+.||..............+......+.. 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccccceecccChHHhhcc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence                     112345679999998642 135789999999999999999999999764332222111111111110000 


Q ss_pred             -----------------------------------CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          288 -----------------------------------LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       288 -----------------------------------~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                                         ...+........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                               000011112346789999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-41  Score=308.04  Aligned_cols=252  Identities=19%  Similarity=0.219  Sum_probs=192.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-----
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-----  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  132 (332)
                      ..++|...+.||+|+||.||++. ..+|+.||+|.+............+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            35789999999999999999998 467899999999755433333445778999999999999999999886443     


Q ss_pred             -ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          133 -ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       133 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                       ..+++|||+++ ++...+..      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             46899999975 56555532      167888899999999999999999   99999999999999999999999999


Q ss_pred             ccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--------
Q 020027          212 LSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--------  278 (332)
Q Consensus       212 ~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--------  278 (332)
                      +++.....     ..++..|+|||.+..   ..++.++|||||||++|||+||+.||.+......+..+...        
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            98754322     356888999999876   67889999999999999999999999865432221111000        


Q ss_pred             ------cccccc--CCcCC------------CC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 ------RFSELL--DPRLA------------IP----CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ------~~~~~~--~~~~~------------~~----~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            ......  .+...            .+    ........+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                  000000  00000            00    00011246789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.7e-41  Score=296.14  Aligned_cols=249  Identities=23%  Similarity=0.281  Sum_probs=195.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecC-----
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAP-----  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----  131 (332)
                      ..+.|+..+.||+|+||.||+|. ..+++.||+|.+....   .....+.+|+.+++++ +|+|++++.+++...     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            45678888999999999999998 4578899999986442   2223568899999888 799999999998643     


Q ss_pred             -CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          132 -GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                       +..+++|||+++++|.+++.....  ..+++..+..++.|++.|++|||++   +++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence             457899999999999999876432  2378999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCcc------cCCcccccCcccccccC--CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          211 GLSFLAPEE------KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       211 g~a~~~~~~------~~~~~~~~~pe~~~~~~--~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      |++......      ..++..|++||.+....  +..++.++|+|||||++|||++|+.||.................  
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~--  233 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--  233 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC--
Confidence            998754321      24678899999886321  34678899999999999999999999976543332222211110  


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         +.   .........+.+++.+||+.||++|||+.++++
T Consensus       234 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         234 ---PR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---CC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence               01   111122346789999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.6e-42  Score=313.13  Aligned_cols=246  Identities=19%  Similarity=0.249  Sum_probs=195.0

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||++. ..+++.||+|.++...... .....+.+|+.++..++|+||+++++.+...+..+++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            468889999999999999998 4578999999997543222 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999875432    78899999999999999999998   999999999999999999999999998753311


Q ss_pred             -----------------------------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH
Q 020027          219 -----------------------------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL  257 (332)
Q Consensus       219 -----------------------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~  257 (332)
                                                               ...||..|+|||.+..   ..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ---TGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC---CCCCCcceeccccceeeecc
Confidence                                                     1257899999999876   67889999999999999999


Q ss_pred             hCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 020027          258 SGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS---IVQVAT  323 (332)
Q Consensus       258 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs---~~~i~~  323 (332)
                      ||+.||.+.........+....      ..+..+.......++.+++.+++. ||.+|++   +.++++
T Consensus       231 tG~~Pf~~~~~~~~~~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         231 IGYPPFCSETPQETYRKVMNWK------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCC------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            9999998776655544443211      111111111122356677777664 9999986   455543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4e-41  Score=308.44  Aligned_cols=252  Identities=19%  Similarity=0.213  Sum_probs=194.1

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  131 (332)
                      ..++|...+.||+|+||.||++. ..+++.||+|.+............+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            35789999999999999999998 45788999999976543333334578899999999999999999987543      


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      ...+++|||+++ ++.+++...      +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhc------CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999965 676666431      67888999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc------c
Q 020027          212 LSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR------F  280 (332)
Q Consensus       212 ~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~------~  280 (332)
                      +++.....     ..++..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+....      +
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99765432     357889999999876   678899999999999999999999998654433322221100      0


Q ss_pred             --------ccccC--C------------cCCCCC----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 --------SELLD--P------------RLAIPC----EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 --------~~~~~--~------------~~~~~~----~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                              .....  +            ....+.    +......+.+++.+|++.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                    00000  0            000000    0111236789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-41  Score=296.21  Aligned_cols=238  Identities=24%  Similarity=0.338  Sum_probs=185.3

Q ss_pred             eeeccCCeEEEEEEeCC-------------------------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCcc
Q 020027           68 IIGQGRLGTVYAALLST-------------------------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV  122 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  122 (332)
                      .||+|+||.||+|....                         ...|++|.+.....  .....+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence            58999999999997421                         13588998864432  2223567888899999999999


Q ss_pred             ceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      ++++++..++..+++|||+++++|..++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++..
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999999999999999999999999999865322   278889999999999999999998   99999999999999754


Q ss_pred             C-------ceEEccCCccccCC--cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH-hCCCCCCchhHHHHH
Q 020027          203 F-------CARVCDYGLSFLAP--EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL-SGRRCEEGLLVKWAL  272 (332)
Q Consensus       203 ~-------~~kl~dfg~a~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~-tg~~p~~~~~~~~~~  272 (332)
                      +       .+|++|||++....  ....++..|++||.+...  ..++.++|||||||++||++ +|..||.+.......
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGG--NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CcccCccceeeecCCccccccccccccccCCcccCchhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            3       47999999875432  223467789999987642  56789999999999999995 688898765443332


Q ss_pred             HHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          273 PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .....         ....+.+.  ...+.+++.+||+.+|++|||+.++++.|+
T Consensus       232 ~~~~~---------~~~~~~~~--~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RFYEK---------KHRLPEPS--CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHh---------ccCCCCCC--ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            22111         01111111  126789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3e-41  Score=304.29  Aligned_cols=237  Identities=19%  Similarity=0.250  Sum_probs=191.8

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEE
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  138 (332)
                      +|+..+.||+|+||.||+|. ..+|+.||+|.+....... .....+..|..++..+. |++|+++++++...+..+++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            36778899999999999998 5578999999987543222 22234567888888775 577888999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999999876432    78999999999999999999998   999999999999999999999999999865321


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                            ...|+..|+|||....   ..++.++|||||||++|||+||+.||.+.........+.....        ..+.
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------~~p~  222 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------SYPK  222 (323)
T ss_pred             CCccccCccCCccccCHHHHcC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCc
Confidence                  2247899999999875   6788999999999999999999999988765555444433221        1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                        ....++.+++.+||+.||.+|++.
T Consensus       223 --~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         223 --SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --cCCHHHHHHHHHHcccCHhhCCCC
Confidence              122367789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7e-41  Score=292.66  Aligned_cols=248  Identities=22%  Similarity=0.382  Sum_probs=200.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|...+.||+|+||.||++...++..+|+|.+.....   ....+.+|+.+++.++|+|++++++.+.. ...+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            4567888999999999999999977778899998875421   22357889999999999999999999877 7789999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....  ..+++.+++.++.|++.|+.|||+.   +++|+||+|+||+++.++.+|++|||.+.....
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          80 EFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999999976432  2378889999999999999999998   999999999999999999999999998865432


Q ss_pred             cc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 EK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..       .++..|++||....   ..++.++|+|||||++||++| |+.||.+.........+....         ..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------~~  222 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------RM  222 (260)
T ss_pred             CCcccccCCcccccccCHhHhcc---CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------CC
Confidence            11       23456999998865   678889999999999999999 899998755444433332211         11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      +.....+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112223468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.9e-42  Score=308.06  Aligned_cols=238  Identities=23%  Similarity=0.212  Sum_probs=189.2

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHH-HhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIK-TLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+++ ..+|+.+|+|.+....... .....+..|.. +++.++||||+++++.+..++..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999 5689999999987543222 12223455544 46778999999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|..++.....    +++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++....     
T Consensus        81 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          81 GELFFHLQRERS----FPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            999988865432    78999999999999999999998   999999999999999999999999999864321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...|+..|+|||.+..   ..++.++|||||||++|||++|..||.+.........+.....        ...  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--------~~~--~~~~  220 (325)
T cd05604         154 TTFCGTPEYLAPEVIRK---QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--------VLR--PGAS  220 (325)
T ss_pred             ccccCChhhCCHHHHcC---CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--------cCC--CCCC
Confidence             1257889999999876   6788999999999999999999999987655554443333211        111  1122


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ..+.+++.+|++.||.+||++.+.++.
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            367789999999999999988644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=288.60  Aligned_cols=248  Identities=18%  Similarity=0.203  Sum_probs=209.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|.|+.|+++. ..+|+.+|+|.+...........++.+|+.+.+.++||||+++.+.....+..++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            5678888999999999999998 678999999999876665555557889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a~~  215 (332)
                      |++.|++|..-+-..    ..+++..+-..+.||+++|.|+|.+   +|||||+||+|+++..   .--+|++|||+|..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999996555432    2367777888999999999999999   9999999999999964   34589999999977


Q ss_pred             CCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....     ..||++|++||....   .+++..+||||.||+||-|+.|..||.+......+..+..+.+      ....
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvrk---dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y------d~~~  233 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY------DYPS  233 (355)
T ss_pred             eCCccccccccCCCcccCHHHhhc---CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc------CCCC
Confidence            6543     369999999999987   7899999999999999999999999999877777777776543      2233


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +.......+..+++++++..||.+|.|+.|.++
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            333344457889999999999999999998764

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-41  Score=290.22  Aligned_cols=242  Identities=27%  Similarity=0.377  Sum_probs=196.4

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      +.||+|+||.||++....++.||+|.+...... .....+.+|+.+++.++|+||+++++++...+..++++||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            368999999999999766999999988754432 2334578999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-------
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-------  219 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-------  219 (332)
                      .+++.....   .+++..++.++.|++.|+.|||++   +++||||+|+||+++.++.+|++|||.+......       
T Consensus        80 ~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          80 LTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            999865322   378889999999999999999998   9999999999999999999999999998754321       


Q ss_pred             -cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          220 -KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       220 -~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...+..|++||....   ..++.++|+||||+++|||+| |..||.+.........+...         ...+.+...+
T Consensus       154 ~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~  221 (251)
T cd05041         154 LKQIPIKWTAPEALNY---GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG---------YRMPAPQLCP  221 (251)
T ss_pred             cCcceeccCChHhhcc---CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC---------CCCCCCccCC
Confidence             122456999998765   678899999999999999999 88888765544333333221         1111122334


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      .++.+++.+||+.+|++|||+.|+++.|..
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-41  Score=306.59  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=198.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAP  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  131 (332)
                      ..++|...+.||+|+||.||+|..      .+++.||+|.++.... ......+.+|+.++..+ +|+||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            346789999999999999999972      3578999999975432 22223567899999999 689999999988654


Q ss_pred             -CceeEEEeccCCCCHHHHhcccCCC------------------------------------------------------
Q 020027          132 -GERIIVSEFINMASLDFYLHENNDG------------------------------------------------------  156 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------  156 (332)
                       +..+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             5678999999999999998653210                                                      


Q ss_pred             ---------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc--------
Q 020027          157 ---------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--------  219 (332)
Q Consensus       157 ---------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--------  219 (332)
                               ...+++..+..++.|++.||+|||++   +++||||||+||+++.++++|++|||++......        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     01367888899999999999999998   9999999999999999999999999998754221        


Q ss_pred             cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHH-HHHHhhhcccccccCCcCCCCCChHHH
Q 020027          220 KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKW-ALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       220 ~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                      ..++..|++||....   ..++.++||||||+++||+++ |..||.+..... ....+..+.       ....+.  ...
T Consensus       241 ~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~--~~~  308 (343)
T cd05103         241 ARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-------RMRAPD--YTT  308 (343)
T ss_pred             CCCCcceECcHHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-------CCCCCC--CCC
Confidence            123567999998765   678899999999999999997 888987643221 222222211       111111  112


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            367899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=290.45  Aligned_cols=244  Identities=26%  Similarity=0.386  Sum_probs=200.7

Q ss_pred             ceeeccCCeEEEEEEeC-C---CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccC
Q 020027           67 RIIGQGRLGTVYAALLS-T---GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      +.||+|+||.||+|... .   +..|++|.+....... ....+.+|+..++.++|+|++++++++...+..+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            46899999999999954 3   7899999997654333 23467899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccCCC-----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          143 MASLDFYLHENNDG-----ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       143 ~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      +++|.+++......     ...+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.+|++|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999865211     23489999999999999999999998   99999999999999999999999999987654


Q ss_pred             cc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          218 EE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       218 ~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ..        ..++..|++||....   ..++.++||||+|+++|||++ |..||.+.........+....       . 
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------~-  225 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD---GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------R-  225 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc---CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------C-
Confidence            32        246778999998876   578899999999999999999 699998776555544444321       1 


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                       ...+.....++.+++.+||+.||++|||+.++++.|+
T Consensus       226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 -LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             1111222347889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-41  Score=299.31  Aligned_cols=259  Identities=23%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC-----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--CCc
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS-----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--PGE  133 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  133 (332)
                      ..|...+.||+|+||.||++...     +++.+|+|.+...... .....+.+|+..++.++|+||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            45777889999999999999842     4789999998765432 233467899999999999999999999877  557


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            8999999999999999976432   378999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHH------hhhc
Q 020027          214 FLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPL------IKEM  278 (332)
Q Consensus       214 ~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~------~~~~  278 (332)
                      ......         ..++..|++||.+..   ..++.++|+||||+++|||+||..|+...........      ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRT---SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHcc---CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            765521         123456899998866   5788999999999999999999998765322211000      0000


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .+.+.+......+.+..+..++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            001111111222222334457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.2e-41  Score=295.89  Aligned_cols=255  Identities=18%  Similarity=0.172  Sum_probs=194.0

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|...+.||+|++|.||+|.. .+++.||+|.++...........+.+|+.+++.++|||++++++++..++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            477788999999999999994 5789999999876543333334578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      ++ ++|.+++..... ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.....  
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 688888865332 22478999999999999999999998   999999999999999999999999999864321  


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHh-hh------ccc-------
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI-KE------MRF-------  280 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~-~~------~~~-------  280 (332)
                          ...++..|+|||.+...  ..++.++|||||||++|||+||+.||.+.......... ..      ..+       
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             ccccCCcccccccChHHhcCC--CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence                12457789999987642  45688999999999999999999999764332211111 00      000       


Q ss_pred             --ccccCC---cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 --SELLDP---RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 --~~~~~~---~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        ......   ............++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              000000   0000000112336779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.1e-41  Score=297.24  Aligned_cols=248  Identities=23%  Similarity=0.311  Sum_probs=191.9

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||+|. ..+++.||+|.+..... ......+.+|+.++++++|||++++++.+..++..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            357788999999999999998 56889999999865422 2222357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++++|..+..        +++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..... 
T Consensus        80 ~~~~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          80 FMDGGSLDVYRK--------IPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             cCCCCChHHhhc--------CCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999976531        67888889999999999999998   999999999999999999999999999865432 


Q ss_pred             ---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 ---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                         ...++..|++||....   ..++.++|+||||+++|||++|+.||........... .........++.........
T Consensus       149 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  224 (279)
T cd06619         149 IAKTYVGTNAYMAPERISG---EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQLLQCIVDEDPPVLPVGQ  224 (279)
T ss_pred             cccCCCCChhhcCceeecC---CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHHHHHHhccCCCCCCCCc
Confidence               2357889999999876   5688999999999999999999999865321110000 00000000000000000111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ...++.+++.+||+.||++||+++|+++.
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            22367899999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=312.58  Aligned_cols=248  Identities=24%  Similarity=0.299  Sum_probs=208.2

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccc-cHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      -|.+++.||.|+||.||-++ ..+.+.||||++.-......+.+ ++..|+..+..++|||+|.+.|++..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            47788999999999999999 67889999999986655554443 68999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC--
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP--  217 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~--  217 (332)
                      ||- |+..+++..+...   +.+..+..|..|.+.||+|||++   +.+|||||..|||++++|.||++|||.|....  
T Consensus       107 YCl-GSAsDlleVhkKp---lqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHh-ccHHHHHHHHhcc---chHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            994 6888888766543   77788889999999999999999   99999999999999999999999999997764  


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                      ++..||+.|||||++.....+.|+-++||||+|+...||...++|.........+.-+-.+.     .|.+.   ..+=.
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-----sPtLq---s~eWS  251 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-----SPTLQ---SNEWS  251 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-----CCCCC---CchhH
Confidence            34589999999999988777899999999999999999999999977655444433332211     12222   23344


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      +.+..++..|++.-|.+|||..+++..
T Consensus       252 ~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  252 DYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            577889999999999999999998763

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.8e-41  Score=307.62  Aligned_cols=254  Identities=17%  Similarity=0.195  Sum_probs=193.7

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----  131 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  131 (332)
                      ...++|...+.||+|+||.||++. ..+++.||+|.+............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            345789999999999999999998 45788999999876543333334567899999999999999999987543     


Q ss_pred             -CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          132 -GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                       ...+++|||+++ ++.+++...      +++..+..++.|+++||.|||++   +++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             346899999975 666666421      68888999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------
Q 020027          211 GLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------  278 (332)
Q Consensus       211 g~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------  278 (332)
                      |+++.....     ..++..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+...       
T Consensus       164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         164 GLARTAGTSFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cccccCCCccccCCccccCCccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999765432     357889999999875   57889999999999999999999999765332221111000       


Q ss_pred             -------ccccccC----------Cc----CCCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          279 -------RFSELLD----------PR----LAIP----CEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       279 -------~~~~~~~----------~~----~~~~----~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                             ......+          +.    ...+    .+......+.+++.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   0000000          00    0000    011123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-41  Score=305.53  Aligned_cols=233  Identities=24%  Similarity=0.256  Sum_probs=185.9

Q ss_pred             ceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHH-HhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIK-TLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|+. .+++.||+|.+....... .....+..|.. +++.++||||+++++.+...+..+++|||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999994 578899999987543222 12223445544 57888999999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|..++.....    +++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....     
T Consensus        81 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          81 GELFFHLQRERC----FLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            999888865332    67888889999999999999998   999999999999999999999999999865321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...|+..|+|||.+..   ..++.++|||||||++|||++|..||.+.........+....        ...+  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--------~~~~--~~~~  220 (321)
T cd05603         154 STFCGTPEYLAPEVLRK---EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--------LQLP--GGKT  220 (321)
T ss_pred             ccccCCcccCCHHHhcC---CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--------CCCC--CCCC
Confidence             1247889999999865   678899999999999999999999998765544443333221        1111  1223


Q ss_pred             HHHHHHHHHcccCCCCCCCCHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIV  319 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~  319 (332)
                      ..+.+++.+||+.||.+||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            4678999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-41  Score=303.93  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeC--------CCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLS--------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGF  127 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  127 (332)
                      +....+|...+.||+|+||.||++...        .+..||+|.++.... ......+.+|+.+++++ +|+||++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            344556888999999999999999731        223689998764321 22233578899999999 79999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCC
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  195 (332)
                      +...+..++++||+++++|.+++.....            ....+++.+++.++.|++.||.|||++   +++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence            9999999999999999999999875321            112378889999999999999999998   9999999999


Q ss_pred             CEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCch
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGL  266 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~  266 (332)
                      ||+++.++.+||+|||+++.....        ..++..|++||.+..   ..++.++||||||+++|||++ |..||.+.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc---CCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999998754321        123456999998876   678899999999999999999 88899876


Q ss_pred             hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ........+.....         .+.+.....++.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         241 PVEELFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             CHHHHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            65555544433211         1111223347889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-40  Score=290.68  Aligned_cols=245  Identities=22%  Similarity=0.355  Sum_probs=199.3

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .+|+..+.||+|+||.||++...++..+|+|.+.....   ....+.+|+++++.++|||++++++++......++++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            46777899999999999999976788999998864432   123578899999999999999999999998999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK  220 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~  220 (332)
                      +++++|.+++.....   .+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.+....+..
T Consensus        81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          81 MEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            999999999865432   278899999999999999999998   99999999999999999999999999987543221


Q ss_pred             -------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          221 -------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       221 -------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                             .++.+|++||....   ..++.++||||||+++||+++ |..||...........+..+.  ....+.     
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~-----  224 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSF---SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLYKPR-----  224 (256)
T ss_pred             ccccCCCccchhhcCHhHhcc---CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCCCCC-----
Confidence                   23457999998865   678899999999999999998 899997665444443333221  111111     


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                        .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              12247889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.5e-41  Score=299.12  Aligned_cols=251  Identities=25%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||++. ..++..+|+|.+..... ......+.+|+++++.++||||+++++.+..++..+++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            468889999999999999998 45788999998865422 1122347889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |+++++|.+++.....    +++..+..++.|+++||.|||+ .   +++|+||||+||++++++.+|++|||++.....
T Consensus        80 y~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          80 HMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             ccCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999976432    7888999999999999999997 4   899999999999999999999999999865432


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC---------
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD---------  285 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  285 (332)
                          ...++..|++||.+..   ..++.++|+||||+++|||+||+.||...........+... ......         
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  228 (308)
T cd06615         153 SMANSFVGTRSYMSPERLQG---THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP-VSEGEAKESHRPVSG  228 (308)
T ss_pred             cccccCCCCcCccChhHhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc-cccccccCCcccccC
Confidence                2356789999998765   56889999999999999999999998754332222111110 000000         


Q ss_pred             ---------------------CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          286 ---------------------PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       286 ---------------------~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                                           .....+.. .....+.+++.+||+.||++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSG-AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCc-ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                 00000000 123468899999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-40  Score=293.35  Aligned_cols=254  Identities=19%  Similarity=0.224  Sum_probs=196.2

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|.+............+.+|+.+++.++|+|++++++++...+..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            4688889999999999999995 478999999986543222222346889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |++++++..++....    .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999988888765432    278999999999999999999998   9999999999999999999999999998765432


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c------------
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R------------  279 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------  279 (332)
                            ..++..|++||.....  ..++.++|+||||+++|||+||+.||.+....+....+...  .            
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cccccCcccccccCCHHHHhCC--CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence                  2356789999987542  45788999999999999999999999765433322211110  0            


Q ss_pred             -c-ccccCCcCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -F-SELLDPRLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -~-~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       + .....+......+     ......+.+++.+||+.||++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             0 0000000000000     011346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-40  Score=289.58  Aligned_cols=245  Identities=23%  Similarity=0.338  Sum_probs=199.2

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||.||++. ..+++.+|+|.+............+.+|+.+++.++|||++++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            47888999999999999998 45888999999876544444445678999999999999999999999989999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccCCccccCCcc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYGLSFLAPEE  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a~~~~~~  219 (332)
                      +++++|.+++.....  ..+++..+..++.|++.|+.|||++   +++|+||+|+||+++++ +.+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999976432  2378899999999999999999998   99999999999999854 56899999998765432


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||....   ...+.++||||||+++|+|++|+.||.+.........+.......       .  +.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------~--~~  223 (256)
T cd08220         156 SKAYTVVGTPCYISPELCEG---KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-------I--SD  223 (256)
T ss_pred             ccccccccCCcccCchhccC---CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-------C--CC
Confidence                 246778999998875   567889999999999999999999997765443333222221111       1  11


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            12336789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.1e-41  Score=294.19  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCC----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ..++|...+.||+|+||.||+|...+    ...||+|....... ......+.+|+.+++.++|||++++++++.. +..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            34568888999999999999998432    34789998865432 2223357889999999999999999998875 456


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....   .+++..++.++.|++.|+.|||+.   +++|+||||+||+++.++.+|++|||+++
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence            899999999999999975432   278999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          215 LAPEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       215 ~~~~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ......       .++..|++||....   ..++.++||||||+++||+++ |..||.+.........+..+.       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------  225 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------  225 (270)
T ss_pred             ecccccceecCCCCccccccChhhhcc---CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            543221       23457999998765   567899999999999999996 999998765444433332221       


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      ..  +.+...+..+.+++.+||..+|++|||+.++++.|+++..+
T Consensus       226 ~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 RL--PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11  11122334788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.3e-40  Score=290.13  Aligned_cols=245  Identities=21%  Similarity=0.278  Sum_probs=197.5

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec-CCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA-PGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  139 (332)
                      +|+..+.||+|++|.||++. ..+++.+|+|.+............+.+|+.+++.++|+|++++++.+.. ++..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            47888999999999999999 4568899999987554333333457889999999999999999988764 456789999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++++|.+++.....  ..+++.++..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++..... 
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999976432  2378999999999999999999998   999999999999999999999999999865432 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ...++..|++||....   ..++.++|+||||+++||+++|+.||.+.........+..+...     .    .+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-----~----~~  223 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSN---KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-----P----MP  223 (257)
T ss_pred             CCccccccCCcCccChhHhcC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----C----Cc
Confidence                 1246788999998876   67788999999999999999999999765444333333232211     1    11


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            123347889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.6e-41  Score=294.82  Aligned_cols=249  Identities=23%  Similarity=0.275  Sum_probs=196.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.||+|+||.||+|. ..+++.||+|.++.....  ....+.+|+.+++.++||||+++++.+...+..++++|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            467788899999999999998 567899999998754321  22246789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++++|.+++.....    +++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..... 
T Consensus        87 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          87 FCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             ccCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999875432    78999999999999999999998   999999999999999999999999999864322 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ...++..|+|||.........++.++|+|||||++|||++|..||..................   .+....  .
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~--~  234 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---PPKLKD--K  234 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---CCcccc--c
Confidence                 225788999999875333356789999999999999999999998654332222211111111   111110  1


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            112235778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-41  Score=295.64  Aligned_cols=257  Identities=22%  Similarity=0.322  Sum_probs=195.4

Q ss_pred             CCCCCceeeccCCeEEEEEEe-----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--Cce
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GER  134 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  134 (332)
                      .|...+.||+|+||.||.++.     .++..||+|.++..... .....+.+|+.+++.++|||++++++++...  ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            468889999999999999973     46789999998754322 2233578999999999999999999998765  568


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.+...   .+++..++.++.|++.||+|||++   +++||||||+||+++.++.++++|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999999865432   378999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhh----hcc--
Q 020027          215 LAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK----EMR--  279 (332)
Q Consensus       215 ~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~----~~~--  279 (332)
                      ....         ...++..|++||....   ..++.++||||||+++||++|++.|+....... .....    ...  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-~~~~~~~~~~~~~~  233 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQ---SKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-LKMIGPTHGQMTVT  233 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhcc---CCCCccccchhhhhhhhhhhcCCCCCccccchh-hhhcccccccccHH
Confidence            5432         1234567999998765   568899999999999999999876543211000 00000    000  


Q ss_pred             -cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          280 -FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       280 -~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                       ...........+.+......+.+++.+||+.||++|||+.++++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence             00000000111112223457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-40  Score=290.51  Aligned_cols=244  Identities=25%  Similarity=0.361  Sum_probs=197.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      ++|...+.||+|+||.||++.. +++.+|+|.++...    ....+.+|+.+++.++|||++++++++..++ .+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEEC
Confidence            4588889999999999999875 67889999986432    2235789999999999999999999986654 6899999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK  220 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~  220 (332)
                      +++++|.+++.....  ..+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||++.......
T Consensus        80 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          80 MSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            999999999976432  2378899999999999999999998   99999999999999999999999999987544322


Q ss_pred             ---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHH
Q 020027          221 ---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP  296 (332)
Q Consensus       221 ---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                         ..+..|++||....   ..++.++|+||||+++|||++ |+.||.+....+....+..+.         ..+.+...
T Consensus       155 ~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~  222 (254)
T cd05083         155 DNSKLPVKWTAPEALKH---KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------RMEPPEGC  222 (254)
T ss_pred             CCCCCCceecCHHHhcc---CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------CCCCCCcC
Confidence               23457999998765   678899999999999999998 999997765544433333221         11111122


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          297 LVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       297 ~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      +..+.+++.+||+.+|++|||+++++..|++
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            3477899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.7e-41  Score=296.69  Aligned_cols=258  Identities=21%  Similarity=0.233  Sum_probs=198.8

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeee--
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQ--  129 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--  129 (332)
                      +.+....++|+..+.||+|+||.||++. ..+++.+|+|.+.....   ....+.+|+.+++.+ +|+|++++++++.  
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            4455678899999999999999999998 45788999998764321   123467889999998 6999999999873  


Q ss_pred             ---cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          130 ---APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       130 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                         .++..+++|||+++++|.+++.........+++..+..++.|++.|+.|||++   +++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence               34568999999999999998764322223478888999999999999999998   999999999999999999999


Q ss_pred             EccCCccccCCc------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc
Q 020027          207 VCDYGLSFLAPE------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       207 l~dfg~a~~~~~------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~  278 (332)
                      ++|||++.....      ...++..|++||.+...  .+..++.++||||+||++|||++|+.||...............
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~  244 (286)
T cd06638         165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN  244 (286)
T ss_pred             EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence            999999865432      22578899999987532  1245788999999999999999999998765432222111111


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .     .+....  +......+.+++.+||+.||++|||+.|+++.
T Consensus       245 ~-----~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         245 P-----PPTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             C-----CCcccC--CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0     011111  11122368899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=288.68  Aligned_cols=251  Identities=25%  Similarity=0.285  Sum_probs=201.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|.. .+++.+++|.+......  ....+.+|+.+++.++|||++++++.+...+..+++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            35788899999999999999994 57889999998754322  3345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .++...+..++.|++.|+.|||++   +++|+||+|+||++++++.+|++|||.+.....
T Consensus        80 e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          80 EYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             eCCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            99999999999876422   278899999999999999999998   999999999999999999999999999865432


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      ..++..|++||.........++.++|+||||+++|||+||+.||.+..............+.   .+.  ...
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~---~~~--~~~  228 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP---PPK--LKD  228 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---Ccc--ccc
Confidence            2      24677899999886532237788999999999999999999999875544333222221111   011  111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......++.+++.+||+.||.+|||+++++.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2233456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-40  Score=295.47  Aligned_cols=249  Identities=23%  Similarity=0.265  Sum_probs=198.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .+.|...+.||+|+||.||+|.. .+++.+++|.+....  ......+.+|+..++.++|+|++++++.+..++..+++|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            46788999999999999999994 568999999986542  222335688999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|..++.+...   .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          89 EFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             ecCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999888765332   278999999999999999999998   999999999999999999999999998764322


Q ss_pred             ------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                            ...++..|++||.+...  ....++.++|+|||||++|||++|+.||...........+....     .+..  
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----~~~~--  235 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-----PPTL--  235 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC-----CccC--
Confidence                  22467889999988532  12457889999999999999999999997654433322222211     1111  


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+.....++.+++.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111222336789999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.5e-41  Score=295.88  Aligned_cols=247  Identities=22%  Similarity=0.274  Sum_probs=194.7

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      |...+.||+|+||+||++. ..+++.+|+|.+......... ...+.+|+.+++.++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            5667889999999999998 468899999998754332222 22467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.....  
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            999999988865332  2389999999999999999999998   999999999999999999999999999865432  


Q ss_pred             ---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 ---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                         ...++..|++||....   ..++.++|+|||||++||++||..||.+.........+... ..   ......  ...
T Consensus       157 ~~~~~~g~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-~~---~~~~~~--~~~  227 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNN---QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-VL---ETEEVY--SAK  227 (285)
T ss_pred             cccCCCCCcCccChHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-hh---cccccc--Ccc
Confidence               2357889999999865   67889999999999999999999999865443322222111 10   001111  111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      ....+.+++.+||+.||++|||     +.++++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            2236778999999999999999     556654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.7e-40  Score=290.84  Aligned_cols=245  Identities=23%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccc----cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS----NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      +|...+.||+|+||.||+|...+++.+|+|.+.......    .....+.+|+..++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467788999999999999998889999999987543221    1122477899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      +||+++++|.+++.+...    +++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999999976432    68888999999999999999998   99999999999999999999999999876432


Q ss_pred             c------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          218 E------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       218 ~------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .            ...++..|++||....   ..++.++|+||||+++||+++|..||...........+....   ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~  227 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINE---SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR---GLM  227 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcC---CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc---CCC
Confidence            1            1246778999998876   567899999999999999999999997643222211111110   001


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +..    +......+.+++.+||+.+|++|||+.++++
T Consensus       228 ~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111    1122346789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.3e-41  Score=328.14  Aligned_cols=256  Identities=21%  Similarity=0.235  Sum_probs=200.0

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+|. ..+|+.||+|+++....... ....+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            478889999999999999999 45789999999975433221 2235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCC-------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          139 EFINMASLDFYLHENNDG-------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      ||+++++|.+++......       ....++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998642110       12256778889999999999999998   99999999999999999999999999


Q ss_pred             ccccCC------------------------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh
Q 020027          212 LSFLAP------------------------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL  267 (332)
Q Consensus       212 ~a~~~~------------------------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~  267 (332)
                      ++....                        ....||+.|+|||....   ..++.++|||||||++|||+||+.||.+..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g---~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG---VPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC---CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            986541                        01247899999998876   678999999999999999999999997643


Q ss_pred             HHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccc
Q 020027          268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP-SIVQVATILNNLV  329 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP-s~~~i~~~L~~~~  329 (332)
                      .......   ..   ..++. ........+..+.+++.+||+.||++|| +++++.+.|+..+
T Consensus       236 ~~ki~~~---~~---i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        236 GRKISYR---DV---ILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhhhhh---hh---ccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            3222110   00   01111 0011112233677899999999999995 6777888877654

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-40  Score=290.44  Aligned_cols=245  Identities=20%  Similarity=0.251  Sum_probs=199.9

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||.+|.+. ..+|+.||+|.+............+.+|+..++.++||||+++++++...+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            47888999999999999998 45789999999875433333334678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.....  ..+++.+++.++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++...... 
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999998875432  2368899999999999999999998   9999999999999999999999999998755432 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||....   ...+.++|+|||||+++|++||+.||......+....+..+...         +.+.
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~---------~~~~  223 (256)
T cd08218         156 ELARTCIGTPYYLSPEICEN---RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP---------PVSS  223 (256)
T ss_pred             hhhhhccCCccccCHHHhCC---CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC---------CCcc
Confidence                 246778999998865   56788999999999999999999999765444433333222111         1112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....++.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            22346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-40  Score=289.60  Aligned_cols=244  Identities=25%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||+|... +++.+++|.+.....    ...+.+|+..++.++|+|++++++.+..+...++++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            367889999999999999999954 588999999865432    346789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++.....
T Consensus        78 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          78 EYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             ecCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            99999999999865332   378999999999999999999998   999999999999999999999999999876443


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      ..++..|++||....   ..++.++||||||+++|||++|+.||...........+....     .+...  .
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~--~  221 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQE---IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP-----PPTLS--D  221 (256)
T ss_pred             CccccccccCCccccCHHHHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC-----CCCCC--c
Confidence            2      236778999998865   578899999999999999999999997654433222211110     01111  1


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +......+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1122346889999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-40  Score=290.25  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=194.9

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-------ccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-------AGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      |...+.||+|+||.||+|.. .+++.+|+|.+........       ....+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            56778999999999999984 5788999998875543222       112467899999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++++|.+++.....    +++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||.++
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999976432    78888999999999999999998   99999999999999999999999999886


Q ss_pred             cCCc------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          215 LAPE------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       215 ~~~~------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      ....            ...++..|++||....   ..++.++|+|||||++|||++|+.||.+.........+...    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ---TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN----  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhcc---CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc----
Confidence            5431            1135678999998875   56788999999999999999999999875433222221111    


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ..+..    +......+.+++.+||+.||++||++.++++
T Consensus       228 -~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 -ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             11111    1122346789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-40  Score=294.75  Aligned_cols=246  Identities=23%  Similarity=0.250  Sum_probs=195.1

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |+..+.||+|+||.||+|.. .++..+++|.+.....  .....+.+|+.+++.++|+|++++++.+..++..++++||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            56678899999999999994 5678899998864432  22235688999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc---
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE---  218 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~---  218 (332)
                      ++++|..++.....   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+|++|||++.....   
T Consensus        85 ~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          85 AGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999988764322   378999999999999999999998   999999999999999999999999999865422   


Q ss_pred             ---ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 ---EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                         ...++..|++||.+...  .+..++.++|+|||||++|||++|+.||...........+.....     +...  .+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~--~~  231 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-----PTLA--QP  231 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC-----CCCC--Cc
Confidence               23578899999987432  235678899999999999999999999987544333222222111     1111  11


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....++.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            122347889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-41  Score=294.55  Aligned_cols=239  Identities=24%  Similarity=0.361  Sum_probs=186.1

Q ss_pred             ceeeccCCeEEEEEEeC-C-------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           67 RIIGQGRLGTVYAALLS-T-------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      +.||+|+||.||+|... +       ...+|+|.+....  ......+.+|+.+++.++|||++++++++..++..+++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            36899999999999842 2       2348888875432  122235688899999999999999999999988999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc--------eEEccC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC--------ARVCDY  210 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~df  210 (332)
                      ||+++++|..++.....   .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.        ++++||
T Consensus        79 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             ecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999999976432   378899999999999999999998   9999999999999987665        699999


Q ss_pred             CccccCCc--ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCC-CCCCchhHHHHHHHhhhcccccccCCc
Q 020027          211 GLSFLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-RCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       211 g~a~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      |.+.....  ...++..|++||.+...  ..++.++||||||+++||+++|. .|+..............         .
T Consensus       153 g~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---------~  221 (258)
T cd05078         153 GISITVLPKEILLERIPWVPPECIENP--QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---------R  221 (258)
T ss_pred             ccccccCCchhccccCCccCchhccCC--CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc---------c
Confidence            99865443  23577889999998752  45788999999999999999985 55554433322221111         1


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      ...+..  ...++.+++.+||+.||++|||++++++.|+
T Consensus       222 ~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 HQLPAP--KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ccCCCC--CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111111  1236789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-40  Score=288.91  Aligned_cols=238  Identities=24%  Similarity=0.373  Sum_probs=186.9

Q ss_pred             ceeeccCCeEEEEEEeCC-C----------CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           67 RIIGQGRLGTVYAALLST-G----------KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      +.||+|+||.||+|...+ +          ..+++|.+......   ...+.+|+.+++.++|||++++++++.. +..+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            368999999999999543 3          25778876544321   3467899999999999999999999987 7789


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-------ceEEc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-------CARVC  208 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-------~~kl~  208 (332)
                      +++||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++       .+|++
T Consensus        77 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            99999999999999976542   378899999999999999999998   999999999999999887       79999


Q ss_pred             cCCccccCCc--ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          209 DYGLSFLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       209 dfg~a~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      |||++.....  ...++..|++||++.... ..++.++||||||+++||+++ |..|+...............       
T Consensus       151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-------  222 (259)
T cd05037         151 DPGIPITVLSREERVERIPWIAPECIRNGQ-ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-------  222 (259)
T ss_pred             CCCcccccccccccccCCCccChhhhcCCC-CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-------
Confidence            9999876543  234667899999986521 367899999999999999999 56777654322221111110       


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .....+..    ..+.+++.+||..+|++|||+.++++.|+
T Consensus       223 ~~~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 HRLPMPDC----AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCCCCCc----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            01111111    47889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-40  Score=290.31  Aligned_cols=252  Identities=21%  Similarity=0.253  Sum_probs=198.0

Q ss_pred             CCCCCceeeccCCeEEEEEEeC--CCCEEEEEEeccCcccc--------cccccHHHHHHHhcc-CCCCCccceeeeeec
Q 020027           62 GFSHRRIIGQGRLGTVYAALLS--TGKLVAVKRIHPRLVLS--------NAGFGFASVIKTLSL-AQHPNIVPILGFSQA  130 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~--------~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  130 (332)
                      +|+..+.||+|+||.||+|...  +++.+|+|.+.......        .....+.+|+.++.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4778899999999999999954  47899999886433211        111235677777764 799999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEcc
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCD  209 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~d  209 (332)
                      .+..+++|||+++++|.+++.........+++..++.++.|++.|+.|||+ .   +++|+||+|+||+++.++.+|++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999885432223348889999999999999999996 5   899999999999999999999999


Q ss_pred             CCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          210 YGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       210 fg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      ||.+......     ..++..|++||....   ..++.++|+||||+++|||++|+.||...........+........ 
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  233 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN---EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-  233 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcC---CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-
Confidence            9998764432     246788999998875   6689999999999999999999999976544333333322211110 


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                             ........+.+++.+||+.||++|||+.|+.++++.
T Consensus       234 -------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         234 -------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             -------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                   011123478899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-41  Score=303.86  Aligned_cols=254  Identities=20%  Similarity=0.224  Sum_probs=193.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  131 (332)
                      ..++|...+.||+|+||.||+|. ..+++.||+|.+............+.+|+.+++.++|+||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            45789999999999999999998 56888999999875543333333467899999999999999999987533      


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      ...++++|++ +++|.+++...     .+++..+..++.|++.||.|||++   +|+||||||+||++++++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            3468999988 78898887532     278999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc---c------
Q 020027          212 LSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM---R------  279 (332)
Q Consensus       212 ~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~------  279 (332)
                      +++.....   ..++..|+|||.+...  ..++.++|||||||++|||++|+.||.+.........+...   .      
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         164 LARQADDEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             cceecCCCcCCccccccccCchHhcCC--ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98765443   2578899999988652  46789999999999999999999999765433222211110   0      


Q ss_pred             ------cccccCCcCCCCCC------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ------FSELLDPRLAIPCE------IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ------~~~~~~~~~~~~~~------~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            ...........+..      ......+.+++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  00000000000000      001124679999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-41  Score=295.02  Aligned_cols=249  Identities=29%  Similarity=0.365  Sum_probs=195.5

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |+..+.||+|+||+||+++. .+++.+|+|.+..............+|+..++.++||||+++++++...+..+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            45678999999999999994 56678999999876544443333456899999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC----
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP----  217 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~----  217 (332)
                      ++++|.+++.....    +++..++.++.|+++||.+||+.   +++|+||||+||++++++.++|+|||.+....    
T Consensus        81 ~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKNKP----LSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             TTEBHHHHHHHHSS----BBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccccc----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999983332    78999999999999999999999   99999999999999999999999999986421    


Q ss_pred             --cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          218 --EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       218 --~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                        ....++..|.|||....  +...+.++|+||+|+++|+|++|..||...........+............   .....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  228 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQ--GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---QQSRE  228 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTT--TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---TSHTT
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---cccch
Confidence              12357889999999871  267899999999999999999999999876222222222111100000000   00001


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  229 KSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1147889999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-40  Score=296.44  Aligned_cols=254  Identities=21%  Similarity=0.277  Sum_probs=196.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|+. .+++.||+|.++..... .....+.+|+..++.++||||+++++++..++..+++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            45788999999999999999984 57889999998754322 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ ++|.+++.....   .+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+|++|||++.....
T Consensus        84 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          84 EYLD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            9997 588888865432   278889999999999999999998   999999999999999999999999999865332


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------ccccccC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RFSELLD  285 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~  285 (332)
                            ...++..|++||.+...  ..++.++|||||||++|||+||+.||.+....+....+...       .+....+
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCcccccceeecccCcHHHhCC--CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence                  12457789999987642  45788999999999999999999999876544333222110       0100000


Q ss_pred             ---------CcCCCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 ---------PRLAIP----CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ---------~~~~~~----~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                               +.....    ........+.+++.+|++.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                     000000    00112336779999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-40  Score=295.29  Aligned_cols=244  Identities=23%  Similarity=0.286  Sum_probs=198.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..+|+..+.||.|+||.||+|. ..+++.|++|.+.....  .....+.+|+..++.++|||++++++++...+..++++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            3468888999999999999998 56889999999865432  22235688999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|..++...     .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          96 EYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999988643     278999999999999999999999   999999999999999999999999998765432


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      ..++..|++||....   ..++.++|+|||||++||+++|+.||.+.........+.....     +.+..  
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~--  237 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-----PELQN--  237 (296)
T ss_pred             ccccCCCcCCCccccCcchhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----cccCC--
Confidence            2      246778999998875   5678999999999999999999999987654433322222111     11111  


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +......+.+++.+||..||++|||+.+++.
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1122336778999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.6e-41  Score=296.67  Aligned_cols=254  Identities=22%  Similarity=0.251  Sum_probs=195.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+............+.+|+.+++.++||||+++++++..++..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            4688889999999999999995 468999999987544333233357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |++++++..+.....    .+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++++|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999999988775432    278999999999999999999998   9999999999999999999999999998754322


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--cccc----------
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--MRFS----------  281 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~----------  281 (332)
                            ..++..|++||.....  ..++.++||||||+++|||++|++||.+....+....+..  ..+.          
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             ccccCcccceeeccCcHHhccc--cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence                  2356789999987642  4567899999999999999999999865432221111110  0000          


Q ss_pred             ----cccCCcCCCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ----ELLDPRLAIPC-----EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ----~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          ....+......     .......+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                00000000000     1122346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=301.43  Aligned_cols=252  Identities=18%  Similarity=0.193  Sum_probs=194.1

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+++ ..+++.||+|.+.+..... .....+.+|+.++..++|+||+++++++..++..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            468889999999999999999 4578999999987532222 22234678899999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999975332   278889999999999999999999   999999999999999999999999999865322


Q ss_pred             c-------cCCcccccCcccccccC--CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          219 E-------KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       219 ~-------~~~~~~~~~pe~~~~~~--~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .       ..|+..|+|||.+....  ...++.++|||||||++|||++|+.||.+....+....+.....      ...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------~~~  228 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------HFQ  228 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------ccc
Confidence            1       24789999999986421  24578899999999999999999999987654444333322110      111


Q ss_pred             CCC-ChHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 020027          290 IPC-EIKPLVRLAKVALACVGN--SRKNRPSIVQVATI  324 (332)
Q Consensus       290 ~~~-~~~~~~~l~~l~~~c~~~--dp~~RPs~~~i~~~  324 (332)
                      .+. .......+.+++.+|+..  ++..||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            111 111233567788887654  34447898888753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.1e-41  Score=294.63  Aligned_cols=241  Identities=23%  Similarity=0.288  Sum_probs=195.4

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .|+..+.||+|+||.||+|. ..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..++++||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35667789999999999998 457889999988644322 2223578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++...     .+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++++|||++...... 
T Consensus        84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999988642     278889999999999999999998   9999999999999999999999999998654432 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||.+..   ..++.++|+|||||++||++||+.|+...........+....     .+.    ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~----~~~  223 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQ---SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-----PPT----LEG  223 (277)
T ss_pred             hhhhcccCcccccCHHHhCc---CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-----CCC----CCc
Confidence                 246778999999876   568899999999999999999999987654433322221111     111    111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....+.+++.+||+.+|++|||+.++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            23346789999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-40  Score=291.03  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=196.0

Q ss_pred             CCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------
Q 020027           63 FSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------  132 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  132 (332)
                      |...+.||+|+||.||+|..    .+++.||+|.+............+.+|+++++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            55678899999999999984    24689999998765433333345788999999999999999999875432      


Q ss_pred             ceeEEEeccCCCCHHHHhcccC--CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          133 ERIIVSEFINMASLDFYLHENN--DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      ..++++||+++++|..++....  .....+++...+.++.|++.|++|||+.   +++||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988875321  1122378889999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccc
Q 020027          211 GLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFS  281 (332)
Q Consensus       211 g~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  281 (332)
                      |+++.....        ..++..|++||.+..   ..++.++|||||||++|||++ |+.||.+.........+..... 
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  233 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLAD---NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-  233 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhc---CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-
Confidence            998754321        123457889998765   567889999999999999999 8888876654444333332210 


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                            ...  +......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       234 ------~~~--~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ------LKQ--PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  111  112234788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-40  Score=289.20  Aligned_cols=247  Identities=20%  Similarity=0.233  Sum_probs=200.5

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--CCceeEEE
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--PGERIIVS  138 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  138 (332)
                      +|+..+.||.|+||.||++. ..+++.+|+|.+............+..|+..++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            47788999999999999998 5688999999987654433344457889999999999999999997753  45678999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhh-----cCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH-----QGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-----~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      ||+++++|.+++.........+++..++.++.|++.|+.|||     +.   +++|+||+|+||++++++.+|++|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999764333344889999999999999999999     66   9999999999999999999999999998


Q ss_pred             ccCCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCc
Q 020027          214 FLAPEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       214 ~~~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      ......      ..++..|++||.+..   ..++.++|+||||+++|+|++|+.||...........+..+...      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  228 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNH---MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR------  228 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcC---CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC------
Confidence            765432      246788999999876   56889999999999999999999999876544443333332211      


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         ..+......+.+++.+||+.+|++|||+.+|++
T Consensus       229 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 ---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               111123347889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=300.95  Aligned_cols=249  Identities=22%  Similarity=0.214  Sum_probs=213.1

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCC-CCCccceeeeeecCCce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  134 (332)
                      ...+.|+..+.||+|.||.||++. ..+|+.+|+|.+.+...... ......+|+.+|+.+. |||||.+++.++..+..
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345678888999999999999999 55799999999987665433 2346799999999998 99999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC----CceEEccC
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK----FCARVCDY  210 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~df  210 (332)
                      +++||++.||.|.+.+...     .+++..+..++.|++.++.|||+.   |++||||||+|+|+...    +.+|++||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            9999999999999999765     178999999999999999999998   99999999999999643    47999999


Q ss_pred             CccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          211 GLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       211 g~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      |+|......     ..||+.|+|||....   ..++..+||||+|+++|.|++|..||.+.........+..+.+     
T Consensus       184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~---~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-----  255 (382)
T KOG0032|consen  184 GLAKFIKPGERLHTIVGTPEYVAPEVLGG---RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-----  255 (382)
T ss_pred             CCceEccCCceEeeecCCccccCchhhcC---CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-----
Confidence            999876552     379999999999876   6899999999999999999999999999877766666666543     


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .+..+........+.+++..++..||..|+|+.++++
T Consensus       256 -~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 -DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence             2233333344557889999999999999999999987

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=293.19  Aligned_cols=259  Identities=19%  Similarity=0.233  Sum_probs=215.5

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeee
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF  127 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  127 (332)
                      +++.....++....++-+|.||.||+|.+.      +.+.|.+|.++.... .-+...++.|-..+..+.|||+.++.+.
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            345555677888889999999999999643      345677777764332 2222347788888888999999999999


Q ss_pred             eecC-CceeEEEeccCCCCHHHHhcccC----CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          128 SQAP-GERIIVSEFINMASLDFYLHENN----DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       128 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      +..+ ...++++.++.-|+|..|+...+    .....++-.+...++.|++.|++|||++   +++|.||..+|+++|+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            8654 67789999999999999997432    2334467778889999999999999999   99999999999999999


Q ss_pred             CceEEccCCccccCC--------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHH
Q 020027          203 FCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP  273 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~  273 (332)
                      ..+|++|=.+++..-        ++......||++|.+..   ..|+.++|+||||+++|||+| |+.|+...++.++..
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n---~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~  509 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN---SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH  509 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh---hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence            999999999987542        23345678999999988   789999999999999999999 999999999999999


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +++++         ++..++.+|+++++.+|.-||+.+|++||+++|++..|.+.
T Consensus       510 ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  510 YLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            98885         34556778889999999999999999999999999999863

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.2e-40  Score=296.35  Aligned_cols=250  Identities=18%  Similarity=0.199  Sum_probs=199.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||++. ..+++.|++|.+....... .....+.+|+.+++.++||||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            468889999999999999999 4578899999987553221 22235678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      ||+++++|.+++....    .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+|++|||+++... 
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999997543    278888999999999999999998   99999999999999999999999999876311 


Q ss_pred             --------------------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh
Q 020027          218 --------------------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       218 --------------------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~  277 (332)
                                          ....++..|++||.+..   ..++.++|+|||||++||+++|..||.+............
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~  230 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  230 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence                                01135678999998865   5678999999999999999999999987655544433332


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ....   .+..    .......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       231 ~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            2111   0110    01223467899999999999999997777766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-41  Score=329.18  Aligned_cols=256  Identities=20%  Similarity=0.230  Sum_probs=198.4

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--CCc
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--PGE  133 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  133 (332)
                      +...++|...+.||+|+||.||+++ ..++..+|+|.+............+..|+.+++.++||||+++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            3456789999999999999999999 4578899999987654444444467899999999999999999998754  456


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC----CCCeeecCCCCCCEEeCC--------
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV----APNIIHGCIKASNILLNE--------  201 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~----~~~ivH~dlk~~Nill~~--------  201 (332)
                      ++++|||+++++|.+++.........+++..++.++.||+.||.|||+..    ..+|+||||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999999764322234899999999999999999999852    125999999999999964        


Q ss_pred             ---------CCceEEccCCccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh
Q 020027          202 ---------KFCARVCDYGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL  267 (332)
Q Consensus       202 ---------~~~~kl~dfg~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~  267 (332)
                               .+.+||+|||++.....     ...+|+.|+|||.+... ...++.++|||||||++|||+||+.||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-TKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-CCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                     33589999999876432     23588999999988542 1457899999999999999999999997543


Q ss_pred             HH-HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          268 VK-WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       268 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .. .....+...       +.+...   ....++.+++..||+.+|++|||+.|++.
T Consensus       248 ~~~qli~~lk~~-------p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFSQLISELKRG-------PDLPIK---GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHHHHHHHHhcC-------CCCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            22 221222111       111111   11246889999999999999999999983

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-40  Score=293.96  Aligned_cols=253  Identities=21%  Similarity=0.179  Sum_probs=192.4

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||.||+|+. .+|+.+|+|.++...........+.+|+..++.++|+|++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            477788999999999999994 5899999999976543333334568899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      ++ ++|.+++.....   .+++..++.++.|+++||.|||++   +++|+||||+||+++.++.+||+|||+++..... 
T Consensus        81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            97 577777754322   278999999999999999999998   9999999999999999999999999998754321 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC-chhHHHHHHHhhhc-------c---cccc
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE-GLLVKWALPLIKEM-------R---FSEL  283 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~-~~~~~~~~~~~~~~-------~---~~~~  283 (332)
                           ..++..|++||.+...  ..++.++|||||||++|||+||+.|+. +.........+...       .   ..+.
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCcCCCccccCCcChHHHhCC--cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence                 2457789999987642  456889999999999999999988853 33222222211110       0   0000


Q ss_pred             cCCc----CCC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LDPR----LAI-----PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~~~----~~~-----~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+..    ...     ........++.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000    000     000112346779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.7e-40  Score=291.37  Aligned_cols=245  Identities=26%  Similarity=0.365  Sum_probs=194.2

Q ss_pred             ceeeccCCeEEEEEEeCC-------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           67 RIIGQGRLGTVYAALLST-------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +.||+|+||.||+|+..+       ++.+|+|.+..... ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998432       25799998864322 2223357899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-----ceEEccCC
Q 020027          140 FINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-----CARVCDYG  211 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~dfg  211 (332)
                      |+++++|.+++.....   ....+++.+++.++.|++.|+.|||+.   +++|+||+|+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999999975321   123378899999999999999999998   999999999999999877     89999999


Q ss_pred             ccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccc
Q 020027          212 LSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       212 ~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      ++......        ..++..|++||.+..   ..++.++|||||||++|||+| |..||...........+..+.   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---  230 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLD---GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---  230 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHcc---CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---
Confidence            98643221        134578999998876   678999999999999999998 999987654444433332211   


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                          .  ...+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       231 ----~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ----R--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ----c--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                1  11122234578899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.4e-41  Score=301.59  Aligned_cols=232  Identities=21%  Similarity=0.280  Sum_probs=185.3

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|+ ..+++.||+|.++....... ....+..|+.++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999 46788999999986543222 222467888888877 699999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC------
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP------  217 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~------  217 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....      
T Consensus        81 ~~L~~~~~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          81 GDLMFHMQRQRK----LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            999988865432    88999999999999999999998   99999999999999999999999999986421      


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-------HHHHHHhhhcccccccCCcCCC
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-------KWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....|+..|+|||.+..   ..++.++|||||||++|||+||+.||.....       +.....+..        .....
T Consensus       154 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~  222 (327)
T cd05617         154 STFCGTPNYIAPEILRG---EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------KPIRI  222 (327)
T ss_pred             ecccCCcccCCHHHHCC---CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------CCCCC
Confidence            12357899999999876   6788999999999999999999999964211       112222211        11122


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      +..  ...++.+++.+||+.||++||++
T Consensus       223 p~~--~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRF--LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCC--CCHHHHHHHHHHhccCHHHcCCC
Confidence            211  22367799999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=291.37  Aligned_cols=243  Identities=26%  Similarity=0.296  Sum_probs=198.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||.|+||.||+|. ..+++.||+|.+..... ......+.+|+.+++.++|+|++++++++..+...++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            367888999999999999999 45789999999875432 2222357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++++|.+++...     .+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++++|||++......
T Consensus        80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            99999999998754     378999999999999999999998   9999999999999999999999999998665432


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                            ..++..|++||....   ..++.++||||||+++||++||+.||.+.........+....     .+.....  
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~---~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~--  221 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQ---SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-----PPSLEGN--  221 (274)
T ss_pred             ccccccccCCccccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-----CCCCccc--
Confidence                  246778999999876   568999999999999999999999997654433322222211     1111110  


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .....+.+++.+||..||++|||++++++
T Consensus       222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             02336789999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-40  Score=295.59  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=193.9

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      |+..+.||+|+||.||++. ..+++.||+|.+......... ...+.+|+.+++.++|+|++.+++.+...+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            6777899999999999998 568899999998754332222 22357899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++++|||++...... 
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999998865332  2378899999999999999999998   9999999999999999999999999998654322 


Q ss_pred             ----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          220 ----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       220 ----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                          ..++..|+|||....   ..++.++||||||+++|||++|+.||.+............. ... .....  +  ..
T Consensus       157 ~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~-~~~-~~~~~--~--~~  227 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKN---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKE-VQEEY--S--EK  227 (285)
T ss_pred             cccCCCCCccccChHHHcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh-hhh-hhhhc--C--cc
Confidence                357889999999876   67889999999999999999999999764221111101000 000 00011  1  11


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      ....+.+++.+||+.||++|||     +.|+++
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            2235779999999999999999     778775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=323.39  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=213.6

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeC----C----CCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCcccee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLS----T----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPIL  125 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~  125 (332)
                      .++...++....+.||+|.||.|++|...    .    ...||||.++..... .+...+..|+.+|+.+ +|+|++.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            45555556666779999999999999831    1    457999999866554 5556789999999988 699999999


Q ss_pred             eeeecCCceeEEEeccCCCCHHHHhcccC---C-CC--------CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCC
Q 020027          126 GFSQAPGERIIVSEFINMASLDFYLHENN---D-GA--------SLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIK  193 (332)
Q Consensus       126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~-~~--------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  193 (332)
                      |+|...+..++++||+..|+|..|++...   . ..        ..++....+.++.|||.||+||++.   +++||||.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence            99999999999999999999999998765   0 00        1378889999999999999999998   99999999


Q ss_pred             CCCEEeCCCCceEEccCCccccCCccc-------CC--cccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 020027          194 ASNILLNEKFCARVCDYGLSFLAPEEK-------RG--LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCE  263 (332)
Q Consensus       194 ~~Nill~~~~~~kl~dfg~a~~~~~~~-------~~--~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~  263 (332)
                      .+|||+..+..+||+|||+|+......       .+  ...|||||.+..   ..++.+|||||||++|||++| |..||
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~---~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD---RVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc---CcccccchhhHHHHHHHHHhhCCCCCC
Confidence            999999999999999999998543321       11  345999999987   789999999999999999999 89999


Q ss_pred             Cchh-HHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          264 EGLL-VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       264 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .+.. ..+....++++         .+...+..|..+++++|+.||+.+|++||+|.++.+.++.++
T Consensus       523 p~~~~~~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  523 PGIPPTEELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCCCcHHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            8744 34444444443         344455566779999999999999999999999999999865

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.1e-40  Score=290.78  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ++|+..+.||+|+||.||+|+.+      +.+.+++|.+..... ......+.+|+.++++++|+|++++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            57889999999999999999843      346799998764322 11223578999999999999999999999998999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCC-----CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEcc
Q 020027          135 IIVSEFINMASLDFYLHENNDGA-----SLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD  209 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~d  209 (332)
                      +++|||+++++|.+++.......     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999997654211     1478999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCc-------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccc
Q 020027          210 YGLSFLAPE-------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFS  281 (332)
Q Consensus       210 fg~a~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  281 (332)
                      ||++.....       ...++..|++||....   ...+.++||||||+++||+++ |..||.+................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~  237 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE---DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE  237 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC
Confidence            999864321       1234567999998765   567889999999999999999 78888765444443333322211


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                              .+.+...+..+.+++.+||+.||++|||+.|+++.|.+
T Consensus       238 --------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         238 --------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                    11111223478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-40  Score=296.13  Aligned_cols=244  Identities=22%  Similarity=0.271  Sum_probs=197.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..+|...+.||+|+||.||+|. ..+++.||+|.+......  ....+.+|+.+++.++|+|++++++.+..++..+++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            4678999999999999999999 468999999998654322  2234688999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.+..     +++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||++.....
T Consensus        96 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          96 EYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cccCCCCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999986432     68889999999999999999998   999999999999999999999999998865432


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      ..++..|++||....   ..++.++|+|||||++|++++|..||.+.........+...       .......
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-------~~~~~~~  237 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-------GTPELQN  237 (297)
T ss_pred             CccCcCcccCCccccCHHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-------CCCCCCC
Confidence            2      246778999998876   66789999999999999999999999765432221111110       0111111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +......+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1222345778999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=294.13  Aligned_cols=250  Identities=22%  Similarity=0.244  Sum_probs=199.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||.|+||.||+|.. .+++.+|+|.+.....  .....+.+|+.++++++|+|++++++.+..++..+++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE--EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            45688899999999999999995 5789999999864422  22235788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          82 EFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            99999999999875432   378999999999999999999998   999999999999999999999999998765432


Q ss_pred             c------cCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 E------KRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .      ..++..|++||.....  ....++.++|+||||+++|||++|+.||.+.........+.....     +.+..
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~  230 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-----PTLDQ  230 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-----CCcCC
Confidence            2      2467889999987532  234578899999999999999999999987644333322222111     11111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                        +......+.+++.+||+.||++|||+.++++.
T Consensus       231 --~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         231 --PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              11223467899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.8e-40  Score=293.44  Aligned_cols=248  Identities=25%  Similarity=0.282  Sum_probs=196.7

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..|...+.||+|+||.||+|.. .+++.||+|.+........ ....+.+|+.+++.++|||++++.+++..++..++++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4588889999999999999984 5789999999864432222 2235788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ +++.+++.....   .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 567666654322   278999999999999999999998   999999999999999999999999999876543


Q ss_pred             c--cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHH
Q 020027          219 E--KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP  296 (332)
Q Consensus       219 ~--~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                      .  ..++..|++||.+.......++.++||||||+++|||+||+.||.+.........+....     .+..   .....
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~---~~~~~  239 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-----SPTL---SSNDW  239 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-----CCCC---Cchhh
Confidence            2  356778999998864434668899999999999999999999997654333222221111     0111   11223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          297 LVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       297 ~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            447889999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.9e-40  Score=289.51  Aligned_cols=242  Identities=20%  Similarity=0.261  Sum_probs=197.4

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.+++.++|+|++++++.+..++..+++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            477788999999999999994 5788999998864422 12233578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++...     .+++.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++...... 
T Consensus        84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999998643     268888999999999999999998   9999999999999999999999999998654332 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||.+..   ...+.++|+|||||++|||+||..||.+.........+....         ......
T Consensus       156 ~~~~~~~~~~~y~apE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---------~~~~~~  223 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQ---SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---------PPTLTG  223 (277)
T ss_pred             cccccccCcccccCHhHhcc---CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---------CCCCch
Confidence                 245778999998865   568899999999999999999999998665443332221110         111122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .....+.+++.+||+.+|++|||+.++++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            344578899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-40  Score=301.88  Aligned_cols=187  Identities=21%  Similarity=0.257  Sum_probs=160.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ...+|...+.||+|+||.||+|+. .+++.||+|.....        ....|+.++++++|+||+++++++...+..+++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            445799999999999999999994 56789999974322        236789999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      +|++. ++|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       136 ~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEccC-CcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99995 688888764322   378999999999999999999998   99999999999999999999999999987532


Q ss_pred             c-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          218 E-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       218 ~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                      .     ...||..|++||.+..   ..++.++|||||||++|||+++..++
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VAPAFLGLAGTVETNAPEVLAR---DKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cCcccccccccccccCCeecCC---CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            2     2357889999999876   67899999999999999999965544

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.6e-40  Score=293.80  Aligned_cols=259  Identities=24%  Similarity=0.254  Sum_probs=200.6

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeee
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQ  129 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  129 (332)
                      +...+....++|...+.||+|+||.||++.. .+++.+|+|.+.....   ....+.+|+.++.++ +|||++++++++.
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            3455566788999999999999999999994 6789999999864321   122457888889888 8999999999986


Q ss_pred             cC-----CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc
Q 020027          130 AP-----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC  204 (332)
Q Consensus       130 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  204 (332)
                      ..     +..++++||+++++|.++++........+++..++.++.|++.||.|||+.   +++|+||||+||++++++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            43     357999999999999998865322233478999999999999999999998   9999999999999999999


Q ss_pred             eEEccCCccccCCc------ccCCcccccCcccccccC--CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhh
Q 020027          205 ARVCDYGLSFLAPE------EKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK  276 (332)
Q Consensus       205 ~kl~dfg~a~~~~~------~~~~~~~~~~pe~~~~~~--~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~  276 (332)
                      +|++|||++.....      ...++..|++||.+....  ...++.++|||||||++|||++|+.||...........+.
T Consensus       167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~  246 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP  246 (291)
T ss_pred             EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence            99999999865432      234678899999875421  2246899999999999999999999997654333222222


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....     +...  .+......+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         247 RNPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cCCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2111     1111  11122336889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3e-40  Score=297.00  Aligned_cols=190  Identities=18%  Similarity=0.240  Sum_probs=155.0

Q ss_pred             CceeeccCCeEEEEEEeC---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--CCceeEEEec
Q 020027           66 RRIIGQGRLGTVYAALLS---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--PGERIIVSEF  140 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  140 (332)
                      .+.||+|+||.||+|+..   +++.+|+|.+....    ......+|+.+++.++||||+++++++..  +...++++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            467999999999999843   56789999986432    12346789999999999999999998854  4567899999


Q ss_pred             cCCCCHHHHhcccCC-----CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe----CCCCceEEccCC
Q 020027          141 INMASLDFYLHENND-----GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL----NEKFCARVCDYG  211 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg  211 (332)
                      +. ++|.+++.....     ....+++..+..++.|++.||.|||++   +|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            95 578777753221     122478889999999999999999999   99999999999999    456789999999


Q ss_pred             ccccCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc
Q 020027          212 LSFLAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       212 ~a~~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      +++....         ...+|..|+|||.+...  ..++.++||||+||++|||+||+.||.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCC--CCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            9875432         12468889999988652  4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-41  Score=308.06  Aligned_cols=200  Identities=25%  Similarity=0.287  Sum_probs=172.0

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-C-----CCccceeeeeecCCce
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-H-----PNIVPILGFSQAPGER  134 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~  134 (332)
                      +|...+.||+|+||.|.+|. .++++.||||++++......   ....|+.+|..++ |     -|+|++++++...++.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~---Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLR---QAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHH---HHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            67888999999999999999 77999999999987643322   2367888888886 3     4999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC--CCceEEccCCc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE--KFCARVCDYGL  212 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~  212 (332)
                      |||+|.+. -+|+++++.+.-.  .++...+..|+.||+.||.+||+.   +|||+||||+|||+.+  ...+||+|||.
T Consensus       264 ciVfELL~-~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  264 CIVFELLS-TNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeehhhh-hhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            99999994 6999999987544  389999999999999999999998   9999999999999964  45799999999


Q ss_pred             cccCCccc---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH
Q 020027          213 SFLAPEEK---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP  273 (332)
Q Consensus       213 a~~~~~~~---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~  273 (332)
                      |.......   ..+..|.|||.+.+   .+|+.+.||||||||+.||+||.+.|.|....+.+.
T Consensus       338 Sc~~~q~vytYiQSRfYRAPEVILG---lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~  398 (586)
T KOG0667|consen  338 SCFESQRVYTYIQSRFYRAPEVILG---LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA  398 (586)
T ss_pred             ccccCCcceeeeeccccccchhhcc---CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence            98876654   34568999999988   899999999999999999999998887765544433

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-40  Score=293.50  Aligned_cols=254  Identities=22%  Similarity=0.260  Sum_probs=197.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||++. .++|+.+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..++++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            4568888999999999999999 45789999998865422 222335789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++....    .+++..+..++.|++.|+.|||+.  .+++|+||+|+||++++++.++++|||++.....
T Consensus        83 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          83 EFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             ecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            9999999999886543    278999999999999999999963  1899999999999999999999999998865322


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH----HHHHhhhcccccccCCcCCC
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW----ALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  290 (332)
                          ...++..|++||....   ..++.++|+|||||++||++||+.||.......    ....+.+ ............
T Consensus       157 ~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  232 (284)
T cd06620         157 SIADTFVGTSTYMSPERIQG---GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEPPPR  232 (284)
T ss_pred             hccCccccCcccCCHHHHcc---CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH-HHHHHhhccCCC
Confidence                2357889999998765   578899999999999999999999997643310    0000000 001111111111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ......+.++.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111233468899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.7e-40  Score=285.93  Aligned_cols=249  Identities=25%  Similarity=0.356  Sum_probs=199.0

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|...+.||+|+||.||+|. ..+++.|++|.++...........+.+|+.+++.++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47788999999999999998 45789999999976654323444678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.....    +++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+||+|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhcCC----CChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999975432    67888999999999999999998   9999999999999999999999999988654321 


Q ss_pred             ---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          220 ---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       220 ---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                               ..++..|++||..........+.++||||||+++||+++|+.||.+....+........      ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~  227 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA------GHKPPI  227 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc------CCCCCC
Confidence                     24567899999987643234789999999999999999999999765322222211111      111112


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +........+.+++.+||+.||++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            222222346779999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=294.85  Aligned_cols=247  Identities=20%  Similarity=0.226  Sum_probs=198.9

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||+|.. .+++.+|+|.+....... .....+..|+..++.++|+||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3688889999999999999994 468999999997654332 23335788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+.+++|.+++.....  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999875422  2378899999999999999999998   999999999999999999999999998754321


Q ss_pred             c-----------------------------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          219 E-----------------------------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       219 ~-----------------------------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                      .                                   ..|+..|++||.+..   ..++.++||||||+++|+|++|+.||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG---DGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC---CCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            1                                   135778999999875   56789999999999999999999999


Q ss_pred             CchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 020027          264 EGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS----IVQVAT  323 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs----~~~i~~  323 (332)
                      .+.........+...        ....+........+.+++.+||+.||++|||    +.|+++
T Consensus       233 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         233 KGSNRDETFSNILKK--------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCchHHHHHHHhcC--------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            876544433322221        1112222223457889999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-40  Score=291.67  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=197.9

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||++.. .+++.||+|.++.... ......+.+|+.++++++|+||+++++.+..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            4678889999999999999995 4889999998865421 2222357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++++|..++..... ...+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+|++|||++..... 
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            9999999998875321 22479999999999999999999963  1899999999999999999999999999865432 


Q ss_pred             ---ccCCcccccCcccccccC---CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 ---EKRGLAGYVDDDYWHEKG---GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~~---~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                         ...++..|++||.+....   ...++.++|+|||||++||+++|+.||...........+...     .... ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~-~~~~  230 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI-----VDGD-PPTL  230 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-----hhcC-CCCC
Confidence               224677899999875431   234688999999999999999999999764433332222111     0000 0111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +......+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1223457789999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.3e-40  Score=291.00  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=191.6

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHH-hccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||++.. .+|+.||+|.++....... ...+..|+.. ++..+|||++++++++..++..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            4688889999999999999994 5799999999876533222 2234555554 56678999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ ++|.+++.........+++..++.++.|++.||.|||+++  +++||||||+||+++.++.+||+|||++.....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9996 6888877653333345899999999999999999999752  799999999999999999999999999875432


Q ss_pred             c-----cCCcccccCcccccccCC-CCCCchhhhHHHHHHHHHHHhCCCCCCchhH-HHHHHHhhhcccccccCCcCCCC
Q 020027          219 E-----KRGLAGYVDDDYWHEKGG-GNATRESDVYGFGVVLLEILSGRRCEEGLLV-KWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       219 ~-----~~~~~~~~~pe~~~~~~~-~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .     ..++..|++||.+..... ..++.++|+|||||++|||++|+.||..... ...........     .+..  +
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~--~  229 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-----SPQL--P  229 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-----CCCC--C
Confidence            2     246778999998865322 4578899999999999999999999864211 11111111110     1111  1


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      . ...+.++.+++.+||+.+|++|||+.++++
T Consensus       230 ~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 A-EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             c-cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1 112346889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.4e-40  Score=288.29  Aligned_cols=253  Identities=23%  Similarity=0.229  Sum_probs=194.0

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      +.+++++.....||+|+||.||+|. ..++..||+|.+.....  .....+.+|+.+++.++|+||+++++++..++..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            3456666777899999999999999 55788999998865432  22235789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLSF  214 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~  214 (332)
                      +++||+++++|.+++...... ...++..+..++.|++.|++|||+.   +++||||||+||+++. ++.++|+|||.+.
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            999999999999998753211 1127788889999999999999998   9999999999999976 6799999999886


Q ss_pred             cCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          215 LAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       215 ~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ....      ...++..|++||.+... ...++.++|+||||+++|||++|+.||.......... .... ..   ... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-~~~~-~~---~~~-  230 (268)
T cd06624         158 RLAGINPCTETFTGTLQYMAPEVIDKG-PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-FKVG-MF---KIH-  230 (268)
T ss_pred             ecccCCCccccCCCCccccChhhhccc-cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-hhhh-hh---ccC-
Confidence            5422      12467899999998542 1347889999999999999999999986532111100 0000 00   001 


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ...+.....++.+++.+||+.+|++|||+.|+++
T Consensus       231 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 -PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             1111223346889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=289.22  Aligned_cols=253  Identities=23%  Similarity=0.262  Sum_probs=198.9

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCC---
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPG---  132 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~---  132 (332)
                      ..+++|+..+.||+|+||.||+|.. .+++.+++|.+.....   ....+.+|+.+++++ +|+||+++++++....   
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            3568899999999999999999995 5788999999875432   223578999999998 7999999999986544   


Q ss_pred             ---ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEcc
Q 020027          133 ---ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD  209 (332)
Q Consensus       133 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~d  209 (332)
                         ..+++|||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+|++|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence               48999999999999999875432223478999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCc------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccc
Q 020027          210 YGLSFLAPE------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS  281 (332)
Q Consensus       210 fg~a~~~~~------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  281 (332)
                      ||++.....      ...++..|+|||.+...  ....++.++||||||+++||++||..||...........+..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-  235 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP-  235 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC-
Confidence            998865432      22467889999987542  234578899999999999999999999976543333222222111 


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +  ....+......+.+++.+||+.||++|||+.++++
T Consensus       236 ----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 ----P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                1  11112223346789999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-40  Score=299.64  Aligned_cols=252  Identities=19%  Similarity=0.201  Sum_probs=195.6

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+++. .+++.+|+|.+.+..... .....+.+|+.++..++|+||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4688899999999999999994 567899999986432222 22224678889999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999976322   278888999999999999999998   999999999999999999999999999864321


Q ss_pred             -------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          219 -------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       219 -------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                             ...||..|+|||.+...  ....++.++|||||||++|||++|+.||.+.........+.....      ...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------~~~  228 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------RFQ  228 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------ccc
Confidence                   12578999999998632  124678999999999999999999999987655554444432211      111


Q ss_pred             CCC-ChHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 020027          290 IPC-EIKPLVRLAKVALACVGNSRK--NRPSIVQVATI  324 (332)
Q Consensus       290 ~~~-~~~~~~~l~~l~~~c~~~dp~--~RPs~~~i~~~  324 (332)
                      .+. .......+.+++.+|+..+++  .||++.++++.
T Consensus       229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            111 112234677888888765444  36888888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-41  Score=302.93  Aligned_cols=237  Identities=19%  Similarity=0.224  Sum_probs=185.3

Q ss_pred             eeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccC---CCCCccceeeeeecCCceeEEEeccCC
Q 020027           69 IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLA---QHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        69 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      ||+|+||.||+|+ ..+++.||+|.+....... ........|..++...   +||||+++++.+..++..+++|||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999999 4578999999986533221 1122344555555544   699999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----  218 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----  218 (332)
                      ++|..++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....     
T Consensus        81 g~L~~~l~~~~~----~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          81 GELFWHLQKEGR----FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             ChHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            999988875432    78999999999999999999998   999999999999999999999999999865321     


Q ss_pred             -ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          219 -EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       219 -~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                       ...|+..|+|||.+...  ..++.++|||||||++|||+||+.||.+.........+..+..        ..+.. ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------~~~~~-~~~  222 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDE--KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--------RFPKN-VLS  222 (330)
T ss_pred             cCccCCccccCHHHHcCC--CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--------CCCCc-cCC
Confidence             23578999999988642  4578999999999999999999999987665555444433221        11111 112


Q ss_pred             HHHHHHHHHcccCCCCCCCC----HHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPS----IVQVAT  323 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs----~~~i~~  323 (332)
                      ..+.+++.+||+.||++||+    +.++++
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            36678999999999999995    555443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-39  Score=284.95  Aligned_cols=244  Identities=21%  Similarity=0.229  Sum_probs=192.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc---ccccHHHHHHHhccCCCCCccceeeeeecC--Cce
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN---AGFGFASVIKTLSLAQHPNIVPILGFSQAP--GER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  134 (332)
                      ++|...+.||+|+||.||.|. ..++..||+|.+........   ....+.+|+.+++.++||||+++++++..+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            468889999999999999998 46789999999864332221   123567899999999999999999988653  467


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....    +++...+.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            899999999999999875432    67888899999999999999998   99999999999999999999999999886


Q ss_pred             cCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....         ...++..|++||.+..   ..++.++|+|||||++|||++|+.||.+.............       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------  224 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISG---EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-------  224 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcC---CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC-------
Confidence            4321         1246778999998865   56789999999999999999999999765333222111111       


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      + .....+......+.+++.+||. +|++|||++++++
T Consensus       225 ~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 P-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             C-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0 0111122333467789999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7e-40  Score=285.42  Aligned_cols=245  Identities=22%  Similarity=0.281  Sum_probs=197.3

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|...+.||+|+||.||+|.. .+|..+|+|.+............+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            477788999999999999994 5788999999876543333334577999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEccCCccccCCcc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCDYGLSFLAPEE  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~~~~  219 (332)
                      +++++|.+++.....  ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++ .+|++|||.+....+.
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999875432  2378999999999999999999998   999999999999998875 4699999988655432


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                            ..++..|++||....   ..++.++|+||||+++||+++|..||...................         ..
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~  223 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQN---RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---------IS  223 (257)
T ss_pred             cccccccCCCccccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---------CC
Confidence                  246778999998765   568899999999999999999999997654433322222221111         11


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+.+++.+||+.+|++|||+.++++
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            112236789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=308.51  Aligned_cols=243  Identities=25%  Similarity=0.292  Sum_probs=197.0

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMAS  145 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  145 (332)
                      -+||+|+||+||.|+ ..+...+|||.+..+..  +...-..+||...+.++|.|||+++|.+..++++-|.||.++||+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            479999999999999 67888999999865542  333457899999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC-CCCceEEccCCccccC------Cc
Q 020027          146 LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLA------PE  218 (332)
Q Consensus       146 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~dfg~a~~~------~~  218 (332)
                      |..++++. +++..=.+.++-.+..||++||.|||++   .|||||||-.|+|++ -.|.+||+|||-++..      .+
T Consensus       659 LSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  659 LSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             HHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            99999763 3331126788888999999999999999   999999999999997 4899999999987543      34


Q ss_pred             ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       219 ~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                      ...||..|||||..... ...|+.++|||||||.+.||.||++||.......+ .+.+.+-+      ..-.+.+.+-..
T Consensus       735 TFTGTLQYMAPEvIDqG-~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMFkVGmy------KvHP~iPeelsa  806 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQG-PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMFKVGMY------KVHPPIPEELSA  806 (1226)
T ss_pred             ccccchhhhChHhhccC-CcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhhhhcce------ecCCCCcHHHHH
Confidence            55799999999998753 35689999999999999999999999974321111 22222211      112344555666


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +...++.+|+.+||.+||+++++++
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhcc
Confidence            8889999999999999999999874

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-39  Score=285.66  Aligned_cols=244  Identities=21%  Similarity=0.285  Sum_probs=190.5

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc---ccccHHHHHHHhccCCCCCccceeeeeec--CCce
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN---AGFGFASVIKTLSLAQHPNIVPILGFSQA--PGER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  134 (332)
                      .+|...+.||+|+||.||+|. ..++..||+|.+........   ....+.+|+.+++.++||||+++++++..  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            468899999999999999998 45789999999875432221   22347789999999999999999998865  3567


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++++|.+++.....    +++...+.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999999875432    78888999999999999999998   99999999999999999999999999986


Q ss_pred             cCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....         ...++..|++||.+..   ..++.++|+|||||++||+++|+.||................    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~----~~  227 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISG---EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP----TN  227 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCC---CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC----CC
Confidence            4321         1246778999998865   668899999999999999999999997653322211111110    01


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +.+  +  ......+.+++ +||..+|++|||++|+++
T Consensus       228 ~~~--~--~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQL--P--SHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC--c--hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111  1  11122455566 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.1e-40  Score=291.68  Aligned_cols=254  Identities=20%  Similarity=0.198  Sum_probs=195.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--CceeEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERIIV  137 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  137 (332)
                      ++|+..+.||+|+||.||+|.. .+++.+|+|.++...........+.+|+.++++++||||+++.+++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            5788899999999999999995 4788999999976544333233467899999999999999999998877  889999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      +||++ ++|.+++.....   .+++...+.++.|++.||.|||+.   +++|+||+|+||++++++.+|++|||+++...
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99997 589888865432   378999999999999999999998   99999999999999999999999999987554


Q ss_pred             cc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------------
Q 020027          218 EE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------------  278 (332)
Q Consensus       218 ~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------------  278 (332)
                      ..      ..++..|++||.....  ...+.++|+||||+++|||++|..||...........+...             
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             CCccccccccccccccCchhhcCC--ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            32      2457789999987642  34688999999999999999999999765433222111100             


Q ss_pred             --------ccccccCCcCCCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 --------RFSELLDPRLAIPCEIK-PLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 --------~~~~~~~~~~~~~~~~~-~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                              .........+....+.. ....+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                    00000000000000100 2346779999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-39  Score=290.89  Aligned_cols=254  Identities=20%  Similarity=0.222  Sum_probs=195.7

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccc---ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVL---SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      +|+..+.||+|+||.||+|.. .+|+.||+|.++.....   ......+..|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999994 57899999999765433   11223457899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+ +++|.+++....   ..+++..+..++.|+++||.|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999997543   2388999999999999999999999   99999999999999999999999999987654


Q ss_pred             cc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------------
Q 020027          218 EE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------------  278 (332)
Q Consensus       218 ~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------------  278 (332)
                      ..      ..++..|++||.....  ..++.++|+|||||++||+++|..||.+.........+...             
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         154 SPNRKMTHQVVTRWYRAPELLFGA--RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCCccccccccceeeeCHHHHhCC--CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            32      1345679999987542  46789999999999999999998887654432222211110             


Q ss_pred             ccccccCCcCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          279 RFSELLDPRLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ............+.+     ......+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000000000     1224578899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-39  Score=285.58  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=194.4

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc--------cccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA--------GFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      +|...+.||+|+||.||+|. ..+|+.+|+|.++........        ...+.+|+..++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46677899999999999998 457899999988643221111        124678899999999999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..++++||+++++|.+++....    .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            9999999999999999997652    278888999999999999999998   999999999999999999999999999


Q ss_pred             cccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          213 SFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       213 a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      +......        ..++..|++||...... ..++.++|+||||+++||+++|..||..................   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  230 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS-QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA---  230 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhcccc-CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC---
Confidence            8654321        24677899999876531 24788999999999999999999999654332222111111101   


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       +.............+.+++.+||+.||++|||+.++++
T Consensus       231 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 -PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             11111111122347889999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.2e-40  Score=311.82  Aligned_cols=254  Identities=19%  Similarity=0.202  Sum_probs=186.8

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC------CCCccceeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ------HPNIVPILGFS  128 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~  128 (332)
                      ++...++|...+.||+|+||+||+|. ..+++.||+|+++....   .......|+.+++.++      |.+++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            34456789999999999999999998 45788999999864321   1112345666665554      45688888888


Q ss_pred             ecC-CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCC---
Q 020027          129 QAP-GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKF---  203 (332)
Q Consensus       129 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~---  203 (332)
                      ..+ +..+++||++ +++|.+++.....    +++..+..++.|++.||.|||+ .   +|+||||||+|||++.++   
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGP----FSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence            654 5788999988 6788888865432    7899999999999999999997 5   899999999999998765   


Q ss_pred             -------------ceEEccCCccccCCc---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh
Q 020027          204 -------------CARVCDYGLSFLAPE---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL  267 (332)
Q Consensus       204 -------------~~kl~dfg~a~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~  267 (332)
                                   .+||+|||.+.....   ...||..|+|||.+..   ..++.++|||||||++|||+||+.||.+..
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLG---LGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhc---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                         499999998764332   2368899999999876   678999999999999999999999998754


Q ss_pred             HHHHHHHhhh--cccc-------------ccc------CCcCC--------C---CCChHHHHHHHHHHHHcccCCCCCC
Q 020027          268 VKWALPLIKE--MRFS-------------ELL------DPRLA--------I---PCEIKPLVRLAKVALACVGNSRKNR  315 (332)
Q Consensus       268 ~~~~~~~~~~--~~~~-------------~~~------~~~~~--------~---~~~~~~~~~l~~l~~~c~~~dp~~R  315 (332)
                      ..+....+..  +.+.             ...      .+...        .   .........+.+++.+||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            4333222211  0000             000      00000        0   0000112356799999999999999


Q ss_pred             CCHHHHHH
Q 020027          316 PSIVQVAT  323 (332)
Q Consensus       316 Ps~~~i~~  323 (332)
                      ||++|+++
T Consensus       430 ~ta~e~L~  437 (467)
T PTZ00284        430 LNARQMTT  437 (467)
T ss_pred             CCHHHHhc
Confidence            99999986

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-39  Score=283.33  Aligned_cols=245  Identities=28%  Similarity=0.403  Sum_probs=197.9

Q ss_pred             CCCCceeeccCCeEEEEEEeC-C----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           63 FSHRRIIGQGRLGTVYAALLS-T----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ++..+.||.|+||.||++... +    +..||+|.++...... ....+..|+..+..++|+|++++++++...+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            356688999999999999953 3    3889999986553221 334678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.......  +++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++....
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EeccCCCCHHHHHHhhhhcc--CCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999997643211  78999999999999999999999   99999999999999999999999999986554


Q ss_pred             cc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          218 EE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       218 ~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      +.       ..++..|++||....   ..++.++|+||+|+++|||++ |..||.+.........+......        
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKD---GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--------  223 (258)
T ss_pred             cccccccccCCCcccccChHHhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence            32       235678999998854   678899999999999999999 78888765554444444332211        


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                       +.+.....++.+++.+||+.||++|||+.++++.|
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             11112344788999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-41  Score=302.07  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=200.1

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      +....|++.+.||.||-+.||++...+.+.+|+|++.....+......|.+|+..|.++ .|.+||+++++-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34567999999999999999999988888999998876655555555799999999999 49999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |||+= ..+|..++++.....  ..| .+..+..|++.++.+.|.+   ||||.||||.|+|+- +|.+||+|||+|...
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~--~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSID--PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCC--chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            99986 579999998754432  234 6778999999999999999   999999999999995 467999999999765


Q ss_pred             Cc--------ccCCcccccCcccccccCCC--------CCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccc
Q 020027          217 PE--------EKRGLAGYVDDDYWHEKGGG--------NATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRF  280 (332)
Q Consensus       217 ~~--------~~~~~~~~~~pe~~~~~~~~--------~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~  280 (332)
                      .+        +..||..||+||.+......        ..+++|||||+|||||+|+.|+.||+.....+.       ++
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-------Kl  582 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-------KL  582 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-------HH
Confidence            43        34799999999998654211        367899999999999999999999987543322       12


Q ss_pred             ccccCCcC--CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 SELLDPRL--AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ~~~~~~~~--~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+.+|.-  ..+.-.+ ..++.++|..||+.||++|||..++++
T Consensus       583 ~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            22334422  2222111 123889999999999999999999986

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.3e-40  Score=289.11  Aligned_cols=253  Identities=19%  Similarity=0.213  Sum_probs=193.4

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||.|++|.||+|+. .+|+.||+|.++...........+.+|++++++++||||+++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            478889999999999999984 5789999999875543333334578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +. ++|..++.....  ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 688888865432  2378999999999999999999998   9999999999999999999999999998654321 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHH-HHhhhcc--------------
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL-PLIKEMR--------------  279 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~--------------  279 (332)
                           ..++..|++||.....  ..++.++||||||+++|||+||+.||.+....... .......              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             cccccccccccccCCeEEecC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence                 1356789999987642  34688999999999999999999999754332211 1111100              


Q ss_pred             -----cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -----FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -----~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           +.......... .......++.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                 00000000000 00011235678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-39  Score=282.48  Aligned_cols=245  Identities=24%  Similarity=0.311  Sum_probs=195.2

Q ss_pred             CCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccc---cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLS---NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      +|...+.||+|+||.||+|... +++.|++|.+.......   .....+.+|+..++.++|+|++++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3677889999999999999954 88999999987543221   1223578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      +||+++++|.+++....    .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999997643    278889999999999999999998   99999999999999999999999999886543


Q ss_pred             c-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 E-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .     ...++..|++||.+...  ..++.++|+||||+++||+++|+.||................  .    ....+ 
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~----~~~~~-  224 (258)
T cd06632         154 EFSFAKSFKGSPYWMAPEVIAQQ--GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--E----LPPIP-  224 (258)
T ss_pred             ccccccccCCCcceeCHHHhcCC--CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--c----CCCcC-
Confidence            2     23467889999988652  237899999999999999999999997654322221111100  0    00111 


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ......+.+++.+||+.+|++|||+.++++
T Consensus       225 -~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         225 -DHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             112346778999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=287.33  Aligned_cols=260  Identities=23%  Similarity=0.330  Sum_probs=197.7

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC----CceeE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP----GERII  136 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~l  136 (332)
                      .+....+.||+|.||.||+|++ .|+.||||++...   ++.+.....||..-..++|+||+.+.+.=..+    ..++|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            4566678999999999999998 5889999999644   33344345666667788999999998875433    35799


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV-----APNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      +++|-+.|+|.+|+....     ++....++++..+|+||++||...     .|+|.|||||..|||+.+++++-|+|+|
T Consensus       287 vTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             eeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            999999999999998643     789999999999999999999643     6789999999999999999999999999


Q ss_pred             ccccCC----------cccCCcccccCcccccccCCC---CCCchhhhHHHHHHHHHHHhC----------CCCCCchhH
Q 020027          212 LSFLAP----------EEKRGLAGYVDDDYWHEKGGG---NATRESDVYGFGVVLLEILSG----------RRCEEGLLV  268 (332)
Q Consensus       212 ~a~~~~----------~~~~~~~~~~~pe~~~~~~~~---~~~~~~DiwS~G~il~el~tg----------~~p~~~~~~  268 (332)
                      +|....          +...||..|||||.+......   ..-..+||||||.++||++-+          ..||.+..+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            985433          334799999999998753211   123468999999999999852          236643211


Q ss_pred             -HHHHHHhhhcccccccCCcCCCCC-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          269 -KWALPLIKEMRFSELLDPRLAIPC-EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       269 -~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                       +...+.+.+--..+.++|.++... +.+.+..+.++|..||..||..|-|+-.|-..|.++.
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence             111112222222233444444332 3456778889999999999999999999999988876

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-40  Score=298.36  Aligned_cols=251  Identities=18%  Similarity=0.192  Sum_probs=194.6

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||+++ ..+++.||+|.+....... .....+.+|+.++..++|+||+++++++..++..+++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            468889999999999999999 4578899999986532211 22224678889999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999976322   278888999999999999999998   999999999999999999999999999865432


Q ss_pred             c-------cCCcccccCcccccccC--CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          219 E-------KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       219 ~-------~~~~~~~~~pe~~~~~~--~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .       ..|+..|+|||.+....  ...++.++|||||||++|||++|+.||.+....+....+....      .++.
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------~~~~  228 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE------ERFQ  228 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC------Cccc
Confidence            1       25889999999886421  1357889999999999999999999998765544443332211      1111


Q ss_pred             CCCC-hHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 020027          290 IPCE-IKPLVRLAKVALACVGNSRKN--RPSIVQVAT  323 (332)
Q Consensus       290 ~~~~-~~~~~~l~~l~~~c~~~dp~~--RPs~~~i~~  323 (332)
                      .+.. .....++.+++.+|+..++++  |++++++++
T Consensus       229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            1111 112346778999998865543  457777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.9e-40  Score=289.33  Aligned_cols=256  Identities=23%  Similarity=0.280  Sum_probs=198.0

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeee
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQ  129 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  129 (332)
                      ++.+.....+.|+..+.||+|+||.||+|. ..+++.+|+|.+....   .....+..|+.+++++ +|+|++++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            334555566789999999999999999999 4678999999876432   1223467888888888 7999999999885


Q ss_pred             c------CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          130 A------PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       130 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      .      .+..+++|||+++++|.+++......  .+++..++.++.|++.|+.|||++   +++|+|++|+||++++++
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN--ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            3      45789999999999999998764322  367888899999999999999998   999999999999999999


Q ss_pred             ceEEccCCccccCCc------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHh
Q 020027          204 CARVCDYGLSFLAPE------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI  275 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~  275 (332)
                      .++|+|||++.....      ...++..|++||.+...  ....++.++|+|||||++|||+||..||...........+
T Consensus       159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            999999999865432      23467889999987532  1346788999999999999999999999765433222211


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....     .+..   ........+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 PRNP-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhCC-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1110     0111   11122347889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.6e-39  Score=287.72  Aligned_cols=253  Identities=20%  Similarity=0.250  Sum_probs=197.8

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||.||+|.. .+|+.||+|.+............+.+|+.+++.++|||++++++++..++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477889999999999999994 5789999999876543333344678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      + +++|.+++....   ..+++.++..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++...... 
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999986543   2388999999999999999999998   9999999999999999999999999998764332 


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------c-------
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------R-------  279 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~-------  279 (332)
                            ..++..|++||.+...  ..++.++||||+|+++|||+||.+||.+.........+...       .       
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CCccccccCcccccCceeeecc--ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence                  2467889999987642  45689999999999999999998888765433322221110       0       


Q ss_pred             --cccccCCcCC-C---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 --FSELLDPRLA-I---PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 --~~~~~~~~~~-~---~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        +.....+... .   ....+....+.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              0000000000 0   000122357889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-40  Score=302.43  Aligned_cols=247  Identities=20%  Similarity=0.213  Sum_probs=190.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..+|...+.||+|+||.||++..   .++..||+|.+...       ....+|+.+++.++||||+++++++...+..++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            45799999999999999999973   34678999987532       134689999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +||++. ++|.+++....    .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++...
T Consensus       164 v~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999995 68888884332    288999999999999999999998   9999999999999999999999999998654


Q ss_pred             Ccc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH---HHHHHhhh----cc--
Q 020027          217 PEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK---WALPLIKE----MR--  279 (332)
Q Consensus       217 ~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~---~~~~~~~~----~~--  279 (332)
                      ...        ..||..|+|||.+..   ..++.++|||||||++|||++|+.||.+....   ..+..+..    ..  
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLAL---DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             CcccccccccccccccCccCHhHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            321        257899999999876   67889999999999999999999998654211   11111100    00  


Q ss_pred             ---------------cccccCCcCCCCCC---hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          280 ---------------FSELLDPRLAIPCE---IKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       280 ---------------~~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                                     +.....+....+..   ......+.+++.+||..||++|||+.|+++.
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                           00000111111100   0113367789999999999999999999863

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.3e-40  Score=292.12  Aligned_cols=241  Identities=21%  Similarity=0.237  Sum_probs=192.8

Q ss_pred             CCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccC
Q 020027           64 SHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      .....||+|+||.||++.. .++..||+|.+.....  .....+.+|+..++.++|+|++++++.+...+..+++|||++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3345699999999999984 5788999999864332  222346889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc---
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE---  219 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~---  219 (332)
                      +++|.+++...     .+++..+..++.|++.||.|||++   +++||||||+||++++++.++|+|||++......   
T Consensus       103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658         103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            99999988542     278889999999999999999998   9999999999999999999999999998643221   


Q ss_pred             ---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHH
Q 020027          220 ---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP  296 (332)
Q Consensus       220 ---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                         ..++..|+|||....   ..++.++|+||||+++||+++|+.||.+.........+...     ..+....  ....
T Consensus       175 ~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~--~~~~  244 (292)
T cd06658         175 RKSLVGTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-----LPPRVKD--SHKV  244 (292)
T ss_pred             CceeecCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----CCCcccc--cccc
Confidence               246788999998865   56789999999999999999999999875544333322221     1111111  1112


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          297 LVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       297 ~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ...+.+++.+||..||.+|||+.++++.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            3367789999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-39  Score=302.66  Aligned_cols=246  Identities=19%  Similarity=0.213  Sum_probs=188.1

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .+|...+.||+|+||.||++.. .+++.||+|....        ..+.+|+.++++++|+||+++++++...+..+++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4688889999999999999994 5688999995321        235789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      ++. ++|..++.....   .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.... 
T Consensus       241 ~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        241 KYR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             ccC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            995 688888765322   389999999999999999999998   999999999999999999999999999875432 


Q ss_pred             -------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch--------hHHHHHHHhhhcccc--
Q 020027          219 -------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL--------LVKWALPLIKEMRFS--  281 (332)
Q Consensus       219 -------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~--------~~~~~~~~~~~~~~~--  281 (332)
                             ...||..|++||++..   ..++.++|||||||++|||++|..++...        ........+......  
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~---~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAG---DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcC---CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence                   1248899999999876   67899999999999999999977543211        111122222211110  


Q ss_pred             ---cc----------------cCCcCCCCCC---hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          282 ---EL----------------LDPRLAIPCE---IKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       282 ---~~----------------~~~~~~~~~~---~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                         ..                ..+....+..   ......+.+++.+||+.||.+|||+.|+++.
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               00                0000000000   0112257789999999999999999999863

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-39  Score=289.23  Aligned_cols=253  Identities=24%  Similarity=0.245  Sum_probs=195.7

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--CCceeEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--PGERIIV  137 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  137 (332)
                      ++|...+.||.|++|.||++.. .+++.+|+|.+...... .....+.+|+++++.++||||+++++++..  .+..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            4678889999999999999995 57889999998754322 223457899999999999999999998854  3468999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.........+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++++|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999988765332233478889999999999999999998   99999999999999999999999999986543


Q ss_pred             cc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-----HHHHHHhhhcccccccCCcC
Q 020027          218 EE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-----KWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       218 ~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ..    ..++..|++||....   ..++.++||||+||++|||++|+.||.....     .+....+........ ... 
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-  231 (287)
T cd06621         157 NSLAGTFTGTSFYMAPERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL-KDE-  231 (287)
T ss_pred             ccccccccCCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh-ccC-
Confidence            22    246778999998865   6788999999999999999999999875421     111121111111000 000 


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ..........+.+++.+||+.||++|||+.|+++
T Consensus       232 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 -PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             1111122447889999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4e-39  Score=289.74  Aligned_cols=250  Identities=24%  Similarity=0.258  Sum_probs=197.9

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .|...+.||+|+||.||+++ ..++..+|+|.+....... .....+.+|+..++.++|+|++++++++..++..+++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            37788899999999999999 4578999999987543222 222357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++ ++.+.+.....   .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++......
T Consensus       106 ~~~g-~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCLG-SASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCCC-CHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9974 77776654322   278999999999999999999998   9999999999999999999999999998655432


Q ss_pred             --cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          220 --KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       220 --~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                        ..++..|++||.+.......++.++|+|||||++|||++|+.||.+.........+.....        .........
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~  250 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--------PTLQSNEWS  250 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC--------CCCCCcccc
Confidence              3577889999998543335688999999999999999999999876544333333322111        011111223


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      ..+.+++.+||+.+|.+|||+.++++.+-
T Consensus       251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         251 DYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            46789999999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-39  Score=289.23  Aligned_cols=242  Identities=18%  Similarity=0.211  Sum_probs=197.4

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||++. ..+++.+|+|.+....... .....+.+|++++++++||||+++++++...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            468888999999999999999 4578999999986543222 22235788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~----l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKSGR----FPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999876532    78899999999999999999998   999999999999999999999999999876543


Q ss_pred             c---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 E---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                      .   ..++..|++||.+..   ...+.++|+||||+++|||++|+.||...........+..+        ....+... 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-  221 (290)
T cd05580         154 RTYTLCGTPEYLAPEIILS---KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--------KVRFPSFF-  221 (290)
T ss_pred             CCCCCCCCccccChhhhcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------CccCCccC-
Confidence            3   246788999998865   56788999999999999999999999766544333333222        11122222 


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRP-----SIVQVA  322 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RP-----s~~~i~  322 (332)
                       ...+.+++.+||+.||++||     +++|++
T Consensus       222 -~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         222 -SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -CHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence             34778999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.1e-40  Score=291.29  Aligned_cols=241  Identities=19%  Similarity=0.226  Sum_probs=193.6

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |+....||+|+||.||++.. .+++.||+|.+......  ....+.+|+..++.++|||++++++++..++..++++||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            33445799999999999984 57899999998654322  2234678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc--
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--  219 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--  219 (332)
                      ++++|..++...     .+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.+||+|||++......  
T Consensus       101 ~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         101 QGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999887542     278999999999999999999998   9999999999999999999999999998643321  


Q ss_pred             ----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          220 ----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       220 ----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                          ..++..|++||.+..   ..++.++|||||||++|||++|+.||...........+....     .+....  ...
T Consensus       173 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~--~~~  242 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISR---TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-----PPKLKN--AHK  242 (297)
T ss_pred             cccceecCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----CCCccc--cCC
Confidence                246788999999865   568899999999999999999999997655444433332211     011111  111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....+.+++.+||+.+|++|||++++++
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            2236778999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-40  Score=289.44  Aligned_cols=254  Identities=22%  Similarity=0.259  Sum_probs=196.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.++...........+.+|+++++.++|+||+++++++..++..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688889999999999999994 478899999987654433334467899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |++++++..+.....    .+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999877776664432    278899999999999999999998   9999999999999999999999999998764432


Q ss_pred             -------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--cccc----cc--c
Q 020027          220 -------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--MRFS----EL--L  284 (332)
Q Consensus       220 -------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~----~~--~  284 (332)
                             ..++..|++||.....  ..++.++|+||||+++|||++|+.||.+....+.......  +...    ..  .
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             ccccccCcccccCCcCCchhcCC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence                   2356779999998762  2778999999999999999999999875432221111110  0000    00  0


Q ss_pred             CCc-----CCC---------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 DPR-----LAI---------PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ~~~-----~~~---------~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ++.     ...         ..+.....++.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000     000         001112457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=285.91  Aligned_cols=254  Identities=22%  Similarity=0.286  Sum_probs=193.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|++|.||+|.. .+++.||+|.+...... .....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            35788899999999999999994 47899999998754322 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ ++|.+++.....   .+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+|++|||+++....
T Consensus        83 e~~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          83 EYLD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             ecCC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            9997 489988865432   378899999999999999999998   999999999999999999999999999865321


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-HHHHHHHhhh-------ccccccc
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL-VKWALPLIKE-------MRFSELL  284 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-~~~~~~~~~~-------~~~~~~~  284 (332)
                            ...++..|++||.+...  ..++.++||||+|+++|||++|+.||.+.. .......+.+       ..+....
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCccccccccccccCCcHHhhcC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence                  12356789999987642  457889999999999999999999996543 1111111100       0000000


Q ss_pred             ------CCcCCC--C-------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 ------DPRLAI--P-------CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ------~~~~~~--~-------~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            ......  +       ........+.+++.+|++.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                  000000  0       00111146779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-39  Score=283.19  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=199.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||.|+||.||+|. ..++..+++|.+....... ....+.+|+..++.++|+|++++++.+...+..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            468889999999999999999 4578899999986543322 33457899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      ++++++|.+++..... ...+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++++|||++......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999975422 12378999999999999999999998   9999999999999999999999999987543321


Q ss_pred             ----------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          220 ----------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       220 ----------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                                ..++..|++||.....  ..++.++|+||||+++|||++|+.||................     .+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~  228 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQV--HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-----PPSLE  228 (267)
T ss_pred             ccccccccccccCChhhcChHHHccc--cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-----CCCcC
Confidence                      1367789999988763  367899999999999999999999997654332222211111     11111


Q ss_pred             CCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCE-IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~-~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .... ......+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1111 123346789999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.1e-39  Score=284.17  Aligned_cols=242  Identities=24%  Similarity=0.292  Sum_probs=196.0

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      -|+..+.||+|+||.||+|. ..+++.+|+|........ .....+.+|+..++.++|||++++++++..++..+++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            36677899999999999998 457889999987643321 2223578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++...     .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++...... 
T Consensus        84 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            9999999998643     278999999999999999999998   9999999999999999999999999998654332 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||....   ...+.++|+|||||++||+++|..||...........+.....     +.+    +.
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~----~~  223 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-----PTL----EG  223 (277)
T ss_pred             hhhccccCCccccChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC-----CCC----Cc
Confidence                 246778999998865   5678899999999999999999999976544333332222111     111    11


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            122367789999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-39  Score=291.76  Aligned_cols=190  Identities=19%  Similarity=0.243  Sum_probs=154.3

Q ss_pred             CceeeccCCeEEEEEEeC---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee--cCCceeEEEec
Q 020027           66 RRIIGQGRLGTVYAALLS---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ--APGERIIVSEF  140 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~  140 (332)
                      .+.||+|+||.||+|+..   ++..||+|.+....    ....+.+|+.+++.++||||+++++++.  .+...++++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            357999999999999853   45789999886432    2234688999999999999999999884  35678999999


Q ss_pred             cCCCCHHHHhcccC-----CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe----CCCCceEEccCC
Q 020027          141 INMASLDFYLHENN-----DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL----NEKFCARVCDYG  211 (332)
Q Consensus       141 ~~~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg  211 (332)
                      ++ ++|.+++....     .....+++..+..++.|++.||.|||+.   +++||||||+||++    +.++.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            96 57777764321     1122478889999999999999999998   99999999999999    466799999999


Q ss_pred             ccccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc
Q 020027          212 LSFLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       212 ~a~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      +++.....         ..++..|+|||.+...  ..++.++|||||||++|||+||+.||..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCC--CccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            98754321         2467889999988652  4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.2e-39  Score=288.25  Aligned_cols=257  Identities=18%  Similarity=0.198  Sum_probs=192.8

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCc-----
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGE-----  133 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  133 (332)
                      ++|+..+.||+|+||.||+|. ..+++.||+|.++...........+.+|+.+++.++ |+|++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468889999999999999999 457899999998765433333345788999999995 6999999999876655     


Q ss_pred             eeEEEeccCCCCHHHHhcccCCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCC
Q 020027          134 RIIVSEFINMASLDFYLHENNDG-ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYG  211 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg  211 (332)
                      .+++|||+++ ++.+++...... ...+++..++.++.||+.||.|||++   +++||||+|+||+++. ++.+|++|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 788887654322 23479999999999999999999998   9999999999999998 8999999999


Q ss_pred             ccccCCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHH-HHhhhcc--ccc
Q 020027          212 LSFLAPEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL-PLIKEMR--FSE  282 (332)
Q Consensus       212 ~a~~~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~--~~~  282 (332)
                      ++......      ..++..|++||.....  ..++.++|+||||+++|||++|..||.+....... .......  ..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            98643221      2356779999987542  45789999999999999999999999765332221 1111000  000


Q ss_pred             ccC-----------CcCCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLD-----------PRLAI----PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~-----------~~~~~----~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...           +....    ........++.+++.+||+.||.+|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000           00000    000112346789999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=293.46  Aligned_cols=245  Identities=18%  Similarity=0.262  Sum_probs=212.0

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .-|+..+.||+|.|..|-.++ .-+|+.||||++.+...+.-....+.+|+..|+.++|||||++|++...+..+||+.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            347778999999999999998 5699999999999877666555568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCccccCCc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLSFLAPE  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~~  218 (332)
                      +=++|+|.+||-.+..+   +.+....+++.||..|+.|+|..   .+|||||||+|+.+.+ -|.+|+.|||++-....
T Consensus        98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999877554   78899999999999999999998   8999999999998864 68899999999865433


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ..+|...|-|||.+.+.  ....+++||||+|||||-|++|+.||+...+.+.+.++.+.++          ..+
T Consensus       172 G~kL~TsCGSLAYSAPEILLGD--sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY----------tvP  239 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGD--SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY----------TVP  239 (864)
T ss_pred             cchhhcccchhhccCchhhhcC--ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc----------cCc
Confidence                 34788899999999874  4456899999999999999999999999888888877776542          223


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .-...++.+||..++..||++|-|.++|+.
T Consensus       240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  240 SHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            344557889999999999999999999875

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=285.41  Aligned_cols=253  Identities=20%  Similarity=0.232  Sum_probs=193.5

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |+..+.||.|++|.||+|. ..+|..||+|.+............+.+|+..++.++|||++++++++..++..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            5677899999999999998 458999999998765433333345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc---
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE---  218 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~---  218 (332)
                      + ++|.+++.....  ..+++..++.++.|+++||.|||++   +++|+||+|+||+++.++.++++|||++.....   
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 689988875432  2378999999999999999999998   999999999999999999999999999865431   


Q ss_pred             ---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHH-HHhhhcc---------cccccC
Q 020027          219 ---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL-PLIKEMR---------FSELLD  285 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~---------~~~~~~  285 (332)
                         ...++..|++||.....  ..++.++|+||||+++|||+||+.||.+....... .......         .....+
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGS--RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             ccCccccccCCCCCceeecC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence               12346789999987542  45688999999999999999999999754332211 1111000         000000


Q ss_pred             -----CcCC----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 -----PRLA----IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 -----~~~~----~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           +...    ..........+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 0000    0001112246779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.9e-39  Score=288.65  Aligned_cols=245  Identities=23%  Similarity=0.277  Sum_probs=196.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||++. ..++..||+|.+.....  .....+.+|+.+++.++|||++++++.+...+..++++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            4678899999999999999998 45788999999864322  22235688999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.+..     +++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          96 EYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             ecCCCCcHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999986532     67888999999999999999999   999999999999999999999999998754332


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      ..++..|++||....   ..++.++|+||||+++||+++|+.||...........+...       .......
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~  237 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-------GTPELQN  237 (293)
T ss_pred             cccccccccCChhhcCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-------CCCCCCC
Confidence            2      246677999998865   56789999999999999999999999765433221111110       1111111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      +......+.+++.+||+.+|++||++.+++..
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12223467799999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.2e-39  Score=282.04  Aligned_cols=247  Identities=21%  Similarity=0.284  Sum_probs=203.3

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||.||++. ..+++.+++|.+............+.+|+..++.++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            47788899999999999998 55889999999876544344444678899999999999999999999988999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.........+++..+..++.|++.|+.|||+.   +++|+||+|.||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999876433233478999999999999999999998   9999999999999999999999999998665432 


Q ss_pred             ---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHH
Q 020027          220 ---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP  296 (332)
Q Consensus       220 ---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                         ..++..|++||.+..   ..++.++|+||||+++||+++|+.||...........+......         +.+...
T Consensus       158 ~~~~~~~~~~~~Pe~~~~---~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~  225 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKG---RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP---------PIPPIY  225 (256)
T ss_pred             cccccCCccccCHHHHCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------CCchhh
Confidence               346788999999876   67788999999999999999999999876554443333322211         111233


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          297 LVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       297 ~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+.+++.+||+.+|++|||+.++++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            457889999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=284.51  Aligned_cols=243  Identities=23%  Similarity=0.321  Sum_probs=194.2

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC---CCCccceeeeeecCCceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  137 (332)
                      .|+..+.||+|+||.||+|. ..+++.+|+|.++.... ......+.+|+.+++.++   |||++++++++...+..+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            47788899999999999999 46889999999875432 222235678888888886   99999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++...     .+++..++.++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          81 MEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            9999999999998643     278999999999999999999998   99999999999999999999999999886543


Q ss_pred             cc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 EE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ..      ..++..|++||....  +..++.++|+||||+++|+|++|..||.+.........+....     .+.+.. 
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~-  224 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITE--GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-----PPRLED-  224 (277)
T ss_pred             CCccccccccCCcceeCHHHhcc--CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC-----CCCCCc-
Confidence            22      246778999998754  2456889999999999999999999997654332221111110     011111 


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .....++.+++.+||+.||++|||+.++++
T Consensus       225 --~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 --NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             --ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence              012346889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-39  Score=283.79  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=194.3

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc----ccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN----AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      +|+..+.||+|+||.||+|. ..+++.+|+|.+........    ....+.+|+..+++++|+|++++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47788999999999999998 57889999999875432211    12357889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEccCCcccc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCDYGLSFL  215 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~  215 (332)
                      ++||+++++|.+++....    .+++.....++.|++.|+.|||++   +++|+||+|+||+++.++ .+||+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999987543    278899999999999999999998   999999999999998765 699999999865


Q ss_pred             CCcc----------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          216 APEE----------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       216 ~~~~----------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....          ..++..|++||.+..   ..++.++|+||+|+++||+++|..||...........+....     .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~  225 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-----S  225 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh-----c
Confidence            4321          235678999998865   567899999999999999999999986432211111111100     0


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .......+.....++.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00111112223347889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.2e-39  Score=285.46  Aligned_cols=254  Identities=20%  Similarity=0.226  Sum_probs=191.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      +++|...+.||+|+||.||+|. ..+|+.||+|.+..... ......+.+|+..++.++|+||+++++++..++..++++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4678999999999999999998 45789999999865432 222335678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+. +++.+++.....   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 677666654322   267888889999999999999998   999999999999999999999999999865322


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhh--c-----------
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKE--M-----------  278 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~--~-----------  278 (332)
                            ...++..|++||.+...  ..++.++||||||+++|||+||+.||.+.... +....+..  +           
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCccccccccCCceeecC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence                  12467889999987642  45788999999999999999999999754321 11111100  0           


Q ss_pred             ---ccc-cccCCcCCC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 ---RFS-ELLDPRLAI-----PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ---~~~-~~~~~~~~~-----~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         .+. .........     .........+.+++.+|++.||++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               000 000000000     000111346778999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1e-39  Score=284.86  Aligned_cols=241  Identities=20%  Similarity=0.225  Sum_probs=196.4

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +|+..+.||.|+||.||+|.. .+++.||+|.+....... .....+.+|+..+++++||||+++++.+..++..++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            477889999999999999995 478999999997544322 233467899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++++|.+++....    .+++..+..++.|+++||.|||++   +++|+||+|+||++++++.++++|||.+......
T Consensus        81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999997652    278899999999999999999998   9999999999999999999999999998765433


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH---HHHHHHhhhcccccccCCcCCCC
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV---KWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                           ..++..|++||....   ..++.++|+||||+++|++++|..||.....   .+.......        ..... 
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~-  221 (258)
T cd05578         154 TLTTSTSGTPGYMAPEVLCR---QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--------ADVLY-  221 (258)
T ss_pred             ccccccCCChhhcCHHHHcc---cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------ccccC-
Confidence                 356788999998876   4578999999999999999999999986542   222211111        01111 


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSI--VQVA  322 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~--~~i~  322 (332)
                       +......+.+++.+||+.||++||++  +|++
T Consensus       222 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 -PATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             11223578899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.3e-39  Score=287.91  Aligned_cols=256  Identities=22%  Similarity=0.266  Sum_probs=196.1

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--Ccee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERI  135 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  135 (332)
                      ..++|+..+.||+|+||.||+|. ..+|+.||+|.++.............+|+.++++++|+|++++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            45689999999999999999999 45799999999875543333233457899999999999999999998655  5689


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+. ++|.+++....   ..+++..+..++.|++.|+.|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            9999996 47888876532   2378999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc---cccc---
Q 020027          216 APEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR---FSEL---  283 (332)
Q Consensus       216 ~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~---  283 (332)
                      ....      ..++..|++||.....  ..++.++||||+||++|||++|+.||.+.........+....   ....   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCC--CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            4422      1245679999987642  457889999999999999999999998765554443332210   0000   


Q ss_pred             cC-----CcCCCC---C-C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LD-----PRLAIP---C-E-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~-----~~~~~~---~-~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+     .....+   . .     ......+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00     000000   0 0     011345678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.3e-39  Score=287.35  Aligned_cols=257  Identities=23%  Similarity=0.222  Sum_probs=194.6

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC----
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG----  132 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  132 (332)
                      ...++|+..+.||+|+||.||+|.. .+|+.||+|.++...........+.+|+.+++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            4567899999999999999999995 57899999999765433333335678999999999999999999886654    


Q ss_pred             ------ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          133 ------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       133 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                            ..++++||+++ ++..++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999976 6666665432   2378999999999999999999998   999999999999999999999


Q ss_pred             EccCCccccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc
Q 020027          207 VCDYGLSFLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR  279 (332)
Q Consensus       207 l~dfg~a~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~  279 (332)
                      |+|||.+......       ..++..|++||.+...  ..++.++|||||||++|||++|+.||...........+....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~  234 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC  234 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999998754322       1346679999987542  356889999999999999999999997654333322222110


Q ss_pred             -------ccccc--------CCcCCC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -------FSELL--------DPRLAI-----PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -------~~~~~--------~~~~~~-----~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                             +....        +.....     ......+..+.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00000        000000     000012347889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-39  Score=284.77  Aligned_cols=245  Identities=26%  Similarity=0.342  Sum_probs=196.6

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||++.. .+++.+|+|.+...... .....+.+|+..++.++||||+++++.+..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            3677888999999999999995 47899999998765432 233457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |+++++|.+++....   ..+++.....++.|++.|+.|||+ .   +++|+||+|+||++++++.++++|||.+.....
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            999999999997643   237888999999999999999999 7   999999999999999999999999999865432


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-----HHHHHHHhhhcccccccCCcCC
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL-----VKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                          ...++..|++||.+..   ..++.++|+||||+++|++++|+.||....     ..+....+...       ....
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~  223 (265)
T cd06605         154 SLAKTFVGTSSYMAPERIQG---NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-------PPPR  223 (265)
T ss_pred             HHhhcccCChhccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-------CCCC
Confidence                1357788999999876   578899999999999999999999986531     11111111111       0111


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.. .....+.+++.+||..||++|||+.+++.
T Consensus       224 ~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSG-KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChh-hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1111 13346789999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.1e-39  Score=280.05  Aligned_cols=244  Identities=26%  Similarity=0.315  Sum_probs=198.8

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|++|.||++.. .+++.|++|.+...... .....+.+|+..+..++|+|++++++++..++..++++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            4688889999999999999995 46999999998765432 233457899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |+++++|.+++....    .+++..++.++.|+++|+.|||+ .   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        80 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          80 YMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             ecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999997642    27899999999999999999999 8   999999999999999999999999999875533


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh---HHHHHHHhhhcccccccCCcCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL---VKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .      ..++..|++||.+..   ..++.++|+||||+++||++||+.||....   .......+....     .+   
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~---  221 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQG---ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-----PP---  221 (264)
T ss_pred             CCCcccceeecccccCHhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-----CC---
Confidence            2      245678999998876   578899999999999999999999997653   111111111110     01   


Q ss_pred             CCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          290 IPCEIK-PLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       290 ~~~~~~-~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                       ..+.. ....+.+++.+||+.+|++|||+.++++.
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 -SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             11111 23478899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.7e-39  Score=288.04  Aligned_cols=256  Identities=22%  Similarity=0.295  Sum_probs=191.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|...+.||+|+||.||++. ..+++.+|+|.+...... .....+.+|+..+.++. |+||+++++++..++..+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            356667889999999999999 567899999998754332 22335788999998886 999999999999899999999


Q ss_pred             eccCCCCHHHHhccc-CCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          139 EFINMASLDFYLHEN-NDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||+. +++.++.... ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+|||++....
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9986 4555443211 011123789999999999999999999631  89999999999999999999999999986543


Q ss_pred             c-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 E-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .     ...++..|++||.+.......++.++|||||||++||+++|+.||.....  ....+....  ....+.+....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~--~~~~~~~~~~~  235 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV--KGDPPILSNSE  235 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc--CCCCCcCCCcC
Confidence            2     22567889999998753223688999999999999999999999975431  111111100  00011121122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ......++.+++.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12344578899999999999999999998863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=326.17  Aligned_cols=248  Identities=25%  Similarity=0.307  Sum_probs=205.7

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +......||.|.||.||.|. ..+|+..|+|.++-............+|.+++..++|||+|+++|+-.+....+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            45556789999999999998 78999999999986655544445688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK  220 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~  220 (332)
                      |++|+|.+.+...+.    .++.-...+..|++.|++|||++   ||||||+||.||+++.+|.+|.+|||.|....+..
T Consensus      1316 C~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             hccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999998865432    45555566789999999999999   99999999999999999999999999997654432


Q ss_pred             ----------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          221 ----------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       221 ----------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                                .||+-|||||.+....+.....++||||+||++.||+||++||.....+|+.-+.....      ..+..
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g------h~Pq~ 1462 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG------HKPQI 1462 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc------CCCCC
Confidence                      59999999999988766667789999999999999999999999888777654333321      11112


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      |  .....+-.+++.+|++.||++|.++.|+++.
T Consensus      1463 P--~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 P--ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             c--hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2  2233356689999999999999999988764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.9e-39  Score=290.02  Aligned_cols=250  Identities=22%  Similarity=0.232  Sum_probs=189.5

Q ss_pred             eeecc--CCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           68 IIGQG--RLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        68 ~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .||+|  +||+||++. ..+|+.||+|.+............+.+|+.+++.++||||+++++++..++..++++||++++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  999999999 468999999998765433333345788899999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc------
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE------  218 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~------  218 (332)
                      ++.+++......  .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||+.+.....      
T Consensus        85 ~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998764322  378888999999999999999998   999999999999999999999999975422111      


Q ss_pred             -------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccc----------
Q 020027          219 -------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS----------  281 (332)
Q Consensus       219 -------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----------  281 (332)
                             ...++..|++||.+... ...++.++|||||||++|||++|+.||.+................          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQD-LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccccccCccCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   01234569999998642 134688999999999999999999999765433222111110000          


Q ss_pred             ---------------------------cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ---------------------------ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ---------------------------~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                                 .........+........+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                       000111112222334567889999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.2e-39  Score=292.78  Aligned_cols=252  Identities=21%  Similarity=0.218  Sum_probs=192.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  131 (332)
                      ..++|+..+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            35679999999999999999999 56899999999865433333333567899999999999999999987543      


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      ...+++|||+. ++|.+.+...      ++...+..++.|++.||.|||++   +++||||||+||+++.++.+|++|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35699999996 5787777532      67888899999999999999998   99999999999999999999999999


Q ss_pred             ccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh---------
Q 020027          212 LSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE---------  277 (332)
Q Consensus       212 ~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~---------  277 (332)
                      +++.....     ..++..|++||....   ..++.++|||||||++|+|++|+.||...........+..         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCCCCCCCcccccccCHHHHhC---CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99765432     246778999998866   6788999999999999999999999975432221111100         


Q ss_pred             --------------cc------cccccCCcCC-C---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 --------------MR------FSELLDPRLA-I---PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 --------------~~------~~~~~~~~~~-~---~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                    ..      +.+....... .   .........+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                          00      0000000000 0   001122446779999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.6e-39  Score=283.68  Aligned_cols=242  Identities=21%  Similarity=0.252  Sum_probs=194.8

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .|...+.||+|++|.||++. ..+++.+++|.+.....  .....+.+|+.+++.++|||++++++++...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            35556799999999999998 46788999998864322  1223467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++...     .+++..+..++.|++.|++|||++   +++||||+|+||+++.++.++++|||.+...... 
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          98 LEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            9999999998752     278889999999999999999998   9999999999999999999999999987643322 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||....   ..++.++|+||||+++|||++|+.||.+.........+....     .+....  ..
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~--~~  239 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-----PPKLKN--LH  239 (285)
T ss_pred             cccccccCCccccCHHHhcC---CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-----CCCCcc--cc
Confidence                 247788999998765   568899999999999999999999987654443333332221     111111  11


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            12347889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.1e-39  Score=285.54  Aligned_cols=255  Identities=18%  Similarity=0.163  Sum_probs=181.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC-C---CCEEEEEEeccCccccccc---------ccHHHHHHHhccCCCCCccce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS-T---GKLVAVKRIHPRLVLSNAG---------FGFASVIKTLSLAQHPNIVPI  124 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~~  124 (332)
                      ...++|...+.||+|+||.||+|... +   +..+|+|............         .....+...+..++|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            34467999999999999999999953 3   4566666543222111000         011233345567789999999


Q ss_pred             eeeeecCC----ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC
Q 020027          125 LGFSQAPG----ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN  200 (332)
Q Consensus       125 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  200 (332)
                      ++.+....    ..++++|++. .++.+.+.....    .++..+..++.|++.||.|||+.   +++||||||+|||++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC----KNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhcc----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            99765443    3467788774 466666544321    46778889999999999999998   999999999999999


Q ss_pred             CCCceEEccCCccccCC-------------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh
Q 020027          201 EKFCARVCDYGLSFLAP-------------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL  267 (332)
Q Consensus       201 ~~~~~kl~dfg~a~~~~-------------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~  267 (332)
                      .++.++|+|||+|+...             ....||..|+|||.+..   ..++.++|||||||++|||++|+.||.+..
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~---~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG---ACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999986432             11258899999998876   678999999999999999999999997652


Q ss_pred             H-HHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          268 V-KWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       268 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      . .............++..+....+.   +...+.+++..||+.+|++||++.++.+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        238 HNGNLIHAAKCDFIKRLHEGKIKIKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             cchHHHHHhHHHHHHHhhhhhhccCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            2 211111111111112222222221   2346889999999999999999999998763

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.9e-39  Score=284.69  Aligned_cols=255  Identities=18%  Similarity=0.161  Sum_probs=191.7

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|++|.||+|.. .+|+.||+|.+............+.+|+.+++.++|+|++++++++...+..+++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            4688899999999999999994 578999999987654333333357889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCccccCCc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLSFLAPE  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~~  218 (332)
                      |++ +++.+++.....  ..+++..+..++.|++.||.|||++   +++|+||+|+||+++. ++.+|++|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 577777754322  1257788889999999999999998   9999999999999985 56799999999865432


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh---ccccccc-----
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE---MRFSELL-----  284 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~-----  284 (332)
                      .      ..++..|++||.+...  ..++.++||||+|+++|+|+||+.||.+.........+..   ....+..     
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CccccccCceeecccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            1      2356789999987542  4578899999999999999999999976433222211110   0000000     


Q ss_pred             --C-----CcCCCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 --D-----PRLAIP----CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 --~-----~~~~~~----~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        +     +.....    .......++.+++.+|++.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0     000000    00112336789999999999999999999885

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.3e-39  Score=286.37  Aligned_cols=255  Identities=20%  Similarity=0.253  Sum_probs=190.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  132 (332)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+............+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            45788999999999999999994 57899999998754433333334568999999999999999999986553      


Q ss_pred             --ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          133 --ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       133 --~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                        ..+++|||+. +++.+++....   ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              3599999996 57777775432   2378999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCcc----------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--
Q 020027          211 GLSFLAPEE----------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--  278 (332)
Q Consensus       211 g~a~~~~~~----------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--  278 (332)
                      |++......          ..++..|+|||.....  ..++.++||||||+++|||+||..||.+.........+...  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCC--cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            998644221          1356679999987542  34688999999999999999999999765443332222110  


Q ss_pred             ccccccCC---------cCCCCC-----------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 RFSELLDP---------RLAIPC-----------EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ~~~~~~~~---------~~~~~~-----------~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....-..+         ....+.           +......+.+++.+||..||++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000000         000000           0011235678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-38  Score=277.20  Aligned_cols=247  Identities=22%  Similarity=0.286  Sum_probs=201.9

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|...+.||+|+||.||++.. .+++.+++|.+............+.+|++.++.++|+|++++.+.+...+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            477888999999999999994 4789999999876544334444578899999999999999999999988999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++.........+++..+..++.+++.|+.|||+.   +++|+||+|+||++++++.++++|||.+...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999976532234489999999999999999999998   9999999999999999999999999998654332 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||....   ..++.++|+||+|+++|++++|+.||...................         .+.
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~  225 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQN---KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---------IPS  225 (258)
T ss_pred             ceecceeeeecccChhHhcc---CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---------CCC
Confidence                 246778999998765   567889999999999999999999997665444333332221111         111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....+.+++.+||..+|++|||+.++++
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            22347889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-38  Score=281.86  Aligned_cols=247  Identities=23%  Similarity=0.293  Sum_probs=200.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++.|+..+.||+|+||.||+|..+ ++..+++|.+.....   ....+.+|+..++.++|+|++++++.+...+..++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            34667888899999999999999954 788999999875432   23356889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ++||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999998754   2388999999999999999999998   9999999999999999999999999987543


Q ss_pred             Ccc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          217 PEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       217 ~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ...      ..++..|++||....   ..++.++|+||||+++|||++|+.||...........+......       ..
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~  236 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKR---KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-------PL  236 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------CC
Confidence            321      235678999998765   56789999999999999999999999865443332222221111       11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .........+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            111112346889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=283.26  Aligned_cols=252  Identities=24%  Similarity=0.263  Sum_probs=194.3

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--CceeEEEe
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERIIVSE  139 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  139 (332)
                      |+..+.||+|+||.||+|.. .+++.+|+|.+............+.+|+.+++.++|+|++++++++...  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            56678899999999999994 4689999999987642233334578899999999999999999999887  88999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++ +|..++....   ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+|++|||++......
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9974 8888876542   2378999999999999999999998   9999999999999999999999999998655432


Q ss_pred             -------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------cccc---
Q 020027          220 -------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RFSE---  282 (332)
Q Consensus       220 -------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~---  282 (332)
                             ..++..|++||.....  ..++.++||||||+++|||+||+.||...........+...       .+..   
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             CcccccccccccccCCceeeEcc--ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence                   2346779999977542  45789999999999999999999999765543332222110       0000   


Q ss_pred             -----ccCCcCCCCC------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 -----LLDPRLAIPC------EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 -----~~~~~~~~~~------~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           ...+....+.      ...+...+.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 0000000000      0001446789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-39  Score=279.10  Aligned_cols=243  Identities=20%  Similarity=0.186  Sum_probs=188.9

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHH-hccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKT-LSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|. ..+|+.||+|.+....... .....+..|... ....+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            568999999999998 4578999999986543221 111223444433 4455899999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--ccC
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--EKR  221 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--~~~  221 (332)
                      ++|.+++.....    +++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++++|||++.....  ...
T Consensus        82 ~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  154 (260)
T cd05611          82 GDCASLIKTLGG----LPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV  154 (260)
T ss_pred             CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence            999999975432    78889999999999999999998   999999999999999999999999999876442  235


Q ss_pred             CcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHH
Q 020027          222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLA  301 (332)
Q Consensus       222 ~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  301 (332)
                      ++..|++||....   ..++.++||||||+++||++||..||...........+......      ............+.
T Consensus       155 ~~~~y~~pe~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~  225 (260)
T cd05611         155 GTPDYLAPETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN------WPEEVKEFCSPEAV  225 (260)
T ss_pred             CCcCccChhhhcC---CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC------CCCcccccCCHHHH
Confidence            7788999999875   45789999999999999999999999876555444433322111      01111112234788


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHH
Q 020027          302 KVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       302 ~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      +++.+||+.||++|||+.++.+.|
T Consensus       226 ~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         226 DLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHccCCHHHccCCCcHHHHH
Confidence            999999999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.5e-38  Score=284.81  Aligned_cols=248  Identities=23%  Similarity=0.269  Sum_probs=194.1

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .|+..+.||+|+||.||+|+ ..+++.+|+|.+....... .....+.+|+.+++.++|+|++++.+++..++..++++|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            36677889999999999999 4578899999986532222 222346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+. +++.+++.....   .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        96 ~~~-~~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 577776654322   278899999999999999999998   9999999999999999999999999998754432


Q ss_pred             --cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          220 --KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       220 --~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                        ..++..|++||..........+.++|||||||++|||++|..||...........+.....     +..   ......
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~---~~~~~~  240 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PAL---QSGHWS  240 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----CCc---Cccccc
Confidence              3567889999987543335678899999999999999999999876543333222222111     111   111233


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ..+.+++.+||+.+|++||++.++++.
T Consensus       241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         241 EYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            467899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-38  Score=278.28  Aligned_cols=237  Identities=19%  Similarity=0.179  Sum_probs=191.7

Q ss_pred             eeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           69 IGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        69 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      ||.|+||.||++.. .+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+..++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999994 468999999997654322 2234578899999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-----cC
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-----KR  221 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-----~~  221 (332)
                      .+++.....    +++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++|||++......     ..
T Consensus        81 ~~~l~~~~~----l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~  153 (262)
T cd05572          81 WTILRDRGL----FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC  153 (262)
T ss_pred             HHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence            999976432    78888999999999999999998   9999999999999999999999999998765543     24


Q ss_pred             CcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh--HHHHHHHhhhcccccccCCcCCCCCChHHHHH
Q 020027          222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL--VKWALPLIKEMRFSELLDPRLAIPCEIKPLVR  299 (332)
Q Consensus       222 ~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (332)
                      ++..|++||.+..   ..++.++|+||+|+++||+++|..||....  .......+..+.      .....+  .....+
T Consensus       154 ~~~~~~~PE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~--~~~~~~  222 (262)
T cd05572         154 GTPEYVAPEIILN---KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN------GKLEFP--NYIDKA  222 (262)
T ss_pred             CCcCccChhHhcC---CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC------CCCCCC--cccCHH
Confidence            6788999998765   567899999999999999999999997654  222222222100      111111  112447


Q ss_pred             HHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          300 LAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       300 l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      +.+++.+||+.||++||+     +.|+++
T Consensus       223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            889999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-38  Score=280.27  Aligned_cols=250  Identities=19%  Similarity=0.188  Sum_probs=189.3

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecC--CceeEEE
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAP--GERIIVS  138 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  138 (332)
                      |...+.||+|+||.||+|. ..+++.+|+|.++....... .....+|+..+.++. |+|++++++++..+  +..++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            4567889999999999999 55789999999876432222 223467888888885 99999999999877  8899999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ +++.+++....   ..+++..+..++.|++.||.|||+.   +++||||+|+||+++. +.+||+|||++.....
T Consensus        80 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          80 ELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             ecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            9997 57777775432   2378999999999999999999998   9999999999999999 9999999999875432


Q ss_pred             c-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--cccc----ccC--
Q 020027          219 E-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--RFSE----LLD--  285 (332)
Q Consensus       219 ~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~----~~~--  285 (332)
                      .     ..++..|++||.+...  ..++.++|||||||++|||++|..||.+....+....+...  ...+    ...  
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTD--GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcC--CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            2     2367789999976542  45788999999999999999999999765433322221110  0000    000  


Q ss_pred             --CcCCCCC---------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 --PRLAIPC---------EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 --~~~~~~~---------~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .....+.         .......+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence              0000000         0123457889999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=285.38  Aligned_cols=256  Identities=18%  Similarity=0.214  Sum_probs=190.0

Q ss_pred             CCCCCceeeccCCeEEEEEEe-C--CCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeecC--Ccee
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-S--TGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERI  135 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~--~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  135 (332)
                      +|+..+.||+|+||.||+|.. .  +++.||+|.+...... ........+|+.+++.++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            477788999999999999994 3  5889999999864321 22223467899999999999999999999887  7899


Q ss_pred             EEEeccCCCCHHHHhcccCCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC----CCceEEccC
Q 020027          136 IVSEFINMASLDFYLHENNDG-ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE----KFCARVCDY  210 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~df  210 (332)
                      ++|||+++ ++.+++...... ...++...+..++.|++.|+.|||+.   +++||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 676666543322 12478899999999999999999998   9999999999999999    999999999


Q ss_pred             CccccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH---------HH
Q 020027          211 GLSFLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW---------AL  272 (332)
Q Consensus       211 g~a~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~---------~~  272 (332)
                      |++......         ..++..|+|||.+...  ..++.++|||||||++|||++|+.||.+...+.         ..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            998754321         2457789999987542  457889999999999999999999987543221         00


Q ss_pred             HHh-h--------------hc-ccccccCC--cCCCC-CCh--------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          273 PLI-K--------------EM-RFSELLDP--RLAIP-CEI--------KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       273 ~~~-~--------------~~-~~~~~~~~--~~~~~-~~~--------~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+ .              .. .+....+.  ....+ ...        ....++.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000 0              00 00000000  00011 000        12236789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=287.67  Aligned_cols=253  Identities=25%  Similarity=0.316  Sum_probs=191.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|.+..... ......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            4679999999999999999998 56889999999864321 22233467899999999999999999987544     35


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .++++||++ +++..++...     .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            799999996 5787777542     278899999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh-------
Q 020027          214 FLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE-------  277 (332)
Q Consensus       214 ~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~-------  277 (332)
                      ......         ..++..|+|||.....  ..++.++||||+||++|||++|+.||.+.........+.+       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~  231 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ  231 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            654321         2467789999986542  4578999999999999999999999976433222111110       


Q ss_pred             --------cccccccC---CcCCCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          278 --------MRFSELLD---PRLAIPC---EIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       278 --------~~~~~~~~---~~~~~~~---~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                              ........   .....+.   ......++.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00000000   0000000   01123467899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-38  Score=285.33  Aligned_cols=250  Identities=20%  Similarity=0.178  Sum_probs=185.8

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      +.+|.|+++.||++.. +++.||+|.++...........+.+|+..++.++|+||+++++++...+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3344555555555544 789999999976533333444688999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--------
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--------  218 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--------  218 (332)
                      .+++......  .+++.....++.|+++||.|||++   +|+||||||+||+++.++.+|++|||.+.....        
T Consensus        87 ~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          87 EDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999764322  278888999999999999999999   999999999999999999999999998753321        


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC--------
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD--------  285 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  285 (332)
                           ...++..|++||.+.... ..++.++|+|||||++|||++|+.||..............+.....++        
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNL-QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence                 123566899999886421 347889999999999999999999997643222111111111100000        


Q ss_pred             ------------Cc----CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 ------------PR----LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ------------~~----~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                  +.    ...........++.+++.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                        00    000111122346789999999999999999999876

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5e-38  Score=282.16  Aligned_cols=246  Identities=24%  Similarity=0.265  Sum_probs=192.6

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      |...+.||+|+||.||+|+. .+++.|++|.+........ ....+.+|+.+++.++|||++++++++...+..+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            56667899999999999994 5788999999875433222 223467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      +. +++.+++.....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+|++|||++.....  
T Consensus       103 ~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~  175 (313)
T cd06633         103 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN  175 (313)
T ss_pred             CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence            96 567776654322   378999999999999999999998   999999999999999999999999999865432  


Q ss_pred             ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       219 ~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                      ...++..|++||.+.......++.++|||||||++|||++|..||.+................     ...   ......
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~---~~~~~~  247 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP-----TLQ---SNEWTD  247 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----CCC---ccccCH
Confidence            235778899999986433356889999999999999999999998765433322222211111     111   111123


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.+++.+||+.+|++|||+.++++
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            5778999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-38  Score=281.05  Aligned_cols=240  Identities=22%  Similarity=0.261  Sum_probs=183.3

Q ss_pred             eeeccCCeEEEEEEe-CCCCEEEEEEeccCccccccc-ccHHHHHHH---hccCCCCCccceeeeeecCCceeEEEeccC
Q 020027           68 IIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAG-FGFASVIKT---LSLAQHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      .||+|+||.||++.. .+++.+|+|.+.+........ ..+.+|..+   +...+|||++.+.+.+..++..+++|||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999994 578999999987654332221 123344333   334479999999999999999999999999


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc----
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE----  218 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~----  218 (332)
                      +++|.+++.....    +++..+..++.|++.||.|||+.   +++||||||+||++++++.++++|||++.....    
T Consensus        81 ~~~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~  153 (279)
T cd05633          81 GGDLHYHLSQHGV----FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (279)
T ss_pred             CCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence            9999999875432    89999999999999999999998   999999999999999999999999999864322    


Q ss_pred             ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       219 ~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                      ...++..|++||....  +..++.++|+||+||++|||++|..||.+...... ..+.....  .....    .+.....
T Consensus       154 ~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~--~~~~~----~~~~~~~  224 (279)
T cd05633         154 ASVGTHGYMAPEVLQK--GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTL--TVNVE----LPDSFSP  224 (279)
T ss_pred             CcCCCcCccCHHHhcC--CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhh--cCCcC----CccccCH
Confidence            2357889999998753  24578999999999999999999999975422111 11111110  00111    1112234


Q ss_pred             HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ++.+++.+||..||++||     |++++++
T Consensus       225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            778999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-39  Score=278.85  Aligned_cols=247  Identities=21%  Similarity=0.207  Sum_probs=205.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .+.|...+.||.|.-|+||.++. .++..+|+|++.+...... ...+...|-.+|+.++||-+..++..++.+...+++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            45677778999999999999994 4668999999987765433 233567788899999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC-
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-  216 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~-  216 (332)
                      ||||+||+|....+.+...  -+++..+..++..++.||+|||-.   |||.|||||+|||+.++|.+-++||.++... 
T Consensus       156 meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            9999999999988765443  388999999999999999999998   9999999999999999999999999875100 


Q ss_pred             ----------------------------------C-c--------------------------ccCCcccccCccccccc
Q 020027          217 ----------------------------------P-E--------------------------EKRGLAGYVDDDYWHEK  235 (332)
Q Consensus       217 ----------------------------------~-~--------------------------~~~~~~~~~~pe~~~~~  235 (332)
                                                        . .                          +-.||..|.|||...+ 
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-  309 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-  309 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence                                              0 0                          0148899999999887 


Q ss_pred             CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCC
Q 020027          236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNR  315 (332)
Q Consensus       236 ~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~R  315 (332)
                        ...+.++|.|+|||++|||+.|..||.|...++.+..+..        ..+..+........+.+||++.|..||.+|
T Consensus       310 --~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--------~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  310 --EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--------QPLKFPEEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             --CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--------CCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence              6678999999999999999999999999877776655543        334455555566688899999999999999


Q ss_pred             CC----HHHHH
Q 020027          316 PS----IVQVA  322 (332)
Q Consensus       316 Ps----~~~i~  322 (332)
                      .-    +.||-
T Consensus       380 lg~~rGA~eIK  390 (459)
T KOG0610|consen  380 LGSKRGAAEIK  390 (459)
T ss_pred             hccccchHHhh
Confidence            87    55554

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=278.58  Aligned_cols=252  Identities=21%  Similarity=0.254  Sum_probs=190.4

Q ss_pred             CCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccC---CCCCccceeeeeecCCc-----
Q 020027           63 FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA---QHPNIVPILGFSQAPGE-----  133 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  133 (332)
                      |+..+.||+|+||.||+|..+ +++.+|+|.++...........+.+|+.+++.+   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999964 589999999976544332233456677666544   69999999999987766     


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||++ ++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+|++|||.+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999997 578888865432  2378999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-cc------c
Q 020027          214 FLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-RF------S  281 (332)
Q Consensus       214 ~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~------~  281 (332)
                      ......     ..++..|++||.+..   ..++.++|+|||||++|||++|..||.+....+....+... ..      .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         155 RIYSFEMALTSVVVTLWYRAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eeccCCcccccccccccccChHHhcc---CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence            665332     235778999999876   56888999999999999999999999876544332222110 00      0


Q ss_pred             c-------ccCCcCCCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 E-------LLDPRLAIPC---EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~-------~~~~~~~~~~---~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .       ..........   .......+.+++.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0       0000000000   0122346779999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.3e-38  Score=280.03  Aligned_cols=254  Identities=19%  Similarity=0.225  Sum_probs=194.7

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||.|++|.||+|+. .+|+.||+|.++..... .....+.+|+.+++.++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            478889999999999999995 57899999998765432 2223467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      +++ +|.+++..... ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++++|||++.....  
T Consensus        80 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          80 MDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             CCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            985 88888865432 22378999999999999999999998   999999999999999999999999999865432  


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------ccc-----c
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RFS-----E  282 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~-----~  282 (332)
                          ...++..|++||.+...  ..++.++|+||||+++||+++|+.||.+....+....+.+.       .+.     .
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             cccccccccccccChHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence                22457789999987542  45688999999999999999999999865443332221110       000     0


Q ss_pred             ccCCcCCCC-------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIP-------CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~-------~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .........       ........+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000       00112346779999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=273.50  Aligned_cols=243  Identities=24%  Similarity=0.333  Sum_probs=197.8

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|++|.||++.. .+++.|++|.+............+.+|++++++++|+|++++++++..++..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            477889999999999999984 5788999999986654323334678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++....    .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999987642    278999999999999999999998   9999999999999999999999999998755432 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           ..++..|++||....   ...+.++|+||+|+++|++++|..||................       ....+  .
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~--~  221 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEM---SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-------HPPLP--E  221 (254)
T ss_pred             ccccccccchhhcCHhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-------CCCCC--C
Confidence                 246778999998865   457889999999999999999999987654322222111111       11111  1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....+.+++.+||+.+|++|||+.+++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            22346779999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-38  Score=289.02  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=193.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec----CCcee
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA----PGERI  135 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  135 (332)
                      ++|+..+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            678889999999999999999 5679999999987654333333456789999999999999999998753    34679


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +++||+. ++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999995 688888864332    78999999999999999999998   999999999999999999999999999864


Q ss_pred             CCc----------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--------
Q 020027          216 APE----------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--------  277 (332)
Q Consensus       216 ~~~----------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--------  277 (332)
                      ...          ...++..|++||.+...  ..++.++|||||||++|||++|+.||.+.........+..        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL--PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCC--cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            322          12467789999987542  4578999999999999999999999976433222111111        


Q ss_pred             -------cccccc---cCCcCCCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 -------MRFSEL---LDPRLAIPC---EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 -------~~~~~~---~~~~~~~~~---~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                             ......   .......+.   ......++.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                   000000   000000000   0112457889999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-38  Score=289.40  Aligned_cols=255  Identities=21%  Similarity=0.243  Sum_probs=194.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.++...........+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            3568889999999999999999 56899999999876543333334567899999999999999999987644     34


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .++++||+. ++|.+++....    .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 68888886543    278999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh----------
Q 020027          214 FLAPEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE----------  277 (332)
Q Consensus       214 ~~~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~----------  277 (332)
                      ......      ..++..|++||.....  ..++.++|+|||||++|||++|+.||.+.........+..          
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNC--SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            765432      2467789999987642  3578999999999999999999999976432221111110          


Q ss_pred             -----cccccccC---CcCCC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          278 -----MRFSELLD---PRLAI---PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       278 -----~~~~~~~~---~~~~~---~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                           ........   .....   ........++.+++.+||+.||++|||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                 00000000   00000   0011233467899999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-39  Score=294.38  Aligned_cols=247  Identities=22%  Similarity=0.296  Sum_probs=211.6

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      .....|.+.+.||+|.|+.|..|+ .-++..||+|.+++..........+.+|+++|..++|||||+++.+...+..+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            446689999999999999999999 4589999999999877666555568999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ||||+.+|.+.+|+..++.    +....+..++.|+..|++|||++   .|+|||||++|+|++.+.++||+|||++...
T Consensus       133 V~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            9999999999999988765    55578889999999999999999   9999999999999999999999999999765


Q ss_pred             C-----cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 P-----EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~-----~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .     .+.+|++.|.|||.+.+.  ...++.+|+||+|+++|-|+.|..||.|....+.......        ..++.+
T Consensus       206 ~~~~~lqt~cgsppyAaPEl~~g~--~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--------gk~rIp  275 (596)
T KOG0586|consen  206 DYGLMLQTFCGSPPYAAPELFNGK--KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--------GKYRIP  275 (596)
T ss_pred             cccccccccCCCCCccChHhhcCc--ccCCcceehhhhhhhheeeeecccccCCcccccccchhee--------eeeccc
Confidence            4     334799999999999886  4668999999999999999999999998765544333333        234444


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....+  ++.+++++.+..+|.+|++.+++-.
T Consensus       276 ~~ms~--dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  276 FYMSC--DCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ceeec--hhHHHHHHhhccCccccCCHHHhhh
Confidence            44443  5568999999999999999998854

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.9e-39  Score=312.24  Aligned_cols=248  Identities=20%  Similarity=0.263  Sum_probs=190.1

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec------
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA------  130 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------  130 (332)
                      .-..+|+....||+||||.||+++. -+|+.+|||++.... .........+|+..+++++|||||+++..+..      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            4556799999999999999999994 499999999998765 44445568899999999999999987742100      


Q ss_pred             -------------------------------------------------C------------------------------
Q 020027          131 -------------------------------------------------P------------------------------  131 (332)
Q Consensus       131 -------------------------------------------------~------------------------------  131 (332)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             ----------------------------------CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHH
Q 020027          132 ----------------------------------GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE  177 (332)
Q Consensus       132 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  177 (332)
                                                        ..+||.||||+..++.+++.++...   -.....++++.+|++||+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence                                              1247889999888888888765432   135678899999999999


Q ss_pred             HhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC------------------------cccCCcccccCccccc
Q 020027          178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP------------------------EEKRGLAGYVDDDYWH  233 (332)
Q Consensus       178 ~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~------------------------~~~~~~~~~~~pe~~~  233 (332)
                      |+|++   ||+||||||.||++++++.|||+|||+|....                        ....||.-|+|||.+.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            99999   99999999999999999999999999985410                        0125899999999998


Q ss_pred             ccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-HHHHHHHhhhcccccccCCcCCCC--CChHHHHHHHHHHHHcccC
Q 020027          234 EKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL-VKWALPLIKEMRFSELLDPRLAIP--CEIKPLVRLAKVALACVGN  310 (332)
Q Consensus       234 ~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~  310 (332)
                      ......|+.|+|+||+|++++||+.   ||...- -..+...++.+        .++.+  ...+....-.+++++++++
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g--------~iP~~~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKG--------SIPEPADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccC--------CCCCCcccccccchHHHHHHHHHhcC
Confidence            7655579999999999999999986   554321 11222233332        22222  1112223456899999999


Q ss_pred             CCCCCCCHHHHHH
Q 020027          311 SRKNRPSIVQVAT  323 (332)
Q Consensus       311 dp~~RPs~~~i~~  323 (332)
                      ||++|||+.|+++
T Consensus       858 dP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  858 DPSKRPTATELLN  870 (1351)
T ss_pred             CCccCCCHHHHhh
Confidence            9999999999985

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.8e-38  Score=287.95  Aligned_cols=254  Identities=23%  Similarity=0.264  Sum_probs=192.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecC--Ccee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAP--GERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~  135 (332)
                      .++|+..+.||+|+||.||+|.. .+++.+|+|.+............+.+|+.+++.+ +|+||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46788899999999999999994 4788999999865433233333467899999999 999999999988654  3679


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||++ ++|..++...     .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+|++|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 5898888653     278888999999999999999998   999999999999999999999999999864


Q ss_pred             CCcc-----------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-----
Q 020027          216 APEE-----------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-----  279 (332)
Q Consensus       216 ~~~~-----------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-----  279 (332)
                      ....           ..++..|++||.+...  ..++.++|+||||+++|||+||+.||.+.........+....     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeecc--ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            4221           1367789999987542  567889999999999999999999997644332211111100     


Q ss_pred             ----------cccccC----CcCCC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          280 ----------FSELLD----PRLAI--PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       280 ----------~~~~~~----~~~~~--~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                                ....++    .....  ........++.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                      000000    00000  0001124478899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.7e-38  Score=274.11  Aligned_cols=244  Identities=24%  Similarity=0.301  Sum_probs=197.5

Q ss_pred             CCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--CceeEEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERIIVS  138 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  138 (332)
                      +|...+.||+|++|.||+|... +++.|++|.+............+.+|+..+++++|+|++++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999954 789999999876543333344678999999999999999999999888  8899999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |++++++|.+++....    .+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999997653    388999999999999999999998   999999999999999999999999998865433


Q ss_pred             c--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-HHHHHHhhhcccccccCCcCC
Q 020027          219 E--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-KWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       219 ~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .        ..++..|.+||....   ...+.++||||||++++++++|..||..... .........        ....
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~  222 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRG---EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--------SGEP  222 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--------cCCC
Confidence            2        246778999998876   4588999999999999999999999976541 111111110        0001


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+......+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1111122457889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-38  Score=277.56  Aligned_cols=240  Identities=23%  Similarity=0.253  Sum_probs=193.3

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           69 IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      ||+|+||.||++... +|+.+++|.+....... .....+.+|+..+++++|+|++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999954 69999999987543321 2233578889999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-------
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-------  219 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-------  219 (332)
                      .+++....    .+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++++|||++......       
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99997643    278999999999999999999998   9999999999999999999999999988653222       


Q ss_pred             -------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          220 -------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       220 -------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                             ..++..|++||....   ...+.++|+||||+++||+++|..||...........+..+.        ...+.
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~  222 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILG---QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--------IEWPE  222 (265)
T ss_pred             ccccccCcccCccccCHHHhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------cCCCc
Confidence                   245678999998866   457889999999999999999999998766555444333321        11111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .......+.+++.+||+.+|++|||+.++.+.|+
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            1112347789999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=273.31  Aligned_cols=244  Identities=20%  Similarity=0.227  Sum_probs=191.9

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc---ccccccHHHHHHHhccCCCCCccceeeeeecC--Cce
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL---SNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  134 (332)
                      .+|...+.||+|+||.||+|. ..+++.||+|.+......   ......+.+|+.++++++|+||+++++++...  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            468889999999999999999 467999999987543211   12223578899999999999999999998654  457


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++++|.+++.....    +++.....++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999999865432    68888999999999999999998   99999999999999999999999999986


Q ss_pred             cCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....         ...++..|++||....   ...+.++|+|||||++||+++|+.||.+..............      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------  225 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISG---EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP------  225 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcC---CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC------
Confidence            5321         1246778999998875   567889999999999999999999997653332221111110      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....  +......+.+++.+||+ +|..|||+.++++
T Consensus       226 ~~~~~--p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 TKPML--PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCC--CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            01111  22233468899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.1e-38  Score=270.58  Aligned_cols=244  Identities=27%  Similarity=0.312  Sum_probs=198.2

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|...+.||+|++|.||++.. .+++.+++|.+.....  .....+.+|+..++.++|+|++++.+++..++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            367788999999999999995 4788999999876543  2334578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +++++|.+++....   ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+...... 
T Consensus        79 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          79 CSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            99999999987642   2379999999999999999999998   9999999999999999999999999998665432 


Q ss_pred             ----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          220 ----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       220 ----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                          ..++..|++||....   ...+.++|+||||+++|++++|+.||..................     .  .+.+..
T Consensus       153 ~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~--~~~~~~  222 (253)
T cd05122         153 ARNTMVGTPYWMAPEVING---KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP-----G--LRNPEK  222 (253)
T ss_pred             cccceecCCcccCHHHHcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC-----C--cCcccc
Confidence                346788999999876   45789999999999999999999999765333332222221111     1  111111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1346889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.7e-38  Score=277.40  Aligned_cols=241  Identities=21%  Similarity=0.238  Sum_probs=187.4

Q ss_pred             eeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           69 IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        69 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      ||+|+||.||++. ..+|+.+|+|.+....... .....+..|+.+++.++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999998 4578999999987543222 2223457899999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-----ccC
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----EKR  221 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-----~~~  221 (332)
                      .+++.....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||.+.....     ...
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            999876442  2378999999999999999999998   999999999999999999999999998865432     124


Q ss_pred             CcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHH
Q 020027          222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLA  301 (332)
Q Consensus       222 ~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  301 (332)
                      ++..|++||.+..   ..++.++|+||||+++|+|++|+.||...........+......    .....+  ......+.
T Consensus       156 ~~~~y~~PE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~--~~~~~~~~  226 (277)
T cd05577         156 GTPGYMAPEVLQG---EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----MAVEYP--DKFSPEAK  226 (277)
T ss_pred             CCCCcCCHHHhcC---CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc----ccccCC--ccCCHHHH
Confidence            6678999999875   55889999999999999999999999764321111111111110    011111  11233678


Q ss_pred             HHHHHcccCCCCCCC-----CHHHHHH
Q 020027          302 KVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       302 ~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      +++.+||+.||++||     ++.++++
T Consensus       227 ~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         227 DLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHccCChhHccCCCcccHHHHHh
Confidence            999999999999999     5555543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.7e-38  Score=280.20  Aligned_cols=238  Identities=21%  Similarity=0.247  Sum_probs=191.3

Q ss_pred             CceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           66 RRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      ...||+|+||.||++.. .+++.||+|.+....  ......+.+|+..++.++|+|++++++.+...+..+++|||++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            35799999999999984 688999999875432  122334788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-----
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-----  219 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-----  219 (332)
                      +|.+++...     .+++.....++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++......     
T Consensus       103 ~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657         103 ALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             cHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            999987542     268889999999999999999998   9999999999999999999999999987644322     


Q ss_pred             -cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHH
Q 020027          220 -KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV  298 (332)
Q Consensus       220 -~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (332)
                       ..++..|++||....   ..++.++|+||+|+++|||++|..||.+.........+....     .+.....  .....
T Consensus       175 ~~~~~~~y~~pE~~~~---~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~--~~~~~  244 (292)
T cd06657         175 SLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPKLKNL--HKVSP  244 (292)
T ss_pred             ccccCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-----CcccCCc--ccCCH
Confidence             246788999998765   567889999999999999999999998754444333332211     1111111  11223


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.+++.+||+.||.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            5778999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-39  Score=294.79  Aligned_cols=240  Identities=21%  Similarity=0.298  Sum_probs=198.5

Q ss_pred             CceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccccc--ccHHHHHHHhccCCCCCccceeeeeecCCc--eeEEEec
Q 020027           66 RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLAQHPNIVPILGFSQAPGE--RIIVSEF  140 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~  140 (332)
                      ...||+|+|-+||+|. -.+|..||--.++.+.......  ..|..|+.+|+.|+||||++++.++.+...  .-+++|+
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            3579999999999999 4578888877666554444333  568999999999999999999999977654  7789999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCccccCCcc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~~~  219 (332)
                      +..|+|..|.++++.    ++...+..++.||++||.|||++ .|+|+|||||..||+++. .|.|||+|+|+|......
T Consensus       125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999998876    78889999999999999999998 668999999999999985 689999999999765433


Q ss_pred             ----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch-hHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          220 ----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL-LVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       220 ----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                          ..||+.|||||.+..    .|+..+||||||++++||+|+..||... .+..+++.+..|.....+..   ...+ 
T Consensus       200 ~aksvIGTPEFMAPEmYEE----~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k---V~dP-  271 (632)
T KOG0584|consen  200 HAKSVIGTPEFMAPEMYEE----NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK---VKDP-  271 (632)
T ss_pred             ccceeccCccccChHHHhh----hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc---cCCH-
Confidence                369999999999984    7899999999999999999999999865 35566666666543222111   1111 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          ++.++|.+|+.. ..+|||+.|++.
T Consensus       272 ----evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  272 ----EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----HHHHHHHHHhcC-chhccCHHHHhh
Confidence                677899999998 999999999875

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-38  Score=276.93  Aligned_cols=252  Identities=21%  Similarity=0.232  Sum_probs=194.3

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |...+.||+|++|.||+|.. .+++.+++|.+............+.+|+..++.++|+|++++++++..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56678899999999999994 57899999998765433233345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc--
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--  219 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--  219 (332)
                      ++ ++.+++....   ..+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++++|||.+......  
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            75 7877776532   2378999999999999999999998   9999999999999999999999999998655432  


Q ss_pred             ----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------ccccccC---
Q 020027          220 ----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RFSELLD---  285 (332)
Q Consensus       220 ----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~---  285 (332)
                          ..++..|++||.....  ...+.++|+||||+++|+++||+.||.+....+....+...       .+....+   
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGD--KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             cccCccCcccccCcHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence                2356779999987652  36889999999999999999999999764432221111110       0000000   


Q ss_pred             ------CcCCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 ------PRLAI----PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ------~~~~~----~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            +....    ........++.+++.+||+.||.+||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  00000    001123457889999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1e-37  Score=275.47  Aligned_cols=237  Identities=20%  Similarity=0.242  Sum_probs=184.0

Q ss_pred             eeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHH---HHhccCCCCCccceeeeeecCCceeEEEeccC
Q 020027           68 IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVI---KTLSLAQHPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        68 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      .||+|+||.||++. ..+++.||+|.+......... ...+..|.   ..++..+|||++++.+.+..++..+++|||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999998 457899999998765432221 11233333   34455689999999999999999999999999


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc----
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE----  218 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~----  218 (332)
                      +++|.+++....    .+++..+..++.|++.|+.|||+.   +++|||+||+||+++.++.+||+|||++.....    
T Consensus        81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~  153 (278)
T cd05606          81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (278)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence            999999886543    389999999999999999999998   999999999999999999999999999864332    


Q ss_pred             ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH---HHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV---KWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                      ...++..|++||.+...  ..++.++||||+|+++|||++|+.||.+...   .........      ....  .+.  .
T Consensus       154 ~~~~~~~y~aPE~~~~~--~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~--~~~--~  221 (278)
T cd05606         154 ASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVE--LPD--S  221 (278)
T ss_pred             CcCCCcCCcCcHHhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc------cCCC--CCC--c
Confidence            23578899999998642  4578999999999999999999999976522   111111111      0111  111  1


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ...++.+++.+|+..||.+||     ++.++++
T Consensus       222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            234788999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.8e-38  Score=273.63  Aligned_cols=246  Identities=22%  Similarity=0.242  Sum_probs=191.1

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcc---cccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLV---LSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      +|...+.||+|+||.||++.. ..+..+++|.++....   .......+..|+.+++.++|||++++++++...+..+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            477889999999999999984 3455566666553222   122223456788999999999999999999988899999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      +||+++++|.+++.........+++..++.++.|++.|+.|||+.   +++|+||+|+||++++ +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998865333334589999999999999999999998   9999999999999975 569999999886543


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .      ...++..|++||....   ..++.++|+||||+++|+|++|..||.+.........+..+.     .+    .
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~----~  224 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKH---QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-----TP----S  224 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-----CC----C
Confidence            2      2246778999998765   567889999999999999999999997654333322222111     11    1


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.....++.+++.+||..||++||++.++++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            12233347889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-37  Score=272.69  Aligned_cols=245  Identities=18%  Similarity=0.174  Sum_probs=187.7

Q ss_pred             HHHHhcCCCCCCcee--eccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeec
Q 020027           55 EIDAATDGFSHRRII--GQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQA  130 (332)
Q Consensus        55 ~~~~~~~~~~~~~~l--g~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  130 (332)
                      +.....++|+..+.+  |+|+||.||++. ..++..+|+|.+.......       .|+.....+ +|+|++++++.+..
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec
Confidence            334444566666666  999999999999 4678899999986542211       122222222 79999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEcc
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCD  209 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~d  209 (332)
                      ++..+++|||+++++|.+++....    .+++..+..++.|+++|+.|||+.   +++||||+|+||+++.++ .++++|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999997653    389999999999999999999998   999999999999999988 999999


Q ss_pred             CCccccCCcc--cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHH-HHhhhcccccccCC
Q 020027          210 YGLSFLAPEE--KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL-PLIKEMRFSELLDP  286 (332)
Q Consensus       210 fg~a~~~~~~--~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~  286 (332)
                      ||++......  ..++..|++||....   ..++.++|+||||+++|||++|+.||......... ..+... .    ..
T Consensus       154 fg~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~----~~  225 (267)
T PHA03390        154 YGLCKIIGTPSCYDGTLDYFSPEKIKG---HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-Q----QK  225 (267)
T ss_pred             CccceecCCCccCCCCCcccChhhhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-h----cc
Confidence            9998765433  357889999999876   56789999999999999999999999754322211 111110 0    11


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPS-IVQVAT  323 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs-~~~i~~  323 (332)
                      ....+  ......+.+++.+||+.||.+||+ ++++++
T Consensus       226 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 KLPFI--KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cCCcc--cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11111  123346889999999999999996 688874

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-38  Score=284.71  Aligned_cols=253  Identities=18%  Similarity=0.235  Sum_probs=190.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  132 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            4689999999999999999999 457999999998754332333335688999999999999999999886542      


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..++++||+. .++..+...      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            4589999996 467665531      278899999999999999999998   999999999999999999999999999


Q ss_pred             cccCCccc---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-c---------
Q 020027          213 SFLAPEEK---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-R---------  279 (332)
Q Consensus       213 a~~~~~~~---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~---------  279 (332)
                      ++......   .++..|++||.....  ..++.++|+|||||++|||++|+.||.+.........+... .         
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADAEMTGYVVTRWYRAPEVILNW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCCCCCCceeeecccChhhhcCc--cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            87654332   456789999987542  45788999999999999999999999865432222211110 0         


Q ss_pred             -----cccccCCcCCCCC-C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          280 -----FSELLDPRLAIPC-E-----IKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       280 -----~~~~~~~~~~~~~-~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                           ...........+. .     ......+.+++.+||+.||++|||++++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 0000000000000 0     0122357799999999999999999999853

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-38  Score=301.78  Aligned_cols=258  Identities=18%  Similarity=0.223  Sum_probs=179.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC--CCCEEEEEEec--------------cCc-ccccccccHHHHHHHhccCCCCCc
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS--TGKLVAVKRIH--------------PRL-VLSNAGFGFASVIKTLSLAQHPNI  121 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~--------------~~~-~~~~~~~~~~~e~~~l~~l~h~ni  121 (332)
                      ..++|...+.||+|+||+||++..+  ++...+.|.+.              +.. ........+.+|+.+++.++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4568999999999999999998742  22223322111              000 011112246789999999999999


Q ss_pred             cceeeeeecCCceeEEEeccCCCCHHHHhcccCCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC
Q 020027          122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDG-ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN  200 (332)
Q Consensus       122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  200 (332)
                      +++++++...+..++++|++. +++..++...... ........+..++.|++.||.|||++   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 5677666432211 11133566778999999999999998   999999999999999


Q ss_pred             CCCceEEccCCccccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCC-CCch---hHH
Q 020027          201 EKFCARVCDYGLSFLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-EEGL---LVK  269 (332)
Q Consensus       201 ~~~~~kl~dfg~a~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p-~~~~---~~~  269 (332)
                      .++.+||+|||+++.....       ..|+..|++||.+..   ..++.++|||||||++|||++|..+ +.+.   ...
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG---DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9999999999999754322       258899999999876   6789999999999999999998754 3321   111


Q ss_pred             HHHHHhhhcc-----ccc-------ccCC-cCC-CCCC-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          270 WALPLIKEMR-----FSE-------LLDP-RLA-IPCE-------IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       270 ~~~~~~~~~~-----~~~-------~~~~-~~~-~~~~-------~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....+....     +.+       .++. .+. .+..       ......+.+++.+|++.||++|||+.|+++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1111111100     000       0000 000 0000       011224667889999999999999999986

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5e-38  Score=277.02  Aligned_cols=243  Identities=23%  Similarity=0.298  Sum_probs=196.3

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCC-CCCccceeeeeecCCceeEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  137 (332)
                      ++|...+.||+|+||.||+|.. .+|+.||+|.+....... .....+.+|..++++++ |+||+++++++..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688889999999999999994 589999999987643222 22335678899999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||++++++|.+++....    .+++..+..++.|++.||.|||+.   +++|+|++|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999997653    389999999999999999999998   99999999999999999999999999886543


Q ss_pred             ccc--------------------------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH
Q 020027          218 EEK--------------------------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA  271 (332)
Q Consensus       218 ~~~--------------------------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~  271 (332)
                      ...                          .++..|++||....   ...+.++|+||||++++|+++|+.||........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE---KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCC---CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            221                          35678999998765   5678899999999999999999999986543333


Q ss_pred             HHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 020027          272 LPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSI----VQVAT  323 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~----~~i~~  323 (332)
                      ...+...        ....+.  .....+.+++.+||+.||++|||+    +++++
T Consensus       231 ~~~~~~~--------~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 FQKILKL--------EYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHhc--------CCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            2222211        111111  113367899999999999999999    76654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-37  Score=281.65  Aligned_cols=256  Identities=20%  Similarity=0.240  Sum_probs=194.6

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec-CCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA-PGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  135 (332)
                      ..+++|+..+.||+|+||.||++. ..+++.||+|.+............+.+|+.+++.++|||++++.+++.. .+..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            457789999999999999999998 5589999999987544333333456789999999999999999998865 46788


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +++||+ +++|..+++...     +++.....++.|+++||.|||+.   +++||||+|+||++++++.++++|||.+..
T Consensus        87 lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          87 FVTELL-GTDLHRLLTSRP-----LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEeehh-ccCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            999998 568888876432     67788888999999999999998   999999999999999999999999999875


Q ss_pred             CCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh---------------
Q 020027          216 APEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE---------------  277 (332)
Q Consensus       216 ~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~---------------  277 (332)
                      ....   ..++..|++||.+...  ..++.++|+||||+++|||+||+.||.+.........+.+               
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDPQMTGYVSTRYYRAPEIMLTW--QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCCCcCCCcccccccCceeeecc--CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            4332   2457789999987542  4678999999999999999999999976433221111110               


Q ss_pred             cccccccCC-cCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          278 MRFSELLDP-RLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       278 ~~~~~~~~~-~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ....+.... ....+.+     .....++.+++.+||+.+|++|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000 0000001     1123478899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=274.27  Aligned_cols=252  Identities=19%  Similarity=0.227  Sum_probs=191.8

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEEec
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      |...+.||+|+||.||+|.. .+++.|++|.+...... .......+|+..+++++ |+|++++++++..++..+++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            56678899999999999995 46889999998754332 12223467888999998 99999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      + +++|.+++....  ...+++..++.++.|++.+|.|||++   +++|+||+|+||++++++.++++|||.+...... 
T Consensus        80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            9 788988886543  12379999999999999999999998   9999999999999999999999999998755432 


Q ss_pred             ----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh---cc----------ccc
Q 020027          220 ----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE---MR----------FSE  282 (332)
Q Consensus       220 ----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~----------~~~  282 (332)
                          ..++..|++||.....  ..++.++|+||||+++|||++|+.||.+.........+..   ..          ...
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRS--TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CcCCCCCcccccCceeeecC--cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence                2467789999987542  4578899999999999999999999875533222111110   00          000


Q ss_pred             ccCCcCCCC--CC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIP--CE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~--~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+......  ..     ......+.+++.+||+.||++|||++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000  00     011346889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-38  Score=285.02  Aligned_cols=259  Identities=20%  Similarity=0.239  Sum_probs=195.2

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-  131 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-  131 (332)
                      ..+...+++|...+.||+|+||.||+|. ..+++.||+|.+............+.+|+.+++.++|+||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            4556678899999999999999999998 56899999999875433222233467899999999999999999987543 


Q ss_pred             -----CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          132 -----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       132 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                           +..+++++++ +++|.+++...     .+++..+..++.|++.|+.|||++   +++||||||+||++++++.+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence                 3467888877 78898887643     278999999999999999999998   999999999999999999999


Q ss_pred             EccCCccccCCccc---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc----
Q 020027          207 VCDYGLSFLAPEEK---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR----  279 (332)
Q Consensus       207 l~dfg~a~~~~~~~---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~----  279 (332)
                      |+|||++.......   .++..|++||.+...  ..++.++|||||||++|||++|+.||...........+....    
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         161 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             EecccccccccccccccccCCCccCHHHHhCc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999987654332   467789999987542  457889999999999999999999986543322211111100    


Q ss_pred             ---c--------c---cccCCcCCCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ---F--------S---ELLDPRLAIPC---EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ---~--------~---~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         .        .   ..+........   ......++.+++.+|++.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence               0        0   00000000000   0012336779999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=282.06  Aligned_cols=253  Identities=18%  Similarity=0.186  Sum_probs=192.2

Q ss_pred             CCCCC-CceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc------------cccHHHHHHHhccCCCCCccceee
Q 020027           61 DGFSH-RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA------------GFGFASVIKTLSLAQHPNIVPILG  126 (332)
Q Consensus        61 ~~~~~-~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~  126 (332)
                      ++|.. .+.||+|+||.||+|. ..+++.||+|.++........            ...+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45543 4679999999999999 457899999998754332210            113678999999999999999999


Q ss_pred             eeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                      ++...+..+++|||++ ++|.+++.....    +++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR----LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999996 688888865332    78899999999999999999998   999999999999999999999


Q ss_pred             EccCCccccCCc--------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch
Q 020027          207 VCDYGLSFLAPE--------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL  266 (332)
Q Consensus       207 l~dfg~a~~~~~--------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~  266 (332)
                      ++|||++.....                    ...++..|++||.....  ..++.++|+|||||++|||+||..||.+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999998865430                    11346679999987642  45689999999999999999999999866


Q ss_pred             hHHHHHHHhhhc---c----cccccC-----C-cCCCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          267 LVKWALPLIKEM---R----FSELLD-----P-RLAIPC-----EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       267 ~~~~~~~~~~~~---~----~~~~~~-----~-~~~~~~-----~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ........+...   .    +.+..+     + ....+.     ......++.+++.+||+.||++|||++|++.
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            544333222110   0    000000     0 000000     0112346789999999999999999999985

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-37  Score=279.37  Aligned_cols=255  Identities=22%  Similarity=0.266  Sum_probs=190.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-------  131 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  131 (332)
                      .++|...+.||+|+||.||+|. ..+++.+|+|.+............+.+|+..++.++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999999 45789999999876543333333567899999999999999999987443       


Q ss_pred             -CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          132 -GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                       ...++++||+.+ ++...+....   ..+++..+..++.|+++||.|||++   +++|+||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence             346899999964 6666665422   2389999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCccc-----------------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH
Q 020027          211 GLSFLAPEEK-----------------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP  273 (332)
Q Consensus       211 g~a~~~~~~~-----------------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~  273 (332)
                      |+++......                 .++..|++||.....  ..++.++|||||||++|||++|+.||.+........
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~  237 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH  237 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC--CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9986533211                 235669999987542  457889999999999999999999997654433222


Q ss_pred             Hhhhc-------cc------ccccC--CcCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          274 LIKEM-------RF------SELLD--PRLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       274 ~~~~~-------~~------~~~~~--~~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+...       .+      ....+  .....+..     ......+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            21110       00      00000  00000000     011236779999999999999999998875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=294.82  Aligned_cols=247  Identities=23%  Similarity=0.279  Sum_probs=200.9

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .+.++-.||.|+||+||++. ..++-..|.|.+....  ..+-.+++-||.+|+..+||+||++++.+.-++.++|..||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            34556679999999999998 4466677778776543  23334689999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC---
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP---  217 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~---  217 (332)
                      |.||-.+..+-..+.   .+++.++..+++|++.||.|||++   +|+|||||..|||++-+|.++++|||.+....   
T Consensus       111 C~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             cCCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            999999988876554   389999999999999999999999   99999999999999999999999999985443   


Q ss_pred             ---cccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 ---EEKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ---~~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                         ++..||+.|||||+..-.  ...+|+.++||||||+.|.||..+.+|.+...+..+.-.+....     .|.+..|.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-----PPTLlqPS  259 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-----PPTLLQPS  259 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-----CCcccCcc
Confidence               344799999999987432  34689999999999999999999999988776655443332211     12233332


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .  =...+.+++.+|+..||..||+++++++
T Consensus       260 ~--Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  260 H--WSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             h--hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            2  2336779999999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.9e-37  Score=276.19  Aligned_cols=252  Identities=20%  Similarity=0.297  Sum_probs=191.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  135 (332)
                      ...++|...+.||+|+||.||+|... +++.||+|.++..... .....+..|+..+.+. .|+||+++++++...+..+
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            34567889999999999999999964 5899999998754322 1223456677666666 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++|||++ +++..++.....   .+++..+..++.|++.|+.|||+ .   +++||||+|+||++++++.+||+|||++.
T Consensus        91 ~v~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          91 ICMELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             EEeeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence            9999985 577776654322   37889999999999999999997 5   89999999999999999999999999986


Q ss_pred             cCCcc-----cCCcccccCcccccccC-CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccccccCCc
Q 020027          215 LAPEE-----KRGLAGYVDDDYWHEKG-GGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFSELLDPR  287 (332)
Q Consensus       215 ~~~~~-----~~~~~~~~~pe~~~~~~-~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  287 (332)
                      ...+.     ..++..|++||.+.... ...++.++|+||||+++|||++|+.||...... +....+....       .
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~  236 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-------P  236 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-------C
Confidence            54322     23567899999986532 234788999999999999999999999753221 1211111111       0


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      ...+.......++.+++.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0111111223478899999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=278.18  Aligned_cols=242  Identities=19%  Similarity=0.269  Sum_probs=203.2

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |+....||+|+||.||++. ..+|..+|+|.+..+.    ...++..|+.+|.+.+.|++|+++|.+.....+|||||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            5667789999999999998 5789999999986543    2335689999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc---
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE---  218 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~---  218 (332)
                      ..|+..+.++....   .+++..+-.++..-++||+|||..   .-+|||||..|||++.+|.+|++|||.|..+.+   
T Consensus       111 GAGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  111 GAGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             CCCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999999975433   388888889999999999999998   889999999999999999999999999976654   


Q ss_pred             ---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 ---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                         ...||+.|||||+.+.   -.|+.++||||+|+...||..|++||.+..+....-++..       .|......+..
T Consensus       185 KRNTVIGTPFWMAPEVI~E---IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-------~PPPTF~KPE~  254 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEE---IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-------KPPPTFKKPEE  254 (502)
T ss_pred             hhCccccCcccccHHHHHH---hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-------CCCCCCCChHh
Confidence               3369999999999988   5688999999999999999999999988765433222222       12222333444


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      -..++.+++++|+..+|++|-|+.++++.
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            56688999999999999999999988763

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-37  Score=283.36  Aligned_cols=256  Identities=21%  Similarity=0.240  Sum_probs=193.9

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC---
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG---  132 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  132 (332)
                      ....++|+..+.||+|+||.||++. ..+|..||+|.+............+.+|+.+++.++||||+++++++..++   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            3456789999999999999999998 568999999998654322222334678999999999999999999886543   


Q ss_pred             ---ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEcc
Q 020027          133 ---ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD  209 (332)
Q Consensus       133 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~d  209 (332)
                         ..+++|||+ +++|..++...     .+++..++.++.|++.|+.|||+.   +++||||||+||++++++.++++|
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence               358999999 67898887642     278999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc------c
Q 020027          210 YGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR------F  280 (332)
Q Consensus       210 fg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~------~  280 (332)
                      ||++......   ..++..|++||.+...  ..++.++|+||||+++|++++|+.||.+.........+....      +
T Consensus       162 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         162 FGLARQTDSEMTGYVVTRWYRAPEVILNW--MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccccCccccccCCcccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9998765433   2467789999987642  357889999999999999999999997653322211110000      0


Q ss_pred             ccccC-----------CcCCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 SELLD-----------PRLAI----PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ~~~~~-----------~~~~~----~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.+.           +....    .........+.+++.+|++.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000           00000    000112335779999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-37  Score=280.30  Aligned_cols=253  Identities=23%  Similarity=0.269  Sum_probs=196.1

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-----cee
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-----ERI  135 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  135 (332)
                      +|...+.||+|+||.||+|+. .+++.||+|.+............+.+|+..++.++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            477889999999999999995 46899999998765433333446789999999999999999999987765     789


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||++ ++|.+++....    .+++..++.++.|++.||.|||+.   +++|+||||.||+++.++.++++|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 58888886543    388999999999999999999998   999999999999999999999999999865


Q ss_pred             CCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc--c----
Q 020027          216 APEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR--F----  280 (332)
Q Consensus       216 ~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~----  280 (332)
                      ....         ..++..|++||.+...  ..++.++|+||||+++|+|++|+.||.+....+....+....  .    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSS--SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED  230 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecc--cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence            4332         2357789999998763  278899999999999999999999998765443322221100  0    


Q ss_pred             ---------ccccC---CcCCCC---CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          281 ---------SELLD---PRLAIP---CEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       281 ---------~~~~~---~~~~~~---~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                               ...+.   .....+   ........+.+++.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     00000   000000   001123467899999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=273.07  Aligned_cols=252  Identities=22%  Similarity=0.246  Sum_probs=194.0

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |+..+.||+|+||.||+|.. .+++.+|+|.+............+..|+.+++.++|+|++++++++...+..++++||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            45667899999999999994 56999999999866533333345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc-
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-  220 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~-  220 (332)
                      + ++|.+++....   ..+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++|+|||.+....... 
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 58999997653   2388999999999999999999998   99999999999999999999999999987543321 


Q ss_pred             -----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------cc---ccc--
Q 020027          221 -----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RF---SEL--  283 (332)
Q Consensus       221 -----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~---~~~--  283 (332)
                           .++..|++||.+...  ..++.++|+||||+++||+++|+.||.+.........+...       .+   ...  
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             ccCccccCcCcCChHHhcCC--cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence                 345679999988652  37789999999999999999999999765433222111100       00   000  


Q ss_pred             cC---CcCCC-CC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LD---PRLAI-PC---EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~---~~~~~-~~---~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+   +.... ..   .......+.+++.+||+.||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00   00000 00   0011346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=245.37  Aligned_cols=253  Identities=22%  Similarity=0.183  Sum_probs=201.1

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +|+..+.||+|+||+||+|+ +.+++.||+|.++.+...+.......+||.+++.++|.|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            46677889999999999999 67899999999998766555555679999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK  220 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~  220 (332)
                      |. .+|..|..+...   .++...+..++.|+++|+.|+|++   ++.|||+||.|.|++.+|+.|++|||+++...-..
T Consensus        83 cd-qdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hh-HHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            95 688888876443   288899999999999999999999   99999999999999999999999999998654322


Q ss_pred             ------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhh-------ccc---ccc
Q 020027          221 ------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKE-------MRF---SEL  283 (332)
Q Consensus       221 ------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~-------~~~---~~~  283 (332)
                            .-|.-|.+|..+.+.  .-|++..|+||.||++.|+.. |++.|.|...++.+..+-.       ..+   ..+
T Consensus       156 rcysaevvtlwyrppdvlfga--kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             EeeeceeeeeeccCcceeeee--ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence                  356788999888764  678999999999999999998 7777888877766554421       111   112


Q ss_pred             cCCcCCCCCC---------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LDPRLAIPCE---------IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~~~~~~~~~---------~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .|...-..++         ++-...=.+++++.+.-+|.+|.++++.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2221111111         111123347888888899999999998765

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-37  Score=283.09  Aligned_cols=254  Identities=19%  Similarity=0.239  Sum_probs=193.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc----
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE----  133 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  133 (332)
                      ..++|...+.||+|+||.||+|+. .+++.||+|.+............+.+|+.+++.++|+|++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            466899999999999999999995 578899999986543222233346789999999999999999998765544    


Q ss_pred             --eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          134 --RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       134 --~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                        .++++||+ +++|.+++...     .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 57999888642     278999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc---ccc---
Q 020027          212 LSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR---FSE---  282 (332)
Q Consensus       212 ~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~---  282 (332)
                      ++......   ..++..|++||.....  ..++.++|||||||++||++||+.||.+.........+.+..   ...   
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         164 LARHTDDEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccccccccCCcccccccCHHHHhCC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            98765432   2467789999987542  357889999999999999999999997654333222221100   000   


Q ss_pred             ---------ccCCcCCCC-CC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 ---------LLDPRLAIP-CE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ---------~~~~~~~~~-~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                               ......... ..     ......+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                     000000000 00     011347889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.4e-37  Score=277.19  Aligned_cols=252  Identities=21%  Similarity=0.218  Sum_probs=186.0

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CC--CCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecC----Cc
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-ST--GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAP----GE  133 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~  133 (332)
                      +|...+.||+|+||.||++.. .+  +..||+|.+............+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            467788999999999999994 34  78999999875433222233567899999988 599999999875332    45


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .++++|++. ++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788899985 68888886433    278999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCc----------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh------
Q 020027          214 FLAPE----------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE------  277 (332)
Q Consensus       214 ~~~~~----------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~------  277 (332)
                      +....          ...++..|++||.....  ..++.++|+||+|+++|++++|+.||.+.........+..      
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSF--QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD  230 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence            64331          12467889999987542  4578999999999999999999999875432222111100      


Q ss_pred             ---------cccccc---cC--CcCCCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 ---------MRFSEL---LD--PRLAIP-CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 ---------~~~~~~---~~--~~~~~~-~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                               ......   ..  +....+ ........+.+++.+||+.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                     000000   00  000000 00112346789999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-37  Score=272.98  Aligned_cols=248  Identities=21%  Similarity=0.205  Sum_probs=189.0

Q ss_pred             CCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCccccc--ccccHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           62 GFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSN--AGFGFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      +|+..+.||+|+||.||.++.    .+|+.||+|.++.......  ....+.+|+.+++.+ +|+||+++++.+..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999984    4789999999875432221  223467899999999 599999999999998999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++++|.+++.....    +++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999999876432    78888999999999999999998   99999999999999999999999999986


Q ss_pred             cCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCc
Q 020027          215 LAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       215 ~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      .....       ..++..|++||...... ..++.++||||||+++||++||..||...........+...    .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~----~~~~~  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGD-GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR----ILKSE  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCC-CCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH----hhccC
Confidence            54331       23678899999876421 34578999999999999999999998632111111111110    00001


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ...  +......+.+++.+||+.||++||     ++.+++.
T Consensus       229 ~~~--~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 PPY--PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCC--CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            111  112233677999999999999997     5666544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.2e-37  Score=279.46  Aligned_cols=250  Identities=21%  Similarity=0.234  Sum_probs=187.5

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--------
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--------  131 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  131 (332)
                      .+|...+.||.|+||.||+|. ..+|+.||+|.+.....  .....+.+|+.+++.++||||+++++.+...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            578889999999999999999 46789999999865432  2233468899999999999999999876543        


Q ss_pred             ------CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC-CCCc
Q 020027          132 ------GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN-EKFC  204 (332)
Q Consensus       132 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~  204 (332)
                            ...++++||++ ++|.+++...     .+++..+..++.|++.||.|||+.   +++||||||+||+++ +++.
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~  153 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence                  35789999997 5888887543     278899999999999999999998   999999999999997 4567


Q ss_pred             eEEccCCccccCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHh
Q 020027          205 ARVCDYGLSFLAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI  275 (332)
Q Consensus       205 ~kl~dfg~a~~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~  275 (332)
                      +|++|||.+.....         ...++..|+|||.+...  ..++.++|||||||++|||++|+.||.+..........
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCc--cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            89999999865321         12356789999986542  45788999999999999999999999765433222221


Q ss_pred             hhcc--------------cccccC-CcCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          276 KEMR--------------FSELLD-PRLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       276 ~~~~--------------~~~~~~-~~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....              ...... .......+     .....++.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            1100              000000 00000000     012246779999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.1e-37  Score=272.86  Aligned_cols=252  Identities=20%  Similarity=0.207  Sum_probs=192.0

Q ss_pred             CCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCccc--ccccccHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           62 GFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVL--SNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      +|...+.||+|+||.||++..    .+++.||+|.++.....  ......+.+|+.++..+ +|||++++++.+...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999873    36789999998753321  12223467899999999 599999999999988999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999886532    278888999999999999999998   99999999999999999999999999986


Q ss_pred             cCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCc
Q 020027          215 LAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       215 ~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (332)
                      .....       ..++..|++||...... ...+.++|+||||+++|||+||..||...........+...    .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~  228 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR----ILKSK  228 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCC-CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH----HHccC
Confidence            53321       24678899999876521 23678999999999999999999998532111111111110    00111


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN  327 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~  327 (332)
                      ...+.  .....+.+++.+||+.||++|||+.++.+.|+-
T Consensus       229 ~~~~~--~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 PPFPK--TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CCCCc--ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11111  122367789999999999999999888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-37  Score=264.91  Aligned_cols=232  Identities=23%  Similarity=0.207  Sum_probs=189.0

Q ss_pred             eeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCH
Q 020027           69 IGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL  146 (332)
Q Consensus        69 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  146 (332)
                      ||+|+||.||++.. .+++.+|+|.+........ ....+..|+.+++.++|+|++++++.+..++..+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999995 4689999999876543222 223578899999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc------c
Q 020027          147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE------K  220 (332)
Q Consensus       147 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~------~  220 (332)
                      .+++....    .+++.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+......      .
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            99997653    278999999999999999999998   9999999999999999999999999998665432      2


Q ss_pred             CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHH
Q 020027          221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL  300 (332)
Q Consensus       221 ~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  300 (332)
                      .++..|++||....   ...+.++|+||||+++||+++|..||...........+..        .....+.  .....+
T Consensus       154 ~~~~~~~~Pe~~~~---~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~l  220 (250)
T cd05123         154 CGTPEYLAPEVLLG---KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--------DPLRFPE--FLSPEA  220 (250)
T ss_pred             cCCccccChHHhCC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--------CCCCCCC--CCCHHH
Confidence            46788999998865   5578899999999999999999999976544333222222        1111211  123477


Q ss_pred             HHHHHHcccCCCCCCCCHHH
Q 020027          301 AKVALACVGNSRKNRPSIVQ  320 (332)
Q Consensus       301 ~~l~~~c~~~dp~~RPs~~~  320 (332)
                      .+++.+||..||++|||+.+
T Consensus       221 ~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         221 RDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHhcCCHhhCCCccc
Confidence            89999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-38  Score=288.71  Aligned_cols=260  Identities=22%  Similarity=0.285  Sum_probs=196.5

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------cee
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------ERI  135 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~  135 (332)
                      ....+.||+|+||.||+|+ ..+|+.||||.+++... ........+|++++++++|+|||++++.-++..      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3455789999999999999 77999999999987552 233335689999999999999999999875543      568


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC--CCC--ceEEccCC
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN--EKF--CARVCDYG  211 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~--~~kl~dfg  211 (332)
                      ++||||.+|+|...+++..+ ...+++...+.++..++.||.|||++   +|+||||||.||++.  .+|  --||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            99999999999999987544 34589999999999999999999999   999999999999984  334  36999999


Q ss_pred             ccccCCccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH----HHH-HHHhhhcc--
Q 020027          212 LSFLAPEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV----KWA-LPLIKEMR--  279 (332)
Q Consensus       212 ~a~~~~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~----~~~-~~~~~~~~--  279 (332)
                      .|+-.++..     .||..|.+||.+...  ..|+..+|.|||||++||++||..||.....    .+. +..+....  
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q--~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQ--KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhc--cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            999887654     699999999999852  7889999999999999999999999853211    111 11111110  


Q ss_pred             c----cc------ccCCcCCCCCC--hHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhccc
Q 020027          280 F----SE------LLDPRLAIPCE--IKPLVRLAKVALACVGNSRKNRP--SIVQVATILNNLV  329 (332)
Q Consensus       280 ~----~~------~~~~~~~~~~~--~~~~~~l~~l~~~c~~~dp~~RP--s~~~i~~~L~~~~  329 (332)
                      .    .+      .....++.+..  ..-...+..++...+..||.+|-  .+.+....+..++
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            0    00      00112222222  22334566778888888888888  6666666655544

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-38  Score=259.06  Aligned_cols=248  Identities=20%  Similarity=0.301  Sum_probs=191.8

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +.+....||.|+.|.|++++ ..+|...|||.+...... .+..+++..+.++.+- +.|.||+.+|+|..+...++.||
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            44455679999999999999 568999999999765432 2233456666666554 48999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      .|. -.++.+++.-..   ++++..+=++..-+..||.||-+++  +|+|||+||+|||+|+.|++|+||||++....++
T Consensus       172 lMs-~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHH-HHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            984 456666654332   2777777788889999999998764  9999999999999999999999999998654433


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccccccCCcCCCCCC
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ..|.+.|||||.+..+....|+-++||||||+.++||.||..||.+...+ +++..+.+.. ...+++...    
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-PP~L~~~~g----  320 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-PPLLPGHMG----  320 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-CCCCCcccC----
Confidence                 36889999999998766678999999999999999999999999985332 3333333311 112222111    


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        -...+.+++..|+..|+.+||...++++
T Consensus       321 --FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  321 --FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             --cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence              2236778999999999999999998875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-38  Score=265.86  Aligned_cols=201  Identities=20%  Similarity=0.239  Sum_probs=168.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC---C--CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec-CC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS---T--GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA-PG  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~  132 (332)
                      ....|+....||+|+||.||++..+   +  .+.+|+|+++........+....+|+..++.++|||++.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3457889999999999999999622   2  2379999998776555555667899999999999999999998876 78


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC----CceEE
Q 020027          133 ERIIVSEFINMASLDFYLHENNDG-ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK----FCARV  207 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl  207 (332)
                      ..++++||.+. +|...|+-+... ...++...+..|+.||+.|+.|||++   -|.||||||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence            89999999975 888888754321 23478889999999999999999999   89999999999999876    89999


Q ss_pred             ccCCccccCCccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc
Q 020027          208 CDYGLSFLAPEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       208 ~dfg~a~~~~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      +|||+++...+..         .-|.-|.|||.+.+.  ..||++.||||.|||+.||+|-++.|.+
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa--~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA--RHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhccc--ccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999998654332         357789999999875  7899999999999999999998776654

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=272.61  Aligned_cols=247  Identities=21%  Similarity=0.256  Sum_probs=199.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ...+.|..-++||+|+||.||-+. ..+|+.+|.|.+.+.....+. ....++|-.++.+++.+-||.+--.+++.+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            445678888999999999999998 569999999999765543332 234678999999999999999988899999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +|+..|.||+|.-.|...+.  ..+++..++.++.+|+.||.+||..   +||.|||||+|||+|++|.++|+|+|+|..
T Consensus       262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence            99999999999988877654  3499999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .++.     ..||.+|||||.+..   ..|+...|.||+||++|||+.|+.||.......-...+.....    ......
T Consensus       337 i~~g~~~~~rvGT~GYMAPEvl~n---e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~----~~~~ey  409 (591)
T KOG0986|consen  337 IPEGKPIRGRVGTVGYMAPEVLQN---EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL----EDPEEY  409 (591)
T ss_pred             cCCCCccccccCcccccCHHHHcC---CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh----cchhhc
Confidence            6543     379999999999988   6699999999999999999999999976533222212222111    111111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                        +.+-..++.++-...++.||.+|--.
T Consensus       410 --~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  410 --SDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             --ccccCHHHHHHHHHHHccCHHHhccC
Confidence              12223356677778999999999643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.8e-36  Score=291.89  Aligned_cols=148  Identities=25%  Similarity=0.349  Sum_probs=129.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|.. .+++.||+|+++....... ....+..|+..++.++|+||+++++.+...+..+++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            36788899999999999999994 4789999999975432221 123568889999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |||+++++|.+++.....    +++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~----l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999975432    78888999999999999999998   99999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=296.68  Aligned_cols=255  Identities=20%  Similarity=0.231  Sum_probs=210.8

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      .++....++|.+.++||+|+||.|..++ .++++.+|.|++.+..... .....|..|-.+|..-+.+.|+.++=.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            4556678899999999999999999999 5789999999998754432 2333578888999988999999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      ..+|+||||++||+|-.++.....    +++..+..++..|+-||.-+|+.   |+||||+||.|||+|..|.+|++|||
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~~----~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFDR----LPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcCC----ChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence            999999999999999999987652    78888999999999999999998   99999999999999999999999999


Q ss_pred             ccccCC-------cccCCcccccCcccccccCC--CCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          212 LSFLAP-------EEKRGLAGYVDDDYWHEKGG--GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       212 ~a~~~~-------~~~~~~~~~~~pe~~~~~~~--~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      .+....       ....|||.|++||.+...++  +.|++.+|.||+||++|||+.|..||.....-+.+..+.+-    
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h----  296 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH----  296 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----
Confidence            875443       23479999999999987643  57999999999999999999999999876555555444332    


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPS---IVQVA  322 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs---~~~i~  322 (332)
                        ...+..|.....+.+..++|.+.+. +|+.|..   ++++-
T Consensus       297 --k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  297 --KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             --hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence              1234455445566678899988775 8888887   66654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=268.27  Aligned_cols=257  Identities=19%  Similarity=0.193  Sum_probs=201.5

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC--C----Cccceeee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH--P----NIVPILGF  127 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~  127 (332)
                      ..+..+++|.+.+.+|+|+||.|.++. ..++..||+|+++.-....+   +..-|+.++.++.+  |    -+|.+.+|
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYre---Aa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYRE---AALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhh---HHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            344557889999999999999999998 55789999999985443322   34678888888842  2    46788889


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC------
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE------  201 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~------  201 (332)
                      +.-.++.+|++|.+ |.++.+++..+.-  ..++..++..|+.|++++++|||+.   +++|-||||+|||+.+      
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence            99999999999998 6799999987644  3488999999999999999999999   9999999999999832      


Q ss_pred             --------------CCceEEccCCccccCCccc---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 020027          202 --------------KFCARVCDYGLSFLAPEEK---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE  264 (332)
Q Consensus       202 --------------~~~~kl~dfg~a~~~~~~~---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~  264 (332)
                                    +..+++.|||.|....+..   ..|..|.|||.+.+   ..++.++||||+||||.|+.||...|+
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLg---LGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILG---LGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheec---cCcCCccCceeeeeEEEEeeccceecc
Confidence                          2358999999998776554   68999999999988   788999999999999999999999887


Q ss_pred             chhHHHHHHHhhh--ccccc---------------ccC------Cc-----C--------CCCCChHHHHHHHHHHHHcc
Q 020027          265 GLLVKWALPLIKE--MRFSE---------------LLD------PR-----L--------AIPCEIKPLVRLAKVALACV  308 (332)
Q Consensus       265 ~~~~~~~~~~~~~--~~~~~---------------~~~------~~-----~--------~~~~~~~~~~~l~~l~~~c~  308 (332)
                      +....+.+.++..  +++..               .+|      .+     .        .......+..++++|+.+++
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            7655453333321  11100               000      00     0        01122355678999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 020027          309 GNSRKNRPSIVQVAT  323 (332)
Q Consensus       309 ~~dp~~RPs~~~i~~  323 (332)
                      .+||.+|+|+.|+++
T Consensus       391 ~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  391 EFDPARRITLREALS  405 (415)
T ss_pred             ccCccccccHHHHhc
Confidence            999999999999875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.3e-36  Score=258.95  Aligned_cols=217  Identities=15%  Similarity=0.126  Sum_probs=171.8

Q ss_pred             cCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCHHHHh
Q 020027           72 GRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYL  150 (332)
Q Consensus        72 G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  150 (332)
                      |.||.||+++ ..+++.+|+|.++...       .+.+|...+....|||++++++++...+..+++|||+++++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            8999999999 5688999999987542       1233444455567999999999999999999999999999999998


Q ss_pred             cccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc---cCCccccc
Q 020027          151 HENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE---KRGLAGYV  227 (332)
Q Consensus       151 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~---~~~~~~~~  227 (332)
                      .....    +++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||.+......   ..++..|+
T Consensus        77 ~~~~~----l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~  149 (237)
T cd05576          77 SKFLN----IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC  149 (237)
T ss_pred             HHhcC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence            75432    78999999999999999999998   9999999999999999999999999987654432   23456799


Q ss_pred             CcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHc
Q 020027          228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALAC  307 (332)
Q Consensus       228 ~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  307 (332)
                      +||....   ..++.++|+||+|+++||+++|+.|+.......     ...       ..+..+.  .....+.+++.+|
T Consensus       150 aPE~~~~---~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~~-------~~~~~~~--~~~~~~~~li~~~  212 (237)
T cd05576         150 APEVGGI---SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NTH-------TTLNIPE--WVSEEARSLLQQL  212 (237)
T ss_pred             CCcccCC---CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----ccc-------cccCCcc--cCCHHHHHHHHHH
Confidence            9998765   567889999999999999999998765432110     000       0011111  1223678999999


Q ss_pred             ccCCCCCCCCHH
Q 020027          308 VGNSRKNRPSIV  319 (332)
Q Consensus       308 ~~~dp~~RPs~~  319 (332)
                      |+.||++|||+.
T Consensus       213 l~~dp~~R~~~~  224 (237)
T cd05576         213 LQFNPTERLGAG  224 (237)
T ss_pred             ccCCHHHhcCCC
Confidence            999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=259.74  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=192.3

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhc-cCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-LAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++.+....||.|+||+|++-. .++|+..|||+++.... ..+..+++.|..... .-+.||||+++|.+..++..|+.|
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            456667789999999999988 57899999999986654 233345777877554 447899999999999999999999


Q ss_pred             eccCCCCHHHHhccc-CCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          139 EFINMASLDFYLHEN-NDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |+|+ .+++.+-+.. .-....+++...-.|..-...||.||-...  .|+|||+||+|||++..|.+|+||||++..+.
T Consensus       143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            9995 5665543321 111223677777777777889999998763  89999999999999999999999999987665


Q ss_pred             ccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-HHHHHHhhhcccccccCCcCCCC
Q 020027          218 EEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-KWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ++.     .|...|||||...... ..|+-+||+||+|+.|+|+.||..|+.+... -+....+..+....+..+.-   
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~-~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~---  295 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSD-KGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE---  295 (361)
T ss_pred             HHHHhhhccCCccccChhccCCcc-CCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc---
Confidence            443     6788999999987642 3589999999999999999999999987543 22333333333222211111   


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .......+..++..|+..|...||...++..
T Consensus       296 -~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  296 -CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             -ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence             1223457889999999999999999998764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=269.11  Aligned_cols=252  Identities=22%  Similarity=0.290  Sum_probs=196.0

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccc-----cHHHHHHHhccCCCCCccceeeeeec-CCc
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-----GFASVIKTLSLAQHPNIVPILGFSQA-PGE  133 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  133 (332)
                      ++|-.+.+||+|||+.||++. +...+.||+|+-.......++..     ...+|..+.+.++||.||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            456666889999999999999 66778999998765443332221     25789999999999999999999854 567


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC---CCCceEEccC
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN---EKFCARVCDY  210 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~df  210 (332)
                      +|-|+|||+|.+|+-|++++..    +++..+..|+.||+.||.||.+. .++|+|-||||.|||+.   ..|.+||.||
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            8899999999999999998764    88999999999999999999986 77899999999999995   4678999999


Q ss_pred             CccccCCccc-------------CCcccccCccccccc-CCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-HHHHHHHh
Q 020027          211 GLSFLAPEEK-------------RGLAGYVDDDYWHEK-GGGNATRESDVYGFGVVLLEILSGRRCEEGLL-VKWALPLI  275 (332)
Q Consensus       211 g~a~~~~~~~-------------~~~~~~~~pe~~~~~-~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-~~~~~~~~  275 (332)
                      |+++......             .||.-|.+||.+... +...++.++||||.|||+|.++.|+.||.... ...++   
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL---  694 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL---  694 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH---
Confidence            9998765432             578889999988653 34678999999999999999999999997542 22222   


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                      .+......-  ....|..+-...+..++|++|+++--++|.+..++.
T Consensus       695 qeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  695 QENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            222211111  112222233344677999999999999998877654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=257.91  Aligned_cols=237  Identities=22%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccc-cHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|+.+++||+|.||+|..++ ..+|+.+|+|++++......... .-..|-+++...+||-+..+.-.++..+++++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            4689999999999999999999 67999999999987765443322 356788899999999999998889999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||..||.|...+....    .+++.....+...|..||.|||++   +||.||||.+|.|+|.+|.+||+|||+++..-
T Consensus       247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999988776543    378888888999999999999999   99999999999999999999999999986432


Q ss_pred             ------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 ------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                            ...+||+.|.|||.+..   ..|..++|.|.+||++|||++|+.||.....+.....+..+        .++.|
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleD---nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--------d~kFP  388 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLED---NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--------DLKFP  388 (516)
T ss_pred             cccceeccccCChhhcCchhhcc---ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------hccCC
Confidence                  23479999999999988   68899999999999999999999999988777666665443        22333


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCC
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRP  316 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RP  316 (332)
                      .....  +...++...+..||++|.
T Consensus       389 r~ls~--eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  389 RTLSP--EAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCH--HHHHHHHHHhhcChHhhc
Confidence            33222  566888899999999995

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=254.67  Aligned_cols=245  Identities=19%  Similarity=0.192  Sum_probs=192.7

Q ss_pred             cCCCCCC-ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeec----CC
Q 020027           60 TDGFSHR-RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQA----PG  132 (332)
Q Consensus        60 ~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~  132 (332)
                      +++|.+. ++||-|-.|.|..+. ..+|+.+|+|++...       ....+|+...-.. .|||||++++++..    ..
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            4566554 579999999999998 568999999998622       2347787766554 69999999998754    35


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEcc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCD  209 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~d  209 (332)
                      .+.+|||.++||.|...+.+.+..  .+++.++-.|+.||+.|+.|||+.   +|.||||||+|+|...   |..+|++|
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            678999999999999999876554  389999999999999999999999   9999999999999964   56799999


Q ss_pred             CCccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          210 YGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       210 fg~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      ||+|+...+     ..+-|+.|.|||.+..   ..|+..+|+||+||++|-|++|.+||........-+.++.    .+-
T Consensus       208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~---eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~----rI~  280 (400)
T KOG0604|consen  208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKR----RIR  280 (400)
T ss_pred             cccccccCCCccccCCcccccccCHHHhCc---hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHh----Hhh
Confidence            999986553     2367899999999876   5789999999999999999999999975433222122211    111


Q ss_pred             CC--cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 DP--RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ~~--~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..  .++.+.....++...++++..+..+|.+|.|+.++.+
T Consensus       281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            12  2333344455667779999999999999999998864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=273.21  Aligned_cols=235  Identities=21%  Similarity=0.202  Sum_probs=191.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  137 (332)
                      +++|.....+|.|+|+.|-.+. ..+++..++|++.....      +..+|+.++... +|||++++.+.+.+....++|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            6678888889999999998888 67888999999976521      224455444444 799999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe-CCCCceEEccCCccccC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL-NEKFCARVCDYGLSFLA  216 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-~~~~~~kl~dfg~a~~~  216 (332)
                      ||.+.++-+.+-+.....     ....+..++.+|+.|+.|||++   |+|||||||+|||+ ++.++++|+|||.++..
T Consensus       395 ~e~l~g~ell~ri~~~~~-----~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPE-----FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             ehhccccHHHHHHHhcch-----hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            999999888777765432     2256667999999999999999   99999999999999 68999999999999887


Q ss_pred             Ccc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccccccCCcCCCCC
Q 020027          217 PEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       217 ~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      ...   .+-|..|.|||....   ..++++||+||||++||+|++|+.||.....+ +....+..+++.           
T Consensus       467 ~~~~~tp~~t~~y~APEvl~~---~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s-----------  532 (612)
T KOG0603|consen  467 ERSCDTPALTLQYVAPEVLAI---QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS-----------  532 (612)
T ss_pred             chhhcccchhhcccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc-----------
Confidence            655   355789999999885   78999999999999999999999999866544 444444443322           


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ......+.+|+.+||+.||.+||++.++..
T Consensus       533 -~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 -ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             233346779999999999999999999864

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=270.57  Aligned_cols=239  Identities=22%  Similarity=0.258  Sum_probs=194.7

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMAS  145 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  145 (332)
                      ++||+|.||+||-|+ .++|+.||||.+.+..-..++.....+|+.++.+++||.||.+.-.|+.++..++|||-+. |+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence            689999999999999 6799999999998877666666678999999999999999999999999999999999996 45


Q ss_pred             HHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEccCCccccCCccc--
Q 020027          146 LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCDYGLSFLAPEEK--  220 (332)
Q Consensus       146 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a~~~~~~~--  220 (332)
                      ..+++-+...+  .+++..-..+..||+.||+|||.+   +|+|+||||+|||+.+   ...+||||||+|+..++..  
T Consensus       649 MLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            55554332222  278888888999999999999999   9999999999999964   4589999999999988754  


Q ss_pred             ---CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          221 ---RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       221 ---~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                         .||+.|.|||.+..   +.|+..-|+||.|||+|--++|..||...  +++-+.+.+..+.-      +.....+-.
T Consensus       724 rsVVGTPAYLaPEVLrn---kGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMy------Pp~PW~eis  792 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRN---KGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMY------PPNPWSEIS  792 (888)
T ss_pred             hhhcCCccccCHHHHhh---ccccccccceeeeEEEEEEecccccCCCc--cchhHHhhcccccc------CCCchhhcC
Confidence               69999999999998   67888999999999999999999999653  22333333322211      111122334


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                      ....++|...++..-.+|-|....+
T Consensus       793 ~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  793 PEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             HHHHHHHHHHHHHHHHHhcchHhhc
Confidence            4678999999999999999887654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-36  Score=252.12  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=194.4

Q ss_pred             ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEeccCCC
Q 020027           67 RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      +.||+|+|+.|-.+. ..+|..+|||++.+...  .......+|+.++... .|+||+.+++|++++..+|||||-|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            579999999999888 78999999999987643  3333568999999877 5999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC---ceEEccCCccccCCc---
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF---CARVCDYGLSFLAPE---  218 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~~~~~---  218 (332)
                      +|...|.+...    +++..+-++..+|+.||.|||.+   ||.||||||+|||..+..   -+|||||.++.....   
T Consensus       162 plLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  162 PLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             hHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            99999987544    88999999999999999999999   999999999999997654   479999987643211   


Q ss_pred             ----------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHH------Hhhhcc
Q 020027          219 ----------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALP------LIKEMR  279 (332)
Q Consensus       219 ----------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~------~~~~~~  279 (332)
                                +..|...|||||....-  ....|+.++|.||+|+++|-|++|.+||.|.... ..+.      ...+.-
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence                      12577899999977532  2367899999999999999999999999875331 1111      011111


Q ss_pred             cccccCCcCCCCCC--hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 FSELLDPRLAIPCE--IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ~~~~~~~~~~~~~~--~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +..+.+..+..|..  -.-..+..+++...+..|+.+|-++.++++
T Consensus       315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            22233344444432  123446779999999999999999998876

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=273.97  Aligned_cols=255  Identities=22%  Similarity=0.281  Sum_probs=208.6

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeee--
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQ--  129 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--  129 (332)
                      +.+...++.|.+..++|.|.+|.||+++ .++++.+|+|+.......+   .+...|..+++.. +|||++.++|++.  
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3334456788999999999999999999 6789999999987664333   2457788888877 6999999999884  


Q ss_pred             ---cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          130 ---APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       130 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                         .++.+|||||||.+|+..++++...  +..+.|..+..|+..++.|+.+||.+   .++|||+|-.|||++.++.||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence               3478999999999999999998654  33488999999999999999999999   999999999999999999999


Q ss_pred             EccCCccccCCcc------cCCcccccCcccccccC--CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc
Q 020027          207 VCDYGLSFLAPEE------KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       207 l~dfg~a~~~~~~------~~~~~~~~~pe~~~~~~--~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~  278 (332)
                      +.|||++......      ..||+.|||||+....+  ...|+..+|+||+|++..||.-|.+|+.+..+.-++-.+...
T Consensus       164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN  243 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  243 (953)
T ss_pred             EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence            9999999776543      36899999999886543  345778999999999999999999999887665554333332


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                             |.+..-.+.+=..++.+++..|+..|-++||++.++++
T Consensus       244 -------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  244 -------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                   22333334445568899999999999999999998874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=255.94  Aligned_cols=239  Identities=19%  Similarity=0.258  Sum_probs=199.9

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccc-cHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~-~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      ....+|..+.+||+|+||+|..+. ..+.+.+|||+++++........ .-+.|-++|+.. +-|-+++++.++...+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            345578889999999999999998 56788999999998765443332 346777788776 578899999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |+||||+.||+|-..+++.+.    +.+..+..++..||-||-+||++   ||+.||||..||+++.+|.+||+|||+++
T Consensus       426 yFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence            999999999999888887655    67788889999999999999999   99999999999999999999999999986


Q ss_pred             cC------CcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          215 LA------PEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       215 ~~------~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ..      ....+||+.|+|||...-   .+|+.++|.|||||+||||+.|.+||.|...++....+.+..+        
T Consensus       499 Eni~~~~TTkTFCGTPdYiAPEIi~Y---qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------  567 (683)
T KOG0696|consen  499 ENIFDGVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------  567 (683)
T ss_pred             ccccCCcceeeecCCCcccccceEEe---cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--------
Confidence            42      233479999999998876   6899999999999999999999999999998888888776432        


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCC
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRP  316 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RP  316 (332)
                        .++-.-+.+..++....+..+|.+|.
T Consensus       568 --syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 --SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --cCcccccHHHHHHHHHHhhcCCcccc
Confidence              22222334666777788889999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.7e-34  Score=244.65  Aligned_cols=233  Identities=25%  Similarity=0.275  Sum_probs=188.6

Q ss_pred             CCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCHHHHhc
Q 020027           73 RLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH  151 (332)
Q Consensus        73 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  151 (332)
                      +||.||+|... +|+.+++|.+........ ...+.+|++.+++++|+|++++++++......++++|++++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999964 689999999876543221 3467899999999999999999999999899999999999999999987


Q ss_pred             ccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-----cCCcccc
Q 020027          152 ENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-----KRGLAGY  226 (332)
Q Consensus       152 ~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-----~~~~~~~  226 (332)
                      ....    +++..+..++.+++.++.|||+.   +++|+|++|+||++++++.++++|||.+......     ..++..|
T Consensus        80 ~~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       80 KRGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             hccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCC
Confidence            5432    78899999999999999999998   9999999999999999999999999998766543     3567789


Q ss_pred             cCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc-hhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHH
Q 020027          227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG-LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVAL  305 (332)
Q Consensus       227 ~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  305 (332)
                      ++||....   ...+.++|+||||+++|++++|..||.. .................       .........++.+++.
T Consensus       153 ~~pE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~  222 (244)
T smart00220      153 MAPEVLLG---KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------PPPEWKISPEAKDLIR  222 (244)
T ss_pred             CCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------ccccccCCHHHHHHHH
Confidence            99998874   6678899999999999999999999976 33333333332221110       0000003347889999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 020027          306 ACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       306 ~c~~~dp~~RPs~~~i~~  323 (332)
                      +||..||++||++.++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHccCCchhccCHHHHhh
Confidence            999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.8e-34  Score=272.56  Aligned_cols=255  Identities=16%  Similarity=0.125  Sum_probs=166.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CC----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeee------
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-ST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF------  127 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------  127 (332)
                      ..++|+..+.||+|+||.||+|+. .+    +..||+|++.....    ......+  .+....+.++..+...      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            567899999999999999999995 45    78999998753211    0001111  1222223333332221      


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCCC----------------CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecC
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDGA----------------SLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGC  191 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  191 (332)
                      +...+..++++||+++++|.+++.......                .......+..++.|++.||.|||++   +|+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence            245567899999999999999986532100                0012334567899999999999998   999999


Q ss_pred             CCCCCEEeCC-CCceEEccCCccccCC-------cccCCcccccCcccccccCC-------------------CCCCchh
Q 020027          192 IKASNILLNE-KFCARVCDYGLSFLAP-------EEKRGLAGYVDDDYWHEKGG-------------------GNATRES  244 (332)
Q Consensus       192 lk~~Nill~~-~~~~kl~dfg~a~~~~-------~~~~~~~~~~~pe~~~~~~~-------------------~~~~~~~  244 (332)
                      |||+|||++. ++.+||+|||+|+...       ....+++.|+|||.+.....                   ..++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999985 6799999999997542       22357889999996542210                   1245577


Q ss_pred             hhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-----cccccCCcCCCC----CC--hHHHHHHHHHHHHcccCCCC
Q 020027          245 DVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-----FSELLDPRLAIP----CE--IKPLVRLAKVALACVGNSRK  313 (332)
Q Consensus       245 DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~----~~--~~~~~~l~~l~~~c~~~dp~  313 (332)
                      |||||||++|||+++..++........ ..+....     +.....+.....    ..  ........+++.+|++.||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLIQFN-RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHHHHH-HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999997766544321111 1111110     111111110000    00  00111345899999999999


Q ss_pred             CCCCHHHHHH
Q 020027          314 NRPSIVQVAT  323 (332)
Q Consensus       314 ~RPs~~~i~~  323 (332)
                      +|||+.|+++
T Consensus       440 kR~ta~e~L~  449 (566)
T PLN03225        440 QRISAKAALA  449 (566)
T ss_pred             cCCCHHHHhC
Confidence            9999999986

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-36  Score=247.08  Aligned_cols=255  Identities=20%  Similarity=0.246  Sum_probs=191.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--------  130 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  130 (332)
                      .+.|.....+|+|.||.||+++ .++|+.||+|++--+.....-.....+|++++..++|+|++.+.+.|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3456777889999999999999 5678889999875433222222346899999999999999999988743        


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      ...+++|+.+|+. +|.-.+.....   .++..++.+++.++..||.|+|..   .|+|||+|++|+|++.++.+||+||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence            2347999999974 77777754322   278899999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCccc----------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh---
Q 020027          211 GLSFLAPEEK----------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE---  277 (332)
Q Consensus       211 g~a~~~~~~~----------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~---  277 (332)
                      |+++......          .-|.-|.+||.+.+.  ..++++.|||+.||++.||+||.+.+++.........+..   
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~--r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD--REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcc--cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            9996543221          237789999998875  7899999999999999999999998887655444333321   


Q ss_pred             ------------cccccccCCc-CC-CC--------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 ------------MRFSELLDPR-LA-IP--------CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 ------------~~~~~~~~~~-~~-~~--------~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                  .++.+-+... +. ..        .+..-..+..+++.+++..||++|+++++++.
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                        1111111000 00 00        00001125779999999999999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=231.55  Aligned_cols=218  Identities=23%  Similarity=0.316  Sum_probs=175.9

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHh-ccCCCCCccceeeeeecCCc
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~  133 (332)
                      ++...+.......||+|++|.|-+-+ .++|...|+|.++.... .....+.++|+.+. +....|.+|.++|.....+.
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            55566667777889999999998887 57999999999986554 22333566777755 44579999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+|.||.|. .+|+.+-.+.......+++.-.=+|+..+.+||.|||++.  .++|||+||+|||++.+|.+|+||||++
T Consensus       120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            999999995 6888776654444455888888899999999999999974  8999999999999999999999999999


Q ss_pred             ccCCccc-----CCcccccCcccccccC-CCCCCchhhhHHHHHHHHHHHhCCCCCCch-hHHHHHHHhhh
Q 020027          214 FLAPEEK-----RGLAGYVDDDYWHEKG-GGNATRESDVYGFGVVLLEILSGRRCEEGL-LVKWALPLIKE  277 (332)
Q Consensus       214 ~~~~~~~-----~~~~~~~~pe~~~~~~-~~~~~~~~DiwS~G~il~el~tg~~p~~~~-~~~~~~~~~~~  277 (332)
                      -.+.++.     .|...|+|||...... ...|+-+|||||+|+.+.||.+++.||... .+-..++.+.+
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            7766553     5778999999886543 347899999999999999999999998643 33344444444

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.1e-33  Score=261.69  Aligned_cols=263  Identities=17%  Similarity=0.127  Sum_probs=179.4

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-----------------CCCCEEEEEEeccCcccc------------cccccHHH
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-----------------STGKLVAVKRIHPRLVLS------------NAGFGFAS  108 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~  108 (332)
                      ...++|+..+.||+|+||.||+|..                 ..++.||||.+.......            ........
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3578999999999999999999963                 245689999986432111            01122445


Q ss_pred             HHHHhccCCCCCc-----cceeeeeec--------CCceeEEEeccCCCCHHHHhcccCCC-------------------
Q 020027          109 VIKTLSLAQHPNI-----VPILGFSQA--------PGERIIVSEFINMASLDFYLHENNDG-------------------  156 (332)
Q Consensus       109 e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------  156 (332)
                      |+.++.+++|.|+     ++++++|..        .+..++|+||+++++|.++++.....                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766544     677777643        35679999999999999998642110                   


Q ss_pred             -CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc-------CCcccccC
Q 020027          157 -ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------RGLAGYVD  228 (332)
Q Consensus       157 -~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~-------~~~~~~~~  228 (332)
                       ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......       ..++.|++
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence             01246778889999999999999998   99999999999999999999999999986543211       23678999


Q ss_pred             cccccccCCC-------------------CCCchhhhHHHHHHHHHHHhCCC-CCCchhHHHH-HHHhh--hcccccccC
Q 020027          229 DDYWHEKGGG-------------------NATRESDVYGFGVVLLEILSGRR-CEEGLLVKWA-LPLIK--EMRFSELLD  285 (332)
Q Consensus       229 pe~~~~~~~~-------------------~~~~~~DiwS~G~il~el~tg~~-p~~~~~~~~~-~~~~~--~~~~~~~~~  285 (332)
                      ||.+......                   ....+.|+||+||+++||+++.. |+.+...... .....  ...+.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            9987542111                   11235799999999999999875 6654211111 00000  000111111


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSR---KNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp---~~RPs~~~i~~  323 (332)
                      .....+..........+++.+++..+|   .+|+|++|+++
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            122222222234467899999998765   68999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=260.87  Aligned_cols=240  Identities=16%  Similarity=0.169  Sum_probs=200.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCC-CEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTG-KLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..+++....||-|+||.|=.++.... ..+|+|.+++...-+. +......|-.+|...+.|.||++|-.+.++...|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            44667778899999999998885433 3589999987665433 333467888899999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||-|-||.+...++..+.    ++..+...++..+.+|+.|||++   +|+.|||||+|.+++.+|.+|+.|||+|+...
T Consensus       499 mEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            999999999999987554    88888889999999999999999   99999999999999999999999999998876


Q ss_pred             ccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 EEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      ...     +||+.|.|||....   ...+.++|.||+|+++|||+||++||.+..+...+..+..+.-      .  ...
T Consensus       572 ~g~KTwTFcGTpEYVAPEIILn---KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------~--i~~  640 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIILN---KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------K--IEF  640 (732)
T ss_pred             cCCceeeecCCcccccchhhhc---cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------h--hhc
Confidence            554     79999999999988   6778999999999999999999999999888877777766421      0  111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCC
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPS  317 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs  317 (332)
                      +..-.....+++.+.+..+|.+|--
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhc
Confidence            2222336778999999999999964

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=269.42  Aligned_cols=240  Identities=24%  Similarity=0.295  Sum_probs=181.5

Q ss_pred             CCCCCceeeccCCeEE-EEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      -|...+.+|.|+-|+| |+|.. .|+.||||.+-....     .-..+|++.++.- +|||||++++.-.++.+.||..|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~-----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF-----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH-----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            4566678999999865 99998 578999998864321     1246899988876 69999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---C--CceEEccCCccc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---K--FCARVCDYGLSF  214 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~--~~~kl~dfg~a~  214 (332)
                      .| ..+|.+++...........-.....+..|+++|+++||+.   +||||||||.||||+.   +  ..++|+|||+++
T Consensus       584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            99 4799999987411110011123456789999999999997   9999999999999975   2  468999999987


Q ss_pred             cCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          215 LAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       215 ~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....         ..||.+|+|||.+..   ..-+.++||+|+||++|..+| |+.||.+....++  .+..+...-. 
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~---~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~-  733 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLRE---DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLV-  733 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhc---cccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCcccee-
Confidence            65432         258999999999987   455679999999999999999 5889987644322  2222211100 


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .+  .....+  +..+||.+++.+||..||++.+|+.
T Consensus       734 --~L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 --HL--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             --ee--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence              01  111122  6779999999999999999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-33  Score=255.39  Aligned_cols=202  Identities=20%  Similarity=0.198  Sum_probs=172.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      +.-|..++.||-|+||+|..++ ..+...+|.|.+++.....+ +......|-.+|+..+++.||+++-.|.+.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            4457778999999999999998 56778999999987665433 333466788899999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc--
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL--  215 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~--  215 (332)
                      |+|++||++-.++-+.+    .+++..+..++..+.+|+++.|..   |++||||||.|||||.+|.+||.|||++.-  
T Consensus       708 MdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence            99999999988887644    378888888999999999999998   999999999999999999999999998610  


Q ss_pred             -------C---------------------------------------CcccCCcccccCcccccccCCCCCCchhhhHHH
Q 020027          216 -------A---------------------------------------PEEKRGLAGYVDDDYWHEKGGGNATRESDVYGF  249 (332)
Q Consensus       216 -------~---------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~  249 (332)
                             .                                       .....||..|+|||++..   ..++..||.||.
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r---~g~~q~cdwws~  857 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR---TGYTQLCDWWSV  857 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc---cCccccchhhHh
Confidence                   0                                       001158999999999987   678999999999


Q ss_pred             HHHHHHHHhCCCCCCchhHHHH
Q 020027          250 GVVLLEILSGRRCEEGLLVKWA  271 (332)
Q Consensus       250 G~il~el~tg~~p~~~~~~~~~  271 (332)
                      |||||||+.|+.||....+.+.
T Consensus       858 gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcc
Confidence            9999999999999987655544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-34  Score=236.48  Aligned_cols=252  Identities=21%  Similarity=0.264  Sum_probs=190.5

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-----ceeE
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-----ERII  136 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  136 (332)
                      .+..+.||-|+||.||.+. -.+|+.||+|++..-...-.....+.+|++++.-++|.|++..++....++     ..|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            4556789999999999998 458999999998654433344456789999999999999999999876553     4578


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ++|.+. .+|...+-+..    .++..++.-+.+||+.||.|||+.   +|.||||||.|.|++.|...||||||+++.-
T Consensus       135 ~TELmQ-SDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHH-hhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence            889885 68877776543    378888888999999999999998   9999999999999999999999999999875


Q ss_pred             Cccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh------------
Q 020027          217 PEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE------------  277 (332)
Q Consensus       217 ~~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~------------  277 (332)
                      ....       .-|..|.+||.+.+.  ..|+.+.||||.|||+.||+.++..|....+-..+..+.+            
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGa--RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGA--RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcc--hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            4322       346789999998775  7899999999999999999988877765444333333222            


Q ss_pred             ---cccccccCCcCCCC---------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          278 ---MRFSELLDPRLAIP---------CEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       278 ---~~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                         +...-+++...+.|         .+.....+...+..+.+.+||+.|.+..+.+..
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence               11111222222211         111122245577788899999999998876653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=234.43  Aligned_cols=237  Identities=20%  Similarity=0.327  Sum_probs=193.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccccccc-HHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~-~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      .++|..+++||+|+|.+|..++ .++.+.+|+|++++....+.+..+ ...|..+.... +||-+|-++.++..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            4678999999999999999999 568899999999987665554443 44666666655 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |.||++||+|--.+.+...    +++.++..+...|+.||.|||++   ||+.||||..|+|+|..|.+|+.|+|+++..
T Consensus       329 vieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999777765443    89999999999999999999999   9999999999999999999999999998642


Q ss_pred             ------CcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc--h------hHHHHHHHhhhccccc
Q 020027          217 ------PEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG--L------LVKWALPLIKEMRFSE  282 (332)
Q Consensus       217 ------~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~--~------~~~~~~~~~~~~~~~~  282 (332)
                            ....+||+.|+|||.+.+   ..|...+|.|++|++++||+.|+.||.-  .      ..+..+..        
T Consensus       402 l~~gd~tstfcgtpnyiapeilrg---eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------  470 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRG---EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------  470 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcc---cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------
Confidence                  233479999999999987   7889999999999999999999999962  1      11222222        


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCC
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP  316 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP  316 (332)
                      ++...++.|.+..  .+...++..-+..||++|.
T Consensus       471 ilekqiriprsls--vkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  471 ILEKQIRIPRSLS--VKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             Hhhhcccccceee--hhhHHHHHHhhcCCcHHhc
Confidence            2333444444433  3666788899999999985

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=252.24  Aligned_cols=251  Identities=23%  Similarity=0.277  Sum_probs=204.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|+....+|.|+||.||+++ ..+++..|+|.++......-.  ...+|+-+++..+||||+.++|.+...+..++.
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~--~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFS--GIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccc--ccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            45689999999999999999999 678999999999865443322  357889999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||||.+|+|++.-+.-    ..+++.++-.+....++|+.|||+.   +-+|||+|-.||++++.|.+|++|||.+....
T Consensus        91 MEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence            9999999998866532    3388888889999999999999999   99999999999999999999999999986554


Q ss_pred             cc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 EE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ..      ..||+.|||||...-...+.|..+||||+.|+...|+.--.+|-.+..+......+....+..   +.+.-.
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp---p~lkDk  240 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP---PTLKDK  240 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC---CcccCC
Confidence            32      369999999998876555788999999999999999988777766666655555554432221   222222


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...  ...+.++++.|+..+|++|||++.+++
T Consensus       241 ~kw--s~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  241 TKW--SEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccc--hHHHHHHHHHHhcCCCccCCChhhhee
Confidence            112  225678999999999999999988765

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=9e-32  Score=218.02  Aligned_cols=246  Identities=16%  Similarity=0.221  Sum_probs=185.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecC--Cce
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAP--GER  134 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~  134 (332)
                      ..++|++.+.+|+|.|+.||.|. ..+.+.++||.+++-.     ...+.+|++++..++ ||||+++++...++  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            35689999999999999999999 6788899999997542     235689999999997 99999999998765  467


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCcc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLS  213 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a  213 (332)
                      .+++||..+.+...+-..       ++...+..++.+++.||.|+|+.   ||+|||+||.|+++|. ....+++|+|+|
T Consensus       111 aLiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             hhHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence            899999988877665432       55667788999999999999999   9999999999999985 568999999999


Q ss_pred             ccCCccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC-chhHHHHH-------------HH
Q 020027          214 FLAPEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE-GLLVKWAL-------------PL  274 (332)
Q Consensus       214 ~~~~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~-~~~~~~~~-------------~~  274 (332)
                      -+.....     ..+..|-.||.+-.-  ..++..-|+|||||++.+|+..+.||. |....+.+             .+
T Consensus       181 EFYHp~~eYnVRVASRyfKGPELLVdy--~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  181 EFYHPGKEYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY  258 (338)
T ss_pred             hhcCCCceeeeeeehhhcCCchheeec--hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence            7654432     344566789987653  567788999999999999999888864 33221111             11


Q ss_pred             hhhcccccccCCcCCC--------C-------CCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          275 IKEMRFSELLDPRLAI--------P-------CEI-KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~--------~-------~~~-~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +..  +.-.++|.+..        +       .+. -...++.+++.+.+.+|-.+|||+.|...
T Consensus       259 l~K--Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  259 LNK--YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHH--HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            111  11112222211        0       000 01247889999999999999999998753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-32  Score=244.05  Aligned_cols=196  Identities=19%  Similarity=0.260  Sum_probs=169.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc------ccccHHHHHHHhccCC---CCCccceeeeee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN------AGFGFASVIKTLSLAQ---HPNIVPILGFSQ  129 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~---h~niv~~~~~~~  129 (332)
                      ..+|...+.+|+|+||.|+.+.. ++...|++|.+.+......      .-.....||++|+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            45689999999999999999994 4667899999987553221      1123688999999997   999999999999


Q ss_pred             cCCceeEEEecc-CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEc
Q 020027          130 APGERIIVSEFI-NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC  208 (332)
Q Consensus       130 ~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  208 (332)
                      +++.++|.||-- ++.+|.+++....+    +++..+..|+.|++.|+++||++   +|||||||-+|+.++.+|.+|++
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            999999999974 45689999976654    88999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCccc----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 020027          209 DYGLSFLAPEEK----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE  264 (332)
Q Consensus       209 dfg~a~~~~~~~----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~  264 (332)
                      |||.|....+..    .||.+|.|||.+.+.  ......-|||++|++||.++....||.
T Consensus       713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~--~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGE--KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCCCcceeeeeccccchhhhCCC--ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999997766543    799999999998774  455678999999999999999888875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.8e-30  Score=215.41  Aligned_cols=206  Identities=33%  Similarity=0.445  Sum_probs=177.2

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCHH
Q 020027           69 IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD  147 (332)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  147 (332)
                      ||+|++|.||++... +++.+++|......... ....+.+|+..++.++|++++++++++...+..++++|++++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999964 58999999987554321 1235789999999999999999999999989999999999999999


Q ss_pred             HHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCccccCCcc------c
Q 020027          148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLSFLAPEE------K  220 (332)
Q Consensus       148 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~~~------~  220 (332)
                      +++....   ..+++..+..++.+++.++.+||+.   +++|+||+|.||+++. ++.++++|||.+......      .
T Consensus        80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            9987642   1278899999999999999999998   9999999999999999 899999999998755433      3


Q ss_pred             CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHH
Q 020027          221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL  300 (332)
Q Consensus       221 ~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  300 (332)
                      .+...|.+||.....  ...+.++|+||+|++++++                                         ..+
T Consensus       154 ~~~~~~~~pe~~~~~--~~~~~~~D~~~lg~~~~~l-----------------------------------------~~~  190 (215)
T cd00180         154 VGTPAYMAPEVLLGK--GYYSEKSDIWSLGVILYEL-----------------------------------------PEL  190 (215)
T ss_pred             cCCCCccChhHhccc--CCCCchhhhHHHHHHHHHH-----------------------------------------HHH
Confidence            467789999988652  3678899999999999998                                         367


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHH
Q 020027          301 AKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       301 ~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .+++..|++.||++||++.++++.
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhC
Confidence            789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-31  Score=223.35  Aligned_cols=250  Identities=21%  Similarity=0.207  Sum_probs=188.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------C
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------G  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  132 (332)
                      ..+|...+.+|.|.- .|..+. .-.+++||+|++..............+|...+..++|+|+++++.++...      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456888888999988 555555 33688999999876654444445678999999999999999999998644      3


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++||+|. .+|.+.+.-.      ++..++..++.|+++|++|||+.   +|+||||||+||++..+..+||.|||+
T Consensus        95 e~y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            5689999995 6888877621      67888999999999999999999   999999999999999999999999999


Q ss_pred             cccCCccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--c----cc-
Q 020027          213 SFLAPEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--M----RF-  280 (332)
Q Consensus       213 a~~~~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--~----~~-  280 (332)
                      |+......     ..|..|.|||...+   ..+.+.+||||.||++.||++|+.-|.|...-+.+..+.+  +    ++ 
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~---~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hcccCcccccCchhheeeccCchheec---cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            98765442     45678999999887   4589999999999999999999987766433222211111  0    00 


Q ss_pred             ----------------------ccc-cCCcCCC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 ----------------------SEL-LDPRLAI--PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ----------------------~~~-~~~~~~~--~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                            .+. -|.....  ..+......+.+++.++|..||++|.|++++++
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                  000 0000000  011112234668999999999999999999885

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=8.5e-29  Score=210.75  Aligned_cols=194  Identities=29%  Similarity=0.423  Sum_probs=166.2

Q ss_pred             CCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           63 FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      |...+.||+|++|.||++... +++.+++|.+...... .....+.+|+..++.++|+|++++++++...+..++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            456788999999999999964 5889999999765432 12335788999999999999999999999989999999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc--
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--  219 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--  219 (332)
                      ++++|.+++......   +++.....++.+++.++.+||+.   +++|+|++|.||+++.++.++++|||.+......  
T Consensus        80 ~~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       80 EGGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999999764321   67889999999999999999998   9999999999999999999999999998765433  


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                           ..++..|++||...  ....++.++|+||||++++|+++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                 24667899999874  336777899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.4e-30  Score=232.81  Aligned_cols=258  Identities=20%  Similarity=0.202  Sum_probs=200.4

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC------CCCccceeee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ------HPNIVPILGF  127 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~  127 (332)
                      -.+..-+.|......|+|-|++|.+|+ ...|+.||||++++.......   -+.|+.+|++|+      --|+++++-.
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt---Gl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT---GLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh---hhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            344455678888889999999999999 556889999999876543332   378999999885      3489999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceE
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCAR  206 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~k  206 (332)
                      |...+++|+|+|.+. -+|.+.++..+.+ ..+....+..++.|+.-||..|-..   +|+|.||||.|||+++ ...+|
T Consensus       503 F~hknHLClVFE~Ls-lNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPLS-LNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             hhhcceeEEEehhhh-chHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence            999999999999985 5899999876543 2377888999999999999999987   9999999999999986 56789


Q ss_pred             EccCCccccCCcccC----CcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh--ccc
Q 020027          207 VCDYGLSFLAPEEKR----GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE--MRF  280 (332)
Q Consensus       207 l~dfg~a~~~~~~~~----~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~  280 (332)
                      |||||.|....+...    -...|.|||.+.+   .+|+...|+||.||.||||.||+..|.|.....++.+..+  +.+
T Consensus       578 LCDfGSA~~~~eneitPYLVSRFYRaPEIiLG---~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  578 LCDFGSASFASENEITPYLVSRFYRAPEIILG---LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eccCccccccccccccHHHHHHhccCcceeec---CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            999999988776542    2347999999887   7899999999999999999999998888766555443322  111


Q ss_pred             c-----------cccCCcCC------------------------------------CC-CChHHHHHHHHHHHHcccCCC
Q 020027          281 S-----------ELLDPRLA------------------------------------IP-CEIKPLVRLAKVALACVGNSR  312 (332)
Q Consensus       281 ~-----------~~~~~~~~------------------------------------~~-~~~~~~~~l~~l~~~c~~~dp  312 (332)
                      .           +..|..+.                                    .+ ........+.+|+..|+..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence            0           01111000                                    00 112334568899999999999


Q ss_pred             CCCCCHHHHHH
Q 020027          313 KNRPSIVQVAT  323 (332)
Q Consensus       313 ~~RPs~~~i~~  323 (332)
                      ++|.|..+.+.
T Consensus       735 ~KRit~nqAL~  745 (752)
T KOG0670|consen  735 EKRITVNQALK  745 (752)
T ss_pred             hhcCCHHHHhc
Confidence            99999998764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=223.26  Aligned_cols=131  Identities=24%  Similarity=0.319  Sum_probs=107.9

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-----C---CCccceeeeeecC
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-----H---PNIVPILGFSQAP  131 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~~  131 (332)
                      .+|...+.||.|.|++||.+. .++.+.||+|+++......+   ..+.||++|++++     |   .+||++++.|...
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtE---aAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTE---AALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHH---HHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            567778999999999999999 67888999999875432222   3478899888773     2   4799999998543


Q ss_pred             ----CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe
Q 020027          132 ----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL  199 (332)
Q Consensus       132 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  199 (332)
                          .++++|+|++ |.+|..+|......+  ++...+.+|+.||+.||.|||..|  ||+|-||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence                5789999999 667877877654333  889999999999999999999998  99999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6e-30  Score=212.19  Aligned_cols=254  Identities=16%  Similarity=0.238  Sum_probs=183.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeee-eecCCcee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGF-SQAPGERI  135 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~  135 (332)
                      ..+.|.+.+.||+|.||.+..++ .++.+.+++|.+.....   ...+|.+|..---.| .|.||+.-++. ++..+.+.
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            45678999999999999999999 56778999998865432   233567776533334 58999988764 67778889


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC--CCCceEEccCCcc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN--EKFCARVCDYGLS  213 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~dfg~a  213 (332)
                      +++||++.|+|..-+...+     +.+.-...++.|+++|+.|+|+.   ++||||||.+|||+-  +...+|+||||.+
T Consensus        99 F~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EeeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence            9999999999998876533     67778889999999999999999   999999999999994  3558999999999


Q ss_pred             ccCCccc---CCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          214 FLAPEEK---RGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       214 ~~~~~~~---~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      +..+...   .-+-.|.+||.....  +.....+.+|+|.||+++|.++||..||+.....+. .++.-..+.....+..
T Consensus       171 ~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  171 RKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQWLKRKNPAL  249 (378)
T ss_pred             cccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHHHhcccCccC
Confidence            8765432   235678888876543  223457889999999999999999999974322111 1222222222222222


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      +-... .-..++.++..+-++++|++|--..+.....
T Consensus       250 P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  250 PKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             chhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            11111 1122677788899999999995555554443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=210.50  Aligned_cols=250  Identities=21%  Similarity=0.359  Sum_probs=197.1

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCC
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMAS  145 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  145 (332)
                      ...|.+...|..|+|+++ |..+++|++..+....+.+.+|..|.-.++.+.||||..++|.|..+....++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            345788889999999995 5677779998888777788889999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEc--cCCccccCCcccCCc
Q 020027          146 LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC--DYGLSFLAPEEKRGL  223 (332)
Q Consensus       146 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~--dfg~a~~~~~~~~~~  223 (332)
                      |+..+++...  ...+..++.+++.+++.|++|||+. .+-|...-|+...+++|++.+.+|+  |--++.+. ....-.
T Consensus       274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe-~gr~y~  349 (448)
T KOG0195|consen  274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-VGRAYS  349 (448)
T ss_pred             HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec-cccccC
Confidence            9999986532  3467889999999999999999986 3345556789999999999998875  43233221 122346


Q ss_pred             ccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH-HHHhhhcccccccCCcCCCCCChHHHHHHHH
Q 020027          224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA-LPLIKEMRFSELLDPRLAIPCEIKPLVRLAK  302 (332)
Q Consensus       224 ~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  302 (332)
                      +.|++||.++.......-.++|+|||++++|||.|...||.+..+.+. ++...++         ++...++.-...+.+
T Consensus       350 pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg---------lrv~ippgis~hm~k  420 (448)
T KOG0195|consen  350 PAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG---------LRVHIPPGISRHMNK  420 (448)
T ss_pred             cccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc---------ccccCCCCccHHHHH
Confidence            789999999875444445689999999999999999999987655433 2222221         222222233346789


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          303 VALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       303 l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +|.-|...||.+||.|..|+-.|+++.
T Consensus       421 lm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  421 LMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            999999999999999999999999874

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=5.8e-29  Score=248.85  Aligned_cols=188  Identities=16%  Similarity=0.184  Sum_probs=136.5

Q ss_pred             cCCC-CCccceeeee-------ecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020027          115 LAQH-PNIVPILGFS-------QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN  186 (332)
Q Consensus       115 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~  186 (332)
                      .++| +||.++++++       .....++.++|++ +++|.+++....   ..+++.+++.++.||++||.|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4456 5888888877       2224566778887 569999997532   2388999999999999999999998   9


Q ss_pred             eeecCCCCCCEEeCC-------------------CCceEEccCCccccCCc----------------------ccCCccc
Q 020027          187 IIHGCIKASNILLNE-------------------KFCARVCDYGLSFLAPE----------------------EKRGLAG  225 (332)
Q Consensus       187 ivH~dlk~~Nill~~-------------------~~~~kl~dfg~a~~~~~----------------------~~~~~~~  225 (332)
                      |+||||||+|||++.                   ++.+|++|||+++....                      ...+|+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999953                   45677788887753211                      0135777


Q ss_pred             ccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHH
Q 020027          226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVAL  305 (332)
Q Consensus       226 ~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  305 (332)
                      |+|||.+..   ..++.++|||||||+||||++|..|+.....  ....+...    ...+..     .....+..+++.
T Consensus       181 Y~APE~~~~---~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~----~~~~~~-----~~~~~~~~~~~~  246 (793)
T PLN00181        181 YTSPEEDNG---SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR----VLPPQI-----LLNWPKEASFCL  246 (793)
T ss_pred             eEChhhhcc---CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh----hcChhh-----hhcCHHHHHHHH
Confidence            999999876   6789999999999999999998887653211  11111111    111111     111224567888


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 020027          306 ACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       306 ~c~~~dp~~RPs~~~i~~  323 (332)
                      +||+.||.+|||+.|+++
T Consensus       247 ~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        247 WLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HhCCCChhhCcChHHHhh
Confidence            999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=3.5e-28  Score=199.85  Aligned_cols=166  Identities=18%  Similarity=0.140  Sum_probs=124.0

Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-ccCC
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRG  222 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-~~~~  222 (332)
                      |+|.+++.....   .+++..++.++.|++.||.|||++   +      ||+||+++.++.+|+  ||++..... ...+
T Consensus         1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g   66 (176)
T smart00750        1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQSRV   66 (176)
T ss_pred             CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccCCC
Confidence            688888875432   389999999999999999999998   5      999999999999999  999876543 3368


Q ss_pred             cccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-HHHHHHhhhcccccccCCcCCCCCChHHH--HH
Q 020027          223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-KWALPLIKEMRFSELLDPRLAIPCEIKPL--VR  299 (332)
Q Consensus       223 ~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  299 (332)
                      +..|+|||.+..   ..++.++|||||||++|||+||+.||..... ......+.... ... .+. ..+......  .+
T Consensus        67 ~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~-~~~~~~~~~~~~~  140 (176)
T smart00750       67 DPYFMAPEVIQG---QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-PAD-DPR-DRSNLESVSAARS  140 (176)
T ss_pred             cccccChHHhcC---CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh-ccC-Ccc-ccccHHHHHhhhh
Confidence            899999999876   6788999999999999999999999965422 11111111110 000 000 001111112  25


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          300 LAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       300 l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +.+++.+||+.||++|||+.|+++.+..+.
T Consensus       141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      141 FADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            889999999999999999999999886543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=5.7e-28  Score=211.60  Aligned_cols=192  Identities=23%  Similarity=0.281  Sum_probs=161.0

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-C---CCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-S---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPG  132 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  132 (332)
                      ...+.|...+.||+|+|+.||++.. .   ..+.||+|.+.......    ....|+.+|..+ .+.||+++.+++..++
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~----ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS----RILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch----HHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3456788899999999999999983 2   56789999987554322    368999999888 5899999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCC
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYG  211 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg  211 (332)
                      ...+++||++.....++...       ++...+..++..+..||+++|.+   ||||||+||+|+|.+. .+.-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            99999999999998888864       56788889999999999999999   9999999999999985 4566899999


Q ss_pred             ccc-----------------cCCc---------------------------------ccCCcccccCcccccccCCCCCC
Q 020027          212 LSF-----------------LAPE---------------------------------EKRGLAGYVDDDYWHEKGGGNAT  241 (332)
Q Consensus       212 ~a~-----------------~~~~---------------------------------~~~~~~~~~~pe~~~~~~~~~~~  241 (332)
                      +|.                 ....                                 .+.||+||.|||++..-  +.-+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~--~~Qt  256 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC--PRQT  256 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc--cCcC
Confidence            873                 0000                                 11589999999998764  5668


Q ss_pred             chhhhHHHHHHHHHHHhCCCCCCc
Q 020027          242 RESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       242 ~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      +++||||.|+|+.-+++++.||..
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             Cccceeeccceeehhhcccccccc
Confidence            999999999999999999999853

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.2e-25  Score=202.55  Aligned_cols=178  Identities=20%  Similarity=0.210  Sum_probs=132.4

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEEeC--CCCEEEEEEeccCcc---cccccccHHHHHHHhccCCCCCccc-ee
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAALLS--TGKLVAVKRIHPRLV---LSNAGFGFASVIKTLSLAQHPNIVP-IL  125 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~-~~  125 (332)
                      |.+......++|...+.||+|+||+||+|...  +++.+|+|++.....   .......+.+|+.+++.++|+|++. ++
T Consensus         9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188          9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            33455566788999999999999999999853  677789998753311   1112234789999999999999985 44


Q ss_pred             eeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCC-CCCCEEeCCCCc
Q 020027          126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCI-KASNILLNEKFC  204 (332)
Q Consensus       126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~  204 (332)
                      ++    +..+++|||+++++|.. ...       ..   ...++.|+++||.|||++   +|+|||| ||+|||++.++.
T Consensus        89 ~~----~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         89 AT----GKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             Ec----CCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCC
Confidence            32    45799999999999963 211       11   135788999999999998   9999999 999999999999


Q ss_pred             eEEccCCccccCCcc--------------cCCcccccCcccccccCC---CCCCchhhhH
Q 020027          205 ARVCDYGLSFLAPEE--------------KRGLAGYVDDDYWHEKGG---GNATRESDVY  247 (332)
Q Consensus       205 ~kl~dfg~a~~~~~~--------------~~~~~~~~~pe~~~~~~~---~~~~~~~Diw  247 (332)
                      +||+|||+|+.....              ..++..|++||.+.....   ...+..+|-|
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999998744322              145677899998865421   2233445655

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-23  Score=188.18  Aligned_cols=252  Identities=21%  Similarity=0.203  Sum_probs=185.7

Q ss_pred             CCCCCceeeccCCeEEEEEEeCC--CCEEEEEEeccCcccccccccHHHHHHHhccCCC----CCccceeeee-ecCCce
Q 020027           62 GFSHRRIIGQGRLGTVYAALLST--GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH----PNIVPILGFS-QAPGER  134 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~  134 (332)
                      +|...+.||+|+||.||.+....  ...+|+|...........  .+..|..++..+..    +++..+++.. ..++..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            79999999999999999999543  357888877654322222  45677787777752    5888888888 477788


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-----CceEEcc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-----FCARVCD  209 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~d  209 (332)
                      ++||+.+ |.+|.++.....  ...++..+.++++.|++.+|.++|+.   |++|||+||.|+++...     ..+.+.|
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            9999998 789999876544  23389999999999999999999999   99999999999999864     4689999


Q ss_pred             CCccc--cC---------Cc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH
Q 020027          210 YGLSF--LA---------PE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP  273 (332)
Q Consensus       210 fg~a~--~~---------~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~  273 (332)
                      ||+++  ..         +.     ...||..|.++..-..   ...+.+.|+||++-++.|+..|..||.+........
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~---~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~  247 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG---IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS  247 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC---CccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence            99998  21         11     1138888888876554   678899999999999999999999997654322222


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .+...........     .....+.++.+++..+-+.+...+|....+...|++..
T Consensus       248 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  248 KFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             HHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            2222111111111     11112235556666666789999999999998887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=2e-22  Score=180.30  Aligned_cols=254  Identities=29%  Similarity=0.354  Sum_probs=192.2

Q ss_pred             CCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCC-CccceeeeeecCCceeEEEec
Q 020027           63 FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHP-NIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  140 (332)
                      |...+.||.|+||.||++...  ..+++|.+........ ....+.+|+..++.+.|+ |++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999975  7899999987665443 344688999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEccCCccccCC--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCDYGLSFLAP--  217 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~~--  217 (332)
                      +.++++.+++...... ..++......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++...  
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999777654311 2378888999999999999999999   999999999999999988 79999999986432  


Q ss_pred             ----------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH----HHHHHHhhhcccccc
Q 020027          218 ----------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV----KWALPLIKEMRFSEL  283 (332)
Q Consensus       218 ----------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~  283 (332)
                                ....++..|++||..........+...|+||+|++++++++|..|+.....    ......+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence                      233678899999988652113678899999999999999999999766542    2333333222111 0


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ................+.+++..|+..+|..|.+..+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            0000000000112236778999999999999998887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=3.4e-23  Score=171.78  Aligned_cols=140  Identities=16%  Similarity=0.164  Sum_probs=107.0

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc-------cccH-----------------HHHHHHhccCCCCCcc
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA-------GFGF-----------------ASVIKTLSLAQHPNIV  122 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~-----------------~~e~~~l~~l~h~niv  122 (332)
                      ..||+|+||.||+|...+|+.||+|.+++.......       ...|                 ..|+..+..+.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            579999999999999779999999999865322111       0111                 2488899988877764


Q ss_pred             ceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeecCCCCCCEEeCC
Q 020027          123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL-HQGVAPNIIHGCIKASNILLNE  201 (332)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dlk~~Nill~~  201 (332)
                      ........  ..+++|||++++++........    .++......++.|++.+|.++ |+.   +|+||||||+||+++ 
T Consensus        83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCcEEEec--CCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            43333222  2389999999877655432221    278889999999999999999 687   999999999999998 


Q ss_pred             CCceEEccCCccccC
Q 020027          202 KFCARVCDYGLSFLA  216 (332)
Q Consensus       202 ~~~~kl~dfg~a~~~  216 (332)
                      ++.++++|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=9.4e-23  Score=187.16  Aligned_cols=210  Identities=24%  Similarity=0.317  Sum_probs=160.5

Q ss_pred             hccCCCCCccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCC
Q 020027          113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCI  192 (332)
Q Consensus       113 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl  192 (332)
                      |+.+.|.|+.++.|.+..++..+++.+||..|+|.+.+.....   .+++.-...+..+++.||.|+|+.  +-.+|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~---~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI---KLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc---CccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            4567899999999999999999999999999999999976332   278888999999999999999986  22399999


Q ss_pred             CCCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCC----CCchhhhHHHHHHHHHHHhCC
Q 020027          193 KASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGN----ATRESDVYGFGVVLLEILSGR  260 (332)
Q Consensus       193 k~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~----~~~~~DiwS~G~il~el~tg~  260 (332)
                      +++|++++....+|++|||+.....+.        .....-|.+||.........    .+.++|+||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998766421        01234588999887642222    578899999999999999999


Q ss_pred             CCCCch----hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          261 RCEEGL----LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       261 ~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .||...    .+++....+.. .......|.+....  +....+..++..||..+|.+||++.++-..++.+..
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccccccccCChHHHHHHHHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            999752    22333333333 11122222222111  223368889999999999999999999998887643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=164.88  Aligned_cols=249  Identities=20%  Similarity=0.243  Sum_probs=179.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC-CCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH-PNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||.|+||.+|.|. ..+|+.||+|.-+....    .-....|.++.+.+++ ..|..+..+......-.+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            34578899999999999999999 78999999998654322    1235778888888875 456666667777788899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEccCCcc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCDYGLS  213 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a  213 (332)
                      ||+.. |.+|+++..-..+.   ++..+++.++-|++.-++|+|.+   +++||||||+|+|..-   ...+.++|||+|
T Consensus        89 VMdLL-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeecc-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            99998 78999888654433   78899999999999999999999   9999999999999963   456889999999


Q ss_pred             ccCCcc-------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH---HHHhhh
Q 020027          214 FLAPEE-------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA---LPLIKE  277 (332)
Q Consensus       214 ~~~~~~-------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~---~~~~~~  277 (332)
                      +..-+.             -.||..|.+-.....   ..-+.+.|+-|+|-+|...--|..||+|..+...   +..+.+
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g---~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E  238 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLG---IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE  238 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhh---hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence            643221             147777766544333   4557789999999999998889999998754332   122222


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      .+..-.+.. +.    ..-+.++...+..|-..--++-|+-.-+.+.+.
T Consensus       239 kK~s~~ie~-LC----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  239 KKMSTPIEV-LC----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             hhcCCCHHH-Hh----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            221110000 00    011336777777887777777777665554443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.4e-22  Score=166.21  Aligned_cols=141  Identities=17%  Similarity=0.119  Sum_probs=109.4

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc------------------------cccHHHHHHHhccCCCCCc
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA------------------------GFGFASVIKTLSLAQHPNI  121 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni  121 (332)
                      ...||+|+||.||+|...+|+.||+|.+++.......                        ......|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999778999999999876321110                        0012467888989999887


Q ss_pred             cceeeeeecCCceeEEEeccCCCCHHHH-hcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEe
Q 020027          122 VPILGFSQAPGERIIVSEFINMASLDFY-LHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILL  199 (332)
Q Consensus       122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill  199 (332)
                      .....+....  .+++|||++++++... +...     .++......++.|++.++.++|+ .   ||+||||||+||++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            5554443332  4899999988755433 3321     26778889999999999999999 8   99999999999999


Q ss_pred             CCCCceEEccCCccccCC
Q 020027          200 NEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       200 ~~~~~~kl~dfg~a~~~~  217 (332)
                      + ++.++++|||++....
T Consensus       152 ~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         152 H-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             E-CCCEEEEEcccceecC
Confidence            8 7899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.9e-23  Score=199.94  Aligned_cols=246  Identities=19%  Similarity=0.174  Sum_probs=171.5

Q ss_pred             CCCceeeccCCeEEEEEE-eCCCCEEEEEEeccC---cccccc-cccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           64 SHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPR---LVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .....+|.|++|.|+... ....+..+.|..+..   ...... ...+..|..+-..+.|+|++.......+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            355789999999777665 334444555544321   111111 112556667778899999988887776655555559


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      |||++ +|..++.....    +....+..++.|+..|+.|+|+.   |+.|||+|++|++++.++.+||+|||.+.... 
T Consensus       401 E~~~~-Dlf~~~~~~~~----~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGK----LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcccc----cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99998 99998876522    66677888999999999999999   99999999999999999999999999874321 


Q ss_pred             ---------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHH-HHhhhcccccccCCc
Q 020027          218 ---------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL-PLIKEMRFSELLDPR  287 (332)
Q Consensus       218 ---------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  287 (332)
                               ....|...|+|||.....  .......||||.|+++..|.+|+.||.-....... ...........    
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~----  546 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI----  546 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc----
Confidence                     223578899999998873  23346789999999999999999998643222111 00110000000    


Q ss_pred             CCCCCC--hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          288 LAIPCE--IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       288 ~~~~~~--~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+..  ...+.+...++.++++.||.+|-|+++|++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            001111  112234567889999999999999999975

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.2e-22  Score=170.71  Aligned_cols=174  Identities=13%  Similarity=0.098  Sum_probs=133.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccc-c------HHHHHHHhccCCCCCccceeeeeec
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF-G------FASVIKTLSLAQHPNIVPILGFSQA  130 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~-~------~~~e~~~l~~l~h~niv~~~~~~~~  130 (332)
                      ...++|...+.+|.|+||.||.... ++..+|+|.+++......... .      +.+|+..+.+++|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4567899999999999999999665 577899999986654332211 1      5789999999999999999888543


Q ss_pred             C--------CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          131 P--------GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       131 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      .        +..+++|||++|.+|.++..        ++.    ....+++.++..+|+.   |++|||++|+|++++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            2        35789999999999988732        232    2456899999999999   99999999999999988


Q ss_pred             CceEEccCCccccCCcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH
Q 020027          203 FCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL  257 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~  257 (332)
                      + ++++|||......+.....      .+...   ..+..++|+||||+.+.-..
T Consensus       172 g-i~liDfg~~~~~~e~~a~d------~~vle---r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAKD------RIDLE---RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhHH------HHHHH---hHhcccccccceeEeehHHH
Confidence            8 9999999886654322110      01122   34557899999999887654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=7e-21  Score=162.68  Aligned_cols=195  Identities=21%  Similarity=0.282  Sum_probs=157.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  137 (332)
                      .-+|...+.||+|+||..+.|+ +-+++.||||.-....    +.-.+..|....+.|. .++|-.++=|....-+-.+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            3478999999999999999999 6689999999753221    1224567777777774 67888888777777777899


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-----CceEEccCCc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-----FCARVCDYGL  212 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~dfg~  212 (332)
                      +|++ |.+|+++..-.++.   ++..+++.++.|+..-++|+|++   .+|-|||||+|+||...     ..+.+.|||+
T Consensus       103 idLL-GPSLEDLFD~CgR~---FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRR---FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCc---ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9998 78999988655443   89999999999999999999999   99999999999999753     3578999999


Q ss_pred             cccCCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH
Q 020027          213 SFLAPE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV  268 (332)
Q Consensus       213 a~~~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~  268 (332)
                      |+...+             +..||..||+-..   +.|.+-+.+.|+-|+|-++...+-|..||.|...
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINT---HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINT---HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeec---cccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            965422             1258899987543   3446778899999999999999999999998643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=3e-20  Score=153.19  Aligned_cols=181  Identities=13%  Similarity=0.066  Sum_probs=132.5

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc--ccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEEec
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN--AGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .....|++|+||+||.+.. .+..++.+.+........  ....+.+|+++|++++ |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997666 677788776654332111  1113678999999995 5789999886    346899999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCC-CCCCEEeCCCCceEEccCCccccCCcc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCI-KASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      ++|.+|......           ....++.|++.++.++|++   ||+|||| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999888653311           1134678999999999999   9999999 799999999999999999999754332


Q ss_pred             c-------------------CCcccccCcccccccCCCCCC-chhhhHHHHHHHHHHHhCCCCCCc
Q 020027          220 K-------------------RGLAGYVDDDYWHEKGGGNAT-RESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       220 ~-------------------~~~~~~~~pe~~~~~~~~~~~-~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      .                   ..++.|++|+.-.-.  ...+ ...+.++-|.-+|.++|++.++.+
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l--~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL--KRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh--ccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            2                   124555555432211  1233 567888999999999999887654

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3e-20  Score=155.66  Aligned_cols=135  Identities=18%  Similarity=0.195  Sum_probs=103.4

Q ss_pred             CCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccC-----CCCCccceeeeeecCC---c-
Q 020027           63 FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-----QHPNIVPILGFSQAPG---E-  133 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-  133 (332)
                      +...+.||+|+||.||. .-.++.. +||++......  ....+.+|+..++.+     +||||++++|++.++.   . 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            45568899999999996 3234444 79988764322  223579999999998     5799999999998763   4 


Q ss_pred             eeEEEec--cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHH-HHhhcCCCCCeeecCCCCCCEEeCC----CCceE
Q 020027          134 RIIVSEF--INMASLDFYLHENNDGASLLDWNRRLRIATGAARGL-EYLHQGVAPNIIHGCIKASNILLNE----KFCAR  206 (332)
Q Consensus       134 ~~lv~e~--~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~k  206 (332)
                      +.+++||  +++++|.+++++..     +++.  ..++.|++.++ .|||++   +|+||||||+|||++.    +..++
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence            3478999  56799999996532     4444  35577888777 899999   9999999999999974    34799


Q ss_pred             EccCC
Q 020027          207 VCDYG  211 (332)
Q Consensus       207 l~dfg  211 (332)
                      |+||+
T Consensus       150 LiDg~  154 (210)
T PRK10345        150 VCDNI  154 (210)
T ss_pred             EEECC
Confidence            99954

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.7e-21  Score=179.29  Aligned_cols=225  Identities=21%  Similarity=0.202  Sum_probs=175.1

Q ss_pred             eeeccCCeEEEEEE----eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEEeccC
Q 020027           68 IIGQGRLGTVYAAL----LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        68 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      ++|+|.||.|+.++    ...|..+|.|.+++.............|-.++...+ ||-+++++-.+..++..+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999876    346778999998876654444334466777788886 9999999999999999999999999


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc--
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK--  220 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~--  220 (332)
                      +|.+...+.....    ++......+...++-++.++|+.   ++++||+|++||+++.+|.+++.|||+++..-+..  
T Consensus        81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9998776654332    55666666777889999999998   99999999999999999999999999998764433  


Q ss_pred             CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHH
Q 020027          221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL  300 (332)
Q Consensus       221 ~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  300 (332)
                      +||..|||||...     ....++|.||||++++||+||..||.+    +....+...          ....+..-...+
T Consensus       154 cgt~eymApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~----------~~~~p~~l~~~a  214 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA----------ELEMPRELSAEA  214 (612)
T ss_pred             ccchhhhhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh----------ccCCchhhhHHH
Confidence            6799999999875     357799999999999999999999988    233333221          122222333355


Q ss_pred             HHHHHHcccCCCCCCCCH
Q 020027          301 AKVALACVGNSRKNRPSI  318 (332)
Q Consensus       301 ~~l~~~c~~~dp~~RPs~  318 (332)
                      .+++......+|.+|--.
T Consensus       215 ~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  215 RSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHhhCHHHHhcc
Confidence            577778888888888643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=5.7e-21  Score=184.61  Aligned_cols=246  Identities=20%  Similarity=0.172  Sum_probs=176.3

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccc--ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL--SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++...+.||++.|=+|.+|+...|. |+||++-+....  -+.......|++ ...++|||++.+.-+-..+...|++-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777889999999999999987776 888988655421  122223455555 566799999999888777778888889


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc--cCC
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF--LAP  217 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~--~~~  217 (332)
                      |.. .+|++.+....    .+..-+..-|+.|++.|+.-+|..   ||+|+|||.+|||++.-+-+.|+||..=+  ..+
T Consensus       102 yvk-hnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHh-hhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            885 58888775432    255566677999999999999998   99999999999999999999999997532  122


Q ss_pred             cc-----------cCCcccccCcccccccC--------CCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhh
Q 020027          218 EE-----------KRGLAGYVDDDYWHEKG--------GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       218 ~~-----------~~~~~~~~~pe~~~~~~--------~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~  277 (332)
                      ++           ......|.|||.+-...        ....+++=||||+||++.||++ |+++|.-...- .+   +.
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~-aY---r~  249 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL-AY---RS  249 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH-hH---hc
Confidence            21           13345799999886532        1226788899999999999999 67777532110 00   11


Q ss_pred             cc--cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          278 MR--FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       278 ~~--~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +.  ..+.+-..+.  .     ..+..++..+++.||.+|-|+++.++.=+++
T Consensus       250 ~~~~~~e~~Le~Ie--d-----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIE--D-----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             cCccCHHHHHHhCc--C-----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            10  0000000000  0     1466889999999999999999999886554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=3.2e-20  Score=162.15  Aligned_cols=192  Identities=19%  Similarity=0.186  Sum_probs=134.0

Q ss_pred             CCCCccceeeeeecC---------------------------CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHH
Q 020027          117 QHPNIVPILGFSQAP---------------------------GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA  169 (332)
Q Consensus       117 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~  169 (332)
                      +|||||+++++|.++                           ...|++|.-.+ .+|.+|+....     .+.....-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence            599999999876321                           24588888774 68999997654     3455566788


Q ss_pred             HHHHHHHHHhhcCCCCCeeecCCCCCCEEe--CCCC--ceEEccCCccccCCc------------ccCCcccccCccccc
Q 020027          170 TGAARGLEYLHQGVAPNIIHGCIKASNILL--NEKF--CARVCDYGLSFLAPE------------EKRGLAGYVDDDYWH  233 (332)
Q Consensus       170 ~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~--~~kl~dfg~a~~~~~------------~~~~~~~~~~pe~~~  233 (332)
                      .|+++|+.|||.+   |+.|||+|..|||+  +++.  ...++|||++.....            +.-|-..-||||...
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999998  3443  467899998743221            113455679999886


Q ss_pred             ccCCCC---CCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh-cccccccCCcCCCCCChHHHHHHHHHHHHccc
Q 020027          234 EKGGGN---ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE-MRFSELLDPRLAIPCEIKPLVRLAKVALACVG  309 (332)
Q Consensus       234 ~~~~~~---~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~  309 (332)
                      ...|..   .-.++|.|+.|.+.||+++...||.+.-.     +..+ ..+++-.-    .+-+..++..+.+++...++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-----m~L~~r~Yqe~qL----Palp~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-----MLLDTRTYQESQL----PALPSRVPPVARQLVFDLLK  495 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-----heechhhhhhhhC----CCCcccCChHHHHHHHHHhc
Confidence            543322   34689999999999999999999976210     0111 11111111    11122333356688889999


Q ss_pred             CCCCCCCCHHHHHHHHh
Q 020027          310 NSRKNRPSIVQVATILN  326 (332)
Q Consensus       310 ~dp~~RPs~~~i~~~L~  326 (332)
                      .||.+|||..-..+.|.
T Consensus       496 r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANVLN  512 (598)
T ss_pred             CCccccCCccHHHhHHH
Confidence            99999999876665543

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.2e-19  Score=153.90  Aligned_cols=143  Identities=17%  Similarity=0.145  Sum_probs=108.7

Q ss_pred             CCCCCceeeccCCeEEEEEE--eCCCCEEEEEEeccCcccccc----------------------cccHHHHHHHhccCC
Q 020027           62 GFSHRRIIGQGRLGTVYAAL--LSTGKLVAVKRIHPRLVLSNA----------------------GFGFASVIKTLSLAQ  117 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~  117 (332)
                      .|...+.||+|+||.||+|.  ..+|+.||+|.++........                      ...+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  578999999999864321100                      012457888888887


Q ss_pred             CCC--ccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeecCCCC
Q 020027          118 HPN--IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN-IIHGCIKA  194 (332)
Q Consensus       118 h~n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~  194 (332)
                      +.+  +.+++++    +..+++|||+++.++..+.....    .........++.|++.++.+||++   + ++|||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            532  3333432    23489999999888766542221    145556778999999999999999   9 99999999


Q ss_pred             CCEEeCCCCceEEccCCccccC
Q 020027          195 SNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       195 ~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +||+++ ++.++++|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999988654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=2.1e-19  Score=155.67  Aligned_cols=235  Identities=17%  Similarity=0.174  Sum_probs=142.7

Q ss_pred             CCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCC----------CCCccceeeeee-
Q 020027           63 FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQ----------HPNIVPILGFSQ-  129 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~----------h~niv~~~~~~~-  129 (332)
                      +.....||.|+++.||.+. -.+|+.+|+|.......... ....+.+|.-....+.          |-.++--++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            3456789999999999999 46799999998875542222 1223444443333322          112222222221 


Q ss_pred             --------cC---C-----ceeEEEeccCCCCHHHHhcc---cCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeec
Q 020027          130 --------AP---G-----ERIIVSEFINMASLDFYLHE---NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHG  190 (332)
Q Consensus       130 --------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~  190 (332)
                              ..   +     ..+++|.-+ .++|.+++..   .......+...-++.+..|+.+.+++||+.   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    11   1     235677777 4688877542   222112233445667789999999999999   99999


Q ss_pred             CCCCCCEEeCCCCceEEccCCccccCCccc---CCcccccCccccccc-----CCCCCCchhhhHHHHHHHHHHHhCCCC
Q 020027          191 CIKASNILLNEKFCARVCDYGLSFLAPEEK---RGLAGYVDDDYWHEK-----GGGNATRESDVYGFGVVLLEILSGRRC  262 (332)
Q Consensus       191 dlk~~Nill~~~~~~kl~dfg~a~~~~~~~---~~~~~~~~pe~~~~~-----~~~~~~~~~DiwS~G~il~el~tg~~p  262 (332)
                      ||+|+|++++.+|.+.++||+.........   ..+..|.+||.....     ....++.+.|.|++|+++|.+++++.|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999998765443322   234667888866442     123578899999999999999999999


Q ss_pred             CCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCC
Q 020027          263 EEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNR  315 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~R  315 (332)
                      |...........            .+. .+. +.++.+..++...+++||.+|
T Consensus       250 f~~~~~~~~~~~------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            986533222110            111 111 334567799999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=7.1e-19  Score=172.48  Aligned_cols=249  Identities=23%  Similarity=0.267  Sum_probs=176.0

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC---CCCccceeeee
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPILGFS  128 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~  128 (332)
                      +..+.+.....|.+.+.+|+|+||.||+|...+|+.||+|.-++...     ++|.=..+++.+|+   -+.|..+....
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHH
Confidence            34455566778999999999999999999977799999999776542     23332334455554   24555565555


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC-------C
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN-------E  201 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-------~  201 (332)
                      .-.+..++++||.+.|+|.++++..    ..++|..++.++.|++.-+..||..   +|||+||||+|+|+.       +
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence            6667789999999999999999833    3389999999999999999999999   999999999999994       2


Q ss_pred             CCceEEccCCcccc---CCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH
Q 020027          202 KFCARVCDYGLSFL---APEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP  273 (332)
Q Consensus       202 ~~~~kl~dfg~a~~---~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~  273 (332)
                      +..++|+|||.|--   .++.     ..+|-.+-++|...+   .+++.++|.|.++.+++-|+.|+.-          .
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g---rpWtYq~DyfGlAa~~h~mLFG~y~----------q  903 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG---RPWTYQIDYFGLAATVHVMLFGKYM----------E  903 (974)
T ss_pred             ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC---CCCchhhhhHHHHHHHHHHHHHHHH----------H
Confidence            45689999998832   2332     134556666676655   8999999999999999999987531          1


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                       ...+.... .+..  .+... ..+-..++....|..|-..=|...++...|++++.
T Consensus       904 -~~~g~~~~-~~~~--~~Ry~-~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  904 -VKNGSSWM-VKTN--FPRYW-KRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             -hcCCccee-cccc--chhhh-hHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence             11111111 1111  11000 11123356666776666666888888888887653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.1e-18  Score=147.72  Aligned_cols=136  Identities=22%  Similarity=0.279  Sum_probs=112.5

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc------ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN------AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      +.||+|++|.||+|.. +|..+++|..........      ....+.+|+..+..++|+|+.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899998654332111      112367889999999999988887777777788999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|++|.+++...       .+ ....++.+++.++.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988642       12 6788999999999999998   999999999999999 78899999998865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2.6e-18  Score=143.91  Aligned_cols=139  Identities=18%  Similarity=0.109  Sum_probs=106.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc--------------------ccccHHHHHHHhccCCCCC
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN--------------------AGFGFASVIKTLSLAQHPN  120 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~h~n  120 (332)
                      ..|...+.||+|+||.||++...+|+.||+|.++.......                    .......|+..+..+.|++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            34777889999999999999988899999998765331100                    0012466788888887764


Q ss_pred             --ccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEE
Q 020027          121 --IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNIL  198 (332)
Q Consensus       121 --iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  198 (332)
                        +...++    .+..+++|||+++++|......          .....++.+++.++.++|+.   +++|+||+|+||+
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil  157 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL  157 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence              333333    2445899999999988765421          22456888999999999998   9999999999999


Q ss_pred             eCCCCceEEccCCccccC
Q 020027          199 LNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       199 l~~~~~~kl~dfg~a~~~  216 (332)
                      +++++.++++|||++...
T Consensus       158 l~~~~~~~liDfg~~~~~  175 (198)
T cd05144         158 VDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             EcCCCcEEEEECCccccC
Confidence            999999999999998544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=3.3e-18  Score=164.12  Aligned_cols=140  Identities=19%  Similarity=0.206  Sum_probs=110.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc------ccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN------AGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ...|...+.||+|+||.||+|.+... .+++|+.........      ....+.+|+.+++.++|+|++....++..+..
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34456678999999999999987443 444444322211111      11246789999999999999988777777777


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.            ....++.|+++++.+||+.   +++|||+||+||++ +++.++++|||++
T Consensus       411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            899999999999998774            2456889999999999998   99999999999999 6778999999998


Q ss_pred             ccC
Q 020027          214 FLA  216 (332)
Q Consensus       214 ~~~  216 (332)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=4e-18  Score=142.89  Aligned_cols=133  Identities=22%  Similarity=0.292  Sum_probs=106.0

Q ss_pred             eeeccCCeEEEEEEeCCCCEEEEEEeccCccccc------ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEecc
Q 020027           68 IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN------AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  141 (332)
                      .||+|+||.||+|.. +|..+++|..........      ....+.+|+..+..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998654321111      1123568999999998887666666666667789999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ++++|.+++....       .    .++.+++.+|.++|+.   +++|+|++|.||+++ ++.+++.|||++...
T Consensus        80 ~g~~l~~~~~~~~-------~----~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------D----ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH-------H----HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998875321       0    6789999999999998   999999999999999 889999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=2.3e-18  Score=166.47  Aligned_cols=199  Identities=20%  Similarity=0.232  Sum_probs=140.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+.++++..|+||.||.++. .+.+.+|.|.-+ +..       +.+-  ++....+|-+|                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-------ilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-------ILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-------hhhc--cccccCCccee----------------
Confidence            46899999999999999999985 466788884322 211       1110  11112222222                


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC--
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA--  216 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~--  216 (332)
                           |+-...++..+.    ++.        +++.+++|||+.   +|+|||+||.|.+++.-|.+|+.|||++.+.  
T Consensus       136 -----gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -----chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                 333333432221    222        237789999998   9999999999999999999999999987431  


Q ss_pred             -------------------CcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh
Q 020027          217 -------------------PEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       217 -------------------~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~  277 (332)
                                         ....+||+.|+|||+...   ..|...+|.|++|+|+||.+-|..||.+..+++.+..+..
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr---qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhh---hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence                               112268999999999987   5688899999999999999999999999988887655433


Q ss_pred             c--ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCC
Q 020027          278 M--RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP  316 (332)
Q Consensus       278 ~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP  316 (332)
                      .  .+.+-         +.....++.+++.+.+..+|..|-
T Consensus       273 d~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  273 DDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence            1  11111         112223677899999999999994

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=8.1e-17  Score=133.52  Aligned_cols=138  Identities=19%  Similarity=0.199  Sum_probs=95.6

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccH----------------------HHHHHHhccCCCCC--c
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGF----------------------ASVIKTLSLAQHPN--I  121 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n--i  121 (332)
                      .+.||+|+||.||+|...+|+.||+|.+++...........                      ..|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999997789999999987643222111111                      23444444443322  2


Q ss_pred             cceeeeeecCCceeEEEeccCCCCHHH-HhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEe
Q 020027          122 VPILGFSQAPGERIIVSEFINMASLDF-YLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILL  199 (332)
Q Consensus       122 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill  199 (332)
                      .+.++.    ...+++|||++++.+.. .+....     .. .....++.+++.++.++|+ .   +++|+|+||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            333332    24589999999854321 111110     11 4567889999999999998 7   99999999999999


Q ss_pred             CCCCceEEccCCccccCC
Q 020027          200 NEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       200 ~~~~~~kl~dfg~a~~~~  217 (332)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=1.2e-17  Score=151.38  Aligned_cols=166  Identities=20%  Similarity=0.267  Sum_probs=122.4

Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      .++|.|++|...+|.+|+..... ....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            47899999999999999975433 2236788889999999999999   5   899999999999999999999999998


Q ss_pred             cccCCcc------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcc
Q 020027          213 SFLAPEE------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMR  279 (332)
Q Consensus       213 a~~~~~~------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~  279 (332)
                      .......            ..||..||+||.+.+   ..|+.++||||||++|+|+++ -...+...   ..+..+.++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g---~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~  476 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG---QQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGI  476 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhh---hhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCC
Confidence            6433221            258999999999887   789999999999999999997 22222111   1112222322


Q ss_pred             cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 020027          280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQ  320 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~  320 (332)
                      +.    +......+     +-..++.+++...|.+||++.+
T Consensus       477 ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  477 IP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             CC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence            21    11111222     3347888999999999994443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=3.6e-16  Score=124.42  Aligned_cols=135  Identities=20%  Similarity=0.179  Sum_probs=111.2

Q ss_pred             CCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC--CCccceeeeeecCCceeEEEeccC
Q 020027           65 HRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH--PNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      +.+.||+|.++.||++...+ ..+++|.......    ...+..|+..++.++|  .++.+++++...++..++++||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            45679999999999999754 7899998865432    2357889999999876  588899888888788999999998


Q ss_pred             CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       143 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++.+..+           +......++.+++++++++|.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8766543           3455667889999999999986445799999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=1.6e-15  Score=130.37  Aligned_cols=138  Identities=17%  Similarity=0.125  Sum_probs=103.6

Q ss_pred             Cceee-ccCCeEEEEEEeCCCCEEEEEEeccCcc-----c------ccccccHHHHHHHhccCCCCCc--cceeeeeecC
Q 020027           66 RRIIG-QGRLGTVYAALLSTGKLVAVKRIHPRLV-----L------SNAGFGFASVIKTLSLAQHPNI--VPILGFSQAP  131 (332)
Q Consensus        66 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  131 (332)
                      ...|| .|+.|+||.+... +..+++|.......     .      ......+.+|+..+..++|+++  .+.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999998874 67899998753211     0      0112246789999999988775  5666664332


Q ss_pred             -C---ceeEEEeccCC-CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          132 -G---ERIIVSEFINM-ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       132 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                       +   ..+++||++++ .+|.+++....     ++..    .+.+++.++.+||+.   ||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence             2   23599999997 68988875421     3433    356899999999999   999999999999999988999


Q ss_pred             EccCCccccC
Q 020027          207 VCDYGLSFLA  216 (332)
Q Consensus       207 l~dfg~a~~~  216 (332)
                      ++|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.3e-17  Score=158.26  Aligned_cols=248  Identities=20%  Similarity=0.202  Sum_probs=179.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe--CCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  136 (332)
                      ...|...+.||+|+|+.|-....  .....+|.|.+...............|..+-..+. |+|++++++....++..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            45678888899999999987764  34456777766544322222222344666666665 9999999999999999999


Q ss_pred             EEeccCCCCHHHHh-cccCCCCCcCCHHHHHHHHHHHHHHHHHhh-cCCCCCeeecCCCCCCEEeCCCC-ceEEccCCcc
Q 020027          137 VSEFINMASLDFYL-HENNDGASLLDWNRRLRIATGAARGLEYLH-QGVAPNIIHGCIKASNILLNEKF-CARVCDYGLS  213 (332)
Q Consensus       137 v~e~~~~~~L~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a  213 (332)
                      .+++..++++...+ .....   ..+......++.|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++|||+|
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence            99999999998887 33221   2445556778999999999999 77   999999999999999999 9999999998


Q ss_pred             ccCCc---------ccCC-cccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccc
Q 020027          214 FLAPE---------EKRG-LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSEL  283 (332)
Q Consensus       214 ~~~~~---------~~~~-~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      .....         ...| +..|++||.....  ....+..|+||.|+++.-+++|..|+........       .+...
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~--~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------~~~~~  243 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK--AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------RYSSW  243 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccch--hhcCCCcccccccccccccccCCCCccccccccc-------cceee
Confidence            65443         1257 8899999988764  3556889999999999999999999865433221       11111


Q ss_pred             cCCc--CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          284 LDPR--LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       284 ~~~~--~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                      ....  ........-.....++..+++..+|+.|.+.+++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            1110  00111111222566777789989999999987763

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=5.5e-15  Score=126.77  Aligned_cols=195  Identities=19%  Similarity=0.247  Sum_probs=135.6

Q ss_pred             HhccCCCCCccceeeeeecC-----CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020027          112 TLSLAQHPNIVPILGFSQAP-----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN  186 (332)
Q Consensus       112 ~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~  186 (332)
                      .+-.+.|.|+|+++.++.+.     ....+++||+..|++..++++-..+...+....-.+++.||..||.|||+ |.|.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            34455699999999988543     45688999999999999998766555556667777899999999999998 5888


Q ss_pred             eeecCCCCCCEEeCCCCceEEccCCccccCC----------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHH
Q 020027          187 IIHGCIKASNILLNEKFCARVCDYGLSFLAP----------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEI  256 (332)
Q Consensus       187 ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~----------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el  256 (332)
                      ++|+++..+.|++..++-+|+.--......+          +...+.++|.+||+=..   ...+.++|||+||+...||
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~---tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT---TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc---cccccchhhhhhhHHHHHH
Confidence            9999999999999999988886322111111          11145678888887544   5667899999999999999


Q ss_pred             HhCCCC-CCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          257 LSGRRC-EEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       257 ~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+..- -.+...-+....+.+-        .+....+     .-...+..|++..|..||+|.+++.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~--------i~~len~-----lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANV--------IIGLENG-----LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhh--------eeeccCc-----cccCcCcccccCCCCCCcchhhhhc
Confidence            876542 1111100000001000        0000000     2225667899999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=3.6e-14  Score=132.17  Aligned_cols=147  Identities=22%  Similarity=0.236  Sum_probs=101.2

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc--------------------------------------cc
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN--------------------------------------AG  103 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~  103 (332)
                      .|+ .+.||+|++|.||+|++.+|+.||||+.++.....-                                      ..
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            344 368999999999999999999999999986531100                                      01


Q ss_pred             ccHHHHHHHhccC----CCCCccceeeee-ecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHH-HHH
Q 020027          104 FGFASVIKTLSLA----QHPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR-GLE  177 (332)
Q Consensus       104 ~~~~~e~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~  177 (332)
                      .++.+|...+.++    +|.+-+.+-..+ ...+..+++|||++|+++.++......+   .+   ...++..++. .+.
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---LD---RKALAENLARSFLN  271 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---CC---HHHHHHHHHHHHHH
Confidence            1345555555444    233334433333 2234568999999999998876532111   22   2345555555 467


Q ss_pred             HhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       178 ~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      .+|..   |++|+|++|.||+++.++.++++|||++...++
T Consensus       272 ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       272 QVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            78887   999999999999999999999999999866543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=2.8e-14  Score=131.80  Aligned_cols=240  Identities=20%  Similarity=0.224  Sum_probs=174.4

Q ss_pred             CCCCCceeec--cCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCcee
Q 020027           62 GFSHRRIIGQ--GRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        62 ~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  135 (332)
                      .|.....+|.  |.+|.||.++.   .++..+|+|.-+...........-.+|.....++ .|+|.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556678999  99999999985   4778899998554433333333346677666777 4999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHH----HHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccC
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDY  210 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~df  210 (332)
                      +-+|+|. .++..+.....+-   ++....+....+..+    |+.++|+.   .++|-|+||.||++..+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~---~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNF---LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhccccc---CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999995 7888887654332   566667777888888    99999998   99999999999999988 88899999


Q ss_pred             CccccCCccc-----------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC-chhHHHHHHHhhhc
Q 020027          211 GLSFLAPEEK-----------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE-GLLVKWALPLIKEM  278 (332)
Q Consensus       211 g~a~~~~~~~-----------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~-~~~~~~~~~~~~~~  278 (332)
                      |+-....+..           .+-..|++||...    +-++..+|+||+|.+..|..++...+. +....|..  ...+
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~----~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~  341 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN----GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQG  341 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhc----cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccc
Confidence            9865443322           4567899999876    467899999999999999999876553 22222221  1110


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                              .+..........++...+.++++.+|-.|++++.+.
T Consensus       342 --------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  342 --------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             --------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence                    011111111222455577899999999999987654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=2.1e-13  Score=128.80  Aligned_cols=147  Identities=15%  Similarity=0.135  Sum_probs=94.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCC-CCEEEEEEeccCcccc--------------------------------------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLST-GKLVAVKRIHPRLVLS--------------------------------------  100 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~--------------------------------------  100 (332)
                      ...|+. +.||+|++|.||+|++.+ |+.||||+.++.....                                      
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999766 9999999998653110                                      


Q ss_pred             cccccHHHHHHHhccC----CCCCccceeeeeec-CCceeEEEeccCCCCHHHHh--cccCCCCCcCCHHHHHHHHHHHH
Q 020027          101 NAGFGFASVIKTLSLA----QHPNIVPILGFSQA-PGERIIVSEFINMASLDFYL--HENNDGASLLDWNRRLRIATGAA  173 (332)
Q Consensus       101 ~~~~~~~~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~l~~~~~~~i~~~i~  173 (332)
                      ....++.+|...+.++    .+.+.+.+-..+.+ .+..+++|||++|+++.++-  ...+.....+.......++.|+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            0011344555444443    23444444333322 34568999999999997743  22211111122223333344443


Q ss_pred             HHHHHhhcCCCCCeeecCCCCCCEEeCCCC----ceEEccCCccccCC
Q 020027          174 RGLEYLHQGVAPNIIHGCIKASNILLNEKF----CARVCDYGLSFLAP  217 (332)
Q Consensus       174 ~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~dfg~a~~~~  217 (332)
                             ..   |++|+|++|.||+++.++    .+++.|||+....+
T Consensus       278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   34   999999999999999887    99999999875544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=5.7e-12  Score=117.95  Aligned_cols=160  Identities=19%  Similarity=0.227  Sum_probs=119.3

Q ss_pred             eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCC
Q 020027           82 LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD  161 (332)
Q Consensus        82 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~  161 (332)
                      ..++.+|.|...+....  .......+-++.++.++||||+++++..+.++..||++|-+.  .|..++++..       
T Consensus        34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------  102 (690)
T ss_pred             eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------
Confidence            56788888888765543  111124566788999999999999999999999999999984  7888887643       


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcccC------CcccccCccccccc
Q 020027          162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR------GLAGYVDDDYWHEK  235 (332)
Q Consensus       162 ~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~------~~~~~~~pe~~~~~  235 (332)
                      .....--+.||+.||.|||+.|  +++|+++.-..|+++..|.-||++|-..........      ....|..|+.... 
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-
Confidence            3334456789999999999765  899999999999999999999999977654432211      1122334433221 


Q ss_pred             CCCCCCchhhhHHHHHHHHHHHhC
Q 020027          236 GGGNATRESDVYGFGVVLLEILSG  259 (332)
Q Consensus       236 ~~~~~~~~~DiwS~G~il~el~tg  259 (332)
                          -....|.|-|||+++|++.|
T Consensus       180 ----s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 ----SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ----cccchhhhhHHHHHHHHhCc
Confidence                12356999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=4.4e-12  Score=103.25  Aligned_cols=130  Identities=16%  Similarity=0.079  Sum_probs=93.6

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCcc-ceeeeeecCCceeEEEeccCCC
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV-PILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .+.++.|.++.||++... ++.+++|.......   ....+..|...++.+.+.+++ +++.+..  +..+++||++++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence            356889999999999864 77899998754421   122457888888887655544 4444432  3457999999998


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV--APNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++....         ..   ....+.+++.+++.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~~---------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTED---------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccccc---------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            775420         11   1234678999999999872  12369999999999998 6679999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.2e-12  Score=121.10  Aligned_cols=246  Identities=18%  Similarity=0.164  Sum_probs=170.9

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe--CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      ....+|.....||.|.|+.|+....  .++..+++|.+.+......+...-..|+.....+ .|.++++++..+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788899999999999998773  4778999999887665544443445666665555 588999988877777777


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccCCcc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYGLS  213 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a  213 (332)
                      ++-.|||.++++...+.-    ...++....+++..|++.++.++|+.   .++|+|++|+||++.++ +..+++|||+.
T Consensus       342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            899999999988776632    12367778889999999999999988   99999999999999886 78899999987


Q ss_pred             ccCCc--c-cCCccccc-CcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          214 FLAPE--E-KRGLAGYV-DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       214 ~~~~~--~-~~~~~~~~-~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ....-  . ....-++. ..|.....  ..+..+.|++|||.-+.|..++..--... ..+  ..+..+        ...
T Consensus       415 t~~~~~~~~~~~~~r~~p~~~~~~e~--~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~~--~~i~~~--------~~p  481 (524)
T KOG0601|consen  415 TRLAFSSGVFHHIDRLYPIAEILLED--YPHLSKADIFSLGLSVDEAITGSPLSESG-VQS--LTIRSG--------DTP  481 (524)
T ss_pred             cccceecccccccccccccchhhccc--cccccccccccccccccccccCcccCccc-ccc--eeeecc--------ccc
Confidence            53211  1 11222333 23333332  67788999999999999999876532110 000  111111        111


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL  325 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L  325 (332)
                      ..  ......+..+.......|+..||++.++....
T Consensus       482 ~~--~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  482 NL--PGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             CC--CchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            11  11113555667778889999999988776543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=2.8e-11  Score=99.89  Aligned_cols=137  Identities=15%  Similarity=0.071  Sum_probs=94.4

Q ss_pred             ceeeccCCeEEEEEEeCC-------CCEEEEEEeccCccccc---------c-----------ccc----HHHHHHHhcc
Q 020027           67 RIIGQGRLGTVYAALLST-------GKLVAVKRIHPRLVLSN---------A-----------GFG----FASVIKTLSL  115 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~---------~-----------~~~----~~~e~~~l~~  115 (332)
                      -.||.|.-+.||.|...+       +..+|+|..+.....-.         .           ...    ..+|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999998542       57999999874321100         0           001    2267778877


Q ss_pred             CCC--CCccceeeeeecCCceeEEEeccCCCCHH-HHhcccCCCCCcCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeecC
Q 020027          116 AQH--PNIVPILGFSQAPGERIIVSEFINMASLD-FYLHENNDGASLLDWNRRLRIATGAARGLEYL-HQGVAPNIIHGC  191 (332)
Q Consensus       116 l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~d  191 (332)
                      +..  -++...+++    ..-+|+|||+.+..+. ..+++.     .++......+..+++.+|..+ |..   +++|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            743  345555544    4568999999764332 122221     134455667789999999998 777   999999


Q ss_pred             CCCCCEEeCCCCceEEccCCccccC
Q 020027          192 IKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       192 lk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |++.||+++ ++.+.++|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 467999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.9e-10  Score=97.75  Aligned_cols=143  Identities=22%  Similarity=0.298  Sum_probs=105.7

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC--CCccceeeeeecC---CceeEEEecc
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH--PNIVPILGFSQAP---GERIIVSEFI  141 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~  141 (332)
                      +.|+.|..+.||++...+|+.+++|........ .....+..|...++.+++  .++.+++.+....   +..+++|||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999999766789999987654321 123357899999998865  3456677776553   3668999999


Q ss_pred             CCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 020027          142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV--------------------------------------  183 (332)
Q Consensus       142 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------  183 (332)
                      ++.++...+..     ..++......++.++++++..||+..                                      
T Consensus        83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            99888765431     11566666677778888888877421                                      


Q ss_pred             ---------------CCCeeecCCCCCCEEeCC--CCceEEccCCcccc
Q 020027          184 ---------------APNIIHGCIKASNILLNE--KFCARVCDYGLSFL  215 (332)
Q Consensus       184 ---------------~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~  215 (332)
                                     ...++|+|+.+.||+++.  ++.+.+.||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           246899999999999998  56688999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=4.7e-10  Score=89.89  Aligned_cols=133  Identities=24%  Similarity=0.301  Sum_probs=94.8

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc-------cccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA-------GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ..+++|+-+.+|.+.+. |..+.+|.=-+ ......       .....+|..+++++.--.|-.-.-+..+++...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~-K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIP-KRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecC-cccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35789999999998763 44455554322 211111       1135678888887754444444445566777889999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |++|..|.+++...           ...++..+-.-+.-||..   +|+|+||.++|+++..++ +.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99999999888754           123455666677889998   999999999999998776 899999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.13  E-value=4.4e-11  Score=116.84  Aligned_cols=246  Identities=15%  Similarity=0.104  Sum_probs=162.6

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ....+.+.+.+-+-+|.++.++.+. ..+|...+.|.......... +......+-.+.-..+||-+++..-.+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            3456778888888999999998877 34454445554432221111 111112221111112345555444444445667


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      .++++|..++++...++....    .+..-.......+.++.+|||+.   .+.|+|++|.|.+...++..+++|||...
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence            899999999999888875442    23333344556688899999987   68999999999999999999999998321


Q ss_pred             cC------------------------------Cc-------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH
Q 020027          215 LA------------------------------PE-------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL  257 (332)
Q Consensus       215 ~~------------------------------~~-------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~  257 (332)
                      ..                              ..       ...+|..|.+||....   ......+|.|+.|++++|.+
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg---~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG---RRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc---ccCCCcchhhhhhhhhhhhh
Confidence            00                              00       0147889999998877   67788999999999999999


Q ss_pred             hCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 020027          258 SGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIV  319 (332)
Q Consensus       258 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~  319 (332)
                      +|..||....+..+...+..+...-     ..  -+.....+..+++...+..+|.+|-.+.
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~~~~-----p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIPW-----PE--GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCCCCC-----CC--CccccChhhhhhhhhhhccCchhccCcc
Confidence            9999999887776665554432111     11  1112233566788888889999996654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.10  E-value=1.5e-09  Score=86.75  Aligned_cols=146  Identities=19%  Similarity=0.174  Sum_probs=102.0

Q ss_pred             CCceeeccCCeEEEEEEeCCCCEEEEEEeccCccc------ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           65 HRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL------SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ....+.+|+-+.|+++.. .|+...||.=..+...      .-......+|.+.+.++.--.|..-.-++.+...-.|.|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999988 5777777753322110      011123567888887765444444444555666678999


Q ss_pred             eccCC-CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC---ceEEccCCccc
Q 020027          139 EFINM-ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF---CARVCDYGLSF  214 (332)
Q Consensus       139 e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~  214 (332)
                      ||.++ .++.+++.......  ........++..|-+.+.-||.+   +++|+||..+||++..++   .+.+.|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 57888887654321  12222357788888999999999   999999999999997654   45799999986


Q ss_pred             cC
Q 020027          215 LA  216 (332)
Q Consensus       215 ~~  216 (332)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            53

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=5.5e-08  Score=89.17  Aligned_cols=169  Identities=17%  Similarity=0.200  Sum_probs=124.9

Q ss_pred             CeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee----cCCceeEEEeccCC-CCHH
Q 020027           74 LGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ----APGERIIVSEFINM-ASLD  147 (332)
Q Consensus        74 ~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-~~L~  147 (332)
                      -.+.|++. .-+|..|++|+++........  ....-++.++++.|+|+|++.+++.    ++..+++|++|.++ ++|.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN--KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcc--cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            35678998 568999999999533222211  2255577899999999999999875    34567899999876 3555


Q ss_pred             HHhcccCC-----------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          148 FYLHENND-----------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       148 ~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ++--....           .....++...+.++.|+..||.++|+.   |+.-+-|.+.+|+++.+..++|+..|..-..
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            54322111           122367889999999999999999999   9999999999999999999999888776555


Q ss_pred             CcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCC
Q 020027          217 PEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR  261 (332)
Q Consensus       217 ~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~  261 (332)
                      .+...        +-++      --.+-|.=.||.++.-|.||..
T Consensus       444 ~~d~~--------~~le------~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDPT--------EPLE------SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCCC--------cchh------HHhhhhHHHHHHHHHHHhhccc
Confidence            44320        1111      1246799999999999999854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=5.2e-09  Score=86.04  Aligned_cols=127  Identities=20%  Similarity=0.225  Sum_probs=79.5

Q ss_pred             EEEEEEeCCCCEEEEEEeccCcccc-----------c-------c------cccHHHHHHHhccCCCC--Cccceeeeee
Q 020027           76 TVYAALLSTGKLVAVKRIHPRLVLS-----------N-------A------GFGFASVIKTLSLAQHP--NIVPILGFSQ  129 (332)
Q Consensus        76 ~V~~~~~~~~~~vavK~~~~~~~~~-----------~-------~------~~~~~~e~~~l~~l~h~--niv~~~~~~~  129 (332)
                      .||.|...+|+.+|+|..+.....-           .       .      .....+|...|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999987432100           0       0      01256788888888654  455555442 


Q ss_pred             cCCceeEEEeccC--CCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHH-hhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          130 APGERIIVSEFIN--MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY-LHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       130 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                         .-.|+|||++  |..+..+....      ++......++.++...+.. +|..   |++|+||++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  65555443321      1122344567777775555 5677   99999999999999887 899


Q ss_pred             EccCCccccC
Q 020027          207 VCDYGLSFLA  216 (332)
Q Consensus       207 l~dfg~a~~~  216 (332)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.91  E-value=2.8e-08  Score=86.52  Aligned_cols=142  Identities=14%  Similarity=0.065  Sum_probs=95.3

Q ss_pred             eeeccCCeEEEEEEeCCCCEEEEEEeccCcccc---------cccccHHHHHHHhccCCCCCc--cceeeeeec-----C
Q 020027           68 IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS---------NAGFGFASVIKTLSLAQHPNI--VPILGFSQA-----P  131 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----~  131 (332)
                      .+-...-..|++... +|+.+.||.........         .....+.+|...+.++...+|  ....++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344333445666655 57789999764332110         111136788887777643232  333444432     2


Q ss_pred             CceeEEEeccCCC-CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-------CC
Q 020027          132 GERIIVSEFINMA-SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-------KF  203 (332)
Q Consensus       132 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------~~  203 (332)
                      ...+++||++++. +|.+++......  ..+......++.+++..+.-||+.   |++|+|++++|||++.       +.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~--~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATN--PPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            3468999999876 898888543211  135566778899999999999999   9999999999999975       46


Q ss_pred             ceEEccCCcccc
Q 020027          204 CARVCDYGLSFL  215 (332)
Q Consensus       204 ~~kl~dfg~a~~  215 (332)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999987753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.77  E-value=4.2e-08  Score=83.45  Aligned_cols=135  Identities=19%  Similarity=0.169  Sum_probs=90.3

Q ss_pred             CCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccc--------------c------ccccHHHHHHHhccCCCC--C
Q 020027           63 FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS--------------N------AGFGFASVIKTLSLAQHP--N  120 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------~------~~~~~~~e~~~l~~l~h~--n  120 (332)
                      ....+.||.|.-+.||.|..+.|..+|+|.-+.....-              .      ......+|...|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34557899999999999999999999999765322110              0      011246777778777533  4


Q ss_pred             ccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC
Q 020027          121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN  200 (332)
Q Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  200 (332)
                      +.+.+++    +.-.++||+++|..|...--..      -+..   .++..|++-+.-.-..   |+||+|+++-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~------en~~---~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRLDV------ENPD---EILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccCcc------cCHH---HHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            5555444    4557999999986665422100      1222   2333444444433344   999999999999999


Q ss_pred             CCCceEEccCCcc
Q 020027          201 EKFCARVCDYGLS  213 (332)
Q Consensus       201 ~~~~~kl~dfg~a  213 (332)
                      ++|.+.++||--+
T Consensus       237 ~dg~~~vIDwPQ~  249 (304)
T COG0478         237 EDGDIVVIDWPQA  249 (304)
T ss_pred             cCCCEEEEeCccc
Confidence            9999999999544

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.70  E-value=3.8e-09  Score=99.66  Aligned_cols=143  Identities=19%  Similarity=0.265  Sum_probs=96.8

Q ss_pred             HHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc---------------CCcccccCcccccc
Q 020027          170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK---------------RGLAGYVDDDYWHE  234 (332)
Q Consensus       170 ~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~---------------~~~~~~~~pe~~~~  234 (332)
                      .+++.|+.|+|..  +++||+++.|++|.++.++..|++.|+.+.......               .....|.+||+...
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455899999986  589999999999999999999999998764433211               23457899998876


Q ss_pred             cCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCC
Q 020027          235 KGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRK  313 (332)
Q Consensus       235 ~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~  313 (332)
                         ...+.++|+||+|+++|.+.. |+.-+..........      .....+..-..-.+.+.+.++.+-+.+.+..++.
T Consensus       184 ---~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  184 ---TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS------FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSA  254 (700)
T ss_pred             ---ccccccccceeeeeEEEEEecCCcchhhccCCcchhh------hhhcccccccccccccCcHHHHHHHHHHhcCCcc
Confidence               677899999999999999985 444333221111100      0001111111111233344677788899999999


Q ss_pred             CCCCHHHHHH
Q 020027          314 NRPSIVQVAT  323 (332)
Q Consensus       314 ~RPs~~~i~~  323 (332)
                      .||++.++..
T Consensus       255 ~rp~~~~l~~  264 (700)
T KOG2137|consen  255 VRPTLDLLLS  264 (700)
T ss_pred             cCcchhhhhc
Confidence            9998776643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.70  E-value=5.8e-08  Score=91.55  Aligned_cols=148  Identities=16%  Similarity=0.126  Sum_probs=93.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc-------------------------------------
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN-------------------------------------  101 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------  101 (332)
                      .-..|+. ..|+.++-|.||+|++++|+.||||+.++.....-                                     
T Consensus       124 ~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l  202 (517)
T COG0661         124 LFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL  202 (517)
T ss_pred             HHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence            3445553 68999999999999999999999999986431100                                     


Q ss_pred             -ccccHHHHHHHhccC----CCCCccceeeee-ecCCceeEEEeccCCCCHHHHh--cccCCCCCcCCHHHHHHHHHHHH
Q 020027          102 -AGFGFASVIKTLSLA----QHPNIVPILGFS-QAPGERIIVSEFINMASLDFYL--HENNDGASLLDWNRRLRIATGAA  173 (332)
Q Consensus       102 -~~~~~~~e~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~l~~~~~~~i~~~i~  173 (332)
                       ...++.+|...+.++    ++..=+++-..+ +-.+...++|||++|-.+.+..  +..+     .+.........++.
T Consensus       203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-----~d~k~ia~~~~~~f  277 (517)
T COG0661         203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-----IDRKELAELLVRAF  277 (517)
T ss_pred             HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-----CCHHHHHHHHHHHH
Confidence             011234444444333    222223333333 2345668999999998888774  3322     44332222222222


Q ss_pred             HHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       174 ~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      --.-+-  .   |++|.|..|.||+++.++..-+.|||+....+
T Consensus       278 ~~q~~~--d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         278 LRQLLR--D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHh--c---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            112222  3   89999999999999999999999999875444

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.69  E-value=2.1e-07  Score=83.57  Aligned_cols=256  Identities=16%  Similarity=0.195  Sum_probs=153.3

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeee------ecCCc-ee
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFS------QAPGE-RI  135 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~------~~~~~-~~  135 (332)
                      ...+.||+|+-+.+|-.-- -+.. +.|+.+.......     .+....|... .||-+-.=+.|-      -..+. .-
T Consensus        14 ~~gr~LgqGgea~ly~l~e-~~d~-VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE-VRDQ-VAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCCccccCCccceeeecch-hhch-hheeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            3457799999999995431 1223 3466654322111     2233445444 566443312221      11122 34


Q ss_pred             EEEeccCCC-CHHHHhccc--CCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEcc---
Q 020027          136 IVSEFINMA-SLDFYLHEN--NDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD---  209 (332)
Q Consensus       136 lv~e~~~~~-~L~~~l~~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~d---  209 (332)
                      +.|..+++. ....+.+..  ........|...++.+..++.+.+-||..   |.+-+|++++|+|+++++.+.+.|   
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            556655442 333333321  11234578999999999999999999999   999999999999999999999886   


Q ss_pred             CCcccc--CCcccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhC-CCCCCchhHH-----HHHHHhhhcc
Q 020027          210 YGLSFL--APEEKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSG-RRCEEGLLVK-----WALPLIKEMR  279 (332)
Q Consensus       210 fg~a~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg-~~p~~~~~~~-----~~~~~~~~~~  279 (332)
                      |-+..-  ...-..|...|.+||.-.-.  -+..-+...|-|.+|+++++++.| +.||.|....     .....+-.+.
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            333210  00112577889999976532  234557789999999999999985 8999874211     1111233333


Q ss_pred             cccccCCc--CC-CC--CChH-HHHHHHHHHHHcccC--CCCCCCCHHHHHHHHhccc
Q 020027          280 FSELLDPR--LA-IP--CEIK-PLVRLAKVALACVGN--SRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       280 ~~~~~~~~--~~-~~--~~~~-~~~~l~~l~~~c~~~--dp~~RPs~~~i~~~L~~~~  329 (332)
                      +....+.+  +. .|  .+.. -+..+..+..+|+..  ++.-|||++.-+..|..+.
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            32222211  11 11  1111 122456778899865  3678999998888887654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.59  E-value=6e-07  Score=75.47  Aligned_cols=104  Identities=19%  Similarity=0.183  Sum_probs=77.9

Q ss_pred             cHHHHHHHhccCCC--CCccceeeeeecC----CceeEEEeccCCC-CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHH
Q 020027          105 GFASVIKTLSLAQH--PNIVPILGFSQAP----GERIIVSEFINMA-SLDFYLHENNDGASLLDWNRRLRIATGAARGLE  177 (332)
Q Consensus       105 ~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  177 (332)
                      ...+|...+..+..  -.+.+.+++....    ...++++|++++. +|.+++.....    .+......++.+++..++
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence            45777777666642  2344455555432    2358999999874 79998875322    345567788999999999


Q ss_pred             HhhcCCCCCeeecCCCCCCEEeCCCC---ceEEccCCcccc
Q 020027          178 YLHQGVAPNIIHGCIKASNILLNEKF---CARVCDYGLSFL  215 (332)
Q Consensus       178 ~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~~  215 (332)
                      -||+.   |++|+|+++.|||++.+.   .+.++||+-++.
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999   999999999999999876   788999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.57  E-value=2e-06  Score=71.42  Aligned_cols=139  Identities=17%  Similarity=0.149  Sum_probs=97.4

Q ss_pred             eeccCCeEEEEEEeCCCCEEEEEEeccCccc----ccccccHHHHHHHhccCCCC--Cccceeeeee---cC--CceeEE
Q 020027           69 IGQGRLGTVYAALLSTGKLVAVKRIHPRLVL----SNAGFGFASVIKTLSLAQHP--NIVPILGFSQ---AP--GERIIV  137 (332)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~--~~~~lv  137 (332)
                      -|+||-+-|++-..+ |..+-+|.-.+....    ......|.+|...+..+..-  .+.+.. ++.   .+  -..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            367888889987764 447888876522111    12233588999988887532  233333 322   11  235799


Q ss_pred             EeccCC-CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc--eEEccCCccc
Q 020027          138 SEFINM-ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC--ARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~dfg~a~  214 (332)
                      +|-+++ .+|.+++.+....  ..+...+..++.+++..++-||+.   |+.|+|+.+.||+++.++.  ++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997653 6888888654322  256677788999999999999999   9999999999999986666  8999996554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=8.9e-07  Score=83.45  Aligned_cols=147  Identities=18%  Similarity=0.188  Sum_probs=93.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccc-----------------------------------ccccc
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS-----------------------------------NAGFG  105 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------------------~~~~~  105 (332)
                      ..|+. +.||.-+.|.||+|++++|+.||||+-++.....                                   ....+
T Consensus       162 ~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  162 SEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             HhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            34443 6799999999999999999999999988643111                                   01123


Q ss_pred             HHHHHHHhccC----CCCCcc---ceeeee-ecCCceeEEEeccCCCCHHHH--hcccCCCCCcCCHHHHHHHHHHHHHH
Q 020027          106 FASVIKTLSLA----QHPNIV---PILGFS-QAPGERIIVSEFINMASLDFY--LHENNDGASLLDWNRRLRIATGAARG  175 (332)
Q Consensus       106 ~~~e~~~l~~l----~h~niv---~~~~~~-~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~l~~~~~~~i~~~i~~~  175 (332)
                      |.+|.+...+.    .|-+..   .+-.++ .-.....|+||||+|..+.+.  +.+.+     ++...+..-+.+...-
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPHDILNKLVEAYLE  315 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-----CCHHHHHHHHHHHHHH
Confidence            45554443332    344411   122222 223457899999999866544  44333     4554444444443333


Q ss_pred             HHHhhcCCCCCeeecCCCCCCEEeCC----CCceEEccCCccccCCc
Q 020027          176 LEYLHQGVAPNIIHGCIKASNILLNE----KFCARVCDYGLSFLAPE  218 (332)
Q Consensus       176 l~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~dfg~a~~~~~  218 (332)
                      +-+-|     |++|+|-.|.||++..    ++.+.+-|||+.....+
T Consensus       316 qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            33333     8999999999999984    66788999998765543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.40  E-value=1.8e-06  Score=72.03  Aligned_cols=141  Identities=13%  Similarity=0.171  Sum_probs=90.8

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccc-------cHHHHHHHhccCCCCCc---cceeee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF-------GFASVIKTLSLAQHPNI---VPILGF  127 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~-------~~~~e~~~l~~l~h~ni---v~~~~~  127 (332)
                      ....+|...+.+-......|.+-.. +|+.+.+|..++........+       ...+++..+..++...+   ..++-.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3456788888888877777776666 568899998876542211111       12333444444432222   222222


Q ss_pred             eec-----CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          128 SQA-----PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       128 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      .+.     ....+++|||++|..|.++..        ++.    .+...+.+++.-+|+.   |++|+|..|+|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            221     134568999999988766432        222    2445677889999999   99999999999999865


Q ss_pred             CceEEccCCcccc
Q 020027          203 FCARVCDYGLSFL  215 (332)
Q Consensus       203 ~~~kl~dfg~a~~  215 (332)
                      + +++.||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            5 99999976654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.33  E-value=4.7e-06  Score=70.38  Aligned_cols=152  Identities=17%  Similarity=0.149  Sum_probs=92.2

Q ss_pred             HHHHHhcCCCCCCc---eeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccc--------------c--------HHH
Q 020027           54 TEIDAATDGFSHRR---IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--------------G--------FAS  108 (332)
Q Consensus        54 ~~~~~~~~~~~~~~---~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~--------------~--------~~~  108 (332)
                      ..+....+...+..   .|++|.-+.||+|...++..+|+|+.+.....-....              .        ...
T Consensus        38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k  117 (268)
T COG1718          38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK  117 (268)
T ss_pred             HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence            34444444444443   4667778899999988899999999975432211100              0        223


Q ss_pred             HHHHhccCC--CCCccceeeeeecCCceeEEEeccCCCC-HHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 020027          109 VIKTLSLAQ--HPNIVPILGFSQAPGERIIVSEFINMAS-LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP  185 (332)
Q Consensus       109 e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~  185 (332)
                      |...|.++.  +-.+.+-+++.    .-.|+|||+.... -.-.++..     .++......+..++.+++.-|-..  .
T Consensus       118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~--a  186 (268)
T COG1718         118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE--A  186 (268)
T ss_pred             HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh--c
Confidence            344444332  22222222221    2369999985431 11111111     123335667778888888887762  2


Q ss_pred             CeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       186 ~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ++||+||+.=|||+. ++.+.++|||-|....
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            999999999999999 8899999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=1e-05  Score=68.99  Aligned_cols=141  Identities=12%  Similarity=0.082  Sum_probs=82.1

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCC--ccceeeeeecCCceeEEEeccCC
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN--IVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      -..||+|.-+.||+.   .|..+++|......    ......+|.+.++.+..-.  +.+.+++....+...++||+++|
T Consensus         6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             heeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            357899999999984   25567788775432    1223578888888775333  45667777777778899999988


Q ss_pred             CC-HHHHhc--------------c-----cCCCCCcCCHHHHH-HHHHH----------HHH-HHHHhhcC-CCCCeeec
Q 020027          144 AS-LDFYLH--------------E-----NNDGASLLDWNRRL-RIATG----------AAR-GLEYLHQG-VAPNIIHG  190 (332)
Q Consensus       144 ~~-L~~~l~--------------~-----~~~~~~~l~~~~~~-~i~~~----------i~~-~l~~Lh~~-~~~~ivH~  190 (332)
                      .+ +...+.              +     +.......+..... .+..+          +.. ...+|... ..+.++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            63 211111              0     00000001111000 00000          001 11222211 13367899


Q ss_pred             CCCCCCEEeCCCCceEEccCCccc
Q 020027          191 CIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       191 dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |+.|.|+++++++ +.+.||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.16  E-value=5.7e-05  Score=62.73  Aligned_cols=136  Identities=18%  Similarity=0.174  Sum_probs=90.3

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCc--------------ccccccccHHHHHHHhccCC------CCCccc
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRL--------------VLSNAGFGFASVIKTLSLAQ------HPNIVP  123 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~  123 (332)
                      +....||+|+.-.||.  +++.....||+.++..              ..........+|+.....+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3456899999999996  4555667889988765              01111234566665544443      889999


Q ss_pred             eeeeeecCCceeEEEeccCC------CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCE
Q 020027          124 ILGFSQAPGERIIVSEFINM------ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI  197 (332)
Q Consensus       124 ~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  197 (332)
                      ++|+.+++--.-+++|.+..      .+|.+++....     ++. .....+.   +=..||-++   .|+.+|++|.||
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NI  149 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNI  149 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccE
Confidence            99999988777888887632      36788885432     444 2333333   334566666   899999999999


Q ss_pred             EeCCC--C--ceEEcc-CCcc
Q 020027          198 LLNEK--F--CARVCD-YGLS  213 (332)
Q Consensus       198 ll~~~--~--~~kl~d-fg~a  213 (332)
                      ++...  +  .+.+.| ||..
T Consensus       150 v~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEEecCCCceEEEEEeCCCCc
Confidence            99632  2  466777 4433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.07  E-value=4.4e-07  Score=85.34  Aligned_cols=183  Identities=15%  Similarity=0.064  Sum_probs=124.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCC-ccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN-IVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l  136 (332)
                      .+..+....-+++|++++++|.+ ..+...+ .+.+...       ....-++++|.+++||| .+..++-+..++..++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            34444445668999999999987 3333333 5555422       23466788999999999 8888888888899999


Q ss_pred             EEeccCCC-CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          137 VSEFINMA-SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       137 v~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      .++++..+ +...-....   ...+...+...+...-+++++++|+.   .=+|+|    ||+..+ +..|..||+.+..
T Consensus       312 ~~~i~s~~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             hhhhhcCCccccccCChh---hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcc
Confidence            99999766 221111100   00022223334455566789999975   458998    777755 6789999998765


Q ss_pred             CCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          216 APEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       216 ~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                      +...     ..+++.+++||....   ..+....|.||.|.--.++.-|-+|-
T Consensus       381 L~~~~~~~t~~~~~~~~~pev~~~---~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  381 LTRTMKPRTAIGTPEPLAPEVIQE---NTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCcccccccCCCCCCCCCchhhcc---cccccCCCccCCCcchhhcCCCCCCC
Confidence            5433     357888999997765   67788899999998766766665543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.07  E-value=8.5e-05  Score=64.11  Aligned_cols=76  Identities=9%  Similarity=0.099  Sum_probs=51.5

Q ss_pred             eeeccCC-eEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEEeccCCCC
Q 020027           68 IIGQGRL-GTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVSEFINMAS  145 (332)
Q Consensus        68 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~  145 (332)
                      .|..|.. +.||+.... +..+.+|......     .....+|+..++.+. +--+.+++++....+..+++||+++|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            3445555 788988764 4678888765332     224577888887773 3445567777766667899999999887


Q ss_pred             HHHH
Q 020027          146 LDFY  149 (332)
Q Consensus       146 L~~~  149 (332)
                      +...
T Consensus        79 l~~~   82 (244)
T cd05150          79 AAAL   82 (244)
T ss_pred             HhHh
Confidence            7643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.97  E-value=4.5e-05  Score=61.16  Aligned_cols=127  Identities=20%  Similarity=0.248  Sum_probs=83.7

Q ss_pred             CCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccc-eeeeeecCCceeEEEeccCC
Q 020027           65 HRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP-ILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~  143 (332)
                      ..+.|++|++|.||.|.+. |..+|+|+-+.+    .....+..|.+++..++-.++.+ ++.+    +.-++.|||+.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G   96 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcC
Confidence            3468999999999999984 458899986543    23335688888888877655543 3333    223456999998


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCC--CCEEeCCCCceEEccCCcccc
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKA--SNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~--~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ..|..+-...       +-.+..    .+++.---|-..   ||-|..++-  .||++.+ +.+.|+||--|++
T Consensus        97 ~~L~~~~~~~-------~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG-------DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc-------cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            8887655321       223333    344443334344   899998875  3555544 4899999987764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.96  E-value=4.6e-05  Score=64.87  Aligned_cols=78  Identities=19%  Similarity=0.183  Sum_probs=53.2

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCC--Cccceeeeee---cCCceeEEEec
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP--NIVPILGFSQ---APGERIIVSEF  140 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~  140 (332)
                      .+.++.|..+.||+....+ ..+++|.....    .......+|..+++.+...  .+.+++....   .....+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            3578999999999999876 59999986543    1222456777777776433  2445555432   23456899999


Q ss_pred             cCCCCHHH
Q 020027          141 INMASLDF  148 (332)
Q Consensus       141 ~~~~~L~~  148 (332)
                      +++..+..
T Consensus        77 i~g~~~~~   84 (239)
T PF01636_consen   77 IPGRPLDD   84 (239)
T ss_dssp             ESSEEHHH
T ss_pred             eccccccc
Confidence            99987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.94  E-value=0.00014  Score=73.69  Aligned_cols=79  Identities=13%  Similarity=0.268  Sum_probs=55.6

Q ss_pred             CceeeccCCeEEEEEEeCCC---CEEEEEEeccCcccccccccHHHHHHHhccCC-CCCc--cceeeeeecC---CceeE
Q 020027           66 RRIIGQGRLGTVYAALLSTG---KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNI--VPILGFSQAP---GERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l  136 (332)
                      .+.++.|.++.+|+....++   ..+++|+....... .....+.+|..+++.+. |+++  .+++.+|.+.   +..++
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            56789999999999876543   36777765433211 12235789999999885 6664  6777777654   46789


Q ss_pred             EEeccCCCC
Q 020027          137 VSEFINMAS  145 (332)
Q Consensus       137 v~e~~~~~~  145 (332)
                      +||+++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.93  E-value=4.6e-05  Score=62.90  Aligned_cols=100  Identities=23%  Similarity=0.197  Sum_probs=77.3

Q ss_pred             HHHHHHhccCCC-CCccceeeeeecCCceeEEEeccCCCCHHHH---hcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcC
Q 020027          107 ASVIKTLSLAQH-PNIVPILGFSQAPGERIIVSEFINMASLDFY---LHENNDGASLLDWNRRLRIATGAARGLEYLHQG  182 (332)
Q Consensus       107 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~  182 (332)
                      ..|.-++..+++ +++.+++|+|-    .+++.||...+++...   +.+.    ...+|..+.+|+.++++.+.++++.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHHHHhcC
Confidence            346667777765 69999999993    2578999976655321   1111    1158999999999999999999986


Q ss_pred             CCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       183 ~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ....+.-.|++++|+-+++++.+|+.|.....
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            44468889999999999999999999987553

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.89  E-value=0.00026  Score=58.51  Aligned_cols=128  Identities=20%  Similarity=0.258  Sum_probs=87.6

Q ss_pred             cCCCCCCceeeccCC-eEEEEEEeCCCCEEEEEEecc---Cc--------ccc--------cccccHHHHHHHhccCC--
Q 020027           60 TDGFSHRRIIGQGRL-GTVYAALLSTGKLVAVKRIHP---RL--------VLS--------NAGFGFASVIKTLSLAQ--  117 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~--------~~~--------~~~~~~~~e~~~l~~l~--  117 (332)
                      +.+++..+.||.|.- |.||+++. +|+.+|+|..+.   ..        ...        .....|..|.+...+++  
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            378888999999999 99999998 577999999321   10        000        01124788888877774  


Q ss_pred             -CCCc--cceeeeeecC------------------CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHH
Q 020027          118 -HPNI--VPILGFSQAP------------------GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL  176 (332)
Q Consensus       118 -h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l  176 (332)
                       +.++  |+.+||..-.                  ....||.||.+...             .+...    -+.+|.+-+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl  177 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDL  177 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHH
Confidence             4566  8889986322                  12246666665432             02222    245677778


Q ss_pred             HHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       177 ~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      ..+|..   ||+-+|+++.|..     .-||+|||.+
T Consensus       178 ~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            889988   9999999999985     3589999854

>PRK10593 hypothetical protein; Provisional

Probab=97.65  E-value=0.0012  Score=58.81  Aligned_cols=79  Identities=15%  Similarity=0.114  Sum_probs=54.7

Q ss_pred             CCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC---CCccceeeeeec---CCceeE
Q 020027           63 FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH---PNIVPILGFSQA---PGERII  136 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~l  136 (332)
                      ....+.||.|..+.||+....++ .+.+|..+..    .....+..|...++.+.-   -.+.++++++..   .+..++
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            34456899999999999876555 4666764321    112246888888887742   356777877643   467899


Q ss_pred             EEeccCCCCH
Q 020027          137 VSEFINMASL  146 (332)
Q Consensus       137 v~e~~~~~~L  146 (332)
                      +||++++.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999988654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.64  E-value=0.00025  Score=71.60  Aligned_cols=190  Identities=18%  Similarity=0.228  Sum_probs=121.8

Q ss_pred             HHHHHHhccCCCCCccceeeeeecCCc----eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcC
Q 020027          107 ASVIKTLSLAQHPNIVPILGFSQAPGE----RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG  182 (332)
Q Consensus       107 ~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~  182 (332)
                      .-|...+.+..|+|++.++.+....-.    ..+..|++...++...+.....    ++..+.+.+..+..+|++|+|+.
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~----i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS----IPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc----cCHHHHHHHHHHHhhhHHHHHHh
Confidence            344556778899999999998754422    2344577777777666654332    67788888899999999999997


Q ss_pred             CCCCeeecCCCCC---CEEeCCCCceEEc--cCCccccCCcccC-----CcccccCcccccccCCCCCCchhhhHHHHHH
Q 020027          183 VAPNIIHGCIKAS---NILLNEKFCARVC--DYGLSFLAPEEKR-----GLAGYVDDDYWHEKGGGNATRESDVYGFGVV  252 (332)
Q Consensus       183 ~~~~ivH~dlk~~---Nill~~~~~~kl~--dfg~a~~~~~~~~-----~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~i  252 (332)
                         ...|.-+..+   +.-.+..+.+.++  ||+.+...++...     ....+.++|...... ...+...|+|.+|..
T Consensus       306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLL  381 (1351)
T ss_pred             ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHH
Confidence               5666655555   4444556667766  8887766554332     233455555544321 223344699999999


Q ss_pred             HHHHHhCCCCCCch-hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          253 LLEILSGRRCEEGL-LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       253 l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      +..+..|..+..-. ....            .++    ....    ....+...+|...++++|+++.+++..
T Consensus       382 ~~~~~~~~~i~~~~~~~~~------------~l~----~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAVPVS------------LLD----VLST----SELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCcccccccchhh------------hhc----cccc----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence            99988876543211 0000            000    0000    034566778999999999999988764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.58  E-value=0.0015  Score=55.93  Aligned_cols=73  Identities=12%  Similarity=0.067  Sum_probs=46.9

Q ss_pred             ceeeccCCeEEEEEEeCC--CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALLST--GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.|..|-.+.+|+....+  ++.+++|......   ....+..+|...++.+...++ .++++...    -.++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence            467778888999988654  6788999765331   112234678888887743333 34444332    2479999988


Q ss_pred             CCH
Q 020027          144 ASL  146 (332)
Q Consensus       144 ~~L  146 (332)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.52  E-value=0.00078  Score=57.77  Aligned_cols=31  Identities=26%  Similarity=0.408  Sum_probs=25.7

Q ss_pred             CCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          184 APNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       184 ~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      .+.++|+|+.+.|++++++...-+.||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            3469999999999999877656799998763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.47  E-value=0.0019  Score=59.58  Aligned_cols=77  Identities=19%  Similarity=0.172  Sum_probs=50.3

Q ss_pred             CceeeccCCeEEEEEEeCCC-CEEEEEEeccCccc--c---cccccHHHHHHHhccCC---CCCccceeeeeecCCceeE
Q 020027           66 RRIIGQGRLGTVYAALLSTG-KLVAVKRIHPRLVL--S---NAGFGFASVIKTLSLAQ---HPNIVPILGFSQAPGERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~--~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  136 (332)
                      .+.||.|.++.||++...+| +.++||.-.+....  .   ........|...|..+.   ..++.+++.+  +++..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36799999999999998776 48999986432111  0   11123456666666542   3456666666  3355789


Q ss_pred             EEeccCCC
Q 020027          137 VSEFINMA  144 (332)
Q Consensus       137 v~e~~~~~  144 (332)
                      +||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99998763

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.45  E-value=0.0015  Score=56.73  Aligned_cols=138  Identities=11%  Similarity=0.078  Sum_probs=74.6

Q ss_pred             eeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCcc-ceeeeeecCCceeEEEeccCCCCHH
Q 020027           69 IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV-PILGFSQAPGERIIVSEFINMASLD  147 (332)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~L~  147 (332)
                      +..|-.+.+|+... +++.+++|.........  ..+..+|...++.+....++ +++...  +  .++++||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            45677788998874 56678888754322111  12457888888877543332 233332  1  36899999886653


Q ss_pred             HH--------------h---cccCCCCCcCCHH-HHHHHHHHH---------HHHHHHhhcC-----CCCCeeecCCCCC
Q 020027          148 FY--------------L---HENNDGASLLDWN-RRLRIATGA---------ARGLEYLHQG-----VAPNIIHGCIKAS  195 (332)
Q Consensus       148 ~~--------------l---~~~~~~~~~l~~~-~~~~i~~~i---------~~~l~~Lh~~-----~~~~ivH~dlk~~  195 (332)
                      .-              +   ++.......++.. .......++         ..-+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21              1   1111001111211 111111111         1111111111     1336899999999


Q ss_pred             CEEeCCCCceEEccCCccc
Q 020027          196 NILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~  214 (332)
                      ||++++++ +.+.||..+.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999877 7899997664

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.23  E-value=0.0025  Score=57.27  Aligned_cols=138  Identities=17%  Similarity=0.192  Sum_probs=88.0

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc-------cccc-----------------HHHHHHHhccCCCCCcc
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN-------AGFG-----------------FASVIKTLSLAQHPNIV  122 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~-----------------~~~e~~~l~~l~h~niv  122 (332)
                      -.|..|.-+.||.+...+|..+|||+.+.....-.       ..+.                 ...|+..|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            46888999999999988999999999875332111       0111                 23445555555433322


Q ss_pred             ceeeeeecCCceeEEEeccCCCCH-HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC
Q 020027          123 PILGFSQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE  201 (332)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  201 (332)
                      .--.....  .-.|||+|+..... .-.++.     ..++...+..+-.|++.-|.-|...|  ++||.||+--|+|.. 
T Consensus       230 ~PePIlLk--~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  230 CPEPILLK--NHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCceeee--cceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence            11111111  12689999842111 111211     12566677777888999999888877  899999999999984 


Q ss_pred             CCceEEccCCccc
Q 020027          202 KFCARVCDYGLSF  214 (332)
Q Consensus       202 ~~~~kl~dfg~a~  214 (332)
                      +|.+.++|-+-+.
T Consensus       300 dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  300 DGKLYIIDVSQSV  312 (520)
T ss_pred             CCEEEEEEccccc
Confidence            5678999987663

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.02  E-value=0.0092  Score=53.17  Aligned_cols=74  Identities=16%  Similarity=0.157  Sum_probs=45.6

Q ss_pred             ceeeccCCeEEEEEEeCC-------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCceeEEE
Q 020027           67 RIIGQGRLGTVYAALLST-------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERIIVS  138 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  138 (332)
                      +.+..|--..+|+....+       ++.+++|.......   ...+..+|..++..+...++ .++++++. +   .+++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence            456666677889888654       57899998654321   12245778777777643333 34455443 2   3578


Q ss_pred             eccCCCCHH
Q 020027          139 EFINMASLD  147 (332)
Q Consensus       139 e~~~~~~L~  147 (332)
                      ||++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            998887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.98  E-value=0.018  Score=51.80  Aligned_cols=32  Identities=16%  Similarity=0.287  Sum_probs=26.8

Q ss_pred             CCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       183 ~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ...+++|+|+.|.||+++++...-+.||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            35589999999999999876656899998764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.96  E-value=0.016  Score=51.75  Aligned_cols=144  Identities=15%  Similarity=0.203  Sum_probs=78.5

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCC--Cccceeeee------ecCCceeEE
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP--NIVPILGFS------QAPGERIIV  137 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~------~~~~~~~lv  137 (332)
                      .+.++.|.-..+|+....+| .+++|..+....    ......|...+..+...  .+.+++...      ...+..+++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            56677777789998876555 577887654211    11234555555555321  233433321      224567899


Q ss_pred             EeccCCCCHHH-----------Hh---cccCCC----C----CcCCHHHHH------------HHHHHHHHHHHHhhc--
Q 020027          138 SEFINMASLDF-----------YL---HENNDG----A----SLLDWNRRL------------RIATGAARGLEYLHQ--  181 (332)
Q Consensus       138 ~e~~~~~~L~~-----------~l---~~~~~~----~----~~l~~~~~~------------~i~~~i~~~l~~Lh~--  181 (332)
                      +||++|..+..           .+   +.....    .    ..-.|....            .....+...+.++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            99998854321           11   110000    0    001111100            001122334544432  


Q ss_pred             --CCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          182 --GVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       182 --~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                        ....+++|+|+.+.|+++++++.+.+.||+.+.
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              234689999999999999988777899998663

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.95  E-value=0.012  Score=52.21  Aligned_cols=144  Identities=17%  Similarity=0.134  Sum_probs=80.9

Q ss_pred             CCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCC--Cccceeee------eecCCceeE
Q 020027           65 HRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP--NIVPILGF------SQAPGERII  136 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~l  136 (332)
                      ..+.+..|....+|+....+ ..+++|.....   .  ......|+..+..+.+.  .+.+.+..      ....+..+.
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~--~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEKV---S--AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             heecccCccccceEEEEeCC-CcEEEEEcCCC---C--hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            35677788888999887644 47888886531   1  12345666666666432  23343331      123456689


Q ss_pred             EEeccCCCCHHH----Hh----------cccCCC--C-----CcCCHHHHH----------HHHHHHHHHHHHhhc----
Q 020027          137 VSEFINMASLDF----YL----------HENNDG--A-----SLLDWNRRL----------RIATGAARGLEYLHQ----  181 (332)
Q Consensus       137 v~e~~~~~~L~~----~l----------~~~~~~--~-----~~l~~~~~~----------~i~~~i~~~l~~Lh~----  181 (332)
                      ++++++|..+..    ..          +.....  .     ....|....          .....+..++.++..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999998876532    00          000000  0     011221110          011122333444442    


Q ss_pred             CCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       182 ~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ....+++|+|+.|.|+++++++.+.|.||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            223479999999999999988777899997664

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.78  E-value=0.0019  Score=56.97  Aligned_cols=134  Identities=16%  Similarity=0.106  Sum_probs=86.7

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccc--------------c------ccccHHHHHHHhccCC-C-C
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS--------------N------AGFGFASVIKTLSLAQ-H-P  119 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------~------~~~~~~~e~~~l~~l~-h-~  119 (332)
                      -++..++||-|.-+.||.+-.+.|++.++|.-+.....-              .      ......+|...|+.+. | -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            456778999999999999999999999998655321100              0      0112345666666553 2 1


Q ss_pred             CccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe
Q 020027          120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL  199 (332)
Q Consensus       120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  199 (332)
                      -+.+.+++    +.-++|||++.+-+|...-+-       .+..++..-+.++   +.-|..+   |++|+|..--||++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~---Iv~la~~---GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGL---IVRLANH---GLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHHHHHHHH---HHHHHHc---CceecccchheeEE
Confidence            22223332    456899999988777653321       2333333322222   2334455   99999999999999


Q ss_pred             CCCCceEEccCCc
Q 020027          200 NEKFCARVCDYGL  212 (332)
Q Consensus       200 ~~~~~~kl~dfg~  212 (332)
                      ++++.++++||--
T Consensus       236 ~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQ  248 (465)
T ss_pred             ecCCCEEEeechH
Confidence            9999999999963

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.72  E-value=0.00038  Score=72.30  Aligned_cols=155  Identities=14%  Similarity=-0.028  Sum_probs=104.8

Q ss_pred             HHHHHhccCCCCCccceeeeee--cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC--
Q 020027          108 SVIKTLSLAQHPNIVPILGFSQ--APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV--  183 (332)
Q Consensus       108 ~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--  183 (332)
                      .|....+...|+++...+.-..  .+...+..++++..|.+...+-......+.++..-+...-.+...+..-+|+..  
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            3444555668888877665442  234568899999999998887654433333333323222233245555555432  


Q ss_pred             CCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-c-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH
Q 020027          184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-K-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL  257 (332)
Q Consensus       184 ~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~  257 (332)
                      +.--+|++||+-|.++..+..+|++++|+.+..... .     .+++-|+.++....   -.++.++|+|+.|+-+|+..
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~---ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE---IKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH---HhhhhHHHHHHHHHHHHHHh
Confidence            234789999999999999999999999999833222 1     34556677776655   46777799999999999988


Q ss_pred             hCCCCCCc
Q 020027          258 SGRRCEEG  265 (332)
Q Consensus       258 tg~~p~~~  265 (332)
                      -|..+|..
T Consensus      1435 ~~n~~fi~ 1442 (2724)
T KOG1826|consen 1435 DGNAYFIF 1442 (2724)
T ss_pred             cccHHHHH
Confidence            88776643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.61  E-value=0.0034  Score=58.67  Aligned_cols=161  Identities=22%  Similarity=0.235  Sum_probs=89.8

Q ss_pred             cHHHHHHHhccCCCCCccceeeeeecC-CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC
Q 020027          105 GFASVIKTLSLAQHPNIVPILGFSQAP-GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV  183 (332)
Q Consensus       105 ~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~  183 (332)
                      ......+.++.+.|+|...++++.... ....+|+|++ +-++++++......    .       ..    ++    .+ 
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~----~-------~s----~~----~~-   86 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK----D-------ES----LL----AH-   86 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc----h-------hh----hc----cc-
Confidence            345556778888999999999987654 3467899998 56898888654311    0       00    01    11 


Q ss_pred             CCCeeecCCCCCCEEeCCCCceEEccCCccccCCcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       184 ~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                        ++.|-     |+       .+++|    .+..       .|  |        ....+|+||||+|.++.|+.-|..-+
T Consensus        87 --~~~~~-----~~-------~~~td----~~~t-------~~--~--------~~~~pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   87 --GVLHL-----NI-------IYITD----HFLT-------KY--P--------SPIGPKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             --cccee-----hh-------hhccc----cccc-------cC--C--------CCCCcchhhhhHHHHHHHHHHhhHHH
Confidence              33332     22       12222    0000       00  0        22236999999999999999887765


Q ss_pred             CchhHHHHHHHhhhcccccccCCcCCC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 020027          264 EGLLVKWALPLIKEMRFSELLDPRLAI--PCEIKPLVRLAKVALACVGNSRKNRPSIVQV  321 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i  321 (332)
                      ......+....+..-...+...-.+..  .....+.....++...|....|..||...++
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            544433333322221100000000000  0112334466788889999999999866554

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.48  E-value=0.077  Score=49.06  Aligned_cols=76  Identities=14%  Similarity=0.153  Sum_probs=48.5

Q ss_pred             CCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccc-----cccccHHHHHHHhccCC---CCCccceeeeeecCCceeE
Q 020027           65 HRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS-----NAGFGFASVIKTLSLAQ---HPNIVPILGFSQAPGERII  136 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  136 (332)
                      ..+.+|-|....||+.... +..++||.-.+.....     ........|...|+.+.   ..++.+++.++.  +...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3567899999999998864 5578999876322211     11222344455554442   347777888877  34578


Q ss_pred             EEeccCC
Q 020027          137 VSEFINM  143 (332)
Q Consensus       137 v~e~~~~  143 (332)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.46  E-value=0.021  Score=50.50  Aligned_cols=76  Identities=13%  Similarity=0.196  Sum_probs=46.1

Q ss_pred             CCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC---CCCccceeeeeecCCceeEEEe
Q 020027           63 FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .+..+.++-|..+.+|+.. .+++.+.+|.-..     .....|..|..-|+.+.   --.+.+++++....+..++++|
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            3445678989999999877 5778999998651     12234677877777663   3456778888877777799999


Q ss_pred             ccCCC
Q 020027          140 FINMA  144 (332)
Q Consensus       140 ~~~~~  144 (332)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            98766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.31  E-value=0.059  Score=48.13  Aligned_cols=32  Identities=25%  Similarity=0.488  Sum_probs=28.3

Q ss_pred             CCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       185 ~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +.++|+|+.+.|++++..+-+-+.||+.+...
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            47999999999999998888899999988654

>PLN02236 choline kinase

Probab=96.24  E-value=0.081  Score=48.14  Aligned_cols=142  Identities=20%  Similarity=0.250  Sum_probs=78.3

Q ss_pred             ceeeccCCeEEEEEEeCC-----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCcc-ceeeeeecCCceeEEEec
Q 020027           67 RIIGQGRLGTVYAALLST-----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV-PILGFSQAPGERIIVSEF  140 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~  140 (332)
                      +.+..|--..+|+....+     ++.+++|......   ....+..+|..+++.+...++. ++++.+.. +   .+.||
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEe
Confidence            455557778899887432     3678888765432   2223457788888777543333 45555532 2   57899


Q ss_pred             cCCCCHHHH-----------------hcccC-CCCC-cCCHHHHHHHHHH-----------------HHHHHHHh----h
Q 020027          141 INMASLDFY-----------------LHENN-DGAS-LLDWNRRLRIATG-----------------AARGLEYL----H  180 (332)
Q Consensus       141 ~~~~~L~~~-----------------l~~~~-~~~~-~l~~~~~~~i~~~-----------------i~~~l~~L----h  180 (332)
                      +++.++..-                 +++.. .... ...+.+......+                 +...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            877665421                 01100 0000 1112222222211                 11111112    2


Q ss_pred             c-CCCCCeeecCCCCCCEEeCC-CCceEEccCCcccc
Q 020027          181 Q-GVAPNIIHGCIKASNILLNE-KFCARVCDYGLSFL  215 (332)
Q Consensus       181 ~-~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~  215 (332)
                      . .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1 22346899999999999986 56899999977643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.15  E-value=0.086  Score=47.87  Aligned_cols=74  Identities=19%  Similarity=0.174  Sum_probs=43.3

Q ss_pred             eeeccCCeEEEEEEeCCC-CEEEEEEeccCccc-----ccccccHHHHHHHhccCC--CC-CccceeeeeecCCceeEEE
Q 020027           68 IIGQGRLGTVYAALLSTG-KLVAVKRIHPRLVL-----SNAGFGFASVIKTLSLAQ--HP-NIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  138 (332)
                      .+|-|....||++..++| +.|+||.-.+-...     .-...+..-|...|+...  -| .+.+++.+  ++....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999997654 58999976532211     111112345555555432  23 33334433  444556899


Q ss_pred             eccCC
Q 020027          139 EFINM  143 (332)
Q Consensus       139 e~~~~  143 (332)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.87  E-value=0.089  Score=46.28  Aligned_cols=31  Identities=19%  Similarity=0.387  Sum_probs=25.2

Q ss_pred             CCeeecCCCCCCEEeCCCCc-eEEccCCcccc
Q 020027          185 PNIIHGCIKASNILLNEKFC-ARVCDYGLSFL  215 (332)
Q Consensus       185 ~~ivH~dlk~~Nill~~~~~-~kl~dfg~a~~  215 (332)
                      +.++|+|+.+.|+++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            36899999999999997554 46999987743

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.75  E-value=0.12  Score=43.54  Aligned_cols=152  Identities=15%  Similarity=0.112  Sum_probs=89.5

Q ss_pred             cCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCCCHHHHhc
Q 020027           72 GRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH  151 (332)
Q Consensus        72 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  151 (332)
                      ++.++...++.+-| +..+|+++.-..... ..-+..+..+++++.  .|+++..=  ....+-++.|.|.....     
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~-~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCIN-DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccc-hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence            34455555553333 445666653322211 123466777777664  45665521  22345688898842110     


Q ss_pred             ccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcccCCcccccCccc
Q 020027          152 ENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY  231 (332)
Q Consensus       152 ~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~pe~  231 (332)
                              ..   .-.+..+ ..+|.-.|+. ..+..|+|..|+||+-|..|.+|+.|-+.-..      .+..|..-||
T Consensus       142 --------~~---~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~------~~V~~vN~~Y  202 (308)
T PF07387_consen  142 --------NF---SNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE------NQVNMVNIEY  202 (308)
T ss_pred             --------ch---hHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh------heeeEEeeec
Confidence                    11   1112222 3567778864 45899999999999999999999999754321      1223333222


Q ss_pred             ccccCCCCCCchhhhHHHHHHHHHHHhC
Q 020027          232 WHEKGGGNATRESDVYGFGVVLLEILSG  259 (332)
Q Consensus       232 ~~~~~~~~~~~~~DiwS~G~il~el~tg  259 (332)
                            ...|+++.+-+|=.-++++...
T Consensus       203 ------~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  203 ------ESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             ------cccChHHHHHHHHHHHHHHHHH
Confidence                  4467888998888888888763

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.46  E-value=0.28  Score=44.25  Aligned_cols=141  Identities=16%  Similarity=0.215  Sum_probs=76.5

Q ss_pred             eeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC---CCCccc---eeeee--ecCC--ceeEE
Q 020027           68 IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVP---ILGFS--QAPG--ERIIV  137 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~---~~~~~--~~~~--~~~lv  137 (332)
                      .|.+ .-..+|+....+|+. ++|..++. ....   +...|+..+..+.   .+-.++   .=|-.  .-.+  +.+-+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRA---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CCHH---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            3444 456789888777766 88888765 2222   2345555555442   111111   11111  1123  67888


Q ss_pred             EeccCCCCHHH-H--------------hccc--------CCCCCcCCHHH-------------HHHHHHHHHHHHHHhhc
Q 020027          138 SEFINMASLDF-Y--------------LHEN--------NDGASLLDWNR-------------RLRIATGAARGLEYLHQ  181 (332)
Q Consensus       138 ~e~~~~~~L~~-~--------------l~~~--------~~~~~~l~~~~-------------~~~i~~~i~~~l~~Lh~  181 (332)
                      ++|++|..+.. .              ++..        ........|..             ......++...+..+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999887773 1              0110        00011123320             00122233344444443


Q ss_pred             C----CCCC---eeecCCCCCCEEeCCCCc-eEEccCCccc
Q 020027          182 G----VAPN---IIHGCIKASNILLNEKFC-ARVCDYGLSF  214 (332)
Q Consensus       182 ~----~~~~---ivH~dlk~~Nill~~~~~-~kl~dfg~a~  214 (332)
                      .    ....   ++|+|+.|.||+++.+.. +.+.||+-+.
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2    2234   999999999999998875 8899998764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.23  E-value=0.33  Score=43.87  Aligned_cols=73  Identities=16%  Similarity=0.234  Sum_probs=44.0

Q ss_pred             ceeeccCCeEEEEEEeCC----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCcc-ceeeeeecCCceeEEEecc
Q 020027           67 RIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV-PILGFSQAPGERIIVSEFI  141 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~  141 (332)
                      +.|..|--..+|+....+    +..|.+|......   ....+..+|..+++.+...++. ++++++. .+   ++.+|+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            455556677888886432    2378888765432   1223457888888877544443 4555542 22   478888


Q ss_pred             CCCCH
Q 020027          142 NMASL  146 (332)
Q Consensus       142 ~~~~L  146 (332)
                      ++..+
T Consensus        93 ~g~~l   97 (330)
T PLN02421         93 NARTL   97 (330)
T ss_pred             cCCCC
Confidence            76654

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.15  E-value=0.081  Score=47.78  Aligned_cols=55  Identities=20%  Similarity=0.169  Sum_probs=46.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          160 LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       160 l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      -.+.+.+.++.+.+.-+.-+-...  ..-|||+.-.|||++ +|++.|+||.+++...
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeeccc
Confidence            467889999998887777776653  678999999999999 9999999999998543

>PRK06148 hypothetical protein; Provisional

Probab=94.43  E-value=0.51  Score=49.32  Aligned_cols=32  Identities=22%  Similarity=0.356  Sum_probs=26.0

Q ss_pred             CCCCeeecCCCCCCEEeCCCC--ceE-EccCCccc
Q 020027          183 VAPNIIHGCIKASNILLNEKF--CAR-VCDYGLSF  214 (332)
Q Consensus       183 ~~~~ivH~dlk~~Nill~~~~--~~k-l~dfg~a~  214 (332)
                      .+.+++|.|+.+.||+++.++  .+. |.|||-+.
T Consensus       201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            355899999999999998775  454 89999764

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=94.30  E-value=0.077  Score=40.03  Aligned_cols=31  Identities=19%  Similarity=0.055  Sum_probs=21.0

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 020027            6 HIAYDCLLAILSLFLIILAIVLIVLCKKKPV   36 (332)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   36 (332)
                      .++.++++++++++++++++.++++|+||+.
T Consensus        65 ~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~   95 (122)
T PF01102_consen   65 AIIGIIFGVMAGVIGIILLISYCIRRLRKKS   95 (122)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred             ceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence            5677777888888888877777776666553

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.29  E-value=0.42  Score=40.52  Aligned_cols=76  Identities=14%  Similarity=0.167  Sum_probs=48.1

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC---CCCccceeeeeecCCceeEEEeccC
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPILGFSQAPGERIIVSEFIN  142 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  142 (332)
                      .+.+.-|.....|.... ...++.+|.-.     ......|..|+.-|+.+.   --++.+++.+....++.++|+||.+
T Consensus        21 r~~v~gG~inea~~v~d-g~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             ccccCCccccceeEeec-CCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            34454444444444433 34578888643     122235678877776664   3456677777788899999999998


Q ss_pred             CCCHH
Q 020027          143 MASLD  147 (332)
Q Consensus       143 ~~~L~  147 (332)
                      .+.+.
T Consensus        95 ~~~~d   99 (286)
T COG3001          95 TGPLD   99 (286)
T ss_pred             CCCCC
Confidence            86655

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.82  E-value=0.47  Score=43.80  Aligned_cols=76  Identities=18%  Similarity=0.128  Sum_probs=44.8

Q ss_pred             CceeeccCCeEEEEEEeCC-CCEEEEEEeccCccc----ccccccHHHHHHHhccCC--CC-CccceeeeeecCCceeEE
Q 020027           66 RRIIGQGRLGTVYAALLST-GKLVAVKRIHPRLVL----SNAGFGFASVIKTLSLAQ--HP-NIVPILGFSQAPGERIIV  137 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv  137 (332)
                      .+.||-|.-..||++...+ ++.|+||.-.+-...    .-...+..-|...|+...  -| .+.+++.+  ++....++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4689999999999999643 568999976532221    111112344555555442  23 34445444  33445678


Q ss_pred             EeccCC
Q 020027          138 SEFINM  143 (332)
Q Consensus       138 ~e~~~~  143 (332)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=93.22  E-value=2.6  Score=37.97  Aligned_cols=71  Identities=15%  Similarity=0.031  Sum_probs=40.8

Q ss_pred             cCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC--CCcccee---e--eeecCCceeEEEeccCCC
Q 020027           72 GRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH--PNIVPIL---G--FSQAPGERIIVSEFINMA  144 (332)
Q Consensus        72 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~---~--~~~~~~~~~lv~e~~~~~  144 (332)
                      +.-..||+....+|..+++|..++...   .......|+..+..+..  -.++...   |  ....++..+.++++++|.
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~---~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERW---SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccC---CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            445789999887888899998764321   12234556665554421  1122211   2  122345677889998776


Q ss_pred             C
Q 020027          145 S  145 (332)
Q Consensus       145 ~  145 (332)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=92.51  E-value=0.032  Score=42.34  Aligned_cols=36  Identities=31%  Similarity=0.407  Sum_probs=30.5

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCc
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRL   97 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~   97 (332)
                      +.|+ .+.||.|+.|.||+|++++|+.||||+.++..
T Consensus        12 ~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i   47 (119)
T PF03109_consen   12 DEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGI   47 (119)
T ss_pred             HHCC-cchhhheehhhheeeeecccchhhhhhcchHH
Confidence            3444 36899999999999999999999999988654

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PTZ00384 choline kinase; Provisional

Probab=92.09  E-value=1.2  Score=41.08  Aligned_cols=75  Identities=17%  Similarity=0.222  Sum_probs=44.2

Q ss_pred             CceeeccCCeEEEEEEeCCC--CE-----EEEEEeccCcccccccccHHHHHHHhccCCCCCcc-ceeeeeecCCceeEE
Q 020027           66 RRIIGQGRLGTVYAALLSTG--KL-----VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV-PILGFSQAPGERIIV  137 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv  137 (332)
                      .+.+..|--+.+|++...++  ..     |.++...   .......+..+|+.+++.+...++. ++++.+.    -.++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l  127 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI  127 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence            34565677889999875432  22     3333321   1122223457788888888654444 4455543    2589


Q ss_pred             EeccCCCCHH
Q 020027          138 SEFINMASLD  147 (332)
Q Consensus       138 ~e~~~~~~L~  147 (332)
                      .||++|..+.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999887654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=90.39  E-value=0.056  Score=50.52  Aligned_cols=73  Identities=21%  Similarity=0.252  Sum_probs=55.3

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ  129 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  129 (332)
                      .....++|+....+|.|+||+|+.+... ++..+|||.+....... ......+|..-++++.|+++++++..+.
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~-s~~rvl~~~~s~a~feh~g~~~~~ha~~  117 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREE-SRSRVLREVSSLAEFEHPGIKRYFHAWY  117 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhh-hhhhhhccccchhhhcccchhhheecee
Confidence            3345678999999999999999999854 44589999987554322 2234577788888999999999876654

>PRK10271 thiK thiamine kinase; Provisional

Probab=90.27  E-value=0.27  Score=40.42  Aligned_cols=30  Identities=17%  Similarity=0.111  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          185 PNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       185 ~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ...+|+|+.|.|+++++++ ++++||+.+..
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            3579999999999998877 89999987754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	332
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-37
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-22
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-22
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-04
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/318 (33%), Positives = 172/318 (54%), Gaps = 27/318 (8%)
Query: 32  KKKP------VESEETLPIKLCAFA-YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLST 84
           +KKP      V +EE   + L     + L E+  A+D FS++ I+G+G  G VY   L+ 
Sbjct: 2   RKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD 61
Query: 85  GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA 144
           G LVAVKR+            F + ++ +S+A H N++ + GF   P ER++V  ++   
Sbjct: 62  GTLVAVKRLKEERX-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC 204
           S+   L E  +    LDW +R RIA G+ARGL YLH    P IIH  +KA+NILL+E+F 
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 205 ARVCDYGLSFLAPEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL 257
           A V D+GL+ L   +        RG  G++  +Y      G ++ ++DV+G+GV+LLE++
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELI 237
Query: 258 SGRRC---------EEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACV 308
           +G+R          ++ +L+ W   L+KE +   L+D  L    + + + +L +VAL C 
Sbjct: 238 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCT 297
Query: 309 GNSRKNRPSIVQVATILN 326
            +S   RP + +V  +L 
Sbjct: 298 QSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 99/292 (33%), Positives = 161/292 (55%), Gaps = 20/292 (6%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVI 110
           + L E+  A+D F ++ I+G+G  G VY   L+ G LVAVKR+            F + +
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERT-QGGELQFQTEV 78
Query: 111 KTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT 170
           + +S+A H N++ + GF   P ER++V  ++   S+   L E  +    LDW +R RIA 
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------RGL 223
           G+ARGL YLH    P IIH  +KA+NILL+E+F A V D+GL+ L   +        RG 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGX 198
Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC---------EEGLLVKWALPL 274
            G++  +Y      G ++ ++DV+G+GV+LLE+++G+R          ++ +L+ W   L
Sbjct: 199 IGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
           +KE +   L+D  L    + + + +L +VAL C  +S   RP + +V  +L 
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 152/289 (52%), Gaps = 23/289 (7%)
Query: 48  AFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFA 107
           ++  PL +++ AT+ F H+ +IG G  G VY  +L  G  VA+KR  P    S     F 
Sbjct: 26  SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFE 83
Query: 108 SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR 167
           + I+TLS  +HP++V ++GF     E I++ +++   +L  +L+ ++     + W +RL 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK------- 220
           I  GAARGL YLH      IIH  +K+ NILL+E F  ++ D+G+S    E         
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 221 -RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-------EEGLLVKWAL 272
            +G  GY+D +Y+ +   G  T +SDVY FGVVL E+L  R         E   L +WA+
Sbjct: 201 VKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 273 PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
                 +  +++DP LA     + L +    A+ C+  S ++RPS+  V
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 152/289 (52%), Gaps = 23/289 (7%)
Query: 48  AFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFA 107
           ++  PL +++ AT+ F H+ +IG G  G VY  +L  G  VA+KR  P    S     F 
Sbjct: 26  SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFE 83
Query: 108 SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR 167
           + I+TLS  +HP++V ++GF     E I++ +++   +L  +L+ ++     + W +RL 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK------- 220
           I  GAARGL YLH      IIH  +K+ NILL+E F  ++ D+G+S    E         
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 221 -RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-------EEGLLVKWAL 272
            +G  GY+D +Y+ +   G  T +SDVY FGVVL E+L  R         E   L +WA+
Sbjct: 201 VKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 273 PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
                 +  +++DP LA     + L +    A+ C+  S ++RPS+  V
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 142/303 (46%), Gaps = 32/303 (10%)
Query: 50  AYPLTEIDAATDGFSHRRI------IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG 103
           ++   E+   T+ F  R I      +G+G  G VY   ++    VAVK++   + ++   
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 104 FG--FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD 161
               F   IK ++  QH N+V +LGFS    +  +V  ++   SL   L    DG   L 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLS 131
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
           W+ R +IA GAA G+ +LH+    + IH  IK++NILL+E F A++ D+GL+  + +  +
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 222 --------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG------RRCEEGLL 267
                   G   Y+      E   G  T +SD+Y FGVVLLEI++G       R  + LL
Sbjct: 189 TVMXXRIVGTTAYM----APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
                   +E    + +D ++    +   +  +  VA  C+   +  RP I +V  +L  
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 328 LVG 330
           +  
Sbjct: 304 MTA 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 142/303 (46%), Gaps = 32/303 (10%)
Query: 50  AYPLTEIDAATDGFSHRRI------IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG 103
           ++   E+   T+ F  R I      +G+G  G VY   ++    VAVK++   + ++   
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 104 FG--FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD 161
               F   IK ++  QH N+V +LGFS    +  +V  ++   SL   L    DG   L 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLS 131
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
           W+ R +IA GAA G+ +LH+    + IH  IK++NILL+E F A++ D+GL+  + +  +
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 222 --------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG------RRCEEGLL 267
                   G   Y+      E   G  T +SD+Y FGVVLLEI++G       R  + LL
Sbjct: 189 TVMXSRIVGTTAYM----APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
                   +E    + +D ++    +   +  +  VA  C+   +  RP I +V  +L  
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 328 LVG 330
           +  
Sbjct: 304 MTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 142/303 (46%), Gaps = 32/303 (10%)
Query: 50  AYPLTEIDAATDGFSHRRI------IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG 103
           ++   E+   T+ F  R I      +G+G  G VY   ++    VAVK++   + ++   
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEE 66
Query: 104 FG--FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD 161
               F   IK ++  QH N+V +LGFS    +  +V  ++   SL   L    DG   L 
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLS 125
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
           W+ R +IA GAA G+ +LH+    + IH  IK++NILL+E F A++ D+GL+  + +  +
Sbjct: 126 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 222 --------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG------RRCEEGLL 267
                   G   Y+      E   G  T +SD+Y FGVVLLEI++G       R  + LL
Sbjct: 183 XVMXXRIVGTTAYM----APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 238
Query: 268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
                   +E    + +D ++    +   +  +  VA  C+   +  RP I +V  +L  
Sbjct: 239 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297
Query: 328 LVG 330
           +  
Sbjct: 298 MTA 300

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 128/267 (47%), Gaps = 20/267 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTV+ A    G  VAVK +  +   +     F   +  +   +HPNIV  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P    IV+E+++  SL   LH++      LD  RRL +A   A+G+ YLH    P I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 189 HGCIKASNILLNEKFCARVCDYGLS------FLAPEEKRGLAGYVDDDYWHEKGGGNATR 242
           H  +K+ N+L+++K+  +VCD+GLS      FL+ +   G   ++  +   ++    +  
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP---SNE 218
Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAK 302
           +SDVY FGV+L E+ + ++    L       ++  + F      RL IP  + P V  A 
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFK---CKRLEIPRNLNPQV--AA 270
Query: 303 VALACVGNSRKNRPSIVQVATILNNLV 329
           +   C  N    RPS   +  +L  L+
Sbjct: 271 IIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 135/299 (45%), Gaps = 32/299 (10%)
Query: 50  AYPLTEIDAATDGFSHRRI------IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG 103
           ++   E+   T+ F  R I       G+G  G VY   ++    VAVK++   + ++   
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEE 63
Query: 104 FG--FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD 161
               F   IK  +  QH N+V +LGFS    +  +V  +    SL   L    DG   L 
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLS 122
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
           W+ R +IA GAA G+ +LH+    + IH  IK++NILL+E F A++ D+GL+  + +  +
Sbjct: 123 WHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 222 --------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG------RRCEEGLL 267
                   G   Y       E   G  T +SD+Y FGVVLLEI++G       R  + LL
Sbjct: 180 XVXXSRIVGTTAYX----APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 235
Query: 268 VKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
                   +E    + +D +     +   +     VA  C+   +  RP I +V  +L 
Sbjct: 236 DIKEEIEDEEKTIEDYIDKKXN-DADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 127/267 (47%), Gaps = 20/267 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTV+ A    G  VAVK +  +   +     F   +  +   +HPNIV  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P    IV+E+++  SL   LH++      LD  RRL +A   A+G+ YLH    P I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 189 HGCIKASNILLNEKFCARVCDYGLS------FLAPEEKRGLAGYVDDDYWHEKGGGNATR 242
           H  +K+ N+L+++K+  +VCD+GLS      FL  +   G   ++  +   ++    +  
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEP---SNE 218
Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAK 302
           +SDVY FGV+L E+ + ++    L       ++  + F      RL IP  + P V  A 
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFK---CKRLEIPRNLNPQV--AA 270
Query: 303 VALACVGNSRKNRPSIVQVATILNNLV 329
           +   C  N    RPS   +  +L  L+
Sbjct: 271 IIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 21/268 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
            AP +  IV+++   +SL  +LH +    +  +  + + IA   ARG++YLH   A +II
Sbjct: 90  TAP-QLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAG---YVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+     +    +   L+G   ++  +    +     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 241 TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL 300
           + +SDVY FG+VL E+++G+     +  +     I EM     L P L+      P  R+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDLSKVRSNCP-KRM 258
Query: 301 AKVALACVGNSRKNRPSIVQVATILNNL 328
            ++   C+   R  RPS  ++   +  L
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH +    +  +  + + IA   ARG++YLH   A +II
Sbjct: 78  TKP-QLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 241 TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL 300
           + +SDVY FG+VL E+++G+     +  +     I EM     L P L+      P  R+
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDLSKVRSNCP-KRM 246
Query: 301 AKVALACVGNSRKNRPSIVQVATILNNL 328
            ++   C+   R  RPS  ++   +  L
Sbjct: 247 KRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 21/268 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH +    +  +  + + IA   ARG++YLH   A +II
Sbjct: 90  TKP-QLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAG---YVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+     +    +   L+G   ++  +    +     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 241 TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRL 300
           + +SDVY FG+VL E+++G+     +  +     I EM     L P L+      P  R+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDLSKVRSNCP-KRM 258
Query: 301 AKVALACVGNSRKNRPSIVQVATILNNL 328
            ++   C+   R  RPS  ++   +  L
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 120/290 (41%), Gaps = 39/290 (13%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGK-LVAVKRIHPRLVLSNAG---------FGFAS 108
           A +   + + IG+G  G V+   L   K +VA+K     L+L ++            F  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKS----LILGDSEGETEMIEKFQEFQR 72
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
            +  +S   HPNIV + G    P    +V EF+    L    H   D A  + W+ +LR+
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRL 127
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILL-----NEKFCARVCDYGLSFLAPEEKRGL 223
               A G+EY+ Q   P I+H  +++ NI L     N   CA+V D+GLS  +     GL
Sbjct: 128 MLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL 186
Query: 224 AGYVDDDYWHEKGGGNATRES-----DVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM 278
            G      W       A  ES     D Y F ++L  IL+G    EG   +++   IK +
Sbjct: 187 LGNFQ---WMAPETIGAEEESYTEKADTYSFAMILYTILTG----EGPFDEYSYGKIKFI 239
Query: 279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                   R  IP +  P  RL  V   C     K RP    +   L+ L
Sbjct: 240 NMIREEGLRPTIPEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 39  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 93
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 152
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 153 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 207
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 262
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 263 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 309

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
            AP +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 74  TAP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 126
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 43/296 (14%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF---------G 105
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+         G
Sbjct: 29  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 83
Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
            AS++       HPNI+ + G        +IV+E++   SLD +L +++   +++     
Sbjct: 84  EASIMGQF---DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 140
Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRG 222
           LR   G A G++YL        +H  + A NIL+N     +V D+GLS +    PE    
Sbjct: 141 LR---GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 223 LAGYVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIK 276
             G      W           T  SDV+ +G+VL E++S      G    W +    +IK
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIK 249
Query: 277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
            +     L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 250 AVDEGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 299

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFASVIKTLSLAQHPN 120
           ++IG G  G V +  L   KL   + I   +    +G+       F S    +    HPN
Sbjct: 13  QVIGAGEFGEVCSGHL---KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           ++ + G        +I++EF+   SLD +L +N+   +++     LR   G A G++YL 
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL- 125
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
                N +H  + A NIL+N     +V D+GLS       R L     D  +    GG  
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTSALGGKI 176
Query: 241 ---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL 284
                          T  SDV+ +G+V+ E++S G R    +  +  +  I++       
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------- 229
Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           D RL  P +      L ++ L C    R +RP   Q+   L+ ++ +P
Sbjct: 230 DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 275

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 43/296 (14%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF---------G 105
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+         G
Sbjct: 12  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
            AS++       HPNI+ + G        +IV+E++   SLD +L +++   +++     
Sbjct: 67  EASIMGQF---DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 123
Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRG 222
           LR   G A G++YL        +H  + A NIL+N     +V D+GLS +    PE    
Sbjct: 124 LR---GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 223 LAGYVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIK 276
             G      W           T  SDV+ +G+VL E++S      G    W +    +IK
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIK 232
Query: 277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
            +     L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 233 AVDEGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFASVIKTLSLAQHPN 120
           ++IG G  G V +  L   KL   + I   +    +G+       F S    +    HPN
Sbjct: 39  QVIGAGEFGEVCSGHL---KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 95
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           ++ + G        +I++EF+   SLD +L +N+   +++     LR   G A G++YL 
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLA 152
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
                N +H  + A NIL+N     +V D+GLS       R L     D  +    GG  
Sbjct: 153 DM---NYVHRDLAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTSALGGKI 202
Query: 241 ---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL 284
                          T  SDV+ +G+V+ E++S G R    +  +  +  I++       
Sbjct: 203 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------- 255
Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           D RL  P +      L ++ L C    R +RP   Q+   L+ ++ +P
Sbjct: 256 DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 301

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E +   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL    A   +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 155 --GIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GL+ +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 74  TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 126
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 76  TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 128
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 189 SFQSDVYAFGIVLYELMTGQ 208

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 118/290 (40%), Gaps = 39/290 (13%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGK-LVAVKRIHPRLVLSNAG---------FGFAS 108
           A +   + + IG+G  G V+   L   K +VA+K     L+L ++            F  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKS----LILGDSEGETEMIEKFQEFQR 72
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
            +  +S   HPNIV + G    P    +V EF+    L    H   D A  + W+ +LR+
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRL 127
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILL-----NEKFCARVCDYGLSFLAPEEKRGL 223
               A G+EY+     P I+H  +++ NI L     N   CA+V D+G S  +     GL
Sbjct: 128 MLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL 186
Query: 224 AGYVDDDYWHEKGGGNATRES-----DVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM 278
            G      W       A  ES     D Y F ++L  IL+G    EG   +++   IK +
Sbjct: 187 LGNFQ---WMAPETIGAEEESYTEKADTYSFAMILYTILTG----EGPFDEYSYGKIKFI 239
Query: 279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                   R  IP +  P  RL  V   C     K RP    +   L+ L
Sbjct: 240 NMIREEGLRPTIPEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 79  TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 131
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 122/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E++   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GL  +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 79  TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 131
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+       F  
Sbjct: 41  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +IV+E +   SLD +L +++   +++     LR 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR- 154
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G A G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 155 --GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+VL E++S      G    W +    +IK + 
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIKAVD 264
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 265 EGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 125/296 (42%), Gaps = 43/296 (14%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF---------G 105
           E+DA     S  +++G G  G V +  L   KL + K I   +     G+         G
Sbjct: 12  ELDATN--ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
            AS++       HPNI+ + G        +IV+E +   SLD +L +++   +++     
Sbjct: 67  EASIMGQF---DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGM 123
Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRG 222
           LR   G A G++YL        +H  + A NIL+N     +V D+GLS +    PE    
Sbjct: 124 LR---GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 223 LAGYVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIK 276
             G      W           T  SDV+ +G+VL E++S      G    W +    +IK
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-----YGERPYWEMSNQDVIK 232
Query: 277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
            +     L P +  P        L ++ L C    R NRP   Q+ +IL+ L+ +P
Sbjct: 233 AVDEGYRLPPPMDCPAA------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 118/290 (40%), Gaps = 39/290 (13%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGK-LVAVKRIHPRLVLSNAG---------FGFAS 108
           A +   + + IG+G  G V+   L   K +VA+K     L+L ++            F  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKS----LILGDSEGETEMIEKFQEFQR 72
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
            +  +S   HPNIV + G    P    +V EF+    L    H   D A  + W+ +LR+
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRL 127
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILL-----NEKFCARVCDYGLSFLAPEEKRGL 223
               A G+EY+     P I+H  +++ NI L     N   CA+V D+ LS  +     GL
Sbjct: 128 MLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL 186
Query: 224 AGYVDDDYWHEKGGGNATRES-----DVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM 278
            G      W       A  ES     D Y F ++L  IL+G    EG   +++   IK +
Sbjct: 187 LGNFQ---WMAPETIGAEEESYTEKADTYSFAMILYTILTG----EGPFDEYSYGKIKFI 239
Query: 279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                   R  IP +  P  RL  V   C     K RP    +   L+ L
Sbjct: 240 NMIREEGLRPTIPEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 28/281 (9%)
Query: 64  SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA------Q 117
           + +++IG G  G VY  +L T      K +   +    AG+     +  L  A       
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSS--GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           H NI+ + G        +I++E++   +LD +L E +   S+L     LR   G A G++
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMK 161
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAGYVDDDYWHE 234
           YL      N +H  + A NIL+N     +V D+GLS +    PE     +G      W  
Sbjct: 162 YLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 235 KGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP 291
                    T  SDV+ FG+V+ E+++      G    W L   + M+    ++    +P
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMT-----YGERPYWELSNHEVMK---AINDGFRLP 270
Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
             +     + ++ + C    R  RP    + +IL+ L+  P
Sbjct: 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 101 TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 153
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 214 SFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 102 TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 154
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+ +          E+  G   ++  +    +     
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 74  TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 126
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAG---YVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+     +    +   L+G   ++  +    +     
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 94  TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 146
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAG---YVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+     +    +   L+G   ++  +    +     
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 207 SFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G  GTVY         VAVK ++           F + +  L   +H NI+  +G+S
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
             P +  IV+++   +SL  +LH       ++   + + IA   A+G++YLH   A +II
Sbjct: 102 TKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLH---AKSII 154
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAG---YVDDDYWHEKGGGNA 240
           H  +K++NI L+E    ++ D+GL+     +    +   L+G   ++  +    +     
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 241 TRESDVYGFGVVLLEILSGR 260
           + +SDVY FG+VL E+++G+
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           EIDA+       ++IG G  G V +  L   K+   + I   +    AG+       F S
Sbjct: 25  EIDASC--IKIEKVIGVGEFGEVCSGRL---KVPGKREICVAIKTLKAGYTDKQRRDFLS 79
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +I++E++   SLD +L +N+   +++     LR 
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR- 138
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G   G++YL    A   +H  + A NIL+N     +V D+G+S +    PE      G
Sbjct: 139 --GIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+V+ E++S      G    W +    +IK + 
Sbjct: 194 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-----YGERPYWDMSNQDVIKAIE 248
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P      + L ++ L C    R +RP   Q+  +L+ L+ +P
Sbjct: 249 EGYRLPPPMDCP------IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNP 295

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           EIDA+       ++IG G  G V +  L   K+   + I   +    AG+       F S
Sbjct: 10  EIDASC--IKIEKVIGVGEFGEVCSGRL---KVPGKREICVAIKTLKAGYTDKQRRDFLS 64
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +I++E++   SLD +L +N+   +++     LR 
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR- 123
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G   G++YL      + +H  + A NIL+N     +V D+G+S +    PE      G
Sbjct: 124 --GIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+V+ E++S      G    W +    +IK + 
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-----YGERPYWDMSNQDVIKAIE 233
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P      + L ++ L C    R +RP   Q+  +L+ L+ +P
Sbjct: 234 EGYRLPPPMDCP------IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNP 280

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFAS 108
           EIDA+       ++IG G  G V +  L   K+   + I   +    AG+       F S
Sbjct: 4   EIDASC--IKIEKVIGVGEFGEVCSGRL---KVPGKREICVAIKTLKAGYTDKQRRDFLS 58
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    HPNI+ + G        +I++E++   SLD +L +N+   +++     LR 
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR- 117
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G   G++YL      + +H  + A NIL+N     +V D+G+S +    PE      G
Sbjct: 118 --GIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 172
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP---LIKEMR 279
                 W           T  SDV+ +G+V+ E++S      G    W +    +IK + 
Sbjct: 173 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-----YGERPYWDMSNQDVIKAIE 227
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               L P +  P      + L ++ L C    R +RP   Q+  +L+ L+ +P
Sbjct: 228 EGYRLPPPMDCP------IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNP 274

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 58/294 (19%)
Query: 68  IIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVP 123
           +IG+G  G V  A +    L    A+KR+       +    FA  ++ L  L  HPNI+ 
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLRIATG 171
           +LG  +  G   +  E+    +L  +L ++            N  AS L   + L  A  
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            ARG++YL Q      IH  + A NIL+ E + A++ D+GLS       RG   YV    
Sbjct: 148 VARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLS-------RGQEVYVKKTM 197
Query: 232 ------WHEKGGGN---ATRESDVYGFGVVLLEILS-------GRRCEEGLLVKWALPLI 275
                 W      N    T  SDV+ +GV+L EI+S       G  C E         L 
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 248
Query: 276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +++     L+  L    E+  L+R       C       RPS  Q+   LN ++
Sbjct: 249 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRML 296

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 58/294 (19%)
Query: 68  IIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVP 123
           +IG+G  G V  A +    L    A+KR+       +    FA  ++ L  L  HPNI+ 
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLRIATG 171
           +LG  +  G   +  E+    +L  +L ++            N  AS L   + L  A  
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            ARG++YL Q      IH  + A NIL+ E + A++ D+GLS       RG   YV    
Sbjct: 141 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS-------RGQEVYVKKTM 190
Query: 232 ------WHEKGGGN---ATRESDVYGFGVVLLEILS-------GRRCEEGLLVKWALPLI 275
                 W      N    T  SDV+ +GV+L EI+S       G  C E         L 
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 241
Query: 276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +++     L+  L    E+  L+R       C       RPS  Q+   LN ++
Sbjct: 242 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRML 289

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 58/294 (19%)
Query: 68  IIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVP 123
           +IG+G  G V  A +    L    A+KR+       +    FA  ++ L  L  HPNI+ 
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLRIATG 171
           +LG  +  G   +  E+    +L  +L ++            N  AS L   + L  A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            ARG++YL Q      IH  + A NIL+ E + A++ D+GLS       RG   YV    
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS-------RGQEVYVKKTM 200
Query: 232 ------WHEKGGGN---ATRESDVYGFGVVLLEILS-------GRRCEEGLLVKWALPLI 275
                 W      N    T  SDV+ +GV+L EI+S       G  C E         L 
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 251
Query: 276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +++     L+  L    E+  L+R       C       RPS  Q+   LN ++
Sbjct: 252 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRML 299

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS 114
           EI+A+    S R  IG G  GTVY         VAVK +            F + +  L 
Sbjct: 32  EIEASEVMLSTR--IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
             +H NI+  +G+        IV+++   +SL  +LH       +    + + IA   A+
Sbjct: 88  KTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQ 143
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP--------EEKRGLAGY 226
           G++YLH   A NIIH  +K++NI L+E    ++ D+GL+ +          E+  G   +
Sbjct: 144 GMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +    +     + +SDVY +G+VL E+++G
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 24/236 (10%)
Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           F S    +   +HPNI+ + G        +I++EF+   +LD +L  N+   +++     
Sbjct: 64  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM 123
Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLA-----PEE 219
           LR   G A G+ YL +    + +H  + A NIL+N     +V D+GLS FL      P E
Sbjct: 124 LR---GIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 220 KRGLAGYVDDDYWHEKGGG--NATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIK 276
              L G +   +   +       T  SD + +G+V+ E++S G R    +  +  +  I+
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE 237
Query: 277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           +       D RL  P +      L ++ L C    R  RP   QV + L+ ++ +P
Sbjct: 238 Q-------DYRLPPPPDCP--TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNP 284

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 33/291 (11%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLS-TGKL---VAVKRIHPRLVLSNAG--FGFAS 108
           EI+A+    +  R+IG G  G V +  L   GK    VA+K +             G AS
Sbjct: 18  EIEASC--ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEAS 75
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
           ++       HPNI+ + G        +IV+E++   SLD +L +N+   +++     LR 
Sbjct: 76  IMGQFD---HPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR- 131
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAG 225
             G + G++YL        +H  + A NIL+N     +V D+GLS +    PE      G
Sbjct: 132 --GISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 186
Query: 226 YVDDDYWHEKGG---GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFS 281
                 W           T  SDV+ +G+V+ E++S G R    +  +  +  ++E    
Sbjct: 187 GKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEE---- 242
Query: 282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
                   +P  +     L ++ L C    R +RP   ++  +L+ L+ +P
Sbjct: 243 -----GYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRNP 288

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 36/242 (14%)
Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           F S    +   +HPNI+ + G        +I++EF+   +LD +L  N+   +++     
Sbjct: 62  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM 121
Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
           LR   G A G+ YL +    + +H  + A NIL+N     +V D+GLS    E       
Sbjct: 122 LR---GIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS---- 171
Query: 226 YVDDDYWHEKGGG--------------NATRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
             D  Y    GG                 T  SD + +G+V+ E++S G R    +  + 
Sbjct: 172 --DPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 229
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
            +  I++       D RL  P +      L ++ L C    R  RP   QV + L+ ++ 
Sbjct: 230 VINAIEQ-------DYRLPPPPDCP--TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280
Query: 331 DP 332
           +P
Sbjct: 281 NP 282

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 117/265 (44%), Gaps = 23/265 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+ A  +    VAVK + P  +   A    A+V+KTL   QH  +V +    
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL---QHDKLVKLHAVV 252
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           ++ P    I++EF+   SL  +L   +D  S     + +  +   A G+ ++ Q    N 
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 188 IHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL++     ++ D+GL+  +   E     G      W        G+ T +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 244 SDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKV 303
           SDV+ FG++L+EI++  R           P +        L+    +P        L  +
Sbjct: 366 SDVWSFGILLMEIVTYGRI--------PYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417
Query: 304 ALACVGNSRKNRPSIVQVATILNNL 328
            + C  N  + RP+   + ++L++ 
Sbjct: 418 MMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 117/265 (44%), Gaps = 23/265 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+ A  +    VAVK + P  +   A    A+V+KTL   QH  +V +    
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL---QHDKLVKLHAVV 79
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           ++ P    I++EF+   SL  +L   +D  S     + +  +   A G+ ++ Q    N 
Sbjct: 80  TKEP--IYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 132
Query: 188 IHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL++     ++ D+GL+  +   E     G      W        G+ T +
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 244 SDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKV 303
           SDV+ FG++L+EI++  R           P +        L+    +P        L  +
Sbjct: 193 SDVWSFGILLMEIVTYGRI--------PYPGMSNPEVIRALERGYRMPRPENCPEELYNI 244
Query: 304 ALACVGNSRKNRPSIVQVATILNNL 328
            + C  N  + RP+   + ++L++ 
Sbjct: 245 MMRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 32/204 (15%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V+    +    VAVK + P  +   A    A+++KTL   QH  +V +    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL---QHDKLVRLYAVV 77
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++   SL  +L  +  G  LL   + +  +   A G+ Y+ +    N I
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERK---NYI 132
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG----------- 237
           H  ++A+N+L++E    ++ D+GL+ +            D++Y   +G            
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIE----------DNEYTAREGAKFPIKWTAPEA 182
Query: 238 ---GNATRESDVYGFGVVLLEILS 258
              G  T +SDV+ FG++L EI++
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 85  GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERIIVSEFIN 142
           G  + VK +  R   +     F      L +  HPN++P+LG  Q+P      +++ ++ 
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK 202
             SL   LHE  +   ++D ++ ++ A   ARG+ +LH  + P I    + + +++++E 
Sbjct: 93  YGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDED 149
Query: 203 FCARV--CDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             AR+   D   SF +P      A +V  +   +K      R +D++ F V+L E+++  
Sbjct: 150 MTARISMADVKFSFQSPGRMYAPA-WVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-- 206
Query: 261 RCEEGLLVKWALPLIKEMRFSELLDP-----------RLAIPCEIKPLVRLAKVALACVG 309
                          +E+ F++L +            R  IP  I P V  +K+   C+ 
Sbjct: 207 ---------------REVPFADLSNMEIGMKVALEGLRPTIPPGISPHV--SKLMKICMN 249
Query: 310 NSRKNRPSIVQVATILNNL 328
                RP    +  IL  +
Sbjct: 250 EDPAKRPKFDMIVPILEKM 268

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 41/294 (13%)
Query: 53  LTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVK--RIHPRLVLSNAGFGFASVI 110
           L EID A    +   IIG G  G VY A    G  VAVK  R  P   +S          
Sbjct: 1   LLEIDFAE--LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 111 KTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLL-DWNRRLRIA 169
           K  ++ +HPNI+ + G         +V EF     L+  L        +L +W      A
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------A 111
Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF--------CARVCDYGLSFLAPEEKR 221
              ARG+ YLH      IIH  +K+SNIL+ +K           ++ D+G   LA E  R
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---LAREWHR 168
Query: 222 GLAGYVDDDY-WHEKGGGNA---TRESDVYGFGVVLLEILSGR---RCEEGLLVKWALPL 274
                    Y W       A   ++ SDV+ +GV+L E+L+G    R  +GL V + + +
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
            K           LA+P         AK+   C      +RPS   +   L  +
Sbjct: 229 NK-----------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 32/204 (15%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V+    +    VAVK + P  +   A    A+++KTL   QH  +V +    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL---QHDKLVRLYAVV 76
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++EF+   SL  +L  +  G  LL   + +  +   A G+ Y+ +    N I
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIER---KNYI 131
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG----------- 237
           H  ++A+N+L++E    ++ D+GL+ +            D++Y   +G            
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIE----------DNEYTAREGAKFPIKWTAPEA 181
Query: 238 ---GNATRESDVYGFGVVLLEILS 258
              G  T +S+V+ FG++L EI++
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 35/280 (12%)
Query: 64  SHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           + +  +G G+ G VY  +     L VAVK +    +        A+V+K +   +HPN+V
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLV 70
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYL 179
            +LG         I++EF+   +L  YL E N     A +L     L +AT  +  +EYL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL 125
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYW---HEK 235
            +    N IH  + A N L+ E    +V D+GLS  +  +     AG      W      
Sbjct: 126 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL--DPRLAIP-- 291
                + +SDV+ FGV+L EI +              P I   +  ELL  D R+  P  
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMS--------PYPGIDPSQVYELLEKDYRMERPEG 234
Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD 331
           C  K    + ++  AC   +  +RPS  ++      +  +
Sbjct: 235 CPEK----VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 43/270 (15%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+ A  +    VAVK + P  +   A    A+V+KTL   QH  +V +    
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL---QHDKLVKLHAVV 246
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           ++ P    I++EF+   SL  +L   +D  S     + +  +   A G+ ++ Q    N 
Sbjct: 247 TKEP--IYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 299
Query: 188 IHGCIKASNILLNEKFCARVCDYGLS---------FLAPEEKRGLAGYVDDDYWHEKGGG 238
           IH  ++A+NIL++     ++ D+GL+         + APE                   G
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTAPE---------------AINFG 344
Query: 239 NATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLV 298
           + T +SDV+ FG++L+EI++  R           P +        L+    +P       
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGRI--------PYPGMSNPEVIRALERGYRMPRPENCPE 396
Query: 299 RLAKVALACVGNSRKNRPSIVQVATILNNL 328
            L  + + C  N  + RP+   + ++L++ 
Sbjct: 397 ELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF------GFASVIKTLSLAQHPN 120
           R+IG G  G V +  L   KL   + +   +     G+       F      +    HPN
Sbjct: 49  RVIGAGEFGEVCSGRL---KLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +V + G        +IV EF+   +LD +L +++   +++     LR   G A G+ YL 
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYL- 161
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAGYVDDDYWHEKGG 237
                  +H  + A NIL+N     +V D+GLS +    PE      G      W     
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 238 ---GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE 293
                 T  SDV+ +G+V+ E++S G R    +  +  +  I+E            +P  
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEE---------GYRLPAP 270
Query: 294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           +     L ++ L C    R  RP   Q+  IL+ ++ +P
Sbjct: 271 MDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNP 309

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 10  YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 68  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 119
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 120 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG 176
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 120/290 (41%), Gaps = 48/290 (16%)
Query: 67  RIIGQGRLGTVYAALLS-----TGKLVAVKRIH----PRLVLSNAGFGFASVIKTLSLAQ 117
           R +G+G  G V           TG++VAVK +     P+L       G+   I+ L    
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQL-----RSGWQREIEILRTLY 69
Query: 118 HPNIVPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
           H +IV   G  +  GE+ +  V E++ + SL  YL  +  G + L     L  A     G
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEG 124
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YW 232
           + YLH   A + IH  + A N+LL+     ++ D+GL+   PE         D D   +W
Sbjct: 125 MAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 181
Query: 233 HEKGGGNATR---ESDVYGFGVVLLEILSGRRCEEGLLVKWALPL------IKEMRFSEL 283
           +        +    SDV+ FGV L E+L+     +    K+   +      +  +R +EL
Sbjct: 182 YAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTEL 241
Query: 284 LD-----PRL-AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
           L+     PR    PCEI  L++       C       RP+   +  IL  
Sbjct: 242 LERGERLPRPDRCPCEIYHLMK------NCWETEASFRPTFQNLVPILQT 285

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 120/290 (41%), Gaps = 48/290 (16%)
Query: 67  RIIGQGRLGTVYAALLS-----TGKLVAVKRIH----PRLVLSNAGFGFASVIKTLSLAQ 117
           R +G+G  G V           TG++VAVK +     P+L       G+   I+ L    
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQL-----RSGWQREIEILRTLY 68
Query: 118 HPNIVPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
           H +IV   G  +  GE+ +  V E++ + SL  YL  +  G + L     L  A     G
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEG 123
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YW 232
           + YLH   A + IH  + A N+LL+     ++ D+GL+   PE         D D   +W
Sbjct: 124 MAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 180
Query: 233 HEKGGGNATR---ESDVYGFGVVLLEILSGRRCEEGLLVKWALPL------IKEMRFSEL 283
           +        +    SDV+ FGV L E+L+     +    K+   +      +  +R +EL
Sbjct: 181 YAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTEL 240
Query: 284 LD-----PRL-AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
           L+     PR    PCEI  L++       C       RP+   +  IL  
Sbjct: 241 LERGERLPRPDRCPCEIYHLMK------NCWETEASFRPTFQNLVPILQT 284

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 67  RIIGQGRLGTVYAALLS-----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           R +G+G  G V           TG++VAVK +       +   G+   I  L    H +I
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS-GWKQEIDILRTLYHEHI 78
Query: 122 VPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           +   G  +  GE+ +  V E++ + SL  YL  ++ G + L     L  A     G+ YL
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 133
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKG 236
           H   A + IH  + A N+LL+     ++ D+GL+   PE         D D   +W+   
Sbjct: 134 H---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 237 GGNATR---ESDVYGFGVVLLEILSGRRCEEGL--------LVKWALPLIKEMRFSELLD 285
                +    SDV+ FGV L E+L+   C+           L+  A   +  +R +ELL+
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 286 -----PRL-AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                PR    PCE+  L++       C       RP+   +  IL  +
Sbjct: 249 RGERLPRPDKCPCEVYHLMK------NCWETEASFRPTFENLIPILKTV 291

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 5   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 63  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 115 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 10  YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 68  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 119
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 120 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 117/278 (42%), Gaps = 31/278 (11%)
Query: 64  SHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           + +  +G G+ G VY  +     L VAVK +    +        A+V+K +   +HPN+V
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLV 91
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYL 179
            +LG         IV+E++   +L  YL E N     A +L     L +AT  +  +EYL
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVL-----LYMATQISSAMEYL 146
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYW---HEK 235
            +    N IH  + A N L+ E    +V D+GLS  +  +     AG      W      
Sbjct: 147 EK---KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 203
Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP--RLAIPCE 293
                + +SDV+ FGV+L EI +              P I   +  +LL+   R+  P  
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIATYGMS--------PYPGIDLSQVYDLLEKGYRMEQPEG 255
Query: 294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD 331
             P  ++ ++  AC   S  +RPS  +       +  D
Sbjct: 256 CPP--KVYELMRACWKWSPADRPSFAETHQAFETMFHD 291

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
            +  +GR G V+ A L   + VAVK I P  +     +     + +L   +H NI+  +G
Sbjct: 30  EVKARGRFGCVWKAQL-LNEYVAVK-IFP--IQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 127 FSQAPGERI-----IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            ++  G  +     +++ F    SL  +L      A+++ WN    IA   ARGL YLH+
Sbjct: 86  -AEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHE 139
Query: 182 -------GVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAGYVDDDYW 232
                  G  P I H  IK+ N+LL     A + D+GL+  F A +      G V    +
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 233 HE----KGGGNATRES----DVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM 278
                 +G  N  R++    D+Y  G+VL E+ S     +G + ++ LP  +E+
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 5   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 63  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 115 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 7   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 64
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 65  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 116
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 117 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 173
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 174 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 7   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 64
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 65  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 116
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 117 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG 173
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 174 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 6   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 63
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 64  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 115
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 116 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG 172
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 173 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 9   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 66
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 67  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 118
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 119 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 7   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 64
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 65  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 116
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 117 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 173
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 174 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 18  YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 75
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 76  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 127
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 128 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 184
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 185 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 5   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 63  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----L 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 115 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 10  YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 68  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----L 119
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 120 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 37/209 (17%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 79
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E++N  SL  +L    +    L   + + ++   A G+ Y+ +    N 
Sbjct: 80  SEEP--IYIVTEYMNKGSLLDFL--KGETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L           ++D+ W  + G          
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARL-----------IEDNEWTARQGAKFPIKWTAP 181
Query: 238 -----GNATRESDVYGFGVVLLEILSGRR 261
                G  T +SDV+ FG++L E+ +  R
Sbjct: 182 EAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 5   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 63  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----L 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 115 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 35/280 (12%)
Query: 64  SHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           + +  +G G+ G VY  +     L VAVK +    +        A+V+K +   +HPN+V
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLV 70
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYL 179
            +LG         I++EF+   +L  YL E N     A +L     L +AT  +  +EYL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL 125
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYW---HEK 235
            +    N IH  + A N L+ E    +V D+GLS  +  +     AG      W      
Sbjct: 126 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESL 182
Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL--DPRLAIP-- 291
                + +SDV+ FGV+L EI +              P I   +  ELL  D R+  P  
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMS--------PYPGIDPSQVYELLEKDYRMERPEG 234
Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD 331
           C  K    + ++  AC   +  +RPS  ++      +  +
Sbjct: 235 CPEK----VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 10  YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I++EF+   +L  YL E N     A +L     L
Sbjct: 68  MKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----L 119
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 120 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 67  RIIGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           R +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NI
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNI 76
Query: 122 VPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           V   G   + G R   ++ EF+   SL  YL ++ +    +D  + L+  +   +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER---IDHIKLLQYTSQICKGMEYL 133
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKG 236
                   IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+   
Sbjct: 134 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 237 GGNATR---ESDVYGFGVVLLEILS 258
               ++    SDV+ FGVVL E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 67  RIIGQGRLGTVYAALLS-----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           R +G+G  G V           TG++VAVK +       +   G+   I  L    H +I
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS-GWKQEIDILRTLYHEHI 78
Query: 122 VPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           +   G  +  GE+ +  V E++ + SL  YL  ++ G + L     L  A     G+ YL
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 133
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKG 236
           H   + + IH  + A N+LL+     ++ D+GL+   PE         D D   +W+   
Sbjct: 134 H---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 237 GGNATR---ESDVYGFGVVLLEILSGRRCEEGL--------LVKWALPLIKEMRFSELLD 285
                +    SDV+ FGV L E+L+   C+           L+  A   +  +R +ELL+
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 286 -----PRL-AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                PR    PCE+  L++       C       RP+   +  IL  +
Sbjct: 249 RGERLPRPDKCPCEVYHLMK------NCWETEASFRPTFENLIPILKTV 291

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 117/280 (41%), Gaps = 35/280 (12%)
Query: 64  SHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           + +  +G G+ G VY  +     L VAVK +    +        A+V+K +   +HPN+V
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLV 70
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYL 179
            +LG         I+ EF+   +L  YL E N     A +L     L +AT  +  +EYL
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL 125
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYW---HEK 235
            +    N IH  + A N L+ E    +V D+GLS  +  +     AG      W      
Sbjct: 126 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL--DPRLAIP-- 291
                + +SDV+ FGV+L EI +              P I   +  ELL  D R+  P  
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMS--------PYPGIDPSQVYELLEKDYRMERPEG 234
Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD 331
           C  K    + ++  AC   +  +RPS  ++      +  +
Sbjct: 235 CPEK----VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 6   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 63
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I+ EF+   +L  YL E N     A +L     L
Sbjct: 64  MKEI---KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----L 115
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 116 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG 172
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 173 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 65  HRRIIGQGRLGT-VYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           H  ++G+G  G  +      TG+++ +K +            F   +K +   +HPN++ 
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
            +G          ++E+I   +L   +   +   S   W++R+  A   A G+ YLH   
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY--------------VDD 229
           + NIIH  + + N L+ E     V D+GL+ L  +EK    G               V +
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 230 DYWHEK---GGGNATRESDVYGFGVVLLEIL 257
            YW       G +   + DV+ FG+VL EI+
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 5   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I+ EF+   +L  YL E N     A +L     L
Sbjct: 63  MKEI---KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----L 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 115 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 10  YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I+ EF+   +L  YL E N     A +L     L
Sbjct: 68  MKEI---KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----L 119
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 120 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV 109
           Y   E++       H+  +G G+ G VY  +     L VAVK +    +        A+V
Sbjct: 5   YDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRL 166
           +K +   +HPN+V +LG         I+ EF+   +L  YL E N     A +L     L
Sbjct: 63  MKEI---KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----L 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAG 225
            +AT  +  +EYL +    N IH  + A N L+ E    +V D+GLS  +  +     AG
Sbjct: 115 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 226 YVDDDYW---HEKGGGNATRESDVYGFGVVLLEILS 258
                 W           + +SDV+ FGV+L EI +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 57/292 (19%)
Query: 67  RIIGQGRLGTV-YAALLSTGKL---VAVKRIHPRLVLSNAGF------GFASVIKTLSLA 116
           +IIG G  G V Y  L   G+    VA+K +        AG+       F S    +   
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-------KAGYTERQRRDFLSEASIMGQF 107
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNI+ + G        +IV+E++   SLD +L  ++   +++     LR   G   G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGM 164
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG 236
            YL        +H  + A N+L++     +V D+GLS +  +         D D  +   
Sbjct: 165 RYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED---------DPDAAYTTT 212
Query: 237 GGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 +  SDV+ FGVV+ E+L+ G R    +  +  +  ++E   
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-- 270
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
                    +P  +     L ++ L C    R  RP   Q+ ++L+ L+  P
Sbjct: 271 -------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 66  RRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           +  +G G+ G VY  +     L VAVK +    +        A+V+K +   +HPN+V +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLVQL 281
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYLHQ 181
           LG         I++EF+   +L  YL E N     A +L     L +AT  +  +EYL +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLEK 336
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYW---HEKGG 237
               N IH  + A N L+ E    +V D+GLS  +  +     AG      W        
Sbjct: 337 ---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 238 GNATRESDVYGFGVVLLEILS 258
              + +SDV+ FGV+L EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 35/235 (14%)
Query: 68  IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           I  +GR G V+ A L     VAVK I P  +     +     I +    +H N++  +  
Sbjct: 22  IKARGRFGCVWKAQL-MNDFVAVK-IFP--LQDKQSWQSEREIFSTPGMKHENLLQFIAA 77
Query: 128 ----SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
               S    E  +++ F +  SL  YL  N     ++ WN    +A   +RGL YLH+ V
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYLHEDV 132
Query: 184 --------APNIIHGCIKASNILLNEKFCARVCDYGLSFL-----APEEKRGLAG---YV 227
                    P+I H   K+ N+LL     A + D+GL+        P +  G  G   Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 228 DDDYWHEKGGGNATRES----DVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM 278
             +    +G  N  R++    D+Y  G+VL E++S  +  +G + ++ LP  +E+
Sbjct: 193 APEVL--EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEI 245

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/264 (22%), Positives = 114/264 (43%), Gaps = 23/264 (8%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VA+K + P  +   +    A ++K L   +H  +V +    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL---KHDKLVQLYAVV 73
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E++N  SL  +L +    A  L     + +A   A G+ Y+ +    N 
Sbjct: 74  SEEP--IYIVTEYMNKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIERM---NY 126
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++++NIL+      ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 244 SDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKV 303
           SDV+ FG++L E+++  R           P +      E ++    +PC     + L ++
Sbjct: 187 SDVWSFGILLTELVTKGRV--------PYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 238
Query: 304 ALACVGNSRKNRPSIVQVATILNN 327
            + C     + RP+   + + L +
Sbjct: 239 MIHCWKKDPEERPTFEYLQSFLED 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 33/277 (11%)
Query: 66  RRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           +  +G G+ G VY  +     L VAVK +    +        A+V+K +   +HPN+V +
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLVQL 320
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYLHQ 181
           LG         I++EF+   +L  YL E N     A +L     L +AT  +  +EYL +
Sbjct: 321 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLEK 375
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYW---HEKGG 237
               N IH  + A N L+ E    +V D+GLS  +  +     AG      W        
Sbjct: 376 ---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 238 GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP--CEI 294
              + +SDV+ FGV+L EI + G     G+ +     L+++       D R+  P  C  
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------DYRMERPEGCPE 485
Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD 331
           K    + ++  AC   +  +RPS  ++      +  +
Sbjct: 486 K----VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 518

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 10/212 (4%)
Query: 52  PLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASV 109
           PL     A + F   R +G+G+ G VY A     K +   ++  +  L  AG        
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
           ++  S  +HPNI+ + G+        ++ E+  + ++    +      S  D  R     
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYI 117
Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVD 228
           T  A  L Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLD 174
Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                   G     + D++  GV+  E L G+
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 57/294 (19%)
Query: 69  IGQGRLGTV----YAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG LVAVK++  +    +    F   I+ L       IV 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 124 ILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G S  PG + +  V E++    L  +L  +    + LD +R L  ++   +G+EYL  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG- 144
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA- 240
             +   +H  + A NIL+  +   ++ D+GL+ L P         +D DY+  +  G + 
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---------LDKDYYVVREPGQSP 193
Query: 241 --------------TRESDVYGFGVVLLEILS--GRRCEEG------LLVKWALPLIKEM 278
                         +R+SDV+ FGVVL E+ +   + C         +  +  +P +  +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 279 RFSELLDPRL----AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                   RL    A P E+  L++L      C   S ++RPS   +   L+ L
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKL------CWAPSPQDRPSFSALGPQLDML 301

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 39/283 (13%)
Query: 67  RIIGQGRLGTV-YAALLSTGKL---VAVKRIHPRLVLSNAGF------GFASVIKTLSLA 116
           +IIG G  G V Y  L   G+    VA+K +        AG+       F S    +   
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-------KAGYTERQRRDFLSEASIMGQF 107
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNI+ + G        +IV+E++   SLD +L  ++   +++     LR   G   G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGM 164
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL---APEEKRGLAGYVDDDYWH 233
            YL        +H  + A N+L++     +V D+GLS +    P+      G      W 
Sbjct: 165 RYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT 221
Query: 234 EKGG---GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLA 289
                     +  SDV+ FGVV+ E+L+ G R    +  +  +  ++E            
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG---------YR 272
Query: 290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           +P  +     L ++ L C    R  RP   Q+ ++L+ L+  P
Sbjct: 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 57/294 (19%)
Query: 69  IGQGRLGTV----YAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG LVAVK++  +    +    F   I+ L       IV 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 124 ILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G S  PG + +  V E++    L  +L  +    + LD +R L  ++   +G+EYL  
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG- 131
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA- 240
             +   +H  + A NIL+  +   ++ D+GL+ L P         +D DY+  +  G + 
Sbjct: 132 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---------LDKDYYVVREPGQSP 180
Query: 241 --------------TRESDVYGFGVVLLEILS--GRRCEEG------LLVKWALPLIKEM 278
                         +R+SDV+ FGVVL E+ +   + C         +  +  +P +  +
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRL 240
Query: 279 RFSELLDPRL----AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                   RL    A P E+  L++L      C   S ++RPS   +   L+ L
Sbjct: 241 LELLEEGQRLPAPPACPAEVHELMKL------CWAPSPQDRPSFSALGPQLDML 288

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 78
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL  +   A  +D  + L+  +   +G+EYL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH---AERIDHIKLLQYTSQICKGMEYLG- 134
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 79
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E++N  SL  +L    +    L   + + ++   A G+ Y+ +    N 
Sbjct: 80  SEEP--IYIVTEYMNKGSLLDFL--KGETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 182
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 74
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 130
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 131 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 73
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 129
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 130 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 75
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 131
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 75
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 131
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 79
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 135
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 136 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPIL 125
           +G+G  G VY A  S G++VA+KRI  RL   + G   ++ I+ +SL +   HPNIV ++
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI--RLDAEDEGIP-STAIREISLLKELHHPNIVSLI 85
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
               +     +V EF+    L   L EN  G  L D   ++ +     RG+ + HQ    
Sbjct: 86  DVIHSERCLTLVFEFME-KDLKKVLDENKTG--LQDSQIKIYLYQ-LLRGVAHCHQH--- 138
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGL--SFLAPEEKRGLAGYVDD--DYWHEK-----G 236
            I+H  +K  N+L+N     ++ D+GL  +F  P     +  Y  +    W+       G
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEVVTLWYRAPDVLMG 193
Query: 237 GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
               +   D++  G +  E+++G+    G+     LP I
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPIL 125
           +G+G  G VY A  S G++VA+KRI  RL   + G   ++ I+ +SL +   HPNIV ++
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI--RLDAEDEGIP-STAIREISLLKELHHPNIVSLI 85
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
               +     +V EF+    L   L EN  G  L D   ++ +     RG+ + HQ    
Sbjct: 86  DVIHSERCLTLVFEFME-KDLKKVLDENKTG--LQDSQIKIYLYQ-LLRGVAHCHQH--- 138
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGL--SFLAPEEKRGLAGYVDD--DYWHEK-----G 236
            I+H  +K  N+L+N     ++ D+GL  +F  P     +  Y  +    W+       G
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEVVTLWYRAPDVLMG 193
Query: 237 GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
               +   D++  G +  E+++G+    G+     LP I
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 75
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 131
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 81
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 137
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 138 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 78
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 134
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 80
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 136
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 137 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 93
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 149
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 150 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 106
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 162
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 57/294 (19%)
Query: 69  IGQGRLGTV----YAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG LVAVK++  +    +    F   I+ L       IV 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 124 ILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G S  PG + +  V E++    L  +L  +    + LD +R L  ++   +G+EYL  
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG- 132
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA- 240
             +   +H  + A NIL+  +   ++ D+GL+ L P         +D DY+  +  G + 
Sbjct: 133 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---------LDKDYYVVREPGQSP 181
Query: 241 --------------TRESDVYGFGVVLLEILS--GRRCEEG------LLVKWALPLIKEM 278
                         +R+SDV+ FGVVL E+ +   + C         +  +  +P +  +
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRL 241
Query: 279 RFSELLDPRL----AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                   RL    A P E+  L++L      C   S ++RPS   +   L+ L
Sbjct: 242 LELLEEGQRLPAPPACPAEVHELMKL------CWAPSPQDRPSFSALGPQLDML 289

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI 183
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 184 EGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 93
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG- 149
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 150 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 92  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 138
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   EGL+    + L  E
Sbjct: 196 GTAQYVSPELLTEK---SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--E 250
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALAC 307
             F E   P+     E K LV  A   L C
Sbjct: 251 YDFPEKFFPKARDLVE-KLLVLDATKRLGC 279

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 76
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 132
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 133 --TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 191 TESKFSVASDVWSFGVVLYELFT 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 72
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 73  SEEP--IXIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 125
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           +H  ++A+NIL+ E    +V D+GL+ L  + E     G      W        G  T +
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L E+ +  R
Sbjct: 186 SDVWSFGILLTELTTKGR 203

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 69  IGQGRLGTV----YAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG++VAVK++            F   I+ L   QH NIV 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVK 82
Query: 124 ILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EYL  
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG- 138
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWHEKGGG 238
                 IH  +   NIL+  +   ++ D+GL+ + P++K         +   +W+     
Sbjct: 139 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 239 NATR---ESDVYGFGVVLLEILS 258
             ++    SDV+ FGVVL E+ +
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT 219

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 52  PLTEIDAATDGFSHR-----RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSN 101
           P TE+D     F  R     R +G+G  G V          +TG+ VAVK + P     +
Sbjct: 9   PATEVDPTH--FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP----ES 62
Query: 102 AGFGFASVIKTLSLAQ---HPNIVPILGFSQAPGERII--VSEFINMASLDFYLHENNDG 156
            G   A + K + + +   H NIV   G     G   I  + EF+   SL  YL +N + 
Sbjct: 63  GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 157 ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA 216
            +L    ++L+ A    +G++YL    +   +H  + A N+L+  +   ++ D+GL+   
Sbjct: 123 INL---KQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
Query: 217 PEEKRGLAGYVDDD---YWHEKGGGNATR---ESDVYGFGVVLLEILS 258
             +K       D D   +W+       ++    SDV+ FGV L E+L+
Sbjct: 177 ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 75
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 76  SEEP--IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 178
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI 181
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 105/256 (41%), Gaps = 38/256 (14%)
Query: 85  GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERIIVSEFIN 142
           G  + VK +  R   +     F      L +  HPN++P+LG  Q+P      +++ +  
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK 202
             SL   LHE  +   ++D ++ ++ A   ARG  +LH  + P I    + + ++ ++E 
Sbjct: 93  YGSLYNVLHEGTN--FVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSRSVXIDED 149
Query: 203 FCARV--CDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             AR+   D   SF +P      A +V  +   +K      R +D + F V+L E+++  
Sbjct: 150 XTARISXADVKFSFQSPGRXYAPA-WVAPEALQKKPEDTNRRSADXWSFAVLLWELVT-- 206
Query: 261 RCEEGLLVKWALPLIKEMRFSELLDP-----------RLAIPCEIKPLVRLAKVALACVG 309
                          +E+ F++L +            R  IP  I P V  +K+   C  
Sbjct: 207 ---------------REVPFADLSNXEIGXKVALEGLRPTIPPGISPHV--SKLXKICXN 249
Query: 310 NSRKNRPSIVQVATIL 325
                RP    +  IL
Sbjct: 250 EDPAKRPKFDXIVPIL 265

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 81
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 133
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 134 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 147
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 148 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMI 204
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 205 EGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 122
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG-LAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI 179
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 122
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 179
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 125/330 (37%), Gaps = 67/330 (20%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P        D     + +G+G  G V  A        +T + VAV
Sbjct: 1   EHAERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 53
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   ++++EF    +L  Y
Sbjct: 54  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTY 113
Query: 150 LHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI 197
           L    +                L     +  +   A+G+E+L    +   IH  + A NI
Sbjct: 114 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 170
Query: 198 LLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN---------------ATR 242
           LL+EK   ++CD+GL+       R +  Y D DY   KG                   T 
Sbjct: 171 LLSEKNVVKICDFGLA-------RDI--YKDPDY-VRKGDARLPLKWMAPETIFDRVYTI 220
Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVR 299
           +SDV+ FGV+L EI S        L     P +K +  F   L    R+  P    P   
Sbjct: 221 QSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--E 270
Query: 300 LAKVALACVGNSRKNRPSIVQVATILNNLV 329
           + +  L C       RP+  ++   L NL+
Sbjct: 271 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 147
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 148 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 204
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 205 EGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 120
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 177
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 178 EGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG-LAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 124
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 92  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 138
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   EGL+    + L  E
Sbjct: 196 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--E 250
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALAC 307
             F E   P+     E K LV  A   L C
Sbjct: 251 YDFPEKFFPKARDLVE-KLLVLDATKRLGC 279

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 183
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG-LAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 81
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 133
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 134 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLAFRHE 83
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 135
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 136 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 121
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 178
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 81
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 133
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 134 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 71
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 72  SEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 124
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 174
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 124
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 181
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG+G  G V       G  VAVK I      + A    ASV+  L   +H N+V +LG
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL---RHSNLVQLLG 66
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +  G   IV+E++   SL  YL     G S+L  +  L+ +      +EYL      
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GN 121
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK---RGLAGYVDDDYWHEKGGGNATR 242
           N +H  + A N+L++E   A+V D+GL+  A   +   +    +   +   EK     + 
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK---KFST 178
Query: 243 ESDVYGFGVVLLEILSGRR 261
           +SDV+ FG++L EI S  R
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 138
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 139 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 195
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 196 EGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 73
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 74  SEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 126
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 176
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYXQRTLREIKILLRFRHE 85
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 137
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 123
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 180
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 40/287 (13%)
Query: 67  RIIGQGRLGTVYAALLS-----TGKLVAVKRIHPRLVLSNAG----FGFASVIKTLSLAQ 117
           R +G+G  G V           TG++VAVK +      ++AG     G+   I  L    
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-----ADAGPQHRSGWKQEIDILRTLY 91
Query: 118 HPNIVPILGFSQAPG--ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
           H +I+   G  +  G     +V E++ + SL  YL  ++ G + L     L  A     G
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEG 146
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YW 232
           + YLH   A + IH  + A N+LL+     ++ D+GL+   PE         D D   +W
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFW 203
Query: 233 HEKGGGNATR---ESDVYGFGVVLLEILSGRRCEEGL--------LVKWALPLIKEMRFS 281
           +        +    SDV+ FGV L E+L+   C+           L+  A   +  +R +
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           ELL+    +P   K    +  +   C       RP+   +  IL  +
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG+G  G V       G  VAVK I      + A    ASV+  L   +H N+V +LG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL---RHSNLVQLLG 253
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +  G   IV+E++   SL  YL     G S+L  +  L+ +      +EYL      
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GN 308
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK---RGLAGYVDDDYWHEKGGGNATR 242
           N +H  + A N+L++E   A+V D+GL+  A   +   +    +   +   EK     + 
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK---KFST 365
Query: 243 ESDVYGFGVVLLEILSGRR 261
           +SDV+ FG++L EI S  R
Sbjct: 366 KSDVWSFGILLWEIYSFGR 384

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 124/323 (38%), Gaps = 63/323 (19%)
Query: 40  ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAVKRI 93
           E LP     + +P   ++         + +G+G  G V  A        +T + VAVK +
Sbjct: 13  ERLPYDASKWEFPRDRLNLG-------KPLGRGAFGQVIEADAFGIDKTATXRTVAVKML 65
Query: 94  HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFYLHE 152
                 S      + +   + +  H N+V +LG    PG   +++ EF    +L  YL  
Sbjct: 66  KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 153 NNDG--------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC 204
             +            L     +  +   A+G+E+L    +   IH  + A NILL+EK  
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNV 182
Query: 205 ARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN---------------ATRESDVYGF 249
            ++CD+GL+       R +  Y D DY   KG                   T +SDV+ F
Sbjct: 183 VKICDFGLA-------RDI--YKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 232
Query: 250 GVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVRLAKVALA 306
           GV+L EI S        L     P +K +  F   L    R+  P    P   + +  L 
Sbjct: 233 GVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--EMYQTMLD 282
Query: 307 CVGNSRKNRPSIVQVATILNNLV 329
           C       RP+  ++   L NL+
Sbjct: 283 CWHGEPSQRPTFSELVEHLGNLL 305

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 83
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 135
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 136 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 125
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 182
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG+G  G V       G  VAVK I      + A    ASV+  L   +H N+V +LG
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL---RHSNLVQLLG 81
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +  G   IV+E++   SL  YL     G S+L  +  L+ +      +EYL      
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GN 136
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK---RGLAGYVDDDYWHEKGGGNATR 242
           N +H  + A N+L++E   A+V D+GL+  A   +   +    +   +   EK     + 
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK---KFST 193
Query: 243 ESDVYGFGVVLLEILS 258
           +SDV+ FG++L EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLAFRHE 83
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 135
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 136 LRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 85
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 137
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 248
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 249 SEEP--IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 351
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 248
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 249 SEEP--IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 351
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 101
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 153
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 154 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 120/287 (41%), Gaps = 48/287 (16%)
Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +++G G  GTVY  +      T K+    +I        A   F      ++   HP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENND--GASLLDWNRRLRIATGAARGLEYLH 180
            +LG   +P  ++ V++ +    L  Y+HE+ D  G+ LL     L      A+G+ YL 
Sbjct: 81  RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE 134
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG-- 238
           +     ++H  + A N+L+      ++ D+GL+       R L G  D+  ++  GG   
Sbjct: 135 ER---RLVHRDLAARNVLVKSPNHVKITDFGLA-------RLLEG--DEKEYNADGGKMP 182
Query: 239 ------------NATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD 285
                         T +SDV+ +GV + E+++ G +  +G+  +            +LL+
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---------EIPDLLE 233
Query: 286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               +P      + +  V + C      +RP   ++A   + +  DP
Sbjct: 234 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 280

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 89
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 141
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 142 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 81
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 133
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 134 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 122
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L+G +D       
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMI 179
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 118
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 175
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 176 EGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 79
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 80  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 132
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 193 SDVWSFGILLTEIVTHGR 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 77
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 78  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 13/215 (6%)
Query: 52  PLTEIDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVI 110
           P  +I    + F   +++G+G  G V+ A    T +  A+K +   +VL +       V 
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 111 K-TLSLA-QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
           K  LSLA +HP +  +    Q       V E++N   L +++          D +R    
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFY 124
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL---SFLAPEEKRGLAG 225
           A     GL++LH   +  I++  +K  NILL++    ++ D+G+   + L   +     G
Sbjct: 125 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCG 181
Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             D        G       D + FGV+L E+L G+
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 83
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 84  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 136
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 197 SDVWSFGILLTEIVTHGR 214

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 85
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ--------I 137
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 120/287 (41%), Gaps = 48/287 (16%)
Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +++G G  GTVY  +      T K+    +I        A   F      ++   HP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENND--GASLLDWNRRLRIATGAARGLEYLH 180
            +LG   +P  ++ V++ +    L  Y+HE+ D  G+ LL     L      A+G+ YL 
Sbjct: 104 RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE 157
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG-- 238
           +     ++H  + A N+L+      ++ D+GL+       R L G  D+  ++  GG   
Sbjct: 158 ER---RLVHRDLAARNVLVKSPNHVKITDFGLA-------RLLEG--DEKEYNADGGKMP 205
Query: 239 ------------NATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD 285
                         T +SDV+ +GV + E+++ G +  +G+  +            +LL+
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---------EIPDLLE 256
Query: 286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
               +P      + +  V + C      +RP   ++A   + +  DP
Sbjct: 257 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 303

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 125/330 (37%), Gaps = 67/330 (20%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P        D     + +G+G  G V  A        +T + VAV
Sbjct: 1   EHCERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 53
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   ++++EF    +L  Y
Sbjct: 54  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTY 113
Query: 150 LHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI 197
           L    +                L     +  +   A+G+E+L    +   IH  + A NI
Sbjct: 114 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 170
Query: 198 LLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN---------------ATR 242
           LL+EK   ++CD+GL+       R +  Y D DY   KG                   T 
Sbjct: 171 LLSEKNVVKICDFGLA-------RDI--YKDPDY-VRKGDARLPLKWMAPETIFDRVYTI 220
Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVR 299
           +SDV+ FGV+L EI S        L     P +K +  F   L    R+  P    P   
Sbjct: 221 QSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--E 270
Query: 300 LAKVALACVGNSRKNRPSIVQVATILNNLV 329
           + +  L C       RP+  ++   L NL+
Sbjct: 271 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 79
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 131
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 132 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 78
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 79  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 131
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 192 SDVWSFGILLTEIVTHGR 209

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 79
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 131
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 132 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 86
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 87  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 139
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 200 SDVWSFGILLTEIVTHGR 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 73
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 74  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 126
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL+++    ++ D+GL+ L            D++Y   +G           
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIE----------DNEYTAREGAKFPIKWTAPE 176
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L EI++  R
Sbjct: 177 AINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 77
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 78  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 77
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 78  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL+++    ++ D+GL+ L            D++Y   +G           
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE----------DNEYTAREGAKFPIKWTAPE 180
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L EI++  R
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 83
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 84  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 136
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL+++    ++ D+GL+ L            D++Y   +G           
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIE----------DNEYTAREGAKFPIKWTAPE 186
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L EI++  R
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 83  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL+++    ++ D+GL+ L            D++Y   +G           
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIE----------DNEYTAREGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L EI++  R
Sbjct: 186 AINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 86
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 138
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 139 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 87
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 139
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 140 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 41/211 (19%)
Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG+G  G V       G  VAVK I      + A    ASV+  L   +H N+V +LG
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL---RHSNLVQLLG 72
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +  G   IV+E++   SL  YL     G S+L  +  L+ +      +EYL      
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GN 127
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLS---------------FLAPEEKRGLAGYVDDD 230
           N +H  + A N+L++E   A+V D+GL+               + APE  R  A      
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAA------ 181
Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                     + +SDV+ FG++L EI S  R
Sbjct: 182 ---------FSTKSDVWSFGILLWEIYSFGR 203

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 78
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 130
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 131 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 84/202 (41%), Gaps = 25/202 (12%)
Query: 69  IGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V++  L +   LVAVK     L   +    F    + L    HPNIV ++G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT------GAARGLEYLHQ 181
                   IV E +     DF      +GA       RLR+ T       AA G+EYL  
Sbjct: 181 CTQKQPIYIVMELVQGG--DFLTFLRTEGA-------RLRVKTLLQMVGDAAAGMEYLES 231
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDD--DYWHEKGGGN 239
                 IH  + A N L+ EK   ++ D+G+S    +     +G +      W      N
Sbjct: 232 KCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 240 ATR---ESDVYGFGVVLLEILS 258
             R   ESDV+ FG++L E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 85
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 137
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 85
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 86  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 138
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 199 SDVWSFGILLTEIVTHGR 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGK-LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D +  + +IG G    V AA  +  K  VA+KRI+     ++        I+ +S   HP
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 68
Query: 120 NIVPILGFSQAPGERIIVSEFINMAS-LDFYLH---ENNDGASLLDWNRRLRIATGAARG 175
           NIV          E  +V + ++  S LD   H   +    + +LD +    I      G
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAP----EEKRGLAGYVDDD 230
           LEYLH+      IH  +KA NILL E    ++ D+G+S FLA        +    +V   
Sbjct: 129 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 231 YWHEKGGGNATR----ESDVYGFGVVLLEILSG 259
            W         R    ++D++ FG+  +E+ +G
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGK-LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D +  + +IG G    V AA  +  K  VA+KRI+     ++        I+ +S   HP
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 73
Query: 120 NIVPILGFSQAPGERIIVSEFINMAS-LDFYLH---ENNDGASLLDWNRRLRIATGAARG 175
           NIV          E  +V + ++  S LD   H   +    + +LD +    I      G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAP----EEKRGLAGYVDDD 230
           LEYLH+      IH  +KA NILL E    ++ D+G+S FLA        +    +V   
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 231 YWHEKGGGNATR----ESDVYGFGVVLLEILSG 259
            W         R    ++D++ FG+  +E+ +G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 50/282 (17%)
Query: 66  RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             ++G+G  G V  A     K VA+K+I       +    F   ++ LS   HPNIV + 
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLY 67
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAARGLEYLHQG 182
           G    P    +V E+    SL   LH    GA  L +      +      ++G+ YLH  
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 183 VAPNIIHGCIKASNILLNEKFCA-RVCDYGLSF---LAPEEKRGLAGYVDDDYWHEKGGG 238
               +IH  +K  N+LL       ++CD+G +          +G A ++  + +    G 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE---GS 178
Query: 239 NATRESDVYGFGVVLLEILSGRRCEE-----GLLVKWAL------PLIKEMRFSELLDPR 287
           N + + DV+ +G++L E+++ R+  +        + WA+      PLIK +         
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP-------- 230
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
                  KP+  L      C       RPS+ ++  I+ +L+
Sbjct: 231 -------KPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 72
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 73  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 125
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL+++    ++ D+GL+ L            D++Y   +G           
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIE----------DNEYTAREGAKFPIKWTAPE 175
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L EI++  R
Sbjct: 176 AINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 87
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 88  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 140
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           IH  ++A+NIL+++    ++ D+GL+ L            D++Y   +G           
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIE----------DNEYTAREGAKFPIKWTAPE 190
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L EI++  R
Sbjct: 191 AINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 37/209 (17%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 331
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
           S+ P    IV+E+++  SL DF   E       L   + + +A   A G+ Y+ +    N
Sbjct: 332 SEEP--IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------- 237
            +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G          
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAP 433
Query: 238 -----GNATRESDVYGFGVVLLEILSGRR 261
                G  T +SDV+ FG++L E+ +  R
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVCEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 92  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNGC-LLKYIRKIGSFDETCTRFYT 138
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 195
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A++ SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 196 GTAQYVSPELLTEK---SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 250
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 251 YDFPEKFFPK 260

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 24/233 (10%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLA 116
           +  F  + ++G+G  G V +A    TG++VA+K+I P        F   ++  IK L   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---FDKPLFALRTLREIKILKHF 66
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +H NI+ I    +          +I    +   LH       L D + +  I     R +
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAV 125
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE----------EKRGLAGY 226
           + LH     N+IH  +K SN+L+N     +VCD+GL+ +  E          ++ G+  Y
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 227 VDDDYWHEK----GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
           V   ++            +R  DV+  G +L E+   R    G   +  L LI
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K +   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKI---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 50/282 (17%)
Query: 66  RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             ++G+G  G V  A     K VA+K+I       +    F   ++ LS   HPNIV + 
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLY 68
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAARGLEYLHQG 182
           G    P    +V E+    SL   LH    GA  L +      +      ++G+ YLH  
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 183 VAPNIIHGCIKASNILLNEKFCA-RVCDYGLSF---LAPEEKRGLAGYVDDDYWHEKGGG 238
               +IH  +K  N+LL       ++CD+G +          +G A ++  + +    G 
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE---GS 179
Query: 239 NATRESDVYGFGVVLLEILSGRRCEE-----GLLVKWAL------PLIKEMRFSELLDPR 287
           N + + DV+ +G++L E+++ R+  +        + WA+      PLIK +         
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP-------- 231
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
                  KP+  L      C       RPS+ ++  I+ +L+
Sbjct: 232 -------KPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 84/202 (41%), Gaps = 25/202 (12%)
Query: 69  IGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V++  L +   LVAVK     L   +    F    + L    HPNIV ++G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT------GAARGLEYLHQ 181
                   IV E +     DF      +GA       RLR+ T       AA G+EYL  
Sbjct: 181 CTQKQPIYIVMELVQGG--DFLTFLRTEGA-------RLRVKTLLQMVGDAAAGMEYLES 231
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDD--DYWHEKGGGN 239
                 IH  + A N L+ EK   ++ D+G+S    +     +G +      W      N
Sbjct: 232 KCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 240 ATR---ESDVYGFGVVLLEILS 258
             R   ESDV+ FG++L E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 39/285 (13%)
Query: 69  IGQGRLGTV----YAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +G+G  G+V    Y  L  +TG LVAVK++  +    +    F   I+ L       IV 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 124 ILGFSQAPG--ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
             G S  PG  E  +V E++    L  +L  +    + LD +R L  ++   +G+EYL  
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG- 128
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWH--EKG 236
             +   +H  + A NIL+  +   ++ D+GL+ L P +K             +W+  E  
Sbjct: 129 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 237 GGNA-TRESDVYGFGVVLLEILS--GRRCEEG------LLVKWALPLIKEMRFSELLDPR 287
             N  +R+SDV+ FGVVL E+ +   + C         +  +  +P +  +        R
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 246
Query: 288 L----AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           L    A P E+  L++L      C   S ++RPS   +   L+ L
Sbjct: 247 LPAPPACPAEVHELMKL------CWAPSPQDRPSFSALGPQLDML 285

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI----HPRLVLSNAGFGFASVIKTLSLAQ 117
           ++    IGQG  GTVY A+ ++TG+ VA++++     P+  L        + I  +   +
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL------IINEILVMRENK 76
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           +PNIV  L       E  +V E++   SL   + E     + +D  +   +     + LE
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 131
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           +LH      +IH  IK+ NILL      ++ D+G       E+   +  V   YW     
Sbjct: 132 FLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM--AP 186
Query: 238 GNATRES-----DVYGFGVVLLEILSGR 260
              TR++     D++  G++ +E++ G 
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G G+ G V+    +    VAVK +    +  +A    A+++K L   QH  +V +    
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLYAVV 77
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           +Q P    I++E++   SL  +L         L  N+ L +A   A G+ ++ +    N 
Sbjct: 78  TQEP--IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           IH  ++A+NIL+++    ++ D+GL+ L  + E     G      W        G  T +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L EI++  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 248
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 249 SEEP--IYIVGEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 351
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  + A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI----HPRLVLSNAGFGFASVIKTLSLAQ 117
           ++    IGQG  GTVY A+ ++TG+ VA++++     P+  L        + I  +   +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL------IINEILVMRENK 75
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           +PNIV  L       E  +V E++   SL   + E     + +D  +   +     + LE
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 130
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           +LH      +IH  IK+ NILL      ++ D+G       E+   +  V   YW     
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM--AP 185
Query: 238 GNATRES-----DVYGFGVVLLEILSGR 260
              TR++     D++  G++ +E++ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 69  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 115
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 116 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 173 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 227
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 228 YDFPEKFFPK 237

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 13/215 (6%)
Query: 52  PLTEIDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVI 110
           P  +I    + F   +++G+G  G V+ A    T +  A+K +   +VL +       V 
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 111 K-TLSLA-QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
           K  LSLA +HP +  +    Q       V E++N   L +++          D +R    
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFY 123
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL---SFLAPEEKRGLAG 225
           A     GL++LH   +  I++  +K  NILL++    ++ D+G+   + L   +     G
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCG 180
Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             D        G       D + FGV+L E+L G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+     +    ++     S  D  R     T  A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANAL 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI----HPRLVLSNAGFGFASVIKTLSLAQ 117
           ++    IGQG  GTVY A+ ++TG+ VA++++     P+  L        + I  +   +
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL------IINEILVMRENK 76
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           +PNIV  L       E  +V E++   SL   + E     + +D  +   +     + LE
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 131
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           +LH      +IH  IK+ NILL      ++ D+G       E+   +  V   YW     
Sbjct: 132 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWM--AP 186
Query: 238 GNATRES-----DVYGFGVVLLEILSGR 260
              TR++     D++  G++ +E++ G 
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 10/202 (4%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLAQH 118
           + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  +H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSY 127
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG-LAGYVDDDYWHEKGG 237
            H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D        G
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEG 184
Query: 238 GNATRESDVYGFGVVLLEILSG 259
                + D++  GV+  E L G
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 70  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 116
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 117 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
           G A YV  +   EK   +A + SD++  G ++ ++++G
Sbjct: 174 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAG 208

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI----HPRLVLSNAGFGFASVIKTLSLAQ 117
           ++    IGQG  GTVY A+ ++TG+ VA++++     P+  L        + I  +   +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL------IINEILVMRENK 75
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           +PNIV  L       E  +V E++   SL   + E     + +D  +   +     + LE
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 130
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           +LH      +IH  IK+ NILL      ++ D+G       E+   +  V   YW     
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWM--AP 185
Query: 238 GNATRES-----DVYGFGVVLLEILSGR 260
              TR++     D++  G++ +E++ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI----HPRLVLSNAGFGFASVIKTLSLAQ 117
           ++    IGQG  GTVY A+ ++TG+ VA++++     P+  L        + I  +   +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL------IINEILVMRENK 75
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           +PNIV  L       E  +V E++   SL   + E     + +D  +   +     + LE
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 130
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           +LH      +IH  IK+ NILL      ++ D+G       E+   +  V   YW     
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWM--AP 185
Query: 238 GNATRES-----DVYGFGVVLLEILSGR 260
              TR++     D++  G++ +E++ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 67  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 113
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 114 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 171 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 225
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 226 YDFPEKFFPK 235

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 74  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 120
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 121 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 177
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 178 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 232
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALAC 307
             F E   P+     E K LV  A   L C
Sbjct: 233 YDFPEKFFPKARDLVE-KLLVLDATKRLGC 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 10/202 (4%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLAQH 118
           + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  +H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSY 127
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEKGG 237
            H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D        G
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 238 GNATRESDVYGFGVVLLEILSG 259
                + D++  GV+  E L G
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---H 118
           R +G+G  G V          +TG+ VAVK + P     + G   A + K + + +   H
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP----ESGGNHIADLKKEIEILRNLYH 70
Query: 119 PNIVPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            NIV   G     G   I  + EF+   SL  YL +N +  +L    ++L+ A    +G+
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAVQICKGM 127
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD---YWH 233
           +YL    +   +H  + A N+L+  +   ++ D+GL+     +K       D D   +W+
Sbjct: 128 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 184
Query: 234 EKGGGNATR---ESDVYGFGVVLLEILS 258
                  ++    SDV+ FGV L E+L+
Sbjct: 185 APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 68  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 114
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 115 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 172 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 226
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 227 YDFPEKFFPK 236

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+     +    ++     S  D  R     T  A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANAL 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ D+G S  AP  +R  L G +D       
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI 183
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVIEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG---GNATRE 243
           +H  ++A+NIL+ E    +V D+GL+ L  + E     G      W        G  T +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 244 SDVYGFGVVLLEILSGRR 261
           SDV+ FG++L E+ +  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 90  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 136
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 194 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 248
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 249 YDFPEKFFPK 258

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 90  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 136
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV 193
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 194 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 248
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 249 YDFPEKFFPK 258

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 93  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 139
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 140 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 196
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 197 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 251
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 252 YDFPEKFFPK 261

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 92  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 138
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 196 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 250
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALAC 307
             F E   P+     E K LV  A   L C
Sbjct: 251 YDFPEKFFPKARDLVE-KLLVLDATKRLGC 279

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGF--GFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++    +      S  D  R     T  A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 124
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ ++G S  AP  +R  L G +D       
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 93  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 139
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 140 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 196
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 197 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 251
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 252 YDFPEKFFPK 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLA 116
           A + F   R +G+G+ G VY A     K +   ++  +  L  AG        ++  S  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HPNI+ + G+        ++ E+  + ++   L +     S  D  R     T  A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 123
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-GLAGYVDDDYWHEK 235
            Y H   +  +IH  IK  N+LL      ++ ++G S  AP  +R  L G +D       
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 180
Query: 236 GGGNATRESDVYGFGVVLLEILSGR 260
            G     + D++  GV+  E L G+
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+++I P     +  +   ++  IK L   +H 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISP---FEHQTYCQRTLREIKILLRFRHE 85
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 137
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 92  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 138
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 196 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 250
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 251 YDFPEKFFPK 260

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVIEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 92  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 138
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 139 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 196 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 250
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 251 YDFPEKFFPK 260

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 61  DGFSHRRIIGQGRLGT-VYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   T V A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 90  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 136
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 194 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 248
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALAC 307
             F E   P+     E K LV  A   L C
Sbjct: 249 YDFPEKFFPKARDLVE-KLLVLDATKRLGC 277

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++   L  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVTEYMSKGCLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 90  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 136
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 194 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 248
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 249 YDFPEKFFPK 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 89  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 135
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 136 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 192
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 193 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 247
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALAC 307
             F E   P+     E K LV  A   L C
Sbjct: 248 YDFPEKFFPKARDLVE-KLLVLDATKRLGC 276

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 101
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   ++  ++   D Y      H +ND      +          
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ--------I 153
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A P+      L  YV  
Sbjct: 154 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 89  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 135
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 136 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 192
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 193 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 247
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALAC 307
             F E   P+     E K LV  A   L C
Sbjct: 248 YDFPEKFFPKARDLVE-KLLVLDATKRLGC 276

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 123/327 (37%), Gaps = 67/327 (20%)
Query: 40  ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAVKRI 93
           E LP     + +P        D     + +G+G  G V  A        +T + VAVK +
Sbjct: 15  ERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 67
Query: 94  HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFYLHE 152
                 S      + +   + +  H N+V +LG    PG   +++ EF    +L  YL  
Sbjct: 68  KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 153 NNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN 200
             +                L     +  +   A+G+E+L    +   IH  + A NILL+
Sbjct: 128 KRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS 184
Query: 201 EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN---------------ATRESD 245
           EK   ++CD+GL+       R +  Y D DY   KG                   T +SD
Sbjct: 185 EKNVVKICDFGLA-------RDI--YKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSD 234
Query: 246 VYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVRLAK 302
           V+ FGV+L EI S        L     P +K +  F   L    R+  P    P   + +
Sbjct: 235 VWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--EMYQ 284
Query: 303 VALACVGNSRKNRPSIVQVATILNNLV 329
             L C       RP+  ++   L NL+
Sbjct: 285 TMLDCWHGEPSQRPTFSELVEHLGNLL 311

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 124/330 (37%), Gaps = 67/330 (20%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P        D     + +G+G  G V  A        +T + VAV
Sbjct: 10  EHCERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 62
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   +++ EF    +L  Y
Sbjct: 63  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 150 LHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI 197
           L    +                L     +  +   A+G+E+L    +   IH  + A NI
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 179
Query: 198 LLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN---------------ATR 242
           LL+EK   ++CD+GL+       R +  Y D DY   KG                   T 
Sbjct: 180 LLSEKNVVKICDFGLA-------RDI--YKDPDY-VRKGDARLPLKWMAPETIFDRVYTI 229
Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVR 299
           +SDV+ FGV+L EI S        L     P +K +  F   L    R+  P    P   
Sbjct: 230 QSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--E 279
Query: 300 LAKVALACVGNSRKNRPSIVQVATILNNLV 329
           + +  L C       RP+  ++   L NL+
Sbjct: 280 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F+           F +   L F L    +G  LL + R++        R  T
Sbjct: 95  PFFVK-LYFT-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 141
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 142 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 198
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
           G A YV  +   EK   +A + SD++  G ++ ++++G
Sbjct: 199 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAG 233

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 85
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 137
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY- 231
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A +      G++ +   
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLXEXVA 193
Query: 232 --WHEK-----GGGNATRESDVYGFGVVLLEILSGR 260
             W+            T+  D++  G +L E+LS R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 86
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 138
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY- 231
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A +      G++ +   
Sbjct: 139 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLXEXVA 194
Query: 232 --WHEK-----GGGNATRESDVYGFGVVLLEILSGR 260
             W+            T+  D++  G +L E+LS R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 24/233 (10%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLA 116
           +  F  + ++G+G  G V +A    TG++VA+K+I P        F   ++  IK L   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---FDKPLFALRTLREIKILKHF 66
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +H NI+ I    +          +I    +   LH       L D + +  I     R +
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAV 125
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE----------EKRGLAGY 226
           + LH     N+IH  +K SN+L+N     +VCD+GL+ +  E          ++ G+  +
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 227 VDDDYWHEK----GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
           V   ++            +R  DV+  G +L E+   R    G   +  L LI
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 125/329 (37%), Gaps = 71/329 (21%)
Query: 40  ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAVKRI 93
           E LP     + +P        D     + +G+G  G V  A        +T + VAVK +
Sbjct: 50  ERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 102
Query: 94  HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFYLHE 152
                 S      + +   + +  H N+V +LG    PG   +++ EF    +L  YL  
Sbjct: 103 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 162
Query: 153 NNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN 200
             +                L     +  +   A+G+E+L    +   IH  + A NILL+
Sbjct: 163 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS 219
Query: 201 EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA-----------------TRE 243
           EK   ++CD+GL+       R +  Y D DY  +   G+A                 T +
Sbjct: 220 EKNVVKICDFGLA-------RDI--YKDPDYVRK---GDARLPLKWMAPETIFDRVYTIQ 267
Query: 244 SDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVRL 300
           SDV+ FGV+L EI S        L     P +K +  F   L    R+  P    P   +
Sbjct: 268 SDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--EM 317
Query: 301 AKVALACVGNSRKNRPSIVQVATILNNLV 329
            +  L C       RP+  ++   L NL+
Sbjct: 318 YQTMLDCWHGEPSQRPTFSELVEHLGNLL 346

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 249
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV+E+++  SL  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 250 SEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 302
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL  L            D++Y   +G           
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIE----------DNEYTARQGAKFPIKWTAPE 352
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 125/293 (42%), Gaps = 35/293 (11%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--AGFGF 106
           E + + +  +  R +GQG  G VY   A  +  G+    VAVK ++    L         
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLL 160
           ASV+K  +     ++V +LG        ++V E +    L  YL       ENN G    
Sbjct: 71  ASVMKGFTCH---HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAP 217
                +++A   A G+ YL+   A   +H  + A N ++   F  ++ D+G++   +   
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
Query: 218 EEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
             ++G  G +   +   +    G  T  SD++ FGVVL EI S   +  +GL  +  L  
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
           + +  +   LD     P  +  L+R+      C   + K RP+ +++  +L +
Sbjct: 245 VMDGGY---LDQPDNCPERVTDLMRM------CWQFNPKMRPTFLEIVNLLKD 288

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQ- 117
           D F   R++G+G  G V  A +  TG L AVK +   ++L +         K  LSLA+ 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           HP +  +    Q P     V EF+N   L F++ +    +   D  R    A      L 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALM 138
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL------SFLAPEEKRGLAGYVDDDY 231
           +LH      II+  +K  N+LL+ +   ++ D+G+      + +      G   Y+  + 
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
             E   G A    D +  GV+L E+L G
Sbjct: 196 LQEMLYGPAV---DWWAMGVLLYEMLCG 220

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 125/293 (42%), Gaps = 35/293 (11%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--AGFGF 106
           E + + +  +  R +GQG  G VY   A  +  G+    VAVK ++    L         
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLL 160
           ASV+K  +     ++V +LG        ++V E +    L  YL       ENN G    
Sbjct: 71  ASVMKGFTCH---HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAP 217
                +++A   A G+ YL+   A   +H  + A N ++   F  ++ D+G++   +   
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA 184
Query: 218 EEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
             ++G  G +   +   +    G  T  SD++ FGVVL EI S   +  +GL  +  L  
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
           + +  +   LD     P  +  L+R+      C   + K RP+ +++  +L +
Sbjct: 245 VMDGGY---LDQPDNCPERVTDLMRM------CWQFNPKMRPTFLEIVNLLKD 288

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 78/335 (23%), Positives = 124/335 (37%), Gaps = 77/335 (22%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P        D     + +G+G  G V  A        +T + VAV
Sbjct: 1   EHAERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 53
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   ++++EF    +L  Y
Sbjct: 54  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTY 113
Query: 150 LHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI 197
           L    +                L     +  +   A+G+E+L    +   IH  + A NI
Sbjct: 114 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 170
Query: 198 LLNEKFCARVCDYGLS--------------------FLAPEEKRGLAGYVDDDYWHEKGG 237
           LL+EK   ++CD+GL+                    ++APE         D  Y      
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPET------IFDRVY------ 218
Query: 238 GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEI 294
              T +SDV+ FGV+L EI S        L     P +K +  F   L    R+  P   
Sbjct: 219 ---TIQSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 267
Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
            P   + +  L C       RP+  ++   L NL+
Sbjct: 268 TP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------E 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL       E
Sbjct: 71  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 127
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 213 S---FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +   +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 245 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 292

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 77/323 (23%), Positives = 123/323 (38%), Gaps = 63/323 (19%)
Query: 40  ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAVKRI 93
           E LP     + +P   ++         + +G+G  G V  A        +T + VAVK +
Sbjct: 13  ERLPYDASKWEFPRDRLNLG-------KPLGRGAFGQVIEADAFGIDKTATXRTVAVKML 65
Query: 94  HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFYLHE 152
                 S      + +   + +  H N+V +LG    PG   +++ EF    +L  YL  
Sbjct: 66  KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 153 NNDG--------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC 204
             +            L     +  +   A+G+E+L    +   IH  + A NILL+EK  
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNV 182
Query: 205 ARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN---------------ATRESDVYGF 249
            ++ D+GL+       R +  Y D DY   KG                   T +SDV+ F
Sbjct: 183 VKIXDFGLA-------RDI--YKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 232
Query: 250 GVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVRLAKVALA 306
           GV+L EI S        L     P +K +  F   L    R+  P    P   + +  L 
Sbjct: 233 GVLLWEIFS--------LGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTP--EMYQTMLD 282
Query: 307 CVGNSRKNRPSIVQVATILNNLV 329
           C       RP+  ++   L NL+
Sbjct: 283 CWHGEPSQRPTFSELVEHLGNLL 305

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 77/330 (23%), Positives = 122/330 (36%), Gaps = 75/330 (22%)
Query: 40  ETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAVKRI 93
           E LP     + +P        D     + +G+G  G V  A        +T + VAVK +
Sbjct: 15  ERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML 67
Query: 94  HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFYLHE 152
                 S      + +   + +  H N+V +LG    PG   +++ EF    +L  YL  
Sbjct: 68  KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 153 NNDG----------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK 202
             +              L     +  +   A+G+E+L    +   IH  + A NILL+EK
Sbjct: 128 KRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEK 184
Query: 203 FCARVCDYGLS--------------------FLAPEEKRGLAGYVDDDYWHEKGGGNATR 242
              ++CD+GL+                    ++APE         D  Y         T 
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPET------IFDRVY---------TI 229
Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVR 299
           +SDV+ FGV+L EI S        L     P +K +  F   L    R+  P    P   
Sbjct: 230 QSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--E 279
Query: 300 LAKVALACVGNSRKNRPSIVQVATILNNLV 329
           + +  L C       RP+  ++   L NL+
Sbjct: 280 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 146
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 195
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 5   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 64
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------E 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL       E
Sbjct: 65  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 213 S---FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +   +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 179 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 238
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 239 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 286

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 39/213 (18%)
Query: 68  IIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++ 
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 124 ILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
           +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL   
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL--- 141
Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGNA 240
            +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G   
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAKL 191
Query: 241 ---------------TRESDVYGFGVVLLEILS 258
                          T +SDV+ FGV+L E+++
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 149
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 198
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 149
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 198
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 55/293 (18%)
Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGF----GFASVIKTLS-LAQHPN 120
           + +G G  G V  A     GK  AV ++  +++ S A         S +K +S L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           IV +LG     G  ++++E+     L  +L      + +L+ +    IA   A   + LH
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK---SRVLETDPAFAIANSTASTRDLLH 168
Query: 181 ------QGVA----PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
                 QG+A     N IH  + A N+LL     A++ D+GL+       R +   ++D 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDI---MNDS 218
Query: 231 YWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL-P 273
            +  KG                   T +SDV+ +G++L EI S G     G+LV      
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
           L+K+    ++  P  A P  I  +++      AC      +RP+  Q+ + L 
Sbjct: 279 LVKDGY--QMAQPAFA-PKNIYSIMQ------ACWALEPTHRPTFQQICSFLQ 322

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 53/290 (18%)
Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGF----GFASVIKTLS-LAQHPN 120
           + +G G  G V  A     GK  AV ++  +++ S A         S +K +S L QH N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH-------ENNDGASLLDWNRRLRIATGAA 173
           IV +LG     G  ++++E+     L  +L        +  DG  L +    L  ++  A
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL-ELRDLLHFSSQVA 162
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
           +G+ +L    + N IH  + A N+LL     A++ D+GL+             ++D  + 
Sbjct: 163 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDSNYI 209
Query: 234 EKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL-PLIK 276
            KG                   T +SDV+ +G++L EI S G     G+LV      L+K
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269
Query: 277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
           +    ++  P  A P  I  +++      AC      +RP+  Q+ + L 
Sbjct: 270 DGY--QMAQPAFA-PKNIYSIMQ------ACWALEPTHRPTFQQICSFLQ 310

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 35/293 (11%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--AGFGF 106
           E + + +  +  R +GQG  G VY   A  +  G+    VAVK ++    L         
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLL 160
           ASV+K  +     ++V +LG        ++V E +    L  YL       ENN G    
Sbjct: 71  ASVMKGFTCH---HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE- 219
                +++A   A G+ YL+   A   +H  + A N ++   F  ++ D+G++    E  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184
Query: 220 --KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
             ++G  G +   +   +    G  T  SD++ FGVVL EI S   +  +GL  +  L  
Sbjct: 185 XXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
           + +  +   LD     P  +  L+R+      C   + K RP+ +++  +L +
Sbjct: 245 VMDGGY---LDQPDNCPERVTDLMRM------CWQFNPKMRPTFLEIVNLLKD 288

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------E 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL       E
Sbjct: 64  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 213 S---FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +   +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 238 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 285

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 35/293 (11%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--AGFGF 106
           E + + +  +  R +GQG  G VY   A  +  G+    VAVK ++    L         
Sbjct: 8   EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 67
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLL 160
           ASV+K  +     ++V +LG        ++V E +    L  YL       ENN G    
Sbjct: 68  ASVMKGFTCH---HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE- 219
                +++A   A G+ YL+   A   +H  + A N ++   F  ++ D+G++    E  
Sbjct: 125 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 181
Query: 220 --KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
             ++G  G +   +   +    G  T  SD++ FGVVL EI S   +  +GL  +  L  
Sbjct: 182 XXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 241
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
           + +  +   LD     P  +  L+R+      C   + K RP+ +++  +L +
Sbjct: 242 VMDGGY---LDQPDNCPERVTDLMRM------CWQFNPKMRPTFLEIVNLLKD 285

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------E 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL       E
Sbjct: 64  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 213 S---FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +   +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 238 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 285

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 168
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 217
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 144
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 193
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 5   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 64
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------E 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL       E
Sbjct: 65  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 213 SFLAPEE---KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +    E    ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 179 TRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 238
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 239 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 286

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 35/208 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +GQG  G V+    +    VA+K + P  +   A    A V+K L   +H  +V +    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVV 82
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
           S+ P    IV E+++   L  +L    +    L   + + +A   A G+ Y+ +    N 
Sbjct: 83  SEEP--IYIVMEYMSKGCLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG---------- 237
           +H  ++A+NIL+ E    +V D+GL+ L            D++Y   +G           
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWTAPE 185
Query: 238 ----GNATRESDVYGFGVVLLEILSGRR 261
               G  T +SDV+ FG++L E+ +  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 147
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 196
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH---PNIVPI 124
           +G+G  G+VY A+   TG++VA+K++    V S+       +IK +S+ Q    P++V  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVP---VESD----LQEIIKEISIMQQCDSPHVVKY 89
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G      +  IV E+    S+   +   N     L  +    I     +GLEYLH    
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH---F 143
Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH-----EKGGGN 239
              IH  IKA NILLN +  A++ D+G++    +        +   +W      ++ G N
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 240 ATRESDVYGFGVVLLEILSGR 260
               +D++  G+  +E+  G+
Sbjct: 204 CV--ADIWSLGITAIEMAEGK 222

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 148
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 197
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 109/250 (43%), Gaps = 44/250 (17%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++      + +  +  +S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL--------RIAT 170
           P  V  L F            F +   L F L    +G  LL + R++        R  T
Sbjct: 97  PFFVK-LYFC-----------FQDDEKLYFGLSYAKNG-ELLKYIRKIGSFDETCTRFYT 143
Query: 171 GA-ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR------- 221
                 LEYLH      IIH  +K  NILLNE    ++ D+G +  L+PE K+       
Sbjct: 144 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 200
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG----RRCEEGLLVKWALPLIKE 277
           G A YV  +   EK   +A + SD++  G ++ ++++G    R   E L+ +  + L  E
Sbjct: 201 GTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 255
Query: 278 MRFSELLDPR 287
             F E   P+
Sbjct: 256 YDFPEKFFPK 265

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 51/289 (17%)
Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGF----GFASVIKTLS-LAQHPN 120
           + +G G  G V  A     GK  AV ++  +++ S A         S +K +S L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHE------NNDGASLLDWNRRLRIATGAAR 174
           IV +LG     G  ++++E+     L  +L        + +    L+    L  ++  A+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           G+ +L    + N IH  + A N+LL     A++ D+GL+             ++D  +  
Sbjct: 172 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDSNYIV 218
Query: 235 KGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL-PLIKE 277
           KG                   T +SDV+ +G++L EI S G     G+LV      L+K+
Sbjct: 219 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 278
Query: 278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
               ++  P  A P  I  +++      AC      +RP+  Q+ + L 
Sbjct: 279 G--YQMAQPAFA-PKNIYSIMQ------ACWALEPTHRPTFQQICSFLQ 318

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 167
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--HEKGGGN 239
             +   +H  + A N +L+EKF  +V D+GL+              D +Y+  H K G  
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLA----------RDMYDKEYYSVHNKTGAK 216
Query: 240 A---------------TRESDVYGFGVVLLEILS 258
                           T +SDV+ FGV+L E+++
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 35/281 (12%)
Query: 67  RIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--AGFGFASVIKTLSLAQH 118
           R +GQG  G VY   A  +  G+    VAVK ++    L         ASV+K  +    
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-- 79
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLLDWNRRLRIATGA 172
            ++V +LG        ++V E +    L  YL       ENN G         +++A   
Sbjct: 80  -HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAPEEKRGLAGYVDD 229
           A G+ YL+   A   +H  + A N ++   F  ++ D+G++   +     ++G  G +  
Sbjct: 139 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 230 DYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP 286
            +   +    G  T  SD++ FGVVL EI S   +  +GL  +  L  + +  +   LD 
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---LDQ 252
Query: 287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
               P  +  L+R+      C   + K RP+ +++  +L +
Sbjct: 253 PDNCPERVTDLMRM------CWQFNPKMRPTFLEIVNLLKD 287

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 75/320 (23%), Positives = 124/320 (38%), Gaps = 47/320 (14%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P        D     + +G+G  G V  A        +T + VAV
Sbjct: 10  EHCERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 62
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   +++ EF    +L  Y
Sbjct: 63  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 150 LHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI 197
           L    +                L     +  +   A+G+E+L    +   IH  + A NI
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 179
Query: 198 LLNEKFCARVCDYGLS---FLAPEEKRGLAGYVDDDYWHEKGGGNA--TRESDVYGFGVV 252
           LL+EK   ++CD+GL+   +  P+  R     +   +   +   +   T +SDV+ FGV+
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 253 LLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVRLAKVALACVG 309
           L EI S        L     P +K +  F   L    R+  P    P   + +  L C  
Sbjct: 240 LWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWH 289
Query: 310 NSRKNRPSIVQVATILNNLV 329
                RP+  ++   L NL+
Sbjct: 290 GEPSQRPTFSELVEHLGNLL 309

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 33  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 92
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------E 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL       E
Sbjct: 93  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 149
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 150 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 206
Query: 213 S---FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +   +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 207 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 266
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 267 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 314

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 123/289 (42%), Gaps = 35/289 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSN--AGFGF 106
           E + A +  +  R +GQG  G VY  +            VA+K ++    +         
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLL 160
           ASV+K  +     ++V +LG        +++ E +    L  YL       ENN   +  
Sbjct: 70  ASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAP 217
             ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G++   +   
Sbjct: 127 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 183
Query: 218 EEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
             ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL  +  L  
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 243
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
           + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 244 VME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 283

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 123/289 (42%), Gaps = 35/289 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSN--AGFGF 106
           E + A +  +  R +GQG  G VY  +            VA+K ++    +         
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLL 160
           ASV+K  +     ++V +LG        +++ E +    L  YL       ENN   +  
Sbjct: 66  ASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAP 217
             ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G++   +   
Sbjct: 123 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 179
Query: 218 EEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
             ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL  +  L  
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 239
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
           + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 240 VME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 279

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 35/289 (12%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSN--AGFGF 106
           E + A +  +  R +GQG  G VY  +            VA+K ++    +         
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLL 160
           ASV+K  +     ++V +LG        +++ E +    L  YL       ENN   +  
Sbjct: 64  ASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE- 219
             ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G++    E  
Sbjct: 121 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 177
Query: 220 --KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL 274
             ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL  +  L  
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 237
Query: 275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
           + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 238 VME---GGLLDKPDNCPDMLLELMRM------CWQYNPKMRPSFLEIIS 277

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILG 126
           +G+G  G V+ ++   TG++VAVK+I      S +A   F  ++    L+ H NIV +L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
             +A  +R +   F  M +    LH     A++L+   +  +     + ++YLH G    
Sbjct: 77  VLRADNDRDVYLVFDYMET---DLHAV-IRANILEPVHKQYVVYQLIKVIKYLHSG---G 129
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----------GLAGYVDD-----D 230
           ++H  +K SNILLN +   +V D+GLS      +R               + DD     D
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 231 Y----WHEK-----GGGNATRESDVYGFGVVLLEILSGR 260
           Y    W+       G    T+  D++  G +L EIL G+
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           +++   IG+G  G V +A  +  K+ VA+K+I P     +  +   ++  IK L   +H 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHE 81
Query: 120 NIVPILGFSQAPGERIIVSEFI--NMASLDFY-----LHENNDGASLLDWNRRLRIATGA 172
           NI+ I    +AP    +   +I  ++   D Y      H +ND      +          
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------I 133
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PEEKRG--LAGYVDD 229
            RGL+Y+H     N++H  +K SN+LLN     ++ D+GL+ +A P+      L  YV  
Sbjct: 134 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 230 DYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            ++            T+  D++  G +L E+LS R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 78/335 (23%), Positives = 123/335 (36%), Gaps = 77/335 (22%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P        D     + +G+G  G V  A        +T + VAV
Sbjct: 1   EHAERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 53
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   +++ EF    +L  Y
Sbjct: 54  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 113
Query: 150 LHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI 197
           L    +                L     +  +   A+G+E+L    +   IH  + A NI
Sbjct: 114 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 170
Query: 198 LLNEKFCARVCDYGLS--------------------FLAPEEKRGLAGYVDDDYWHEKGG 237
           LL+EK   ++CD+GL+                    ++APE         D  Y      
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPET------IFDRVY------ 218
Query: 238 GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEI 294
              T +SDV+ FGV+L EI S        L     P +K +  F   L    R+  P   
Sbjct: 219 ---TIQSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 267
Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
            P   + +  L C       RP+  ++   L NL+
Sbjct: 268 TP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 74/319 (23%), Positives = 124/319 (38%), Gaps = 46/319 (14%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P   ++         + +G+G  G V  A        +T + VAV
Sbjct: 11  EHCERLPYDASKWEFPRDRLNLG-------KPLGRGAFGQVIEADAFGIDKTATCRTVAV 63
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   +++ EF    +L  Y
Sbjct: 64  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 123
Query: 150 LHENNDG-----------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNIL 198
           L    +               L     +  +   A+G+E+L    +   IH  + A NIL
Sbjct: 124 LRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNIL 180
Query: 199 LNEKFCARVCDYGLS---FLAPEEKRGLAGYVDDDYWHEKGGGNA--TRESDVYGFGVVL 253
           L+EK   ++CD+GL+      P+  R     +   +   +   +   T +SDV+ FGV+L
Sbjct: 181 LSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 254 LEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVRLAKVALACVGN 310
            EI S        L     P +K +  F   L    R+  P    P   + +  L C   
Sbjct: 241 WEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHG 290
Query: 311 SRKNRPSIVQVATILNNLV 329
               RP+  ++   L NL+
Sbjct: 291 EPSQRPTFSELVEHLGNLL 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 24/233 (10%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLA 116
           +  F  + ++G+G  G V +A    TG++VA+K+I P        F   ++  IK L   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---FDKPLFALRTLREIKILKHF 66
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +H NI+ I    +          +I    +   LH       L D + +  I     R +
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAV 125
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE----------EKRGLAGY 226
           + LH     N+IH  +K SN+L+N     +VCD+GL+ +  E          ++ G+   
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 227 VDDDYWHEK----GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
           V   ++            +R  DV+  G +L E+   R    G   +  L LI
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 43/275 (15%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VAVK I    +  +  F  A  +  LS   HP +V   G  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS---HPKLVKFYGVC 72
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  IV+E+I+   L  YL  +  G   L+ ++ L +      G+ +L    +   I
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG---------- 238
           H  + A N L++   C +V D+G++            YV DD +    G           
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMT-----------RYVLDDQYVSSVGTKFPVKWSAPE 175
Query: 239 -----NATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE 293
                  + +SDV+ FG+++ E+ S  +    L    +  ++K  +   L  P LA    
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQGHRLYRPHLASDT- 233
Query: 294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                 + ++  +C     + RP+  Q+ + +  L
Sbjct: 234 ------IYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           RI+G+G  G VY  + +  K     VAVK       L N    F S    +    HP+IV
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-KFMSEAVIMKNLDHPHIV 72
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            ++G  +     II+ E      L  YL  N +   +L     +  +    + + YL   
Sbjct: 73  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLE-- 126
Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD-DDYWHEKGGGNAT 241
            + N +H  I   NIL+    C ++ D+GLS    +E    A        W      N  
Sbjct: 127 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 242 R---ESDVYGFGVVLLEILS 258
           R    SDV+ F V + EILS
Sbjct: 186 RFTTASDVWMFAVCMWEILS 205

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 8/205 (3%)
Query: 61  DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D F   R++G+G  G V+A  + +TGKL A K+++ + +    G+  A V K +    H 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 120 NIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
             +  L ++ +   +  +V   +N   + ++++  ++        R +        GLE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG-- 236
           LHQ    NII+  +K  N+LL++    R+ D GL+      +    GY     +      
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 237 -GGNATRESDVYGFGVVLLEILSGR 260
            G       D +  GV L E+++ R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--A 102
           Y   E + + +  +  R +GQG  G VY   A  +  G+    VAVK ++    L     
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 103 GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDG 156
               ASV+K  +     ++V +LG        ++V E +    L  YL       ENN G
Sbjct: 67  FLNEASVMKGFTCH---HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 157 ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--- 213
                    +++A   A G+ YL+   A   +H  + A N ++   F  ++ D+G++   
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 214 FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
           +     ++G  G +   +   +    G  T  SD++ FGVVL EI S   +  +GL  + 
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
            L  + +  +   LD     P  +  L+R+      C   +   RP+ +++  +L +
Sbjct: 241 VLKFVMDGGY---LDQPDNCPERVTDLMRM------CWQFNPNMRPTFLEIVNLLKD 288

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--A 102
           Y   E + + +  +  R +GQG  G VY   A  +  G+    VAVK ++    L     
Sbjct: 8   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 103 GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDG 156
               ASV+K  +     ++V +LG        ++V E +    L  YL       ENN G
Sbjct: 68  FLNEASVMKGFTCH---HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 124
Query: 157 ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--- 213
                    +++A   A G+ YL+   A   +H  + A N ++   F  ++ D+G++   
Sbjct: 125 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI 181
Query: 214 FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
           +     ++G  G +   +   +    G  T  SD++ FGVVL EI S   +  +GL  + 
Sbjct: 182 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 241
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
            L  + +  +   LD     P  +  L+R+      C   +   RP+ +++  +L +
Sbjct: 242 VLKFVMDGGY---LDQPDNCPERVTDLMRM------CWQFNPNMRPTFLEIVNLLKD 289

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 55/293 (18%)
Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGF----GFASVIKTLS-LAQHPN 120
           + +G G  G V  A     GK  AV ++  +++ S A         S +K +S L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENN-----DGA-----SLLDWNRRLRIAT 170
           IV +LG     G  ++++E+     L  +L   +     D A     S L     L  ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
             A+G+ +L    + N IH  + A N+LL     A++ D+GL+             ++D 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDS 218
Query: 231 YWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL-P 273
            +  KG                   T +SDV+ +G++L EI S G     G+LV      
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
           L+K+    ++  P  A P  I  +++      AC      +RP+  Q+ + L 
Sbjct: 279 LVKDGY--QMAQPAFA-PKNIYSIMQ------ACWALEPTHRPTFQQICSFLQ 322

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           RI+G+G  G VY  + +  K     VAVK       L N    F S    +    HP+IV
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-KFMSEAVIMKNLDHPHIV 88
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            ++G  +     II+ E      L  YL  N +   +L     +  +    + + YL   
Sbjct: 89  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLE-- 142
Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD-DDYWHEKGGGNAT 241
            + N +H  I   NIL+    C ++ D+GLS    +E    A        W      N  
Sbjct: 143 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 242 R---ESDVYGFGVVLLEILS 258
           R    SDV+ F V + EILS
Sbjct: 202 RFTTASDVWMFAVCMWEILS 221

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVY---AALLSTGKL---VAVKRIHPRLVLSN--A 102
           Y   E + + +  +  R +GQG  G VY   A  +  G+    VAVK ++    L     
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 103 GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDG 156
               ASV+K  +     ++V +LG        ++V E +    L  YL       ENN G
Sbjct: 67  FLNEASVMKGFTCH---HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 157 ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA 216
                    +++A   A G+ YL+   A   +H  + A N ++   F  ++ D+G++   
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 217 PEE---KRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            E    ++G  G +   +   +    G  T  SD++ FGVVL EI S   +  +GL  + 
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
            L  + +  +   LD     P  +  L+R+      C   +   RP+ +++  +L +
Sbjct: 241 VLKFVMDGGY---LDQPDNCPERVTDLMRM------CWQFNPNMRPTFLEIVNLLKD 288

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 8/205 (3%)
Query: 61  DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D F   R++G+G  G V+A  + +TGKL A K+++ + +    G+  A V K +    H 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 120 NIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
             +  L ++ +   +  +V   +N   + ++++  ++        R +        GLE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG-- 236
           LHQ    NII+  +K  N+LL++    R+ D GL+      +    GY     +      
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 237 -GGNATRESDVYGFGVVLLEILSGR 260
            G       D +  GV L E+++ R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +  +R++G+G  G V       TG+  AVK I  R V            ++ L    
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW--NRRLRIATGAAR- 174
           HPNI+ +  F +  G   +V E                G  L D   +R+      AAR 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYT-------------GGELFDEIISRKRFSEVDAARI 137
Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLNEKF---CARVCDYGLS--FLAP---EEK 220
                 G+ Y+H+     I+H  +K  N+LL  K      R+ D+GLS  F A    ++K
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            G A Y+  +  H    G    + DV+  GV+L  +LSG
Sbjct: 195 IGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSG 229

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           RI+G+G  G VY  + +  K     VAVK       L N    F S    +    HP+IV
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-KFMSEAVIMKNLDHPHIV 76
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            ++G  +     II+ E      L  YL  N +   +L     +  +    + + YL   
Sbjct: 77  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLE-- 130
Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD-DDYWHEKGGGNAT 241
            + N +H  I   NIL+    C ++ D+GLS    +E    A        W      N  
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 242 R---ESDVYGFGVVLLEILS 258
           R    SDV+ F V + EILS
Sbjct: 190 RFTTASDVWMFAVCMWEILS 209

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 35/293 (11%)
Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSN--A 102
           Y   E + A +  +  R +GQG  G VY  +            VA+K ++    +     
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 103 GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDG 156
               ASV+K  +     ++V +LG        +++ E +    L  YL       ENN  
Sbjct: 62  FLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 157 ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--- 213
            +    ++ +++A   A G+ YL+   A   +H  + A N  + E F  ++ D+G++   
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDI 175
Query: 214 FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
           +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL  + 
Sbjct: 176 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 235
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
            L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 236 VLRFVME---GGLLDKPDNCPDMLLELMRM------CWQYNPKMRPSFLEIIS 279

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +  +R++G+G  G V       TG+  AVK I  R V            ++ L    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW--NRRLRIATGAAR- 174
           HPNI+ +  F +  G   +V E                G  L D   +R+      AAR 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYT-------------GGELFDEIISRKRFSEVDAARI 131
Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLNEKF---CARVCDYGLS--FLAP---EEK 220
                 G+ Y+H+     I+H  +K  N+LL  K      R+ D+GLS  F A    ++K
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            G A Y+  +  H    G    + DV+  GV+L  +LSG
Sbjct: 189 IGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSG 223

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++L  
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 150
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+       F +   K G    V       
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++L  
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 150
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+       F +   K G    V       
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 8/205 (3%)
Query: 61  DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D F   R++G+G  G V+A  + +TGKL A K+++ + +    G+  A V K +    H 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 120 NIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
             +  L ++ +   +  +V   +N   + ++++  ++        R +        GLE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG-- 236
           LHQ    NII+  +K  N+LL++    R+ D GL+      +    GY     +      
Sbjct: 305 LHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 237 -GGNATRESDVYGFGVVLLEILSGR 260
            G       D +  GV L E+++ R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 8/205 (3%)
Query: 61  DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D F   R++G+G  G V+A  + +TGKL A K+++ + +    G+  A V K +    H 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 120 NIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
             +  L ++ +   +  +V   +N   + ++++  ++        R +        GLE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG-- 236
           LHQ    NII+  +K  N+LL++    R+ D GL+      +    GY     +      
Sbjct: 305 LHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 237 -GGNATRESDVYGFGVVLLEILSGR 260
            G       D +  GV L E+++ R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++L  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 149
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+       F +   K G    V       
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++L  
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 147
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+       F +   K G    V       
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++L  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 149
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+       F +   K G    V       
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++L  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 208
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+       F +   K G    V       
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++L  
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 154
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+       F +   K G    V       
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPILG 126
           +G G  G V       TG  VAVK ++ + + S    G     I+ L L +HP+I+ +  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
               P +  +V E+++   L  Y+ +N      LD     R+      G++Y H+ +   
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM--- 136
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWHEKGGGNAT 241
           ++H  +K  N+LL+    A++ D+GLS +  + +      G   Y   +     G   A 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVI--SGRLYAG 194
Query: 242 RESDVYGFGVVLLEILSG 259
            E D++  GV+L  +L G
Sbjct: 195 PEVDIWSSGVILYALLCG 212

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 18/214 (8%)
Query: 57  DAATDGFSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL 115
           D   D F   R IG+G  G V       T K+ A+K ++ +  +        +V K L +
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQI 68
Query: 116 AQ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
            Q   HP +V +    Q   +  +V + +    L ++L +N       +   +L I    
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICE-L 124
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYV 227
              L+YL       IIH  +K  NILL+E     + D+ ++ + P E +     G   Y+
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
             + +  + G   +   D +  GV   E+L GRR
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------ 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL        
Sbjct: 71  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 213 S---FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +   +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 245 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 292

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 67  RIIGQGRLGTVYAALL--STGKLV--AVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L  + GK +  AVK ++ R+        F +    +    HPN++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++YL  
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 148
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAGYVDDDYWHE 234
             +   +H  + A N +L+EKF  +V D+GL+         +   K G    V       
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 235 KGGGNATRESDVYGFGVVLLEILS 258
                 T +SDV+ FGV+L E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/320 (23%), Positives = 123/320 (38%), Gaps = 47/320 (14%)
Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAV 90
           E  E LP     + +P        D     + +G+G  G V  A        +T + VAV
Sbjct: 10  EHCERLPYDASKWEFP-------RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 62
Query: 91  KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERIIVSEFINMASLDFY 149
           K +      S      + +   + +  H N+V +LG    PG   +++ EF    +L  Y
Sbjct: 63  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 150 LHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI 197
           L    +                L     +  +   A+G+E+L    +   IH  + A NI
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 179
Query: 198 LLNEKFCARVCDYGLS---FLAPEEKRGLAGYVDDDYWHEKGGGNA--TRESDVYGFGVV 252
           LL+EK   ++CD+GL+      P+  R     +   +   +   +   T +SDV+ FGV+
Sbjct: 180 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 253 LLEILSGRRCEEGLLVKWALPLIK-EMRFSELLD--PRLAIPCEIKPLVRLAKVALACVG 309
           L EI S        L     P +K +  F   L    R+  P    P   + +  L C  
Sbjct: 240 LWEIFS--------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWH 289
Query: 310 NSRKNRPSIVQVATILNNLV 329
                RP+  ++   L NL+
Sbjct: 290 GEPSQRPTFSELVEHLGNLL 309

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---H 118
           FS  R IG G  G VY A  +   ++VA+K++      SN  +    +IK +   Q   H
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW--QDIIKEVRFLQKLRH 113
Query: 119 PNIVPILGFSQAPGERIIVSEF-INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           PN +   G         +V E+ +  AS    +H+       L       +  GA +GL 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLA 168
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG-LSFLAPEEKRGLAGYVDDDYWHEK- 235
           YLH   + N+IH  +KA NILL+E    ++ D+G  S +AP        +V   YW    
Sbjct: 169 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPE 220
Query: 236 -----GGGNATRESDVYGFGVVLLEI 256
                  G    + DV+  G+  +E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 35/297 (11%)
Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLS 100
            A  Y   E + A +  +  R +GQG  G VY  +            VA+K ++    + 
Sbjct: 1   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 60
Query: 101 N--AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------ 152
                   ASV+K  +     ++V +LG        +++ E +    L  YL        
Sbjct: 61  ERIEFLNEASVMKEFNCH---HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 117
Query: 153 NNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           NN   +    ++ +++A   A G+ YL+   A   +H  + A N ++ E F  ++ D+G+
Sbjct: 118 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 174
Query: 213 S---FLAPEEKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +   +     ++G  G +   +   +    G  T  SDV+ FGVVL EI +   +  +GL
Sbjct: 175 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 234
Query: 267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
             +  L  + E     LLD     P  +  L+R+      C   + K RPS +++ +
Sbjct: 235 SNEQVLRFVME---GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 282

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +  +R++G+G  G V       TG+  AVK I  R V            ++ L    
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW--NRRLRIATGAAR- 174
           HPNI+ +  F +  G   +V E                G  L D   +R+      AAR 
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYT-------------GGELFDEIISRKRFSEVDAARI 154
Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLNEKFCA---RVCDYGLS--FLAP---EEK 220
                 G+ Y+H+     I+H  +K  N+LL  K      R+ D+GLS  F A    ++K
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            G A Y+  +  H    G    + DV+  GV+L  +LSG
Sbjct: 212 IGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSG 246

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 107/267 (40%), Gaps = 39/267 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G+G  G V     + +G+++AVKRI   +           +  ++     P  V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               G+  I  E ++  SLD +  +  D    +  +   +IA    + LE+LH  ++  +
Sbjct: 75  LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG--------- 238
           IH  +K SN+L+N     ++CD+G+S           GY+ DD   +   G         
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGIS-----------GYLVDDVAKDIDAGCKPYMAPER 180
Query: 239 --------NATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI 290
                     + +SD++  G+ ++E+   R   +     W  P  +  +  E   P+L  
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS----WGTPFQQLKQVVEEPSPQL-- 234
Query: 291 PCEIKPLVRLAKVALACVGNSRKNRPS 317
           P + K           C+  + K RP+
Sbjct: 235 PAD-KFSAEFVDFTSQCLKKNSKERPT 260

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +  +R++G+G  G V       TG+  AVK I  R V            ++ L    
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW--NRRLRIATGAAR- 174
           HPNI+ +  F +  G   +V E                G  L D   +R+      AAR 
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYT-------------GGELFDEIISRKRFSEVDAARI 155
Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLNEKFCA---RVCDYGLS--FLAP---EEK 220
                 G+ Y+H+     I+H  +K  N+LL  K      R+ D+GLS  F A    ++K
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            G A Y+  +  H    G    + DV+  GV+L  +LSG
Sbjct: 213 IGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSG 247

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---H 118
           FS  R IG G  G VY A  +   ++VA+K++      SN  +    +IK +   Q   H
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW--QDIIKEVRFLQKLRH 74
Query: 119 PNIVPILGFSQAPGERIIVSEF-INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           PN +   G         +V E+ +  AS    +H+       L       +  GA +GL 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLA 129
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG-LSFLAPEEKRGLAGYVDDDYWHEK- 235
           YLH   + N+IH  +KA NILL+E    ++ D+G  S +AP        +V   YW    
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPE 181
Query: 236 -----GGGNATRESDVYGFGVVLLEI 256
                  G    + DV+  G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+GR G V+      G+ VAVK          A +   + I    L +H NI   LGF 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENI---LGFI 97
Query: 129 QAP-------GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            A         +  +++++    SL  YL      ++ LD    L++A  +  GL +LH 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 182 GV-----APNIIHGCIKASNILLNEKFCARVCDYGLSF----------LAPEEKRGLAGY 226
            +      P I H  +K+ NIL+ +     + D GL+           + P  + G   Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 227 VDDDYWHEKGGGNATRE---SDVYGFGVVLLEILSGRRCEEGLLV-KWALP 273
           +  +   E    N  +    +D+Y FG++L E+   RRC  G +V ++ LP
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLP 261

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 57/295 (19%)
Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGF----GFASVIKTLS-LAQHPN 120
           + +G G  G V  A     GK  AV ++  +++ S A         S +K +S L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 121 IVPILGFSQAPGERIIVSEF------INM------ASLDFYLHENNDGASLLDWNRRLRI 168
           IV +LG     G  ++++E+      +N         L++  + +++    L     L  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           ++  A+G+ +L    + N IH  + A N+LL     A++ D+GL+       R +   ++
Sbjct: 172 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDI---MN 218
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
           D  +  KG                   T +SDV+ +G++L EI S G     G+LV    
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 278
Query: 273 -PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN 326
             L+K+    ++  P  A P  I  +++      AC      +RP+  Q+ + L 
Sbjct: 279 YKLVKDGY--QMAQPAFA-PKNIYSIMQ------ACWALEPTHRPTFQQICSFLQ 324

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 10/202 (4%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLAQH 118
           D F   R +G+G+ G VY A     K +   ++  +  L   G        I+  S  +H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNI+ +  +        ++ EF     L   L ++       D  R        A  L Y
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHY 129
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG 237
            H+     +IH  IK  N+L+  K   ++ D+G S  AP   +R + G +D        G
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 238 GNATRESDVYGFGVVLLEILSG 259
                + D++  GV+  E L G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 10/202 (4%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG--FGFASVIKTLSLAQH 118
           D F   R +G+G+ G VY A     K +   ++  +  L   G        I+  S  +H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNI+ +  +        ++ EF     L   L ++       D  R        A  L Y
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHY 130
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-EKRGLAGYVDDDYWHEKGG 237
            H+     +IH  IK  N+L+  K   ++ D+G S  AP   +R + G +D        G
Sbjct: 131 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 238 GNATRESDVYGFGVVLLEILSG 259
                + D++  GV+  E L G
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVG 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 120/299 (40%), Gaps = 61/299 (20%)
Query: 69  IGQGRLGTVYAA----LL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +G+G  G V+ A    LL      LVAVK +  +    +A   F    + L++ QH +IV
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 83
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLL-----------DWNRRLRIATG 171
              G        ++V E++    L+ +L  +   A LL              + L +A+ 
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            A G+ YL      + +H  +   N L+ +    ++ D+G+S       R +  Y  D Y
Sbjct: 144 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS-------RDI--YSTDYY 191
Query: 232 WHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP 273
              + GG                   T ESDV+ FGVVL EI + G++    L    A+ 
Sbjct: 192 ---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 248
Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
            I + R  EL  PR A P E+  ++R       C     + R SI  V   L  L   P
Sbjct: 249 CITQGR--ELERPR-ACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAP 298

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 13/194 (6%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G+ G V+         VA+K I    +        A V+  LS   HP +V + G  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS---HPKLVQLYGVC 72
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  +V+EF+    L  YL        L      L +      G+ YL +     +I
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGGGNATR---ES 244
           H  + A N L+ E    +V D+G++ F+  ++     G      W      + +R   +S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 245 DVYGFGVVLLEILS 258
           DV+ FGV++ E+ S
Sbjct: 187 DVWSFGVLMWEVFS 200

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 120/299 (40%), Gaps = 61/299 (20%)
Query: 69  IGQGRLGTVYAA----LL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +G+G  G V+ A    LL      LVAVK +  +    +A   F    + L++ QH +IV
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 77
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLL-----------DWNRRLRIATG 171
              G        ++V E++    L+ +L  +   A LL              + L +A+ 
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            A G+ YL      + +H  +   N L+ +    ++ D+G+S       R +  Y  D Y
Sbjct: 138 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS-------RDI--YSTDYY 185
Query: 232 WHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP 273
              + GG                   T ESDV+ FGVVL EI + G++    L    A+ 
Sbjct: 186 ---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 242
Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
            I + R  EL  PR A P E+  ++R       C     + R SI  V   L  L   P
Sbjct: 243 CITQGR--ELERPR-ACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAP 292

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 116/296 (39%), Gaps = 59/296 (19%)
Query: 66  RRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           +R +G+G  G V+ A            LVAVK +  +    NA   F    + L+  QH 
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTNLQHE 75
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL---------LDWNRRLRIAT 170
           +IV   G        I+V E++    L+ +L  +   A L         L  ++ L IA 
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
             A G+ YL    + + +H  +   N L+ E    ++ D+G+S                D
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS----------RDVYSTD 182
Query: 231 YWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
           Y+  + GG+                  T ESDV+  GVVL EI + G++    L     +
Sbjct: 183 YY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240
Query: 273 PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             I + R   L  PR   P E+  L+      L C       R +I  + T+L NL
Sbjct: 241 ECITQGRV--LQRPR-TCPQEVYELM------LGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPI 124
           + +G+G  G V  A   +TG+ VA+K I+ +++  +   G     I  L L +HP+I+ +
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               ++  E I+V E+      D+ +  +      +      R        +EY H+   
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 122
Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GGGNAT 241
             I+H  +K  N+LL+E    ++ D+GLS +  +           +Y   +   G   A 
Sbjct: 123 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 242 RESDVYGFGVVLLEILSGR 260
            E DV+  GV+L  +L  R
Sbjct: 182 PEVDVWSCGVILYVMLCRR 200

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 120/299 (40%), Gaps = 61/299 (20%)
Query: 69  IGQGRLGTVYAA----LL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +G+G  G V+ A    LL      LVAVK +  +    +A   F    + L++ QH +IV
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 106
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLL-----------DWNRRLRIATG 171
              G        ++V E++    L+ +L  +   A LL              + L +A+ 
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            A G+ YL      + +H  +   N L+ +    ++ D+G+S       R +  Y  D Y
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS-------RDI--YSTDYY 214
Query: 232 WHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP 273
              + GG                   T ESDV+ FGVVL EI + G++    L    A+ 
Sbjct: 215 ---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271
Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
            I + R  EL  PR A P E+  ++R       C     + R SI  V   L  L   P
Sbjct: 272 CITQGR--ELERPR-ACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAP 321

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPI 124
           + +G+G  G V  A   +TG+ VA+K I+ +++  +   G     I  L L +HP+I+ +
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               ++  E I+V E+      D+ +  +      +      R        +EY H+   
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 126
Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GGGNAT 241
             I+H  +K  N+LL+E    ++ D+GLS +  +           +Y   +   G   A 
Sbjct: 127 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 242 RESDVYGFGVVLLEILSGR 260
            E DV+  GV+L  +L  R
Sbjct: 186 PEVDVWSCGVILYVMLCRR 204

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPI 124
           + +G+G  G V  A   +TG+ VA+K I+ +++  +   G     I  L L +HP+I+ +
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               ++  E I+V E+      D+ +  +      +      R        +EY H+   
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 132
Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS 213
             I+H  +K  N+LL+E    ++ D+GLS
Sbjct: 133 -KIVHRDLKPENLLLDEHLNVKIADFGLS 160

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPI 124
           + +G+G  G V  A   +TG+ VA+K I+ +++  +   G     I  L L +HP+I+ +
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               ++  E I+V E+      D+ +  +      +      R        +EY H+   
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRH-- 131
Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS 213
             I+H  +K  N+LL+E    ++ D+GLS
Sbjct: 132 -KIVHRDLKPENLLLDEHLNVKIADFGLS 159

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 64/302 (21%)
Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGF----GFASVIKTLS-LAQHPN 120
           + +G G  G V  A     GK  AV ++  +++ S A         S +K +S L QH N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENND---GASL----------------LD 161
           IV +LG     G  ++++E+     L  +L    +   G SL                L+
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
               L  ++  A+G+ +L    + N IH  + A N+LL     A++ D+GL+        
Sbjct: 157 LRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------- 205
Query: 222 GLAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEG 265
                ++D  +  KG                   T +SDV+ +G++L EI S G     G
Sbjct: 206 --RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 263
Query: 266 LLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI 324
           +LV      L+K+    ++  P  A P  I  +++      AC      +RP+  Q+ + 
Sbjct: 264 ILVNSKFYKLVKDGY--QMAQPAFA-PKNIYSIMQ------ACWALEPTHRPTFQQICSF 314
Query: 325 LN 326
           L 
Sbjct: 315 LQ 316

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 59
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++M   DF       G  L      L       +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL---FQLLQ 116
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 108/256 (42%), Gaps = 17/256 (6%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G+G  G V     + +G+++AVKRI   +           +  ++     P  V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               G+  I  E ++  SLD +  +  D    +  +   +IA    + LE+LH  ++  +
Sbjct: 119 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 188 IHGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAGYVDDDYWH-EKGGGNAT 241
           IH  +K SN+L+N     ++CD+G+S      +A     G   Y+  +  + E      +
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYS 235
Query: 242 RESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLA 301
            +SD++  G+ ++E+   R   +     W  P  +  +  E   P+L  P + K      
Sbjct: 236 VKSDIWSLGITMIELAILRFPYDS----WGTPFQQLKQVVEEPSPQL--PAD-KFSAEFV 288
Query: 302 KVALACVGNSRKNRPS 317
                C+  + K RP+
Sbjct: 289 DFTSQCLKKNSKERPT 304

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 60
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++M   DF       G  L      L       +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL---FQLLQ 117
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 20/259 (7%)
Query: 69  IGQGRLGTVYAALLSTGKL-VAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G + TVY A  +   + VA+K I  P          F   +   S   H NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
             +      +V E+I   +L  Y+    +    L  +  +        G+++ H      
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM---R 131
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYV--DDDYWH-EKGGGNATRE 243
           I+H  IK  NIL++     ++ D+G++    E       +V     Y+  E+  G AT E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 244 -SDVYGFGVVLLEILSGRRCEEG-LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLA 301
            +D+Y  G+VL E+L G     G   V  A+  I++   +   D R  IP        L+
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ------SLS 245
Query: 302 KVALACVGNSRKNRPSIVQ 320
            V L      + NR   +Q
Sbjct: 246 NVILRATEKDKANRYKTIQ 264

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 66  RRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVP 123
           R  +G+G  G V  A    T + VA+K I  +L+  S+        I  L L +HP+I+ 
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +      P + ++V E+      D+ + +        D  RR       A  +EY H+  
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE---DEGRRFFQQIICA--IEYCHRH- 127
Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-----EKRGLAGYVDDDYWHEKGGG 238
              I+H  +K  N+LL++    ++ D+GLS +  +        G   Y   +  +  G  
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN--GKL 183
Query: 239 NATRESDVYGFGVVLLEILSGR 260
            A  E DV+  G+VL  +L GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 33  KKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVK 91
           +K +ES++    + C +      I    + FS  RIIG+G  G VY    + TGK+ A+K
Sbjct: 163 QKFIESDKF--TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 92  RIHPRLVLSNAGFGFA----SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD 147
            +  + +    G   A     ++  +S    P IV +      P +   + + +N   L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
           ++L ++       + + R   A     GLE++H      +++  +K +NILL+E    R+
Sbjct: 281 YHLSQH---GVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 208 CDYGL----SFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            D GL    S   P    G  GY+  +   +    +++  +D +  G +L ++L G
Sbjct: 334 SDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 33  KKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVK 91
           +K +ES++    + C +      I    + FS  RIIG+G  G VY    + TGK+ A+K
Sbjct: 163 QKFIESDKF--TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 92  RIHPRLVLSNAGFGFA----SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD 147
            +  + +    G   A     ++  +S    P IV +      P +   + + +N   L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
           ++L ++       + + R   A     GLE++H      +++  +K +NILL+E    R+
Sbjct: 281 YHLSQH---GVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 208 CDYGL----SFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            D GL    S   P    G  GY+  +   +    +++  +D +  G +L ++L G
Sbjct: 334 SDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRG 387

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 13/194 (6%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G+ G V+         VA+K I    +        A V+  LS   HP +V + G  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS---HPKLVQLYGVC 71
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  +V EF+    L  YL        L      L +      G+ YL +    ++I
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---SVI 125
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGGGNATR---ES 244
           H  + A N L+ E    +V D+G++ F+  ++     G      W      + +R   +S
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 245 DVYGFGVVLLEILS 258
           DV+ FGV++ E+ S
Sbjct: 186 DVWSFGVLMWEVFS 199

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G+V   +   +G+++AVKRI   +           +   +  +  P IV   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               G+  I  E ++ +   FY +  +    ++      +I     + L +L + +   I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 188 IHGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAGYVDDDYWHEKGGGNATR 242
           IH  IK SNILL+     ++CD+G+S      +A     G   Y+      E+   +A+R
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA----PERIDPSASR 203
Query: 243 E-----SDVYGFGVVLLEILSGR 260
           +     SDV+  G+ L E+ +GR
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR 226

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 33  KKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVK 91
           +K +ES++    + C +      I    + FS  RIIG+G  G VY    + TGK+ A+K
Sbjct: 162 QKFIESDKF--TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 219
Query: 92  RIHPRLVLSNAGFGFA----SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD 147
            +  + +    G   A     ++  +S    P IV +      P +   + + +N   L 
Sbjct: 220 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 279
Query: 148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
           ++L ++       + + R   A     GLE++H      +++  +K +NILL+E    R+
Sbjct: 280 YHLSQH---GVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 332
Query: 208 CDYGL----SFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            D GL    S   P    G  GY+  +   +    +++  +D +  G +L ++L G
Sbjct: 333 SDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 33  KKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVK 91
           +K +ES++    + C +      I    + FS  RIIG+G  G VY    + TGK+ A+K
Sbjct: 163 QKFIESDKF--TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 92  RIHPRLVLSNAGFGFA----SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD 147
            +  + +    G   A     ++  +S    P IV +      P +   + + +N   L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
           ++L ++       + + R   A     GLE++H      +++  +K +NILL+E    R+
Sbjct: 281 YHLSQH---GVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 208 CDYGL----SFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            D GL    S   P    G  GY+  +   +    +++  +D +  G +L ++L G
Sbjct: 334 SDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRG 387

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +  +R++G+G  G V       TG+  AVK I  R V            ++ L    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW--NRRLRIATGAAR- 174
           HPNI  +  F +  G   +V E                G  L D   +R+      AAR 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYT-------------GGELFDEIISRKRFSEVDAARI 131
Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLNEKFCA---RVCDYGLS--FLAPE---EK 220
                 G+ Y H+     I+H  +K  N+LL  K      R+ D+GLS  F A +   +K
Sbjct: 132 IRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK 188
Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            G A Y+  +  H    G    + DV+  GV+L  +LSG
Sbjct: 189 IGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSG 223

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 13/194 (6%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G+ G V+         VA+K I    +        A V+  LS   HP +V + G  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS---HPKLVQLYGVC 71
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  +V EF+    L  YL        L      L +      G+ YL +     +I
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGGGNATR---ES 244
           H  + A N L+ E    +V D+G++ F+  ++     G      W      + +R   +S
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 245 DVYGFGVVLLEILS 258
           DV+ FGV++ E+ S
Sbjct: 186 DVWSFGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 13/194 (6%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G+ G V+         VA+K I    +        A V+  LS   HP +V + G  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS---HPKLVQLYGVC 69
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  +V EF+    L  YL        L      L +      G+ YL +     +I
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGGGNATR---ES 244
           H  + A N L+ E    +V D+G++ F+  ++     G      W      + +R   +S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 245 DVYGFGVVLLEILS 258
           DV+ FGV++ E+ S
Sbjct: 184 DVWSFGVLMWEVFS 197

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 13/194 (6%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G+ G V+         VA+K I    +  +     A V+  LS   HP +V + G  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLS---HPKLVQLYGVC 91
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  +V EF+    L  YL        L      L +      G+ YL +     +I
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGGGNATR---ES 244
           H  + A N L+ E    +V D+G++ F+  ++     G      W      + +R   +S
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 245 DVYGFGVVLLEILS 258
           DV+ FGV++ E+ S
Sbjct: 206 DVWSFGVLMWEVFS 219

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+GR G V+      G+ VAVK    R     + F  A + +T+ L +H NI   LGF 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENI---LGFI 63
Query: 129 QAPG-------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            A         +  +VS++    SL  YL+        +     +++A   A GL +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 118
Query: 182 GVA-----PNIIHGCIKASNILLNEKFCARVCDYGLSF----------LAPEE----KRG 222
            +      P I H  +K+ NIL+ +     + D GL+           +AP      KR 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG 265
           +A  V DD  + K   +  R +D+Y  G+V  EI   RRC  G
Sbjct: 179 MAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI--ARRCSIG 218

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 13/194 (6%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG G+ G V+         VA+K I    +        A V+  LS   HP +V + G  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS---HPKLVQLYGVC 74
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  +V EF+    L  YL        L      L +      G+ YL +     +I
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKGGGNATR---ES 244
           H  + A N L+ E    +V D+G++ F+  ++     G      W      + +R   +S
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 245 DVYGFGVVLLEILS 258
           DV+ FGV++ E+ S
Sbjct: 189 DVWSFGVLMWEVFS 202

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+GR G V+      G+ VAVK    R     + F  A + +T+ L +H NI   LGF 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENI---LGFI 64
Query: 129 QAPG-------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            A         +  +VS++    SL  YL+        +     +++A   A GL +LH 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 119
Query: 182 GVA-----PNIIHGCIKASNILLNEKFCARVCDYGLSF----------LAPEE----KRG 222
            +      P I H  +K+ NIL+ +     + D GL+           +AP      KR 
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG 265
           +A  V DD  + K   +  R +D+Y  G+V  EI   RRC  G
Sbjct: 180 MAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI--ARRCSIG 219

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+GR G V+      G+ VAVK    R     + F  A + +T+ L +H NI   LGF 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENI---LGFI 89
Query: 129 QAPG-------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            A         +  +VS++    SL  YL+        +     +++A   A GL +LH 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 144
Query: 182 GVA-----PNIIHGCIKASNILLNEKFCARVCDYGLSF----------LAPEE----KRG 222
            +      P I H  +K+ NIL+ +     + D GL+           +AP      KR 
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG 265
           +A  V DD  + K   +  R +D+Y  G+V  EI   RRC  G
Sbjct: 205 MAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI--ARRCSIG 244

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+GR G V+      G+ VAVK    R     + F  A + +T+ L +H NI   LGF 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENI---LGFI 102
Query: 129 QAPG-------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            A         +  +VS++    SL  YL+        +     +++A   A GL +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 157
Query: 182 GVA-----PNIIHGCIKASNILLNEKFCARVCDYGLSF----------LAPEE----KRG 222
            +      P I H  +K+ NIL+ +     + D GL+           +AP      KR 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG 265
           +A  V DD  + K   +  R +D+Y  G+V  EI   RRC  G
Sbjct: 218 MAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI--ARRCSIG 257

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+GR G V+      G+ VAVK    R     + F  A + +T+ L +H NI   LGF 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENI---LGFI 66
Query: 129 QAPG-------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            A         +  +VS++    SL  YL+        +     +++A   A GL +LH 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 121
Query: 182 GVA-----PNIIHGCIKASNILLNEKFCARVCDYGLSF----------LAPEE----KRG 222
            +      P I H  +K+ NIL+ +     + D GL+           +AP      KR 
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG 265
           +A  V DD  + K   +  R +D+Y  G+V  EI   RRC  G
Sbjct: 182 MAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI--ARRCSIG 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           IG+GR G V+      G+ VAVK    R     + F  A + +T+ L +H NI   LGF 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENI---LGFI 69
Query: 129 QAPG-------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            A         +  +VS++    SL  YL+        +     +++A   A GL +LH 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 124
Query: 182 GVA-----PNIIHGCIKASNILLNEKFCARVCDYGLSF----------LAPEE----KRG 222
            +      P I H  +K+ NIL+ +     + D GL+           +AP      KR 
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG 265
           +A  V DD  + K   +  R +D+Y  G+V  EI   RRC  G
Sbjct: 185 MAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI--ARRCSIG 224

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 104/240 (43%), Gaps = 33/240 (13%)
Query: 100 SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL 159
           S + F  AS++  LS   H ++V   G      E I+V EF+   SLD YL +N +  ++
Sbjct: 56  SESFFEAASMMSKLS---HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI 112
Query: 160 LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---------NEKFCARVCDY 210
           L W  +L +A   A  + +L +     +IHG + A NILL         N  F  ++ D 
Sbjct: 113 L-W--KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI-KLSDP 165
Query: 211 GLSF--LAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV 268
           G+S   L  +  +    +V  +    +   N    +D + FG  L EI SG     G   
Sbjct: 166 GISITVLPKDILQERIPWVPPECI--ENPKNLNLATDKWSFGTTLWEICSG-----GDKP 218
Query: 269 KWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             AL   ++++F E    R  +P        LA +   C+     +RPS   +   LN+L
Sbjct: 219 LSALDSQRKLQFYE---DRHQLPA--PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
           F+  R++G+G  G+V  A L         VAVK +   ++ S+    F      +    H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 119 PNIVPILGFS---QAPGER---IIVSEFINMASLDFYLHENNDGASL--LDWNRRLRIAT 170
           P++  ++G S   +A G     +++  F+    L  +L  +  G +   L     +R   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAPEEKRGLAGYV 227
             A G+EYL    + N IH  + A N +L E     V D+GLS   +     ++G A  +
Sbjct: 145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 228 DDDYWHEKGGGNA--TRESDVYGFGVVLLEILS 258
              +   +   +   T  SDV+ FGV + EI++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 101/249 (40%), Gaps = 49/249 (19%)
Query: 63  FSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPN 120
           F + +++G+G  G V      +TG+  A+K +   ++++        +  + L  ++HP 
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 212
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +  +    Q       V E+ N   L F+L        +   +R           L+YLH
Sbjct: 213 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH 268
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRG 222
                N+++  +K  N++L++    ++ D+GL                   +LAPE    
Sbjct: 269 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE---- 322
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCEEGLLVKWALPLIKE 277
                D+DY          R  D +G GVV+ E++ GR     +  E L     L L++E
Sbjct: 323 --VLEDNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELILMEE 368
Query: 278 MRFSELLDP 286
           +RF   L P
Sbjct: 369 IRFPRTLGP 377

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 101/249 (40%), Gaps = 49/249 (19%)
Query: 63  FSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPN 120
           F + +++G+G  G V      +TG+  A+K +   ++++        +  + L  ++HP 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +  +    Q       V E+ N   L F+L        +   +R           L+YLH
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH 265
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRG 222
                N+++  +K  N++L++    ++ D+GL                   +LAPE    
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE---- 319
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCEEGLLVKWALPLIKE 277
                D+DY          R  D +G GVV+ E++ GR     +  E L     L L++E
Sbjct: 320 --VLEDNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELILMEE 365
Query: 278 MRFSELLDP 286
           +RF   L P
Sbjct: 366 IRFPRTLGP 374

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 102/249 (40%), Gaps = 49/249 (19%)
Query: 63  FSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPN 120
           F + +++G+G  G V      +TG+  A+K +   ++++        +  + L  ++HP 
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 70
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +  +    Q       V E+ N   L F+L        +   +R           L+YLH
Sbjct: 71  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH 126
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRG 222
                N+++  +K  N++L++    ++ D+GL                   +LAPE    
Sbjct: 127 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE- 183
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCEEGLLVKWALPLIKE 277
                D+DY          R  D +G GVV+ E++ GR     +  E L   + L L++E
Sbjct: 184 -----DNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEE 226
Query: 278 MRFSELLDP 286
           +RF   L P
Sbjct: 227 IRFPRTLGP 235

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 102/249 (40%), Gaps = 49/249 (19%)
Query: 63  FSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPN 120
           F + +++G+G  G V      +TG+  A+K +   ++++        +  + L  ++HP 
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +  +    Q       V E+ N   L F+L        +   +R           L+YLH
Sbjct: 72  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH 127
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRG 222
                N+++  +K  N++L++    ++ D+GL                   +LAPE    
Sbjct: 128 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE- 184
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCEEGLLVKWALPLIKE 277
                D+DY          R  D +G GVV+ E++ GR     +  E L   + L L++E
Sbjct: 185 -----DNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEE 227
Query: 278 MRFSELLDP 286
           +RF   L P
Sbjct: 228 IRFPRTLGP 236

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 29/217 (13%)
Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D F   R+ GQG  GTV      STG  VA+K++       N       +++ L++  HP
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---QIMQDLAVLHHP 79
Query: 120 NIVPILGFSQAPGERIIVSEFIN--MASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           NIV +  +    GER     ++N  M  +   LH         ++ RR ++A        
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR-----CCRNYYRR-QVAPPPILIKV 133
Query: 178 YLHQGV---------APNIIHGCIKASNILLNE-KFCARVCDYGLS-FLAPEEKRGLAGY 226
           +L Q +         + N+ H  IK  N+L+NE     ++CD+G +  L+P E      Y
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--VAY 191
Query: 227 VDDDYWHEK----GGGNATRESDVYGFGVVLLEILSG 259
           +   Y+       G  + T   D++  G +  E++ G
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 102/249 (40%), Gaps = 49/249 (19%)
Query: 63  FSHRRIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPN 120
           F + +++G+G  G V      +TG+  A+K +   ++++        +  + L  ++HP 
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +  +    Q       V E+ N   L F+L        +   +R           L+YLH
Sbjct: 70  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH 125
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKRG 222
                N+++  +K  N++L++    ++ D+GL                   +LAPE    
Sbjct: 126 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE- 182
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-----RCEEGLLVKWALPLIKE 277
                D+DY          R  D +G GVV+ E++ GR     +  E L   + L L++E
Sbjct: 183 -----DNDY---------GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEE 225
Query: 278 MRFSELLDP 286
           +RF   L P
Sbjct: 226 IRFPRTLGP 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 104/240 (43%), Gaps = 33/240 (13%)
Query: 100 SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL 159
           S + F  AS++  LS   H ++V   G      E I+V EF+   SLD YL +N +  ++
Sbjct: 56  SESFFEAASMMSKLS---HKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINI 112
Query: 160 LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---------NEKFCARVCDY 210
           L W  +L +A   A  + +L +     +IHG + A NILL         N  F  ++ D 
Sbjct: 113 L-W--KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI-KLSDP 165
Query: 211 GLSF--LAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV 268
           G+S   L  +  +    +V  +    +   N    +D + FG  L EI SG     G   
Sbjct: 166 GISITVLPKDILQERIPWVPPECI--ENPKNLNLATDKWSFGTTLWEICSG-----GDKP 218
Query: 269 KWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             AL   ++++F E    R  +P        LA +   C+     +RPS   +   LN+L
Sbjct: 219 LSALDSQRKLQFYE---DRHQLPA--PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 46/314 (14%)
Query: 38  SEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRL 97
           S  + P K    +  L E D   +      +IG+GR G VY         VA++ I    
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIER 67
Query: 98  VLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGA 157
              +    F   +      +H N+V  +G   +P    I++      +L   +    D  
Sbjct: 68  DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDAK 124
Query: 158 SLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG------ 211
            +LD N+  +IA    +G+ YLH   A  I+H  +K+ N+  +      + D+G      
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKVV-ITDFGLFSISG 180
Query: 212 -----------------LSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLL 254
                            L  LAPE  R L+   ++D          ++ SDV+  G +  
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED------KLPFSKHSDVFALGTIWY 234
Query: 255 EILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKN 314
           E L  R  E     + A  +I +M     + P L+   +I     ++ + L C    ++ 
Sbjct: 235 E-LHAR--EWPFKTQPAEAIIWQM--GTGMKPNLS---QIGMGKEISDILLFCWAFEQEE 286
Query: 315 RPSIVQVATILNNL 328
           RP+  ++  +L  L
Sbjct: 287 RPTFTKLMDMLEKL 300

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ DYGL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 90/241 (37%), Gaps = 56/241 (23%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           D      +IG+GR G VY   L   + VAVK        +   F     I  + L +H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFS---FANRQNFINEKNIYRVPLMEHDN 68
Query: 121 IVP-ILGFSQAPG----ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
           I   I+G  +       E ++V E+    SL  YL  +       DW    R+A    RG
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRG 123
Query: 176 LEYLHQGV------APNIIHGCIKASNILLNEKFCARVCDYGLS---------------- 213
           L YLH  +       P I H  + + N+L+       + D+GLS                
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 214 ----------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE 263
                     ++APE   G     D +        +A ++ D+Y  G++  EI    RC 
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXE--------SALKQVDMYALGLIYWEIFM--RCT 233
Query: 264 E 264
           +
Sbjct: 234 D 234

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 63  FSHRRIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHP 119
           ++  + IG+G  G V +A     K  VA+K+I P     +  +   ++  I+ L   +H 
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISP---FEHQTYCQRTLREIQILLRFRHE 101
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           N++ I    +A     +   +I    ++  L++      L + +          RGL+Y+
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSN-DHICYFLYQILRGLKYI 160
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-PE-EKRGLAGYVDDDYWHEK-- 235
           H     N++H  +K SN+L+N     ++CD+GL+ +A PE +  G         W+    
Sbjct: 161 HSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 236 ---GGGNATRESDVYGFGVVLLEILSGR 260
                   T+  D++  G +L E+LS R
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 44  IKLCAFAYPLTEIDAATD--GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN 101
           IK  A  + + E     D   F   +++GQG  G V+     +G     ++++   VL  
Sbjct: 6   IKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGS--DARQLYAMKVLKK 63
Query: 102 AGFGFASVIKT------LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND 155
           A       ++T      L    HP IV +    Q  G+  ++ +F+    L   L +   
Sbjct: 64  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-- 121
Query: 156 GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL 215
                + + +  +A   A  L++LH   +  II+  +K  NILL+E+   ++ D+GLS  
Sbjct: 122 -VMFTEEDVKFYLAE-LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 176
Query: 216 APEEKR------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK 269
           + + ++      G   Y+  +  + +G    T+ +D + FGV++ E+L+G    +G   K
Sbjct: 177 SIDHEKKAYSFCGTVEYMAPEVVNRRG---HTQSADWWSFGVLMFEMLTGTLPFQGKDRK 233
Query: 270 WALPLIKEMRFSELLDPRLAIPCEIKP 296
             + +I        L  +L +P  + P
Sbjct: 234 ETMTMI--------LKAKLGMPQFLSP 252

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +    I+G G +  V+ A  L   + VAVK +   L    + +  F    +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 118 HPNIVPI--LGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           HP IV +   G ++ P   +  IV E+++  +L   +H        +   R + +   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 126
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLA 224
           + L + HQ     IIH  +K +NIL++     +V D+G++    +            G A
Sbjct: 127 QALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            Y+  +   +  G +    SDVY  G VL E+L+G
Sbjct: 184 QYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 57
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++    DF       G  L      L       +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYL---FQLLQ 114
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 115 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 150

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 44  IKLCAFAYPLTEIDAATD--GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN 101
           IK  A  + + E     D   F   +++GQG  G V+     +G     ++++   VL  
Sbjct: 5   IKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGS--DARQLYAMKVLKK 62
Query: 102 AGFGFASVIKT------LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND 155
           A       ++T      L    HP IV +    Q  G+  ++ +F+    L   L +   
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-- 120
Query: 156 GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL 215
                + + +  +A   A  L++LH   +  II+  +K  NILL+E+   ++ D+GLS  
Sbjct: 121 -VMFTEEDVKFYLAE-LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175
Query: 216 APEEKR------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK 269
           + + ++      G   Y+  +  + +G    T+ +D + FGV++ E+L+G    +G   K
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRG---HTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232
Query: 270 WALPLIKEMRFSELLDPRLAIPCEIKP 296
             + +I        L  +L +P  + P
Sbjct: 233 ETMTMI--------LKAKLGMPQFLSP 251

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 120/309 (38%), Gaps = 65/309 (21%)
Query: 63  FSHRRIIGQGRLG-----TVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLS-L 115
            S  + +G G  G     T Y  + S   + VAVK + P   L+       S +K LS L
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLSYL 106
Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG--------------ASLLD 161
             H NIV +LG     G  ++++E+     L  +L    D                  LD
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
               L  +   A+G+ +L    + N IH  + A NILL      ++CD+GL+     + +
Sbjct: 167 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RDIK 219
Query: 222 GLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCE 263
             + YV          GNA                 T ESDV+ +G+ L E+ S G    
Sbjct: 220 NDSNYVVK--------GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271
Query: 264 EGLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA 322
            G+ V      +IKE     +L P  A P E+  +++       C       RP+  Q+ 
Sbjct: 272 PGMPVDSKFYKMIKEG--FRMLSPEHA-PAEMYDIMK------TCWDADPLKRPTFKQIV 322
Query: 323 TILNNLVGD 331
            ++   + +
Sbjct: 323 QLIEKQISE 331

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 120/309 (38%), Gaps = 65/309 (21%)
Query: 63  FSHRRIIGQGRLG-----TVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLS-L 115
            S  + +G G  G     T Y  + S   + VAVK + P   L+       S +K LS L
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLSYL 83
Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG--------------ASLLD 161
             H NIV +LG     G  ++++E+     L  +L    D                  LD
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
               L  +   A+G+ +L    + N IH  + A NILL      ++CD+GL+     + +
Sbjct: 144 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RDIK 196
Query: 222 GLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCE 263
             + YV          GNA                 T ESDV+ +G+ L E+ S G    
Sbjct: 197 NDSNYVVK--------GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 264 EGLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA 322
            G+ V      +IKE     +L P  A P E+  +++       C       RP+  Q+ 
Sbjct: 249 PGMPVDSKFYKMIKEG--FRMLSPEHA-PAEMYDIMK------TCWDADPLKRPTFKQIV 299
Query: 323 TILNNLVGD 331
            ++   + +
Sbjct: 300 QLIEKQISE 308

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 120/309 (38%), Gaps = 65/309 (21%)
Query: 63  FSHRRIIGQGRLG-----TVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLS-L 115
            S  + +G G  G     T Y  + S   + VAVK + P   L+       S +K LS L
Sbjct: 41  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLSYL 99
Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG--------------ASLLD 161
             H NIV +LG     G  ++++E+     L  +L    D                  LD
Sbjct: 100 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 159
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
               L  +   A+G+ +L    + N IH  + A NILL      ++CD+GL+     + +
Sbjct: 160 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RDIK 212
Query: 222 GLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCE 263
             + YV          GNA                 T ESDV+ +G+ L E+ S G    
Sbjct: 213 NDSNYVVK--------GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 264
Query: 264 EGLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA 322
            G+ V      +IKE     +L P  A P E+  +++       C       RP+  Q+ 
Sbjct: 265 PGMPVDSKFYKMIKEG--FRMLSPEHA-PAEMYDIMK------TCWDADPLKRPTFKQIV 315
Query: 323 TILNNLVGD 331
            ++   + +
Sbjct: 316 QLIEKQISE 324

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           IG G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 94  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEI 198
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 126/288 (43%), Gaps = 50/288 (17%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA----QHPNI 121
           +++G G  GTV+  + +  G+ + +  +  +++   +G      +    LA     H +I
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIP-VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 122 VPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGAS---LLDWNRRLRIATGAARGLE 177
           V +LG    PG  + +V++++ + SL  ++ ++        LL+W  ++      A+G+ 
Sbjct: 96  VRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMY 147
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDY-WHEK 235
           YL +     ++H  + A N+LL      +V D+G++  L P++K+ L         W   
Sbjct: 148 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 236 GG---GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD-----P 286
                G  T +SDV+ +GV + E+++ G     GL            R +E+ D      
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL------------RLAEVPDLLEKGE 252
Query: 287 RLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           RLA P  C I     +  V + C       RP+  ++A     +  DP
Sbjct: 253 RLAQPQICTID----VYMVMVKCWMIDENIRPTFKELANEFTRMARDP 296

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 126/288 (43%), Gaps = 50/288 (17%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA----QHPNI 121
           +++G G  GTV+  + +  G+ + +  +  +++   +G      +    LA     H +I
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIP-VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 122 VPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGAS---LLDWNRRLRIATGAARGLE 177
           V +LG    PG  + +V++++ + SL  ++ ++        LL+W  ++      A+G+ 
Sbjct: 78  VRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMY 129
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDY-WHEK 235
           YL +     ++H  + A N+LL      +V D+G++  L P++K+ L         W   
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 236 GG---GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD-----P 286
                G  T +SDV+ +GV + E+++ G     GL            R +E+ D      
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL------------RLAEVPDLLEKGE 234
Query: 287 RLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           RLA P  C I     +  V + C       RP+  ++A     +  DP
Sbjct: 235 RLAQPQICTID----VYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 120/309 (38%), Gaps = 65/309 (21%)
Query: 63  FSHRRIIGQGRLG-----TVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLS-L 115
            S  + +G G  G     T Y  + S   + VAVK + P   L+       S +K LS L
Sbjct: 43  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLSYL 101
Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG--------------ASLLD 161
             H NIV +LG     G  ++++E+     L  +L    D                  LD
Sbjct: 102 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 161
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
               L  +   A+G+ +L    + N IH  + A NILL      ++CD+GL+     + +
Sbjct: 162 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RDIK 214
Query: 222 GLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCE 263
             + YV          GNA                 T ESDV+ +G+ L E+ S G    
Sbjct: 215 NDSNYVVK--------GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 266
Query: 264 EGLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA 322
            G+ V      +IKE     +L P  A P E+  +++       C       RP+  Q+ 
Sbjct: 267 PGMPVDSKFYKMIKEG--FRMLSPEHA-PAEMYDIMK------TCWDADPLKRPTFKQIV 317
Query: 323 TILNNLVGD 331
            ++   + +
Sbjct: 318 QLIEKQISE 326

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   +AG+V   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 85  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLK 135
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 189
Query: 236 --GGGNATRESDVYGFGVVLLEILSGRRCEEG 265
                +  +  D++  G ++ E+L+GR    G
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 44  IKLCAFAYPLTEIDAATD--GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN 101
           IK  A  + + E     D   F   +++GQG  G V+     +G     ++++   VL  
Sbjct: 5   IKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGS--DARQLYAMKVLKK 62
Query: 102 AGFGFASVIKT------LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENND 155
           A       ++T      L    HP IV +    Q  G+  ++ +F+    L   L +   
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-- 120
Query: 156 GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL 215
                + + +  +A   A  L++LH   +  II+  +K  NILL+E+   ++ D+GLS  
Sbjct: 121 -VMFTEEDVKFYLAE-LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175
Query: 216 APEEKR------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK 269
           + + ++      G   Y+  +  + +G    T+ +D + FGV++ E+L+G    +G   K
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRG---HTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232
Query: 270 WALPLIKEMRFSELLDPRLAIPCEIKP 296
             + +I        L  +L +P  + P
Sbjct: 233 ETMTMI--------LKAKLGMPQFLSP 251

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 60
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++M    F       G  L      L       +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL---FQLLQ 117
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 153

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 98
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 99  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 149
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 150 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 203
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 58
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++M    F       G  L      L       +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL---FQLLQ 115
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKTLSLAQ 117
           D F     +G G  G V+  +   +G ++A K IH  +   + N        ++ L    
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQVLHECN 65
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
            P IV   G   + GE  I  E ++  SLD  L +    A  +      +++    +GL 
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLT 121
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDDYWH 233
           YL +     I+H  +K SNIL+N +   ++CD+G+S    +E      G   Y+  +   
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQ 179
Query: 234 EKGGGNATRESDVYGFGVVLLEILSGR 260
              G + + +SD++  G+ L+E+  GR
Sbjct: 180 ---GTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   +AG+V   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRI---HPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
            +G+G+  TVY A   +T ++VA+K+I   H               IK L    HPNI+ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII- 75
Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
             G   A G +  +S   +    D  +   ++   L   + +  +     +GLEYLHQ  
Sbjct: 76  --GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLEYLHQHW 132
Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGL--SFLAP 217
              I+H  +K +N+LL+E    ++ D+GL  SF +P
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 32/225 (14%)
Query: 67  RIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKT------LSLA 116
           +++GQG  G V+     T    G L A+K      VL  A       ++T      L+  
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMK------VLKKATLKVRDRVRTKMERDILADV 87
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HP +V +    Q  G+  ++ +F+    L   L +        + + +  +A   A GL
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAE-LALGL 143
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR------GLAGYVDDD 230
           ++LH   +  II+  +K  NILL+E+   ++ D+GLS  A + ++      G   Y+  +
Sbjct: 144 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE 200
Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
             + +G  ++   +D + +GV++ E+L+G    +G   K  + LI
Sbjct: 201 VVNRQGHSHS---ADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 85  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 189
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 107
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 108 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 159 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 212
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 192
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 193 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251
Query: 273 PLIKE 277
            L+KE
Sbjct: 252 KLLKE 256

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 109 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 213
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 95  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 199
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 26/203 (12%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI---HPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           IG+G  G V+      TG++VA+K+        V+         ++K L   +HPN+V +
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL---KHPNLVNL 67
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
           L   +      +V E+ +   L    HE +     +  +    I     + + + H+   
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-- 121
Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY---WHEK-----G 236
            N IH  +K  NIL+ +    ++CD+G + L      G + Y DD+    W+       G
Sbjct: 122 -NCIHRDVKPENILITKHSVIKLCDFGFARLL----TGPSDYYDDEVATRWYRSPELLVG 176
Query: 237 GGNATRESDVYGFGVVLLEILSG 259
                   DV+  G V  E+LSG
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 121/299 (40%), Gaps = 62/299 (20%)
Query: 66  RRIIGQGRLGTVYAAL---LSTGK---LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           +R +G+G  G V+ A    LS  K   LVAVK +    + +   F   +  + L+  QH 
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA--ELLTNLQHE 77
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENN-DGASLLDWNRR-----------LR 167
           +IV   G        I+V E++    L+ +L  +  D   L+D   R           L 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYV 227
           IA+  A G+ YL    + + +H  +   N L+      ++ D+G+S              
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----------RDVY 184
Query: 228 DDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVK 269
             DY+  + GG+                  T ESDV+ FGV+L EI + G++    L   
Sbjct: 185 STDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
Query: 270 WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             +  I + R  E   PR+  P E+        V L C     + R +I ++  IL+ L
Sbjct: 243 EVIECITQGRVLE--RPRVC-PKEV------YDVMLGCWQREPQQRLNIKEIYKILHAL 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI----HPRLVLSNAGFGFASVIKTL 113
           + + + +  ++G+G  G V       TG++VA+K+       ++V   A       IK L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----MREIKLL 78
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLD-FYLHENNDGASLLDWNRRLRIATGA 172
              +H N+V +L   +      +V EF++   LD   L  N      LD+    +     
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQI 133
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLA--GYVDDD 230
             G+ + H   + NIIH  IK  NIL+++    ++CD+G +       R LA  G V DD
Sbjct: 134 INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA-------RTLAAPGEVYDD 183
Query: 231 ----YWHEK-----GGGNATRESDVYGFGVVLLEILSG 259
                W+       G     +  DV+  G ++ E+  G
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 79/204 (38%), Gaps = 33/204 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS---HEKLVQLYGVC 73
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++    L  YL E           + L +       +EYL    +   +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR------ 242
           H  + A N L+N++   +V D+GLS             +DD+Y   +G     R      
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYV----------LDDEYTSSRGSKFPVRWSPPEV 177
Query: 243 --------ESDVYGFGVVLLEILS 258
                   +SD++ FGV++ EI S
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +    I+G G +  V+ A  L   + VAVK +   L    + +  F    +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 118 HPNIVPI--LGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           HP IV +   G ++ P   +  IV E+++  +L   +H        +   R + +   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 126
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLA 224
           + L + HQ     IIH  +K +NI+++     +V D+G++    +            G A
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            Y+  +   +  G +    SDVY  G VL E+L+G
Sbjct: 184 QYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 85  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   +AG+V   ++     
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAPEI 189
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 188
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 189 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 273 PLIKE 277
            L+KE
Sbjct: 248 KLLKE 252

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 99
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 100 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 151 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEI 204
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 94  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEI 198
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 119/309 (38%), Gaps = 65/309 (21%)
Query: 63  FSHRRIIGQGRLG-----TVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLS-L 115
            S  + +G G  G     T Y  + S   + VAVK + P   L+       S +K LS L
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLSYL 106
Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDG--------------ASLLD 161
             H NIV +LG     G  ++++E+     L  +L    D                  LD
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
               L  +   A+G+ +L    + N IH  + A NILL      ++CD+GL+       +
Sbjct: 167 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RHIK 219
Query: 222 GLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCE 263
             + YV          GNA                 T ESDV+ +G+ L E+ S G    
Sbjct: 220 NDSNYVVK--------GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271
Query: 264 EGLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA 322
            G+ V      +IKE     +L P  A P E+  +++       C       RP+  Q+ 
Sbjct: 272 PGMPVDSKFYKMIKEG--FRMLSPEHA-PAEMYDIMK------TCWDADPLKRPTFKQIV 322
Query: 323 TILNNLVGD 331
            ++   + +
Sbjct: 323 QLIEKQISE 331

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 102/267 (38%), Gaps = 39/267 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G+G  G V     + +G++ AVKRI   +           +  +      P  V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               G+  I  E  +  SLD +  +  D    +  +   +IA    + LE+LH  ++  +
Sbjct: 102 LFREGDVWICXELXD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 158
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG--------- 238
           IH  +K SN+L+N     + CD+G+S           GY+ DD   +   G         
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGIS-----------GYLVDDVAKDIDAGCKPYXAPER 207
Query: 239 --------NATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI 290
                     + +SD++  G+  +E+   R   +     W  P  +  +  E   P+L  
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYDS----WGTPFQQLKQVVEEPSPQL-- 261
Query: 291 PCEIKPLVRLAKVALACVGNSRKNRPS 317
           P + K           C+  + K RP+
Sbjct: 262 PAD-KFSAEFVDFTSQCLKKNSKERPT 287

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 203
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 204 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 273 PLIKE 277
            L+KE
Sbjct: 263 KLLKE 267

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL     +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 195
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 196 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254
Query: 273 PLIKE 277
            L+KE
Sbjct: 255 KLLKE 259

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 196
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 197 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255
Query: 273 PLIKE 277
            L+KE
Sbjct: 256 KLLKE 260

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 17/197 (8%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G G  G VY A    TG L A K I  +         +   I+ L+   HP IV +LG 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               G+  I+ EF    ++D  + E + G +        +I     + LE L+   +  I
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLT------EPQIQVVCRQMLEALNFLHSKRI 130
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--------HEKGGGN 239
           IH  +KA N+L+  +   R+ D+G+S    +  +    ++   YW               
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 240 ATRESDVYGFGVVLLEI 256
              ++D++  G+ L+E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 203
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 204 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 273 PLIKE 277
            L+KE
Sbjct: 263 KLLKE 267

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +    I+G G +  V+ A  L   + VAVK +   L    + +  F    +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 118 HPNIVPI--LGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           HP IV +   G ++ P   +  IV E+++  +L   +H        +   R + +   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 126
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLA 224
           + L + HQ     IIH  +K +NI+++     +V D+G++    +            G A
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            Y+  +   +  G +    SDVY  G VL E+L+G
Sbjct: 184 QYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +    I+G G +  V+ A  L   + VAVK +   L    + +  F    +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 118 HPNIVPI--LGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           HP IV +   G ++ P   +  IV E+++  +L   +H        +   R + +   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 126
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------------------- 213
           + L + HQ     IIH  +K +NI+++     +V D+G++                    
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 214 -FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            +L+PE+ RG                +    SDVY  G VL E+L+G
Sbjct: 184 QYLSPEQARG---------------DSVDARSDVYSLGCVLYEVLTG 215

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 96  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEI 200
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 22/139 (15%)
Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
           ++ L     P IV   G   + GE  I  E ++  SLD  L E    A  +      +++
Sbjct: 65  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVS 120
Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL----------------S 213
               RGL YL +     I+H  +K SNIL+N +   ++CD+G+                S
Sbjct: 121 IAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178
Query: 214 FLAPEEKRGLAGYVDDDYW 232
           ++APE  +G    V  D W
Sbjct: 179 YMAPERLQGTHYSVQSDIW 197

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +    I+G G +  V+ A  L   + VAVK +   L    + +  F    +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 118 HPNIVPI--LGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           HP IV +   G ++ P   +  IV E+++  +L   +H        +   R + +   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 126
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLA 224
           + L + HQ     IIH  +K +NI+++     +V D+G++    +            G A
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            Y+  +   +  G +    SDVY  G VL E+L+G
Sbjct: 184 QYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 94  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 198
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 203
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 204 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 273 PLIKE 277
            L+KE
Sbjct: 263 KLLKE 267

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 96  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEI 200
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 69/312 (22%), Positives = 111/312 (35%), Gaps = 69/312 (22%)
Query: 61  DGFSHRRIIGQGRLGTVYAAL------LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS 114
           +   + R IG+G  G V+ A            +VAVK +      ++    F      ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMA 105
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE--------------------NN 154
              +PNIV +LG         ++ E++    L+ +L                      ++
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 155 DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF 214
            G   L    +L IA   A G+ YL +      +H  +   N L+ E    ++ D+GLS 
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS- 221
Query: 215 LAPEEKRGLAGYVDDDYWHEKGG---------------GNATRESDVYGFGVVLLEILSG 259
                          DY+   G                   T ESDV+ +GVVL EI S 
Sbjct: 222 ---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS- 271
Query: 260 RRCEEGLLVKWALP---LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP 316
                GL   + +    +I  +R   +L      P E+  L+RL      C      +RP
Sbjct: 272 ----YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL------CWSKLPADRP 321
Query: 317 SIVQVATILNNL 328
           S   +  IL  +
Sbjct: 322 SFCSIHRILQRM 333

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 96  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 200
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 94  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 198
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 87
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 88  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 138
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 139 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 192
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 96  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEI 200
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 85
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 86  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 137 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 190
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 17/197 (8%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           +G G  G VY A    TG L A K I  +         +   I+ L+   HP IV +LG 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNI 187
               G+  I+ EF    ++D  + E + G +        +I     + LE L+   +  I
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLT------EPQIQVVCRQMLEALNFLHSKRI 138
Query: 188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--------HEKGGGN 239
           IH  +KA N+L+  +   R+ D+G+S    +  +    ++   YW               
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 240 ATRESDVYGFGVVLLEI 256
              ++D++  G+ L+E+
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 91  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRAPEI 195
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 85
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 86  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 137 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 190
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 91  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 195
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 85  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 189
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 95  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 199
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 91  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 195
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 95  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 199
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 91  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 195
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 101 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 205
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 101 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 205
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQ 117
           +D +    I+G G +  V+ A  L   + VAVK +   L    + +  F    +  +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 118 HPNIVPI--LGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           HP IV +   G ++ P   +  IV E+++  +L   +H        +   R + +   A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 143
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLA 224
           + L + HQ     IIH  +K +NI+++     +V D+G++    +            G A
Sbjct: 144 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            Y+  +   +  G +    SDVY  G VL E+L+G
Sbjct: 201 QYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 99
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 100 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 151 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 204
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 95  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRAPEI 199
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 111
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 112 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 163 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 216
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 107
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 108 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 159 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 212
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 29/235 (12%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 121 IVPILGFSQAPGERIIVSEFINMAS------------LDFYLHENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +            L+F  + +++    L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAPEEKRGLAG 225
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+         K+   G
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 226 YVDDDYWHEKGGGNA--TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKE 277
            +   +   +   +   T +SDV+ FGV+L EI + G     G+ V+    L+KE
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 267

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 67  RIIGQGRLGTVY-------------AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL 113
           R+IG+G  G VY              A+ S  ++  ++++        A      +++ L
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-------EAFLREGLLMRGL 79
Query: 114 SLAQHPNIVPILGFSQAP-GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           +   HPN++ ++G    P G   ++  ++    L  ++       ++ D    +      
Sbjct: 80  N---HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQV 133
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FLAPEEKRGLAG 225
           ARG+EYL +      +H  + A N +L+E F  +V D+GL+       + + ++ R    
Sbjct: 134 ARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILS 258
            V             T +SDV+ FGV+L E+L+
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 69  IGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAG-FGFASVIKTLSL----AQHPN 120
           +G+G  G V  A    L   K   V ++  +++ S+A     + +I  + +     +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH------------ENNDGASLLDWNRRLRI 168
           I+ +LG     G   ++ E+ +  +L  YL              +++    L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +     
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHHI-- 244
Query: 229 DDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGLLVKWAL 272
            DY+ +   G                 T +SDV+ FGV+L EI + G     G+ V+   
Sbjct: 245 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 273 PLIKE 277
            L+KE
Sbjct: 304 KLLKE 308

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 101 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 205
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 86
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 87  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 137
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 138 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 191
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 109 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 213
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 19/216 (8%)
Query: 54  TEIDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGF--GFASVI 110
           T I    + F    ++G+G    VY A  + TG  VA+K I  +  +  AG      + +
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-AMYKAGMVQRVQNEV 62
Query: 111 KTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT 170
           K     +HP+I+ +  + +      +V E  +   ++ YL    +       N       
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMH 119
Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKR----GLA 224
               G+ YLH   +  I+H  +  SN+LL      ++ D+GL+     P EK     G  
Sbjct: 120 QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            Y+  +       G    ESDV+  G +   +L GR
Sbjct: 177 NYISPEIATRSAHG---LESDVWSLGCMFYTLLIGR 209

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 111
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 112 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 163 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MXGYVATRWYRAPEI 216
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 67  RIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TGK VAVK I    + S++       ++ + +  HPNIV + 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR------GL 176
                        E I      + + E   G  + D+   + R++     A+       +
Sbjct: 80  -------------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDY 231
           +Y HQ     I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPEL 183
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +G      E DV+  GV+L  ++SG
Sbjct: 184 F--QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 20/237 (8%)
Query: 32  KKKPVESEETLPIKLCAFAYPLTEI-DAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVA 89
           K + +E +E    +L AF     ++ +   D F     +G G  G V+  +   +G ++A
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 90  VKRIHPRL--VLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD 147
            K IH  +   + N        ++ L     P IV   G   + GE  I  E ++  SLD
Sbjct: 63  RKLIHLEIKPAIRNQ---IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
             L +    A  +      +++    +GL YL +     I+H  +K SNIL+N +   ++
Sbjct: 120 QVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 173
Query: 208 CDYGLSFLAPEEKR----GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           CD+G+S    +       G   Y+  +      G + + +SD++  G+ L+E+  GR
Sbjct: 174 CDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 56  IDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKT 112
           ++   D F     +G G  G V+  +   +G ++A K IH  +   + N        ++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQV 57
Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           L     P IV   G   + GE  I  E ++  SLD  L +    A  +      +++   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVD 228
            +GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+ 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 171
Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            +      G + + +SD++  G+ L+E+  GR
Sbjct: 172 PERLQ---GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 17/204 (8%)
Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA---QHPNIVP 123
           +IG+G    V   +   TG+  AVK +      S+ G     + +  S+    +HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           +L    + G   +V EF++ A L F + +  D   +                L Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 184 APNIIHGCIKASNILLNEKFCA---RVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA 240
             NIIH  +K  N+LL  K  +   ++ D+G++    E      G V     H       
Sbjct: 150 --NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP--HFMAPEVV 205
Query: 241 TRES-----DVYGFGVVLLEILSG 259
            RE      DV+G GV+L  +LSG
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSG 229

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 56  IDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKT 112
           ++   D F     +G G  G V+  +   +G ++A K IH  +   + N        ++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQV 57
Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           L     P IV   G   + GE  I  E ++  SLD  L +    A  +      +++   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVD 228
            +GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+ 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 171
Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            +      G + + +SD++  G+ L+E+  GR
Sbjct: 172 PERLQ---GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 56  IDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKT 112
           ++   D F     +G G  G V+  +   +G ++A K IH  +   + N        ++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQV 57
Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           L     P IV   G   + GE  I  E ++  SLD  L +    A  +      +++   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVD 228
            +GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+ 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 171
Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            +      G + + +SD++  G+ L+E+  GR
Sbjct: 172 PERLQ---GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 74
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 133
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 187
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 56  IDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKT 112
           ++   D F     +G G  G V+  +   +G ++A K IH  +   + N        ++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQV 57
Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           L     P IV   G   + GE  I  E ++  SLD  L +    A  +      +++   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVD 228
            +GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+ 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 171
Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            +      G + + +SD++  G+ L+E+  GR
Sbjct: 172 PERLQ---GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
           RGL+Y+H   +  IIH  +K SN+ +NE    R+ D+GL+  A EE   + GYV   ++ 
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE---MTGYVATRWYR 195
Query: 234 EK----GGGNATRESDVYGFGVVLLEILSGR 260
                    +  +  D++  G ++ E+L G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL    F     ++ +    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFK-NRELQIMRKLDHCN 74
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 133
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 187
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 21/159 (13%)
Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL----SLAQHPN 120
           RR++ +G    VY A  + +G+  A+KR+     LSN      ++I+ +     L+ HPN
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRL-----LSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 121 IVPILGFSQ--------APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           IV     +            E ++++E      ++F     + G   L  +  L+I    
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQT 145
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
            R ++++H+   P IIH  +K  N+LL+ +   ++CD+G
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFG 183

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N     + D N  +
Sbjct: 421 ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNR---HVKDKNI-I 472
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 473 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 520
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 581 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 631
Query: 331 D 331
           D
Sbjct: 632 D 632

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TGK VAVK I    + S++       ++ + +  HPNIV + 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR------GL 176
                        E I      + + E   G  + D+   + R++     A+       +
Sbjct: 80  -------------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDY 231
           +Y HQ     I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +G      E DV+  GV+L  ++SG
Sbjct: 184 F--QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 33/204 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS---HEKLVQLYGVC 68
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++    L  YL E           + L +       +EYL    +   +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR------ 242
           H  + A N L+N++   +V D+GLS             +DD+Y    G     R      
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYV----------LDDEYTSSVGSKFPVRWSPPEV 172
Query: 243 --------ESDVYGFGVVLLEILS 258
                   +SD++ FGV++ EI S
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 33/204 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS---HEKLVQLYGVC 72
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++    L  YL E           + L +       +EYL    +   +
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFL 126
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR------ 242
           H  + A N L+N++   +V D+GLS             +DD+Y    G     R      
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYV----------LDDEYTSSVGSKFPVRWSPPEV 176
Query: 243 --------ESDVYGFGVVLLEILS 258
                   +SD++ FGV++ EI S
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 59
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 116
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 SFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N     + D N  +
Sbjct: 422 ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNR---HVKDKNI-I 473
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 474 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 521
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 522 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 581
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 582 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 632
Query: 331 D 331
           D
Sbjct: 633 D 633

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TGK VAVK I    + S++       ++ + +  HPNIV + 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR------GL 176
                        E I      + + E   G  + D+   + R++     A+       +
Sbjct: 80  -------------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDY 231
           +Y HQ     I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +G      E DV+  GV+L  ++SG
Sbjct: 184 F--QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 10/91 (10%)
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
           RGL+Y+H      IIH  +K SN+ +NE    R+ D+GL+  A EE   + GYV   ++ 
Sbjct: 134 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEE---MTGYVATRWYR 187
Query: 234 EK----GGGNATRESDVYGFGVVLLEILSGR 260
                    +  +  D++  G ++ E+L G+
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
           RGL+Y+H   +  IIH  +K SN+ +NE    R+ D+GL+  A EE   + GYV   ++ 
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE---MTGYVATRWYR 195
Query: 234 EK----GGGNATRESDVYGFGVVLLEILSGR 260
                    +  +  D++  G ++ E+L G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 56  IDAATDGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKT 112
           ++   D F     +G G  G V+  +   +G ++A K IH  +   + N        ++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQV 57
Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           L     P IV   G   + GE  I  E ++  SLD  L +    A  +      +++   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVD 228
            +GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+ 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 171
Query: 229 DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            +      G + + +SD++  G+ L+E+  GR
Sbjct: 172 PERLQ---GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 57
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 114
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 57
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 114
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 33/204 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS---HEKLVQLYGVC 73
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++    L  YL E           + L +       +EYL    +   +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR------ 242
           H  + A N L+N++   +V D+GLS             +DD+Y    G     R      
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYV----------LDDEYTSSVGSKFPVRWSPPEV 177
Query: 243 --------ESDVYGFGVVLLEILS 258
                   +SD++ FGV++ EI S
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL    F     ++ +    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRE-LQIMRKLDHCN 74
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 133
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 187
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 57
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 114
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 28/160 (17%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNIVP 123
           IGQG  G V+ A    TG+ VA+K++    ++ N   GF       IK L L +H N+V 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 124 ILGFSQ---APGERIIVSEFINMASLDFYLHENNDGASLLD-------WNRRLRIATGAA 173
           ++   +   +P  R   S ++     DF  H   D A LL         +   R+     
Sbjct: 82  LIEICRTKASPYNRCKASIYL---VFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            GL Y+H+     I+H  +KA+N+L+      ++ D+GL+
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 87
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 146
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 147 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 200
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKTLSLAQ 117
           D F     +G G  G V+  +   +G ++A K IH  +   + N       +I+ L +  
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRELQVLH 121
Query: 118 HPNIVPILGFSQA---PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
             N   I+GF  A    GE  I  E ++  SLD  L +    A  +      +++    +
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 177
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDD 230
           GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+  +
Sbjct: 178 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 235
Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                 G + + +SD++  G+ L+E+  GR
Sbjct: 236 RLQ---GTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 60
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 117
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 59
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 116
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 59
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 116
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 152

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+   +LA      + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDF---YLARHTDDEMTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N     + D N  +
Sbjct: 77  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNR---HVKDKNI-I 128
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 129 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 176
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 177 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 236
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 237 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 287
Query: 331 D 331
           D
Sbjct: 288 D 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 59
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 116
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 63
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 120
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 154

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 60
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 117
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 57
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 114
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H   +  ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 16/196 (8%)
Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A + S+GKLVAVK++  R         F  V+  +   QH N+V +   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVV-IMRDYQHENVVEMYNS 85
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                E  +V EF+   +L D   H   +   +        +     + L  LH   A  
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------AVCLAVLQALSVLH---AQG 136
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNAT---RE 243
           +IH  IK+ +ILL      ++ D+G      +E       V   YW      +      E
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 244 SDVYGFGVVLLEILSG 259
            D++  G++++E++ G
Sbjct: 197 VDIWSLGIMVIEMVDG 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N            +
Sbjct: 63  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD----KNII 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 162
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 163 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 223 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 273
Query: 331 D 331
           D
Sbjct: 274 D 274

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 16/196 (8%)
Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A + S+GKLVAVK++  R         F  V+  +   QH N+V +   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVV-IMRDYQHENVVEMYNS 94
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                E  +V EF+   +L D   H   +   +        +     + L  LH   A  
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLH---AQG 145
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNAT---RE 243
           +IH  IK+ +ILL      ++ D+G      +E       V   YW      +      E
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 244 SDVYGFGVVLLEILSG 259
            D++  G++++E++ G
Sbjct: 206 VDIWSLGIMVIEMVDG 221

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 58
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 115
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 59
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 116
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 58
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 115
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 58
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 115
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 33/204 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS---HEKLVQLYGVC 79
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++    L  YL E           + L +       +EYL    +   +
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFL 133
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR------ 242
           H  + A N L+N++   +V D+GLS             +DD+Y    G     R      
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYV----------LDDEYTSSVGSKFPVRWSPPEV 183
Query: 243 --------ESDVYGFGVVLLEILS 258
                   +SD++ FGV++ EI S
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 63  FSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL--SLAQHP 119
           F   R+IG+G    V    L  T ++ A+K +   LV  +    +    K +    + HP
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            +V +    Q       V E++N   L F++        L + + R   A   +  L YL
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAE-ISLALNYL 137
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKR 221
           H+     II+  +K  N+LL+ +   ++ DYG+                  +++APE  R
Sbjct: 138 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           G       D+W                 GV++ E+++GR
Sbjct: 195 GEDYGFSVDWW---------------ALGVLMFEMMAGR 218

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 58
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 115
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N            +
Sbjct: 69  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD----KNII 120
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 121 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 168
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 229 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 279
Query: 331 D 331
           D
Sbjct: 280 D 280

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N            +
Sbjct: 79  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD----KNII 130
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 131 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 178
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 179 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 239 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 289
Query: 331 D 331
           D
Sbjct: 290 D 290

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N            +
Sbjct: 79  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD----KNII 130
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 131 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 178
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 179 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 239 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 289
Query: 331 D 331
           D
Sbjct: 290 D 290

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 109 VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E  G         W+    
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVA----TRWYRAPE 212
Query: 236 ---GGGNATRESDVYGFGVVLLEILSGR 260
                 +  +  D++  G ++ E+L+GR
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 58
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 115
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    R+ D+GL+       R 
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLA-------RD 206
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 207 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 264 PVEELFKLLKE 274

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 58
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 115
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 66
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 123
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 157

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 61
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQ 118
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 154

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 63  FSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL--SLAQHP 119
           F   R+IG+G    V    L  T ++ A+K +   LV  +    +    K +    + HP
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            +V +    Q       V E++N   L F++        L + + R   A   +  L YL
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAE-ISLALNYL 122
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKR 221
           H+     II+  +K  N+LL+ +   ++ DYG+                  +++APE  R
Sbjct: 123 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           G       D+W                 GV++ E+++GR
Sbjct: 180 GEDYGFSVDWW---------------ALGVLMFEMMAGR 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 60
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V EF++     F       G  L      L       +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL---FQLLQ 117
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 58
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 115
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 16/196 (8%)
Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A + S+GKLVAVK++  R         F  V+  +   QH N+V +   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVV-IMRDYQHENVVEMYNS 96
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                E  +V EF+   +L D   H      + ++  +   +     + L  LH   A  
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQG 147
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNAT---RE 243
           +IH  IK+ +ILL      ++ D+G      +E       V   YW      +      E
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 244 SDVYGFGVVLLEILSG 259
            D++  G++++E++ G
Sbjct: 208 VDIWSLGIMVIEMVDG 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N            +
Sbjct: 59  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD----KNII 110
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 158
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 219 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 269
Query: 331 D 331
           D
Sbjct: 270 D 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 33/204 (16%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS---HEKLVQLYGVC 88
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++    L  YL E           + L +       +EYL    +   +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 189 HGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR------ 242
           H  + A N L+N++   +V D+GLS             +DD+Y    G     R      
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYV----------LDDEYTSSVGSKFPVRWSPPEV 192
Query: 243 --------ESDVYGFGVVLLEILS 258
                   +SD++ FGV++ EI S
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 69  IGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPI 124
           +G+G   TVY      T  LVA+K I     L +      + I+ +SL +   H NIV +
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
                      +V E+++   L  YL   +D  ++++ +          RGL Y H+   
Sbjct: 66  HDIIHTEKSLTLVFEYLD-KDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHR--- 118
Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD----YWHEK----- 235
             ++H  +K  N+L+NE+   ++ D+GL+       + +     D+     W+       
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLA-----RAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI 275
           G  + + + D++G G +  E+ +GR    G  V+  L  I
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 59
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 116
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 24/244 (9%)
Query: 52  PLTEI-DAATDGFSHRR-----IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL--SNAG 103
           PL EI D   D  + +R      +G+G     Y       K V   ++ P+ +L   +  
Sbjct: 27  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 86
Query: 104 FGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWN 163
              ++ I       +P++V   GF +      +V E     SL   LH+     +  +  
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR 145
Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF---LAPEEK 220
             +R      +G++YLH      +IH  +K  N+ LN+    ++ D+GL+       E K
Sbjct: 146 YFMR---QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 221 RGLAG---YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE 277
           + L G   Y+  +   +KG    + E D++  G +L  +L G+   E   +K     IK+
Sbjct: 200 KDLCGTPNYIAPEVLCKKG---HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK 256
Query: 278 MRFS 281
             +S
Sbjct: 257 NEYS 260

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 24/244 (9%)
Query: 52  PLTEI-DAATDGFSHRR-----IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL--SNAG 103
           PL EI D   D  + +R      +G+G     Y       K V   ++ P+ +L   +  
Sbjct: 11  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 70
Query: 104 FGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWN 163
              ++ I       +P++V   GF +      +V E     SL   LH+     +  +  
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR 129
Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF---LAPEEK 220
             +R      +G++YLH      +IH  +K  N+ LN+    ++ D+GL+       E K
Sbjct: 130 YFMR---QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 183
Query: 221 RGLAG---YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE 277
           + L G   Y+  +   +KG    + E D++  G +L  +L G+   E   +K     IK+
Sbjct: 184 KDLCGTPNYIAPEVLCKKG---HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK 240
Query: 278 MRFS 281
             +S
Sbjct: 241 NEYS 244

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 66
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 123
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 157

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 16/196 (8%)
Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A + S+GKLVAVK++  R         F  V+  +   QH N+V +   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVV-IMRDYQHENVVEMYNS 89
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                E  +V EF+   +L D   H      + ++  +   +     + L  LH   A  
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQG 140
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNAT---RE 243
           +IH  IK+ +ILL      ++ D+G      +E       V   YW      +      E
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 244 SDVYGFGVVLLEILSG 259
            D++  G++++E++ G
Sbjct: 201 VDIWSLGIMVIEMVDG 216

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N            +
Sbjct: 57  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD----KNII 108
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS          A  
Sbjct: 109 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS---------KALR 156
Query: 227 VDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKW 270
            D++Y+  +  G                 + +SDV+ FGV++ E  S G++   G+    
Sbjct: 157 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216
Query: 271 ALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG 330
              ++++    E +      P E+  L+ L      C     +NRP    V   L N   
Sbjct: 217 VTAMLEK---GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYY 267
Query: 331 D 331
           D
Sbjct: 268 D 268

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 60
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 117
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 79
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 138
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 139 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 192
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRL--VLSNAGFGFASVIKTLSLAQ 117
           D F     +G G  G V+  +   +G ++A K IH  +   + N        ++ L    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQVLHECN 81
Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
            P IV   G   + GE  I  E ++  SLD  L +    A  +      +++    +GL 
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLT 137
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDDYWH 233
           YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+  +   
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 195
Query: 234 EKGGGNATRESDVYGFGVVLLEILSGR 260
              G + + +SD++  G+ L+E+  GR
Sbjct: 196 ---GTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 59
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 116
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 13/194 (6%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G G+ G V          VA+K I    +  +     A V+  LS   H  +V + G  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS---HEKLVQLYGVC 88
Query: 129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII 188
                  I++E++    L  YL E           + L +       +EYL    +   +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 189 HGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEKG---GGNATRES 244
           H  + A N L+N++   +V D+GLS ++  +E+    G      W           + +S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 245 DVYGFGVVLLEILS 258
           D++ FGV++ EI S
Sbjct: 203 DIWAFGVLMWEIYS 216

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 63  FSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL--SLAQHP 119
           F   R+IG+G    V    L  T ++ A+K +   LV  +    +    K +    + HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            +V +    Q       V E++N   L F++        L + + R   A   +  L YL
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAE-ISLALNYL 126
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKR 221
           H+     II+  +K  N+LL+ +   ++ DYG+                  +++APE  R
Sbjct: 127 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           G       D+W                 GV++ E+++GR
Sbjct: 184 GEDYGFSVDWW---------------ALGVLMFEMMAGR 207

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E  G         W+    
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVA----TRWYRAPE 192
Query: 236 ---GGGNATRESDVYGFGVVLLEILSGR 260
                 +  +  D++  G ++ E+L+GR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 132
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 179
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 230
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 231 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 130
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 177
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 228
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 102
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 161
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 162 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 215
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 134
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 181
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 232
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 233 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 284

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 133
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 180
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 231
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 232 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 283

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 131
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 178
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 229
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 230 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 281

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGM 131
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 178
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 229
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 230 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 281

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 56  IDAATDGFSH------RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFAS 108
           I +ATD   H      ++ IG+G    V  A  + TG+ VAVK I    +   +      
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRR 165
            ++ + +  HPNIV +              E I      + + E   G  + D+   + R
Sbjct: 64  EVRIMKILNHPNIVKLF-------------EVIETEKTLYLVMEYASGGEVFDYLVAHGR 110
Query: 166 LRIATGAAR------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAP 217
           ++     A+       ++Y HQ     I+H  +KA N+LL+     ++ D+G S  F   
Sbjct: 111 MKEKEARAKFRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG 167
Query: 218 EEKRGLAG---YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            +     G   Y   + +  +G      E DV+  GV+L  ++SG
Sbjct: 168 NKLDTFCGSPPYAAPELF--QGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 68  IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL----AQHPNIV 122
           ++G G  G VY    + TG+L A+K      V+   G     + + +++    + H NI 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIK------VMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 123 PILGF---SQAPG---ERIIVSEFINMASLDFYLHENNDGASLLD-WNRRLRIATGAARG 175
              G       PG   +  +V EF    S+   + +N  G +L + W     I     RG
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEW--IAYICREILRG 141
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW--- 232
           L +LHQ     +IH  IK  N+LL E    ++ D+G+S            ++   YW   
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 233 -----HEKGGGNATRESDVYGFGVVLLEILSG 259
                 E        +SD++  G+  +E+  G
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 124
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 171
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 222
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 24/244 (9%)
Query: 52  PLTEI-DAATDGFSHRR-----IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL--SNAG 103
           PL EI D   D  + +R      +G+G     Y       K V   ++ P+ +L   +  
Sbjct: 27  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 86
Query: 104 FGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWN 163
              ++ I       +P++V   GF +      +V E     SL   LH+     +  +  
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR 145
Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF---LAPEEK 220
             +R      +G++YLH      +IH  +K  N+ LN+    ++ D+GL+       E K
Sbjct: 146 YFMR---QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 221 RGLAG---YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE 277
           + L G   Y+  +   +KG    + E D++  G +L  +L G+   E   +K     IK+
Sbjct: 200 KTLCGTPNYIAPEVLCKKG---HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK 256
Query: 278 MRFS 281
             +S
Sbjct: 257 NEYS 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 203 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 252
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 253 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 310 PVEELFKLLKE 320

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 133
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 180
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 231
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 232 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 283

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 102 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 155
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 156 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 202
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 203 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 253
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 254 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 305

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 24/244 (9%)
Query: 52  PLTEI-DAATDGFSHRR-----IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL--SNAG 103
           PL EI D   D  + +R      +G+G     Y       K V   ++ P+ +L   +  
Sbjct: 27  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 86
Query: 104 FGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWN 163
              ++ I       +P++V   GF +      +V E     SL   LH+     +  +  
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR 145
Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF---LAPEEK 220
             +R      +G++YLH      +IH  +K  N+ LN+    ++ D+GL+       E K
Sbjct: 146 YFMR---QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 221 RGLAG---YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE 277
           + L G   Y+  +   +KG    + E D++  G +L  +L G+   E   +K     IK+
Sbjct: 200 KXLCGTPNYIAPEVLCKKG---HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK 256
Query: 278 MRFS 281
             +S
Sbjct: 257 NEYS 260

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 133
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 180
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 231
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 232 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 283

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 27/232 (11%)
Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL 166
           A+V++ L    +P IV ++G  +A    ++V E   +  L+ YL +N            +
Sbjct: 63  ANVMQQLD---NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD----KNII 114
Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGY 226
            +    + G++YL +    N +H  + A N+LL  +  A++ D+GLS     ++      
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ 171
Query: 227 VDDDY---WHEKGGGNATR---ESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMR 279
               +   W+     N  +   +SDV+ FGV++ E  S G++   G+       ++++  
Sbjct: 172 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-- 229
Query: 280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD 331
             E +      P E+  L+ L      C     +NRP    V   L N   D
Sbjct: 230 -GERMGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYYD 274

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 130
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 177
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 228
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 83  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 136
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 137 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 183
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 184 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 234
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 235 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 286

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 108
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 167
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 221
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 21/205 (10%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQHPN 120
           F   R +G G  G V+       G+  A+K +   +V+        +  +  LS+  HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR------IATGAAR 174
           I+ + G  Q   +  ++ ++I    L           SLL  ++R         A     
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGEL----------FSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
            LEYLH   + +II+  +K  NILL++    ++ D+G +   P+    L G  D      
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEV 174
Query: 235 KGGGNATRESDVYGFGVVLLEILSG 259
                  +  D + FG+++ E+L+G
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGM 130
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 177
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 228
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 132
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 179
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 230
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 231 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 23/203 (11%)
Query: 67  RIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TGK VAVK I    + S++       ++ + +  HPNIV + 
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR----GLEYLHQ 181
              +      +V E+ +   +  YL  +        W +  + A    R     ++Y HQ
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYLVAHG-------WMKE-KEARAKFRQIVSAVQYCHQ 124
Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDYWHEKG 236
                I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + +  +G
Sbjct: 125 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF--QG 179
Query: 237 GGNATRESDVYGFGVVLLEILSG 259
                 E DV+  GV+L  ++SG
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 97  IGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 206
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 207 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 264 PVEELFKLLKE 274

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 40/217 (18%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 130
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 177
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS 258
           GG                 T +SDV+ +GV + E+++
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 84  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 143
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 144 KDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLA-------RD 193
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 194 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 250
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 251 PVEELFKLLKE 261

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 16/196 (8%)
Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A + S+GKLVAVK++  R         F  V+  +   QH N+V +   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVV-IMRDYQHENVVEMYNS 139
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                E  +V EF+   +L D   H      + ++  +   +     + L  LH   A  
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQG 190
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GGGNATRE 243
           +IH  IK+ +ILL      ++ D+G      +E       V   YW             E
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 244 SDVYGFGVVLLEILSG 259
            D++  G++++E++ G
Sbjct: 251 VDIWSLGIMVIEMVDG 266

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TGK VAV+ I    + S++       ++ + +  HPNIV + 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR------GL 176
                        E I      + + E   G  + D+   + R++     A+       +
Sbjct: 80  -------------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDY 231
           +Y HQ     I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +G      E DV+  GV+L  ++SG
Sbjct: 184 F--QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 40/217 (18%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 87  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 140
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 141 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 187
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS 258
           GG                 T +SDV+ +GV + E+++
Sbjct: 188 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 47/218 (21%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS 128
           +G+GR G V+  L   G+ VAVK    R     + F    +  T+ L +H NI   LGF 
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRD--EQSWFRETEIYNTV-LLRHDNI---LGF- 67
Query: 129 QAPGERIIVSEFI--NMASLDFYLHENNDGASLLDWNRR--------LRIATGAARGLEY 178
                  I S+    N ++  + +   ++  SL D+ +R        LR+A  AA GL +
Sbjct: 68  -------IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAH 120
Query: 179 LH------QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-------------- 218
           LH      QG  P I H   K+ N+L+       + D GL+ +  +              
Sbjct: 121 LHVEIFGTQG-KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVG 179
Query: 219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEI 256
            KR +A  V D+         + + +D++ FG+VL EI
Sbjct: 180 TKRYMAPEVLDEQ-IRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TGK VAV+ I    + S++       ++ + +  HPNIV + 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR------GL 176
                        E I      + + E   G  + D+   + R++     A+       +
Sbjct: 80  -------------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-----EEKRGLAGYVDDDY 231
           +Y HQ     I+H  +KA N+LL+     ++ D+G S         +E  G   Y   + 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPEL 183
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +G      E DV+  GV+L  ++SG
Sbjct: 184 F--QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 16/196 (8%)
Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A + S+GKLVAVK++  R         F  V+  +   QH N+V +   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVV-IMRDYQHENVVEMYNS 216
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                E  +V EF+   +L D   H      + ++  +   +     + L  LH   A  
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQG 267
Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GGGNATRE 243
           +IH  IK+ +ILL      ++ D+G      +E       V   YW             E
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 244 SDVYGFGVVLLEILSG 259
            D++  G++++E++ G
Sbjct: 328 VDIWSLGIMVIEMVDG 343

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 40/217 (18%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 133
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 180
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS 258
           GG                 T +SDV+ +GV + E+++
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 110
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 169
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 170 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 223
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 137
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 184
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 235
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 236 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 28/160 (17%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNIVP 123
           IGQG  G V+ A    TG+ VA+K++    ++ N   GF       IK L L +H N+V 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 124 ILGFSQ---APGERIIVSEFINMASLDFYLHENNDGASLLD-------WNRRLRIATGAA 173
           ++   +   +P  R   S ++     DF  H   D A LL         +   R+     
Sbjct: 81  LIEICRTKASPYNRCKGSIYL---VFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            GL Y+H+     I+H  +KA+N+L+      ++ D+GL+
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  +       VA+K         +    F     T+    HP+IV
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 75  KLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 133 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 172
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  + +     VA+K         +    F     T+    HP+IV
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 75  KLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 133 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 172
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  + +     VA+K         +    F     T+    HP+IV
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 72  KLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 130 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 169
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 15/154 (9%)
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
            +A HP+I+ ++   ++     +V + +    L  YL E     +L +   R  I     
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETR-SIMRSLL 210
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR----GLAGYVD 228
             + +LH   A NI+H  +K  NILL++    R+ D+G S  L P EK     G  GY+ 
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 229 DDYWH---EKGGGNATRESDVYGFGVVLLEILSG 259
            +      ++      +E D++  GV+L  +L+G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 153
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 212
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 213 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 266
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 28/160 (17%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNIVP 123
           IGQG  G V+ A    TG+ VA+K++    ++ N   GF       IK L L +H N+V 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 124 ILGFSQ---APGERIIVSEFINMASLDFYLHENNDGASLLD-------WNRRLRIATGAA 173
           ++   +   +P  R   S ++     DF  H   D A LL         +   R+     
Sbjct: 82  LIEICRTKASPYNRCKGSIYL---VFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            GL Y+H+     I+H  +KA+N+L+      ++ D+GL+
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 89  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 148
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 149 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 198
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 199 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 255
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 256 PVEELFKLLKE 266

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 112
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 171
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG     Y+   Y
Sbjct: 172 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRY 225
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 28/160 (17%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNIVP 123
           IGQG  G V+ A    TG+ VA+K++    ++ N   GF       IK L L +H N+V 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 124 ILGFSQ---APGERIIVSEFINMASLDFYLHENNDGASLLD-------WNRRLRIATGAA 173
           ++   +   +P  R   S ++     DF  H   D A LL         +   R+     
Sbjct: 82  LIEICRTKASPYNRCKGSIYL---VFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            GL Y+H+     I+H  +KA+N+L+      ++ D+GL+
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  + +     VA+K         +    F     T+    HP+IV
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 77  KLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 134
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 135 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 174
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 63  FSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL--SLAQHP 119
           F   R+IG+G    V    L  T ++ A++ +   LV  +    +    K +    + HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            +V +    Q       V E++N   L F++        L + + R   A   +  L YL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAE-ISLALNYL 169
Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGL------------------SFLAPEEKR 221
           H+     II+  +K  N+LL+ +   ++ DYG+                  +++APE  R
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           G       D+W                 GV++ E+++GR
Sbjct: 227 GEDYGFSVDWW---------------ALGVLMFEMMAGR 250

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 97  IGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 206
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 207 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 264 PVEELFKLLKE 274

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  + +     VA+K         +    F     T+    HP+IV
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 78  KLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 135
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 136 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 175
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 40/217 (18%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W          A+G+
Sbjct: 111 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 164
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 165 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 211
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS 258
           GG                 T +SDV+ +GV + E+++
Sbjct: 212 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 86  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 145
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 146 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 195
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 196 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 252
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 253 PVEELFKLLKE 263

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  + +     VA+K         +    F     T+    HP+IV
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 103 KLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 160
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 161 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 200
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  + +     VA+K         +    F     T+    HP+IV
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 80  KLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 138 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 177
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLKEL 58
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG- 175
            HPNIV +L       +  +V E           H + D  + +D +    I     +  
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFE-----------HVHQDLKTFMDASALTGIPLPLIKSY 107
Query: 176 LEYLHQGVA----PNIIHGCIKASNILLNEKFCARVCDYGLS 213
           L  L QG+A      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 206
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 207 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 264 PVEELFKLLKE 274

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  +       VA+K         +    F     T+    HP+IV
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 75  KLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 133 VHRDIA---------ARNVLVSATDCVKLGDFGLS-----------RYMEDSTYYKASKG 172
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A G+
Sbjct: 74  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEGM 127
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 128 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 174
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 175 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 225
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 226 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 277

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G+GR G V+      G+ VAVK    R     + F    +  T+ L +H NI   LGF 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRD--EKSWFRETELYNTVML-RHENI---LGFI 68
Query: 128 ------SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH- 180
                   +  +  +++ +  M SL  YL       + LD    LRI    A GL +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 181 -----QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--------------KR 221
                QG  P I H  +K+ NIL+ +     + D GL+ +  +               KR
Sbjct: 124 EIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPL 274
            +A  V D+   +    ++ +  D++ FG+VL E+ + R    G++  +  P 
Sbjct: 183 YMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV-ARRMVSNGIVEDYKPPF 233

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G+GR G V+      G+ VAVK    R     + F    +  T+ L +H NI   LGF 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRD--EKSWFRETELYNTVML-RHENI---LGFI 68
Query: 128 ------SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH- 180
                   +  +  +++ +  M SL  YL       + LD    LRI    A GL +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 181 -----QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--------------KR 221
                QG  P I H  +K+ NIL+ +     + D GL+ +  +               KR
Sbjct: 124 EIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPL 274
            +A  V D+   +    ++ +  D++ FG+VL E+ + R    G++  +  P 
Sbjct: 183 YMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV-ARRMVSNGIVEDYKPPF 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
           + + F     IG+G  G VY A    TG++VA+K+I  RL     G   ++ I+ +SL +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVP-STAIREISLLK 60
Query: 118 ---HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
              HPNIV +L       +  +V E           H + D    +D +    I     +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFE-----------HVDQDLKKFMDASALTGIPLPLIK 109
Query: 175 G-LEYLHQGVA----PNIIHGCIKASNILLNEKFCARVCDYGLS 213
             L  L QG+A      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 41/175 (23%)
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A+G+E+L    +   IH  + A NILL+EK   ++CD+GL+       R +  Y D DY 
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA-------RDI--YKDPDYV 257
Query: 233 HEKGGGN---------------ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK- 276
             KG                   T +SDV+ FGV+L EI S        L     P +K 
Sbjct: 258 R-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------LGASPYPGVKI 308
Query: 277 EMRFSELLD--PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +  F   L    R+  P    P   + +  L C       RP+  ++   L NL+
Sbjct: 309 DEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 361

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 17/217 (7%)
Query: 53  LTEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK 111
           L E D   D    R ++G+G  G VYA   LS    +A+K I  R   S         I 
Sbjct: 14  LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIA 71
Query: 112 TLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG 171
                +H NIV  LG     G   I  E +   SL   L   +    L D  + +   T 
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIGFYTK 129
Query: 172 AA-RGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYG----LSFLAP--EEKRGL 223
               GL+YLH      I+H  IK  N+L+N      ++ D+G    L+ + P  E   G 
Sbjct: 130 QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186
Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             Y+  +   +KG     + +D++  G  ++E+ +G+
Sbjct: 187 LQYMAPEII-DKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 80/197 (40%), Gaps = 18/197 (9%)
Query: 69  IGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF 127
           IG+G  G V  A    TGK VAVK++  R         F  V+  +    H N+V +   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVV-IMRDYHHDNVVDMYSS 110
Query: 128 SQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLH-QGVAP 185
                E  +V EF+   +L D   H   +   +        +     R L YLH QGV  
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQGV-- 162
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNAT---R 242
             IH  IK+ +ILL      ++ D+G      +E       V   YW      +      
Sbjct: 163 --IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 243 ESDVYGFGVVLLEILSG 259
           E D++  G++++E++ G
Sbjct: 221 EVDIWSLGIMVIEMIDG 237

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  +       VA+K         +    F     T+    HP+IV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 455 KLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 513 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTYYKASKG 552
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 41/175 (23%)
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A+G+E+L    +   IH  + A NILL+EK   ++CD+GL+       R +  Y D DY 
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA-------RDI--YKDPDYV 248
Query: 233 HEKGGGN---------------ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK- 276
             KG                   T +SDV+ FGV+L EI S        L     P +K 
Sbjct: 249 R-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------LGASPYPGVKI 299
Query: 277 EMRFSELLD--PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +  F   L    R+  P    P   + +  L C       RP+  ++   L NL+
Sbjct: 300 DEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 352

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V AA    TG  VAVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 89  VFTPARS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++  +GL+    +E   + GYV   ++     
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE---MTGYVATRWYRAPEI 193
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +  +  D++  G ++ E+L+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 76/191 (39%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 206
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+     G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 207 INNI---DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 264 PVEELFKLLKE 274

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 41/175 (23%)
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A+G+E+L    +   IH  + A NILL+EK   ++CD+GL+       R +  Y D DY 
Sbjct: 208 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA-------RDI--YKDPDYV 255
Query: 233 HEKGGGN---------------ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK- 276
             KG                   T +SDV+ FGV+L EI S        L     P +K 
Sbjct: 256 R-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------LGASPYPGVKI 306
Query: 277 EMRFSELLD--PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +  F   L    R+  P    P   + +  L C       RP+  ++   L NL+
Sbjct: 307 DEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 359

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 41/175 (23%)
Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A+G+E+L    +   IH  + A NILL+EK   ++CD+GL+       R +  Y D DY 
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA-------RDI--YKDPDYV 250
Query: 233 HEKGGGN---------------ATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK- 276
             KG                   T +SDV+ FGV+L EI S        L     P +K 
Sbjct: 251 R-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------LGASPYPGVKI 301
Query: 277 EMRFSELLD--PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
           +  F   L    R+  P    P   + +  L C       RP+  ++   L NL+
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TGK VAVK I    + S++       ++   +  HPNIV + 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +      +V E+ +   +  YL  +          +  +I +     ++Y HQ    
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS----AVQYCHQKF-- 133
Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDYWHEKGGGNA 240
            I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + +  +G    
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF--QGKKYD 190
Query: 241 TRESDVYGFGVVLLEILSG 259
             E DV+  GV+L  ++SG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 69  IGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF- 127
           +G+GR G V+      G+ VAVK    R     + F    +  T+ L +H NI   LGF 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRD--EKSWFRETELYNTVML-RHENI---LGFI 97
Query: 128 ------SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH- 180
                   +  +  +++ +  M SL  YL       + LD    LRI    A GL +LH 
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 181 -----QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE--------------KR 221
                QG  P I H  +K+ NIL+ +     + D GL+ +  +               KR
Sbjct: 153 EIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPL 274
            +A  V D+   +    ++ +  D++ FG+VL E+ + R    G++  +  P 
Sbjct: 212 YMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV-ARRMVSNGIVEDYKPPF 262

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 84  TGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFIN 142
           TG  VAVK ++ + + S    G     I+ L L +HP+I+ +      P +  +V E+++
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK 202
              L  Y+ ++     +       R+       ++Y H+ +   ++H  +K  N+LL+  
Sbjct: 95  GGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH 147
Query: 203 FCARVCDYGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL 257
             A++ D+GLS +  +     +  G   Y   +     G   A  E D++  GV+L  +L
Sbjct: 148 MNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVI--SGRLYAGPEVDIWSCGVILYALL 205
Query: 258 SG 259
            G
Sbjct: 206 CG 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 34/216 (15%)
Query: 60  TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKR----IHPRLVLSNAGFGFASVIKTLSL 115
           ++ +   + +G G  G V   LL   K+  V+R    I    V +++       +  L L
Sbjct: 36  SEMYQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASL-DFYLHE---NNDGASLLDWNRRLRIATG 171
             HPNI+ +  F +      +V E      L D  +H    N   A++        I   
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV--------IIKQ 144
Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEK---FCARVCDYGLSFLAPEEKR-----GL 223
              G+ YLH+    NI+H  +K  N+LL  K      ++ D+GLS +   +K+     G 
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201
Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
           A Y+  +   +K       + DV+  GV+L  +L+G
Sbjct: 202 AYYIAPEVLRKK----YDEKCDVWSIGVILFILLAG 233

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+ +I  RL     G   ++ I+ +SL +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI--RLDTETEGVP-STAIREISLLKEL 59
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 116
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-- 117
           + F     IG+G  G VY A    TG++VA+ +I  RL     G   ++ I+ +SL +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI--RLDTETEGVP-STAIREISLLKEL 58
Query: 118 -HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            HPNIV +L       +  +V EF++     F       G  L      L       +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGL 115
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  +       VA+K         +    F     T+    HP+IV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 455 KLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D  +++   G
Sbjct: 513 VHRDIA---------ARNVLVSATDCVKLGDFGLS-----------RYMEDSTYYKASKG 552
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL    F     ++ +    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRE-LQIMRKLDHCN 74
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 133
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            L Y+H      I H  IK  N+LL+ +    ++CD+G +      +  ++      Y  
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 190
Query: 234 EK---GGGNATRESDVYGFGVVLLEILSGR 260
            +   G  + T   DV+  G VL E+L G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 75
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 134
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG      +   Y
Sbjct: 135 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSXICSRY 188
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 82/180 (45%), Gaps = 11/180 (6%)
Query: 84  TGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFIN 142
           TG  VAVK ++ + + S    G     I+ L L +HP+I+ +      P +  +V E+++
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 143 MASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK 202
              L  Y+ ++     +       R+       ++Y H+ +   ++H  +K  N+LL+  
Sbjct: 95  GGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH 147
Query: 203 FCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GGGNATRESDVYGFGVVLLEILSG 259
             A++ D+GLS +  + +         +Y   +   G   A  E D++  GV+L  +L G
Sbjct: 148 MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 74
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 133
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG      +   Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSXICSRY 187
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 19/218 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRL-VLSNAGFGFASVIKTLSLAQH 118
           D +     IG G  G V +A    TG+ VA+K+I     V++NA       +K L   +H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRE-LKILKHFKH 112
Query: 119 PNIVPI---LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
            NI+ I   L  +   GE   V   +++   D  LH+    +  L             RG
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF---LAPEEKRGLAGYVDDDYW 232
           L+Y+H      +IH  +K SN+L+NE    ++ D+G++     +P E +          W
Sbjct: 171 LKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 233 HEKGG-----GNATRESDVYGFGVVLLEILSGRRCEEG 265
           +            T+  D++  G +  E+L+ R+   G
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 16/150 (10%)
Query: 64  SHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +H+  +G+G  G V+      TG   AVK++   +  +      A +         P IV
Sbjct: 77  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS-------PRIV 129
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
           P+ G  +      I  E +   SL   + E       L  +R L     A  GLEYLH  
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQG----CLPEDRALYYLGQALEGLEYLH-- 183
Query: 183 VAPNIIHGCIKASNILLNEKFC-ARVCDYG 211
            +  I+HG +KA N+LL+     A +CD+G
Sbjct: 184 -SRRILHGDVKADNVLLSSDGSHAALCDFG 212

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 74
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 133
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG      +   Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSXICSRY 187
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 16/150 (10%)
Query: 64  SHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           +H+  +G+G  G V+      TG   AVK++   +  +      A +         P IV
Sbjct: 96  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS-------PRIV 148
Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
           P+ G  +      I  E +   SL   + E       L  +R L     A  GLEYLH  
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQG----CLPEDRALYYLGQALEGLEYLH-- 202
Query: 183 VAPNIIHGCIKASNILLNEKFC-ARVCDYG 211
            +  I+HG +KA N+LL+     A +CD+G
Sbjct: 203 -SRRILHGDVKADNVLLSSDGSHAALCDFG 231

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
             + F   R++G+G  G V A  + +TGK+ A K++  + +    G   A   K +    
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 118 HPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +   V  L ++    + + +V   +N   L F+++  + G +     R +  A     GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGL 299
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDY 231
           E LH+     I++  +K  NILL++    R+ D GL+   PE +      G  GY+  + 
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSGR 260
              +     T   D +  G +L E+++G+
Sbjct: 357 VKNE---RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 74
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 133
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGL--AGYVDDDY 231
            L Y+H      I H  IK  N+LL+ +    ++CD+G    A +  RG      +   Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSXICSRY 187
Query: 232 WHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           +       G  + T   DV+  G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL 113
           E D   D    R ++G+G  G VYA   LS    +A+K I  R   S         I   
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALH 59
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
              +H NIV  LG     G   I  E +   SL   L   +    L D  + +   T   
Sbjct: 60  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIGFYTKQI 117
Query: 174 -RGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYG----LSFLAP--EEKRGLAG 225
             GL+YLH      I+H  IK  N+L+N      ++ D+G    L+ + P  E   G   
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           Y+  +   +KG     + +D++  G  ++E+ +G+
Sbjct: 175 YMAPEII-DKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/292 (19%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 134
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+G +  L  EEK           +H +
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE----------YHAE 181
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 232
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 233 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 284

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/292 (19%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++  G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 137
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 184
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 235
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 236 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRI-HPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           +G G  G+V ++  + +G  +AVK++  P   + +A   +   ++ L   +H N++ +L 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 117
Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--------RGLE 177
            F+ A      + EF      D YL  +  GA L +  +  ++             RGL+
Sbjct: 118 VFTPATS----LEEFN-----DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 168
Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   + GYV   ++     
Sbjct: 169 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI 222
Query: 236 --GGGNATRESDVYGFGVVLLEILSGR 260
                +     D++  G ++ E+L+GR
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 78
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 137
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            L Y+H      I H  IK  N+LL+ +    ++CD+G +      +  ++      Y  
Sbjct: 138 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 194
Query: 234 EK---GGGNATRESDVYGFGVVLLEILSGR 260
            +   G  + T   DV+  G VL E+L G+
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/292 (19%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 132
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+G +  L  EEK           +H +
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE----------YHAE 179
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 230
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 231 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 93
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 152
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            L Y+H      I H  IK  N+LL+ +    ++CD+G +      +  ++      Y  
Sbjct: 153 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 209
Query: 234 EK---GGGNATRESDVYGFGVVLLEILSGR 260
            +   G  + T   DV+  G VL E+L G+
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
            +H+  +G+G  G V+      TG   AVK++  RL +    F    ++    L+  P I
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEV----FRVEELVACAGLSS-PRI 128
Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           VP+ G  +      I  E +   SL   + +       L  +R L     A  GLEYLH 
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH- 183
Query: 182 GVAPNIIHGCIKASNILLNEKFC-ARVCDYG 211
                I+HG +KA N+LL+     A +CD+G
Sbjct: 184 --TRRILHGDVKADNVLLSSDGSRAALCDFG 212

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 82
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 141
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            L Y+H      I H  IK  N+LL+ +    ++CD+G +      +  ++      Y  
Sbjct: 142 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 198
Query: 234 EK---GGGNATRESDVYGFGVVLLEILSGR 260
            +   G  + T   DV+  G VL E+L G+
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 93/217 (42%), Gaps = 40/217 (18%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I+        LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 132
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+G +  L  EEK           +H +
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE----------YHAE 179
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS 258
           GG                 T +SDV+ +GV + E+++
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++  G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 130
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 177
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 228
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 86
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 145
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            L Y+H      I H  IK  N+LL+ +    ++CD+G +      +  ++      Y  
Sbjct: 146 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 202
Query: 234 EK---GGGNATRESDVYGFGVVLLEILSGR 260
            +   G  + T   DV+  G VL E+L G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 19/218 (8%)
Query: 61  DGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRL-VLSNAGFGFASVIKTLSLAQH 118
           D +     IG G  G V +A    TG+ VA+K+I     V++NA       +K L   +H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRE-LKILKHFKH 113
Query: 119 PNIVPI---LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
            NI+ I   L  +   GE   V   +++   D  LH+    +  L             RG
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF---LAPEEKRGLAGYVDDDYW 232
           L+Y+H      +IH  +K SN+L+NE    ++ D+G++     +P E +          W
Sbjct: 172 LKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 233 HEKGG-----GNATRESDVYGFGVVLLEILSGRRCEEG 265
           +            T+  D++  G +  E+L+ R+   G
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 266

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 59  ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ 117
             + F   R++G+G  G V A  + +TGK+ A K++  + +    G   A   K +    
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 118 HPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +   V  L ++    + + +V   +N   L F+++  + G +     R +  A     GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGL 299
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDY 231
           E LH+     I++  +K  NILL++    R+ D GL+   PE +      G  GY+  + 
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSGR 260
              +     T   D +  G +L E+++G+
Sbjct: 357 VKNE---RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 33/208 (15%)
Query: 67  RIIGQGRLGTV-YAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TG+ VA+K I    +   +       ++ + +  HPNIV + 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR------GL 176
                        E I      + + E   G  + D+   + R++     ++       +
Sbjct: 81  -------------EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDY 231
           +Y HQ     I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + 
Sbjct: 128 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +G      E DV+  GV+L  ++SG
Sbjct: 185 F--QGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 77/196 (39%), Gaps = 51/196 (26%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------- 213
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+         
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 214 -----------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRR 261
                      ++APE         D  Y H         +SDV+ FGV++ EI + G  
Sbjct: 214 KKTTNGRLPVKWMAPE------ALFDRVYTH---------QSDVWSFGVLMWEIFTLGGS 258
Query: 262 CEEGLLVKWALPLIKE 277
              G+ V+    L+KE
Sbjct: 259 PYPGIPVEELFKLLKE 274

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
            +H+  +G+G  G V+      TG   AVK++  RL +    F    ++    L+  P I
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEV----FRVEELVACAGLSS-PRI 112
Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           VP+ G  +      I  E +   SL   + +       L  +R L     A  GLEYLH 
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH- 167
Query: 182 GVAPNIIHGCIKASNILLNEKFC-ARVCDYG 211
                I+HG +KA N+LL+     A +CD+G
Sbjct: 168 --TRRILHGDVKADNVLLSSDGSRAALCDFG 196

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 77/196 (39%), Gaps = 51/196 (26%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++ E+ +  +L  YL              N      + +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------- 213
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+         
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 214 -----------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRR 261
                      ++APE         D  Y H         +SDV+ FGV++ EI + G  
Sbjct: 214 KKTTNGRLPVKWMAPE------ALFDRVYTH---------QSDVWSFGVLMWEIFTLGGS 258
Query: 262 CEEGLLVKWALPLIKE 277
              G+ V+    L+KE
Sbjct: 259 PYPGIPVEELFKLLKE 274

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 130
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+G +  L  EEK           +H +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE----------YHAE 177
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 228
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 86
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 145
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            L Y+H      I H  IK  N+LL+ +    ++CD+G +      +  ++      Y  
Sbjct: 146 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 202
Query: 234 EK---GGGNATRESDVYGFGVVLLEILSGR 260
            +   G  + T   DV+  G VL E+L G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 67  RIIGQGRLGTVYAA----LLSTGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           +++G G  G V  A    +  TG    VAVK +  +   S      + +     L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLH-------------------ENNDGASLLD 161
           IV +LG     G   ++ E+     L  YL                    E  +  ++L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------- 213
           +   L  A   A+G+E+L      + +H  + A N+L+      ++CD+GL+        
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 214 FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS 258
           ++     R    ++  +   E   G  T +SDV+ +G++L EI S
Sbjct: 228 YVVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFS 269

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           SLA H ++V   GF +      +V E     SL   LH+     +  +    LR      
Sbjct: 73  SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR---QIV 127
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP---EEKRGLAG---YV 227
            G +YLH+     +IH  +K  N+ LNE    ++ D+GL+       E K+ L G   Y+
Sbjct: 128 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYI 184
Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
             +   +KG    + E DV+  G ++  +L G+   E   +K     IK+  +S      
Sbjct: 185 APEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 235
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
             IP  I P+   A +    +      RP+I ++
Sbjct: 236 --IPKHINPVA--ASLIQKMLQTDPTARPTINEL 265

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 62  GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL--SLAQHP 119
            F  + ++G G  GT+    +   + VAVKRI P        F FA     L     +HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHP 78
Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL-LDWNRRLRIATGAARGLEY 178
           N++      +    + I  E +  A+L  Y+ E  D A L L+    L+  T    GL +
Sbjct: 79  NVIRYFCTEKDRQFQYIAIE-LCAATLQEYV-EQKDFAHLGLEPITLLQQTTS---GLAH 133
Query: 179 LHQGVAPNIIHGCIKASNILLNE-----KFCARVCDYGL---------SFLAPEEKRGLA 224
           LH   + NI+H  +K  NIL++      K  A + D+GL         SF       G  
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS 258
           G++  +   E    N T   D++  G V   ++S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++  G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 137
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+GL+  L  EEK           +H +
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----------YHAE 184
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 235
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 236 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           SLA H ++V   GF +      +V E     SL   LH+     +  +    LR      
Sbjct: 77  SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR---QIV 131
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP---EEKRGLAG---YV 227
            G +YLH+     +IH  +K  N+ LNE    ++ D+GL+       E K+ L G   Y+
Sbjct: 132 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYI 188
Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
             +   +KG    + E DV+  G ++  +L G+   E   +K     IK+  +S      
Sbjct: 189 APEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 239
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
             IP  I P+   A +    +      RP+I ++
Sbjct: 240 --IPKHINPVA--ASLIQKMLQTDPTARPTINEL 269

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 40/217 (18%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 132
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+G +  L  EEK           +H +
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE----------YHAE 179
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS 258
           GG                 T +SDV+ +GV + E+++
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK---TLSLAQH 118
           F   +++G G  GTVY  L +  G+ V +      L  + +      ++     ++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYL-HENNDGAS-LLDWNRRLRIATGAARGL 176
           P++  +LG       ++I         LD+   H++N G+  LL+W  ++      A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 137
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKRGLAGYVDDDYWHEK 235
            YL       ++H  + A N+L+      ++ D+G +  L  EEK           +H +
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE----------YHAE 184
Query: 236 GGGNA--------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRF 280
           GG                 T +SDV+ +GV + E+++ G +  +G         I     
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------IPASEI 235
Query: 281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S +L+    +P      + +  + + C      +RP   ++    + +  DP
Sbjct: 236 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           SLA H ++V   GF +      +V E     SL   LH+     +  +    LR      
Sbjct: 73  SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR---QIV 127
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP---EEKRGLAG---YV 227
            G +YLH+     +IH  +K  N+ LNE    ++ D+GL+       E K+ L G   Y+
Sbjct: 128 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYI 184
Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
             +   +KG    + E DV+  G ++  +L G+   E   +K     IK+  +S      
Sbjct: 185 APEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 235
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
             IP  I P+   A +    +      RP+I ++
Sbjct: 236 --IPKHINPVA--ASLIQKMLQTDPTARPTINEL 265

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
            +H+  +G+G  G V+      TG   AVK++  RL +    F    ++    L+  P I
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKV--RLEV----FRVEELVACAGLSS-PRI 126
Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           VP+ G  +      I  E +   SL   + +       L  +R L     A  GLEYLH 
Sbjct: 127 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH- 181
Query: 182 GVAPNIIHGCIKASNILLNEKFC-ARVCDYG 211
                I+HG +KA N+LL+     A +CD+G
Sbjct: 182 --TRRILHGDVKADNVLLSSDGSRAALCDFG 210

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++  + +  +L  YL              N      + +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 206
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 207 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 264 PVEELFKLLKE 274

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 62  GFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
            ++  ++IG G  G VY A L  +G+LVA+K+     VL +  F     ++ +    H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRE-LQIMRKLDHCN 108
Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
           IV +  F  + GE+       +V +++         H +    +L     +L +     R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFR 167
Query: 175 GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            L Y+H      I H  IK  N+LL+ +    ++CD+G +      +  ++      Y  
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 224
Query: 234 EK---GGGNATRESDVYGFGVVLLEILSGR 260
            +   G  + T   DV+  G VL E+L G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 46/214 (21%)
Query: 67  RIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +  +       VA+K         +    F     T+    HP+IV
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 123 PILG-FSQAPGERIIVSEFINMASLDFYLHENN---DGASLLDWNRRLRIATGAARGLEY 178
            ++G  ++ P    I+ E   +  L  +L       D ASL+ +  +L  A        +
Sbjct: 75  KLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           +H+ +A         A N+L++   C ++ D+GLS            Y++D    +   G
Sbjct: 133 VHRDIA---------ARNVLVSSNDCVKLGDFGLS-----------RYMEDSTXXKASKG 172
Query: 239 NA---------------TRESDVYGFGVVLLEIL 257
                            T  SDV+ FGV + EIL
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           SLA H ++V   GF +      +V E     SL   LH+     +  +    LR      
Sbjct: 71  SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR---QIV 125
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP---EEKRGLAG---YV 227
            G +YLH+     +IH  +K  N+ LNE    ++ D+GL+       E K+ L G   Y+
Sbjct: 126 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182
Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
             +   +KG    + E DV+  G ++  +L G+   E   +K     IK+  +S      
Sbjct: 183 APEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 233
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSI 318
             IP  I P+   A +    +      RP+I
Sbjct: 234 --IPKHINPVA--ASLIQKMLQTDPTARPTI 260

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 33/208 (15%)
Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG+G    V  A  + TG+ VA+K I    +   +       ++ + +  HPNIV + 
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR------GL 176
                        E I      + + E   G  + D+   + R++     ++       +
Sbjct: 78  -------------EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 124
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAG---YVDDDY 231
           +Y HQ     I+H  +KA N+LL+     ++ D+G S  F    +     G   Y   + 
Sbjct: 125 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPEL 181
Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSG 259
           +  +G      E DV+  GV+L  ++SG
Sbjct: 182 F--QGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 28/161 (17%)
Query: 69  IGQGRLGTVYAA--LLSTGKLVAVKRIHPRLVLSNAGFGFAS-----VIKTLSLAQHPNI 121
           IG+G  G V+ A  L + G+ VA+KR+  R+     G   ++     V++ L   +HPN+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 122 VPILGFSQAPGERIIVSEFINMASLDF-YLHENNDGASLLDWNRRLRIATGAA------- 173
           V +            VS       L   + H + D  + LD      + T          
Sbjct: 77  VRLFDVC-------TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 174 -RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            RGL++LH   +  ++H  +K  NIL+      ++ D+GL+
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 28/161 (17%)
Query: 69  IGQGRLGTVYAA--LLSTGKLVAVKRIHPRLVLSNAGFGFAS-----VIKTLSLAQHPNI 121
           IG+G  G V+ A  L + G+ VA+KR+  R+     G   ++     V++ L   +HPN+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 122 VPILGFSQAPGERIIVSEFINMASLDF-YLHENNDGASLLDWNRRLRIATGAA------- 173
           V +            VS       L   + H + D  + LD      + T          
Sbjct: 77  VRLFDVC-------TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 174 -RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            RGL++LH   +  ++H  +K  NIL+      ++ D+GL+
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 15/203 (7%)
Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F+    IG+G  G V+  + + T K+VA+K I       +        I  LS    P +
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 122 VPILGFSQAPGERIIVSEFINMAS-LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
               G      +  I+ E++   S LD            LD  +   I     +GL+YLH
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLH 141
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GG 237
              +   IH  IKA+N+LL+E    ++ D+G++    + +     +V   +W        
Sbjct: 142 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 238 GNATRESDVYGFGVVLLEILSGR 260
                ++D++  G+  +E+  G 
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           SLA H ++V   GF +      +V E     SL   LH+     +  +    LR      
Sbjct: 95  SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR---QIV 149
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP---EEKRGLAG---YV 227
            G +YLH+     +IH  +K  N+ LNE    ++ D+GL+       E K+ L G   Y+
Sbjct: 150 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 206
Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
             +   +KG    + E DV+  G ++  +L G+   E   +K     IK+  +S      
Sbjct: 207 APEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 257
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
             IP  I P+   A +    +      RP+I ++
Sbjct: 258 --IPKHINPVA--ASLIQKMLQTDPTARPTINEL 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 15/203 (7%)
Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F+    IG+G  G V+  + + T K+VA+K I       +        I  LS    P +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 122 VPILGFSQAPGERIIVSEFINMAS-LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
               G      +  I+ E++   S LD            LD  +   I     +GL+YLH
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLH 121
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GG 237
              +   IH  IKA+N+LL+E    ++ D+G++    + +     +V   +W        
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 238 GNATRESDVYGFGVVLLEILSGR 260
                ++D++  G+  +E+  G 
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           SLA H ++V   GF +      +V E     SL   LH+     +  +    LR      
Sbjct: 97  SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR---QIV 151
Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP---EEKRGLAG---YV 227
            G +YLH+     +IH  +K  N+ LNE    ++ D+GL+       E K+ L G   Y+
Sbjct: 152 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 208
Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
             +   +KG    + E DV+  G ++  +L G+   E   +K     IK+  +S      
Sbjct: 209 APEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 259
Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
             IP  I P+   A +    +      RP+I ++
Sbjct: 260 --IPKHINPVA--ASLIQKMLQTDPTARPTINEL 289

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 28/161 (17%)
Query: 69  IGQGRLGTVYAA--LLSTGKLVAVKRIHPRLVLSNAGFGFAS-----VIKTLSLAQHPNI 121
           IG+G  G V+ A  L + G+ VA+KR+  R+     G   ++     V++ L   +HPN+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 122 VPILGFSQAPGERIIVSEFINMASLDF-YLHENNDGASLLDWNRRLRIATGAA------- 173
           V +            VS       L   + H + D  + LD      + T          
Sbjct: 77  VRLFDVC-------TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 174 -RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            RGL++LH   +  ++H  +K  NIL+      ++ D+GL+
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 15/203 (7%)
Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F+    IG+G  G V+  + + T K+VA+K I       +        I  LS    P +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 122 VPILGFSQAPGERIIVSEFINMAS-LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
               G      +  I+ E++   S LD            LD  +   I     +GL+YLH
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLH 121
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GG 237
              +   IH  IKA+N+LL+E    ++ D+G++    + +     +V   +W        
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 238 GNATRESDVYGFGVVLLEILSGR 260
                ++D++  G+  +E+  G 
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 15/203 (7%)
Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F+    IG+G  G V+  + + T K+VA+K I       +        I  LS    P +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 122 VPILGFSQAPGERIIVSEFINMAS-LDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
               G      +  I+ E++   S LD            LD  +   I     +GL+YLH
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLH 136
Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK---GG 237
              +   IH  IKA+N+LL+E    ++ D+G++    + +     +V   +W        
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 238 GNATRESDVYGFGVVLLEILSGR 260
                ++D++  G+  +E+  G 
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 41/191 (21%)
Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHE------------NNDGASLLDW 162
           + +H NI+ +LG     G   ++  + +  +L  YL              N      + +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
              +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R 
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RD 206
Query: 223 LAGYVDDDYWHEKGGGN---------------ATRESDVYGFGVVLLEILS-GRRCEEGL 266
           +      DY+ +   G                 T +SDV+ FGV++ EI + G     G+
Sbjct: 207 INNI---DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 267 LVKWALPLIKE 277
            V+    L+KE
Sbjct: 264 PVEELFKLLKE 274

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 63  FSHRRIIGQGRLGTVYAAL----LSTGKLVAVKRIHPRLVLSNAGFGFASVIK--TLSLA 116
           F   R++G+G  G V+        +TGK+ A+K +   +++ NA     +  +   L   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HP IV ++   Q  G+  ++ E+++   L  ++    +G  + D           A G 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG- 135
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
            +LHQ     II+  +K  NI+LN +   ++ D+GL
Sbjct: 136 -HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 63  FSHRRIIGQGRLGTVYAAL----LSTGKLVAVKRIHPRLVLSNAGFGFASVIK--TLSLA 116
           F   R++G+G  G V+        +TGK+ A+K +   +++ NA     +  +   L   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           +HP IV ++   Q  G+  ++ E+++   L  ++    +G  + D           A G 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG- 135
Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
            +LHQ     II+  +K  NI+LN +   ++ D+GL
Sbjct: 136 -HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 99/254 (38%), Gaps = 31/254 (12%)
Query: 52  PLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLV-AVKRIHPRLVLSNAGFGFASVI 110
           P +   A    F   ++IG+G  G V  A     ++  AVK +  + +L           
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 111 KTLSL--AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
           + + L   +HP +V +    Q   +   V ++IN   L ++L         L+   R   
Sbjct: 89  RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARF-Y 144
Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR------G 222
           A   A  L YLH   + NI++  +K  NILL+ +    + D+GL     E         G
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE 282
              Y+  +  H++      R  D +  G VL E+L G            LP       +E
Sbjct: 202 TPEYLAPEVLHKQP---YDRTVDWWCLGAVLYEMLYG------------LPPFYSRNTAE 246
Query: 283 LLDPRLAIPCEIKP 296
           + D  L  P ++KP
Sbjct: 247 MYDNILNKPLQLKP 260

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	332
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-90
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-84
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-78
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-39
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-22
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-17
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-16
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-16
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-16
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-16
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-16
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-15
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-15
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-15
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-14
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-14
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-14
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-14
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-14
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-14
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-13
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-13
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-13
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-12
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-12
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-12
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-12
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-11
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-11
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-11
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-11
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-11
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-11
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-10
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-10
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-10
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-10
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-10
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-09
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-09
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-09
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-08
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-08
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-08
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-08
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-08
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-07
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-07
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-07
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-07
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-07
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-07
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-07
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-06
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-06
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-06
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-05
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-05
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-04
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  272 bits (698), Expect = 2e-90
 Identities = 101/296 (34%), Positives = 162/296 (54%), Gaps = 30/296 (10%)

Query: 51  YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFG----- 105
           + L E+  A+D FS++ I+G+G  G VY   L+ G LVAVKR      L           
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR------LKEERTQGGELQ 73

Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           F + ++ +S+A H N++ + GF   P ER++V  ++   S+   L E  +    LDW +R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK----- 220
            RIA G+ARGL YLH    P IIH  +KA+NILL+E+F A V D+GL+ L   +      
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193

Query: 221 --RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC---------EEGLLVK 269
             RG  G++  +Y      G ++ ++DV+G+GV+LLE+++G+R          ++ +L+ 
Sbjct: 194 AVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 270 WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL 325
           W   L+KE +   L+D  L    + + + +L +VAL C  +S   RP + +V  +L
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  255 bits (654), Expect = 6e-84
 Identities = 100/309 (32%), Positives = 157/309 (50%), Gaps = 27/309 (8%)

Query: 33  KKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKR 92
              + S   +P +      PL +++ AT+ F H+ +IG G  G VY  +L  G  VA+KR
Sbjct: 13  NDALSSSYLVPFESYRV--PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70

Query: 93  IHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH 151
             P    S+ G   F + I+TLS  +HP++V ++GF     E I++ +++   +L  +L+
Sbjct: 71  RTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127

Query: 152 ENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
            ++     + W +RL I  GAARGL YLH      IIH  +K+ NILL+E F  ++ D+G
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184

Query: 212 LSFLAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR-- 261
           +S    E          +G  GY+D +Y+     G  T +SDVY FGVVL E+L  R   
Sbjct: 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFI---KGRLTEKSDVYSFGVVLFEVLCARSAI 241

Query: 262 -----CEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP 316
                 E   L +WA+      +  +++DP LA     + L +    A+ C+  S ++RP
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301

Query: 317 SIVQVATIL 325
           S+  V   L
Sbjct: 302 SMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  239 bits (612), Expect = 8e-78
 Identities = 87/315 (27%), Positives = 148/315 (46%), Gaps = 34/315 (10%)

Query: 37  ESEETLPIKLCAFAYPLTEIDAATDGFSHRR------IIGQGRLGTVYAALLSTGKLVAV 90
           +S E    +  +F++   E+   T+ F  R        +G+G  G VY   ++    VAV
Sbjct: 3   KSLEVSDTRFHSFSF--YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAV 59

Query: 91  KRIHPRLVL-SNAGFG-FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDF 148
           K++   + + +      F   IK ++  QH N+V +LGFS    +  +V  ++   SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 149 YLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC 208
            L    DG   L W+ R +IA GAA G+ +LH+    + IH  IK++NILL+E F A++ 
Sbjct: 120 RLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKIS 175

Query: 209 DYGLSFLAPEEKR--------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           D+GL+  + +  +        G   Y+  +       G  T +SD+Y FGVVLLEI++G 
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALR----GEITPKSDIYSFGVVLLEIITGL 231

Query: 261 RC-----EEGLLVKWALPLIKEMR-FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKN 314
                  E  LL+     +  E +   + +D ++    +   +  +  VA  C+   +  
Sbjct: 232 PAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNK 290

Query: 315 RPSIVQVATILNNLV 329
           RP I +V  +L  + 
Sbjct: 291 RPDIKKVQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  171 bits (435), Expect = 3e-51
 Identities = 64/314 (20%), Positives = 114/314 (36%), Gaps = 49/314 (15%)

Query: 52  PLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIK 111
               +   +       +  +GR G V+ A L   + VAVK    +       +     + 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVY 70

Query: 112 TLSLAQHPNIVPILGFSQAP----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR 167
           +L   +H NI+  +G  +       +  +++ F    SL  +L  N     ++ WN    
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCH 125

Query: 168 IATGAARGLEYLHQGVA-------PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK 220
           IA   ARGL YLH+ +        P I H  IK+ N+LL     A + D+GL+      K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 221 -----RGLAG--------YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL 267
                 G  G         ++     ++   +A    D+Y  G+VL E+ S     +G +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQR---DAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 268 ---------VKWALPLIKEMR---FSELLDPRLAIPCEIKPLVR-LAKVALACVGNSRKN 314
                         P +++M+     +   P L    +    +  L +    C  +  + 
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 315 RPSIVQVATILNNL 328
           R S   V   +  +
Sbjct: 303 RLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  144 bits (364), Expect = 1e-40
 Identities = 68/328 (20%), Positives = 108/328 (32%), Gaps = 60/328 (18%)

Query: 49  FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFAS 108
            A     +D   D      +IG+GR G VY   L   + VAVK        +   F    
Sbjct: 3   AAASEPSLD--LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA---NRQNFINEK 56

Query: 109 VIKTLSLAQHPNIVPILGFSQAPG-----ERIIVSEFINMASLDFYLHENNDGASLLDWN 163
            I  + L +H NI   +   +        E ++V E+    SL  YL  +       DW 
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWV 111

Query: 164 RRLRIATGAARGLEYLHQGVA------PNIIHGCIKASNILLNEKFCARVCDYGLSFLAP 217
              R+A    RGL YLH  +       P I H  + + N+L+       + D+GLS    
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 218 EEKRGLAGYVDDDYWHEKG------------------GGNATRESDVYGFGVVLLEILSG 259
             +    G  D+    E G                    +A ++ D+Y  G++  EI   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM- 230

Query: 260 RRCEEGL-------------LVKWALPLIKEMRFSELLD-PRLAIPCEIKP----LVRLA 301
            RC +                     P  ++M+     +  R   P   K     +  L 
Sbjct: 231 -RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 302 KVALACVGNSRKNRPSIVQVATILNNLV 329
           +    C     + R +       +  L+
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELM 317

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  140 bits (356), Expect = 4e-40
 Identities = 55/277 (19%), Positives = 110/277 (39%), Gaps = 39/277 (14%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
             + +   G ++      G  + VK +  R   +     F      L +  HPN++P+LG
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 127 FSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
             Q+P      +++ ++   SL   LHE  +   ++D ++ ++ A   ARG+ +LH  + 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH-TLE 131

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW-------HEKGG 237
           P I    + + +++++E   AR+    + F    +  G         W        +   
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFS--FQSPGRMYAP---AWVAPEALQKKPED 186

Query: 238 GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL------DPRLAIP 291
            N  R +D++ F V+L E+++             +P   ++   E+         R  IP
Sbjct: 187 TN-RRSADMWSFAVLLWELVTRE-----------VPF-ADLSNMEIGMKVALEGLRPTIP 233

Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             I P   ++K+   C+      RP    +  IL  +
Sbjct: 234 PGISP--HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  140 bits (356), Expect = 1e-39
 Identities = 58/284 (20%), Positives = 102/284 (35%), Gaps = 32/284 (11%)

Query: 53  LTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT 112
           L  ID          ++G+G  G V  A     K VA+K+I            F   ++ 
Sbjct: 2   LHMIDY--KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA----FIVELRQ 54

Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           LS   HPNIV + G    P    +V E+    SL   LH   +          +      
Sbjct: 55  LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQC 111

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCDYGLSFLAPEEKRGLAGYVDDDY 231
           ++G+ YLH      +IH  +K  N+LL       ++CD+G +           G      
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA---A 168

Query: 232 W-------HEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL 284
           W               + + DV+ +G++L E+++ R+  + +        I     +   
Sbjct: 169 WMAPEVFEGSN----YSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAVHNGT- 221

Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             R  +   +     +  +   C       RPS+ ++  I+ +L
Sbjct: 222 --RPPLIKNLPK--PIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  139 bits (352), Expect = 2e-39
 Identities = 71/278 (25%), Positives = 109/278 (39%), Gaps = 31/278 (11%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFG-----FASVIKTLSLAQHPN 120
           + IG+G  G V+   L+    +VA+K +                 F   +  +S   HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           IV + G    P    +V EF+    L   L +       + W+ +LR+    A G+EY+ 
Sbjct: 85  IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ 139

Query: 181 QGVAPNIIHGCIKASNILLNEK-----FCARVCDYGLSFLAPEEKRGLAGYVDDDYW--- 232
               P I+H  +++ NI L         CA+V D+GLS  +     GL G      W   
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNF---QWMAP 195

Query: 233 --HEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI 290
                   + T ++D Y F ++L  IL+G    +       +  I  +R   L   R  I
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-GKIKFINMIREEGL---RPTI 251

Query: 291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           P +  P  RL  V   C     K RP    +   L+ L
Sbjct: 252 PEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  139 bits (353), Expect = 3e-39
 Identities = 61/292 (20%), Positives = 104/292 (35%), Gaps = 35/292 (11%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTL 113
                     H  ++G+G  G         TG+++ +K +            F   +K +
Sbjct: 6   IFRP--SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVM 61

Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
              +HPN++  +G          ++E+I   +L   +   +   S   W++R+  A   A
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIA 118

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------FLAPEEKRGLAGYV 227
            G+ YLH     NIIH  + + N L+ E     V D+GL+         PE  R L    
Sbjct: 119 SGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 228 DDDYWHEKG-----------GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK 276
               +   G           G +   + DV+ FG+VL EI+     +        LP   
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LPRTM 230

Query: 277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           +   +         P    P      + + C     + RPS V++   L  L
Sbjct: 231 DFGLNVRGFLDRYCPPNCPP--SFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  138 bits (351), Expect = 5e-39
 Identities = 77/273 (28%), Positives = 120/273 (43%), Gaps = 30/273 (10%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
             IG G  GTV+ A    G  VAVK +  +   +     F   +  +   +HPNIV  +G
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
               P    IV+E+++  SL   LH++     L D  RRL +A   A+G+ YLH    P 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL-DERRRLSMAYDVAKGMNYLHNR-NPP 159

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG---------- 236
           I+H  +K+ N+L+++K+  +VCD+GLS L                    G          
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--------AAGTPEWMAPEVL 211

Query: 237 -GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK 295
               +  +SDVY FGV+L E+ + ++    L       ++  + F      RL IP  + 
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKCK---RLEIPRNLN 265

Query: 296 PLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           P  ++A +   C  N    RPS   +  +L  L
Sbjct: 266 P--QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  130 bits (329), Expect = 1e-35
 Identities = 56/286 (19%), Positives = 109/286 (38%), Gaps = 48/286 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
            +IG+GR G VY      G+ VA++ I       +    F   +      +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
              +P    I++      +L   + +      +LD N+  +IA    +G+ YLH   A  
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLS-----------------------FLAPEEKRGL 223
           I+H  +K+ N+  +      + D+GL                         LAPE  R L
Sbjct: 151 ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI-KEMRFSE 282
           +   ++D          ++ SDV+  G +  E+ +     +    +  +  +   M+   
Sbjct: 210 SPDTEEDKLP------FSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--- 260

Query: 283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
               ++ +  EI  ++        C    ++ RP+  ++  +L  L
Sbjct: 261 PNLSQIGMGKEISDILL------FCWAFEQEERPTFTKLMDMLEKL 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (327), Expect = 3e-35
 Identities = 63/307 (20%), Positives = 110/307 (35%), Gaps = 65/307 (21%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG+GR G V+      G+ VAVK        S   +   + I    L +H NI+  + 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGFIA 98

Query: 127 FSQAPGERI----IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
                        +++++    SL  YL         LD    L++A  +  GL +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153

Query: 183 VA-----PNIIHGCIKASNILLNEKFCARVCDYGLSFL---------------------- 215
           +      P I H  +K+ NIL+ +     + D GL+                        
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 216 APEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK------ 269
            PE                         +D+Y FG++L E+   RRC  G +V+      
Sbjct: 214 PPEVLDESLNRNHFQS---------YIMADMYSFGLILWEVA--RRCVSGGIVEEYQLPY 262

Query: 270 ----WALPLIKEMRFSELLD-PRLAIPCEIKP---LVRLAKVALACVGNSRKNRPSIVQV 321
                + P  ++MR    +   R + P        L ++ K+   C  ++  +R + ++V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 322 ATILNNL 328
              L  +
Sbjct: 323 KKTLAKM 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (322), Expect = 2e-34
 Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 65/306 (21%)

Query: 68  IIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG- 126
            IG+GR G V+      G+ VAVK    R   S   +   + I    + +H NI+  +  
Sbjct: 49  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAA 104

Query: 127 ---FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
               +    +  +VS++    SL  YL+        +     +++A   A GL +LH  +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEI 159

Query: 184 A-----PNIIHGCIKASNILLNEKFCARVCDYGLSFL----------------------A 216
                 P I H  +K+ NIL+ +     + D GL+                        A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 217 PEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK------- 269
           PE           +           + +D+Y  G+V  EI   RRC  G + +       
Sbjct: 220 PEVLDDSINMKHFES---------FKRADIYAMGLVFWEIA--RRCSIGGIHEDYQLPYY 268

Query: 270 ---WALPLIKEMRFSELLD-PRLAIPCEIK---PLVRLAKVALACVGNSRKNRPSIVQVA 322
               + P ++EMR        R  IP   +    L  +AK+   C   +   R + +++ 
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

Query: 323 TILNNL 328
             L+ L
Sbjct: 329 KTLSQL 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  126 bits (319), Expect = 2e-34
 Identities = 67/307 (21%), Positives = 110/307 (35%), Gaps = 65/307 (21%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
             +G+GR G V+      G+ VAVK    R   S   +   + +    + +H NI+  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGFIA 69

Query: 127 ----FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
                  +  +  +++ +  M SL  YL         LD    LRI    A GL +LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIE 124

Query: 183 VA-----PNIIHGCIKASNILLNEKFCARVCDYGLSFL---------------------- 215
           +      P I H  +K+ NIL+ +     + D GL+ +                      
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 216 APEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK------ 269
           APE           D           +  D++ FG+VL E+   RR     +V+      
Sbjct: 185 APEVLDETIQVDCFDS---------YKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPF 233

Query: 270 ----WALPLIKEMRFSELLD-PRLAIPCEIKP---LVRLAKVALACVGNSRKNRPSIVQV 321
                  P  ++MR    +D  R  IP        L  LAK+   C   +   R + +++
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

Query: 322 ATILNNL 328
              L  +
Sbjct: 294 KKTLTKI 300

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  125 bits (317), Expect = 3e-34
 Identities = 70/280 (25%), Positives = 106/280 (37%), Gaps = 39/280 (13%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLV--LSNAGFGFASVIKTLSLAQHPNIVPI 124
            IIG G  G VY A    G  VAVK         +S          K  ++ +HPNI+ +
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G         +V EF     L+  L         +  +  +  A   ARG+ YLH    
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAI 126

Query: 185 PNIIHGCIKASNILLNEKF--------CARVCDYGLS-FLAPEEKRGLAGYVDDDYW--- 232
             IIH  +K+SNIL+ +K           ++ D+GL+       K   AG      W   
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA---WMAP 183

Query: 233 ----HEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL 288
                       ++ SDV+ +GV+L E+L+G     G+     L +   +  ++L    L
Sbjct: 184 EVIRASM----FSKGSDVWSYGVLLWELLTGEVPFRGID---GLAVAYGVAMNKL---AL 233

Query: 289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
            IP         AK+   C      +RPS   +   L  +
Sbjct: 234 PIPSTCPE--PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  125 bits (316), Expect = 5e-34
 Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 27/273 (9%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG G  GTVY      G  VAVK ++           F + +  L   +H NI+  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
           +S AP +  IV+++   +SL  +LH +    +  +  + + IA   ARG++YLH   A +
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKS 140

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLS-----FLAPEEKRGLAGYVDDDYW------HEK 235
           IIH  +K++NI L+E    ++ D+GL+     +    +   L+G +    W        +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI---LWMAPEVIRMQ 197

Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK 295
                + +SDVY FG+VL E+++G+     +  +    +I+ +    L      +     
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLSPDLSKVRSNCP 255

Query: 296 PLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
              R+ ++   C+   R  RPS  ++   +  L
Sbjct: 256 K--RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  101 bits (254), Expect = 4e-24
 Identities = 72/323 (22%), Positives = 128/323 (39%), Gaps = 56/323 (17%)

Query: 30  LCKK--KPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL 87
           LC +      + +     L   A+   EI    +       +GQG  G V+    +    
Sbjct: 239 LCHRLTTVCPTSKPQTQGLAKDAW---EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR 293

Query: 88  VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG-FSQAPGERIIVSEFINMASL 146
           VA+K + P  +   A    A V+K L   +H  +V +    S+ P    IV+E+++  SL
Sbjct: 294 VAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVVSEEP--IYIVTEYMSKGSL 348

Query: 147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR 206
             +L         L   + + +A   A G+ Y+ +    N +H  ++A+NIL+ E    +
Sbjct: 349 LDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK 403

Query: 207 VCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------------GNATRESDVYGFGVV 252
           V D+GL+       R +    D++Y   +G               G  T +SDV+ FG++
Sbjct: 404 VADFGLA-------RLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453

Query: 253 LLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP--CEIKPLVRLAKVALACVG 309
           L E+ + GR    G++ +  L  ++          R+  P  C   P   L  +   C  
Sbjct: 454 LTELTTKGRVPYPGMVNREVLDQVER-------GYRMPCPPEC---P-ESLHDLMCQCWR 502

Query: 310 NSRKNRPSIVQVATILNNLVGDP 332
              + RP+   +   L +     
Sbjct: 503 KEPEERPTFEYLQAFLEDYFTST 525

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  100 bits (250), Expect = 6e-24
 Identities = 67/321 (20%), Positives = 111/321 (34%), Gaps = 52/321 (16%)

Query: 32  KKKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL-VAV 90
            ++P+  +  + +   A       ++   +       IG+G  G V++  L      VAV
Sbjct: 88  TQQPLTKKSGVVLHR-AVPKDKWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAV 144

Query: 91  KRIHPRLVLSNAGFGF---ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLD 147
           K      +  +    F   A ++K      HPNIV ++G         IV E +      
Sbjct: 145 KSCRET-LPPDLKAKFLQEARILKQY---SHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200

Query: 148 FYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV 207
            +L       + L     L++   AA G+EYL        IH  + A N L+ EK   ++
Sbjct: 201 TFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKI 254

Query: 208 CDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA---------------TRESDVYGFGVV 252
            D+G+S       R  A   D  Y    G                   + ESDV+ FG++
Sbjct: 255 SDFGMS-------REEA---DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304

Query: 253 LLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNS 311
           L E  S G      L  +     +++         RL  P        + ++   C    
Sbjct: 305 LWETFSLGASPYPNLSNQQTREFVEK-------GGRLPCPELCPD--AVFRLMEQCWAYE 355

Query: 312 RKNRPSIVQVATILNNLVGDP 332
              RPS   +   L ++    
Sbjct: 356 PGQRPSFSTIYQELQSIRKRH 376

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 96.9 bits (242), Expect = 1e-23
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 38/223 (17%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS 114
           E+    +       +G G+ G V+    +    VAVK +    +  +A    A+++K L 
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL- 65

Query: 115 LAQHPNIVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
             QH  +V +    +Q P    I++E++   SL  +L   +     L  N+ L +A   A
Sbjct: 66  --QHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIA 119

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH 233
            G+ ++ +    N IH  ++A+NIL+++    ++ D+GL+       R +    D++Y  
Sbjct: 120 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA-------RLIE---DNEYTA 166

Query: 234 EKGG--------------GNATRESDVYGFGVVLLEILS-GRR 261
            +G               G  T +SDV+ FG++L EI++ GR 
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 71/321 (22%), Positives = 127/321 (39%), Gaps = 52/321 (16%)

Query: 30  LCKK--KPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL 87
           LC +      + +     L   A+   EI    +       +GQG  G V+    +    
Sbjct: 156 LCHRLTTVCPTSKPQTQGLAKDAW---EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR 210

Query: 88  VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG-FSQAPGERIIVSEFINMASL 146
           VA+K + P  +   A    A V+K L   +H  +V +    S+ P    IV+E+++  SL
Sbjct: 211 VAIKTLKPGTMSPEAFLQEAQVMKKL---RHEKLVQLYAVVSEEP--IYIVTEYMSKGSL 265

Query: 147 DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR 206
             +L         L   + + +A   A G+ Y+ +    N +H  ++A+NIL+ E    +
Sbjct: 266 LDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCK 320

Query: 207 VCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------------GNATRESDVYGFGVV 252
           V D+GL+       R +    D++Y   +G               G  T +SDV+ FG++
Sbjct: 321 VADFGLA-------RLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370

Query: 253 LLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNS 311
           L E+ + GR    G++ +  L  ++          R+  P E      L  +   C    
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQVER-------GYRMPCPPECPE--SLHDLMCQCWRKE 421

Query: 312 RKNRPSIVQVATILNNLVGDP 332
            + RP+   +   L +     
Sbjct: 422 PEERPTFEYLQAFLEDYFTST 442

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 95.4 bits (238), Expect = 5e-23
 Identities = 52/229 (22%), Positives = 84/229 (36%), Gaps = 36/229 (15%)

Query: 48  AFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFA 107
              Y   EID      +  + +G G+ G V          VA+K I    +  +     A
Sbjct: 13  GLGYGSWEIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA 70

Query: 108 SVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR 167
            V+  L    H  +V + G         I++E++    L  YL E             L 
Sbjct: 71  KVMMNL---SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLE 124

Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYV 227
           +       +EYL        +H  + A N L+N++   +V D+GLS       R +    
Sbjct: 125 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVL--- 171

Query: 228 DDDYWHEKGG--------------GNATRESDVYGFGVVLLEILS-GRR 261
           DD+Y    G                  + +SD++ FGV++ EI S G+ 
Sbjct: 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 94.6 bits (236), Expect = 9e-23
 Identities = 49/210 (23%), Positives = 79/210 (37%), Gaps = 34/210 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + +G G+ G V          VAVK I    +  +  F  A  +  L    HP +V   G
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL---SHPKLVKFYG 70

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                    IV+E+I+   L  YL  +  G         L +      G+ +L       
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ---LLEMCYDVCEGMAFLES---HQ 124

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------- 237
            IH  + A N L++   C +V D+G++       R +    DD Y    G          
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT-------RYVL---DDQYVSSVGTKFPVKWSAP 174

Query: 238 -----GNATRESDVYGFGVVLLEILS-GRR 261
                   + +SDV+ FG+++ E+ S G+ 
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 94.6 bits (236), Expect = 1e-22
 Identities = 49/210 (23%), Positives = 79/210 (37%), Gaps = 34/210 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG G+ G V+         VA+K I    +        A V+  L    HP +V + G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL---SHPKLVQLYG 70

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                    +V+EF+    L  YL       +       L +      G+ YL +     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEE---AC 124

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------- 237
           +IH  + A N L+ E    +V D+G++       R +    DD Y    G          
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMT-------RFVL---DDQYTSSTGTKFPVKWASP 174

Query: 238 -----GNATRESDVYGFGVVLLEILS-GRR 261
                   + +SDV+ FGV++ E+ S G+ 
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 38/231 (16%)

Query: 47  CAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGF 106
             +     EI    +     + +G G+ G V+ A  +    VAVK + P  +   A    
Sbjct: 176 KPWEKDAWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAE 233

Query: 107 ASVIKTLSLAQHPNIVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           A+V+KTL   QH  +V +    ++ P    I++EF+   SL  +L  +    S     + 
Sbjct: 234 ANVMKTL---QHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDFLKSD--EGSKQPLPKL 286

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
           +  +   A G+ ++ Q    N IH  ++A+NIL++     ++ D+GL+       R +  
Sbjct: 287 IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLA-------RVIE- 335

Query: 226 YVDDDYWHEKGG--------------GNATRESDVYGFGVVLLEILS-GRR 261
             D++Y   +G               G+ T +SDV+ FG++L+EI++ GR 
Sbjct: 336 --DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 70/299 (23%), Positives = 118/299 (39%), Gaps = 55/299 (18%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQHPN 120
             +G+G  G+V          +TG LVAVK++          F     ++K L       
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL---HSDF 85

Query: 121 IVPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           IV   G S  PG +   +V E++    L  +L  +      LD +R L  ++   +G+EY
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 142

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           L        +H  + A NIL+  +   ++ D+GL+       + L   +D DY+  +  G
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLA-------KLL--PLDKDYYVVREPG 190

Query: 239 NA---------------TRESDVYGFGVVLLEILS-GRR--CEEGLLVKWALPLIKEMRF 280
            +               +R+SDV+ FGVVL E+ +   +        ++           
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250

Query: 281 SELLDP-----RLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           S LL+      RL  P  C   P   + ++   C   S ++RPS   +   L+ L    
Sbjct: 251 SRLLELLEEGQRLPAPPAC---PA-EVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 66/300 (22%), Positives = 123/300 (41%), Gaps = 56/300 (18%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQHPN 120
           + +G+G  G+V          +TG++VAVK++          F     ++K+L   QH N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL---QHDN 72

Query: 121 IVPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           IV   G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EY
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEY 129

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           L        IH  +   NIL+  +   ++ D+GL+       + L    D +++  K  G
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLT-------KVL--PQDKEFFKVKEPG 177

Query: 239 NA---------------TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE----MR 279
            +               +  SDV+ FGVVL E+ +     +    ++   +  +    M 
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237

Query: 280 FSELLDP-----RLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
              L++      RL  P  C   P   +  +   C  N+   RPS   +A  ++ +  + 
Sbjct: 238 VFHLIELLKNNGRLPRPDGC---PD-EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 52/295 (17%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           R +G+G  G V          +TG+ VAVK + P     N        I+ L    H NI
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENI 85

Query: 122 VPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           V   G     G     ++ EF+   SL  YL +N +    ++  ++L+ A    +G++YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN 239
                   +H  + A N+L+  +   ++ D+GL+       + +    D +Y+  K   +
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLT-------KAI--ETDKEYYTVKDDRD 190

Query: 240 A---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLI--KEMRFS 281
           +                  SDV+ FGV L E+L+        + +   +      +M  +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250

Query: 282 ELLDP-----RLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
            L++      RL  P  C   P   + ++   C      NR S   +      L+
Sbjct: 251 RLVNTLKEGKRLPCPPNC---PD-EVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 71/317 (22%), Positives = 123/317 (38%), Gaps = 47/317 (14%)

Query: 33  KKPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVK 91
             P        I   +  Y   E++      + +  +G G+ G VY  +       VAVK
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 251

Query: 92  RIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH 151
            +    +        A+V+K +   +HPN+V +LG         I++EF+   +L  YL 
Sbjct: 252 TLKEDTMEVEEFLKEAAVMKEI---KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308

Query: 152 ENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
           E N     +     L +AT  +  +EYL +    N IH  + A N L+ E    +V D+G
Sbjct: 309 ECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFG 363

Query: 212 LSFLAPEEKRGLAGYVDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEI 256
           LS       R     +  D +    G                  + +SDV+ FGV+L EI
Sbjct: 364 LS-------R----LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

Query: 257 LS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNR 315
            + G     G+ +     L+++       D R+  P       ++ ++  AC   +  +R
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEK-------DYRMERPEGCPE--KVYELMRACWQWNPSDR 463

Query: 316 PSIVQVATILNNLVGDP 332
           PS  ++      +  + 
Sbjct: 464 PSFAEIHQAFETMFQES 480

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.8 bits (234), Expect = 4e-22
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 51/222 (22%)

Query: 67  RIIGQGRLGTVYAALLSTGKL-----VAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQH 118
           +++G G  GTVY  L           VA+K +        A       A V+ ++    +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV---DN 76

Query: 119 PNIVPILGF-SQAPGERIIVSEFINMASLDFYLHENNDG---ASLLDWNRRLRIATGAAR 174
           P++  +LG    +     ++++ +    L  Y+ E+ D      LL+W          A+
Sbjct: 77  PHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           G+ YL       ++H  + A N+L+      ++ D+GL+       + L    ++  +H 
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEYHA 176

Query: 235 KGG--------------GNATRESDVYGFGVVLLEILS-GRR 261
           +GG                 T +SDV+ +GV + E+++ G +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 92.8 bits (231), Expect = 5e-22
 Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 43/217 (19%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
              IG+G   TVY  L   T   VA   +  R +  +    F    + L   QHPNIV  
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 125 LGFSQAPGER----IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
               ++  +     ++V+E +   +L  YL        ++             +GL++LH
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH 146

Query: 181 QGVAPNIIHGCIKASNILLNEKF-CARVCDYGLS----------------FLAPEEKRGL 223
               P IIH  +K  NI +       ++ D GL+                F+APE     
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPE----- 200

Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               ++ Y             DVY FG+ +LE+ +  
Sbjct: 201 --MYEEKY---------DESVDVYAFGMCMLEMATSE 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 92.7 bits (231), Expect = 6e-22
 Identities = 51/218 (23%), Positives = 83/218 (38%), Gaps = 45/218 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
           R IG+G+ G V+  +  + +     VA+K         +    F   A  ++      HP
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF---DHP 76

Query: 120 NIVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           +IV ++G  ++ P    I+ E   +  L  +L        L      +  A   +  L Y
Sbjct: 77  HIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAY 131

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG- 237
           L        +H  I A N+L++   C ++ D+GLS       R +    D  Y+    G 
Sbjct: 132 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYME---DSTYYKASKGK 178

Query: 238 -------------GNATRESDVYGFGVVLLEILS-GRR 261
                           T  SDV+ FGV + EIL  G +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.4 bits (230), Expect = 1e-21
 Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 56/296 (18%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGF-GFASVIKTLSLAQHPN 120
           + +G+G  G+V          +TG++VAVK++          F     ++K+L   QH N
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL---QHDN 103

Query: 121 IVPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           IV   G   + G R   ++ E++   SL  YL ++ +    +D  + L+  +   +G+EY
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEY 160

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           L        IH  +   NIL+  +   ++ D+GL+ + P+         D +Y+  K  G
Sbjct: 161 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ---------DKEYYKVKEPG 208

Query: 239 NA---------------TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE----MR 279
            +               +  SDV+ FGVVL E+ +     +    ++   +  +    M 
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268

Query: 280 FSELLDP-----RLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
              L++      RL  P  C   P   +  +   C  N+   RPS   +A  ++ +
Sbjct: 269 VFHLIELLKNNGRLPRPDGC---PD-EIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 44/218 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHPN 120
           + +G G  GTV        K+   VAVK +                A+V++ L    +P 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL---DNPY 79

Query: 121 IVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           IV ++G  +   E   +V E   +  L+ YL +N      +     + +    + G++YL
Sbjct: 80  IVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL 133

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN 239
            +    N +H  + A N+LL  +  A++ D+GLS       + L    D++Y+  +  G 
Sbjct: 134 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLS-------KAL--RADENYYKAQTHGK 181

Query: 240 ------A---------TRESDVYGFGVVLLEILS-GRR 261
                 A         + +SDV+ FGV++ E  S G++
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.4 bits (225), Expect = 5e-21
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKL-VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G G+ G VY  +     L VAVK +    +        A+V+K +   +HPN+V +L
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLVQLL 75

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
           G         I++EF+   +L  YL E N     +     L +AT  +  +EYL +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---K 130

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN------ 239
           N IH  + A N L+ E    +V D+GLS       R     +  D +    G        
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLS-------R----LMTGDTYTAHAGAKFPIKWT 179

Query: 240 A---------TRESDVYGFGVVLLEILS-GRR 261
           A         + +SDV+ FGV+L EI + G  
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 89.6 bits (223), Expect = 7e-21
 Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 44/219 (20%)

Query: 66  RRIIGQGRLGTVYAALLSTGK---LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
              +G G  G+V   +    K    VA+K +                A ++  L    +P
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQL---DNP 70

Query: 120 NIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
            IV ++G  Q   E + +V E      L  +L    +    +  +    +    + G++Y
Sbjct: 71  YIVRLIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKY 125

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           L +    N +H  + A N+LL  +  A++ D+GLS       + L    DD Y+  +  G
Sbjct: 126 LEE---KNFVHRDLAARNVLLVNRHYAKISDFGLS-------KAL--GADDSYYTARSAG 173

Query: 239 N------A---------TRESDVYGFGVVLLEILS-GRR 261
                  A         +  SDV+ +GV + E LS G++
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 90.1 bits (224), Expect = 7e-21
 Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 54/294 (18%)

Query: 67  RIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           R +G+G  G V           TG++VAVK +           G+   I  L    H +I
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHI 95

Query: 122 VPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           +   G  +  G     +V E++ + SL  YL  ++     +   + L  A     G+ YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 150

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGN 239
           H     + IH  + A N+LL+     ++ D+GL+       + +      +Y+  +  G+
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLA-------KAV--PEGHEYYRVREDGD 198

Query: 240 A---------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLI--KEMRFS 281
           +                  SDV+ FGV L E+L+     +        L  I   +M   
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258

Query: 282 ELLDP-----RLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
            L +      RL  P  C   P   +  +   C       RP+   +  IL  +
Sbjct: 259 RLTELLERGERLPRPDKC---PA-EVYHLMKNCWETEASFRPTFENLIPILKTV 308

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 89.2 bits (222), Expect = 9e-21
 Identities = 57/218 (26%), Positives = 87/218 (39%), Gaps = 45/218 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGKL----VAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
           RI+G+G  G VY  + +  K     VAVK         +    F   A ++K L    HP
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNL---DHP 73

Query: 120 NIVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           +IV ++G   + P    I+ E      L  YL  N +   +L     +  +    + + Y
Sbjct: 74  HIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAY 128

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG- 237
           L      N +H  I   NIL+    C ++ D+GLS       R +    D+DY+      
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLS-------RYIE---DEDYYKASVTR 175

Query: 238 -------------GNATRESDVYGFGVVLLEILS-GRR 261
                           T  SDV+ F V + EILS G++
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 89.7 bits (223), Expect = 1e-20
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 46/220 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
           +IIG G  G V    L         VA+K +            F   AS++       HP
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQF---DHP 110

Query: 120 NIVPILG--FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           NI+ + G          +IV+E++   SLD +L  ++   +++     + +  G   G+ 
Sbjct: 111 NIIRLEGVVTRGRL--AMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGMR 165

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG 237
           YL        +H  + A N+L++     +V D+GLS       R L    D D  +   G
Sbjct: 166 YLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLS-------RVL--EDDPDAAYTTTG 213

Query: 238 GN------A---------TRESDVYGFGVVLLEILS-GRR 261
           G       A         +  SDV+ FGVV+ E+L+ G R
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 45/220 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK-----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQH 118
           ++IG G  G VY  +L T        VA+K +            F   A ++       H
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQF---SH 105

Query: 119 PNIVPILG--FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
            NI+ + G      P   +I++E++   +LD +L E +   S+L     + +  G A G+
Sbjct: 106 HNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAGM 160

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKG 236
           +YL      N +H  + A NIL+N     +V D+GLS       R L    +  Y    G
Sbjct: 161 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS-------RVLEDDPEATY-TTSG 209

Query: 237 G--------------GNATRESDVYGFGVVLLEILS-GRR 261
           G                 T  SDV+ FG+V+ E+++ G R
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 87.6 bits (218), Expect = 3e-20
 Identities = 60/232 (25%), Positives = 93/232 (40%), Gaps = 48/232 (20%)

Query: 49  FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGF-- 106
           F      ++         + IG+G  G V       G  VAVK I            F  
Sbjct: 11  FYRSGWALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA----FLA 63

Query: 107 -ASVIKTLSLAQHPNIVPILGF-SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNR 164
            ASV+  L   +H N+V +LG   +  G   IV+E++   SL  YL     G S+L  + 
Sbjct: 64  EASVMTQL---RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDC 118

Query: 165 RLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLA 224
            L+ +      +EYL      N +H  + A N+L++E   A+V D+GL+       +   
Sbjct: 119 LLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT-------K--- 165

Query: 225 GYVDDDYWHEKGG--------------GNATRESDVYGFGVVLLEILS-GRR 261
               +    +  G                 + +SDV+ FG++L EI S GR 
Sbjct: 166 ----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 62/291 (21%), Positives = 106/291 (36%), Gaps = 58/291 (19%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
           R IG+G+ G V+  +  + +     VA+K         +    F   A  ++      HP
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQF---DHP 451

Query: 120 NIVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           +IV ++G  ++ P    I+ E   +  L  +L        L      +  A   +  L Y
Sbjct: 452 HIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQLSTALAY 506

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG- 237
           L        +H  I A N+L++   C ++ D+GLS       R +    D  Y+    G 
Sbjct: 507 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYME---DSTYYKASKGK 553

Query: 238 -------------GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSEL 283
                           T  SDV+ FGV + EIL  G +  +G+     +  I+       
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------ 607

Query: 284 LDPRLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
              RL +P  C       L  +   C       RP   ++   L+ ++ + 
Sbjct: 608 -GERLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 57/295 (19%), Positives = 116/295 (39%), Gaps = 64/295 (21%)

Query: 67  RIIGQGRLGTVYAALLSTGK-----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQH 118
           +++G G  GTVY  L           VA+K +        A       A V+ ++    +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV---DN 76

Query: 119 PNIVPILGF-SQAPGERIIVSEFINMASLDFYLHENNDG---ASLLDWNRRLRIATGAAR 174
           P++  +LG    +     ++++ +    L  Y+ E+ D      LL+W          A+
Sbjct: 77  PHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           G+ YL       ++H  + A N+L+      ++ D+GL+       + L    ++  +H 
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEYHA 176

Query: 235 KGG--------------GNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMR 279
           +GG                 T +SDV+ +GV + E+++ G +  +G+       ++++  
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-- 234

Query: 280 FSELLDPRLAIP--CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
                  RL  P  C I     +  + + C      +RP   ++    + +  DP
Sbjct: 235 -----GERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 48/232 (20%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---A 107
           E+DA     S  +++G G  G V +  L         VA+K +            F   A
Sbjct: 41  ELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEA 97

Query: 108 SVIKTLSLAQHPNIVPILG--FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           S++       HPNI+ + G      P   +IV+E++   SLD +L +++         + 
Sbjct: 98  SIMGQF---DHPNIIRLEGVVTKSKP--VMIVTEYMENGSLDSFLRKHDA---QFTVIQL 149

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
           + +  G A G++YL        +H  + A NIL+N     +V D+GL        R L  
Sbjct: 150 VGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLG-------RVL-- 197

Query: 226 YVDDDYWHEKGGGNA---------------TRESDVYGFGVVLLEILS-GRR 261
             D +  +   GG                 T  SDV+ +G+VL E++S G R
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 87.7 bits (218), Expect = 5e-20
 Identities = 47/223 (21%), Positives = 81/223 (36%), Gaps = 51/223 (22%)

Query: 67  RIIGQGRLGTVYAALLSTGKL----VAVKRIHPRLVLSNAGFG-F---ASVIKTLSLAQH 118
             +G G  G V              VAVK + P ++        F    + + +L    H
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL---DH 80

Query: 119 PNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDG---ASLLDWNRRLRIATGAAR 174
            N++ + G        + +V+E   + SL   L ++       +L  +      A   A 
Sbjct: 81  RNLIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAE 132

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           G+ YL        IH  + A N+LL  +   ++ D+GL        R L    +DD++  
Sbjct: 133 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM-------RAL--PQNDDHYVM 180

Query: 235 KGGGN------A---------TRESDVYGFGVVLLEILS-GRR 261
           +          A         +  SD + FGV L E+ + G+ 
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 66/253 (26%), Positives = 101/253 (39%), Gaps = 51/253 (20%)

Query: 30  LCKK--KPVESEETLPIKLCAFAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKL 87
           LC +  KP   E T+      F      ++         + IG+G  G V       G  
Sbjct: 163 LCTRLIKPKVMEGTVAA-QDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGDY-RGNK 218

Query: 88  VAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHPNIVPILGF-SQAPGERIIVSEFINM 143
           VAVK I            F   ASV+  L   +H N+V +LG   +  G   IV+E++  
Sbjct: 219 VAVKCIKNDATAQA----FLAEASVMTQL---RHSNLVQLLGVIVEEKGGLYIVTEYMAK 271

Query: 144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF 203
            SL  YL     G S+L  +  L+ +      +EYL      N +H  + A N+L++E  
Sbjct: 272 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDN 326

Query: 204 CARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------------GNATRESDVYGF 249
            A+V D+GL+       +       +    +  G                 + +SDV+ F
Sbjct: 327 VAKVSDFGLT-------K-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372

Query: 250 GVVLLEILS-GRR 261
           G++L EI S GR 
Sbjct: 373 GILLWEIYSFGRV 385

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 89.2 bits (221), Expect = 8e-20
 Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 44/216 (20%)

Query: 69  IGQGRLGTVYAALLSTGK---LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHPNIV 122
           +G G  G+V   +    K    VA+K +      ++        A ++  L    +P IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQL---DNPYIV 399

Query: 123 PILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            ++G  Q   E + +V E      L  +L    +    +  +    +    + G++YL +
Sbjct: 400 RLIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE 454

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNA- 240
               N +H  + A N+LL  +  A++ D+GLS       + L    DD Y+  +  G   
Sbjct: 455 ---KNFVHRNLAARNVLLVNRHYAKISDFGLS-------KAL--GADDSYYTARSAGKWP 502

Query: 241 --------------TRESDVYGFGVVLLEILS-GRR 261
                         +  SDV+ +GV + E LS G++
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 46/220 (20%), Positives = 77/220 (35%), Gaps = 51/220 (23%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG--F---ASVIKTLSLAQHPN 120
             +G G + TVY A        VA+K I              F         LS   H N
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLS---HQN 72

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           IV ++   +      +V E+I   +L  Y+  +  G   L  +  +        G+++ H
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GP--LSVDTAINFTNQILDGIKHAH 128

Query: 181 QGVAPNIIHGCIKASNILLNEKFCARVCDYGL-------------------SFLAPEEKR 221
                 I+H  IK  NIL++     ++ D+G+                    + +PE+ +
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
           G                     +D+Y  G+VL E+L G  
Sbjct: 186 G---------------EATDECTDIYSIGIVLYEMLVGEP 210

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.5 bits (212), Expect = 4e-19
 Identities = 47/222 (21%), Positives = 88/222 (39%), Gaps = 51/222 (22%)

Query: 67  RIIGQGRLGTVYAALLSTGKL-----VAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQH 118
           +++G G  GTV+  +           V +K I  +     +          I +L    H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSL---DH 74

Query: 119 PNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGAS---LLDWNRRLRIATGAAR 174
            +IV +LG    PG  + +V++++ + SL  ++ ++        LL+W          A+
Sbjct: 75  AHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAK 126

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE 234
           G+ YL +     ++H  + A N+LL      +V D+G++         L    DD     
Sbjct: 127 GMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVA-------DLL--PPDDKQLLY 174

Query: 235 KGG--------------GNATRESDVYGFGVVLLEILS-GRR 261
                            G  T +SDV+ +GV + E+++ G  
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.0 bits (211), Expect = 4e-19
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 45/221 (20%)

Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
           +I+G+G  G+V    L     T   VAVK +            F   A+ +K      HP
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF---SHP 96

Query: 120 NIVPILG-----FSQAPGERIIVSEFINMASLDFYL--HENNDGASLLDWNRRLRIATGA 172
           N++ +LG      SQ   + +++  F+    L  YL       G   +     L+     
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW 232
           A G+EYL      N +H  + A N +L +     V D+GLS       + +      DY+
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------KKIY---SGDYY 203

Query: 233 HEKGGGNA---------------TRESDVYGFGVVLLEILS 258
            +                     T +SDV+ FGV + EI +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 35/216 (16%)

Query: 63  FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLS-LAQ 117
           F  + ++G G  GT+    +   + VAVKRI P            S     ++ L    +
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---------CFSFADREVQLLRESDE 76

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           HPN++      +    + I  E    A+L  Y+ + +     L+    + +      GL 
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLA 132

Query: 178 YLHQGVAPNIIHGCIKASNILLNEK-----FCARVCDYGLS-FLAPEEK--RGLAGYVDD 229
           +LH     NI+H  +K  NIL++         A + D+GL   LA         +G    
Sbjct: 133 HLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 230 DYWH------EKGGGNATRESDVYGFGVVLLEILSG 259
           + W       E    N T   D++  G V   ++S 
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 84.2 bits (209), Expect = 8e-19
 Identities = 52/221 (23%), Positives = 80/221 (36%), Gaps = 51/221 (23%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG--F---ASVIKTLSLAQHP 119
           RR++G+G +G VY A      ++VA+K +   L  S+  F       A     L     P
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQ---EP 94

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           ++VPI  F +  G+  +    IN   L   L     G   L   R + I       L+  
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GP--LAPPRAVAIVRQIGSALDAA 150

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGL-------------------SFLAPEEK 220
           H        H  +K  NIL++    A + D+G+                    ++APE  
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                             +AT  +D+Y    VL E L+G  
Sbjct: 208 SE---------------SHATYRADIYALTCVLYECLTGSP 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 85.2 bits (211), Expect = 9e-19
 Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 43/216 (19%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
            +IG+G  G VY   L          AVK ++    +      F     ++K      HP
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDF---SHP 150

Query: 120 NIVPILGF-SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           N++ +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G+++
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKF 207

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           L    +   +H  + A N +L+EKF  +V D+GL+       R +  Y  +        G
Sbjct: 208 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDM--YDKEFDSVHNKTG 255

Query: 239 NA----------------TRESDVYGFGVVLLEILS 258
                             T +SDV+ FGV+L E+++
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 84.3 bits (209), Expect = 9e-19
 Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 46/222 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
           R++G+G  G+V  A L         VAVK +   ++ S+    F   A+ +K      HP
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF---DHP 85

Query: 120 NIVPILG--FSQAPGERI----IVSEFINMASLDFYL--HENNDGASLLDWNRRLRIATG 171
           ++  ++G         R+    ++  F+    L  +L      +    L     +R    
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            A G+EYL      N IH  + A N +L E     V D+GLS       R +      DY
Sbjct: 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------RKIY---SGDY 192

Query: 232 WHEKGGGNA---------------TRESDVYGFGVVLLEILS 258
           + +                     T  SDV+ FGV + EI++
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 45/217 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
           R+IG+G  G VY              A+K +     +      F     +++ L    HP
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLREGLLMRGL---NHP 82

Query: 120 NIVPILGF-SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           N++ ++G      G   ++  ++    L  ++       ++ D    +      ARG+EY
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEY 139

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           L        +H  + A N +L+E F  +V D+GL+       R +    D +Y+  +   
Sbjct: 140 LA---EQKFVHRDLAARNCMLDESFTVKVADFGLA-------RDIL---DREYYSVQQHR 186

Query: 239 NA-----------------TRESDVYGFGVVLLEILS 258
           +A                 T +SDV+ FGV+L E+L+
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 83.2 bits (206), Expect = 3e-18
 Identities = 46/218 (21%), Positives = 76/218 (34%), Gaps = 42/218 (19%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
            +H+  +G+G  G V+      TG   AVK++   +            +   +    P I
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE-------LVACAGLSSPRI 112

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA------RG 175
           VP+ G  +      I  E +   SL            L+     L              G
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSL----------GQLIKQMGCLPEDRALYYLGQALEG 162

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYGLSFLAPEEKRGLAGYVDDD---- 230
           LEYLH      I+HG +KA N+LL+     A +CD+G +     +  G +    D     
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 231 -YW------HEKGGGNATRESDVYGFGVVLLEILSGRR 261
                      K       + D++    ++L +L+G  
Sbjct: 220 ETHMAPEVVMGKP---CDAKVDIWSSCCMMLHMLNGCH 254

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 25/294 (8%), Positives = 62/294 (21%), Gaps = 50/294 (17%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRI-------------------------HPRLVLS 100
             +  G    V+    +   +  A+K                                 +
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 101 NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFI----NMASLDFYLHENNDG 156
                       +++   P    +            +        ++  L   L      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 157 ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA 216
                      +     R    L    +  ++HG     N+ +       + D    +  
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 217 PEEKRGLAG--YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR----RCEEGLLVKW 270
                  +         +        T   + +  G+ +  +            G+   W
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304

Query: 271 ALPLIKEMRFSELLDPRLA-IPCEIKPLVR--LAKVALACVGNSRKNRPSIVQV 321
             P ++      L       +P  +K L+   L           R+ R   ++ 
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF--------DRRRRLLPLEA 350

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 45/217 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK----LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHP 119
            +IG+G  G VY   L          AVK ++    +      F     ++K      HP
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDF---SHP 86

Query: 120 NIVPILGF-SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           N++ +LG   ++ G  ++V  ++    L  ++       ++ D    +      A+G++Y
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKY 143

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           L    +   +H  + A N +L+EKF  +V D+GL+       R +    D +Y+      
Sbjct: 144 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDM---YDKEYYSVHNKT 190

Query: 239 NA-----------------TRESDVYGFGVVLLEILS 258
            A                 T +SDV+ FGV+L E+++
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 57/226 (25%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG--F---ASVIKTLSLAQHPN 120
            I+G G +  V+ A  L   + VAVK +   L   +  F   F   A     L+   HP 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALN---HPA 73

Query: 121 IVPIL--GFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           IV +   G ++ P   +  IV E+++  +L   +H    G   +   R + +   A + L
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GP--MTPKRAIEVIADACQAL 129

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL---------------------SFL 215
            + HQ     IIH  +K +NI+++     +V D+G+                      +L
Sbjct: 130 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 216 APEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
           +PE+ RG                +    SDVY  G VL E+L+G  
Sbjct: 187 SPEQARG---------------DSVDARSDVYSLGCVLYEVLTGEP 217

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 81.6 bits (202), Expect = 9e-18
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 52/225 (23%)

Query: 67  RIIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHPN 120
            +IG+G  G V  A +    L    A+KR+       +    F     V+  L    HPN
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLG--HHPN 87

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLRI 168
           I+ +LG  +  G   +  E+    +L  +L ++            N  AS L   + L  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A   ARG++YL Q      IH  + A NIL+ E + A++ D+GLS       R       
Sbjct: 148 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS-------R------G 191

Query: 229 DDYWHEKGGGN------A---------TRESDVYGFGVVLLEILS 258
            + + +K  G       A         T  SDV+ +GV+L EI+S
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 51/225 (22%), Positives = 84/225 (37%), Gaps = 51/225 (22%)

Query: 67  RIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGF---ASVIKTLSL 115
             +GQG    ++  +              V +K +       N    F   AS++  L  
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSKL-- 69

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
             H ++V   G      E I+V EF+   SLD YL +N +  ++L    +L +A   A  
Sbjct: 70  -SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW---KLEVAKQLAAA 125

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKF--------CARVCDYGLSFLAPEEKRGLAGYV 227
           + +L +     +IHG + A NILL  +           ++ D G+S         +   +
Sbjct: 126 MHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITV---L 172

Query: 228 DDDYWHE----------KGGGNATRESDVYGFGVVLLEILS-GRR 261
             D   E          +   N    +D + FG  L EI S G +
Sbjct: 173 PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 79.3 bits (196), Expect = 5e-17
 Identities = 52/277 (18%), Positives = 97/277 (35%), Gaps = 48/277 (17%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFA-SVIKTLSLAQHPNIVPI 124
           + IG+G+   VY A  L  G  VA+K++    ++           I  L    HPN++  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
                   E  IV E  +   L   +        L+      +        LE++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLAGY 226
             ++H  IK +N+ +      ++ D GL                   +++PE        
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-------- 206

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR--CEEGLLVKWALPLIKEMRFSELL 284
                 HE G      +SD++  G +L E+ + +     + + +      I++  +  L 
Sbjct: 207 ----RIHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL- 258

Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
            P      E++ LV +      C+    + RP +  V
Sbjct: 259 -PSDHYSEELRQLVNM------CINPDPEKRPDVTYV 288

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.6 bits (194), Expect = 6e-17
 Identities = 32/244 (13%), Positives = 70/244 (28%), Gaps = 37/244 (15%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA--QHPNIV 122
               G       + AL  +  + VA+  + P+ V         ++ +TL L+    P + 
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            +L         ++V+E+I   SL      +            +R     A   +  H+ 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA 148

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATR 242
               +       S + ++      +       +                        A  
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPA--TMPD----------------------ANP 181

Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAK 302
           + D+ G G  L  +L  R       V+  L   +     + ++P          +  +A 
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241

Query: 303 VALA 306
            ++ 
Sbjct: 242 RSVQ 245

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 27/238 (11%), Positives = 60/238 (25%), Gaps = 43/238 (18%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAG------------------ 103
                ++GQ        A    TG+   V   +      +                    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 104 -----FGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINM-------ASLDFYLH 151
                      I    L + P    ++       +  ++S F           +    L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 152 ENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
            ++     L  + RL++     R L  LH      ++H  ++  +I+L+++    +  + 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 212 LSFLAPEEKRGLAG-------YVD--DDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                        G               + +      T   D +  G+ +  I    
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 47/216 (21%), Positives = 76/216 (35%), Gaps = 27/216 (12%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV-IKTLSLAQHPNIVP 123
            + +G+G    V     L  G   A+KRI   L         A        L  HPNI+ 
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 124 ILGF----SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           ++ +      A  E  ++  F    +L   +    D  + L  ++ L +  G  RGLE +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA--PEEKRGLAGYVDDDY------ 231
           H        H  +K +NILL ++    + D G    A    E    A  + D        
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 232 -------WHEKGGGNATRESDVYGFGVVLLEILSGR 260
                  +  +        +DV+  G VL  ++ G 
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 39/214 (18%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK----TLSLAQHPNIVP 123
           IG+G  G+V   +   +G+++AVKRI      +        ++      +  +  P IV 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
             G     G+  I  E ++ +   FY +  +    ++      +I     + L +L +  
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-- 143

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLS-----------------FLAPEEKRGLAGY 226
              IIH  IK SNILL+     ++CD+G+S                 ++APE  R     
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE--RIDPSA 201

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               Y            SDV+  G+ L E+ +GR
Sbjct: 202 SRQGY---------DVRSDVWSLGITLYELATGR 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 53/263 (20%), Positives = 85/263 (32%), Gaps = 66/263 (25%)

Query: 66  RRIIGQGRLGTVYAAL---LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ--HPN 120
           +  I  G LG +Y AL   ++ G+ V +K +       +A     ++ +   LA+  HP+
Sbjct: 85  KGCIAHGGLGWIYLALDRNVN-GRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPS 140

Query: 121 IVPILGFSQAPGERI-----IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
           IV I  F +           IV E++   SL     +       L     +         
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPA 194

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL--------------SFLAPEEKR 221
           L YLH   +  +++  +K  NI+L E+   ++ D G                F APE  R
Sbjct: 195 LSYLH---SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLYGTPGFQAPEIVR 250

Query: 222 GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS 281
                              T  +D+Y  G  L  +        G  V             
Sbjct: 251 T----------------GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE-------- 286

Query: 282 ELLDPRLAIPCEIKPLVR--LAK 302
              DP L        L+R  +  
Sbjct: 287 --DDPVLKTYDSYGRLLRRAIDP 307

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 51/224 (22%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQ 117
           R +GQG  G VY  +            VA+K ++           F   ASV+K      
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEF---N 86

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYL------HENNDGASLLDWNRRLRIATG 171
             ++V +LG        +++ E +    L  YL        NN   +    ++ +++A  
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDY 231
            A G+ YL+       +H  + A N ++ E F  ++ D+G++       R +  Y  D Y
Sbjct: 147 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-------RDI--YETDYY 194

Query: 232 WHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
              + GG                   T  SDV+ FGVVL EI +
Sbjct: 195 ---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 39/305 (12%), Positives = 82/305 (26%), Gaps = 76/305 (24%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAG---------------------- 103
            ++GQ        A    TG+   V   +      +                        
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 104 ----FGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF----INMASLDFYLHENND 155
                 F      +   Q   ++ +    +          +     N+ +    L  ++ 
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 156 GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-- 213
               L  + RL++     R L  LH      ++H  ++  +I+L+++    +  +     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 214 ------------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                       F  PE    L        +H       T   D +  G+V+  I     
Sbjct: 256 DGARVVSSVSRGFEPPE----LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310

Query: 262 CEEGLLVKWALPLIKE---MRFSELLDPRLAIPCEIKPLVR--LAKVALACVGNSRKNRP 316
                     LP+ K+        +      IP  ++ L+   L           +++R 
Sbjct: 311 ----------LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--------PKEDRL 352

Query: 317 SIVQV 321
             +Q 
Sbjct: 353 LPLQA 357

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 77.2 bits (190), Expect = 4e-16
 Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 57/230 (24%)

Query: 57  DAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASV---IKT 112
           +   D F     +G G  G V+      +G ++A K IH    L         +   ++ 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQV 84

Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL------ 166
           L     P IV   G   + GE  I  E ++  SLD           +L    R+      
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD----------QVLKKAGRIPEQILG 134

Query: 167 RIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------- 213
           +++    +GL YL +     I+H  +K SNIL+N +   ++CD+G+S             
Sbjct: 135 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 192

Query: 214 ---FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              +++PE  +G   Y              + +SD++  G+ L+E+  GR
Sbjct: 193 TRSYMSPERLQG-THY--------------SVQSDIWSMGLSLVEMAVGR 227

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 55/226 (24%), Positives = 87/226 (38%), Gaps = 50/226 (22%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-LAQHP 119
           + +G G  G V  A             VAVK +      ++      S +K +S L QH 
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHE 110

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYL----------HENNDGASLLDWNRRLRIA 169
           NIV +LG     G  ++++E+     L  +L                 S       L  +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 170 TGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDD 229
           +  A+G+ +L      N IH  + A N+LL     A++ D+GL+       R +    D 
Sbjct: 171 SQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDI--MNDS 218

Query: 230 DYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
           +Y      GNA                 T +SDV+ +G++L EI S
Sbjct: 219 NY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 27/210 (12%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           R ++G+G  G VYA   LS    +A+K I      S         I      +H NIV  
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
           LG     G   I  E +   SL   L  +  G    +             GL+YLH    
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141

Query: 185 PNIIHGCIKASNILLNEKF-CARVCDYGLSFLAPEEKRGLAGYVDDD-------YWH--- 233
             I+H  IK  N+L+N      ++ D+G S      KR LAG             +    
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTS------KR-LAGINPCTETFTGTLQYMAPE 193

Query: 234 --EKGGGNATRESDVYGFGVVLLEILSGRR 261
             +KG     + +D++  G  ++E+ +G+ 
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 43/213 (20%), Positives = 72/213 (33%), Gaps = 42/213 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
             +G G  G V+       G+L AVKR   P     +     A V     + QHP  V +
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
               +  G   + +E     SL  +        + L   +           L +LH    
Sbjct: 123 EQAWEEGGILYLQTELCGP-SLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS--- 175

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS-----------------FLAPEEKRGLAGYV 227
             ++H  +K +NI L  +   ++ D+GL                  ++APE  +G   Y 
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SY- 232

Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                           +DV+  G+ +LE+    
Sbjct: 233 -------------GTAADVFSLGLTILEVACNM 252

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 76.3 bits (188), Expect = 5e-16
 Identities = 44/233 (18%), Positives = 79/233 (33%), Gaps = 50/233 (21%)

Query: 54  TEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKT 112
               A  +   +   +G G  G V+      TG ++AVK++      S        ++  
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEENKRILMD 73

Query: 113 L----SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
           L         P IV   G      +  I  E +   +              +      ++
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----IPERILGKM 129

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------------- 213
                + L YL +     +IH  +K SNILL+E+   ++CD+G+S               
Sbjct: 130 TVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC 187

Query: 214 --FLAPE----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             ++APE           Y                 +DV+  G+ L+E+ +G+
Sbjct: 188 AAYMAPERIDPPDPTKPDY--------------DIRADVWSLGISLVELATGQ 226

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 75.8 bits (187), Expect = 8e-16
 Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 55/230 (23%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQ 117
           + +G+G  G V  A        +T + VAVK +       +          ++  +    
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIG--H 89

Query: 118 HPNIVPILGF-SQAPGERIIVSEFINMASLDFYL------------HENNDGASLLDWNR 164
           H N+V +LG  ++  G  +++ EF    +L  YL               +     L    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 165 RLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLA 224
            +  +   A+G+E+L        IH  + A NILL+EK   ++CD+GL+       R + 
Sbjct: 150 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA-------RDI- 198

Query: 225 GYVDDDYWHEKGGGNA----------------TRESDVYGFGVVLLEILS 258
            Y D DY   + G                   T +SDV+ FGV+L EI S
Sbjct: 199 -YKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 36/247 (14%), Positives = 65/247 (26%), Gaps = 58/247 (23%)

Query: 52  PLTEIDAATDGFSHRRIIGQGRLGTVYAA------LLSTGKLVAVKRIHPRLVLSNAGFG 105
           P TE    +       ++G+G    VY A           +   +K   P        + 
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--WEFYI 113

Query: 106 FASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASL-DFYLHENNDGASLLDWNR 164
              +++ L  +     +            ++V E  +  +L +      N    ++    
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 165 RLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA-----------RVCDYGLS 213
            +  A      +E +H      IIHG IK  N +L   F              + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230

Query: 214 --------------------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVL 253
                               F   E       +                + D +G    +
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PW--------------NYQIDYFGVAATV 275

Query: 254 LEILSGR 260
             +L G 
Sbjct: 276 YCMLFGT 282

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 41/216 (18%), Positives = 77/216 (35%), Gaps = 43/216 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVP 123
           + IG+G  G          G+   +K I   +   ++     S   +  L+  +HPNIV 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQ 87

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
                +  G   IV ++     L   ++       L   ++ L         L+++H   
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGV--LFQEDQILDWFVQICLALKHVHD-- 143

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGLAG 225
              I+H  IK+ NI L +    ++ D+G++                  +L+PE       
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE------- 195

Query: 226 YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                    K       +SD++  G VL E+ + + 
Sbjct: 196 -----ICENKP---YNNKSDIWALGCVLYELCTLKH 223

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 50/230 (21%), Positives = 84/230 (36%), Gaps = 54/230 (23%)

Query: 67  RIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-LAQ 117
           + +G+G  G V  A               VAVK +              S ++ +  + +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGK 99

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYL------------HENNDGASLLDWNRR 165
           H NI+ +LG     G   ++ E+ +  +L  YL              N      + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
           +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +  
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RDI-- 207

Query: 226 YVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
              D Y   K   N                  T +SDV+ FGV++ EI +
Sbjct: 208 NNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 48/230 (20%), Positives = 84/230 (36%), Gaps = 57/230 (24%)

Query: 67  RIIGQGRLGTVYAALLSTGK------LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQ 117
             +G+ R G VY   L           VA+K +            F   A +   L   Q
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEAMLRARL---Q 70

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRR------------ 165
           HPN+V +LG         ++  + +   L  +L   +  + +   +              
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
           + +    A G+EYL      +++H  +   N+L+ +K   ++ D GL        R +  
Sbjct: 131 VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------REV-- 178

Query: 226 YVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
           Y  D Y   K  GN+                 + +SD++ +GVVL E+ S
Sbjct: 179 YAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 50/230 (21%), Positives = 84/230 (36%), Gaps = 54/230 (23%)

Query: 67  RIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-LAQ 117
           + +G+G  G V  A               VAVK +              S ++ +  + +
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGK 145

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYL------------HENNDGASLLDWNRR 165
           H NI+ +LG     G   ++ E+ +  +L  YL              N      + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
           +      ARG+EYL    +   IH  + A N+L+ E    ++ D+GL+       R +  
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------RDI-- 253

Query: 226 YVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
              D Y   K   N                  T +SDV+ FGV++ EI +
Sbjct: 254 NNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 46/220 (20%), Positives = 88/220 (40%), Gaps = 52/220 (23%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIK----TLSLAQHPNIVP 123
           +G+G  G V     + +G+++AVKRI      +        ++     ++     P  V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDISMRTVDCPFTVT 70

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRL------RIATGAARGLE 177
             G     G+  I  E ++ +   FY         ++D  + +      +IA    + LE
Sbjct: 71  FYGALFREGDVWICMELMDTSLDKFY-------KQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-----------------FLAPEEK 220
           +LH     ++IH  +K SN+L+N     ++CD+G+S                 ++APE  
Sbjct: 124 HLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE-- 179

Query: 221 RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           R         Y         + +SD++  G+ ++E+   R
Sbjct: 180 RINPELNQKGY---------SVKSDIWSLGITMIELAILR 210

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 26/168 (15%)

Query: 60  TDGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRI--HPRLVLSNAGFGFA----SVIKT 112
            D F   R+ GQG  GTV      STG  VA+K++   PR         F      +++ 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---------FRNRELQIMQD 72

Query: 113 LSLAQHPNIVPILGFSQAPGER-------IIVSEFINMASLDFYLHENNDGASLLDWNRR 165
           L++  HPNIV +  +    GER        +V E++         +      +      +
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA-RVCDYGL 212
           + +     R +  LH     N+ H  IK  N+L+NE     ++CD+G 
Sbjct: 133 VFLFQ-LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGS 178

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 37/217 (17%), Positives = 69/217 (31%), Gaps = 28/217 (12%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFAS---VIKTLSLAQHPNIV 122
             IG G  G+V+  +    G + A+KR   +  L+ +     +   V     L QH ++V
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRS--KKPLAGSVDEQNALREVYAHAVLGQHSHVV 74

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
                       +I +E+ N  SL   + EN    S         +     RGL Y+H  
Sbjct: 75  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS- 133

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR--------GLAGYVDDDYWHE 234
              +++H  IK SNI ++                    +        G    +      E
Sbjct: 134 --MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 235 -----------KGGGNATRESDVYGFGVVLLEILSGR 260
                      +       ++D++   + ++      
Sbjct: 192 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 52/232 (22%), Positives = 87/232 (37%), Gaps = 58/232 (25%)

Query: 67  RIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGF---ASVIKTLSL 115
           + +G+G  G V  A          +    VAVK +                  ++K +  
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIG- 132

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYL------------HENNDGASLLDWN 163
            +H NI+ +LG     G   ++ E+ +  +L  YL            + +++    L   
Sbjct: 133 -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGL 223
             +  A   ARG+EYL        IH  + A N+L+ E    ++ D+GL+       R +
Sbjct: 192 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDI 241

Query: 224 AGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
             +  D Y   K   N                  T +SDV+ FGV+L EI +
Sbjct: 242 --HHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 46/154 (29%), Positives = 65/154 (42%), Gaps = 17/154 (11%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIVPI 124
           IG G    V AA      + VA+KRI+    L         +   I+ +S   HPNIV  
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAMSQCHHPNIVSY 78

Query: 125 LGFSQAPGERI-IVSEFINMASL-DFYLHENNDGASLLDWNRRLRIAT---GAARGLEYL 179
              S    + + +V + ++  S+ D   H    G           IAT       GLEYL
Sbjct: 79  YT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           H+      IH  +KA NILL E    ++ D+G+S
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 73.0 bits (180), Expect = 7e-15
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 54/228 (23%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGF-ASVIKTLSLAQHP 119
           R +G+G  G V+ A            LVAVK +    + +   F   A ++  L   QH 
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL---QHE 77

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNRRLR 167
           +IV   G        I+V E++    L+ +L  +                  L  ++ L 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 168 IATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYV 227
           IA+  A G+ YL      + +H  +   N L+      ++ D+G+S       R +  Y 
Sbjct: 138 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------RDV--YS 185

Query: 228 DDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
            D Y   + GG+                  T ESDV+ FGV+L EI +
Sbjct: 186 TDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 60/224 (26%), Positives = 81/224 (36%), Gaps = 51/224 (22%)

Query: 67  RIIGQGRLGTVYAALLSTGK------LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQ 117
           R +G G  G VY   +S          VAVK +            F   A +I       
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKF---N 91

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHEN---NDGASLLDWNRRLRIATGAAR 174
           H NIV  +G S     R I+ E +    L  +L E        S L     L +A   A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC---DYGLSFLAPEEKRGLAGYVDDDY 231
           G +YL +    + IH  I A N LL      RV    D+G++       R +  Y    Y
Sbjct: 152 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------RDI--YRASYY 199

Query: 232 WHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
              + GG A                 T ++D + FGV+L EI S
Sbjct: 200 ---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 53/227 (23%), Positives = 85/227 (37%), Gaps = 53/227 (23%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGF-ASVIKTLSLAQHP 119
             +G+G  G V+ A            LVAVK +      +   F   A ++  L   QH 
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML---QHQ 103

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYL-----------HENNDGASLLDWNRRLRI 168
           +IV   G        ++V E++    L+ +L              +     L   + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVD 228
           A+  A G+ YL      + +H  +   N L+ +    ++ D+G+S       R +  Y  
Sbjct: 164 ASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS-------RDI--YST 211

Query: 229 DDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
           D Y   + GG                   T ESDV+ FGVVL EI +
Sbjct: 212 DYY---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 49/223 (21%), Positives = 81/223 (36%), Gaps = 52/223 (23%)

Query: 69  IGQGR--LGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNI 121
           IG+G   L TV  A    TG+ V V+RI+    L        +     +    L  HPNI
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRIN----LEACSNEMVTFLQGELHVSKLFNHPNI 88

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD-----WNRRLR---IAT--- 170
           VP      A  E  +V+ F  MA             S  D     +   +    IA    
Sbjct: 89  VPYRATFIADNELWVVTSF--MA-----------YGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAGYVD 228
           G  + L+Y+H       +H  +KAS+IL++      +     +   ++  +++ +     
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 229 DD-----YW------HEKGGGNATRESDVYGFGVVLLEILSGR 260
                   W       +   G    +SD+Y  G+   E+ +G 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGH 234

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 36/216 (16%), Positives = 80/216 (37%), Gaps = 35/216 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN--IVPI 124
           + IG G    V+  L    ++ A+K ++     +     + + I  L+  Q  +  I+ +
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
             +        +V E  N   L+ +L +       +D   R          +  +HQ   
Sbjct: 122 YDYEITDQYIYMVMECGN-IDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 174

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS--------------------FLAPEEKRGLA 224
             I+H  +K +N L+ +    ++ D+G++                    ++ PE  + ++
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              ++     K       +SDV+  G +L  +  G+
Sbjct: 233 SSRENGKSKSKIS----PKSDVWSLGCILYYMTYGK 264

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 50/227 (22%), Positives = 80/227 (35%), Gaps = 56/227 (24%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
            +IG G  G V+ A     GK   +KR+  +     A       +K L+   H NIV   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRV--KYNNEKA----EREVKALAKLDHVNIVHYN 70

Query: 126 GFSQAPGERIIVSEFINMASLDFYLH---ENNDGASLLDW--NRR---------LRIATG 171
           G           S   +  S    L    E  D  +L  W   RR         L +   
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-----------------F 214
             +G++Y+H      +I+  +K SNI L +    ++ D+GL                  +
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187

Query: 215 LAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
           ++PE+      Y               +E D+Y  G++L E+L    
Sbjct: 188 MSPEQISS-QDY--------------GKEVDLYALGLILAELLHVCD 219

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 30/160 (18%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           IGQG  G V+ A    TG+ VA+K++   +     GF   ++  IK L L +H N+V ++
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 126 GFSQAPGERIIVSEFINMASL--DFYL---HENNDGASLLDWNRRLRIATGAA------- 173
                    I  ++           YL      +D A LL  N  ++             
Sbjct: 83  E--------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQML 133

Query: 174 -RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
             GL Y+H+     I+H  +KA+N+L+      ++ D+GL
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 56/294 (19%), Positives = 99/294 (33%), Gaps = 57/294 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
           + +G+G  G V+ A         A+KRI     L N       V   +K L+  +HP IV
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIR----LPNRELAREKVMREVKALAKLEHPGIV 66

Query: 123 ------------PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT 170
                         L  S       I  +     +L  +++         + +  L I  
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFL 125

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAGYVD 228
             A  +E+LH      ++H  +K SNI        +V D+GL       EE++ +   + 
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 229 DDYWHEKGGGNAT---------------RESDVYGFGVVLLEILSGRRCEEGLLVKWALP 273
               H    G  T                + D++  G++L E+L        +     L 
Sbjct: 183 AYARHTGQVG--TKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLT 238

Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
            ++ ++F  L   +         +V+        +  S   RP  +    I+ N
Sbjct: 239 DVRNLKFPPLFTQKYP---CEYVMVQ------DMLSPSPMERPEAIN---IIEN 280

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 57/236 (24%), Positives = 85/236 (36%), Gaps = 66/236 (27%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFG----F---ASVIKTL 113
           + +G G  G V  A             VAVK + P     +A             V+  L
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-----SAHLTEREALMSELKVLSYL 83

Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYL--------------HENNDGASL 159
               H NIV +LG     G  ++++E+     L  +L                  D    
Sbjct: 84  G--NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 160 LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE 219
           LD    L  +   A+G+ +L    + N IH  + A NILL      ++CD+GL+      
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA------ 192

Query: 220 KRGLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
            R +    D +Y      GNA                 T ESDV+ +G+ L E+ S
Sbjct: 193 -RDI--KNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 69/299 (23%), Positives = 102/299 (34%), Gaps = 61/299 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGK------LVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQ 117
           R +G G  G VY   +S          VAVK +            F   A +I       
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKF---N 132

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHEN---NDGASLLDWNRRLRIATGAAR 174
           H NIV  +G S     R I+ E +    L  +L E        S L     L +A   A 
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC---DYGLSFLAPEEKRGLAGYVDDDY 231
           G +YL +    + IH  I A N LL      RV    D+G++       R +  Y    Y
Sbjct: 193 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------RDI--YRAGYY 240

Query: 232 WHEKGGGNA-----------------TRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP 273
              + GG A                 T ++D + FGV+L EI S G         +  L 
Sbjct: 241 ---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297

Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
            +           R+  P        + ++   C  +  ++RP+   +   +     DP
Sbjct: 298 FVTSGG-------RMDPPKNCPG--PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 36/216 (16%), Positives = 80/216 (37%), Gaps = 35/216 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN--IVPI 124
           + IG G    V+  L    ++ A+K ++     +     + + I  L+  Q  +  I+ +
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
             +        +V E  N   L+ +L +       +D   R          +  +HQ   
Sbjct: 75  YDYEITDQYIYMVMECGN-IDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 127

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS--------------------FLAPEEKRGLA 224
             I+H  +K +N L+ +    ++ D+G++                    ++ PE  + ++
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              ++     K       +SDV+  G +L  +  G+
Sbjct: 186 SSRENGKSKSKIS----PKSDVWSLGCILYYMTYGK 217

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 44/222 (19%), Positives = 77/222 (34%), Gaps = 46/222 (20%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKTLSLAQ 117
           R I  G  G V A + S G  VA+KR+   +         +           I+ L+   
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 118 HPNIVPILGFSQAPGERI-----IVSEFINMASLDFYLHENNDGAS----------LLDW 162
           HPNI+ +        E       +V+E +    L   +H+     S          +L  
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHIL-- 144

Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRG 222
                       GL  LH+     ++H  +   NILL +     +CD+ L+     +   
Sbjct: 145 -----------LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN- 189

Query: 223 LAGYVDDDYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
              YV   ++            T+  D++  G V+ E+ + +
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 69.9 bits (172), Expect = 7e-14
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 28/206 (13%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           R +G+G+ G VY A       ++A+K +   +L            I+  S  +HPNI+ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
             +        ++ EF     L   L ++       D  R        A  L Y H+   
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE--- 132

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYV------DDDYWHE 234
             +IH  IK  N+L+  K   ++ D+G S  AP  +R    G   Y+         +   
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTH--- 189

Query: 235 KGGGNATRESDVYGFGVVLLEILSGR 260
                   + D++  GV+  E L G 
Sbjct: 190 ------DEKVDLWCAGVLCYEFLVGM 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 37/233 (15%), Positives = 73/233 (31%), Gaps = 59/233 (25%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASV---------------IK 111
           R + QG+   +        K  A+K+    L+     F  ++                ++
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 112 TLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG 171
            ++  ++   +   G      E  I+ E++   S+  +          LD N    I   
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV----LDKNYTCFIPIQ 151

Query: 172 AAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---------- 213
             +           Y+H     NI H  +K SNIL+++    ++ D+G S          
Sbjct: 152 VIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209

Query: 214 ------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                 F+ PE     + Y                + D++  G+ L  +    
Sbjct: 210 SRGTYEFMPPEFFSNESSYNG-------------AKVDIWSLGICLYVMFYNV 249

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 59/235 (25%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           R IG+G  G V+ A            +VAVK +      ++    F      ++   +PN
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPN 111

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHEN--------------------NDGASLL 160
           IV +LG         ++ E++    L+ +L                       + G   L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK 220
               +L IA   A G+ YL +      +H  +   N L+ E    ++ D+GLS       
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS------- 221

Query: 221 RGLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
           R +  Y  D Y   K  GN                  T ESDV+ +GVVL EI S
Sbjct: 222 RNI--YSADYY---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 36/216 (16%), Positives = 80/216 (37%), Gaps = 35/216 (16%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN--IVPI 124
           + IG G    V+  L    ++ A+K ++     +     + + I  L+  Q  +  I+ +
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
             +        +V E  N   L+ +L +       +D   R          +  +HQ   
Sbjct: 94  YDYEITDQYIYMVMECGN-IDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 146

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLS--------------------FLAPEEKRGLA 224
             I+H  +K +N L+ +    ++ D+G++                    ++ PE  + ++
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              ++     K       +SDV+  G +L  +  G+
Sbjct: 205 SSRENGKSKSKIS----PKSDVWSLGCILYYMTYGK 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 67/239 (28%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFG----FASVIKTLS-L 115
           +++G G  G V  A             VAVK +        A         S +K ++ L
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-----KADSSEREALMSELKMMTQL 105

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYL-------------------HENNDG 156
             H NIV +LG     G   ++ E+     L  YL                    E  + 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 157 ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA 216
            ++L +   L  A   A+G+E+L      + +H  + A N+L+      ++CD+GL+   
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA--- 219

Query: 217 PEEKRGLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
               R +    D +Y      GNA                 T +SDV+ +G++L EI S
Sbjct: 220 ----RDI--MSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 59/235 (25%)

Query: 67  RIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN 120
           + +G+G  G V  A        +    VAVK +       +      S    L    HP+
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPH 87

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYL--------------------HENNDGASLL 160
           ++ + G     G  +++ E+    SL  +L                      ++     L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK 220
                +  A   ++G++YL +     ++H  + A NIL+ E    ++ D+GLS       
Sbjct: 148 TMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS------- 197

Query: 221 RGLAGYVDDDYWHEKGGGNA-----------------TRESDVYGFGVVLLEILS 258
           R +  Y +D Y                          T +SDV+ FGV+L EI++
Sbjct: 198 RDV--YEEDSY---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 46/200 (23%), Positives = 84/200 (42%), Gaps = 16/200 (8%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           R +G+G+ G VY A    +  ++A+K +   +L  +         ++  S  +HPNI+ +
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G+        ++ E+  + ++   L + +      D  R     T  A  L Y H    
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS--- 127

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDDYWHEKGGGNA 240
             +IH  IK  N+LL      ++ D+G S  AP  +R    G   Y+  +    +     
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD-- 185

Query: 241 TRESDVYGFGVVLLEILSGR 260
             + D++  GV+  E L G+
Sbjct: 186 -EKVDLWSLGVLCYEFLVGK 204

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 42/218 (19%), Positives = 76/218 (34%), Gaps = 38/218 (17%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             IG G  G        S GK++  K +    +         S +  L   +HPNIV   
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 126 G-FSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-- 181
                     + IV E+     L   + +       LD    LR+ T     L+  H+  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEEKRGL 223
                ++H  +K +N+ L+ K   ++ D+GL+                  +++PE+   +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191

Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
             Y                +SD++  G +L E+ +   
Sbjct: 192 -SY--------------NEKSDIWSLGCLLYELCALMP 214

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 34/164 (20%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQH 118
           F+    IG+G  G V+  +   T K+VA+K I     L  A      +   I  LS    
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCDS 79

Query: 119 PNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDW--NRRLR---IAT-- 170
           P +    G S     ++ I+ E++              G S LD      L    IAT  
Sbjct: 80  PYVTKYYG-SYLKDTKLWIIMEYL-------------GGGSALDLLEPGPLDETQIATIL 125

Query: 171 -GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               +GL+YLH       IH  IKA+N+LL+E    ++ D+G++
Sbjct: 126 REILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 35/164 (21%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRI----HPRLVLSNAGFGFASVIKTLSLAQ 117
           ++    IGQG  GTVY A+ ++TG+ VA++++     P+  L        + I  +   +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL------IINEILVMRENK 75

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD--WNRRLR---IAT-- 170
           +PNIV  L       E  +V E++              G SL D      +    IA   
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIAAVC 122

Query: 171 -GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               + LE+LH      +IH  IK+ NILL      ++ D+G  
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 49/225 (21%), Positives = 79/225 (35%), Gaps = 42/225 (18%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASV-IKTLS-LAQHPNIVPI 124
           +I+G G  GTV       G+ VAVKR+             A + IK L+    HPN++  
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRY 74

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHEN---NDGASLLDWNRRLRIATGAARGLEYLHQ 181
                      I  E  N  +L   +      ++   L      + +    A G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVC-------------DYGLS-FLAPEEKR------ 221
                IIH  +K  NIL++                     D+GL   L   +        
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 222 ---GLAGY----VDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
              G +G+    + ++  + +     TR  D++  G V   ILS 
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 27/163 (16%)

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQH 118
           + +     +G+G  G VY A  S G++VA+KRI  RL   + G    ++  I  L    H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI--RLDAEDEGIPSTAIREISLLKELHH 78

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA----- 173
           PNIV ++    +     +V EF+             D   +LD   +  +          
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-----------DLKKVLD-ENKTGLQDSQIKIYLY 126

Query: 174 ---RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
              RG+ + HQ     I+H  +K  N+L+N     ++ D+GL+
Sbjct: 127 QLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA 166

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 19/158 (12%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQH 118
           FS  R IG G  G VY A  +   ++VA+K++        +   +  +   ++ L   +H
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT---GAARG 175
           PN +   G         +V E+   ++ D            L     + IA    GA +G
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQ---EVEIAAVTHGALQG 166

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           L YLH     N+IH  +KA NILL+E    ++ D+G +
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 42/158 (26%), Positives = 62/158 (39%), Gaps = 35/158 (22%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIH----PRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           IG+G  G V  A    +G+ VAVK +      R  L        + +  +   QH N+V 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL------LFNEVVIMRDYQHFNVVE 106

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD--WNRRLR---IAT---GAARG 175
           +        E  ++ EF+              G +L D     RL    IAT      + 
Sbjct: 107 MYKSYLVGEELWVLMEFL-------------QGGALTDIVSQVRLNEEQIATVCEAVLQA 153

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           L YLH   A  +IH  IK+ +ILL      ++ D+G  
Sbjct: 154 LAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.8 bits (164), Expect = 9e-13
 Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 27/163 (16%)

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQH 118
           + +     IG+G  G VY A  + G+  A+K+I  RL   + G    ++  I  L   +H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI--RLEKEDEGIPSTTIREISILKELKH 59

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA----- 173
            NIV +          ++V E ++            D   LLD      + +  A     
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-----------DLKKLLD-VCEGGLESVTAKSFLL 107

Query: 174 ---RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               G+ Y H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 108 QLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.8 bits (164), Expect = 9e-13
 Identities = 39/164 (23%), Positives = 68/164 (41%), Gaps = 36/164 (21%)

Query: 69  IGQGRLGTVYAA--LLSTGKLVAVKRIHPRLVLSNAGFGF-----ASVIKTLSLAQHPNI 121
           IG+G  G V+ A  L + G+ VA+KR+  R+     G         +V++ L   +HPN+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76

Query: 122 VPIL----GFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA--- 173
           V +             ++ +V E ++            D  + LD      + T      
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-----------DLTTYLDKVPEPGVPTETIKDM 125

Query: 174 -----RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
                RGL++LH      ++H  +K  NIL+      ++ D+GL
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 38/166 (22%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGF--------ASVIKTLSLAQHP 119
           IG G  GTVY A    +G  VA+K +  R+     G G          ++++ L   +HP
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 120 NIVPIL----GFSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA- 173
           N+V ++            ++ +V E ++            D  + LD      +      
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-----------DLRTYLDKAPPPGLPAETIK 123

Query: 174 -------RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
                  RGL++LH      I+H  +K  NIL+      ++ D+GL
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 65.6 bits (161), Expect = 2e-12
 Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 27/164 (16%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQ 117
           + F     IG+G  G VY A    TG++VA+K+I  RL     G    ++  I  L    
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKELN 60

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA---- 173
           HPNIV +L       +  +V EF++            D    +D +    I         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----------DLKKFMDASALTGIPLPLIKSYL 109

Query: 174 ----RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               +GL + H      ++H  +K  N+L+N +   ++ D+GL+
Sbjct: 110 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 34/158 (21%), Positives = 60/158 (37%), Gaps = 30/158 (18%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           +G+G  G VY A+   T + VA+KRI  RL     G    ++  +  L   QH NI+ + 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA------RGLEYL 179
                     ++ E+              D    +D N  + +    +       G+ + 
Sbjct: 100 SVIHHNHRLHLIFEYAEN-----------DLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCAR-----VCDYGL 212
           H       +H  +K  N+LL+    +      + D+GL
Sbjct: 149 HS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 43/217 (19%), Positives = 78/217 (35%), Gaps = 22/217 (10%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
             +    I+GQG    V+      TG L A+K  +    L           + L    H 
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD-VQMREFEVLKKLNHK 67

Query: 120 NIVPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           NIV +    +    R  +++ EF    SL   L E ++   L + +  L +      G+ 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLRDVVGGMN 126

Query: 178 YLHQGVAPNIIHGCIKASNILL----NEKFCARVCDYGLS-FLAPEEKR----GLAGYV- 227
           +L +     I+H  IK  NI+     + +   ++ D+G +  L  +E+     G   Y+ 
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 228 ----DDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               +     +          D++  GV      +G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 42/162 (25%), Positives = 61/162 (37%), Gaps = 29/162 (17%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           +     +G G  G VY A    TG L A K I            +   I+ L+   HP I
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYI 78

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD----WNRRLR---IAT---G 171
           V +LG     G+  I+ EF               G ++       +R L    I      
Sbjct: 79  VKLLGAYYHDGKLWIMIEFC-------------PGGAVDAIMLELDRGLTEPQIQVVCRQ 125

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               L +LH      IIH  +KA N+L+  +   R+ D+G+S
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 64.8 bits (159), Expect = 4e-12
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 32/158 (20%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           IG+G  GTV+ A    T ++VA+KR+  RL   + G   +++  I  L   +H NIV + 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGAS----------LLDWNRRLRIATGAARG 175
               +  +  +V EF +   L  Y    N              LL             +G
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL-------------KG 113

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           L + H     N++H  +K  N+L+N     ++ ++GL+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 40/241 (16%), Positives = 80/241 (33%), Gaps = 74/241 (30%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKT 112
           +   + +G G  G V++A+     K VA+K+I                         IK 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-----------LTDPQSVKHALREIKI 61

Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
           +    H NIV +       G ++             Y+ +       ++ +    +  G 
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQE-----YMETDLANVLEQGP 116

Query: 173 A-------------RGLEYLHQGVAPNIIHGCIKASNILLNEKFCA-RVCDYGLS---FL 215
                         RGL+Y+H     N++H  +K +N+ +N +    ++ D+GL+     
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 216 APEEKRGLAGYVDDDYWHEKGGGNATR----------------ESDVYGFGVVLLEILSG 259
               K  L+  +             T+                  D++  G +  E+L+G
Sbjct: 174 HYSHKGHLSEGL------------VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

Query: 260 R 260
           +
Sbjct: 222 K 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 31/162 (19%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F     +G+G  G+VY A+   TG++VA+K++     + +        I  +     P++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPHV 86

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD----WNRRLR---IAT---G 171
           V   G      +  IV E+                 S+ D     N+ L    IAT    
Sbjct: 87  VKYYGSYFKNTDLWIVMEYC-------------GAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
             +GLEYLH       IH  IKA NILLN +  A++ D+G++
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 41/224 (18%), Positives = 75/224 (33%), Gaps = 36/224 (16%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
             +    I+GQG    V+      TG L A+K  +    L           + L    H 
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD-VQMREFEVLKKLNHK 67

Query: 120 NIVPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           NIV +    +    R  +++ EF    SL   L E ++   L + +  L +      G+ 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLRDVVGGMN 126

Query: 178 YLHQGVAPNIIHGCIKASNILL----NEKFCARVCDYGLS-----------------FLA 216
           +L +     I+H  IK  NI+     + +   ++ D+G +                 +L 
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 217 PEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           P+         +     +          D++  GV      +G 
Sbjct: 184 PD-------MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.3 bits (157), Expect = 6e-12
 Identities = 44/168 (26%), Positives = 65/168 (38%), Gaps = 34/168 (20%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLS-LAQ 117
           F    ++G G  G VY    + TG+L A+K      V+   G     +   I  L   + 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIK------VMDVTGDEEEEIKQEINMLKKYSH 79

Query: 118 HPNIVPILG-FSQAPGERIIVSEFINMASLDFYLHENNDGASLLD-----WNRRLR---I 168
           H NI    G F +     +    ++ M        E     S+ D         L+   I
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVM--------EFCGAGSVTDLIKNTKGNTLKEEWI 131

Query: 169 AT---GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           A       RGL +LHQ     +IH  IK  N+LL E    ++ D+G+S
Sbjct: 132 AYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 64.2 bits (157), Expect = 8e-12
 Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 12/148 (8%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           +G+G  G V       TG++VA+K+        +      ++  IK L   +H N+V +L
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +      +V EF++  ++   L    +G   LD+    +       G+ + H     
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH--- 143

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLS 213
           NIIH  IK  NIL+++    ++CD+G +
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFA 171

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 66/226 (29%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFG--FASVIKTLSLAQHPNIVP 123
           R +G+G     +      T ++ A K I P+ +L         +  I       H ++V 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD-WNRRLRIATGAAR-------- 174
             GF +      +V E                  SLL+   RR  +    AR        
Sbjct: 106 FHGFFEDNDFVFVVLELCR-------------RRSLLELHKRRKALTEPEARYYLRQIVL 152

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLA 216
           G +YLH+     +IH  +K  N+ LNE    ++ D+GL+                  ++A
Sbjct: 153 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

Query: 217 PE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           PE   K+   G+    +           E DV+  G ++  +L G+
Sbjct: 210 PEVLSKK---GH---SF-----------EVDVWSIGCIMYTLLVGK 238

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 41/218 (18%)

Query: 63  FSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQHPN 120
           F   R++G+G  G V A  + +TGK+ A K++  + +    G   A   K  L       
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 121 IVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           +V  L ++ +      +V   +N   L F+++  + G +     R +  A     GLE L
Sbjct: 246 VVS-LAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-----------------FLAPEEKRG 222
           H+     I++  +K  NILL++    R+ D GL+                 ++APE  + 
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              Y              T   D +  G +L E+++G+
Sbjct: 360 E-RY--------------TFSPDWWALGCLLYEMIAGQ 382

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 41/224 (18%), Positives = 85/224 (37%), Gaps = 35/224 (15%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV-IKTL-SLAQHPNIV 122
           RR++ +G    VY A  + +G+  A+KR+   L             +  +  L+ HPNIV
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 123 PILGFSQAPGER--------IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
                +    E         ++++E      ++F     + G   L  +  L+I     R
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCR 147

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------FLAPEEKRGLAGYVD 228
            ++++H+   P IIH  +K  N+LL+ +   ++CD+G +             +  A   +
Sbjct: 148 AVQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 229 DDYWH------------EKGGGNATRESDVYGFGVVLLEILSGR 260
           +   +                     + D++  G +L  +   +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 32/160 (20%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVPIL 125
           +G G   TVY  L  +TG  VA+K +  +L  S  G    ++  I  +   +H NIV + 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV--KLD-SEEGTPSTAIREISLMKELKHENIVRLY 69

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA------------ 173
                  +  +V EF++            D    +D         G              
Sbjct: 70  DVIHTENKLTLVFEFMDN-----------DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           +GL + H+     I+H  +K  N+L+N++   ++ D+GL+
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 62.6 bits (153), Expect = 2e-11
 Identities = 48/226 (21%), Positives = 80/226 (35%), Gaps = 66/226 (29%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFG--FASVIKTLSLAQHPNIVP 123
           R +G+G     +      T ++ A K I P+ +L         +  I       H ++V 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD-WNRRLRIATGAAR-------- 174
             GF +      +V E                  SLL+   RR  +    AR        
Sbjct: 80  FHGFFEDNDFVFVVLELCR-------------RRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLA 216
           G +YLH+     +IH  +K  N+ LNE    ++ D+GL+                  ++A
Sbjct: 127 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 217 PE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           PE   K+G +                  E DV+  G ++  +L G+
Sbjct: 184 PEVLSKKGHSF-----------------EVDVWSIGCIMYTLLVGK 212

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 27/156 (17%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASV--IKTLSLAQHPNIVPI 124
           +G+G+  TVY A   +T ++VA+K+I       +  G    ++  IK L    HPNI+ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG--------AARGL 176
           L          +V +F+             D   ++  +  L +             +GL
Sbjct: 78  LDAFGHKSNISLVFDFMET-----------DLEVIIK-DNSLVLTPSHIKAYMLMTLQGL 125

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           EYLHQ     I+H  +K +N+LL+E    ++ D+GL
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 62.6 bits (153), Expect = 2e-11
 Identities = 43/222 (19%), Positives = 78/222 (35%), Gaps = 57/222 (25%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
            ++G+G    VY A  + TG  VA+K I    +  +       + +K     +HP+I+ +
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA------ARGLEY 178
             + +      +V E  +   ++ YL             +                G+ Y
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRV---------KPFSENEARHFMHQIITGMLY 127

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPE-- 218
           LH      I+H  +  SN+LL      ++ D+GL+                  +++PE  
Sbjct: 128 LHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            +            H         ESDV+  G +   +L GR
Sbjct: 185 TRSA----------H-------GLESDVWSLGCMFYTLLIGR 209

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 51/223 (22%), Positives = 79/223 (35%), Gaps = 58/223 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + +G G  G V       T    A+K I    V +++       +  L L  HPNI+ + 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT-------GAAR---- 174
            F +      +V E                G  L D      I          AA     
Sbjct: 103 DFFEDKRNYYLVMECY-------------KGGELFD-----EIIHRMKFNEVDAAVIIKQ 144

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-FLAPEEKR----GL 223
              G+ YLH+    NI+H  +K  N+LL    +    ++ D+GLS     ++K     G 
Sbjct: 145 VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201

Query: 224 AGYV-----DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
           A Y+        Y           + DV+  GV+L  +L+G  
Sbjct: 202 AYYIAPEVLRKKY---------DEKCDVWSIGVILFILLAGYP 235

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 34/159 (21%), Positives = 61/159 (38%), Gaps = 36/159 (22%)

Query: 69  IGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV----IKTLSLAQHPNIVP 123
           IG+G  G V+      TG++VA+K+       S        +    I+ L   +HPN+V 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFL----ESEDDPVIKKIALREIRMLKQLKHPNLVN 66

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGAS----------LLDWNRRLRIATGAA 173
           +L   +      +V E+ +  ++   L     G             L             
Sbjct: 67  LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL------------- 112

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL 212
           + + + H+    N IH  +K  NIL+ +    ++CD+G 
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF 148

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 61.6 bits (150), Expect = 5e-11
 Identities = 40/230 (17%), Positives = 70/230 (30%), Gaps = 43/230 (18%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           F    ++GQG  G V  A      +  A+K+I       +      S +  L+   H  +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST---ILSEVMLLASLNHQYV 64

Query: 122 VPILGFSQAPGERIIVSEFINMASLDF----YLHENNDGASLLDW--NRRLRIATGAAR- 174
           V            +     +   S  F    Y     +  +L D   +  L         
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC----ENGTLYDLIHSENLNQQRDEYWR 120

Query: 175 -------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYV 227
                   L Y+H      IIH  +K  NI ++E    ++ D+GL+         L    
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 228 DDDYWHE------------------KGGGNATRESDVYGFGVVLLEILSG 259
            +                        G G+   + D+Y  G++  E++  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 40/221 (18%)

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQH 118
           D F   R++G+G  G V+A  + +TGKL A K+++ + +    G+  A V K  L+    
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 119 PNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
             IV  L ++ +   +  +V   +N   + ++++  ++        R +        GLE
Sbjct: 245 RFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------FLAPEE 219
           +LHQ    NII+  +K  N+LL++    R+ D GL+                  F+APE 
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 220 KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             G   Y                  D +  GV L E+++ R
Sbjct: 361 LLGE-EY--------------DFSVDYFALGVTLYEMIAAR 386

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 61.5 bits (150), Expect = 6e-11
 Identities = 37/164 (22%), Positives = 63/164 (38%), Gaps = 29/164 (17%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQ 117
           + +     +G+G   TVY      T  LVA+K I         G    ++  +  L   +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLK 58

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA---- 173
           H NIV +           +V E+++            D    LD +    I         
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-----------DLKQYLD-DCGNIINMHNVKLFL 106

Query: 174 ----RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
               RGL Y H+     ++H  +K  N+L+NE+   ++ D+GL+
Sbjct: 107 FQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLA 147

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 47/222 (21%), Positives = 79/222 (35%), Gaps = 47/222 (21%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G G  G V   +   TG+ VA+K+    L   N    +   I+ +    HPN+V   
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE-RWCLEIQIMKKLNHPNVVSAR 78

Query: 126 ------GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
                          ++  E+     L  YL++  +   L +   R  + +  +  L YL
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYL 137

Query: 180 HQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-----------------FLAPEE 219
           H+     IIH  +K  NI+L    ++   ++ D G +                 +LAPE 
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 220 KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                 Y              T   D + FG +  E ++G R
Sbjct: 195 LEQ-KKY--------------TVTVDYWSFGTLAFECITGFR 221

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 61.1 bits (149), Expect = 6e-11
 Identities = 52/247 (21%), Positives = 81/247 (32%), Gaps = 81/247 (32%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------------- 109
             IG+G  G V  A   +     A+K +  + ++  AGF                     
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 110 --------IKTLSLAQHPNIVPILGFSQAPGERII--VSEFINMASLDFYLHENNDGASL 159
                   I  L    HPN+V ++     P E  +  V E +N                +
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN-------------QGPV 125

Query: 160 LDWNRRLRIATGAAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG 211
           ++      ++   AR        G+EYLH      IIH  IK SN+L+ E    ++ D+G
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 212 LS------------------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVL 253
           +S                  F+APE                 G     +  DV+  GV L
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFS-------G-----KALDVWAMGVTL 230

Query: 254 LEILSGR 260
              + G+
Sbjct: 231 YCFVFGQ 237

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 61.7 bits (150), Expect = 6e-11
 Identities = 29/187 (15%), Positives = 55/187 (29%), Gaps = 52/187 (27%)

Query: 67  RIIGQGRLGTVYAALLS-TGKLVAVKRI--HPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           + +G G  G V       +GK  A+K++   PR             +  + +  H NI+ 
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE--------LDIMKVLDHVNIIK 64

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLL---------------------DW 162
           ++ +    G+                   N                              
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124

Query: 163 NRRLRIATGAA----------------RGLEYLHQGVAPNIIHGCIKASNILLNEKFCA- 205
           ++ L+    +                 R + ++H      I H  IK  N+L+N K    
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181

Query: 206 RVCDYGL 212
           ++CD+G 
Sbjct: 182 KLCDFGS 188

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.1 bits (149), Expect = 8e-11
 Identities = 37/171 (21%), Positives = 66/171 (38%), Gaps = 60/171 (35%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--------IKTL-SLA 116
           R +G+G+   V+ A+ ++  + V VK + P             V        IK L +L 
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKP-------------VKKKKIKREIKILENLR 88

Query: 117 QHPNIVPILGFSQAPGER--IIVSEFINMASLD------------FYLHENNDGASLLDW 162
             PNI+ +    + P  R   +V E +N                 FY++E      +L  
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE------IL-- 140

Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA-RVCDYGL 212
                      + L+Y H      I+H  +K  N++++ +    R+ D+GL
Sbjct: 141 -----------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.8 bits (150), Expect = 8e-11
 Identities = 44/232 (18%), Positives = 80/232 (34%), Gaps = 63/232 (27%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--------- 109
              + + + IG G  G V AA      + VA+K++      S     F +          
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRP---FQNQTHAKRAYRE 111

Query: 110 IKTLSLAQHPNIVPILGFSQAPGER------IIVSEFINMASLDFYLHENNDGASLLDWN 163
           +  +    H NI+ +L                +V E ++ A+L   +         LD  
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME------LDHE 164

Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGL 223
           R   +      G+++LH      IIH  +K SNI++      ++ D+GL+  A      +
Sbjct: 165 RMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-M 220

Query: 224 AGYVDDDYWHEKGGGNATR---------------ESDVYGFGVVLLEILSGR 260
             YV             TR                 D++  G ++ E++  +
Sbjct: 221 TPYV------------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 60.7 bits (148), Expect = 9e-11
 Identities = 49/228 (21%), Positives = 79/228 (34%), Gaps = 62/228 (27%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
            ++G+G  G V   L   T    AVK I  +  L     G A+V   I+ L   +H N++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 123 PILG--FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR------ 174
            ++   +++   +  +V E+                  +LD     R     A       
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYC-----------VCGMQEMLDSVPEKRFPVCQAHGYFCQL 118

Query: 175 --GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------- 213
             GLEYLH      I+H  IK  N+LL      ++   G++                   
Sbjct: 119 IDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 214 -FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            F  PE   GL  +             +  + D++  GV L  I +G 
Sbjct: 176 AFQPPEIANGLDTF-------------SGFKVDIWSAGVTLYNITTGL 210

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 42/170 (24%)

Query: 63  FSHRRIIGQGRLGTVYAALLS-TGKLVAVKRI--HPRLVLSNAGFGFASVIKTLSLAQHP 119
           ++  ++IG G  G VY A L  +G+LVA+K++    R             ++ +    H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE--------LQIMRKLDHC 107

Query: 120 NIVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           NIV +  F  + GE+       +V +++       Y         +     R +      
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE---TVY--------RVARHYSRAKQTLPVI 156

Query: 174 ----------RGLEYLHQGVAPNIIHGCIKASNILLNEKFCA-RVCDYGL 212
                     R L Y+H      I H  IK  N+LL+      ++CD+G 
Sbjct: 157 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 46/189 (24%), Positives = 74/189 (39%), Gaps = 49/189 (25%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKT 112
           +++   IG+G  G V +A        VA+K+I P          F            IK 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTLREIKI 78

Query: 113 LSLAQHPNIVPILGFSQAPGERI-----IVSEFINMASLDFYLHENNDGASLLDWNRR-- 165
           L   +H NI+ I    +AP         IV +      ++  L++      L + +    
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYF 133

Query: 166 ----LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---FLAPE 218
               LR       GL+Y+H     N++H  +K SN+LLN     ++CD+GL+       +
Sbjct: 134 LYQILR-------GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 219 EKRGLAGYV 227
               L  YV
Sbjct: 184 HTGFLTEYV 192

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 46/218 (21%), Positives = 81/218 (37%), Gaps = 41/218 (18%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKT 112
           + + + IG G  G V AA      + VA+K++      S     F +          +  
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL------SRP---FQNQTHAKRAYRELVL 77

Query: 113 LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL-------LDWNRR 165
           +    H NI+ +L         +   +       D Y+      A+L       LD  R 
Sbjct: 78  MKCVNHKNIIGLL--------NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 129

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
             +      G+++LH      IIH  +K SNI++      ++ D+GL+  A      +  
Sbjct: 130 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTP 185

Query: 226 YVDDDYWH--EKGGGNA-TRESDVYGFGVVLLEILSGR 260
           YV   Y+   E   G       D++  G ++ E++ G 
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 52/234 (22%), Positives = 77/234 (32%), Gaps = 69/234 (29%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV-----------IKTLS 114
           R +G G  G V      +     A+K I                           I  L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT---- 170
              HPNI+ +    +      +V+EF              +G  L +     +I      
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFY-------------EGGELFE-----QIINRHKF 143

Query: 171 ---GAAR-------GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-FLA 216
               AA        G+ YLH+    NI+H  IK  NILL   N     ++ D+GLS F +
Sbjct: 144 DECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 217 PEEKR----GLAGYV-----DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
            + K     G A Y+        Y           + DV+  GV++  +L G  
Sbjct: 201 KDYKLRDRLGTAYYIAPEVLKKKY---------NEKCDVWSCGVIMYILLCGYP 245

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 40/163 (24%), Positives = 62/163 (38%), Gaps = 31/163 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV------IKTLSLAQHP 119
             +G G  G V+ A+     K V VK I    VL +       +      I  LS  +H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR---- 174
           NI+ +L   +  G   +V E             +  G  L  + +R  R+    A     
Sbjct: 90  NIIKVLDIFENQGFFQLVMEK------------HGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 175 ----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
                + YL      +IIH  IK  NI++ E F  ++ D+G +
Sbjct: 138 QLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 52/223 (23%), Positives = 77/223 (34%), Gaps = 58/223 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
            ++G+G  G V       T +  AVK I+     +         ++ L    HPNI+ + 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT-------GAAR---- 174
              +      IV E                G  L D      I          AAR    
Sbjct: 88  EILEDSSSFYIVGELY-------------TGGELFD-----EIIKRKRFSEHDAARIIKQ 129

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-FLAPEEKR----GL 223
              G+ Y+H+    NI+H  +K  NILL    +    ++ D+GLS       K     G 
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186

Query: 224 AGYV-----DDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
           A Y+        Y           + DV+  GV+L  +LSG  
Sbjct: 187 AYYIAPEVLRGTY---------DEKCDVWSAGVILYILLSGTP 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 42/221 (19%), Positives = 86/221 (38%), Gaps = 42/221 (19%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--------- 109
              +     +G G  G+V +A+   +G+ VA+K++      S     F S          
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL------SRP---FQSEIFAKRAYRE 73

Query: 110 IKTLSLAQHPNIVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWN 163
           +  L   QH N++ +L                +V  F+    L   +          +  
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLK-----FSEEK 127

Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGL 223
            +  +     +GL+Y+H      ++H  +K  N+ +NE    ++ D+GL+  A  E   +
Sbjct: 128 IQY-LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---M 180

Query: 224 AGYVDDDYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            GYV   ++          +  +  D++  G ++ E+L+G+
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 48/170 (28%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKTLSLA 116
            +IG+G  G VY A   +T K VA+K++      +     F  +         I  L+  
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKV------NRM---FEDLIDCKRILREITILNRL 82

Query: 117 QHPNIVPILGFSQAPGERI-----IVSEFINMASLDFY--LHENNDGASLLDWNRR---- 165
           +   I+ +                IV E     S D             L + + +    
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEI--ADS-DLKKLFKTPIF---LTEEHIKTILY 136

Query: 166 --LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
             L        G  ++H+     IIH  +K +N LLN+    +VCD+GL+
Sbjct: 137 NLLL-------GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 46/168 (27%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKTLSLA 116
            ++G+G  G V +A    TG++VA+K+I P          F            IK L   
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFALRTLREIKILKHF 66

Query: 117 QHPNIVPILGFSQAPGERI-----IVSEFINMASLDFYLHENNDGASLLDWNRR------ 165
           +H NI+ I    +           I+ E   M + D  LH       L D + +      
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQEL--MQT-D--LHRVISTQMLSDDHIQYFIYQT 121

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
           LR        ++ LH     N+IH  +K SN+L+N     +VCD+GL+
Sbjct: 122 LR-------AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 54/223 (24%), Positives = 83/223 (37%), Gaps = 59/223 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           R++G+G  G V       TG+  AVK I   ++            ++ L    HPNI+ +
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT-------GAAR--- 174
             F +  G   +V E                G  L D      I +        AAR   
Sbjct: 92  YEFFEDKGYFYLVGEVY-------------TGGELFD-----EIISRKRFSEVDAARIIR 133

Query: 175 ----GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-FLAPEEKR----G 222
               G+ Y+H+     I+H  +K  N+LL   ++    R+ D+GLS      +K     G
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190

Query: 223 LAGYV-----DDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            A Y+        Y           + DV+  GV+L  +LSG 
Sbjct: 191 TAYYIAPEVLHGTY---------DEKCDVWSTGVILYILLSGC 224

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 58.4 bits (142), Expect = 5e-10
 Identities = 46/227 (20%), Positives = 79/227 (34%), Gaps = 58/227 (25%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL--------SLAQ 117
            I+G+G    V   +   T K  AVK I      S +      + +           ++ 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI--------- 168
           HPNI+ +    +      +V + +                 L D      +         
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLM-------------KKGELFD-----YLTEKVTLSEK 124

Query: 169 -ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR- 221
                 R     +  LH+    NI+H  +K  NILL++    ++ D+G S  L P EK  
Sbjct: 125 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181

Query: 222 ---GLAGYV------DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
              G   Y+           +  G G   +E D++  GV++  +L+G
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYG---KEVDMWSTGVIMYTLLAG 225

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 36/164 (21%), Positives = 59/164 (35%), Gaps = 36/164 (21%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVP 123
            +IG G  G V  A      ++VA+K+I    V  +       +  I  L+   H ++V 
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVK 116

Query: 124 ILGFSQAPGERI-----IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA------ 172
           +L               +V E       D           L      L   T        
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEI-----ADSDFK------KLFRTPVYL---TELHIKTLL 162

Query: 173 ---ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
                G++Y+H      I+H  +K +N L+N+    +VCD+GL+
Sbjct: 163 YNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 55/217 (25%), Positives = 81/217 (37%), Gaps = 41/217 (18%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV------IKTLSLAQHP 119
           + +G G  G V  A    T K VA++ I  R     +             I+ L    HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAA--- 173
            I+ I  F  A  +  IV E +              G  L D    N+RL+ AT      
Sbjct: 201 CIIKIKNFFDAE-DYYIVLELME-------------GGELFDKVVGNKRLKEATCKLYFY 246

Query: 174 ---RGLEYLHQGVAPNIIHGCIKASNILLNEK---FCARVCDYGLSFLAPEEKR-----G 222
                ++YLH+     IIH  +K  N+LL+ +      ++ D+G S +  E        G
Sbjct: 247 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303

Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
              Y+  +     G     R  D +  GV+L   LSG
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 34/131 (25%), Positives = 57/131 (43%), Gaps = 26/131 (19%)

Query: 142 NMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE 201
           +++ ++      +     L     +  +   A+G+E+L    +   IH  + A NILL+E
Sbjct: 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 228

Query: 202 KFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGG--------------GNATRESDVY 247
           K   ++CD+GL+       R +  Y D DY  +                    T +SDV+
Sbjct: 229 KNVVKICDFGLA-------RDI--YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 279

Query: 248 GFGVVLLEILS 258
            FGV+L EI S
Sbjct: 280 SFGVLLWEIFS 290

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 45/214 (21%), Positives = 84/214 (39%), Gaps = 41/214 (19%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKTLSLA 116
           + +G G  G V +A+   TG  VA+K++            F S          ++ L   
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKL------YRP---FQSELFAKRAYRELRLLKHM 81

Query: 117 QHPNIVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT 170
           +H N++ +L                +V  F+    L   +         L  +R   +  
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEK-----LGEDRIQFLVY 135

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDD 230
              +GL Y+H      IIH  +K  N+ +NE    ++ D+GL+  A  E   + GYV   
Sbjct: 136 QMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTR 189

Query: 231 YWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
           ++            T+  D++  G ++ E+++G+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 31/170 (18%), Positives = 61/170 (35%), Gaps = 46/170 (27%)

Query: 69  IGQGRLGTVYAA---LLSTGKLVAVKRIHPRLVLSNAGFGFASV--IKTLSLAQHPNIVP 123
           +G+G  G VY A        K  A+K+I         G   ++   I  L   +HPN++ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACREIALLRELKHPNVIS 82

Query: 124 ILGFSQAPGERII--VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA-------- 173
           +     +  +R +  + ++              D   ++ ++R  +              
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-----------DLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 174 -------RGLEYLHQGVAPNIIHGCIKASNILL----NEKFCARVCDYGL 212
                   G+ YLH      ++H  +K +NIL+     E+   ++ D G 
Sbjct: 132 SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 60/228 (26%)

Query: 63  FSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFA----SVIKTLSLAQ 117
           FS  RIIG+G  G VY      TGK+ A+K +  + +    G   A     ++  +S   
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 118 HPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR-- 174
            P IV  + ++   P +   + + +N   L ++L             +    +    R  
Sbjct: 251 CPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLS------------QHGVFSEADMRFY 297

Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS--------------- 213
                 GLE++H      +++  +K +NILL+E    R+ D GL+               
Sbjct: 298 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354

Query: 214 -FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            ++APE  +    Y                 +D +  G +L ++L G 
Sbjct: 355 GYMAPEVLQKGVAY--------------DSSADWFSLGCMLFKLLRGH 388

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 34/170 (20%), Positives = 61/170 (35%), Gaps = 51/170 (30%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHP------RLVLSNAGFGFASVIKTLSLAQHPN 120
           ++IG G  G V+ A L     VA+K++        R             ++ + + +HPN
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------------ELQIMRIVKHPN 93

Query: 121 IVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA- 173
           +V +  F  + G++       +V E++       Y               +L+       
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE---TVY--------RASRHYAKLKQTMPMLL 142

Query: 174 ---------RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV--CDYGL 212
                    R L Y+H   +  I H  IK  N+LL+      +   D+G 
Sbjct: 143 IKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPP-SGVLKLIDFGS 188

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 51/221 (23%), Positives = 78/221 (35%), Gaps = 58/221 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
            ++G+G  G V       T +  AVK I+     +         ++ L    HPNI+ + 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT-------GAAR---- 174
              +      IV E                G  L D      I          AAR    
Sbjct: 88  EILEDSSSFYIVGELYT-------------GGELFD-----EIIKRKRFSEHDAARIIKQ 129

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR-----GL 223
              G+ Y+H+    NI+H  +K  NILL    +    ++ D+GLS    +  +     G 
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186

Query: 224 AGYV-----DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
           A Y+        Y           + DV+  GV+L  +LSG
Sbjct: 187 AYYIAPEVLRGTY---------DEKCDVWSAGVILYILLSG 218

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 47/226 (20%), Positives = 79/226 (34%), Gaps = 57/226 (25%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-------LAQH 118
            +IG+G    V   +  +TG   AVK +       +          T         +A H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI-ATG------ 171
           P+I+ ++   ++     +V + +                 L D      +          
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLM-------------RKGELFD-----YLTEKVALSEKE 201

Query: 172 AAR-------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-FLAPEEKR-- 221
                      + +LH     NI+H  +K  NILL++    R+ D+G S  L P EK   
Sbjct: 202 TRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258

Query: 222 --GLAGYV------DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
             G  GY+              G G   +E D++  GV+L  +L+G
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYG---KEVDLWACGVILFTLLAG 301

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 57/173 (32%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---------IKTLS-L 115
           + +G+G  G V+ ++   TG++VAVK+I       +A   F +          I  L+ L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKI------FDA---FQNSTDAQRTFREIMILTEL 65

Query: 116 AQHPNIVPILGFSQAPGER--IIVSEF--------INMASLD-----FYLHENNDGASLL 160
           + H NIV +L   +A  +R   +V ++        I    L+     + +++      L+
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ------LI 119

Query: 161 DWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
                        + ++YLH G    ++H  +K SNILLN +   +V D+GLS
Sbjct: 120 -------------KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 49/222 (22%), Positives = 84/222 (37%), Gaps = 59/222 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPI 124
           + IG+G    V  A  + TG+ VA+K I  +  L+          ++ + +  HPNIV +
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR--------G 175
               +      ++ E+ +             G  + D+     R+    AR         
Sbjct: 80  FEVIETEKTLYLIMEYAS-------------GGEVFDYLVAHGRMKEKEARSKFRQIVSA 126

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-----------------FLAPE 218
           ++Y HQ     I+H  +KA N+LL+     ++ D+G S                 + APE
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183

Query: 219 EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             +G   Y                E DV+  GV+L  ++SG 
Sbjct: 184 LFQGK-KY-------------DGPEVDVWSLGVILYTLVSGS 211

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 49/270 (18%), Positives = 81/270 (30%), Gaps = 82/270 (30%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQH 118
           F   + +G+G  G V+ A         A+KRI     L N       V   +K L+  +H
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR----LPNRELAREKVMREVKALAKLEH 63

Query: 119 PNIVPILGF---------------------------------SQAPGERIIVSEFINMAS 145
           P IV                                           +   +  F    +
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 146 LDFYLHENN-----------DGASLLDWNRR------------LRIATGAARGLEYLHQG 182
           +      +               +L DW  R            L I    A  +E+LH  
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS- 182

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLS--FLAPEEKRGLAGYVDDDYWHEKG---- 236
               ++H  +K SNI        +V D+GL       EE++ +   +     H       
Sbjct: 183 --KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 237 ---------GGNATRESDVYGFGVVLLEIL 257
                    G N + + D++  G++L E+L
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 49/221 (22%), Positives = 92/221 (41%), Gaps = 41/221 (18%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV--------- 109
            + + +   +G G  G+V AA    TG  VAVK++      S     F S+         
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRP---FQSIIHAKRTYRE 78

Query: 110 IKTLSLAQHPNIVPILGFSQAPGERI------IVSEFINMASLDFYLHENNDGASLLDWN 163
           ++ L   +H N++ +L                +V+       +   L+       L D +
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDH 133

Query: 164 RRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGL 223
            +  +     RGL+Y+H     +IIH  +K SN+ +NE    ++ D+GL+    +E   +
Sbjct: 134 VQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---M 186

Query: 224 AGYVDDDYWHEK----GGGNATRESDVYGFGVVLLEILSGR 260
            GYV   ++          +  +  D++  G ++ E+L+GR
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 51/226 (22%), Positives = 82/226 (36%), Gaps = 55/226 (24%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
            +IG+G    V   +   TG+  AVK +      S+ G     +        + +HP+IV
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI-------------- 168
            +L    + G   +V EF+             DGA L        I              
Sbjct: 90  ELLETYSSDGMLYMVFEFM-------------DGADLCF-----EIVKRADAGFVYSEAV 131

Query: 169 ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCA---RVCDYGLSFLAPEEKR 221
           A+   R     L Y H     NIIH  +K   +LL  K  +   ++  +G++    E   
Sbjct: 132 ASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188

Query: 222 ------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                 G   ++  +    +  G   +  DV+G GV+L  +LSG  
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYG---KPVDVWGCGVILFILLSGCL 231

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 62/224 (27%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
             +G G  G V       TG  VAVK ++  ++   +        I+ L L +HP+I+ +
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR--------G 175
                 P +  +V E+++             G  L D+  +  R+    AR         
Sbjct: 77  YQVISTPTDFFMVMEYVS-------------GGELFDYICKHGRVEEMEARRLFQQILSA 123

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FL----------APE 218
           ++Y H+     ++H  +K  N+LL+    A++ D+GLS       FL          APE
Sbjct: 124 VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 180

Query: 219 --EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               R  AG                 E D++  GV+L  +L G 
Sbjct: 181 VISGRLYAG----------------PEVDIWSCGVILYALLCGT 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 64/225 (28%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
             +G G  G V       TG  VAVK ++ + + S    G   +   I+ L L +HP+I+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG--KIRREIQNLKLFRHPHII 79

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR-------- 174
            +      P +  +V E+++   L  Y+ +N             R+    +R        
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDEKESRRLFQQILS 127

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FL----------AP 217
           G++Y H+     ++H  +K  N+LL+    A++ D+GLS       FL          AP
Sbjct: 128 GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184

Query: 218 E--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           E    R  AG                 E D++  GV+L  +L G 
Sbjct: 185 EVISGRLYAG----------------PEVDIWSSGVILYALLCGT 213

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 51.9 bits (125), Expect = 7e-08
 Identities = 39/231 (16%), Positives = 83/231 (35%), Gaps = 68/231 (29%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVK-----RIHPRLVLSNAGFGF--ASVIKTLSLA-Q 117
            ++G+G  GTV+A   L+    VA+K     R+     LS++       +++  +     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR-- 174
           HP ++ +L + +     ++V E                   L D+   +  +  G +R  
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPL------------PAQDLFDYITEKGPLGEGPSRCF 144

Query: 175 ------GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLS-------------- 213
                  +++ H      ++H  IK  NIL++  + CA++ D+G                
Sbjct: 145 FGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGT 201

Query: 214 --FLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             +  PE   +                       + V+  G++L +++ G 
Sbjct: 202 RVYSPPEWISRHQYHA----------------LPATVWSLGILLYDMVCGD 236

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 51.9 bits (125), Expect = 8e-08
 Identities = 57/217 (26%), Positives = 80/217 (36%), Gaps = 41/217 (18%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV------IKTLSLAQHP 119
           + +G G  G V  A    T K VA+K I  R     +             I+ L    HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAA--- 173
            I+ I  F  A  +  IV E +              G  L D    N+RL+ AT      
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELME-------------GGELFDKVVGNKRLKEATCKLYFY 121

Query: 174 ---RGLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR-----G 222
                ++YLH+     IIH  +K  N+LL    E    ++ D+G S +  E        G
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178

Query: 223 LAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
              Y+  +     G     R  D +  GV+L   LSG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 41/194 (21%), Positives = 72/194 (37%), Gaps = 52/194 (26%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSL 115
            D +     +G G  G V+  +  +TG++   K I+    L        +V   I  ++ 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-----DKYTVKNEISIMNQ 104

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI------- 168
             HP ++ +    +   E +++ EF+              G  L D     RI       
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFL-------------SGGELFD-----RIAAEDYKM 146

Query: 169 ----ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLS-FLAP 217
                    R    GL+++H+    +I+H  IK  NI+   K  + V   D+GL+  L P
Sbjct: 147 SEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203

Query: 218 EEKR----GLAGYV 227
           +E        A + 
Sbjct: 204 DEIVKVTTATAEFA 217

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 49/234 (20%), Positives = 81/234 (34%), Gaps = 70/234 (29%)

Query: 63  FSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT------LSL 115
           F   R IG+G  G V       T K+ A+K ++ +  +         V         +  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN-----EVRNVFKELQIMQG 71

Query: 116 AQHPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
            +HP +V  L +S Q   +  +V + +    L ++L             + +       +
Sbjct: 72  LEHPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHL------------QQNVHFKEETVK 118

Query: 175 --------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------- 213
                    L+YL       IIH  +K  NILL+E     + D+ ++             
Sbjct: 119 LFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA 175

Query: 214 ----FLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
               ++APE    R  AGY              +   D +  GV   E+L GRR
Sbjct: 176 GTKPYMAPEMFSSRKGAGY--------------SFAVDWWSLGVTAYELLRGRR 215

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 39/190 (20%), Positives = 71/190 (37%), Gaps = 44/190 (23%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSL 115
            D +     +G G  G V+     +TG   A K +              +V   I+T+S+
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSV 210

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFIN-------MASLDFYLHENNDGASLLDWNRRLRI 168
            +HP +V +    +   E +++ EF++       +A     + E                
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE--------------DE 256

Query: 169 ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLS-FLAPEEKR 221
           A    R    GL ++H+    N +H  +K  NI+   K    +   D+GL+  L P++  
Sbjct: 257 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

Query: 222 ----GLAGYV 227
               G A + 
Sbjct: 314 KVTTGTAEFA 323

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 51.8 bits (125), Expect = 9e-08
 Identities = 39/189 (20%), Positives = 66/189 (34%), Gaps = 49/189 (25%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPR-LVLSNAGFGFASV---IKTLSLAQHPNI 121
             +G G+   V       TGK  A K I  R L  S  G     +   +  L   +HPNI
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI----------ATG 171
           + +    +   + +++ E +              G  L D      +          AT 
Sbjct: 71  ITLHDIFENKTDVVLILELV-------------SGGELFD-----FLAEKESLTEDEATQ 112

Query: 172 AAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCA----RVCDYGLS-FLAPEEKR- 221
             +    G+ YLH      I H  +K  NI+L +K       ++ D+G++  +    +  
Sbjct: 113 FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169

Query: 222 ---GLAGYV 227
              G   +V
Sbjct: 170 NIFGTPEFV 178

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 51.9 bits (125), Expect = 9e-08
 Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 63/224 (28%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
             +G+G  G V  A    T + VA+K I    L  S+        I  L L +HP+I+ +
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR--------G 175
                 P + ++V E+               G  L D+   + R+     R         
Sbjct: 75  YDVITTPTDIVMVIEYA--------------GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------FL----------APE 218
           +EY H+     I+H  +K  N+LL++    ++ D+GLS       FL          APE
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177

Query: 219 --EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               +  AG                 E DV+  G+VL  +L GR
Sbjct: 178 VINGKLYAG----------------PEVDVWSCGIVLYVMLVGR 205

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 36/194 (18%), Positives = 68/194 (35%), Gaps = 53/194 (27%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSL 115
            + +     +G+G  G V+  +  S+ K    K +  +      G     V   I  L++
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNI 57

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT----- 170
           A+H NI+ +    ++  E +++ EFI              G  + +     RI T     
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFI-------------SGLDIFE-----RINTSAFEL 99

Query: 171 ---GAAR-------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLS-FLAP 217
                          L++LH     NI H  I+  NI+   +  + +   ++G +  L P
Sbjct: 100 NEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156

Query: 218 EEKR----GLAGYV 227
            +          Y 
Sbjct: 157 GDNFRLLFTAPEYY 170

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 69/234 (29%)

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT------L 113
           + F + +++G+G  G V      +TG+  A+K +   ++++        V  T      L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD-----EVAHTLTENRVL 202

Query: 114 SLAQHPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
             ++HP +   L +S Q       V E+ N   L F+L             R    +   
Sbjct: 203 QNSRHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLS------------RERVFSEDR 249

Query: 173 AR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------- 213
           AR         L+YLH     N+++  +K  N++L++    ++ D+GL            
Sbjct: 250 ARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307

Query: 214 -------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                  +LAPE       Y               R  D +G GVV+ E++ GR
Sbjct: 308 TFCGTPEYLAPEVLEDN-DY--------------GRAVDWWGLGVVMYEMMCGR 346

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 58/227 (25%)

Query: 63  FSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIK---------- 111
           F   +I+G+G   TV  A  L+T +  A+K      +L         +IK          
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK------ILEKR-----HIIKENKVPYVTRE 80

Query: 112 --TLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
              +S   HP  V +    Q   +      +     L  Y+             +     
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI------------RKIGSFD 128

Query: 170 TGAAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR 221
               R         LEYLH      IIH  +K  NILLNE    ++ D+G + +   E +
Sbjct: 129 ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185

Query: 222 --------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                   G A YV  +   EK    A + SD++  G ++ ++++G 
Sbjct: 186 QARANSFVGTAQYVSPELLTEKS---ACKSSDLWALGCIIYQLVAGL 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 40/196 (20%), Positives = 67/196 (34%), Gaps = 49/196 (25%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPR-LVLSNAGFGFASV---IKTLS 114
            D +     +G G+   V      STG   A K I  R    S  G     +   +  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI------ 168
             QHPN++ +    +   + I++ E +              G  L D      +      
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELV-------------AGGELFD-----FLAEKESL 111

Query: 169 ----ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCA----RVCDYGLS-FL 215
               AT   +    G+ YLH      I H  +K  NI+L ++       ++ D+GL+  +
Sbjct: 112 TEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168

Query: 216 APEEKR----GLAGYV 227
               +     G   +V
Sbjct: 169 DFGNEFKNIFGTPEFV 184

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 42/254 (16%), Positives = 73/254 (28%), Gaps = 72/254 (28%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
             IGQG  G V  A+   T  + A+K ++   +          +   ++ +    HPNI 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG----------- 171
            +    +      +V E  +   L   L+   D ++       ++               
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 172 ------------------AAR-------GLEYLHQGVAPNIIHGCIKASNILLNEKFCAR 206
                              +         L YLH      I H  IK  N L +      
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208

Query: 207 V--CDYGLSFLAPEEKR----------GLAGYV--------DDDYWHEKGGGNATRESDV 246
           +   D+GLS    +             G   +V        ++ Y           + D 
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY---------GPKCDA 259

Query: 247 YGFGVVLLEILSGR 260
           +  GV+L  +L G 
Sbjct: 260 WSAGVLLHLLLMGA 273

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 51/228 (22%), Positives = 72/228 (31%), Gaps = 72/228 (31%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
           + IG G  G         T +LVAVK I     +        +V   I      +HPNIV
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE------NVQREIINHRSLRHPNIV 79

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR------- 174
                   P    I+ E+ +             G  L +      R +   AR       
Sbjct: 80  RFKEVILTPTHLAIIMEYAS-------------GGELYERICNAGRFSEDEARFFFQQLL 126

Query: 175 -GLEYLHQGVAPNIIHGCIKASNILLNEKFCAR--VCDYGLS-------FL--------- 215
            G+ Y H      I H  +K  N LL+     R  +CD+G S                  
Sbjct: 127 SGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183

Query: 216 -APE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            APE   ++   G                + +DV+  GV L  +L G 
Sbjct: 184 IAPEVLLRQEYDG----------------KIADVWSCGVTLYVMLVGA 215

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 37/229 (16%), Positives = 75/229 (32%), Gaps = 66/229 (28%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIH-PRLVLSNAGFGFASV---IKTLSLAQH--P 119
            ++G G  G+VY+ + +S    VA+K +   R+           V   +  L        
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR---- 174
            ++ +L + + P   +++ E                   L D+   R  +    AR    
Sbjct: 109 GVIRLLDWFERPDSFVLILERP------------EPVQDLFDFITERGALQEELARSFFW 156

Query: 175 ----GLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLS---------------- 213
                + + H      ++H  IK  NIL++  +   ++ D+G                  
Sbjct: 157 QVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 213

Query: 214 FLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           +  PE        G                R + V+  G++L +++ G 
Sbjct: 214 YSPPEWIRYHRYHG----------------RSAAVWSLGILLYDMVCGD 246

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 43/234 (18%), Positives = 82/234 (35%), Gaps = 69/234 (29%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS----- 114
             F+   ++G+G  G V  +    T +L AVK +   +V+ +       V  T+      
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-----DVECTMVEKRVL 395

Query: 115 --LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGA 172
               + P +  +    Q       V E++N   L +++             +  R     
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ------------QVGRFKEPH 443

Query: 173 AR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------- 213
           A         GL +L       II+  +K  N++L+ +   ++ D+G+            
Sbjct: 444 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 500

Query: 214 -------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                  ++APE       Y               +  D + FGV+L E+L+G+
Sbjct: 501 TFCGTPDYIAPEIIAYQ-PY--------------GKSVDWWAFGVLLYEMLAGQ 539

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 47/231 (20%), Positives = 81/231 (35%), Gaps = 75/231 (32%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
           + +G+G  G V  A+   T + VAVK +  +  +        ++   I    +  H N+V
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE----NIKKEICINKMLNHENVV 68

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW---NRRLRIATGAAR----- 174
              G  +    + +  E+ +             G  L D    +  +      A+     
Sbjct: 69  KFYGHRREGNIQYLFLEYCS-------------GGELFDRIEPDIGMPEPD--AQRFFHQ 113

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------FL------ 215
              G+ YLH      I H  IK  N+LL+E+   ++ D+GL+           L      
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 216 ----APE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
               APE  ++R                       DV+  G+VL  +L+G 
Sbjct: 171 LPYVAPELLKRREFHA----------------EPVDVWSCGIVLTAMLAGE 205

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 38/196 (19%), Positives = 65/196 (33%), Gaps = 49/196 (25%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPR-LVLSNAGFGFASV---IKTLS 114
            D +     +G G+   V      STG   A K I  R    S  G     +   +  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI------ 168
              H N++ +    +   + +++ E +              G  L D      +      
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELV-------------SGGELFD-----FLAQKESL 112

Query: 169 ----ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCA----RVCDYGLS-FL 215
               AT   +    G+ YLH      I H  +K  NI+L +K       ++ D+GL+  +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 216 APEEKR----GLAGYV 227
               +     G   +V
Sbjct: 170 EDGVEFKNIFGTPEFV 185

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 35/160 (21%), Positives = 63/160 (39%), Gaps = 33/160 (20%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
           + +G+G  G V  A+   T + VAVK +  +  +        ++   I    +  H N+V
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE----NIKKEICINKMLNHENVV 68

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDW-NRRLRIATGAAR------- 174
              G  +    + +  E+ +             G  L D     + +    A+       
Sbjct: 69  KFYGHRREGNIQYLFLEYCS-------------GGELFDRIEPDIGMPEPDAQRFFHQLM 115

Query: 175 -GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
            G+ YLH      I H  IK  N+LL+E+   ++ D+GL+
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 40/196 (20%), Positives = 66/196 (33%), Gaps = 49/196 (25%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPR-LVLSNAGFGFASV---IKTLS 114
            D +     +G G+   V      STG   A K I  R    S  G     +   +  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI------ 168
              HPNI+ +    +   + +++ E +              G  L D      +      
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELV-------------SGGELFD-----FLAQKESL 112

Query: 169 ----ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCA----RVCDYGLS-FL 215
               AT   +    G+ YLH      I H  +K  NI+L +K       ++ D+GL+  +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 216 APEEKR----GLAGYV 227
               +     G   +V
Sbjct: 170 EDGVEFKNIFGTPEFV 185

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 44/227 (19%), Positives = 81/227 (35%), Gaps = 56/227 (24%)

Query: 63  FSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQHPN 120
           +   ++IG+G  G V      ST K+ A+K +    ++  +   F    +  ++ A  P 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 121 IVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR------ 174
           +V +    Q      +V E++              G  L++      +    AR      
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMP-------------GGDLVNLMSNYDVPEKWARFYTAEV 177

Query: 175 --GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------------- 213
              L+ +H       IH  +K  N+LL++    ++ D+G                     
Sbjct: 178 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234

Query: 214 FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           +++PE  +            + G G   RE D +  GV L E+L G 
Sbjct: 235 YISPEVLKS-----------QGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 45/215 (20%), Positives = 75/215 (34%), Gaps = 48/215 (22%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
            ++G G    V+      TGKL A+K I       ++     + I  L   +H NIV + 
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL--ENEIAVLKKIKHENIVTLE 72

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI----------ATGAAR- 174
              ++     +V + +              G  L D     RI          A+   + 
Sbjct: 73  DIYESTTHYYLVMQLV-------------SGGELFD-----RILERGVYTEKDASLVIQQ 114

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-FLAPEEKRGLAG-- 225
               ++YLH+     I+H  +K  N+L     E     + D+GLS            G  
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP 171

Query: 226 -YVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            YV  +   +K      +  D +  GV+   +L G
Sbjct: 172 GYVAPEVLAQKPYS---KAVDCWSIGVITYILLCG 203

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 40/223 (17%), Positives = 78/223 (34%), Gaps = 60/223 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G+G    V   + +  G+  A   I+ + + +          +   L +HPNIV + 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI----------ATGAAR- 174
                 G   ++ + +              G  L +      I          A+   + 
Sbjct: 77  DSISEEGHHYLIFDLV-------------TGGELFE-----DIVAREYYSEADASHCIQQ 118

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILLNEK---FCARVCDYGLS-FLAPEEKR-----G 222
               + + HQ     ++H  +K  N+LL  K      ++ D+GL+  +  E++      G
Sbjct: 119 ILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

Query: 223 LAGYV------DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
             GY+       D Y          +  D++  GV+L  +L G
Sbjct: 176 TPGYLSPEVLRKDPY---------GKPVDLWACGVILYILLVG 209

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 49.1 bits (118), Expect = 5e-07
 Identities = 42/222 (18%), Positives = 76/222 (34%), Gaps = 59/222 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G+G    V   +  +TG   A K I+ + + +          +     QHPNIV + 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI----------ATGAAR- 174
              Q      +V + +              G  L +      I          A+   + 
Sbjct: 72  DSIQEESFHYLVFDLV-------------TGGELFE-----DIVAREFYSEADASHCIQQ 113

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR-----GL 223
               + Y H      I+H  +K  N+LL    +    ++ D+GL+    + +      G 
Sbjct: 114 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170

Query: 224 AGYV------DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            GY+       D Y         ++  D++  GV+L  +L G
Sbjct: 171 PGYLSPEVLKKDPY---------SKPVDIWACGVILYILLVG 203

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 41/191 (21%), Positives = 71/191 (37%), Gaps = 52/191 (27%)

Query: 63  FSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQH 118
            S   I+G GR G V+     +TG  +A K I  R +          V   I  ++   H
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK-----DKEEVKNEISVMNQLDH 145

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI---------- 168
            N++ +    ++  + ++V E++             DG  L D     RI          
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYV-------------DGGELFD-----RIIDESYNLTEL 187

Query: 169 -ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLS-FLAPEEK 220
                 +    G+ ++HQ     I+H  +K  NIL   +   ++   D+GL+    P EK
Sbjct: 188 DTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244

Query: 221 R----GLAGYV 227
                G   ++
Sbjct: 245 LKVNFGTPEFL 255

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 43/222 (19%), Positives = 76/222 (34%), Gaps = 59/222 (26%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G+G    V   +  +TG   A K I+ + + +          +     QHPNIV + 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI----------ATGAAR- 174
              Q      +V + +              G  L +      I          A+   + 
Sbjct: 95  DSIQEESFHYLVFDLV-------------TGGELFE-----DIVAREFYSEADASHCIQQ 136

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILLNEKFCA---RVCDYGLSFLAPEEKR-----GL 223
               + Y H      I+H  +K  N+LL  K      ++ D+GL+    + +      G 
Sbjct: 137 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193

Query: 224 AGYV------DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            GY+       D Y         ++  D++  GV+L  +L G
Sbjct: 194 PGYLSPEVLKKDPY---------SKPVDIWACGVILYILLVG 226

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 50/233 (21%), Positives = 85/233 (36%), Gaps = 68/233 (29%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT------L 113
           + F + +++G+G  G V      +TG+  A+K +   ++++        V  T      L
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-----EVAHTVTESRVL 59

Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
              +HP +  +    Q       V E+ N   L F+L             R        A
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS------------RERVFTEERA 107

Query: 174 R--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------------ 213
           R         LEYLH     ++++  IK  N++L++    ++ D+GL             
Sbjct: 108 RFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164

Query: 214 ------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                 +LAPE       Y               R  D +G GVV+ E++ GR
Sbjct: 165 FCGTPEYLAPEVLEDN-DY--------------GRAVDWWGLGVVMYEMMCGR 202

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 33/189 (17%), Positives = 60/189 (31%), Gaps = 57/189 (30%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTL-SLAQHPNI 121
           + +G+G        +   + +  AVK I  R+         A+    I  L     HPNI
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME--------ANTQKEITALKLCEGHPNI 68

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI-ATG------AAR 174
           V +           +V E +N             G  L +     RI          A+ 
Sbjct: 69  VKLHEVFHDQLHTFLVMELLN-------------GGELFE-----RIKKKKHFSETEASY 110

Query: 175 -------GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-FLAPEEKR-- 221
                   + ++H      ++H  +K  N+L    N+    ++ D+G +    P+ +   
Sbjct: 111 IMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 222 ---GLAGYV 227
                  Y 
Sbjct: 168 TPCFTLHYA 176

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 50/235 (21%), Positives = 85/235 (36%), Gaps = 71/235 (30%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS----L 115
             F   R+IG+G    V    L  T ++ A++ +   LV  +       +    +     
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-----DIDWVQTEKHVF 106

Query: 116 AQ---HPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG 171
            Q   HP +V  L    Q       V E++N   L F++             R+ ++   
Sbjct: 107 EQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ------------RQRKLPEE 153

Query: 172 AAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---------- 213
            AR         L YLH+     II+  +K  N+LL+ +   ++ DYG+           
Sbjct: 154 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210

Query: 214 --------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                   ++APE  RG   Y                  D +  GV++ E+++GR
Sbjct: 211 STFCGTPNYIAPEILRG-EDY--------------GFSVDWWALGVLMFEMMAGR 250

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 46/220 (20%), Positives = 76/220 (34%), Gaps = 53/220 (24%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           R +G G  G V+     S+G    +K I+             + I+ L    HPNI+ I 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDHPNIIKIF 86

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG------AAR----- 174
              +      IV E               +G  LL+     +           A      
Sbjct: 87  EVFEDYHNMYIVMETC-------------EGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 175 --GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR-----GLA 224
              L Y H     +++H  +K  NIL    +     ++ D+GL+ L   ++      G A
Sbjct: 134 MNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190

Query: 225 GYV-----DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            Y+       D          T + D++  GVV+  +L+G
Sbjct: 191 LYMAPEVFKRDV---------TFKCDIWSAGVVMYFLLTG 221

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 47/230 (20%), Positives = 79/230 (34%), Gaps = 53/230 (23%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQH 118
           D F   ++IG+G    V    +  TG++ A+K ++   +L           +  L     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 119 PNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR--- 174
             I   L F+ Q      +V E+     L   L +  +           RI    AR   
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-----------RIPAEMARFYL 168

Query: 175 -----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---------------- 213
                 ++ +H+      +H  IK  NILL+     R+ D+G                  
Sbjct: 169 AEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225

Query: 214 ---FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
              +L+PE  + + G          G G+   E D +  GV   E+  G+
Sbjct: 226 TPDYLSPEILQAVGG--------GPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 36/189 (19%), Positives = 59/189 (31%), Gaps = 53/189 (28%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
           ++++G G  G V       TG+  A+K ++              V      +  P+IV I
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ------EVDHHWQASGGPHIVCI 87

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLH---ENNDGASLLDWNRRLRIATG---------A 172
           L              + NM      L    E  +G  L       RI            A
Sbjct: 88  LDV------------YENMHHGKRCLLIIMECMEGGELFS-----RIQERGDQAFTEREA 130

Query: 173 AR-------GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR- 221
           A         +++LH     NI H  +K  N+L     +    ++ D+G +    +    
Sbjct: 131 AEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187

Query: 222 ---GLAGYV 227
                  YV
Sbjct: 188 TPCYTPYYV 196

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 51/235 (21%), Positives = 85/235 (36%), Gaps = 71/235 (30%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS----L 115
             F   R+IG+G    V    L  T ++ A+K +   LV  +       +    +     
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-----DIDWVQTEKHVF 63

Query: 116 AQ---HPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG 171
            Q   HP +V  L    Q       V E++N   L F++             R+ ++   
Sbjct: 64  EQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ------------RQRKLPEE 110

Query: 172 AAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---------- 213
            AR         L YLH+     II+  +K  N+LL+ +   ++ DYG+           
Sbjct: 111 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167

Query: 214 --------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                   ++APE  RG   Y                  D +  GV++ E+++GR
Sbjct: 168 STFCGTPNYIAPEILRGE-DY--------------GFSVDWWALGVLMFEMMAGR 207

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 44/228 (19%), Positives = 78/228 (34%), Gaps = 55/228 (24%)

Query: 63  FSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT-LSLAQHPN 120
           F   ++IG+G  G V    L +  K+ A+K ++   +L  A        +  L       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 121 IVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNR----RLRIATGAARG 175
           I   L ++ Q      +V ++     L   L    +     +  R     + IA      
Sbjct: 136 ITT-LHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIA------ 187

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------------------FLA 216
           ++ +HQ    + +H  IK  NIL++     R+ D+G                     +++
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244

Query: 217 PE----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
           PE     + G   Y                E D +  GV + E+L G 
Sbjct: 245 PEILQAMEGGKGRY--------------GPECDWWSLGVCMYEMLYGE 278

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 51/229 (22%), Positives = 82/229 (35%), Gaps = 71/229 (31%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-------LAQH 118
           R++G+G  G V  A +  TG L AVK +   ++L +       V  T++          H
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD-----DVECTMTEKRILSLARNH 83

Query: 119 PNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR--- 174
           P +   L    Q P     V EF+N   L F++             +  R     AR   
Sbjct: 84  PFLTQ-LFCCFQTPDRLFFVMEFVNGGDLMFHIQ------------KSRRFDEARARFYA 130

Query: 175 -----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---------------- 213
                 L +LH      II+  +K  N+LL+ +   ++ D+G+                 
Sbjct: 131 AEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT 187

Query: 214 --FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             ++APE  +    Y                  D +  GV+L E+L G 
Sbjct: 188 PDYIAPEILQE-MLY--------------GPAVDWWAMGVLLYEMLCGH 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 35/190 (18%), Positives = 58/190 (30%), Gaps = 56/190 (29%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVPI 124
           +++G G  G V       T +  A+K +                ++     +Q P+IV I
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-------VELHWRASQCPHIVRI 120

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLH---ENNDGASLLDWNRRLRI-ATG--------A 172
           +              + N+ +    L    E  DG  L       RI   G        A
Sbjct: 121 VDV------------YENLYAGRKCLLIVMECLDGGELFS-----RIQDRGDQAFTEREA 163

Query: 173 AR-------GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR- 221
           +         ++YLH     NI H  +K  N+L          ++ D+G +         
Sbjct: 164 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220

Query: 222 ----GLAGYV 227
                   YV
Sbjct: 221 TTPCYTPYYV 230

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 46.4 bits (111), Expect = 4e-06
 Identities = 46/221 (20%), Positives = 72/221 (32%), Gaps = 60/221 (27%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             IG+G  G V  A+   T    A K+I    V     F     I+ +    HPNI+ + 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF--KQEIEIMKSLDHPNIIRLY 72

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT-------GAAR---- 174
              +   +  +V E                G  L +     R+          AAR    
Sbjct: 73  ETFEDNTDIYLVMELCT-------------GGELFE-----RVVHKRVFRESDAARIMKD 114

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR-----GL 223
               + Y H+    N+ H  +K  N L    +     ++ D+GL+      K      G 
Sbjct: 115 VLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGT 171

Query: 224 AGYV-----DDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
             YV     +  Y           E D +  GV++  +L G
Sbjct: 172 PYYVSPQVLEGLY---------GPECDEWSAGVMMYVLLCG 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 43/193 (22%), Positives = 65/193 (33%), Gaps = 51/193 (26%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
           TDG+  +  IG G        +  +T    AVK I               +   L   QH
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQH 75

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI---------- 168
           PNI+ +           +V+E +              G  LLD     +I          
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMK-------------GGELLD-----KILRQKFFSERE 117

Query: 169 ATGAAR----GLEYLHQGVAPNIIHGCIKASNILLNEK----FCARVCDYGLS-FLAPEE 219
           A+         +EYLH      ++H  +K SNIL  ++       R+CD+G +  L  E 
Sbjct: 118 ASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 220 KR-----GLAGYV 227
                    A +V
Sbjct: 175 GLLMTPCYTANFV 187

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 38/176 (21%), Positives = 56/176 (31%), Gaps = 45/176 (25%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRI------HPRLVL------SNAGFGFASVIKTL 113
           + IG G  G +Y A   +  +  A   +      +  L          A           
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 114 SLAQHPNIVPILGFSQAPGE----RIIVSEFINMASLDFYLHENNDGASL---LDWNRR- 165
               +  I    G      +    R +V     M  L         G  L      N   
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMV-----MERL---------GIDLQKISGQNGTF 148

Query: 166 -----LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLSF 214
                L++       LEY+H+      +HG IKA+N+LL  K   +V   DYGLS+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 42/228 (18%), Positives = 80/228 (35%), Gaps = 69/228 (30%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-------LAQH 118
            ++G+G  G V  +    T +L AVK +   +V+ +       V  T+          + 
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-----DVECTMVEKRVLALPGKP 80

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR---- 174
           P +  +    Q       V E++N   L +++             +  R     A     
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ------------QVGRFKEPHAVFYAA 128

Query: 175 ----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------------- 213
               GL +L       II+  +K  N++L+ +   ++ D+G+                  
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 185

Query: 214 -FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            ++APE       Y               +  D + FGV+L E+L+G+
Sbjct: 186 DYIAPEIIAYQ-PY--------------GKSVDWWAFGVLLYEMLAGQ 218

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 45.2 bits (108), Expect = 1e-05
 Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 72/237 (30%)

Query: 61  DGFSHRRIIGQGRLGTVY----AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT---- 112
           + F   R++G+G  G V+        +TGK+ A+K +   +++ NA         T    
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK----DTAHTKAER 72

Query: 113 --LSLAQHPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
             L   +HP IV  L ++ Q  G+  ++ E+++   L   L             R     
Sbjct: 73  NILEEVKHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMQLE------------REGIFM 119

Query: 170 TGAAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------- 213
              A          L +LHQ     II+  +K  NI+LN +   ++ D+GL         
Sbjct: 120 EDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176

Query: 214 ----------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                     ++APE      G+               R  D +  G ++ ++L+G 
Sbjct: 177 VTHTFCGTIEYMAPEILMRS-GH--------------NRAVDWWSLGALMYDMLTGA 218

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 44.9 bits (107), Expect = 1e-05
 Identities = 34/187 (18%), Positives = 61/187 (32%), Gaps = 47/187 (25%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVPI 124
           + +G+G+   V   +  STG+  A K +  R    +        I  L      P ++ +
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI------------ATGA 172
               +   E I++ E+               G  +                         
Sbjct: 95  HEVYENTSEIILILEYA-------------AGGEIFS-----LCLPELAEMVSENDVIRL 136

Query: 173 AR----GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS-FLAPEEKR--- 221
            +    G+ YLHQ    NI+H  +K  NILL         ++ D+G+S  +    +    
Sbjct: 137 IKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI 193

Query: 222 -GLAGYV 227
            G   Y+
Sbjct: 194 MGTPEYL 200

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 45/238 (18%), Positives = 78/238 (32%), Gaps = 81/238 (34%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT------- 112
           D F   + +G G  G V       +G   A+K      +L         V+K        
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK------ILDKQ-----KVVKLKQIEHTL 89

Query: 113 -----LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR 167
                L     P +V +    +      +V E++    +  +L             R  R
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGR 137

Query: 168 IATGAAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS------ 213
            +   AR          EYLH     ++I+  +K  N+L++++   +V D+G +      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194

Query: 214 ---------FLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                     LAPE    +G    V  D+W                 GV++ E+ +G 
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAV--DWW---------------ALGVLIYEMAAGY 235

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 40/166 (24%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
             ++G+G    V   + L T +  AVK I  +     +   F  V        H N++ +
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQGHRNVLEL 76

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI----------ATGAAR 174
           + F +      +V E +              G S+L       I          A+   +
Sbjct: 77  IEFFEEEDRFYLVFEKMR-------------GGSILS-----HIHKRRHFNELEASVVVQ 118

Query: 175 ----GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS 213
                L++LH      I H  +K  NIL    N+    ++CD+ L 
Sbjct: 119 DVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 44.5 bits (106), Expect = 2e-05
 Identities = 48/237 (20%), Positives = 88/237 (37%), Gaps = 74/237 (31%)

Query: 61  DGFSHRRIIGQGRLGTVY----AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT---- 112
             F   +++GQG  G V+     +     +L A+K +    +           ++T    
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR------DRVRTKMER 77

Query: 113 --LSLAQHPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
             L    HP IV  L ++ Q  G+  ++ +F+    L   L             + +   
Sbjct: 78  DILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLS------------KEVMFT 124

Query: 170 TGAAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------- 213
               +         L++LH      II+  +K  NILL+E+   ++ D+GLS        
Sbjct: 125 EEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181

Query: 214 ----------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                     ++APE      G+              T+ +D + FGV++ E+L+G 
Sbjct: 182 KAYSFCGTVEYMAPEVVNRR-GH--------------TQSADWWSFGVLMFEMLTGT 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 55/235 (23%), Positives = 80/235 (34%), Gaps = 71/235 (30%)

Query: 61  DGFSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS----L 115
             F   ++IG+G  G V  A   +     AVK +  + +L             +S    L
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-----EEKHIMSERNVL 92

Query: 116 AQ---HPNIVPILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG 171
            +   HP +V  L FS Q   +   V ++IN   L ++L             R       
Sbjct: 93  LKNVKHPFLVG-LHFSFQTADKLYFVLDYINGGELFYHLQ------------RERCFLEP 139

Query: 172 AAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS---------- 213
            AR         L YLH     NI++  +K  NILL+ +    + D+GL           
Sbjct: 140 RARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196

Query: 214 --------FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                   +LAPE       Y               R  D +  G VL E+L G 
Sbjct: 197 STFCGTPEYLAPEVLHKQ-PY--------------DRTVDWWCLGAVLYEMLYGL 236

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.0 bits (104), Expect = 3e-05
 Identities = 37/179 (20%), Positives = 61/179 (34%), Gaps = 48/179 (26%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRI---------HPRLVL------SNAGFGFASVIK 111
             IGQG  G +Y A +++ + V              +  L          A         
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 112 TLSLAQHPNIVPILGF----SQAPGERIIVSEFINMASLDFYLHENNDGASL---LDWNR 164
                ++  +    G           R ++     M            G+ L    + N 
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMI-----MDRF---------GSDLQKIYEANA 146

Query: 165 R-------LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLSF 214
           +       L+++      LEY+H+      +HG IKASN+LLN K   +V   DYGL++
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 44.1 bits (105), Expect = 3e-05
 Identities = 45/228 (19%), Positives = 82/228 (35%), Gaps = 69/228 (30%)

Query: 67  RIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-------LAQH 118
           +++G+G  G V+ A    T +  A+K +   +VL +       V  T+          +H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-----DVECTMVEKRVLSLAWEH 77

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR---- 174
           P +  +    Q       V E++N   L +++                +     A     
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ------------SCHKFDLSRATFYAA 125

Query: 175 ----GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS----------------- 213
               GL++LH      I++  +K  NILL++    ++ D+G+                  
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTP 182

Query: 214 -FLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
            ++APE   G   Y                  D + FGV+L E+L G+
Sbjct: 183 DYIAPEILLGQ-KY--------------NHSVDWWSFGVLLYEMLIGQ 215

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 34/172 (19%), Positives = 66/172 (38%), Gaps = 24/172 (13%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-------- 117
           R +G G   TV+ A  +     VA+K +    V + A      +++ ++ A         
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 118 HPNIVPILG---FSQAPGERI-IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
             +I+ +L         G  + +V E +   +L   + +       L + ++  I+    
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQLL 141

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNE------KFCARVCDYGLSFLAPEE 219
            GL+Y+H+     IIH  IK  N+L+            ++ D G +    E 
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 34/160 (21%), Positives = 61/160 (38%), Gaps = 14/160 (8%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP---NIV 122
           ++IG+G  G V  A      + VA+K +               +++ L         N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLR-IATGAARGLEYLHQ 181
            +L          +  E ++M   +        G SL      +R  A    + L+ LH+
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL----PLVRKFAHSILQCLDALHK 218

Query: 182 GVAPNIIHGCIKASNILLNEKFCA--RVCDYGLSFLAPEE 219
                IIH  +K  NILL ++  +  +V D+G S    + 
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 35/175 (20%), Positives = 56/175 (32%), Gaps = 52/175 (29%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           +++G G  G V       T +  A+K +               V      +Q P+IV I+
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRIV 77

Query: 126 GFSQAPGERIIVSEFINMASLDFYLH---ENNDGASLLDWNRRLRI------------AT 170
                         + N+ +    L    E  DG  L       RI            A+
Sbjct: 78  DV------------YENLYAGRKCLLIVMECLDGGELFS-----RIQDRGDQAFTEREAS 120

Query: 171 GAAR----GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPE 218
              +     ++YLH     NI H  +K  N+L          ++ D+G    A E
Sbjct: 121 EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE 169

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 46/216 (21%), Positives = 74/216 (34%), Gaps = 51/216 (23%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G+G    VY      T K  A+K +   +          + I  L    HPNI+ + 
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPNIIKLK 114

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI----------ATGAAR- 174
              + P E  +V E +              G  L D     RI          A  A + 
Sbjct: 115 EIFETPTEISLVLELV-------------TGGELFD-----RIVEKGYYSERDAADAVKQ 156

Query: 175 ---GLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFLAPEEKR-----GL 223
               + YLH+     I+H  +K  N+L          ++ D+GLS +   +       G 
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT 213

Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG 259
            GY   +       G    E D++  G++   +L G
Sbjct: 214 PGYCAPEILRGCAYG---PEVDMWSVGIITYILLCG 246

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 41.7 bits (99), Expect = 2e-04
 Identities = 48/236 (20%), Positives = 83/236 (35%), Gaps = 81/236 (34%)

Query: 63  FSHRRIIGQGRLGTVY-AALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKT--------- 112
           F   R +G G  G V+       G+  A+K      VL         V++          
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMK------VLKKE-----IVVRLKQVEHTNDE 56

Query: 113 ---LSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIA 169
              LS+  HP I+ + G  Q   +  ++ ++I    L   L             +  R  
Sbjct: 57  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL------------RKSQRFP 104

Query: 170 TGAAR--------GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS-------- 213
              A+         LEYLH     +II+  +K  NILL++    ++ D+G +        
Sbjct: 105 NPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161

Query: 214 -------FLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
                  ++APE    +     +D   W              + FG+++ E+L+G 
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKSID---W--------------WSFGILIYEMLAGY 200

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 40.6 bits (94), Expect = 4e-04
 Identities = 27/195 (13%), Positives = 53/195 (27%), Gaps = 43/195 (22%)

Query: 59  ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIH---PRLVLSNAGFGFASVIKTLSL 115
            T+       IG+G  G V+  +      VA+K I    P LV  +    F  ++  + +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 116 AQ------------HPNIVPILGFSQAPGE--RIIVSEFINMAS---------------- 145
           ++                + +       G    +++  + +  S                
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 146 LDFYLHENNDGASLLDWNRRLR-------IATGAARGLEYLHQGVAPNIIHGCIKASNIL 198
           L   L     G  L     +L        I       L       +    H  +   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 199 LNEKFCARVCDYGLS 213
           L +    ++      
Sbjct: 195 LKKTSLKKLHYTLNG 209

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	332
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.65
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.35
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.87
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.81
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.75
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.66
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.57
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.14
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.91
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.83
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.65
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.53
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.29
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.24
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.13
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	93.96
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.48
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.16
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.98
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.95
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.49
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.18
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	82.17
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	81.95
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	80.62

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-60  Score=420.82  Aligned_cols=259  Identities=23%  Similarity=0.344  Sum_probs=208.9

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      +...+++...+.||+|+||+||+|++.+  .||||.++...........|.+|+.++++++|||||+++|++.. +..+|
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            3456778888999999999999998743  69999997654444444568999999999999999999999865 56899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |||||++|+|.+++.....   .+++.+++.++.|||.||.|||++   +|+||||||+|||+++++.+||+|||+|+..
T Consensus       109 VmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            9999999999999975432   289999999999999999999998   9999999999999999999999999999764


Q ss_pred             Cc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHH-HHhhhcccccccCCc
Q 020027          217 PE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL-PLIKEMRFSELLDPR  287 (332)
Q Consensus       217 ~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  287 (332)
                      ..        ...||+.|||||.+.......++.++|||||||++|||+||+.||.+....... ..+..+.    ..|.
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~----~~p~  258 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY----ASPD  258 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC----CCCC
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----CCCC
Confidence            32        236899999999997654567999999999999999999999999875433322 2222221    1111


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +. ..+..++..+.+++.+||+.||++||||.||++.|+.+.
T Consensus       259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            11 112234457889999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-60  Score=427.11  Aligned_cols=255  Identities=24%  Similarity=0.313  Sum_probs=210.3

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ++|...+.||+|+||+||+|++.      +++.||||.++...  ......|.+|+.+|++++|||||+++|+|.+++..
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45666788999999999999853      57899999997543  22334689999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCC-----------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          135 IIVSEFINMASLDFYLHENNDG-----------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      +||||||++|+|.++++.....           ...++|.+++.++.|++.||.|||++   +|+||||||+|||+++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence            9999999999999999764321           23489999999999999999999998   999999999999999999


Q ss_pred             ceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHH
Q 020027          204 CARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL  274 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~  274 (332)
                      .+||+|||+|+....        ...||+.|||||.+..   ..++.++|||||||++|||+| |+.||.+....+....
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~---~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY---RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcC---CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999976432        2257899999999876   789999999999999999999 8999998777776666


Q ss_pred             hhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                      +..+.       ++  +.+..++.++.+++.+||+.||++||||+||++.|+.+...|
T Consensus       273 i~~g~-------~~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          273 ITQGR-------EL--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             HHHTC-------CC--CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             HHcCC-------CC--CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            65532       11  122234457889999999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-60  Score=423.40  Aligned_cols=251  Identities=20%  Similarity=0.310  Sum_probs=210.2

Q ss_pred             CCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           62 GFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ++...+.||+|+||+||+|.+      .+++.||||.++.... ......|.+|+.++++++|||||+++|+|..++..+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            355668899999999999985      3567899999975432 223346899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          136 IVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      ||||||++|+|.+++.....            ....++|..++.++.|||.||.|||++   +|+||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence            99999999999999965321            113489999999999999999999999   999999999999999999


Q ss_pred             ceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHH
Q 020027          204 CARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPL  274 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~  274 (332)
                      .+||+|||+|+....        ...||+.|+|||.+..   ..++.++|||||||++|||+| |..||.+....+....
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~---~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY---GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999975432        2357889999999987   789999999999999999999 8999998877777666


Q ss_pred             hhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      +..+..         .+.+..++..+.++|.+||+.||++||||+||++.|+..
T Consensus       260 i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 IRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            655321         222334456788999999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.8e-61  Score=424.19  Aligned_cols=253  Identities=25%  Similarity=0.323  Sum_probs=212.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      .++|...+.||+|+||+||+|++.      ++..||||.++...  ......|.+|+.++++++|||||+++|+|.+++.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            356778899999999999999852      57789999997543  2233468999999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccC---------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc
Q 020027          134 RIIVSEFINMASLDFYLHENN---------DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC  204 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  204 (332)
                      .+||||||++|+|.++++...         .....++|.+++.++.||+.||.|||++   +|+||||||+|||+++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence            999999999999999997642         1223589999999999999999999998   9999999999999999999


Q ss_pred             eEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHh
Q 020027          205 ARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLI  275 (332)
Q Consensus       205 ~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~  275 (332)
                      +||+|||+|+.....        ..||+.|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~---~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999754322        247889999999987   789999999999999999999 89999988777776666


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ..+..         .+.+..++.++.+++.+||+.||++||||+||++.|+++.
T Consensus       244 ~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          244 TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            55432         1122234457889999999999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.2e-59  Score=419.58  Aligned_cols=247  Identities=19%  Similarity=0.248  Sum_probs=207.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||+||+|+ ..+|+.||||+++...........+.+|+.++++++|||||++++++.+++..||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            3689999999999999999999 568999999999876554444456899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |||++|+|.+++.....  ..+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       103 Ey~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999976432  2378999999999999999999999   999999999999999999999999999987654


Q ss_pred             c------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 E------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .      ..||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+....+....+..+.+..         .
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~---~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------~  245 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICEN---KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---------V  245 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---------C
T ss_pred             CcccccccCCCccccCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---------C
Confidence            3      259999999999876   678999999999999999999999999887777666665543211         1


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +.....++.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1122346889999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.5e-58  Score=410.51  Aligned_cols=243  Identities=20%  Similarity=0.226  Sum_probs=207.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +.|+..+.||+|+||+||+|+ ..+|+.||||+++.....  ....+.+|+.+|+.++|||||++++++.+++..|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            458889999999999999999 568999999999765432  23357899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      ||++|+|.+++....     +++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.... 
T Consensus       152 y~~gg~L~~~l~~~~-----l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          152 FLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999997532     89999999999999999999999   999999999999999999999999999976532 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ...||+.|+|||.+..   ..|+.++||||+||++|||+||+.||.+.........+.....     +.  .+..
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----~~--~~~~  293 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----PR--LKNL  293 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-----CC--CSCG
T ss_pred             CCcccccccCcCcCCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CC--CCcc
Confidence                 2369999999999876   6789999999999999999999999998776666665544321     11  1122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....++.+++.+||+.||++|||+.|+++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            233347889999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.3e-58  Score=409.40  Aligned_cols=246  Identities=21%  Similarity=0.215  Sum_probs=205.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .+.|...+.||+|+||.||+|+ ..+|+.||||+++.+.       ...+|+.+++.++|||||++++++.+++..+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3457777889999999999999 5689999999997532       1257999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEccCCccccCC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCDYGLSFLAP  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~~  217 (332)
                      |||++|+|.++++....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++ .+||+|||+|+...
T Consensus       130 Ey~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             eccCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999986543    89999999999999999999999   999999999999999987 59999999997643


Q ss_pred             c-----------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          218 E-----------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       218 ~-----------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      .           ...||+.|||||.+..   ..++.++|||||||++|||+||+.||.+.........+......     
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----  274 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMG---KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-----  274 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-----
T ss_pred             CCCcccceecCCccccCccccCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-----
Confidence            2           1258999999999876   67899999999999999999999999876554444444332211     


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ....  +......+.+++.+||+.||++|||+.|+++.|...+
T Consensus       275 ~~~~--~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          275 IREI--PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             GGGS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhc--CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            0011  1223347789999999999999999999999887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-57  Score=398.06  Aligned_cols=241  Identities=21%  Similarity=0.292  Sum_probs=195.9

Q ss_pred             CCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec----CCceeEEE
Q 020027           64 SHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA----PGERIIVS  138 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  138 (332)
                      ...+.||+|+||+||+|. ..++..||+|.+............+.+|+.++++++|||||++++++..    ++..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            445679999999999999 5688999999997665444444568999999999999999999999864    35579999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeecCCCCCCEEeCC-CCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN--IIHGCIKASNILLNE-KFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~-~~~~kl~dfg~a~~  215 (332)
                      |||++|+|.+++.....    +++..+..++.||+.||.|||++   +  |+||||||+|||++. ++.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            99999999999986543    89999999999999999999998   6  999999999999984 78999999999976


Q ss_pred             CCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-HHHHHHHhhhcccccccCCcCCC
Q 020027          216 APEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL-VKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....    ..||+.|||||.+.    +.++.++|||||||++|||+||+.||.+.. .......+..+....    .+. 
T Consensus       182 ~~~~~~~~~~GTp~YmAPE~~~----~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~----~~~-  252 (290)
T 3fpq_A          182 KRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----SFD-  252 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----GGG-
T ss_pred             CCCCccCCcccCccccCHHHcC----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC----CCC-
Confidence            5432    36999999999875    358999999999999999999999997643 233333333321111    111 


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         .....++.+++.+||+.||++|||++|+++
T Consensus       253 ---~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 ---KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111236789999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.5e-57  Score=393.92  Aligned_cols=243  Identities=23%  Similarity=0.319  Sum_probs=195.5

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||+|.+++...... ....+.+|+.+++.++|||||++++++.+++..+++|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            689999999999999999999 56899999999986554332 2335789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+ +|+|.+++.+...    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+...+
T Consensus        93 Ey~-~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 6799999876543    89999999999999999999999   999999999999999999999999999976543


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ...||+.|+|||.+...  ..++.++||||+||++|||+||+.||.+.........+..+..        ..+. 
T Consensus       165 ~~~~~~~~GT~~Y~APE~~~~~--~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--------~~p~-  233 (275)
T 3hyh_A          165 GNFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--------TLPK-  233 (275)
T ss_dssp             ----------CTTSCHHHHSSS--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------CCCT-
T ss_pred             CCccCCeeECcccCChhhhcCC--CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--------CCCC-
Confidence                 23699999999998762  3346899999999999999999999998776666665555432        1111 


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ....++.+++.+||+.||++|||++|+++
T Consensus       234 -~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          234 -FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             12236789999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.4e-58  Score=413.70  Aligned_cols=263  Identities=26%  Similarity=0.372  Sum_probs=214.1

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCC-CCccce
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH-PNIVPI  124 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~  124 (332)
                      ..++++...++|+..+.||+|+||+||+|...      +++.||||.++.... ......+.+|+.+|++++| ||||++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            44567777889999999999999999999842      235899999975432 2223468999999999965 899999


Q ss_pred             eeeeecC-CceeEEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecC
Q 020027          125 LGFSQAP-GERIIVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGC  191 (332)
Q Consensus       125 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  191 (332)
                      +|+|..+ +..+||||||++|+|.++++....            ....+++.+++.++.|||.||.|||++   +|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999764 568999999999999999975321            123489999999999999999999999   999999


Q ss_pred             CCCCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCC
Q 020027          192 IKASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRC  262 (332)
Q Consensus       192 lk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p  262 (332)
                      |||+|||+++++.+||+|||+|+.....        ..||+.|||||.+..   ..++.++|||||||++|||+| |+.|
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~---~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc---CCCCCcccEeehHHHHHHHHhCCCCC
Confidence            9999999999999999999999865332        247889999999987   789999999999999999998 8999


Q ss_pred             CCchhH-HHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          263 EEGLLV-KWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       263 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      |.+... ......+..+.       ++  +.+..++.++.+++.+||+.||++||||+||++.|++++.
T Consensus       288 f~~~~~~~~~~~~i~~g~-------~~--~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          288 YPGVKIDEEFCRRLKEGT-------RM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             STTCCCSHHHHHHHHHTC-------CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCC-------CC--CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            987543 33334444332       11  1222334578899999999999999999999999998763

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.8e-58  Score=403.56  Aligned_cols=243  Identities=21%  Similarity=0.274  Sum_probs=209.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|+..+.||+|+||+||+|+ ..+|+.||+|.+.+..... .....+.+|+++++.++|||||++++++.+++..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4679999999999999999999 5689999999997654322 2334578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||||++|+|.+++.....    +++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       111 mEy~~gG~L~~~i~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            999999999999987543    89999999999999999999999   99999999999999999999999999997643


Q ss_pred             c--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          218 E--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       218 ~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .        ..+||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+..+.+        .
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--------~  252 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTE---KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--------D  252 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHH---SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------C
T ss_pred             CCCCcccccCcccCcccCCHHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------C
Confidence            1        2369999999999987   6789999999999999999999999998877777666655432        1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                      .+..  ...++.+++.+||+.||++|||++|++
T Consensus       253 ~p~~--~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPEK--FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCTT--CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCcc--cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            2211  223678999999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-56  Score=411.12  Aligned_cols=243  Identities=21%  Similarity=0.226  Sum_probs=207.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +.|+..+.||+|+||.||+|+ ..+|+.||||++......  ....+.+|+.+|+.++|||||++++++..++..|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            468899999999999999999 568999999999765432  23357899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      ||++|+|.+++....     +++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.... 
T Consensus       229 y~~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          229 FLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             CCTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999997532     89999999999999999999999   999999999999999999999999999976532 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ...||+.|||||.+..   ..|+.++|||||||++|||++|+.||.+.........+.....     +.+..  .
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----~~~~~--~  370 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----PRLKN--L  370 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCCSC--T
T ss_pred             CccccccccCcCcCCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CCCcc--c
Confidence                 2368999999999876   6789999999999999999999999998777666665554321     11111  1


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....++.+++.+||+.||++|||+.|+++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            122347889999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-57  Score=401.47  Aligned_cols=238  Identities=21%  Similarity=0.244  Sum_probs=199.4

Q ss_pred             CCCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ++|+..+.||+|+||+||+|+.    .+++.||+|.+++..........+.+|+.+++.++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999984    357899999998765544444567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +||||++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999987543    89999999999999999999999   9999999999999999999999999999754


Q ss_pred             Cc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          217 PE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       217 ~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..      ...||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+....+....+.....        ..
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------~~  245 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--------GM  245 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CC
T ss_pred             cCCCccccccccCcccCCHHHhcc---CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------CC
Confidence            22      2369999999999876   6789999999999999999999999998877777666655421        11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      +.  ..+.++.+++.+||+.||++|||+
T Consensus       246 p~--~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          246 PQ--FLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CC--cCCHHHHHHHHHHcccCHHHCCCC
Confidence            21  223467899999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-57  Score=401.48  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=198.7

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC----ceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG----ERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  137 (332)
                      +|...+.||+|+||+||+|++ +|+.||||+++...   .....+..|+..+..++|||||+++|++..++    ..+||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            466678999999999999998 68999999986432   12223456777778899999999999997654    57999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV-----APNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ||||++|+|.++++...     ++|..+++++.|++.||+|||+++     .++|+||||||+|||++.++++||+|||+
T Consensus        80 ~Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            99999999999997642     799999999999999999999762     45899999999999999999999999999


Q ss_pred             cccCCc----------ccCCcccccCcccccccC---CCCCCchhhhHHHHHHHHHHHhCCCCCCchh------------
Q 020027          213 SFLAPE----------EKRGLAGYVDDDYWHEKG---GGNATRESDVYGFGVVLLEILSGRRCEEGLL------------  267 (332)
Q Consensus       213 a~~~~~----------~~~~~~~~~~pe~~~~~~---~~~~~~~~DiwS~G~il~el~tg~~p~~~~~------------  267 (332)
                      |+....          ...||+.|+|||.+....   ...++.++|||||||++|||+||..||....            
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            865432          125899999999987531   1246789999999999999999987654211            


Q ss_pred             ---HHHHHHHhhhcccccccCCcCCC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          268 ---VKWALPLIKEMRFSELLDPRLAI-PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       268 ---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                         .......+..    +..+|.++. ..+.++...+.+++.+||+.||++||||.||++.|+++.++
T Consensus       235 ~~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          235 DPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cchHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence               1111111111    122222211 12345667888999999999999999999999999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-54  Score=381.92  Aligned_cols=243  Identities=20%  Similarity=0.278  Sum_probs=187.5

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-------
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-------  132 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  132 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||+|+++.... ......+.+|+.+++.++|||||++++++...+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            358889999999999999999 56899999999975432 222235789999999999999999999986543       


Q ss_pred             -----ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEE
Q 020027          133 -----ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV  207 (332)
Q Consensus       133 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  207 (332)
                           ..+++||||++|+|.+++..... ....++..++.++.|+++||.|||++   +|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence                 36899999999999999976432 22356777889999999999999999   9999999999999999999999


Q ss_pred             ccCCccccCCcc------------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH
Q 020027          208 CDYGLSFLAPEE------------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK  269 (332)
Q Consensus       208 ~dfg~a~~~~~~------------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~  269 (332)
                      +|||+|+.....                  ..||+.|||||.+..   ..++.++|||||||++|||++   ||.+....
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyell~---Pf~~~~~~  233 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG---NSYSHKVDIFSLGLILFELLY---PFSTQMER  233 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTT---CCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC---CCCCCHHHHHHHHHHHHHHcc---CCCCccHH
Confidence            999999764321                  258999999999876   678999999999999999997   77654322


Q ss_pred             -HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          270 -WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .....+....+.         +........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VRTLTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             111222221111         001122235668999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=384.70  Aligned_cols=253  Identities=21%  Similarity=0.235  Sum_probs=201.8

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec------CCc
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA------PGE  133 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  133 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||||+++...........+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            568899999999999999999 5689999999997655444444457899999999999999999998754      357


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .|||||||+ |+|.+++....    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 67999987643    289999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCc----------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccc--c
Q 020027          214 FLAPE----------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRF--S  281 (332)
Q Consensus       214 ~~~~~----------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~  281 (332)
                      +....          ...||+.|+|||.+...  ..++.++||||+||++|||+||+.||.+....+....+.....  .
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~--~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL--HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCC--CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            75422          23689999999988653  4578999999999999999999999998766665554432110  0


Q ss_pred             -cccC------------C-cCCCCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 -ELLD------------P-RLAIPCEI-----KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 -~~~~------------~-~~~~~~~~-----~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ....            . ....+.+.     ....++.+++.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             0000            0 00001111     11236789999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.1e-51  Score=368.98  Aligned_cols=192  Identities=22%  Similarity=0.322  Sum_probs=166.7

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPG  132 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  132 (332)
                      ...+.|+..+.||+|+||+||+|+.    .+++.||+|.+.+..    ....+.+|+++++.+ +||||+++++++..++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3467899999999999999999973    357899999986542    223468899999988 6999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccCC
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYG  211 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg  211 (332)
                      ..+++|||+++++|.++++.       +++..+..++.|++.||.|||++   +|+||||||+|||++.+ +.+||+|||
T Consensus        94 ~~~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999842       78999999999999999999999   99999999999999876 799999999


Q ss_pred             ccccCCc----------------------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHH
Q 020027          212 LSFLAPE----------------------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL  257 (332)
Q Consensus       212 ~a~~~~~----------------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~  257 (332)
                      +|+...+                                  ...||+.|+|||.+...  ..++.++||||+||++|||+
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC--PNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHH
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCCccchhhhHHHHHHHH
Confidence            9964322                                  12589999999998652  45899999999999999999


Q ss_pred             hCCCCCCc
Q 020027          258 SGRRCEEG  265 (332)
Q Consensus       258 tg~~p~~~  265 (332)
                      ||+.||.+
T Consensus       242 ~G~~Pf~~  249 (361)
T 4f9c_A          242 SGRYPFYK  249 (361)
T ss_dssp             HTCSSSSC
T ss_pred             HCCCCCCC
Confidence            99999854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.3e-50  Score=358.99  Aligned_cols=276  Identities=36%  Similarity=0.634  Sum_probs=231.4

Q ss_pred             cCCChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeee
Q 020027           49 FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS  128 (332)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  128 (332)
                      ..++..++....++|...+.||+|+||.||+|+..+|+.||+|.+....... ....+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4567899999999999999999999999999998889999999997654322 223578999999999999999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEc
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC  208 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  208 (332)
                      ..++..+++|||+++++|.+++.........+++..+..++.|++.||.|||+++.++++||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998765555568999999999999999999999877799999999999999999999999


Q ss_pred             cCCccccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh---------HHHHH
Q 020027          209 DYGLSFLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL---------VKWAL  272 (332)
Q Consensus       209 dfg~a~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~---------~~~~~  272 (332)
                      |||++......       ..||..|+|||.+..   ..++.++|||||||++|||+||+.||....         .++..
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH---SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhcc---CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999754322       248999999999876   568999999999999999999999996321         11222


Q ss_pred             HHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          273 PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      ............+.......+......+.+++.+||+.||++|||++|+++.|++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            22233334455555666666777888999999999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-50  Score=388.20  Aligned_cols=246  Identities=18%  Similarity=0.194  Sum_probs=207.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||.||+|+ ..+|+.||+|.+......  ....+.+|+.+|+.++|||||++++++.+++..+++||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            578999999999999999999 568999999999765422  22356899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC--CceEEccCCccccCC
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK--FCARVCDYGLSFLAP  217 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~dfg~a~~~~  217 (332)
                      ||++|+|.+++.....   .+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+|+...
T Consensus       235 ~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          235 FMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             CCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             ecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999864322   289999999999999999999999   99999999999999854  899999999998765


Q ss_pred             cc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 EE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      ..     ..||+.|+|||.+..   ..++.++||||+||++|||++|..||.+....+....+....+..      ..+.
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~---~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~------~~~~  379 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEG---KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------DDSA  379 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC------CSGG
T ss_pred             CCCceeeeEECccccCHHHhCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC------Cccc
Confidence            43     268999999999876   678999999999999999999999999887777766665543211      1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .......+.+++.+||+.||++|||+.|+++
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112346789999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-50  Score=386.35  Aligned_cols=244  Identities=22%  Similarity=0.272  Sum_probs=198.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccc-cHH---HHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGF-GFA---SVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~-~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|+..+.||+|+||+||+|+ ..+|+.||+|++++......... ...   .++.+++.++|||||++++++.+++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            4689999999999999999999 56899999999976543222211 223   335677888999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      |+|||||+||+|.+++.....    +++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~----l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence            999999999999999987543    89999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCc----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH---HHHhhhcccccccCCc
Q 020027          215 LAPE----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA---LPLIKEMRFSELLDPR  287 (332)
Q Consensus       215 ~~~~----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  287 (332)
                      ....    ..+||+.|+|||.+...  ..|+.++|+||+||++|||+||+.||.+......   ...+...        .
T Consensus       341 ~~~~~~~~t~~GTp~YmAPEvl~~~--~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--------~  410 (689)
T 3v5w_A          341 DFSKKKPHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------A  410 (689)
T ss_dssp             ECSSCCCCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--------C
T ss_pred             ecCCCCCCCccCCcCccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--------C
Confidence            6543    34799999999998642  4689999999999999999999999986533222   2222221        1


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPS-----IVQVA  322 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs-----~~~i~  322 (332)
                      +..+..  ...++.+++.+||+.||++|++     ++||.
T Consensus       411 ~~~p~~--~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          411 VELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             CCCCTT--SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             CCCCcc--CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            122222  2336789999999999999998     56665

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2e-49  Score=355.94  Aligned_cols=273  Identities=35%  Similarity=0.617  Sum_probs=226.8

Q ss_pred             CCChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee
Q 020027           50 AYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ  129 (332)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  129 (332)
                      .++..++...+++|...+.||+|+||.||+|...+++.||+|.+.....  .....+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            3445556667899999999999999999999988899999998875432  22335789999999999999999999999


Q ss_pred             cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEcc
Q 020027          130 APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD  209 (332)
Q Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~d  209 (332)
                      ..+..+++|||+++++|.+++.........+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999976544334589999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-------HHHHH
Q 020027          210 YGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-------WALPL  274 (332)
Q Consensus       210 fg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-------~~~~~  274 (332)
                      ||++......        ..|+..|+|||.+..   ..++.++|||||||++|||+||+.||.+..+.       +....
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH---CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             cccccccccccccccccccCCCccccCHHHhcC---CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            9998653321        237889999999876   67899999999999999999999998754322       12222


Q ss_pred             hhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          275 IKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .....+....++.............+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            23344455566666556667788889999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-48  Score=351.18  Aligned_cols=246  Identities=20%  Similarity=0.270  Sum_probs=208.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|.. .+|+.||+|.+............+.+|+.+++.++||||+++++++..++..+++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            456899999999999999999994 7899999999976544333344578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            999999999999976543    78999999999999999999999   99999999999999999999999999987543


Q ss_pred             c-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 E-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .     ...||+.|+|||.+...  ...+.++||||+||++|||+||+.||.+.........+..+..        ..+.
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------~~p~  235 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--------RIPF  235 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHHTC--CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCCT
T ss_pred             CCCccccccCCcceeCcccccCC--CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCC
Confidence            2     23689999999998762  3335899999999999999999999998877666655555432        1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .....+.+++.+||+.||.+|||++|+++
T Consensus       236 --~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          236 --YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              12236779999999999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.7e-49  Score=349.72  Aligned_cols=261  Identities=29%  Similarity=0.442  Sum_probs=208.5

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++...++|...+.||+|+||.||+|+. +|+.||+|.+............+.+|+.++++++||||+++++++...+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3445567889999999999999999987 688999999976554333344678999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeecCCCCCCEEeCCCCceEEccCCc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN--IIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      +++|||+++++|.+++..... ...+++..++.++.|++.||.|||++   +  ++||||||+||+++.++.+||+|||+
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             EEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            999999999999999975431 12378999999999999999999998   8  99999999999999999999999999


Q ss_pred             cccCCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          213 SFLAPEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       213 a~~~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ++.....      ..||..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....      .
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~------~  256 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------K  256 (309)
T ss_dssp             ----------------CCTTSCHHHHTT---CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC------C
T ss_pred             CccccccccccccCCCCccccChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------C
Confidence            8754332      368999999999876   678999999999999999999999998876555544332211      1


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      ....+  ......+.+++.+||+.||++|||+.++++.|+.++..
T Consensus       257 ~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 RLEIP--RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11111  22234788999999999999999999999999988753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.8e-48  Score=356.74  Aligned_cols=253  Identities=24%  Similarity=0.406  Sum_probs=202.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|...+.||+|+||.||+|+..    ++..||+|.++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            457999999999999999999853    577899999975432 223346889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999976432   388999999999999999999999   999999999999999999999999999976


Q ss_pred             CCccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          216 APEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       216 ~~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....         .++..|+|||.+..   ..++.++|||||||++||+++ |+.||.+.........+..+.      
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------  267 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY---RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------  267 (373)
T ss_dssp             -----------------CTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE------
T ss_pred             cccCCccceeccCCCcCCCccChhhhcc---CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            54321         23567999999876   678999999999999999998 999998776655554443321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                         ..+.+..+...+.+++.+||+.||++|||+.++++.|++++.+
T Consensus       268 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 ---RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ---ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence               1122223345788999999999999999999999999988754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=349.63  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=209.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|...+.||+|+||.||+|...    .+..||+|.++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            456777899999999999999953    344699999975432 222345789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....   .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       127 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999965432   289999999999999999999999   999999999999999999999999999976


Q ss_pred             CCccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          216 APEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       216 ~~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....         .+|..|+|||.+..   ..++.++|||||||++|||++ |..||.+.........+..+.      
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------  271 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF---RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY------  271 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------
Confidence            53321         34567999999876   678999999999999999999 999998876666555444421      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                         ..+.+......+.+++.+||+.||++|||+.++++.|+.++..|
T Consensus       272 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          272 ---RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ---CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence               11222233447889999999999999999999999999987653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9e-48  Score=341.59  Aligned_cols=244  Identities=22%  Similarity=0.270  Sum_probs=204.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.+......  ....+.+|+.+++.++||||+++++++...+..+++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            5679999999999999999999 578999999998754322  2334789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++....     +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        97 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           97 EYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             ECCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ECCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999997642     78999999999999999999999   999999999999999999999999999865432


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                            ...||..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+......       ....
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~  238 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-------ELQN  238 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHC---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-------CCSC
T ss_pred             cccccCCccCCcCccChhhhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------CCCC
Confidence                  2358899999999876   67899999999999999999999999876554443333222111       1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +......+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            2233346889999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.1e-48  Score=353.47  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=209.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe--------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeec
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQA  130 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  130 (332)
                      .++|...+.||+|+||.||+|+.        .++..||+|.++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            45788889999999999999984        2455799999975532 22233578999999999 89999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEE
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNIL  198 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  198 (332)
                      ++..+++|||+++++|.+++......            ...+++..++.++.|++.||.|||++   +|+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence            99999999999999999999865321            12378999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHH
Q 020027          199 LNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVK  269 (332)
Q Consensus       199 l~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~  269 (332)
                      ++.++.+||+|||+++.....        ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999754321        235678999999876   678999999999999999999 99999887665


Q ss_pred             HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          270 WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .....+..+..         ...+..+...+.+++.+||+.||++|||+.|+++.|++++
T Consensus       313 ~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          313 ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             GHHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            55544444321         1112233447889999999999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-48  Score=357.89  Aligned_cols=255  Identities=24%  Similarity=0.341  Sum_probs=211.7

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      +....++|...+.||+|+||.||+|.. .+++.||+|.++.... ......+.+|+.+++.++||||+++++++..++..
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            344556788889999999999999996 4889999999875422 22233578999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            999999999999999976432   278999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCccc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ...+..        .++..|+|||.+..   ..++.++|||||||++|||+| |..||.+.........+..+.      
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------  332 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNY---GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG------  332 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            543321        23567999999876   678999999999999999999 999998876665554444321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                         ..+.+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       333 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence               11222233457889999999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-47  Score=335.42  Aligned_cols=251  Identities=20%  Similarity=0.306  Sum_probs=211.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|...+.||+|+||.||+|...+++.||+|.+.....   ....+.+|+.++++++||||+++++++..++..+++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            3567888999999999999999987888999999975432   2235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             ECCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999975432   378999999999999999999999   999999999999999999999999999975432


Q ss_pred             c-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 E-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .       ..++..|+|||.+..   ..++.++||||+|+++|||+| |+.||.+.........+....         ..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~---------~~  226 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------RL  226 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---------CC
T ss_pred             cccccccCcccccccCCHHHhcC---CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc---------cC
Confidence            2       245667999999876   678999999999999999999 999998876665555444421         11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ..+......+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            1111123468899999999999999999999999998864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.7e-48  Score=362.93  Aligned_cols=256  Identities=21%  Similarity=0.362  Sum_probs=214.1

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ..++...++|...+.||+|+||.||+|...++..||+|.++...   .....+.+|+.+++.++||||+++++++. .+.
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            34455677888899999999999999998888899999997543   22346899999999999999999999986 567


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++|+|.+++.....  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             cEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            8999999999999999975421  1278889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          214 FLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       214 ~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      +.....       ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+.      
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------  402 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------  402 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC------
T ss_pred             eEcCCCceeccCCCcccccccCHHHhcc---CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            765422       235678999999876   678999999999999999999 999998876666655554421      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                         ..+.+..++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus       403 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence               122223344578899999999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-47  Score=335.00  Aligned_cols=257  Identities=18%  Similarity=0.292  Sum_probs=210.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--CceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+.. ++.||+|.++...........+.+|+.+++.++||||+++++++..+  +..+++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            467889999999999999999984 88999999987654444445688999999999999999999999877  788999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN--IIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      |||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +  ++||||||+||+++.++.++++|||++..
T Consensus        88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            999999999999986432  2379999999999999999999998   7  99999999999999999999998887654


Q ss_pred             CC-cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          216 AP-EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       216 ~~-~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      .. ....+|..|+|||.+.......++.++|||||||++|||+||+.||.+................        ...+.
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~  234 (271)
T 3kmu_A          163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR--------PTIPP  234 (271)
T ss_dssp             TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC--------CCCCT
T ss_pred             ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC--------CCCCC
Confidence            33 3346899999999987643334455899999999999999999999876555443333222111        11112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .....+.+++.+||+.||++|||++++++.|+++.+
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            223478899999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.9e-47  Score=336.34  Aligned_cols=257  Identities=20%  Similarity=0.267  Sum_probs=207.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+ ..+++.||+|.+........ ....+.+|+..++.++||||+++++++..++..+++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            4678999999999999999999 46889999999865443222 223578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999976543    89999999999999999999999   99999999999999999999999999997653


Q ss_pred             cc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          218 EE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       218 ~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..       ..||+.|+|||.+..   ..++.++||||||+++|||+||+.||.+..................     ..
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~  234 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKG---EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV-----TT  234 (294)
T ss_dssp             ------------CCSSCCHHHHHT---CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH-----HH
T ss_pred             cccccccCccccCccccCHhHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc-----ch
Confidence            32       257999999999876   6788999999999999999999999987654443222222111110     00


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccccC
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRP-SIVQVATILNNLVGD  331 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RP-s~~~i~~~L~~~~~~  331 (332)
                      ......+..+.+++.+||+.||++|| +++++.+.|+.++..
T Consensus       235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            00111234688999999999999998 999999999988753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-47  Score=332.39  Aligned_cols=251  Identities=20%  Similarity=0.301  Sum_probs=209.9

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|...+.||+|+||.||+|...++..||+|.++....   ....+.+|+..++.++||||+++++++..++..+++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            4567889999999999999999988888999999975432   2235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             ECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            99999999999976432   378999999999999999999999   999999999999999999999999999875433


Q ss_pred             c-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 E-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 ~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .       ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+.........+.....       ...
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~  226 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHY---FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-------LYR  226 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHH---SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-------CCC
T ss_pred             hhhhcccCCCcCcccCCHHHHhc---cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-------CCC
Confidence            2       234567999999876   568899999999999999999 9999987665555444433211       111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                        +......+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence              11122368899999999999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=340.29  Aligned_cols=252  Identities=22%  Similarity=0.354  Sum_probs=203.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+....  ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            45788899999999999999994 579999999885432  223345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        87 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             ECCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999986433   289999999999999999999999   999999999999999999999999999865422


Q ss_pred             --------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc
Q 020027          219 --------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       219 --------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~  278 (332)
                                          ...||..|+|||.+..   ..++.++||||||+++|||++|..|+............   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---  234 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---  234 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---
Confidence                                2257889999999876   67899999999999999999999988653221110000   


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ......+...    +...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       235 ~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          235 NVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             CHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0000000000    1111236788999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.3e-47  Score=355.95  Aligned_cols=250  Identities=25%  Similarity=0.347  Sum_probs=208.7

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC-ceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG-ERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~l  136 (332)
                      ...++|...+.||+|+||.||+|... |+.||||.++...    ....+.+|+.++++++||||+++++++...+ ..++
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            34567888899999999999999974 7799999997543    3346799999999999999999999987654 7899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       265 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            9999999999999986543  2368899999999999999999999   9999999999999999999999999998754


Q ss_pred             Ccc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          217 PEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       217 ~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      ...   ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+.         ..+.
T Consensus       340 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------~~~~  407 (450)
T 1k9a_A          340 SSTQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------KMDA  407 (450)
T ss_dssp             C------CCCTTTSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC---------CCCC
T ss_pred             cccccCCCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------CCCC
Confidence            322   246788999999876   678999999999999999999 999998766555544444321         1222


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2334457889999999999999999999999998875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.7e-47  Score=344.98  Aligned_cols=248  Identities=20%  Similarity=0.230  Sum_probs=206.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc----ccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN----AGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .+.|...+.||+|+||.||+|+ ..+|+.||+|.++.......    ....+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4678899999999999999999 45799999999986554322    123578999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC----ceEEccC
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF----CARVCDY  210 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~df  210 (332)
                      +++|||+++++|.+++....    .+++..+..++.|++.||.|||++   +|+||||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999997543    289999999999999999999999   999999999999998776    7999999


Q ss_pred             CccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          211 GLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       211 g~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      |++......     ..||+.|+|||.+..   ..++.++|||||||++|||++|..||.+.........+....+.-  +
T Consensus       164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~  238 (361)
T 2yab_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF--D  238 (361)
T ss_dssp             SSCEECCTTCCCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--C
T ss_pred             CCceEcCCCCccccCCCCccEECchHHcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--C
Confidence            999765432     358999999999876   678999999999999999999999998877666655554432110  0


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +..    .......+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          239 EEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000    0112236789999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.7e-47  Score=337.12  Aligned_cols=253  Identities=19%  Similarity=0.272  Sum_probs=209.4

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ....++|...+.||+|+||.||+|...++..||+|.++....   ....+.+|+.+++.++||||+++++++...+..++
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            345678889999999999999999988888999999975432   22357899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             EEeccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccc
Confidence            9999999999999976322   289999999999999999999999   9999999999999999999999999999754


Q ss_pred             Ccc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          217 PEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       217 ~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ...       ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+.........+.....        
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------  239 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------  239 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--------
T ss_pred             cccccccccCCccCcccCCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--------
Confidence            322       245678999999886   678999999999999999999 9999987766555544443211        


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                       ...+......+.+++.+||+.||++|||+.++++.|+++++
T Consensus       240 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 -LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence             11111122468899999999999999999999999998875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.1e-47  Score=341.75  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=199.3

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeC-CCC---EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLS-TGK---LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ....++|...+.||+|+||.||+|... +++   .||+|.++...........+.+|+.+++.++||||+++++++...+
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            345678999999999999999999953 333   7999999866544444456889999999999999999999997765


Q ss_pred             ce------eEEEeccCCCCHHHHhcccCC--CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc
Q 020027          133 ER------IIVSEFINMASLDFYLHENND--GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC  204 (332)
Q Consensus       133 ~~------~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  204 (332)
                      ..      +++|||+++++|.+++.....  ....+++..++.++.|++.||.|||++   +++||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            54      999999999999999865321  122488999999999999999999999   9999999999999999999


Q ss_pred             eEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHh
Q 020027          205 ARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLI  275 (332)
Q Consensus       205 ~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~  275 (332)
                      +||+|||+++.....        ..++..|+|||.+..   ..++.++|||||||++|||+| |..||.+.........+
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  252 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD---NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL  252 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcC---CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            999999999754322        235668999999877   678999999999999999999 89999876655555444


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                      .....         .+.+......+.+++.+||+.||++|||+.++++.|++++..|
T Consensus       253 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          253 IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            33221         1111223347889999999999999999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-46  Score=336.97  Aligned_cols=255  Identities=18%  Similarity=0.196  Sum_probs=207.4

Q ss_pred             cCCChHHHHHhcCC----------CCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCC
Q 020027           49 FAYPLTEIDAATDG----------FSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ  117 (332)
Q Consensus        49 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~  117 (332)
                      ..++.+++...++.          |+..+.||+|+||.||+|+. .+|+.||+|.+.....  .....+.+|+.+++.++
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCC
Confidence            34566666655543          55667899999999999995 4899999999975432  22235789999999999


Q ss_pred             CCCccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCE
Q 020027          118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI  197 (332)
Q Consensus       118 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  197 (332)
                      ||||+++++++...+..+++|||+++++|.+++...     .+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  172 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI  172 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            999999999999999999999999999999998643     279999999999999999999998   999999999999


Q ss_pred             EeCCCCceEEccCCccccCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH
Q 020027          198 LLNEKFCARVCDYGLSFLAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA  271 (332)
Q Consensus       198 ll~~~~~~kl~dfg~a~~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~  271 (332)
                      +++.++.+||+|||++.....      ...||..|+|||.+..   ..++.++||||||+++|||+||+.||.+......
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~  249 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR---SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA  249 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999865432      2358899999999876   6789999999999999999999999987655555


Q ss_pred             HHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          272 LPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+.....     +.  ..........+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~-----~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          250 MKRLRDSPP-----PK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHHHSSC-----CC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCC-----CC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            444433211     11  1111122346889999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=353.92  Aligned_cols=249  Identities=16%  Similarity=0.171  Sum_probs=208.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|. ..+|+.+|+|.+............+.+|+.+++.++||||+++++++..++..+++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            35678899999999999999998 56899999999987654444444678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC---CCCceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN---EKFCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a~  214 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~E~~~gg~L~~~i~~~~~----~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999876533    89999999999999999999999   999999999999998   46789999999997


Q ss_pred             cCCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          215 LAPEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       215 ~~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      .....      ..||+.|+|||.+..   ..++.++||||+||++|||++|..||.+.........+..+....      
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------  232 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF------  232 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC------
T ss_pred             EecCCCceeecccCCcccCCHHHhcC---CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC------
Confidence            65432      368999999999876   678999999999999999999999998877766666665543211      


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+.......++.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11111122347889999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-47  Score=344.29  Aligned_cols=252  Identities=19%  Similarity=0.351  Sum_probs=201.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCE----EEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKL----VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|+. .+++.    ||+|.++.... ......+.+|+.+++.++||||+++++++..++ .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            45688899999999999999994 45554    58887764322 223346789999999999999999999998755 7


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            789999999999999976543   288999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....        ..+|..|+|||.+..   ..++.++|||||||++|||+| |+.||.+.........+..+.      
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------  236 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------  236 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------
T ss_pred             EccCCcccccccCCCccccccChHHhcc---CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC------
Confidence            54322        235678999999886   678999999999999999999 999998766555544443321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                         ..+.+......+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence               1122223344788999999999999999999999999987754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-47  Score=344.19  Aligned_cols=260  Identities=23%  Similarity=0.347  Sum_probs=214.1

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ  129 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  129 (332)
                      +....++|...+.||+|+||.||+|+.      .+++.||+|.++.... ......+.+|+.+++.++||||+++++++.
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344568899999999999999999995      3457899999975432 222335789999999999999999999999


Q ss_pred             cCCceeEEEeccCCCCHHHHhcccCCC--------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 020027          130 APGERIIVSEFINMASLDFYLHENNDG--------------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIH  189 (332)
Q Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH  189 (332)
                      ..+..+++|||+++++|.+++......                    ...+++..++.++.|++.||.|||++   +++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            999999999999999999999764311                    13488999999999999999999999   9999


Q ss_pred             cCCCCCCEEeCCCCceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CC
Q 020027          190 GCIKASNILLNEKFCARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GR  260 (332)
Q Consensus       190 ~dlk~~Nill~~~~~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~  260 (332)
                      |||||+||+++.++.+||+|||++.....        ...++..|+|||.+..   ..++.++||||||+++|||+| |.
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc---CCcCcccccHHHHHHHHHHHhcCC
Confidence            99999999999999999999999864321        2246788999999876   678999999999999999999 99


Q ss_pred             CCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          261 RCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       261 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      .||.+....+....+..+....         .+......+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       275 ~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          275 QPYYGMAHEEVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CcCCCCChHHHHHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            9998876666655554432211         1122334788999999999999999999999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-46  Score=340.30  Aligned_cols=244  Identities=20%  Similarity=0.268  Sum_probs=204.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+++.... ......+.+|+.+++.++||||+++++++...+..+++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            46788999999999999999994 58999999999764322 22333578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|..++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999976543    78999999999999999999999   99999999999999999999999999987532


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .      ...||+.|+|||.+..   ..++.++|+|||||++|||++|+.||.+.........+.....        ..+
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------~~p  225 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------RFP  225 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSS---SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCC
T ss_pred             cCCCcccccccChhhCChhhhcC---CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCC
Confidence            1      2358999999999876   6789999999999999999999999988766655554444321        111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .  ....++.+++.+||+.||++||     +++|+++
T Consensus       226 ~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          226 R--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             T--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            1  1223678999999999999999     8888865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=349.93  Aligned_cols=256  Identities=23%  Similarity=0.272  Sum_probs=209.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      .++|...+.||+|+||.||+|..      .+++.||+|.++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            46788889999999999999984      2566899999864322 2223357899999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC---ceEE
Q 020027          134 RIIVSEFINMASLDFYLHENND---GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF---CARV  207 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl  207 (332)
                      .+++|||+++++|.+++.....   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence            9999999999999999976532   123488999999999999999999999   999999999999999554   5999


Q ss_pred             ccCCccccCC--------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhc
Q 020027          208 CDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       208 ~dfg~a~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~  278 (332)
                      +|||+++...        ....+|..|+|||.+..   ..++.++|||||||++|||+| |..||.+.........+..+
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999986421        12246788999999876   678999999999999999998 99999887766665555443


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      ..         ...+......+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       303 ~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          303 GR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            21         111122234688999999999999999999999999887654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.6e-47  Score=361.42  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=213.7

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeC-CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      .++...++|...+.||+|+||.||+|... ++..||+|.++....   ....+.+|+.++++++||||+++++++...+.
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            34445667888899999999999999954 588999999975432   23457999999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence            9999999999999999976432  2378999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          214 FLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       214 ~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      +.....       ..++..|+|||.+..   ..++.++|||||||++|||+| |..||.+.........+...       
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------  435 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------  435 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhc---CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------
Confidence            765432       134568999999876   678999999999999999999 99999876655554444332       


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                        ...+.+..++..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence              11222233445788999999999999999999999999998653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6e-47  Score=345.28  Aligned_cols=249  Identities=18%  Similarity=0.207  Sum_probs=207.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++||||+++++++..++..+++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            34678999999999999999999 45789999999986554333344578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC---CceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK---FCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~dfg~a~  214 (332)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||++   +|+||||||+|||++.+   +.+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999887543    278999999999999999999999   99999999999999865   459999999997


Q ss_pred             cCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          215 LAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       215 ~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .....     ..||+.|+|||.+..   ..++.++|||||||++|||++|..||.+.........+..+....      .
T Consensus       180 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------~  250 (362)
T 2bdw_A          180 EVNDSEAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------P  250 (362)
T ss_dssp             CCTTCCSCCCSCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------C
T ss_pred             EecCCcccccCCCCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------C
Confidence            65432     368999999999876   678999999999999999999999998876666655555443211      1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.......++.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111122347889999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.7e-46  Score=331.65  Aligned_cols=272  Identities=29%  Similarity=0.505  Sum_probs=219.7

Q ss_pred             ccCCChHHHHHhcCCCCCC------ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccc--cccccHHHHHHHhccCCCC
Q 020027           48 AFAYPLTEIDAATDGFSHR------RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLAQHP  119 (332)
Q Consensus        48 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~  119 (332)
                      ...++..++...+++|...      +.||+|+||.||+|.. +++.||+|.+.......  .....+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3467788999999999888      8999999999999987 68899999987543222  2233578999999999999


Q ss_pred             CccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe
Q 020027          120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL  199 (332)
Q Consensus       120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  199 (332)
                      ||+++++++...+..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||++   +++||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999875322 22488999999999999999999999   99999999999999


Q ss_pred             CCCCceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH
Q 020027          200 NEKFCARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA  271 (332)
Q Consensus       200 ~~~~~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~  271 (332)
                      +.++.+||+|||++.....        ...|+..|+|||.+..    .++.++||||||+++|||+||..||.+......
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT----EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC----CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            9999999999999865432        2257899999998753    478999999999999999999999976432211


Q ss_pred             H----HHhhh--cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          272 L----PLIKE--MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       272 ~----~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .    ..+..  ..+.+.+++.. ...+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1    11111  11222233322 2334566678999999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.7e-47  Score=357.56  Aligned_cols=255  Identities=22%  Similarity=0.365  Sum_probs=210.1

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++...++|...+.||+|+||.||+|...++..||+|.++....   ....+.+|+.+++.++||||+++++++.. +..
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            34455677888899999999999999987778899999975432   22357999999999999999999999876 678


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence            999999999999999975321  1278999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          215 LAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       215 ~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      .....       ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+.       
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------  398 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------  398 (452)
T ss_dssp             --------------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------
T ss_pred             ecCCCceecccCCcccccccCHhHHhc---CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            65422       235678999999876   678999999999999999999 999998876666555544321       


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                        ..+.+..++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus       399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence              122223344578899999999999999999999999998864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-47  Score=338.59  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=204.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--  131 (332)
                      ..++|+..+.||+|+||.||+|++     .+++.||+|.+....  ......+.+|+.+++.++||||+++++++...  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            346788899999999999999983     378899999987542  22223578999999999999999999998543  


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      ...+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence            568999999999999999976432   378999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc----
Q 020027          212 LSFLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM----  278 (332)
Q Consensus       212 ~a~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~----  278 (332)
                      ++......         ..++..|+|||.+..   ..++.++||||||+++|||+||..|+........ ......    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~  235 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDKQGQ  235 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH-HHHCTTCCTH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcC---CCCChHHHHHHHHHHHHHHHhcccccCCChHHHH-hhhcCccccc
Confidence            99765332         235667999999876   6789999999999999999999999876533221 111110    


Q ss_pred             ----ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          279 ----RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       279 ----~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                          ...+.+......+.+..++.++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                00111111112223334445788999999999999999999999999988753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=334.40  Aligned_cols=249  Identities=19%  Similarity=0.226  Sum_probs=196.9

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc------------------------ccccHHHHHHHh
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN------------------------AGFGFASVIKTL  113 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~e~~~l  113 (332)
                      ..++|...+.||+|+||.||+|+ ..+++.||+|.+........                        ....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            35789999999999999999999 46789999999976542211                        123578999999


Q ss_pred             ccCCCCCccceeeeeec--CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecC
Q 020027          114 SLAQHPNIVPILGFSQA--PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGC  191 (332)
Q Consensus       114 ~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  191 (332)
                      +.++||||+++++++..  .+..+++|||+++++|.+++...     .+++..+..++.|++.||.|||++   +++|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  162 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD  162 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            99999999999999976  56789999999999998765432     389999999999999999999999   999999


Q ss_pred             CCCCCEEeCCCCceEEccCCccccCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc
Q 020027          192 IKASNILLNEKFCARVCDYGLSFLAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       192 lk~~Nill~~~~~~kl~dfg~a~~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      |||+||+++.++.+||+|||++.....      ...||..|+|||.+........+.++|||||||++|||++|+.||.+
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999999876432      23689999999998753222247899999999999999999999987


Q ss_pred             hhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .........+.....        ..+........+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMCLHSKIKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHHHHHHHHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHHHHHHHhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            655544443333221        11111122346889999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.6e-46  Score=331.91  Aligned_cols=254  Identities=18%  Similarity=0.195  Sum_probs=200.8

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      ++|...+.||+|+||.||+|+..+|+.||+|++............+.+|+.+++.++||||+++++++..++..+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999988899999999976654444444678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      +++ +|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....  
T Consensus        82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            975 89888875432   278999999999999999999999   999999999999999999999999999865432  


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-------cccc-----
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-------RFSE-----  282 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~-----  282 (332)
                          ...+|..|+|||.+...  ..++.++|||||||++|||+||+.||.+.........+...       .+..     
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             -------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccccCchheeCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence                22578999999988642  45899999999999999999999999876544433322110       0000     


Q ss_pred             ccCCcCCCC-------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIP-------CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~-------~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..++.....       .......++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            001111000       00112346789999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.5e-47  Score=338.21  Aligned_cols=256  Identities=21%  Similarity=0.233  Sum_probs=199.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|...+.||+|+||.||+|+..+|+.||+|.+............+.+|+.+++.++||||+++++++..++..+++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            35789999999999999999999888999999999765443333345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++ +|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        99 e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99974 78777765432   378999999999999999999999   999999999999999999999999999976432


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-------ccccc-
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-------FSELL-  284 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~-  284 (332)
                            ...+|..|+|||.+...  ..++.++||||+||++|||++|+.||.+....+....+....       +.... 
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CcccccCCcccCCcCCHHHhcCC--CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence                  22578999999988652  568999999999999999999999998755444333322100       00000 


Q ss_pred             -----CCcCCC--CCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 -----DPRLAI--PCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 -----~~~~~~--~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           +.....  ..+     .....++.+++.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 000000  000     011236789999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=346.47  Aligned_cols=257  Identities=24%  Similarity=0.320  Sum_probs=212.2

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEe--------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGF  127 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  127 (332)
                      +...++|...+.||+|+||.||+|+.        .++..||+|.++.... ......+.+|+.+++.+ +||||++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            44567888899999999999999983        2335799999975532 22234578999999999 89999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCC
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  195 (332)
                      +..++..+++|||+++++|.+++......            ...+++..++.++.|++.||.|||++   +|+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            99999999999999999999999765321            12489999999999999999999999   9999999999


Q ss_pred             CEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCch
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGL  266 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~  266 (332)
                      |||++.++.+||+|||+++.....        ..++..|+|||.+..   ..++.++|||||||++|||+| |..||.+.
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999754321        245678999999876   678999999999999999999 99999887


Q ss_pred             hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ........+..+...         ..+.....++.+++.+||+.||++|||+.|+++.|++++
T Consensus       298 ~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          298 PVEELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             CHHHHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            766665555443211         111223347889999999999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6e-47  Score=340.46  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=203.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCE----EEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKL----VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|.. .+++.    ||+|.+..... ......+.+|+..++.++||||+++++++.. +..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            45788889999999999999994 45554    77777754322 2233456889999999999999999999864 568


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence            89999999999999997542   2378889999999999999999999   99999999999999999999999999997


Q ss_pred             cCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....        ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+.........+......    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----  236 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHF---GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL----  236 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC----
T ss_pred             ccCcccccccccCCCCcccccChHHhcc---CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC----
Confidence            65322        245678999999976   678999999999999999999 99999876655554444433211    


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                         ..  +..+...+.+++.+||+.||++|||+.++++.|+++..+
T Consensus       237 ---~~--~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          237 ---AQ--PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ---CC--CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ---CC--CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               11  111222567899999999999999999999999988754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-46  Score=328.17  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccc--cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|.. +++.||+|.++......  .....+.+|+.+++.++||||+++++++..++..+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46788899999999999999997 48899999987654332  1223578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC---eeecCCCCCCEEeCC--------CCceE
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN---IIHGCIKASNILLNE--------KFCAR  206 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~---ivH~dlk~~Nill~~--------~~~~k  206 (332)
                      |||+++++|.+++...     .+++..++.++.|++.||.|||++   +   ++||||||+||+++.        ++.+|
T Consensus        85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence            9999999999998643     278999999999999999999998   7   999999999999986        67899


Q ss_pred             EccCCccccCCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          207 VCDYGLSFLAPEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       207 l~dfg~a~~~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      |+|||++......    ..++..|+|||.+..   ..++.++||||||+++|||+||+.||.+...............  
T Consensus       157 l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--  231 (271)
T 3dtc_A          157 ITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA---SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL--  231 (271)
T ss_dssp             ECCCCC-------------CCGGGSCHHHHHH---CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC--
T ss_pred             EccCCcccccccccccCCCCccceeCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC--
Confidence            9999998754332    357899999999876   6789999999999999999999999987655444333332211  


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                            ..+.+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus       232 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                  1112223334788999999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.1e-47  Score=340.52  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=202.0

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC----c
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG----E  133 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  133 (332)
                      ...++|...+.||+|+||.||+|+.. ++.||+|.+....   ........|+..++.++||||+++++++...+    .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            44568999999999999999999874 7899999986432   22234567888999999999999999997654    3


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-------CCCeeecCCCCCCEEeCCCCceE
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV-------APNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-------~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                      .+++|||+++++|.+++....     +++..++.++.|++.||.|||+.+       .++|+||||||+|||++.++.+|
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            699999999999999997642     899999999999999999999752       33899999999999999999999


Q ss_pred             EccCCccccCCc--------ccCCcccccCcccccccCC--CCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHH--
Q 020027          207 VCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGG--GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPL--  274 (332)
Q Consensus       207 l~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~--~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~--  274 (332)
                      |+|||+++....        ...||..|+|||.+.....  ..++.++|||||||++|||+||+.||.+.........  
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999965322        1357899999999865211  2456789999999999999999999875322111000  


Q ss_pred             ----------hhhcccccccCCcCCC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          275 ----------IKEMRFSELLDPRLAI-PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       275 ----------~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                                +..........+.+.. .....+...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      0000000111111111 012345567899999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.3e-47  Score=346.41  Aligned_cols=263  Identities=26%  Similarity=0.383  Sum_probs=211.2

Q ss_pred             CChHHHHHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccc
Q 020027           51 YPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVP  123 (332)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~  123 (332)
                      +....++...++|...+.||+|+||.||+|+.      .+++.||+|.++.... ......+.+|+.+++.+ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-HHHHHHHHHHHHHHHhhcCCcceee
Confidence            44567777889999999999999999999972      3567999999975432 22233578999999999 7999999


Q ss_pred             eeeeeecCC-ceeEEEeccCCCCHHHHhcccCCC----------------------------------------------
Q 020027          124 ILGFSQAPG-ERIIVSEFINMASLDFYLHENNDG----------------------------------------------  156 (332)
Q Consensus       124 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------------------  156 (332)
                      +++++...+ ..+++|||+++++|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999987754 489999999999999999764321                                              


Q ss_pred             ----------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          157 ----------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       157 ----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                                      ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++...... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            11278999999999999999999999   9999999999999999999999999999754322 


Q ss_pred             -------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHH-HHHHhhhcccccccCCcCCC
Q 020027          220 -------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKW-ALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       220 -------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  290 (332)
                             ..+|..|+|||.+..   ..++.++|||||||++|||+| |..||.+..... ....+.....         .
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------~  315 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---------M  315 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC---------C
T ss_pred             cchhccccCCCceeEChhhhcC---CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC---------C
Confidence                   246778999999876   678999999999999999999 999998754322 2222222211         1


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ..+.....++.+++.+||+.||++|||+.|+++.|++++
T Consensus       316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            111122346889999999999999999999999999876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.6e-47  Score=351.80  Aligned_cols=259  Identities=18%  Similarity=0.196  Sum_probs=209.2

Q ss_pred             hHHHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeec
Q 020027           53 LTEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQA  130 (332)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  130 (332)
                      ..++....++|+..+.||+|+||+||+|+. .+++.||+|.+++..... .....+.+|..++..++||||+++++++..
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            344555678999999999999999999995 568899999997543222 223357899999999999999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      ++..+++|||+++|+|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999999999976322   289999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCc-------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccc
Q 020027          211 GLSFLAPE-------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS  281 (332)
Q Consensus       211 g~a~~~~~-------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  281 (332)
                      |+++....       ...||+.|+|||.+...  ....++.++|||||||++|||+||+.||.+....+....+......
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  299 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER  299 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence            99965432       13689999999998632  1256899999999999999999999999987666665554332110


Q ss_pred             cccCCcCCCCCC-hHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 020027          282 ELLDPRLAIPCE-IKPLVRLAKVALACVGNSRKN--RPSIVQVAT  323 (332)
Q Consensus       282 ~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~dp~~--RPs~~~i~~  323 (332)
                            +..+.. ......+.+++.+||..+|++  ||+++|+++
T Consensus       300 ------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          300 ------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                  111111 112336789999999888888  999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=337.91  Aligned_cols=248  Identities=20%  Similarity=0.219  Sum_probs=204.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc----ccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN----AGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .+.|...+.||+|+||.||+|.. .+|+.||+|.+........    ....+.+|+.+++.++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34688889999999999999994 5799999999976543322    123578999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC----ceEEccC
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF----CARVCDY  210 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~df  210 (332)
                      +++|||+++++|.+++....    .+++..+..++.|++.||.|||++   +++||||||+||+++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999997543    288999999999999999999999   999999999999999877    7999999


Q ss_pred             CccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          211 GLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       211 g~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      |++.....     ...||+.|+|||.+..   ..++.++|||||||++|||++|..||.+.........+......    
T Consensus       163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----  235 (326)
T 2y0a_A          163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----  235 (326)
T ss_dssp             TTCEECCTTSCCCCCCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC----
T ss_pred             CCCeECCCCCccccccCCcCcCCceeecC---CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC----
Confidence            99976532     2358999999999865   67899999999999999999999999877665555444332211    


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        ............+.+++.+||+.||++|||+.|+++
T Consensus       236 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 --FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              000000112236779999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-46  Score=336.83  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=211.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      ...++|...+.||+|+||.||+|..      .+++.||+|.++.... ......+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            3466788899999999999999984      3457899999975432 22234578999999999999999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCC--------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDG--------------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGC  191 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  191 (332)
                      +..+++|||+++++|.+++......                    ...+++..++.++.|++.||.|||++   +++|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence            9999999999999999999865321                    12378999999999999999999999   999999


Q ss_pred             CCCCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCC
Q 020027          192 IKASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRC  262 (332)
Q Consensus       192 lk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p  262 (332)
                      |||+||+++.++.+||+|||++......        ..++..|+|||.+..   ..++.++|||||||++|||+| |..|
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC---CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999998754321        245678999999876   678999999999999999999 9999


Q ss_pred             CCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          263 EEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      |.+.........+.....         ...+......+.+++.+||+.||++|||+.++++.|++++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             STTCCGGGHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            987766555544443321         111122334788999999999999999999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=336.52  Aligned_cols=246  Identities=15%  Similarity=0.159  Sum_probs=204.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|. ..+++.+|+|.+....   .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            4678899999999999999999 4578899999987432   22234689999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC--CCceEEccCCccccC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE--KFCARVCDYGLSFLA  216 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~~  216 (332)
                      ||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.  ++.+||+|||++...
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           81 EFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EeCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999999975432   388999999999999999999999   9999999999999987  789999999999765


Q ss_pred             Ccc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 PEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ...     ..+|+.|+|||.+..   ..++.++|||||||++|||++|..||.+.........+........  ..    
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--~~----  225 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQH---DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--EE----  225 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTT---CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--HH----
T ss_pred             CCCCccccccCChhhcCcHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC--hh----
Confidence            433     257899999999876   5678999999999999999999999988766665555544322100  00    


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .......++.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00012346889999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.4e-46  Score=329.96  Aligned_cols=261  Identities=24%  Similarity=0.390  Sum_probs=201.6

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      +...++|...+.||+|+||.||+|+..  ..||+|.++...........+.+|+.+++.++||||+++++++. .+..++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence            455678999999999999999999864  35999999766544444456889999999999999999999764 456889


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEecCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            9999999999999965432   388999999999999999999999   9999999999999999999999999998654


Q ss_pred             Cc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccccccCCc
Q 020027          217 PE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFSELLDPR  287 (332)
Q Consensus       217 ~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  287 (332)
                      ..        ...++..|+|||.+....+..++.++||||||+++|||++|+.||.+.... .....+..........  
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  248 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS--  248 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT--
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh--
Confidence            32        225789999999987544477899999999999999999999999764332 2323333322211111  


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                         ......+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus       249 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          249 ---KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             ---SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             ---hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence               01112334788999999999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-46  Score=326.61  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=210.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ..++|...+.||+|+||.||+|...+++.||+|.+.....   ....+.+|+.+++.++||||+++++++..++..+++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            3467888999999999999999988888999999976532   2235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CCCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eCCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            99999999999976432   378999999999999999999999   999999999999999999999999999875432


Q ss_pred             -------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 -------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 -------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                             ...++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+.........+..+..         .
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~---------~  224 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------L  224 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------C
T ss_pred             ccccccccccccccccChhhhcC---CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc---------C
Confidence                   2245678999999876   678999999999999999999 8999987665555444443211         1


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ..+......+.+++.+||+.||++|||++++++.|+++.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1111223468899999999999999999999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=342.46  Aligned_cols=246  Identities=23%  Similarity=0.278  Sum_probs=203.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc-ccccccHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      ...++|...+.||+|+||.||+|+ ..+|+.||+|.+++.... ......+.+|..+++.+ +||||+++++++..++..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            446789999999999999999999 457899999999764322 22233467889999887 799999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|..++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence            999999999999999976543    89999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          215 LAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       215 ~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ....      ...||+.|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+.....        
T Consensus       173 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------  241 (353)
T 3txo_A          173 EGICNGVTTATFCGTPDYIAPEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--------  241 (353)
T ss_dssp             CSCC---------CCGGGCCHHHHHH---HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             ecccCCccccccCCCcCeEChhhcCC---CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            5322      2368999999999876   5688999999999999999999999998877766666655321        


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSI------VQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~------~~i~~  323 (332)
                      ..+.  .....+.+++.+||+.||++||++      .|+++
T Consensus       242 ~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1111  122367899999999999999998      66653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.3e-46  Score=328.19  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccccc-----ccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAG-----FGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ..++|...+.||+|+||.||+|+. .+++.||+|.+..........     ..+.+|+.+++.++||||+++++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            356789999999999999999994 689999999987654332211     35789999999999999999999987655


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeecCCCCCCEEeCCCCc-----e
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN--IIHGCIKASNILLNEKFC-----A  205 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~-----~  205 (332)
                        +++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +  ++||||||+||+++.++.     +
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             --eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence              799999999999888865432   389999999999999999999998   8  999999999999988776     9


Q ss_pred             EEccCCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH--HHHhhhccc
Q 020027          206 RVCDYGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA--LPLIKEMRF  280 (332)
Q Consensus       206 kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~--~~~~~~~~~  280 (332)
                      ||+|||+++.....   ..++..|+|||.+... ...++.++|||||||++|||++|+.||.+......  ...+.....
T Consensus       169 kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          169 KVADFGLSQQSVHSVSGLLGNFQWMAPETIGAE-EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             EECCCTTCBCCSSCEECCCCCCTTSCGGGSSCS-SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             EeCCCCccccccccccccCCCccccCchhhccC-CCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            99999999765433   3578999999988431 25578999999999999999999999976432222  111222111


Q ss_pred             ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                              ....+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       248 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 --------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                    1111222334788999999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.3e-46  Score=329.16  Aligned_cols=254  Identities=20%  Similarity=0.180  Sum_probs=197.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.||+|+||+||+|+. .+++.||+|.++...........+.+|+.+++.++||||+++++++..++..+++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4688899999999999999994 578999999998665444444567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++ ++.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..... 
T Consensus        82 ~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9975 55555544322   289999999999999999999999   999999999999999999999999999975432 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC-CchhHHHHHHHhhhcc-------cc---c
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE-EGLLVKWALPLIKEMR-------FS---E  282 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~-~~~~~~~~~~~~~~~~-------~~---~  282 (332)
                           ...+|..|+|||.+...  ..++.++|||||||++|||+||..|| .+.........+....       +.   .
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             cccccCCccccCCcChHHHcCC--CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence                 23578899999998652  44799999999999999999988774 4443333333222100       00   0


Q ss_pred             ccCC---------cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDP---------RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~---------~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+.         .............+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000         0000011123346789999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-46  Score=333.81  Aligned_cols=244  Identities=20%  Similarity=0.248  Sum_probs=204.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+++. .+|+.||+|.+++..... .....+.+|..+++.++||||+++++++...+..+++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            46788999999999999999994 589999999997643322 2233467899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999976433    78999999999999999999998   99999999999999999999999999997654


Q ss_pred             cc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          218 EE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       218 ~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      +.   ..||+.|+|||.+..   ..++.++|+|||||++|||++|+.||.+.........+.....        ..+.  
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------~~p~--  224 (318)
T 1fot_A          158 DVTYTLCGTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------RFPP--  224 (318)
T ss_dssp             SCBCCCCSCTTTCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--------CCCT--
T ss_pred             CccccccCCccccCHhHhcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCC--
Confidence            32   368999999999876   6789999999999999999999999987766555554444321        1111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ....++.+++.+||+.||++||     +++++++
T Consensus       225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            1223678999999999999999     8888874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-46  Score=335.86  Aligned_cols=253  Identities=23%  Similarity=0.406  Sum_probs=203.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC-C----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS-T----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|... +    +..||+|.++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            345666789999999999999843 2    23599999975432 22233578999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            999999999999999976432   288999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          215 LAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       215 ~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....         ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+.........+..+.     
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-----  267 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-----  267 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----
T ss_pred             hhccccccccccCCCCccccccCchhccc---CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-----
Confidence            65332         134667999999876   678999999999999999999 999998776655555444321     


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                          ..+.+......+.+++.+||+.||++|||+.++++.|++++..
T Consensus       268 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                1111223334788999999999999999999999999987643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-46  Score=341.89  Aligned_cols=251  Identities=21%  Similarity=0.259  Sum_probs=200.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc---ccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN---AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .+.|...+.||+|+||.||+|. ..+|+.||+|.+........   ....+.+|+.+++.++||||+++++++..++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4568899999999999999998 46899999999865332211   2335789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc---eEEccCCc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC---ARVCDYGL  212 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~dfg~  212 (332)
                      ++|||+++++|.+++.........+++..+..++.|++.||.|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999888765432223478999999999999999999999   9999999999999986554   99999999


Q ss_pred             cccCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          213 SFLAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       213 a~~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      +.....      ...||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+.... ....+..+....  .+
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~--~~  253 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKM--NP  253 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCC--CH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC---CCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCC--Cc
Confidence            976543      2358999999999876   67899999999999999999999999875432 223332222110  00


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..    .......+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          254 RQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00    0011236789999999999999999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.1e-47  Score=340.36  Aligned_cols=244  Identities=22%  Similarity=0.316  Sum_probs=198.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.+....... .....+.+|+.+++.++||||+++++++..++..+++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4678999999999999999999 4789999999997543322 2233578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+ +|+|.+++.....    +++..+..++.|++.||.|||++   +++||||||+|||+++++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 6888888876543    88999999999999999999999   99999999999999999999999999997654


Q ss_pred             c-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 E-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .     ...||+.|+|||.+...  ...++++|||||||++|||++|+.||.+.........        ........+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------i~~~~~~~p~  229 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGK--LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------VNSCVYVMPD  229 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCS--GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC--------CCSSCCCCCT
T ss_pred             CCcccccccCCcCcCCHHHHcCC--CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH--------HHcCCCCCcc
Confidence            3     23689999999998752  2237899999999999999999999976432222111        1111111221


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .....+.+++.+||+.||.+|||++|+++
T Consensus       230 --~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          230 --FLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              22336789999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=336.13  Aligned_cols=253  Identities=19%  Similarity=0.358  Sum_probs=202.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCE----EEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKL----VAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|. ..+++.    ||+|.+.... .......+.+|+.+++.++||||+++++++..++ .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            4678999999999999999999 445654    4667665332 2223345789999999999999999999998765 7


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++|++++++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             eEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            889999999999999976533   278999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          215 LAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       215 ~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .....        ..++..|+|||.+..   ..++.++|||||||++|||+| |..||.+.........+....      
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------  236 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------  236 (327)
T ss_dssp             --------------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------
T ss_pred             EccCccccccccCCCccccccCHHHHcC---CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------
Confidence            64322        135668999999886   678999999999999999999 999998876555544443321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                         ..+.+......+.+++.+||+.||++|||+.|+++.|+++..+|
T Consensus       237 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          237 ---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence               11122223347889999999999999999999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=340.30  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=206.8

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFS  128 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  128 (332)
                      ++...++|...+.||+|+||.||+|..      .++..||+|.+..... ......+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445567889999999999999999984      2456899999975432 22334678999999999 899999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCCC-------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENNDG-------------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIH  189 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH  189 (332)
                      ...+..+++|||+++++|.+++......                   ...+++..++.++.|++.||.|||++   +|+|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            9999999999999999999999764321                   12378999999999999999999999   9999


Q ss_pred             cCCCCCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CC
Q 020027          190 GCIKASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GR  260 (332)
Q Consensus       190 ~dlk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~  260 (332)
                      |||||+||+++.++.+||+|||++......        ..++..|+|||.+..   ..++.++|||||||++|||+| |.
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc---CCCChhHhHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999754322        135678999999876   678999999999999999998 99


Q ss_pred             CCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          261 RCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       261 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      .||.+..............        ...+.+......+.+++.+||+.||++|||+.++++.|+.++..
T Consensus       273 ~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          273 NPYPGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CSSTTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCcccCCcHHHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            9998754332222221111        11111222334788999999999999999999999999988754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.3e-46  Score=338.01  Aligned_cols=244  Identities=16%  Similarity=0.148  Sum_probs=206.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+++. .+|+.||+|.+.+..... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            46788999999999999999994 589999999997543322 2233578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence            999999999999986543    78999999999999999999999   99999999999999999999999999997654


Q ss_pred             cc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          218 EE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       218 ~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      ..   ..||+.|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+..+..        ..+.  
T Consensus       193 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------~~p~--  259 (350)
T 1rdq_E          193 GRTWTLCGTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------RFPS--  259 (350)
T ss_dssp             SCBCCCEECGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCCT--
T ss_pred             CCcccccCCccccCHHHhcC---CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC--------CCCC--
Confidence            32   368999999999876   6789999999999999999999999988766666555554321        1111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      .....+.+++.+||+.||++||+     ++|+++
T Consensus       260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            12336889999999999999998     777764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=342.80  Aligned_cols=248  Identities=21%  Similarity=0.270  Sum_probs=202.1

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||++. ..+++.||+|.+....... .....+.+|+.+++.++||||+++++++...+..++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34678999999999999999999 5578999999997544222 233357899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|..++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        93 v~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             EECCCTTEEHHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            9999999999999976432    89999999999999999999999   9999999999999999999999999999765


Q ss_pred             Cc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH---HHHHHHhhhcccccccCCcC
Q 020027          217 PE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV---KWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       217 ~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ..     ...||+.|+|||.+....+..++.++|||||||++|||+||+.||.+...   ......+...        ..
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------~~  237 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------VV  237 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------CC
T ss_pred             cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------cc
Confidence            33     23689999999998765446789999999999999999999999975322   2222222221        11


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPS-IVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs-~~~i~~  323 (332)
                      ..+  ......+.+++.+||+.||++||+ ++++.+
T Consensus       238 ~~p--~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 TYP--SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCC--TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCC--CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            111  122347889999999999999998 666653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-46  Score=331.70  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=198.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ...++|...+.||+|+||.||+|...    .+..||+|.+..... ......+.+|+..++.++||||+++++++. ++.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            34567888999999999999999853    345799999865422 222335789999999999999999999984 466


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             cEEEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence            8899999999999999976432   278999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          214 FLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       214 ~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      +.....       ..++..|+|||.+..   ..++.++||||||+++|||++ |..||.+.........+.....     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-----  235 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-----  235 (281)
T ss_dssp             ---------------CCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred             cccCcccccccccCCCcccccChhhccc---CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-----
Confidence            765432       235678999999876   678999999999999999997 9999987655555444433221     


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                          .+.+...+..+.+++.+||+.||++|||+.++++.|+++++
T Consensus       236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          236 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                11122233478899999999999999999999999998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.8e-46  Score=325.88  Aligned_cols=248  Identities=18%  Similarity=0.198  Sum_probs=206.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++||||+++++++..++..+++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            5678999999999999999999 457899999999765543333445789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc---eEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC---ARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~dfg~a~~  215 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999888876532    78999999999999999999999   9999999999999986655   99999999865


Q ss_pred             CCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....     ..++..|+|||.+..   ..++.++||||||+++|||++|+.||.+.........+..+....      ..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------~~  228 (284)
T 3kk8_A          158 VNDSEAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------PS  228 (284)
T ss_dssp             CCSSCBCCCSCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------CT
T ss_pred             cccCccccCCCCCcCCcCchhhcC---CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC------Cc
Confidence            4432     358899999999876   678999999999999999999999998876666555554433211      11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +........+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111122346889999999999999999999976

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.2e-46  Score=333.19  Aligned_cols=258  Identities=21%  Similarity=0.270  Sum_probs=188.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|. ..+|+.||+|.++.... ......+.+|+.+++.++||||+++++++..++..+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            35679999999999999999999 45799999999976542 22233578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccC--CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          138 SEFINMASLDFYLHENN--DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      |||++ ++|.+++....  .....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99997 58998886532  1123478999999999999999999999   999999999999999999999999999875


Q ss_pred             CCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c-----ccc
Q 020027          216 APE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R-----FSE  282 (332)
Q Consensus       216 ~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~-----~~~  282 (332)
                      ...      ...+|..|+|||.+...  ..++.++|||||||++|||+||+.||.+....+....+...  .     +..
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            432      23578999999998642  46799999999999999999999999877655544433221  0     000


Q ss_pred             ---c--cCCcCCC--CC----------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 ---L--LDPRLAI--PC----------EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ---~--~~~~~~~--~~----------~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                         .  ..+....  +.          .......+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence               0  0000000  00          0012236889999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.9e-46  Score=346.49  Aligned_cols=255  Identities=18%  Similarity=0.242  Sum_probs=208.7

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      .+....++|...+.||+|+||.||+|+. .+++.||+|.+++.... ......+.+|+.+++.++||||+++++++.+++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            4445678899999999999999999994 57899999999754322 223335789999999999999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++|+|.+++....     +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999997532     78999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCc-------ccCCcccccCcccccccCC-CCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          213 SFLAPE-------EKRGLAGYVDDDYWHEKGG-GNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       213 a~~~~~-------~~~~~~~~~~pe~~~~~~~-~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      ++....       ...||+.|+|||.+....+ ..++.++|||||||++|||+||+.||.+.........+.....    
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----  290 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----  290 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc----
Confidence            965432       3368999999999876321 2278999999999999999999999988766666555543211    


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKN--RPSIVQVAT  323 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~--RPs~~~i~~  323 (332)
                        .+..+.......++.+++.+||+.+|.+  ||+++|+++
T Consensus       291 --~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 --SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             --HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             --cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence              1111211122346789999999999988  999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-46  Score=339.77  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=203.3

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccc-ccccccHHHHHHHhccC-CCCCccceeeeeecC
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLA-QHPNIVPILGFSQAP  131 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  131 (332)
                      ......++|...+.||+|+||.||+|+. .+|+.||+|.+++.... ......+..|..++..+ +||||+++++++...
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            3445678899999999999999999995 57899999999764322 22223467888888876 899999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      +..+++|||+++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeECh
Confidence            999999999999999999976533    78999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          212 LSFLAP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       212 ~a~~~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      +++...      ....||+.|+|||.+..   ..++.++|+|||||++|||++|+.||.+.........+.....     
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----  235 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLG---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-----  235 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcC---CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-----
Confidence            987532      22368999999999876   6789999999999999999999999998776666555544321     


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIV-QVA  322 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~-~i~  322 (332)
                         ..+.  .....+.+++.+||+.||++||++. +++
T Consensus       236 ---~~p~--~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 ---FYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---CCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCCc--ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence               1111  1223678999999999999999987 554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-46  Score=336.51  Aligned_cols=250  Identities=17%  Similarity=0.165  Sum_probs=202.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+ ..+|+.||+|.+....    ....+.+|+.+++.+ +||||+++++++...+..+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            4678899999999999999999 4689999999986542    223578999999999 999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc-----eEEccCCc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC-----ARVCDYGL  212 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~dfg~  212 (332)
                      |||+ +++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.     +||+|||+
T Consensus        84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEeC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999 8999999986422   389999999999999999999999   9999999999999998887     99999999


Q ss_pred             cccCCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH---HHHHHhh
Q 020027          213 SFLAPE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK---WALPLIK  276 (332)
Q Consensus       213 a~~~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~---~~~~~~~  276 (332)
                      ++....             ...||..|+|||.+..   ..++.++|||||||++|||++|+.||.+....   +....+.
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~  233 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG---KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG  233 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcC---CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence            975321             2358899999999876   67899999999999999999999999874322   2222222


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .......  ......   ..+ ++.+++.+||+.||.+|||++++.+.|+++.
T Consensus       234 ~~~~~~~--~~~~~~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          234 DTKRATP--IEVLCE---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHHSC--HHHHTT---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhccCC--HHHHhc---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            2111000  000000   112 7889999999999999999999999998765

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-46  Score=331.38  Aligned_cols=252  Identities=21%  Similarity=0.309  Sum_probs=204.8

Q ss_pred             hcCCCCCCc-eeeccCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           59 ATDGFSHRR-IIGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        59 ~~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ..++|...+ .||+|+||.||+|..   .+++.||+|.++...........+.+|+.+++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            345677777 999999999999953   4578999999976543333344688999999999999999999999 55678


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....    +++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCCHHHHHHhCcC----CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            899999999999999986532    78999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          215 LAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       215 ~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....         ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+.........+..+..    
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----  238 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----  238 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----
T ss_pred             eeccCCCcccccccCCCCceeeChHHhcc---CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----
Confidence            54322         134578999999876   567899999999999999999 9999988766655554444321    


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                           ...+......+.+++.+||+.||++|||+.++++.|+++..
T Consensus       239 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 11112233478899999999999999999999999998753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=339.37  Aligned_cols=247  Identities=17%  Similarity=0.201  Sum_probs=204.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|.+......  ....+.+|+.+++.++||||+++++++...+..+++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            4678999999999999999999 458899999998754322  2235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC--CCceEEccCCccccC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE--KFCARVCDYGLSFLA  216 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~~  216 (332)
                      ||+++++|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.  ++.+||+|||++...
T Consensus       128 E~~~gg~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             ECCCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999975432   389999999999999999999999   9999999999999974  577999999999765


Q ss_pred             Ccc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 PEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ...     ..+|..|+|||.+..   ..++.++|||||||++|||+||..||.+.........+....+..      ...
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~------~~~  272 (387)
T 1kob_A          202 NPDEIVKVTTATAEFAAPEIVDR---EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF------DED  272 (387)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC------CSS
T ss_pred             CCCcceeeeccCCCccCchhccC---CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------Ccc
Confidence            432     258999999999876   678999999999999999999999998876655555444432211      111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .......++.+++.+||+.||++|||+.|+++
T Consensus       273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            11122347889999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.4e-46  Score=331.39  Aligned_cols=255  Identities=22%  Similarity=0.308  Sum_probs=193.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhc--cCCCCCccceeeeeec----CCc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS--LAQHPNIVPILGFSQA----PGE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~----~~~  133 (332)
                      .++|...+.||+|+||.||+|+. +++.||+|.+....     ...+..|..++.  .++||||+++++++..    .+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            56789999999999999999988 68899999986432     223345555544  4899999999998644    345


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeeecCCCCCCEEeCCCCce
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH--------QGVAPNIIHGCIKASNILLNEKFCA  205 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~Nill~~~~~~  205 (332)
                      .+++|||+++++|.++++..     .+++..++.++.|++.||.|||        +.   +++||||||+|||++.++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             eEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            79999999999999999643     2899999999999999999999        77   99999999999999999999


Q ss_pred             EEccCCccccCCc----------ccCCcccccCcccccccCCC---CCCchhhhHHHHHHHHHHHhC----------CCC
Q 020027          206 RVCDYGLSFLAPE----------EKRGLAGYVDDDYWHEKGGG---NATRESDVYGFGVVLLEILSG----------RRC  262 (332)
Q Consensus       206 kl~dfg~a~~~~~----------~~~~~~~~~~pe~~~~~~~~---~~~~~~DiwS~G~il~el~tg----------~~p  262 (332)
                      ||+|||+++....          ...||..|+|||.+......   .++.++|||||||++|||+||          +.|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            9999999854322          12688999999998763111   345799999999999999999          778


Q ss_pred             CCchhHHH-HHHHhhhcccccccCCcCCC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          263 EEGLLVKW-ALPLIKEMRFSELLDPRLAI-PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       263 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      |.+..... ....+..........+.... ..+......+.+++.+||+.||++|||+.++++.|+++
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            75432110 00111110000111111110 01234566899999999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=359.31  Aligned_cols=256  Identities=21%  Similarity=0.364  Sum_probs=213.2

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ..++...++|...+.||+|+||.||+|....+..||||.++....   ....+.+|+.+++.++|+||+++++++.. +.
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            334455677888899999999999999987778899999975432   22357999999999999999999999876 67


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             ceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            8999999999999999975321  1278999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          214 FLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       214 ~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      +.....       ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+.      
T Consensus       411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~------  481 (535)
T 2h8h_A          411 RLIEDNEYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------  481 (535)
T ss_dssp             TTCCCHHHHTTCSTTSCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC------
T ss_pred             eecCCCceecccCCcCcccccCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            765432       235678999999876   678999999999999999999 999998876666655554321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                         ..+.+..+...+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       482 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          482 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence               112222334578899999999999999999999999998864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=330.36  Aligned_cols=264  Identities=18%  Similarity=0.195  Sum_probs=205.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC--ceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG--ERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  136 (332)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+  ..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            45688899999999999999994 57999999999754322 22335689999999999999999999987654  7799


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe----CCCCceEEccCCc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL----NEKFCARVCDYGL  212 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg~  212 (332)
                      +|||+++++|.+++...... ..+++..++.++.|++.||.|||++   +|+||||||+||++    +.++.+||+|||+
T Consensus        87 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            99999999999999764322 2378999999999999999999999   99999999999999    7888899999999


Q ss_pred             cccCCcc-----cCCcccccCccccccc-----CCCCCCchhhhHHHHHHHHHHHhCCCCCCchh----HHHHHHHhhhc
Q 020027          213 SFLAPEE-----KRGLAGYVDDDYWHEK-----GGGNATRESDVYGFGVVLLEILSGRRCEEGLL----VKWALPLIKEM  278 (332)
Q Consensus       213 a~~~~~~-----~~~~~~~~~pe~~~~~-----~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~----~~~~~~~~~~~  278 (332)
                      ++.....     ..+|..|+|||.+...     .+..++.++|||||||++|||+||+.||....    .......+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            9765432     2578999999988632     13678999999999999999999999996322    12222222211


Q ss_pred             ccccc-------------cCCcC--CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          279 RFSEL-------------LDPRL--AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       279 ~~~~~-------------~~~~~--~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .....             ..+.+  ....+......+.+++.+||+.||++|||++|+++...+-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11000             00011  1122345566788999999999999999999999987654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-46  Score=343.28  Aligned_cols=259  Identities=20%  Similarity=0.214  Sum_probs=200.9

Q ss_pred             hcCCCCCCceeecc--CCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           59 ATDGFSHRRIIGQG--RLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        59 ~~~~~~~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ..++|...+.||+|  +||.||+|+. .+|+.||+|.++...........+.+|+.+++.++||||+++++++..++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35679999999999  9999999994 58999999999866543333345778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++......  .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||.+..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            999999999999999765322  288999999999999999999999   999999999999999999999999998743


Q ss_pred             CC-------------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          216 AP-------------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       216 ~~-------------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      ..             ....||..|+|||.+... ...++.++|||||||++|||++|+.||.+............+....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eccccccccccccccccccccccccCHHHHhcc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            21             112578889999998652 1357899999999999999999999997643332222111111111


Q ss_pred             ccCCc------------------------------------CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPR------------------------------------LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~------------------------------------~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+..                                    ...+.+......+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00000                                    000111122346889999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.3e-46  Score=336.07  Aligned_cols=258  Identities=22%  Similarity=0.325  Sum_probs=210.0

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEe--------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILG  126 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  126 (332)
                      +....++|...+.||+|+||.||+|+.        .++..||+|.++.... ......+.+|+.+++.+ +||||+++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            334567899999999999999999984        3567899999975432 22233578999999999 8999999999


Q ss_pred             eeecCCceeEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCC
Q 020027          127 FSQAPGERIIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKA  194 (332)
Q Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~  194 (332)
                      ++...+..+++|||+++++|.+++......            ...+++..++.++.|++.||.|||++   +++||||||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  185 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  185 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence            999999999999999999999999764321            12378999999999999999999999   999999999


Q ss_pred             CCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCc
Q 020027          195 SNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEG  265 (332)
Q Consensus       195 ~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~  265 (332)
                      +||+++.++.+||+|||++......        ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC---CCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            9999999999999999998754322        245678999999876   578999999999999999999 9999988


Q ss_pred             hhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ....+....+..+...         +.+......+.+++.+||+.||++|||+.|+++.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          263 IPVEELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             CCHHHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7666655555443211         111223347889999999999999999999999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.3e-46  Score=336.38  Aligned_cols=248  Identities=23%  Similarity=0.280  Sum_probs=200.8

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      +.|...+.||+|+||.||+|+ ..+|+.||+|.+........ ....+.+|+.+++.++||||+++++++..++..+++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            447888999999999999999 46899999999975433222 2235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||++ |++.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 678777754332   278999999999999999999999   999999999999999999999999999976543


Q ss_pred             --ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHH
Q 020027          219 --EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKP  296 (332)
Q Consensus       219 --~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                        ...||..|+|||.+.......++.++|||||||++|||+||+.||.+.........+.....     +...   +...
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~~---~~~~  278 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PALQ---SGHW  278 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCCC---CTTS
T ss_pred             CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----CCCC---CCCC
Confidence              33689999999998643346789999999999999999999999987654433333322211     1111   1122


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          297 LVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       297 ~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+.+++.+||+.||++|||++++++
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            346779999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6e-46  Score=333.69  Aligned_cols=246  Identities=20%  Similarity=0.209  Sum_probs=197.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+....... ....+.+|+.+++.++||||+++++++..++..+++|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            46789999999999999999994 589999999987543322 2245789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.... 
T Consensus        85 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             ECCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            99999999999875432    89999999999999999999998   99999999999999999999999999996532 


Q ss_pred             -------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH-HHHhhhcccccccCCcCC
Q 020027          218 -------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA-LPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       218 -------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  289 (332)
                             ....||..|+|||.+...  ...+.++|||||||++|||+||+.||.+...... .......        ...
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------~~~  227 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--------KTY  227 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCS--SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT--------CTT
T ss_pred             CCcccccCCCccCcCccCcHHhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc--------ccc
Confidence                   123689999999998752  3347899999999999999999999976433211 1111111        011


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+........+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1111222346779999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.3e-46  Score=333.68  Aligned_cols=262  Identities=22%  Similarity=0.304  Sum_probs=203.2

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ  129 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  129 (332)
                      ..+....++|...+.||+|+||.||+|...    ++..||+|.++...........+.+|+..++.++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            444455678888899999999999999842    4558999999765443333446789999999999999999999987


Q ss_pred             cCC-----ceeEEEeccCCCCHHHHhcccC--CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          130 APG-----ERIIVSEFINMASLDFYLHENN--DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       130 ~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      ..+     ..+++|||+++++|.+++....  .....+++..++.++.|++.||.|||++   +++||||||+||+++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            654     4599999999999999985422  1223489999999999999999999998   99999999999999999


Q ss_pred             CceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHH
Q 020027          203 FCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALP  273 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~  273 (332)
                      +.+||+|||++......        ..++..|+|||.+..   ..++.++||||||+++|||+| |..||.+........
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcC---CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            99999999998754322        245678999999876   678999999999999999999 888998765555444


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .+..+..         ...+......+.+++.+||+.||++|||+.++++.|++++.
T Consensus       261 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          261 YLLHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HHHTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            4433211         11112223478899999999999999999999999998763

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-46  Score=331.44  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=212.1

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      +++...++|...+.||+|+||.||+|.. .++..||+|.+....   .....+.+|+.+++.++||||+++++++..++.
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3445677889999999999999999995 468899999987532   223357899999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             EEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999976433  2388999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          214 FLAPEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       214 ~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      .......       .++..|+|||.+..   ..++.++||||||+++|||++ |..||.+.........+....      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~------  229 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------  229 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------
T ss_pred             eeccCCccccccCCccccCcCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC------
Confidence            7654322       34668999999876   678999999999999999999 999998765554444333321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                         ..+.+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       230 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence               111122233478899999999999999999999999998753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.2e-46  Score=331.09  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=201.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-----eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--C
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-----LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--G  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  132 (332)
                      .+.|...+.||+|+||.||+|+     ..+++.||+|.++.... ......+.+|+.+++.++||||+++++++..+  +
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            3457888999999999999998     34788999999976542 22234578999999999999999999999776  6


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             eEEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            68999999999999999965433   278999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHH------hhh
Q 020027          213 SFLAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPL------IKE  277 (332)
Q Consensus       213 a~~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~------~~~  277 (332)
                      +.....         ...++..|+|||.+..   ..++.++||||||+++|||+||..|+...........      ...
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQ---SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecC---CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            875432         2246777999999876   6778999999999999999999988654321111000      000


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .............+.+......+.+++.+||+.||++|||+.++++.|++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            00000111111222223334578899999999999999999999999998763

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-45  Score=330.85  Aligned_cols=245  Identities=20%  Similarity=0.255  Sum_probs=196.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccc--cccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ..++|...+.||+|+||.||+++.    .+|+.||+|.++......  .....+.+|+.+++.++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            356799999999999999999985    588999999998654322  22234678999999999999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            99999999999999999976533    78899999999999999999999   999999999999999999999999999


Q ss_pred             cccCC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          213 SFLAP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       213 a~~~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ++...      ....||..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+.....      
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------  238 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------  238 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTT---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------
T ss_pred             ccccccCCccccccCCCcCccCHhhCcC---CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------
Confidence            86532      12358999999999876   6789999999999999999999999988766555544444321      


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                        ..+.  .....+.+++.+||+.||++||     ++.|+++
T Consensus       239 --~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 --NLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --CCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --CCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              1111  1223678999999999999999     6777764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=358.17  Aligned_cols=242  Identities=19%  Similarity=0.298  Sum_probs=200.5

Q ss_pred             eeeccCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           68 IIGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        68 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .||+|+||.||+|..   .++..||||.++.... ......+.+|+.+++.++||||+++++++.. +..+++|||++++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            699999999999984   3566799999976532 2233468999999999999999999999976 5689999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCccc----
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK----  220 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~----  220 (332)
                      +|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......    
T Consensus       421 ~L~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          421 PLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             BHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             cHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            99999975432   389999999999999999999999   99999999999999999999999999997653221    


Q ss_pred             -----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          221 -----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       221 -----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                           .++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+.         ..+.+.
T Consensus       495 ~~~~~~~~~~y~APE~~~~---~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~---------~~~~p~  562 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------RMECPP  562 (613)
T ss_dssp             -------CCTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC---------CCCCCT
T ss_pred             eccCCCCccceeCHhhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------CCCCCC
Confidence                 24578999999876   678999999999999999998 999998876666655554432         112222


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .++.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            34457889999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.1e-46  Score=326.97  Aligned_cols=252  Identities=21%  Similarity=0.340  Sum_probs=207.6

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      +...++|...+.||+|+||.||+|...+++.||+|.+.....   ....+.+|+.+++.++||||+++++++.. +..++
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            344567889999999999999999988888999999875432   23357899999999999999999999864 45889


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+||++++++.+||+|||++...
T Consensus        85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            9999999999999975321  1278999999999999999999999   9999999999999999999999999998765


Q ss_pred             Ccc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          217 PEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       217 ~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ...       ..++..|+|||....   ..++.++||||||+++|||+| |+.||.+.........+..+.         
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---------  227 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------  227 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred             cCcccccccCCCCccCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc---------
Confidence            432       235678999999876   678899999999999999999 899998766555544443321         


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ....+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            11111222347889999999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-45  Score=332.25  Aligned_cols=257  Identities=26%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCE--EEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKL--VAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      ..++|...+.||+|+||.||+|+. .++..  +|+|.++.... ......+.+|+.+++++ +||||+++++++...+..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            346789999999999999999994 46664  49998874332 22334578999999999 899999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccC------------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          135 IIVSEFINMASLDFYLHENN------------DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      +++|||+++++|.+++....            .....+++..++.++.|++.||.|||++   +++||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999997643            1123489999999999999999999999   99999999999999999


Q ss_pred             CceEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhh
Q 020027          203 FCARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIK  276 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~  276 (332)
                      +.+||+|||+++.....     ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+.........+.
T Consensus       179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CeEEEcccCcCccccccccccCCCCCccccChhhhcc---ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            99999999998744322     245778999999876   568899999999999999998 999998876655544443


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      .+.         ....+......+.+++.+||+.||++|||+.++++.|+++++.
T Consensus       256 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          256 QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            321         1111222234788999999999999999999999999987643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=333.14  Aligned_cols=243  Identities=18%  Similarity=0.201  Sum_probs=193.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|+..+.||+|+||+||+|+. .+|+.||+|++...............|+..+..+ +||||+++++++...+..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            346788999999999999999995 4899999999876544333333455666655555 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+ +++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       135 v~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            99999 6789888876532   389999999999999999999998   9999999999999999999999999998765


Q ss_pred             Ccc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 PEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ...     ..||..|+|||.+..    .++.++|||||||++|||++|..|+.+....   ..+......    +...  
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~----~~~~--  274 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAPELLQG----SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLP----PEFT--  274 (311)
T ss_dssp             C------CCCCCGGGCCGGGGGT----CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCC----HHHH--
T ss_pred             ccCCCCcccCCCccccCHhHhcC----CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCC----cccc--
Confidence            432     257899999998763    6899999999999999999998776654321   112221111    0000  


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        ......+.+++.+||+.||++|||+.|+++
T Consensus       275 --~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 --AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              112246889999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-45  Score=325.54  Aligned_cols=253  Identities=19%  Similarity=0.196  Sum_probs=203.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||+|. ..+|+.||+|.+....    ....+.+|+..++.+ +|+|++++++++...+..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            35678999999999999999999 4689999999986432    233578999999999 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc-----eEEccCC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC-----ARVCDYG  211 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~dfg  211 (332)
                      +|||+ +++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.     +||+|||
T Consensus        84 v~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            99999 9999999986432   289999999999999999999998   9999999999999987765     9999999


Q ss_pred             ccccCCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh---HHHHHHHh
Q 020027          212 LSFLAPE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL---VKWALPLI  275 (332)
Q Consensus       212 ~a~~~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~---~~~~~~~~  275 (332)
                      ++.....             ...||..|+|||.+..   ..++.++||||||+++|||++|+.||.+..   .......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  233 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcC---CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence            9865432             2257899999999876   678999999999999999999999998632   22222222


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ......... +...    ...+..+.+++.+||+.||++|||++++++.|++++.
T Consensus       234 ~~~~~~~~~-~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          234 GEKKQSTPL-RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHSCH-HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HhhccCccH-HHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            211110000 0000    0122478899999999999999999999999998763

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.4e-46  Score=328.94  Aligned_cols=254  Identities=20%  Similarity=0.235  Sum_probs=207.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee--cCCceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ--APGERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  136 (332)
                      .++|...+.||+|+||.||++.. .+++.||+|.+............+.+|+..++.++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46788999999999999999994 58899999999865544444446789999999999999999999874  4578899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eeecCCCCCCEEeCCCCceEEccCC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN-----IIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-----ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      +|||+++++|.+++.........+++..++.++.|++.||.|||+.   +     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999976433333489999999999999999999998   7     9999999999999999999999999


Q ss_pred             ccccCCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          212 LSFLAPEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       212 ~a~~~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ++......      ..++..|+|||.+..   ..++.++||||||+++|||+||+.||.+.........+..+....   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---  235 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNR---MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---  235 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHC---C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred             hheeeccccccccccCCCccccChHHhcc---CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---
Confidence            98765432      257889999999876   578999999999999999999999998876655555554443211   


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                          .  +.....++.+++.+||+.||++|||+.|+++.+...
T Consensus       236 ----~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          236 ----I--PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             ----C--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             ----C--CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                1  112234788999999999999999999999876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-45  Score=324.38  Aligned_cols=244  Identities=21%  Similarity=0.316  Sum_probs=203.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.+....... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4678899999999999999998 4578899999986543222 2233578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999976533    78999999999999999999998   99999999999999999999999999986554


Q ss_pred             cc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          218 EE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       218 ~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                      ..    ..++..|+|||.+..   ..++.++||||||+++|||++|..||.+....+....+.....        ..+  
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~--  227 (279)
T 3fdn_A          161 SSRRTDLCGTLDYLPPEMIEG---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------TFP--  227 (279)
T ss_dssp             -------CCCCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------CCC--
T ss_pred             cccccccCCCCCccCHhHhcc---CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------CCC--
Confidence            32    367899999999876   6778999999999999999999999988766655554443221        111  


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          228 DFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            112236779999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.9e-46  Score=332.38  Aligned_cols=264  Identities=21%  Similarity=0.316  Sum_probs=215.1

Q ss_pred             CChHHHHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccce
Q 020027           51 YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI  124 (332)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  124 (332)
                      +..++++...++|...+.||+|+||.||+|...      +++.||+|.+..... ......+.+|+.+++.++||||+++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCEeee
Confidence            334566677788999999999999999999843      477899999875432 2223357899999999999999999


Q ss_pred             eeeeecCCceeEEEeccCCCCHHHHhcccCC------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEE
Q 020027          125 LGFSQAPGERIIVSEFINMASLDFYLHENND------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNIL  198 (332)
Q Consensus       125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  198 (332)
                      ++++...+..+++|||+++++|.+++.....      ....+++..++.++.|++.||.|||++   +++||||||+||+
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence            9999999999999999999999999875321      112368899999999999999999999   9999999999999


Q ss_pred             eCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHH
Q 020027          199 LNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVK  269 (332)
Q Consensus       199 l~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~  269 (332)
                      ++.++.+||+|||++......        ..++..|+|||.+..   ..++.++||||||+++|||+| |..||.+....
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc---CCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence            999999999999998754322        134678999999876   678999999999999999999 88999877665


Q ss_pred             HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          270 WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .....+..+....         .+......+.+++.+||+.||++|||+.|+++.|++++.
T Consensus       248 ~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 QVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            5555444432111         112223468899999999999999999999999998765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.9e-45  Score=338.25  Aligned_cols=240  Identities=21%  Similarity=0.295  Sum_probs=195.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccC-CCCCccceeeeeecCCcee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  135 (332)
                      ..++|...+.||+|+||.||+|+ ..+++.||+|++++...... ....+.+|..++..+ +||||+++++++..++..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            45679999999999999999999 45788999999986544332 223467888888876 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++|+|..++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       130 lV~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999999976543    89999999999999999999999   999999999999999999999999999975


Q ss_pred             CC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH---------HHHHHHhhhccc
Q 020027          216 AP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV---------KWALPLIKEMRF  280 (332)
Q Consensus       216 ~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~---------~~~~~~~~~~~~  280 (332)
                      ..      ....||+.|+|||.+..   ..++.++|+|||||++|||++|+.||.+...         +.....+...  
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--  277 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--  277 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--
T ss_pred             cccCCCccccccCCcccCCchhhcC---CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--
Confidence            22      22368999999999876   6789999999999999999999999964311         1122222221  


Q ss_pred             ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                            .+..+..  ...++.+++.+||+.||++||++
T Consensus       278 ------~~~~p~~--~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 ------QIRIPRS--LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------CCCCCTT--SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------ccCCCCc--CCHHHHHHHHHHhcCCHhHcCCC
Confidence                  2222222  23367899999999999999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.1e-46  Score=347.06  Aligned_cols=245  Identities=19%  Similarity=0.259  Sum_probs=198.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||+|+ ..+|+.||+|.++...... .....+.+|+.+++.++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            34678899999999999999999 5689999999997543222 223356789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +|||+++++|.+++.....    +++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.+||+|||+++.
T Consensus       226 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            9999999999999976543    8899999999999999999998 7   999999999999999999999999999975


Q ss_pred             CCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          216 APE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       216 ~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ...      ...||..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+.....        .
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------~  367 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------R  367 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------C
T ss_pred             ccCCCcccccccCCccccCHhhcCC---CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------C
Confidence            322      2368999999999876   6789999999999999999999999988766655555444321        1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      .+..  ....+.+++.+||+.||++||     |++|+++
T Consensus       368 ~p~~--~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCTT--SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCcc--CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            1111  223678999999999999999     9999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=330.37  Aligned_cols=263  Identities=19%  Similarity=0.267  Sum_probs=210.0

Q ss_pred             CChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec
Q 020027           51 YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA  130 (332)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  130 (332)
                      ....+.+...++|...+.||+|+||.||+|....  .+|+|.++...........+.+|+..++.++||||+++++++..
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            3445666778899999999999999999998743  49999998665444444567889999999999999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      ++..+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++ ++.+||+||
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCC---CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence            9999999999999999999976432   378899999999999999999999   999999999999998 679999999


Q ss_pred             CccccCCc-----------ccCCcccccCcccccccC------CCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH
Q 020027          211 GLSFLAPE-----------EKRGLAGYVDDDYWHEKG------GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP  273 (332)
Q Consensus       211 g~a~~~~~-----------~~~~~~~~~~pe~~~~~~------~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~  273 (332)
                      |++.....           ...++..|+|||.+....      ...++.++||||||+++|||+||+.||.+........
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  253 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW  253 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            98764321           124788999999886421      2457899999999999999999999998876665554


Q ss_pred             HhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .+..+.......        ......+.+++.+||+.||++|||+.++++.|+++..
T Consensus       254 ~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          254 QMGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HHHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             HhccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            444332111110        0112257799999999999999999999999998864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9e-46  Score=359.89  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=202.6

Q ss_pred             ceeeccCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||.||+|.+   .+++.||||.++...........+.+|+.+++.++||||+++++++.. +..+++|||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999963   356789999998654444344568999999999999999999999975 457899999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE----  219 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~----  219 (332)
                      ++|.+++.....    +++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus       454 g~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCCC----CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999976433    78999999999999999999999   9999999999999999999999999998754322    


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ..++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+..         .+.+
T Consensus       527 ~~~~~~~~t~~y~APE~~~~---~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---------~~~p  594 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------MGCP  594 (635)
T ss_dssp             --------CGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------CCCC
T ss_pred             ccccCCCCceeeeChhhhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------CCCC
Confidence                 135678999999976   678999999999999999998 9999998777666655554321         1122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ..++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            233457889999999999999999999999999865

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=330.13  Aligned_cols=254  Identities=20%  Similarity=0.234  Sum_probs=198.9

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.||+|+||.||+|.. .+|+.||+|.+............+.+|+.+++.++||||+++++++...+..+++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            5788899999999999999995 579999999987654333333457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..... 
T Consensus        83 ~~~~~~l~~~~~~~~~----~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQRG----VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTSSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhhcC----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999988865432    78999999999999999999999   999999999999999999999999999976542 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc--c----------c
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR--F----------S  281 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~----------~  281 (332)
                           ...++..|+|||.+...  ..++.++||||||+++|||+||+.||.+....+....+....  .          .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ----------GGGCCHHHHHTC--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             ccccCCCcCCccccChHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence                 23578899999998642  567999999999999999999999998765544433222110  0          0


Q ss_pred             cc-cCCcCCCCC---C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 EL-LDPRLAIPC---E-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~-~~~~~~~~~---~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .. .......+.   +     ......+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00 000000000   0     112335789999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9e-46  Score=337.47  Aligned_cols=248  Identities=21%  Similarity=0.243  Sum_probs=191.9

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+++. .+++.||+|.+.....   ....+.+|+..++.++||||+++++++..++..+++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            457899999999999999999994 5899999999975432   223468999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc--eEEccCCcccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC--ARVCDYGLSFL  215 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~dfg~a~~  215 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+||+++.++.  +||+|||+++.
T Consensus        95 ~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           95 MEYASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEeCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            999999999999976443    89999999999999999999999   9999999999999987765  99999999874


Q ss_pred             CC-----cccCCcccccCcccccccCCCCCC-chhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          216 AP-----EEKRGLAGYVDDDYWHEKGGGNAT-RESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       216 ~~-----~~~~~~~~~~~pe~~~~~~~~~~~-~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ..     ....||+.|+|||.+..   ..++ .++|||||||++|||++|+.||.+............    ........
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~  240 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLR---QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ----RILSVKYS  240 (361)
T ss_dssp             -------------CTTSCHHHHHC---SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH----HHHTTCCC
T ss_pred             ccccCCCCCCcCCCCcCChhhhcC---CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH----HHhcCCCC
Confidence            32     22368999999999876   4454 449999999999999999999986533221111111    11111222


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+........+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          241 IPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            2222222347789999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-45  Score=324.29  Aligned_cols=249  Identities=21%  Similarity=0.248  Sum_probs=199.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||++. ..++..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3568889999999999999999 46789999999876542 222345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe---CCCCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~  215 (332)
                      ||+++++|.+++.........+++..++.++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999998865322223389999999999999999999999   99999999999999   4567899999999976


Q ss_pred             CCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ...     ...++..|+|||.+.    ..++.++||||||+++|||++|+.||.+................      ...
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------~~~  246 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFK----RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN------YAV  246 (285)
T ss_dssp             ----------CTTGGGCCHHHHT----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------CCC
T ss_pred             cCCcccCcCcccccCcCChHHhc----cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc------ccc
Confidence            432     235789999999875    46789999999999999999999999887655544333322111      110


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .. ......+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~-~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 EC-RPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc-CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 011236779999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-45  Score=346.30  Aligned_cols=245  Identities=22%  Similarity=0.315  Sum_probs=204.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+....... .....+.+|+.+++.++||||+++++++..++..+++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46789999999999999999995 589999999997543222 2223578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        95 ~E~~~gg~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTTSSSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999975432    89999999999999999999998   99999999999999999999999999997654


Q ss_pred             c-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          218 E-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       218 ~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      .     ...||+.|+|||.+...  ...+.++||||+||++|||++|+.||.+.........+..+..        ..+.
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------~~p~  237 (476)
T 2y94_A          168 DGEFLRTSCGSPNYAAPEVISGR--LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------YTPQ  237 (476)
T ss_dssp             TTCCBCCCCSCSTTCCHHHHTTC--CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--------CCCT
T ss_pred             ccccccccCCCcCeEChhhccCC--CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--------CCCc
Confidence            3     23689999999998762  2347899999999999999999999987665555544444321        1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .....+.+++.+||+.||++|||+.|+++
T Consensus       238 --~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          238 --YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              11236789999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.5e-45  Score=334.51  Aligned_cols=241  Identities=20%  Similarity=0.241  Sum_probs=200.8

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccC-CCCCccceeeeeecCCce
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGER  134 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  134 (332)
                      ...++|...+.||+|+||.||+|+. .+|+.||+|.+++..... .....+..|..++..+ +||||+++++++...+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            4467899999999999999999995 468899999997653322 2233467889999887 799999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            999999999999999976543    88999999999999999999999   99999999999999999999999999987


Q ss_pred             cCC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          215 LAP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       215 ~~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ...      ....||+.|+|||.+..   ..++.++|+|||||++|||++|+.||.+.........+.....        
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------  238 (353)
T 2i0e_A          170 ENIWDGVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------  238 (353)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTT---CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             ccccCCcccccccCCccccChhhhcC---CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--------
Confidence            532      22368999999999876   6789999999999999999999999998776666555554321        


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      ..+.  ....++.+++.+||+.||++||++
T Consensus       239 ~~p~--~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          239 AYPK--SMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             CCCT--TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             CCCC--CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            1111  223367899999999999999964

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-46  Score=335.58  Aligned_cols=261  Identities=17%  Similarity=0.158  Sum_probs=195.5

Q ss_pred             hHHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           53 LTEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      ........++|...+.||+|+||.||+|. ..+++.||+|.++...........+.+|+.+++.++||||+++++++..+
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            33445567789999999999999999998 56889999999976654444444578999999999999999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe-----CCCCceE
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL-----NEKFCAR  206 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-----~~~~~~k  206 (332)
                      +..+++|||++ ++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||+     +.++.+|
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEE
T ss_pred             CEEEEEEecCC-CCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEE
Confidence            99999999997 599999976543    78999999999999999999999   99999999999999     4555699


Q ss_pred             EccCCccccCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-c
Q 020027          207 VCDYGLSFLAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-R  279 (332)
Q Consensus       207 l~dfg~a~~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~  279 (332)
                      |+|||++.....      ...+|..|+|||.+...  ..++.++|||||||++|||++|+.||.+.........+... .
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          178 IGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             ECCTTHHHHHC-----------CCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ECcCCCccccCCcccccCCCcCCccccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            999999865432      22568899999998652  45899999999999999999999999876554443332211 0


Q ss_pred             cc--ccc---------CCcCC-C-CCCh------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 FS--ELL---------DPRLA-I-PCEI------KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ~~--~~~---------~~~~~-~-~~~~------~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..  ...         ..... . ....      ....++.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00  000         00000 0 0000      02346789999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.9e-46  Score=331.67  Aligned_cols=260  Identities=24%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeee
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFS  128 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  128 (332)
                      ++...++|...+.||+|+||.||+|..      .+++.||+|.++..... .....+.+|+.+++.+ +||||+++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            344567889999999999999999983      35679999999755321 2234578999999999 999999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCCC--------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCC
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENNDG--------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKA  194 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~  194 (332)
                      ..++..+++|||+++++|.+++......              ...+++..++.++.|++.||.|||++   +++||||||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence            9999999999999999999999765321              12378999999999999999999999   999999999


Q ss_pred             CCEEeCCCCceEEccCCccccCCccc--------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCc
Q 020027          195 SNILLNEKFCARVCDYGLSFLAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEG  265 (332)
Q Consensus       195 ~Nill~~~~~~kl~dfg~a~~~~~~~--------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~  265 (332)
                      +||+++.++.+||+|||++.......        .++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999987654322        34668999998876   678999999999999999999 9999976


Q ss_pred             hhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ................        ...+......+.+++.+||+.||++|||+.|+++.|+++++
T Consensus       251 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          251 MPVDSKFYKMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             CCSSHHHHHHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchhHHHHHhccCCC--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            5432222211111111        11112223478899999999999999999999999998874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.8e-46  Score=326.69  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=200.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCC-------CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STG-------KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      .++|...+.||+|+||.||+|.. .++       ..||+|.+.....  .....+.+|+.+++.++||||+++++++..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            45788889999999999999984 334       4799999865432  2233578999999999999999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc-------
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC-------  204 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------  204 (332)
                      +..+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.       
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            999999999999999999976432   278999999999999999999999   9999999999999988876       


Q ss_pred             -eEEccCCccccCCcc--cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCC-CCCchhHHHHHHHhhhccc
Q 020027          205 -ARVCDYGLSFLAPEE--KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR-CEEGLLVKWALPLIKEMRF  280 (332)
Q Consensus       205 -~kl~dfg~a~~~~~~--~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~-p~~~~~~~~~~~~~~~~~~  280 (332)
                       +||+|||++......  ..++..|+|||.+...  ..++.++|||||||++|||+||.. |+...............  
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~--  234 (289)
T 4fvq_A          159 FIKLSDPGISITVLPKDILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR--  234 (289)
T ss_dssp             EEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCG--GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--
T ss_pred             eeeeccCcccccccCccccCCcCcccCHHHhCCC--CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc--
Confidence             999999998765433  2578899999998753  468899999999999999999554 55444333332222211  


Q ss_pred             ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                           .......    ..++.+++.+||+.||++|||+.++++.|+++..
T Consensus       235 -----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          235 -----HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -----CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -----CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                 0111111    1257789999999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-46  Score=337.74  Aligned_cols=260  Identities=23%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeC-CC-----CEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLS-TG-----KLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGF  127 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  127 (332)
                      .++...++|...+.||+|+||.||+|... ++     ..||+|.+..... ......+.+|+.+++.+ +||||++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            45566788999999999999999999942 33     4799999875432 12233578999999999 89999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCC----------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCE
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENND----------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNI  197 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  197 (332)
                      +..++..+++|||+++++|.+++.....          ....+++..++.++.|++.||.|||++   +++||||||+||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV  195 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence            9999999999999999999999875321          012378999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhH
Q 020027          198 LLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLV  268 (332)
Q Consensus       198 ll~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~  268 (332)
                      +++.++.+||+|||++......        ..++..|+|||.+..   ..++.++|||||||++|||+| |..||.+...
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc---CCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            9999999999999999754322        234668999999876   678999999999999999999 8899976543


Q ss_pred             HHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          269 KWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ............        ....+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       273 ~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          273 NSKFYKLVKDGY--------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             SHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            322222211111        11111122347889999999999999999999999999865

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=332.45  Aligned_cols=245  Identities=19%  Similarity=0.215  Sum_probs=189.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..+.|...+.||+|+||.||+|+. .+++.||+|.++...    ....+.+|+.+++.++||||+++++++..++..+++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            456788899999999999999995 478899999997543    223467899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a~  214 (332)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||++   +++||||||+||+++.   ++.+||+|||+++
T Consensus       127 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            99999999999997543    278999999999999999999999   9999999999999975   8899999999987


Q ss_pred             cCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH-HHHHhhhcccccccCCcC
Q 020027          215 LAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW-ALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       215 ~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  288 (332)
                      .....     ..||..|+|||.+..   ..++.++|||||||++|||+||..||.+..... ....+......      .
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~------~  270 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY------F  270 (349)
T ss_dssp             -------------CGGGSCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC------C
T ss_pred             ccCcccccccccCCCCccCHHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc------c
Confidence            65432     357899999999876   678999999999999999999999997654332 33333332211      1


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+........+.+++.+||+.||++|||+.|+++
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111223347889999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.8e-45  Score=325.20  Aligned_cols=257  Identities=22%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ...++|...+.||+|+||.||+|.. .+++.||+|.+......... ...+.+|+..++.++||||+++++++..++..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            3457899999999999999999994 57889999999765432221 235789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....    +++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus       111 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEEEecCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            99999999999999986532    78999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          216 APEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       216 ~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ....       ..++..|+|||.+..   ..++.++||||||+++|||+||+.||.+.........+.... ..   +. 
T Consensus       184 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~---~~-  255 (309)
T 2h34_A          184 TTDEKLTQLGNTVGTLYYMAPERFSE---SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PR---PS-  255 (309)
T ss_dssp             -------------CCGGGCCGGGTCC-------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC-CC---GG-
T ss_pred             ccccccccccccCCCcCccCHHHHcC---CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC-CC---cc-
Confidence            4332       257889999999876   678899999999999999999999998876553333222211 00   00 


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccccC
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRP-SIVQVATILNNLVGD  331 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RP-s~~~i~~~L~~~~~~  331 (332)
                        ..+...+..+.+++.+||+.||++|| |++++++.|++.+..
T Consensus       256 --~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          256 --TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             --GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             --ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence              00111223678999999999999999 999999999988754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-46  Score=342.16  Aligned_cols=260  Identities=20%  Similarity=0.166  Sum_probs=199.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCC------CCEEEEEEeccCccccc---------ccccHHHHHHHhccCCCCCcc
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLST------GKLVAVKRIHPRLVLSN---------AGFGFASVIKTLSLAQHPNIV  122 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv  122 (332)
                      ...++|...+.||+|+||.||+|...+      ++.||+|.+........         .......|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            345689999999999999999998543      47899999875432110         111234556677788999999


Q ss_pred             ceeeeeecC----CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEE
Q 020027          123 PILGFSQAP----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNIL  198 (332)
Q Consensus       123 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  198 (332)
                      ++++++...    ...+++|||+ +++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil  184 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL  184 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence            999998664    4579999999 9999999976432   389999999999999999999999   9999999999999


Q ss_pred             eC--CCCceEEccCCccccCCcc-------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          199 LN--EKFCARVCDYGLSFLAPEE-------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       199 l~--~~~~~kl~dfg~a~~~~~~-------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                      ++  .++.+||+|||+++.....             ..||..|+|||.+..   ..++.++|||||||++|||+||+.||
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG---VAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC---CCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            98  8899999999999654321             138999999999876   67899999999999999999999999


Q ss_pred             CchhHHHHHHHhh----hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          264 EGLLVKWALPLIK----EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       264 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .+...+.......    ........++.+...   ..+.++.+++..||+.||++|||+.++++.|++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             GGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHHHHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            8643222111111    111122222222111   123478899999999999999999999999998763

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.6e-45  Score=332.35  Aligned_cols=239  Identities=22%  Similarity=0.307  Sum_probs=195.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      .++|...+.||+|+||.||+|+. .+++.||+|.+++...... ....+.+|..+++.+ +||||+++++++..++..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            45788899999999999999994 5789999999986543322 223467889999887 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999999999999976533    88999999999999999999999   9999999999999999999999999999753


Q ss_pred             C------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch---------hHHHHHHHhhhcccc
Q 020027          217 P------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL---------LVKWALPLIKEMRFS  281 (332)
Q Consensus       217 ~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~---------~~~~~~~~~~~~~~~  281 (332)
                      .      ....||+.|+|||.+..   ..++.++|+|||||++|||++|+.||...         ........+...   
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---  234 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---  234 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---
T ss_pred             cCCCCcccccCCCccccCccccCC---CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---
Confidence            2      22368999999999876   67899999999999999999999999642         111122222221   


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                           ....+.  .....+.+++.+||+.||++||++
T Consensus       235 -----~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          235 -----QIRIPR--SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCCCC--CCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 112222  223367899999999999999996

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-46  Score=339.23  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=192.7

Q ss_pred             CCCCCceeeccCCeEEEEEEeC--CC--CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee-cCCceeE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLS--TG--KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ-APGERII  136 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~l  136 (332)
                      .|...+.||+|+||.||+|...  ++  ..||+|.++... .......+.+|+.++++++||||+++++++. .++..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            3555678999999999999842  22  368999886432 2223345789999999999999999999875 4567899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       169 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999975432   278899999999999999999999   9999999999999999999999999999754


Q ss_pred             Ccc----------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          217 PEE----------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       217 ~~~----------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ...          ..++..|+|||.+..   ..++.++|||||||++|||+| |..||.+.........+..+.      
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~------  313 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------  313 (373)
T ss_dssp             ---------------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC------
T ss_pred             cccccccccccCCCCCcccccChHHhcC---CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC------
Confidence            221          235678999999876   678999999999999999999 677776654433333333321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                       .  ...+..++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       314 -~--~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 -R--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -C--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             1  11112233478899999999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.3e-46  Score=332.32  Aligned_cols=260  Identities=20%  Similarity=0.236  Sum_probs=203.4

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee----cCC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ----APG  132 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~  132 (332)
                      ...++|...+.||+|+||.||++.. .+++.||+|.+.....  .....+.+|+.+++.++||||+++++++.    ..+
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            3456799999999999999999994 6899999999865322  22335789999999999999999999986    335


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++++|.+++.........+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            78999999999999999976433334489999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCcc---------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH--HHHHHh
Q 020027          213 SFLAPEE---------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK--WALPLI  275 (332)
Q Consensus       213 a~~~~~~---------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~--~~~~~~  275 (332)
                      +......               ..++..|+|||.+.......++.++||||||+++|||++|+.||......  .....+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            8654321               13588999999986532234688999999999999999999999653211  111111


Q ss_pred             hhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          276 KEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      ..         ....+........+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       261 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          261 QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            11         111122222334788999999999999999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-45  Score=336.02  Aligned_cols=246  Identities=22%  Similarity=0.197  Sum_probs=196.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHH-hccCCCCCccceeeeeecCCcee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKT-LSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ..++|...+.||+|+||.||+|+. .+++.||+|.+++...... ....+.+|..+ ++.++||||+++++++...+..+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            456799999999999999999994 5788999999986543322 22345666665 56789999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       116 lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            99999999999999976543    78899999999999999999999   999999999999999999999999999875


Q ss_pred             CC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          216 AP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       216 ~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ..      ....||+.|+|||.+..   ..++.++|+|||||++|||++|..||.+....+....+.....        .
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------~  257 (373)
T 2r5t_A          189 NIEHNSTTSTFCGTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------Q  257 (373)
T ss_dssp             GBCCCCCCCSBSCCCCCCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--------C
T ss_pred             cccCCCccccccCCccccCHHHhCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------C
Confidence            32      22368999999999876   6789999999999999999999999988776666655554321        1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .+.  .....+.+++.+||+.||++||++.+.++.
T Consensus       258 ~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          258 LKP--NITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             CCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             CCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence            111  122367899999999999999998644433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3e-45  Score=326.98  Aligned_cols=258  Identities=19%  Similarity=0.259  Sum_probs=198.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ...++|...+.||+|+||.||+|. ..+|+.||+|.++...... .....+.+|+..++.++||||+++++++...+..+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            345679999999999999999999 4689999999997543222 22335789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999975332233488999999999999999999999   999999999999999999999999999875


Q ss_pred             CCcc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH--HHHHHhhhcccccccCCc
Q 020027          216 APEE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK--WALPLIKEMRFSELLDPR  287 (332)
Q Consensus       216 ~~~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  287 (332)
                      ....      ..++..|++||.+..   ..++.++||||||+++|||++|+.||.+....  .....+.......     
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  257 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-----  257 (310)
T ss_dssp             -------------CCSSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-----
T ss_pred             ecCCCccccccCCCeeEeChHHhCC---CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-----
Confidence            4332      257889999999876   67899999999999999999999999764221  1222222221111     


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                         .........+.+++.+||+.||++|||+.++++.|+++.
T Consensus       258 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          258 ---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             ---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence               111122346889999999999999999999999998875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-45  Score=329.15  Aligned_cols=248  Identities=19%  Similarity=0.226  Sum_probs=204.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc----ccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN----AGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+........    ....+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45688899999999999999994 5789999999986543322    123478999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC----ceEEccC
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF----CARVCDY  210 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~df  210 (332)
                      +++|||+++++|.+++....    .+++..+..++.|++.||.|||++   +++||||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999997543    278999999999999999999999   999999999999999887    7999999


Q ss_pred             CccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          211 GLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       211 g~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      |++......     ..++..|+|||.+..   ..++.++||||||+++|||+||+.||.+.........+......  .+
T Consensus       164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~  238 (321)
T 2a2a_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--FD  238 (321)
T ss_dssp             TTCEECCTTCCCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CC
T ss_pred             ccceecCccccccccCCCCCccCcccccC---CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--cC
Confidence            998765432     358899999999875   67899999999999999999999999887665555444432211  00


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +...    ......+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          239 EEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000    011236789999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=324.34  Aligned_cols=250  Identities=18%  Similarity=0.276  Sum_probs=203.4

Q ss_pred             cCCCCCCc-eeeccCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRR-IIGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|.... .||+|+||.||+|..   .++..||+|.++.... ......+.+|+.+++.++||||+++++++ ..+..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            34555665 899999999999984   3677899999976532 22233578999999999999999999999 455689


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCCc---cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            99999999999999965332   389999999999999999999999   999999999999999999999999999875


Q ss_pred             CCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          216 APEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       216 ~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....         ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+.........+..+..     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-----  231 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  231 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred             eccCcceeeccccccccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-----
Confidence            4321         135678999999876   578899999999999999999 9999987655555444443221     


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                          .+.+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       232 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          232 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                1111223347889999999999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=330.70  Aligned_cols=241  Identities=21%  Similarity=0.236  Sum_probs=199.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc------ccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN------AGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      ..++|...+.||+|+||.||+|+ ..+++.||+|.++.......      ....+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35679999999999999999999 56889999999986543222      233568899999999999999999999999


Q ss_pred             CceeEEEeccCCC-CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          132 GERIIVSEFINMA-SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       132 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      +..+++|||+.+| +|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999998776 99999976543    89999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          211 GLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       211 g~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      |++......     ..||..|+|||.+...  ...+.++|||||||++|||++|+.||.+....              ..
T Consensus       175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~  238 (335)
T 3dls_A          175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VE  238 (335)
T ss_dssp             TTCEECCTTCCBCEECSCGGGCCHHHHTTC--CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TT
T ss_pred             ccceECCCCCceeccCCCccccChhhhcCC--CCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------Hh
Confidence            999765433     2589999999998762  23488999999999999999999999763210              01


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .....+..  ....+.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~--~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 AAIHPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TCCCCSSC--CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hccCCCcc--cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111111  22368899999999999999999999873

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3e-45  Score=329.51  Aligned_cols=245  Identities=19%  Similarity=0.265  Sum_probs=193.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  132 (332)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|+++.... ......+.+|+.+++.++||||+++++++...+      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            35688889999999999999995 4899999999975432 223345789999999999999999999885443      


Q ss_pred             ---------------------------------------------------ceeEEEeccCCCCHHHHhcccCCCCCcCC
Q 020027          133 ---------------------------------------------------ERIIVSEFINMASLDFYLHENNDGASLLD  161 (332)
Q Consensus       133 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~  161 (332)
                                                                         ..+++|||+++++|.+++..... ....+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  162 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE  162 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence                                                               37999999999999999986543 23357


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc------------------cCCc
Q 020027          162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE------------------KRGL  223 (332)
Q Consensus       162 ~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~------------------~~~~  223 (332)
                      +..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.....                  ..||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            778899999999999999999   9999999999999999999999999998765432                  2588


Q ss_pred             ccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHH
Q 020027          224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKV  303 (332)
Q Consensus       224 ~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  303 (332)
                      ..|+|||.+..   ..++.++|||||||++|||++|..|+....  ............         .........+.++
T Consensus       240 ~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~~~~~l  305 (332)
T 3qd2_B          240 KLYMSPEQIHG---NNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFP---------LLFTQKYPQEHMM  305 (332)
T ss_dssp             GGGSCHHHHHC---CCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHTTCCC---------HHHHHHCHHHHHH
T ss_pred             cCccChHHhcC---CCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhccCCC---------cccccCChhHHHH
Confidence            99999999876   678999999999999999999877653321  111111111110         0011223466799


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 020027          304 ALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       304 ~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +.+||+.||++|||+.|+++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHccCCCCcCCCHHHHhh
Confidence            99999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.3e-45  Score=346.56  Aligned_cols=248  Identities=21%  Similarity=0.233  Sum_probs=207.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|+. .+++.||+|.+............+.+|+.+++.++||||+++++++...+..+++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            346789999999999999999994 5899999999976544344445678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC---CCCceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN---EKFCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a~  214 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999998876533    89999999999999999999999   999999999999995   45679999999997


Q ss_pred             cCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          215 LAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       215 ~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .....     ..||+.|+|||.+..    .++.++||||+||++|||++|..||.+....+....+..+.+..      .
T Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------~  242 (486)
T 3mwu_A          173 CFQQNTKMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------D  242 (486)
T ss_dssp             TBCCC----CCTTGGGGCCGGGGGS----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------C
T ss_pred             ECCCCCccCCCcCCCCCCCHHHhCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------C
Confidence            54332     358999999999864    58999999999999999999999999877766666665543221      1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+........+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111223347889999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=324.31  Aligned_cols=257  Identities=20%  Similarity=0.225  Sum_probs=197.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc---cccccHHHHHHHhccC---CCCCccceeeeeec
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS---NAGFGFASVIKTLSLA---QHPNIVPILGFSQA  130 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~  130 (332)
                      ...++|...+.||+|+||.||+|+ ..+++.||+|.++......   .....+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            446789999999999999999999 4689999999997543221   1122456777777666   49999999999976


Q ss_pred             CC-----ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCce
Q 020027          131 PG-----ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA  205 (332)
Q Consensus       131 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  205 (332)
                      ..     ..+++|||+. ++|.+++......  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            54     4789999996 6999999765432  389999999999999999999999   99999999999999999999


Q ss_pred             EEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-
Q 020027          206 RVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-  279 (332)
Q Consensus       206 kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-  279 (332)
                      ||+|||+++.....     ..+|..|+|||.+..   ..++.++|||||||++|||++|+.||.+.........+.... 
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  236 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT---SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999999765432     357899999999876   678999999999999999999999998776555444332210 


Q ss_pred             ------ccccc---CCcCC--CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ------FSELL---DPRLA--IPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ------~~~~~---~~~~~--~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            +....   ...+.  .+.+     ......+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                  00000   00000  0000     112346789999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.7e-45  Score=346.80  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=200.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .+.|...+.||+|+||.||+|+. .++..||+|.+............+.+|+.+++.++||||+++++++...+..+++|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            34688899999999999999994 58899999999876544444556889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a~~  215 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|||++..
T Consensus       116 e~~~~g~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999988876533    78999999999999999999999   9999999999999976   45599999999876


Q ss_pred             CCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ...     ...||+.|+|||.+.    ..++.++||||+||++|||++|..||.+....+....+..+....      ..
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------~~  258 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLR----KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF------DS  258 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------CS
T ss_pred             CCCCccccccCCCcCeeCHHHHc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------Cc
Confidence            543     235899999999875    468999999999999999999999999887777666665543211      11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +........+.+++.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            111122346789999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-46  Score=332.38  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=197.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCc----
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGE----  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  133 (332)
                      .++|...+.||+|+||.||+++ ..+++.||+|.++........ ...+.+|+..++.++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            5679999999999999999999 478899999999765432222 2357899999999999999999999876543    


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....    +++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            4999999999999999976543    78999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          214 FLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       214 ~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      ......         ..|+..|+|||.+..   ..++.++||||||+++|||+||+.||.+.................  
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--  238 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--  238 (311)
T ss_dssp             ------------------CCTTCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--
T ss_pred             ccccccccccccccccCcCcccCCHHHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--
Confidence            754322         247899999999876   678999999999999999999999998766554433322211100  


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHHhcc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQ-VATILNNL  328 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~-i~~~L~~~  328 (332)
                       +.   .........+.+++.+||+.||++||++.+ +.+.+..+
T Consensus       239 -~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          239 -PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -HH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -cc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence             00   000112336889999999999999996555 44555443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=340.29  Aligned_cols=259  Identities=18%  Similarity=0.160  Sum_probs=207.7

Q ss_pred             hHHHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeec
Q 020027           53 LTEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQA  130 (332)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  130 (332)
                      +.+.....++|...+.||+|+||.||+++. .+|+.||+|++++.... ......+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            344555678999999999999999999995 58999999999754322 2233457899999999999999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      ++..+++|||+++|+|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999976432   288999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCc-------ccCCcccccCccccccc----CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc
Q 020027          211 GLSFLAPE-------EKRGLAGYVDDDYWHEK----GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR  279 (332)
Q Consensus       211 g~a~~~~~-------~~~~~~~~~~pe~~~~~----~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~  279 (332)
                      |+++....       ...||+.|+|||.+...    ....++.++|+|||||++|||++|+.||.+....+....+....
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  286 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK  286 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            99965432       23689999999998732    12568999999999999999999999998876666554443321


Q ss_pred             cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 020027          280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNR---PSIVQVAT  323 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~R---Ps~~~i~~  323 (332)
                      .. ..-+..    +.....++.+++.+||. +|++|   |+++|+++
T Consensus       287 ~~-~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          287 EH-LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH-CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cC-cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            00 000110    11122368899999999 99998   58888864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.9e-45  Score=329.67  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=202.5

Q ss_pred             CCCCceeeccCCeEEEEEEe-----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC--Ccee
Q 020027           63 FSHRRIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP--GERI  135 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  135 (332)
                      |...+.||+|+||.||++.+     .+++.||+|.++.... ......+.+|+.+++.++||||+++++++...  ...+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            48889999999999998863     3788999999975532 22233578999999999999999999999774  5789


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ++|||+++++|.+++....     +++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999997643     78999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH------Hhhhccc
Q 020027          216 APEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP------LIKEMRF  280 (332)
Q Consensus       216 ~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~------~~~~~~~  280 (332)
                      ....         ..++..|+|||.+..   ..++.++||||||+++|||+||+.||..........      .......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKE---YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            5432         246777999999876   678899999999999999999999987643321100      0000011


Q ss_pred             ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .+.+......+.+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111122222333334457889999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.5e-45  Score=323.03  Aligned_cols=251  Identities=24%  Similarity=0.310  Sum_probs=202.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ..++|...+.||+|+||.||+|...    ++..||+|.+..... ......+.+|+.+++.++||||+++++++..+ ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            4567889999999999999999843    234699999876532 22234578999999999999999999998654 56


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            899999999999999976532   278999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          215 LAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       215 ~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      .....       ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||...........+.....      
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~------  232 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINF---RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR------  232 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC------
T ss_pred             ccccccccccccCCCCcceeCchhhcc---CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC------
Confidence            65432       245678999999876   678999999999999999998 9999976554444443333211      


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                         .+.+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          233 ---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence               1111122346889999999999999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=332.04  Aligned_cols=248  Identities=19%  Similarity=0.263  Sum_probs=196.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC--CCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH--PNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l  136 (332)
                      ..+.|...+.||+|+||.||++...+++.||+|.+............+.+|+.+++.++|  +||+++++++..++..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            456789999999999999999998889999999997654433333457899999999976  999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +||+ .+++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++ ++.+||+|||+++..
T Consensus        87 v~e~-~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EECC-CSEEHHHHHHHSCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEeC-CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            9995 57899999986543    78999999999999999999999   999999999999996 678999999999765


Q ss_pred             Cc--------ccCCcccccCccccccc--------CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH-HHHHhhhcc
Q 020027          217 PE--------EKRGLAGYVDDDYWHEK--------GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW-ALPLIKEMR  279 (332)
Q Consensus       217 ~~--------~~~~~~~~~~pe~~~~~--------~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~-~~~~~~~~~  279 (332)
                      ..        ...||+.|+|||.+...        ....++.++|||||||++|||++|+.||.+..... ....+.   
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---  234 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---  234 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---
Confidence            32        23589999999998641        12568899999999999999999999997642211 111111   


Q ss_pred             cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           ++......+......+.+++.+||+.||++|||+.|+++
T Consensus       235 -----~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          235 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                 111111222222346789999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.8e-45  Score=333.12  Aligned_cols=263  Identities=19%  Similarity=0.178  Sum_probs=205.2

Q ss_pred             cCCChHHHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCC-----CCCcc
Q 020027           49 FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-----HPNIV  122 (332)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  122 (332)
                      ..++..+.....++|...+.||+|+||.||+|+. .+++.||+|.++...   .....+..|+.+++.++     ||||+
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3445556666778999999999999999999994 688999999986432   12224567888888775     99999


Q ss_pred             ceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-
Q 020027          123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-  201 (332)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-  201 (332)
                      ++++++...+..+++|||+ +++|.+++......  .+++..+..++.|++.||.|||++   +|+||||||+|||++. 
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence            9999999999999999999 89999999865432  378999999999999999999999   9999999999999975 


Q ss_pred             ------------------------CCceEEccCCccccCCc---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHH
Q 020027          202 ------------------------KFCARVCDYGLSFLAPE---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLL  254 (332)
Q Consensus       202 ------------------------~~~~kl~dfg~a~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~  254 (332)
                                              ++.+||+|||++.....   ...||..|+|||.+..   ..++.++|||||||++|
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILN---LGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTT---CCCCTTHHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcC---CCCCCccchHHHHHHHH
Confidence                                    78899999999976543   2368999999999876   67899999999999999


Q ss_pred             HHHhCCCCCCchhHHHHHHHhhhcc--cc-------------cccC-C--cCCCCC---ChH---------------HHH
Q 020027          255 EILSGRRCEEGLLVKWALPLIKEMR--FS-------------ELLD-P--RLAIPC---EIK---------------PLV  298 (332)
Q Consensus       255 el~tg~~p~~~~~~~~~~~~~~~~~--~~-------------~~~~-~--~~~~~~---~~~---------------~~~  298 (332)
                      ||+||+.||.+.........+....  ..             ...+ .  ....+.   ...               ...
T Consensus       251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            9999999998765544433332210  00             0000 0  000000   000               014


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          299 RLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       299 ~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.+++.+||+.||++|||++|+++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhc
Confidence            5779999999999999999999874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-45  Score=338.91  Aligned_cols=255  Identities=23%  Similarity=0.288  Sum_probs=191.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCC--ce
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPG--ER  134 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~  134 (332)
                      ..++|...+.||+|+||.||+|. ..+|+.||+|++............+.+|+.+++.+. ||||+++++++..++  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            45689999999999999999999 568999999999755443344445789999999997 999999999997544  68


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||++ ++|..++...     .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999997 6899888753     278899999999999999999999   99999999999999999999999999997


Q ss_pred             cCCc---------------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh
Q 020027          215 LAPE---------------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL  267 (332)
Q Consensus       215 ~~~~---------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~  267 (332)
                      ....                           ...||..|+|||.+...  ..++.++||||+||++|||++|+.||.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5421                           12588999999988653  578999999999999999999999998765


Q ss_pred             HHHHHHHhhhc-ccc--c----ccCC----------------cCCCC--------------CChHHHHHHHHHHHHcccC
Q 020027          268 VKWALPLIKEM-RFS--E----LLDP----------------RLAIP--------------CEIKPLVRLAKVALACVGN  310 (332)
Q Consensus       268 ~~~~~~~~~~~-~~~--~----~~~~----------------~~~~~--------------~~~~~~~~l~~l~~~c~~~  310 (332)
                      .......+... ...  +    ...+                .....              ........+.+++.+||+.
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            55444333210 000  0    0000                00000              0001234678999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 020027          311 SRKNRPSIVQVATI  324 (332)
Q Consensus       311 dp~~RPs~~~i~~~  324 (332)
                      ||++|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999998763

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-45  Score=339.06  Aligned_cols=246  Identities=19%  Similarity=0.257  Sum_probs=195.3

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC--CCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ--HPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  138 (332)
                      +.|...+.||+|+||.||++...+++.||+|.+............+.+|+.+++.++  ||||+++++++..++..+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458899999999999999999777999999999765443333446789999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      | +.+++|.+++....    .+++..+..++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||+++....
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 56789999998654    278889999999999999999998   999999999999995 57899999999976432


Q ss_pred             --------ccCCcccccCccccccc--------CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccc
Q 020027          219 --------EKRGLAGYVDDDYWHEK--------GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFS  281 (332)
Q Consensus       219 --------~~~~~~~~~~pe~~~~~--------~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~  281 (332)
                              ...||+.|+|||.+...        ....++.++|||||||++|||++|+.||.+.... .....+..    
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~----  282 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----  282 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence                    23589999999998642        1246899999999999999999999999764221 11111111    


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +....+.+......+.+++.+||+.||++|||+.|+++
T Consensus       283 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          283 ----PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ----TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                11111111112346789999999999999999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.9e-45  Score=323.19  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCC----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeee-ecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS-QAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~  134 (332)
                      ..+|...+.||+|+||.||+|...+    +..+|+|.+..... ......+.+|+.++++++||||+++++++ ..++..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            4567888999999999999998432    23589998875322 22233578999999999999999999986 455678


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            999999999999999975432   378999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCcc----------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccc
Q 020027          215 LAPEE----------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSEL  283 (332)
Q Consensus       215 ~~~~~----------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      ...+.          ..++..|+|||.+..   ..++.++||||||+++|||++ |.+||.+.........+..+..   
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---  250 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  250 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred             cccccchhccccccCCCCCccccChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence            54322          235678999999876   678999999999999999999 5566665444333333333211   


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                            ...+......+.+++.+||+.||++|||++|+++.|+++..
T Consensus       251 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          251 ------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                  11111223468899999999999999999999999998764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=334.33  Aligned_cols=241  Identities=19%  Similarity=0.188  Sum_probs=193.8

Q ss_pred             CceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCCC
Q 020027           66 RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .+.||+|+||.||+|. ..+|+.||+|.++....  .....+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            4679999999999999 46899999999976532  22335789999999999999999999999999999999999999


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe--CCCCceEEccCCccccCCcc---
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL--NEKFCARVCDYGLSFLAPEE---  219 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~~~kl~dfg~a~~~~~~---  219 (332)
                      +|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++.....   
T Consensus       172 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          172 ELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             EEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            9998886532   2378999999999999999999999   99999999999999  56789999999999765432   


Q ss_pred             --cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          220 --KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       220 --~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                        ..||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....+... ...     .....
T Consensus       246 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~-----~~~~~  316 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNY---DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE-DEE-----FQDIS  316 (373)
T ss_dssp             CCCCSSCTTCCHHHHTT---CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-SGG-----GTTSC
T ss_pred             ccccCCCcEeChhhccC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-hhh-----hccCC
Confidence              258899999998865   6789999999999999999999999988766655555544322110 000     01122


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .++.+++.+||+.||.+|||+.|+++
T Consensus       317 ~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          317 EEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            46889999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-45  Score=331.76  Aligned_cols=259  Identities=18%  Similarity=0.165  Sum_probs=203.8

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc---ccccccHHHHHHHhccCCCCCccceeeeeec
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL---SNAGFGFASVIKTLSLAQHPNIVPILGFSQA  130 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  130 (332)
                      .+....++|...+.||+|+||.||+|. ..+++.||+|.+......   ......+.+|+.+++.++||||+++++++..
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            344566778999999999999999999 468889999998754321   2223357899999999999999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCC------------------------------------CCcCCHHHHHHHHHHHHH
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDG------------------------------------ASLLDWNRRLRIATGAAR  174 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~  174 (332)
                      .+..+++|||+++++|.+++......                                    ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998631100                                    112356778889999999


Q ss_pred             HHHHhhcCCCCCeeecCCCCCCEEeCCCC--ceEEccCCccccCCc----------ccCCcccccCcccccccCCCCCCc
Q 020027          175 GLEYLHQGVAPNIIHGCIKASNILLNEKF--CARVCDYGLSFLAPE----------EKRGLAGYVDDDYWHEKGGGNATR  242 (332)
Q Consensus       175 ~l~~Lh~~~~~~ivH~dlk~~Nill~~~~--~~kl~dfg~a~~~~~----------~~~~~~~~~~pe~~~~~~~~~~~~  242 (332)
                      ||.|||++   +++||||||+||+++.++  .+||+|||++.....          ...+|+.|+|||.+... ...++.
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  255 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-NESYGP  255 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-SSCCCT
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-CCCCCc
Confidence            99999999   999999999999998766  899999999875321          23588999999988632 246789


Q ss_pred             hhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       243 ~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                      ++|||||||++|||++|+.||.+....+....+......      ...+........+.+++.+||+.||++|||+.+++
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            999999999999999999999887665554444432211      11111111234788999999999999999999998


Q ss_pred             H
Q 020027          323 T  323 (332)
Q Consensus       323 ~  323 (332)
                      +
T Consensus       330 ~  330 (345)
T 3hko_A          330 Q  330 (345)
T ss_dssp             H
T ss_pred             c
Confidence            6

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1e-45  Score=332.66  Aligned_cols=260  Identities=24%  Similarity=0.325  Sum_probs=204.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee--cCC
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ--APG  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~  132 (332)
                      .++|...+.||+|+||.||+|+.     .+++.||+|.+.....  .....+.+|+.+++.++||||+++++++.  ..+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            46788899999999999999983     4788999999875432  22235789999999999999999999886  456


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             eEEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            68999999999999999976432   279999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-----
Q 020027          213 SFLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-----  278 (332)
Q Consensus       213 a~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-----  278 (332)
                      +......         ..++..|+|||.+..   ..++.++||||||+++|||++|..||...............     
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSD---NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL  250 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhcc---CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence            9754322         246677999999876   56789999999999999999999998765443221110000     


Q ss_pred             -ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          279 -RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       279 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                       ...+........+.+......+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             0011111122222333444578899999999999999999999999998864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.3e-45  Score=338.77  Aligned_cols=252  Identities=22%  Similarity=0.256  Sum_probs=193.0

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc------ccccccHHHHHHHhccCCCCCccceeeeeec
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL------SNAGFGFASVIKTLSLAQHPNIVPILGFSQA  130 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  130 (332)
                      ...++|...+.||+|+||.||+|. ..+++.||+|.+......      ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            446789999999999999999998 567899999999764321      1122357899999999999999999999865


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC---CceEE
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK---FCARV  207 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl  207 (332)
                      + ..+++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.+   +.+||
T Consensus       212 ~-~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 E-DYYIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             S-EEEEEEECCTTCBGGGGTSSSCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             C-ceEEEEEcCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence            4 57899999999999998875432    89999999999999999999999   99999999999999754   45999


Q ss_pred             ccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccc
Q 020027          208 CDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFS  281 (332)
Q Consensus       208 ~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~  281 (332)
                      +|||+++.....     ..||+.|+|||.+.......++.++|||||||++|||+||..||.+.... .....+..+...
T Consensus       284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~  363 (419)
T 3i6u_A          284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  363 (419)
T ss_dssp             CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred             eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence            999999876443     25899999999986544467889999999999999999999999764322 112222222111


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..  +.    ........+.+++.+||+.||++|||+.|+++
T Consensus       364 ~~--~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 FI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC--ch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00  00    00112346889999999999999999999886

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=321.39  Aligned_cols=249  Identities=20%  Similarity=0.274  Sum_probs=197.3

Q ss_pred             CCCCCceeeccCCeEEEEEEe-CCCC---EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce-eE
Q 020027           62 GFSHRRIIGQGRLGTVYAALL-STGK---LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER-II  136 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~-~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~l  136 (332)
                      .|...+.||+|+||.||+|.. .+++   .||+|.+..... ......+.+|+.+++.++||||+++++++...+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            455568899999999999984 3333   799999865322 22233578999999999999999999999766554 99


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+.+++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus       101 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999999999976432   378999999999999999999999   9999999999999999999999999998643


Q ss_pred             Cc----------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCC-CCchhHHHHHHHhhhcccccccC
Q 020027          217 PE----------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-EEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       217 ~~----------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ..          ...++..|++||....   ..++.++||||||+++|||+||..| |.+.........+....      
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------  245 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQT---YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR------  245 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTT---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC------
T ss_pred             cCCcccccccCcCCCCCccccChhhhcc---CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC------
Confidence            22          1246778999999876   6789999999999999999995554 55444433333333321      


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                         ..+.+......+.+++.+||+.||++|||+.++++.|++++
T Consensus       246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               11112222347889999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-45  Score=329.77  Aligned_cols=264  Identities=26%  Similarity=0.380  Sum_probs=210.1

Q ss_pred             CChHHHHHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccc
Q 020027           51 YPLTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVP  123 (332)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~  123 (332)
                      +...++....++|...+.||+|+||.||+|..      .+++.||+|.++.... ......+.+|+.+++.+ +||||++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeee
Confidence            34456666778999999999999999999973      3568999999975432 22223578999999999 7999999


Q ss_pred             eeeeeecCC-ceeEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeec
Q 020027          124 ILGFSQAPG-ERIIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHG  190 (332)
Q Consensus       124 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~  190 (332)
                      +++++..++ ..+++|||+++++|.+++......            ...+++..++.++.|++.||.|||++   +++||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999987654 589999999999999999765431            11278899999999999999999999   99999


Q ss_pred             CCCCCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCC
Q 020027          191 CIKASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRR  261 (332)
Q Consensus       191 dlk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~  261 (332)
                      ||||+||+++.++.+||+|||+++.....        ..++..|+|||.+..   ..++.++||||||+++|||+| |..
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc---ccccchhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999754322        235678999999876   678999999999999999999 999


Q ss_pred             CCCchhHH-HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          262 CEEGLLVK-WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       262 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ||.+.... .....+..+..       ...  +......+.+++.+||+.||++|||+.|+++.|++++.
T Consensus       250 p~~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          250 PYPGVKIDEEFCRRLKEGTR-------MRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             SSTTCCCSHHHHHHHHHTCC-------CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccchhHHHHHHhccCcc-------CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            99765422 22222222211       111  11123368899999999999999999999999998763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-45  Score=322.60  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=200.1

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-CceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-GERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~l  136 (332)
                      ...++|...+.||+|+||.||+|.. +|+.||+|.++...    ....+.+|+.+++.++||||+++++++... +..++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            3456789999999999999999987 48899999987432    233578999999999999999999987544 57899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....  ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        93 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            9999999999999975421  2268889999999999999999999   9999999999999999999999999998755


Q ss_pred             Ccc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          217 PEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       217 ~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                      ...   ..++..|+|||.+..   ..++.++||||||+++|||+| |+.||.+.........+..+.         ....
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------~~~~  235 (278)
T 1byg_A          168 SSTQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------KMDA  235 (278)
T ss_dssp             --------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------CCCC
T ss_pred             cccccCCCccccccCHHHhCC---CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------CCCC
Confidence            432   246788999999876   678999999999999999998 999998765554444333321         1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            1223347889999999999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.9e-45  Score=341.85  Aligned_cols=251  Identities=18%  Similarity=0.193  Sum_probs=194.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------C
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------G  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  132 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|++............+.+|+.+++.++||||+++++++...      +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4679999999999999999998 56789999999976543333344678999999999999999999998654      3


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++ ++.+.+...      +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~~------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            56999999975 466666421      78999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc--------
Q 020027          213 SFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR--------  279 (332)
Q Consensus       213 a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--------  279 (332)
                      ++.....     ..+|..|+|||.+..   ..++.++||||+||++|||++|+.||.+......+..+....        
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          211 ARTAGTSFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             C-----CCCC----CCCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeecCCCcccCCCcccccccCHHHHcC---CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9765433     368999999999876   678999999999999999999999998865444433322100        


Q ss_pred             ------cccccCCcCC--------------CCCCh----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ------FSELLDPRLA--------------IPCEI----KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ------~~~~~~~~~~--------------~~~~~----~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            ..........              .+...    .....+.+++.+||+.||++|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  0000000000              00010    11456889999999999999999999886

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-44  Score=322.09  Aligned_cols=246  Identities=19%  Similarity=0.231  Sum_probs=203.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+++. .+|+.||+|.++.....  ....+.+|+.+++.++||||+++++++...+..+++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            45688899999999999999994 58999999999754322  2234789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe---CCCCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~  215 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++..
T Consensus        86 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           86 QLVSGGELFDRILERGV----YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EcCCCccHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            99999999999876532    78999999999999999999999   99999999999999   7789999999999876


Q ss_pred             CCccc----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          216 APEEK----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       216 ~~~~~----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .....    .++..|+|||.+..   ..++.++||||||+++|||++|..||.+.........+..+...      ...+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~------~~~~  229 (304)
T 2jam_A          159 EQNGIMSTACGTPGYVAPEVLAQ---KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE------FESP  229 (304)
T ss_dssp             CCCBTTHHHHSCCCBCCTTTBSS---CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC------CCTT
T ss_pred             cCCCccccccCCCCccChHHhcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC------CCcc
Confidence            54432    47899999999876   67899999999999999999999999877665555555443221      1111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ........+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          230 FWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122347889999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.7e-45  Score=322.27  Aligned_cols=247  Identities=19%  Similarity=0.259  Sum_probs=199.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+............+.+|+..+..+ +||||+++++++..++..+++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            45688899999999999999995 5899999999986654444445678899999888 899999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC----------------
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE----------------  201 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----------------  201 (332)
                      |||+++++|.+++.........+++..++.++.|++.||.|||++   +++||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999976432223389999999999999999999999   9999999999999984                


Q ss_pred             ---CCceEEccCCccccCCcc--cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhh
Q 020027          202 ---KFCARVCDYGLSFLAPEE--KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK  276 (332)
Q Consensus       202 ---~~~~kl~dfg~a~~~~~~--~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~  276 (332)
                         ...+||+|||.+......  ..++..|+|||.+...  ..+++++|||||||++|||++|.+++.....   ...+.
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~  241 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQEN--YTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIR  241 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTC--CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHH
T ss_pred             cCCceEEEEcccccccccCCccccCCCccccChhHhcCC--CCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHH
Confidence               447999999998765433  3588999999998752  4567899999999999999999987755422   12222


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+...     .+  +  ......+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~-----~~--~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          242 QGRLP-----RI--P--QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             TTCCC-----CC--S--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCC-----CC--C--cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            22211     11  1  112236889999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.3e-45  Score=345.00  Aligned_cols=247  Identities=24%  Similarity=0.290  Sum_probs=206.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+....... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            45688899999999999999994 589999999997654332 2334578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe---CCCCceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~  214 (332)
                      |||+.+++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||++.
T Consensus       105 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSC----CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999998875432    88999999999999999999999   99999999999999   467899999999987


Q ss_pred             cCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          215 LAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       215 ~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      .....     ..||+.|+|||.+..    .++.++||||+||++|||++|..||.+....+....+..+....      .
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------~  247 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF------E  247 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHHT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------C
T ss_pred             EcccccccccCCCCccccCceeecC----CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------C
Confidence            65432     258999999998863    58899999999999999999999999887776666665543221      1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+........+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1111223347889999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=325.54  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=194.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .++|...+.||+|+||.||+|+. .++.||+|.+...    .....+.+|+..+++++||||+++++++.+  ..+++||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            45688889999999999999987 4788999998643    223457899999999999999999998874  4789999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc-eEEccCCccccCCc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC-ARVCDYGLSFLAPE  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~dfg~a~~~~~  218 (332)
                      |+++++|.+++..... ...+++..++.++.|+++||.|||+....+++||||||+||+++.++. +||+|||++.....
T Consensus        80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             CCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             cCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999999976432 223688899999999999999999932239999999999999988876 79999999875433


Q ss_pred             ---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH--HHHHHhhhcccccccCCcCCCCCC
Q 020027          219 ---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK--WALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 ---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                         ...|+..|+|||.+..   ..++.++||||||+++|||+||+.||......  ........+..     +.    ..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~----~~  226 (307)
T 2eva_A          159 HMTNNKGSAAWMAPEVFEG---SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-----PP----LI  226 (307)
T ss_dssp             ------CCTTSSCHHHHTC---CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-----CC----CB
T ss_pred             ccccCCCCCceEChhhhCC---CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-----CC----cc
Confidence               2358999999999875   67899999999999999999999999753221  11111111110     11    11


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ......+.+++.+||+.||++|||++++++.|+.+.
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            122346789999999999999999999999998865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.5e-45  Score=327.49  Aligned_cols=256  Identities=18%  Similarity=0.212  Sum_probs=206.9

Q ss_pred             HHHHHhcCCCCCC-ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeec
Q 020027           54 TEIDAATDGFSHR-RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQA  130 (332)
Q Consensus        54 ~~~~~~~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  130 (332)
                      ...+...+.|... +.||+|+||.||+|. ..+++.||+|.+............+.+|+.++..+ +||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            4445556667766 889999999999999 45799999999986654444445678999999988 56999999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEE
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARV  207 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl  207 (332)
                      .+..+++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+||+++.   ++.+||
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence            9999999999999999999865322  2389999999999999999999999   9999999999999987   789999


Q ss_pred             ccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          208 CDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       208 ~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      +|||+++.....     ..++..|+|||.+..   ..++.++||||||+++|||+||+.||.+.........+...... 
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-  251 (327)
T 3lm5_A          176 VDFGMSRKIGHACELREIMGTPEYLAPEILNY---DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-  251 (327)
T ss_dssp             CCGGGCEEC---------CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-
T ss_pred             eeCccccccCCccccccccCCcCccCCeeecC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc-
Confidence            999999765432     258999999999876   67899999999999999999999999887665554444332211 


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           ...+........+.+++.+||+.||++|||+.++++
T Consensus       252 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          252 -----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                 111111223346789999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-44  Score=317.83  Aligned_cols=243  Identities=21%  Similarity=0.287  Sum_probs=195.9

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec----CCceeE
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA----PGERII  136 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  136 (332)
                      .|...+.||+|+||.||+|. ..++..||+|.+............+.+|+.+++.++||||+++++++..    .+..++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            46667789999999999999 4678899999997655444444467899999999999999999998864    356899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeecCCCCCCEEeC-CCCceEEccCCcc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN--IIHGCIKASNILLN-EKFCARVCDYGLS  213 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~dfg~a  213 (332)
                      +|||+++++|.+++.....    +++..+..++.|++.||.|||++   +  ++||||||+||+++ .++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHHccC----CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999976433    78999999999999999999998   7  99999999999998 7899999999999


Q ss_pred             ccCCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-HHHHHHhhhcccccccCCcC
Q 020027          214 FLAPEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-KWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       214 ~~~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ......    ..++..|+|||.+.    ..++.++||||||+++|||+||+.||.+... ......+..+....    ..
T Consensus       180 ~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~  251 (290)
T 1t4h_A          180 TLKRASFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----SF  251 (290)
T ss_dssp             GGCCTTSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----GG
T ss_pred             ccccccccccccCCcCcCCHHHHh----ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc----cc
Confidence            654433    35889999999876    3589999999999999999999999976432 22222222221111    01


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +......+.+++.+||+.||++|||+.|+++
T Consensus       252 ----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          252 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                1111236889999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=327.73  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=195.6

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|...+.||+|+||.||+|+. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..+++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            5688899999999999999995 58899999999754422 222245679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      |++ ++|.+++.....   .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..... 
T Consensus        81 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CCS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             ccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            997 588888876433   378999999999999999999999   999999999999999999999999999875432 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-------cccccC-
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-------FSELLD-  285 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~-  285 (332)
                           ...+|..|+|||.+...  ..++.++|||||||++|||+||+.||.+....+....+....       +..... 
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             ---------CGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             ccccccccCcccccChhhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence                 22568899999988652  568999999999999999999999998876655544332210       000000 


Q ss_pred             --------CcCCCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 --------PRLAIP----CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 --------~~~~~~----~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                              +.....    ........+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                    000000    00112346789999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=325.31  Aligned_cols=267  Identities=21%  Similarity=0.306  Sum_probs=199.8

Q ss_pred             CChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhcc--CCCCCccceeeee
Q 020027           51 YPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL--AQHPNIVPILGFS  128 (332)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~  128 (332)
                      .+........++|...+.||+|+||.||+|+.. ++.||+|.+....     ...+..|..++..  ++||||+++++++
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            344444555678999999999999999999874 8899999986432     1223445555444  4899999999998


Q ss_pred             ecC----CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeecCCCCCCEEe
Q 020027          129 QAP----GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV-----APNIIHGCIKASNILL  199 (332)
Q Consensus       129 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill  199 (332)
                      ...    +..+++|||+++++|.++++...     +++..++.++.|++.||.|||++.     .++++||||||+||++
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence            776    67899999999999999997542     789999999999999999999752     3389999999999999


Q ss_pred             CCCCceEEccCCccccCCc----------ccCCcccccCcccccccCCCCCCc------hhhhHHHHHHHHHHHhC----
Q 020027          200 NEKFCARVCDYGLSFLAPE----------EKRGLAGYVDDDYWHEKGGGNATR------ESDVYGFGVVLLEILSG----  259 (332)
Q Consensus       200 ~~~~~~kl~dfg~a~~~~~----------~~~~~~~~~~pe~~~~~~~~~~~~------~~DiwS~G~il~el~tg----  259 (332)
                      +.++.+||+|||++.....          ...||..|+|||.+...   ..+.      ++|||||||++|||+||    
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES---LNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC---CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc---cCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            9999999999999864322          23588999999998763   3333      49999999999999999    


Q ss_pred             ------CCCCCchhHHH-HHHHhhhcccccccCCcCCC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          260 ------RRCEEGLLVKW-ALPLIKEMRFSELLDPRLAI-PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       260 ------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                            ..||....... ...............+.... .....+..++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence                  56665421110 00111110001111111111 11235677899999999999999999999999999998754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.9e-45  Score=319.66  Aligned_cols=244  Identities=21%  Similarity=0.260  Sum_probs=203.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+. .+++.||+|.+........ ....+.+|+.+++.++||||+++++++...+..+++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            46788999999999999999994 5788999999875432222 223578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            999999999999976543    78999999999999999999998   99999999999999999999999999986543


Q ss_pred             c----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          218 E----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       218 ~----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                      .    ...++..|+|||.+..   ..++.++||||||+++|||++|..||.+.........+....        ...+. 
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~-  233 (284)
T 2vgo_A          166 SLRRRTMCGTLDYLPPEMIEG---KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--------LKFPP-  233 (284)
T ss_dssp             SSCBCCCCSCGGGCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------CCCCT-
T ss_pred             ccccccccCCCCcCCHHHhcc---CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--------cCCCC-
Confidence            3    2357889999999876   678899999999999999999999998765555444333321        11111 


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .....+.+++.+||+.||++|||+.++++
T Consensus       234 -~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          234 -FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence             12236789999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.9e-45  Score=319.60  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=202.2

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc----ccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN----AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ++|...+.||+|+||.||+++. .+|+.||+|.++.......    ....+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            4688889999999999999995 4799999999976543322    1235789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC----ceEEccCC
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF----CARVCDYG  211 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~dfg  211 (332)
                      ++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999976432    78999999999999999999999   999999999999998877    89999999


Q ss_pred             ccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          212 LSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       212 ~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ++......     ..++..|+|||.+..   ..++.++||||||+++|||++|..||.+.........+.......  .+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~  232 (283)
T 3bhy_A          158 IAHKIEAGNEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF--DE  232 (283)
T ss_dssp             TCEECC--------CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--CH
T ss_pred             cceeccCCCcccccCCCcCccCcceecC---CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC--cc
Confidence            98765332     257889999998875   678999999999999999999999998876555544443322110  00


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..    .......+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          233 EY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00    0111236789999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-45  Score=331.38  Aligned_cols=255  Identities=21%  Similarity=0.254  Sum_probs=199.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+............+.+|+.+++.++||||+++++++...+..+++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            46788889999999999999994 57999999998765433333335678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.++......    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHSTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999887654332    89999999999999999999999   999999999999999999999999999965432


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--------------
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--------------  278 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--------------  278 (332)
                            ...++..|+|||.+...  ..++.++|||||||++|||++|+.||.+....+....+...              
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             CccccCCCcCCccccCcccccCC--CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence                  23578899999998652  46889999999999999999999999876544332222110              


Q ss_pred             -c-cccccCCcCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 -R-FSELLDPRLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 -~-~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       . +.....+......+     ......+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             0 00000111111111     122347889999999999999999998875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.2e-45  Score=327.98  Aligned_cols=258  Identities=23%  Similarity=0.268  Sum_probs=206.1

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP  131 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  131 (332)
                      ...++|...+.||+|+||.||+|+.      .+++.||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            3457899999999999999999983      3577899999964432 22233578999999999999999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCC---CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCce
Q 020027          132 GERIIVSEFINMASLDFYLHENNDG---ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCA  205 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~  205 (332)
                      +..+++|||+++++|.+++......   ...+++..++.++.|++.||.|||++   +++||||||+||+++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence            9999999999999999999865421   13478999999999999999999999   9999999999999984   4569


Q ss_pred             EEccCCccccCC--------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhh
Q 020027          206 RVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIK  276 (332)
Q Consensus       206 kl~dfg~a~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~  276 (332)
                      ||+|||++....        ....++..|+|||.+..   ..++.++||||||+++|||+| |..||.+.........+.
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            999999986422        12246778999999876   678999999999999999999 999998766555554444


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      .+...         ..+......+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       260 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          260 SGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            43211         11112234788999999999999999999999999887543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.6e-44  Score=317.13  Aligned_cols=245  Identities=20%  Similarity=0.179  Sum_probs=202.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||+|. ..++..+|+|.+......  ....+.+|+.+++.++||||+++++++...+..+++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            4568889999999999999999 456789999998754332  2335789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe---CCCCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~  215 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++..
T Consensus        86 e~~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             ECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eccCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999998876543    78999999999999999999999   99999999999999   7889999999999865


Q ss_pred             CCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ...     ...++..|+|||.+..    .++.++||||||+++|||+||+.||.+....+....+..+.....      .
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~  228 (277)
T 3f3z_A          159 FKPGKMMRTKVGTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP------E  228 (277)
T ss_dssp             CCTTSCBCCCCSCTTTCCHHHHTT----CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------H
T ss_pred             ccCccchhccCCCCCccChHHhcc----cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------c
Confidence            432     2358899999998753    488999999999999999999999988766665555544321110      0


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .........+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000012346789999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-44  Score=325.32  Aligned_cols=263  Identities=22%  Similarity=0.306  Sum_probs=205.6

Q ss_pred             CCChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhcc--CCCCCccceeee
Q 020027           50 AYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL--AQHPNIVPILGF  127 (332)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~  127 (332)
                      ..|........++|...+.||+|+||.||+|+. +|+.||+|.+....     ...+.+|..++..  ++||||++++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            445555556677899999999999999999997 58999999986432     2345677777765  789999999999


Q ss_pred             eecCC----ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeeecCCCCC
Q 020027          128 SQAPG----ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH--------QGVAPNIIHGCIKAS  195 (332)
Q Consensus       128 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~  195 (332)
                      +...+    ..+++|||+++++|.+++....     +++..++.++.|++.||.|||        +.   +++||||||+
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~  176 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK  176 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhccC-----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence            98775    7899999999999999997542     789999999999999999999        77   9999999999


Q ss_pred             CEEeCCCCceEEccCCccccCCc----------ccCCcccccCcccccccCCC---CCCchhhhHHHHHHHHHHHhC---
Q 020027          196 NILLNEKFCARVCDYGLSFLAPE----------EKRGLAGYVDDDYWHEKGGG---NATRESDVYGFGVVLLEILSG---  259 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~----------~~~~~~~~~~pe~~~~~~~~---~~~~~~DiwS~G~il~el~tg---  259 (332)
                      ||+++.++.+||+|||++.....          ...++..|+|||.+......   .++.++|||||||++|||+||   
T Consensus       177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~  256 (342)
T 1b6c_B          177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  256 (342)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence            99999999999999999865332          22588999999998753111   234789999999999999999   


Q ss_pred             -------CCCCCchh-----HHHHHHHhhhcccccccCCcCCCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          260 -------RRCEEGLL-----VKWALPLIKEMRFSELLDPRLAIP-CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       260 -------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                             ..||.+..     .......+...    ...+.+... .+......+.+++.+||+.||++|||+.++++.|+
T Consensus       257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CCcccccccCccccCcCcccHHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                   67776532     11222222111    111111110 12356678999999999999999999999999999


Q ss_pred             cccc
Q 020027          327 NLVG  330 (332)
Q Consensus       327 ~~~~  330 (332)
                      ++..
T Consensus       333 ~i~~  336 (342)
T 1b6c_B          333 QLSQ  336 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=321.58  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=183.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||+|.. .+|+.||+|.+........ ....+.+|+.+++.++||||+++++++...+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            346788999999999999999994 6899999999975432222 22357899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            9999999999999975422   378999999999999999999999   9999999999999999999999999998764


Q ss_pred             Cc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          217 PE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       217 ~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..      ...++..|+|||.+..   ..++.++||||||+++|||+||+.||...........+.        ......
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~  231 (278)
T 3cok_A          163 KMPHEKHYTLCGTPNYISPEIATR---SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--------LADYEM  231 (278)
T ss_dssp             C-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--------SSCCCC
T ss_pred             cCCCCcceeccCCCCcCCcchhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--------hcccCC
Confidence            32      2357889999998876   567899999999999999999999997653322221111        111111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +  ......+.+++.+||+.||++|||++++++
T Consensus       232 ~--~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 P--SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C--TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c--cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1  122346789999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.4e-45  Score=346.03  Aligned_cols=248  Identities=20%  Similarity=0.217  Sum_probs=202.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-----------cccccHHHHHHHhccCCCCCccceee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-----------NAGFGFASVIKTLSLAQHPNIVPILG  126 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~~~~  126 (332)
                      ..++|...+.||+|+||.||+|. ..+++.||+|.+.......           .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999 4578999999997654321           12235789999999999999999999


Q ss_pred             eeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC---
Q 020027          127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF---  203 (332)
Q Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---  203 (332)
                      ++...+..+++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            99999999999999999999998876533    89999999999999999999999   999999999999998775   


Q ss_pred             ceEEccCCccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc
Q 020027          204 CARVCDYGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~  278 (332)
                      .+||+|||++.....     ...||+.|+|||.+.    ..++.++||||+||++|+|++|..||.+.........+..+
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc----cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            699999999976543     236899999999875    35899999999999999999999999988777776666554


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......      +.......++.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          263 KYYFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CCCCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            321100      000112246889999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-44  Score=320.29  Aligned_cols=244  Identities=20%  Similarity=0.267  Sum_probs=203.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||++.. .+++.||+|.+....... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            45788899999999999999994 578899999987654322 2233578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999999876432    78999999999999999999999   99999999999999999999999999987543


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .      ...++..|+|||.+..   ..++.++||||||+++|||+||+.||.+....+....+.....        ..+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~  235 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSK---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------SIP  235 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTT---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------CCC
T ss_pred             cCccccccccCCCCcCCcchhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--------CCc
Confidence            2      2257889999999876   5678999999999999999999999988765554444333211        111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .  .....+.+++.+||+.||++|||+.|+++
T Consensus       236 ~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          236 K--HINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             T--TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             c--ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            1  12236789999999999999999999886

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=333.77  Aligned_cols=258  Identities=21%  Similarity=0.183  Sum_probs=193.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCccccc---------ccccHHHHHHHhccCCCCCccceee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSN---------AGFGFASVIKTLSLAQHPNIVPILG  126 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~  126 (332)
                      .++|...+.||+|+||.||+|...    ++..+|+|..........         ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999954    678999999875532110         1123567888899999999999999


Q ss_pred             eeec----CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          127 FSQA----PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       127 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                      ++..    .+..+++|||+ +++|.+++....    .+++..++.++.|++.||.|||++   +|+||||||+||+++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            9877    67889999999 999999998654    389999999999999999999999   99999999999999887


Q ss_pred             C--ceEEccCCccccCC-------------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh
Q 020027          203 F--CARVCDYGLSFLAP-------------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL  267 (332)
Q Consensus       203 ~--~~kl~dfg~a~~~~-------------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~  267 (332)
                      +  .+||+|||+++...             ....+|..|+|||.+..   ..++.++|||||||++|||+||+.||.+..
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG---VALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            7  99999999996542             12258899999999876   678999999999999999999999996532


Q ss_pred             HHHH-HHHhhhcccccccCCcC-CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          268 VKWA-LPLIKEMRFSELLDPRL-AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       268 ~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .... ....... ......... ........+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       265 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          265 KDPVAVQTAKTN-LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TCHHHHHHHHHH-HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cccHHHHHHHHh-hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1111 1111110 000000000 00000012237889999999999999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=326.28  Aligned_cols=257  Identities=21%  Similarity=0.223  Sum_probs=194.9

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc---ccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN---AGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ...++|...+.||+|+||.||+|.. .+|+.||+|.+........   ....+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3457899999999999999999994 5799999999975433221   12357899999999999999999999999999


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++ +|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999975 88888865432   377888999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-------c
Q 020027          214 FLAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-------F  280 (332)
Q Consensus       214 ~~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~  280 (332)
                      +....      ...+|..|+|||.+...  ..++.++|||||||++|||++|..||.+.........+....       +
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eeccCCcccCCcccccccccCchHhhCC--CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            76532      23578899999988642  457899999999999999999999998766554443332210       0


Q ss_pred             ccccC-Cc-CC----CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 SELLD-PR-LA----IPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ~~~~~-~~-~~----~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..... +. ..    ...+     ......+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00000 00 00    0000     112347889999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-45  Score=333.73  Aligned_cols=256  Identities=16%  Similarity=0.196  Sum_probs=192.9

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec----
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA----  130 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----  130 (332)
                      ++...++|...+.||+|+||.||+|. ..+|+.||+|++.....      ...+|+.+++.++||||+++++++..    
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            34567789999999999999999998 57899999999864321      22579999999999999999999843    


Q ss_pred             ----------------------------------CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHH
Q 020027          131 ----------------------------------PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL  176 (332)
Q Consensus       131 ----------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l  176 (332)
                                                        ....+++|||++ ++|.+.+.........+++..+..++.|++.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              234789999998 577777764222223489999999999999999


Q ss_pred             HHhhcCCCCCeeecCCCCCCEEeC-CCCceEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHH
Q 020027          177 EYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFG  250 (332)
Q Consensus       177 ~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G  250 (332)
                      .|||+.   +|+||||||+||+++ .++.+||+|||+++.....     ..++..|+|||.+...  ..++.++||||+|
T Consensus       155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG  229 (383)
T 3eb0_A          155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA--TEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC--SSCCTHHHHHHHH
T ss_pred             HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC--CCCCcchhhhhHH
Confidence            999998   999999999999997 6889999999999754322     2578889999988652  4589999999999


Q ss_pred             HHHHHHHhCCCCCCchhHHHHHHHhhhc--------------ccccccCCcCCCC-----CChHHHHHHHHHHHHcccCC
Q 020027          251 VVLLEILSGRRCEEGLLVKWALPLIKEM--------------RFSELLDPRLAIP-----CEIKPLVRLAKVALACVGNS  311 (332)
Q Consensus       251 ~il~el~tg~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~d  311 (332)
                      |++|||++|+.||.+....+....+...              .+.+..-+.....     .+......+.+++.+||+.|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999999876554443332210              0000000000000     11112346889999999999


Q ss_pred             CCCCCCHHHHHH
Q 020027          312 RKNRPSIVQVAT  323 (332)
Q Consensus       312 p~~RPs~~~i~~  323 (332)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-44  Score=338.57  Aligned_cols=189  Identities=23%  Similarity=0.305  Sum_probs=152.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      .++|...+.||+|+||.||+|+ ..+++.||+|++............+.+|+.+++.++||||+++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            3679999999999999999998 55899999999976544333344678999999999999999999998433     56


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+ +++|..++....    .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 478998887543    289999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCc---------------------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh
Q 020027          214 FLAPE---------------------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS  258 (332)
Q Consensus       214 ~~~~~---------------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t  258 (332)
                      +....                                 ...||..|+|||.+...  ..++.++|||||||++|||+|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ--ENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC--CCCCcHhHHHHHHHHHHHHHH
Confidence            76431                                 12468889999986432  568999999999999999999

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=332.44  Aligned_cols=252  Identities=19%  Similarity=0.222  Sum_probs=198.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeC---------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccc-------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLS---------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP-------  123 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------  123 (332)
                      .++|...+.||+|+||.||+|+..         +++.||+|.+...       ..+.+|+.+++.++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            468999999999999999999954         3789999998643       35689999999999999988       


Q ss_pred             --------eeeeeec-CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCC
Q 020027          124 --------ILGFSQA-PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKA  194 (332)
Q Consensus       124 --------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~  194 (332)
                              +++++.. ++..+++|||+ +++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp  187 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA  187 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence                    5666655 67889999999 9999999986421  2389999999999999999999999   999999999


Q ss_pred             CCEEeCCCC--ceEEccCCccccCCcc-------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhC
Q 020027          195 SNILLNEKF--CARVCDYGLSFLAPEE-------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG  259 (332)
Q Consensus       195 ~Nill~~~~--~~kl~dfg~a~~~~~~-------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg  259 (332)
                      +||+++.++  .+||+|||+++.....             ..+|..|+|||.+..   ..++.++|||||||++|||+||
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG---CGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHS
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhC
Confidence            999999988  8999999999654321             257889999999876   6789999999999999999999


Q ss_pred             CCCCCchh--HHHHHHHhhh--cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          260 RRCEEGLL--VKWALPLIKE--MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       260 ~~p~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      +.||.+..  ..........  .......+...   ........+.+++.+||+.||++|||++++++.|++++.
T Consensus       265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          265 FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCcccCCcCHHHHHHHHHhccCChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            99998653  2222211111  11111111100   001112478899999999999999999999999998763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.9e-45  Score=321.70  Aligned_cols=253  Identities=20%  Similarity=0.254  Sum_probs=196.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeee-ecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS-QAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||+|+ ..+++.||+|.+....    ....+.+|+.+++.++|+|++..++.+ ...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            35689999999999999999999 4688999999875442    223578999999999988887777665 66678899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe---CCCCceEEccCCcc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLS  213 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a  213 (332)
                      +|||+ +++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||++   +.++.+||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            99999 8999999975432   289999999999999999999999   99999999999999   78899999999998


Q ss_pred             ccCCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH---HHHHhhh
Q 020027          214 FLAPE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW---ALPLIKE  277 (332)
Q Consensus       214 ~~~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~---~~~~~~~  277 (332)
                      +....             ...+|..|+|||.+..   ..++.++|||||||++|||++|+.||.+.....   ....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcC---CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence            65432             2357899999999876   678999999999999999999999997632211   1111111


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ........ ...    ...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus       233 ~~~~~~~~-~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          233 KKMSTPIE-VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHSCHH-HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccccchhh-hhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            11000000 000    0112378899999999999999999999999998763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-44  Score=326.35  Aligned_cols=245  Identities=20%  Similarity=0.267  Sum_probs=203.9

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||++.. .+++.||+|.+....... .....+.+|+.+++.++||||+++++++...+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            346788899999999999999994 578899999987554322 223357889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....    +++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       119 v~e~~~~~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            9999999999999876432    78999999999999999999999   9999999999999999999999999998754


Q ss_pred             Cc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          217 PE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       217 ~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..      ...++..|++||.+..   ..++.++||||||+++|||++|+.||.+....+....+.....        ..
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~  260 (335)
T 2owb_A          192 EYDGERKKVLCGTPNYIAPEVLSK---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------SI  260 (335)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHHT---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------CC
T ss_pred             ccCcccccccCCCccccCHHHhcc---CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--------CC
Confidence            32      2257889999999876   5678999999999999999999999987665555444433221        11


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +.  .....+.+++.+||+.||++|||+.|+++
T Consensus       261 ~~--~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 PK--HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             Cc--cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11  11236779999999999999999999876

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-44  Score=327.95  Aligned_cols=255  Identities=20%  Similarity=0.248  Sum_probs=198.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--------  130 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  130 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|++............+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46799999999999999999995 689999999997665444444467899999999999999999999876        


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      .+..+++|||+++ ++...+.....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            3468999999975 67666654322   289999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCC----------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-
Q 020027          211 GLSFLAP----------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-  279 (332)
Q Consensus       211 g~a~~~~----------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-  279 (332)
                      |+++...          ....+|..|+|||.+...  ..++.++|||||||++|||+||+.||.+.........+.... 
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCC--CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9986543          122468899999988652  457899999999999999999999998876555444332210 


Q ss_pred             -cccccCC---------cC----CCCCChHH-------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -FSELLDP---------RL----AIPCEIKP-------LVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -~~~~~~~---------~~----~~~~~~~~-------~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .....-+         ..    ........       ...+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence             0000000         00    00000000       235779999999999999999999886

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-45  Score=327.88  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=202.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-----CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC--
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG--  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  132 (332)
                      .++|...+.||+|+||.||+++.     .+++.||+|.+....  ......+.+|+.+++.++||||+++++++...+  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            45688889999999999999983     478899999987542  222335789999999999999999999986543  


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence            78999999999999999976532   278999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-----
Q 020027          213 SFLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-----  278 (332)
Q Consensus       213 a~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-----  278 (332)
                      +......         ..++..|+|||.+..   ..++.++||||||+++|||+||..|+........ ......     
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~-~~~~~~~~~~~  267 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDKQGQM  267 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH-HHHCTTCCTHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcC---CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH-Hhhccccchhh
Confidence            8765332         235667999999876   5678999999999999999999998865422211 110000     


Q ss_pred             ---ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          279 ---RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       279 ---~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                         ...+.+......+.+...+.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               0011111111122233344578899999999999999999999999998753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-44  Score=325.39  Aligned_cols=235  Identities=17%  Similarity=0.234  Sum_probs=176.6

Q ss_pred             CceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEEeccCC
Q 020027           66 RRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      .+.||+|+||.||+|.. .+++.||+|.+...     ....+.+|+..++.+. ||||+++++++..++..+++|||+++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            47899999999999994 57899999998643     2234678999999996 99999999999999999999999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC---ceEEccCCccccCCcc-
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF---CARVCDYGLSFLAPEE-  219 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~~~~~~-  219 (332)
                      ++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+||+++.++   .+||+|||+++..... 
T Consensus        91 ~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           91 GELFERIKKKKH----FSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             CBHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            999999976532    89999999999999999999999   999999999999997665   8999999999754322 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH-------HHHHHHhhhcccccccCCc
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV-------KWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~  287 (332)
                           ..+|..|+|||.+..   ..++.++|||||||++|||++|+.||.+...       .+....+..+.        
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------  232 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------  232 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------
T ss_pred             CcccccCCCcCccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------
Confidence                 257889999999876   6789999999999999999999999976432       12222222221        


Q ss_pred             CCCCCC--hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          288 LAIPCE--IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       288 ~~~~~~--~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+..  .....++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            111110  112347889999999999999999998863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=328.53  Aligned_cols=252  Identities=19%  Similarity=0.212  Sum_probs=193.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  132 (332)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999994 68999999999755433333345789999999999999999999987653      


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+ +++|.+++...     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            459999999 78999998753     278999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--cc-------
Q 020027          213 SFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--RF-------  280 (332)
Q Consensus       213 a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~-------  280 (332)
                      ++.....   ..+|..|+|||.+...  ..++.++||||+||++|||++|+.||.+.........+...  ..       
T Consensus       175 a~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          175 ARQADSEMTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CEECCSSCCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccccccccCcCcCCCCcCCHHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9765432   3578899999988653  56899999999999999999999999876544433322210  00       


Q ss_pred             -------------ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 -------------SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 -------------~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                   .......+. .........+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                         000000000 000112346789999999999999999999987

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.3e-45  Score=328.60  Aligned_cols=243  Identities=21%  Similarity=0.213  Sum_probs=196.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||+|.. .+|+.||+|.+....      ....+|+.++.++ +||||+++++++..++..++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            356788999999999999999994 578999999997542      1336788888877 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC----CceEEccCCc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK----FCARVCDYGL  212 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~dfg~  212 (332)
                      +|||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||+.++    +.+||+|||+
T Consensus        94 v~E~~~gg~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKF----FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999875432    89999999999999999999999   99999999999998543    3599999999


Q ss_pred             cccCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch---hHHHHHHHhhhcccccc
Q 020027          213 SFLAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL---LVKWALPLIKEMRFSEL  283 (332)
Q Consensus       213 a~~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~  283 (332)
                      +.....      ...+|..|+|||.+..   ..++.++|||||||++|||++|..||.+.   ...+....+..+.+.  
T Consensus       167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~--  241 (342)
T 2qr7_A          167 AKQLRAENGLLMTPCYTANFVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS--  241 (342)
T ss_dssp             CEECBCTTCCBCCSSCCSSCCCHHHHHH---HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC--
T ss_pred             cccCcCCCCceeccCCCccccCHHHhcC---CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc--
Confidence            975432      2357899999999876   45788999999999999999999999753   333444444443321  


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +...........+.+++.+||+.||++|||+.++++
T Consensus       242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                111111222347889999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.7e-44  Score=315.36  Aligned_cols=246  Identities=22%  Similarity=0.309  Sum_probs=198.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||+|.. .+|+.||+|.+....... .....+.+|+..++.++||||+++++++..++..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            456889999999999999999995 489999999987543222 223357899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....    +++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            9999999999999976543    78999999999999999999999   9999999999999999999999999998765


Q ss_pred             Ccc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 PEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ...     ..++..|++||.+...  ...+.++||||||+++|||++|+.||.+.........+.....        ..+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~  231 (276)
T 2h6d_A          162 SDGEFLRTSCGSPNYAAPEVISGR--LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF--------YIP  231 (276)
T ss_dssp             CC-------------CCTGGGTTS--CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCC
T ss_pred             CCCcceecccCCccccCHHHHcCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------cCc
Confidence            432     2578899999998752  2346899999999999999999999987665555444443221        111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .  .....+.+++.+||+.||++|||+.|+++
T Consensus       232 ~--~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          232 E--YLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             T--TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h--hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            1  12236789999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=333.10  Aligned_cols=266  Identities=18%  Similarity=0.191  Sum_probs=206.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC--ceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG--ERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  136 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+...... .....+.+|+.+++.++||||+++++++...+  ..++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            45688899999999999999994 57999999999754322 22335679999999999999999999987654  6799


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe----CCCCceEEccCCc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL----NEKFCARVCDYGL  212 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg~  212 (332)
                      +|||+++++|.+++...... ..+++..++.++.|++.||.|||++   +|+||||||+||++    +.++.+||+|||+
T Consensus        87 v~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            99999999999999764322 2278999999999999999999999   99999999999999    7788899999999


Q ss_pred             cccCCcc-----cCCcccccCcccccccC-----CCCCCchhhhHHHHHHHHHHHhCCCCCCchh----HHHHHHHhhhc
Q 020027          213 SFLAPEE-----KRGLAGYVDDDYWHEKG-----GGNATRESDVYGFGVVLLEILSGRRCEEGLL----VKWALPLIKEM  278 (332)
Q Consensus       213 a~~~~~~-----~~~~~~~~~pe~~~~~~-----~~~~~~~~DiwS~G~il~el~tg~~p~~~~~----~~~~~~~~~~~  278 (332)
                      ++.....     ..||..|+|||.+....     ...++.++|||||||++|||+||+.||.+..    ..+....+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            9765432     35889999999886421     1346789999999999999999999986421    11222222221


Q ss_pred             ccccc-------------cCCcCC--CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          279 RFSEL-------------LDPRLA--IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       279 ~~~~~-------------~~~~~~--~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .....             ....++  ...+......+.+++.+||+.||++|||+.++++.+++++.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            11000             001111  12234556678899999999999999999999999988765

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=327.92  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=194.2

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee-----cCC
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ-----APG  132 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----~~~  132 (332)
                      ...++|...+.||+|+||.||+|+. +++.||+|.+....   ........|+..+..++||||+++++.+.     ...
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            3457899999999999999999987 68899999986432   11112234444455689999999998543     233


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC------CCCeeecCCCCCCEEeCCCCceE
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV------APNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                      ..+++|||+++++|.+++....     .++..++.++.|++.||.|||+.+      .++|+||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            5789999999999999997643     588899999999999999999863      23899999999999999999999


Q ss_pred             EccCCccccCCc--------------ccCCcccccCcccccccCC----CCCCchhhhHHHHHHHHHHHhCCCCCCch-h
Q 020027          207 VCDYGLSFLAPE--------------EKRGLAGYVDDDYWHEKGG----GNATRESDVYGFGVVLLEILSGRRCEEGL-L  267 (332)
Q Consensus       207 l~dfg~a~~~~~--------------~~~~~~~~~~pe~~~~~~~----~~~~~~~DiwS~G~il~el~tg~~p~~~~-~  267 (332)
                      |+|||+++....              ...||..|+|||.+.....    ..++.++|||||||++|||+||..||... .
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999965432              1258899999998864211    24567899999999999999997765321 1


Q ss_pred             HH-----------------HHHHHhhhcccccccCCcCC--CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          268 VK-----------------WALPLIKEMRFSELLDPRLA--IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       268 ~~-----------------~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      ..                 ........    ....+.+.  ..........+.+++.+||+.||++|||++|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSR----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTT----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcc----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            00                 00000001    01111111  122334566799999999999999999999999999998


Q ss_pred             cc
Q 020027          329 VG  330 (332)
Q Consensus       329 ~~  330 (332)
                      +.
T Consensus       317 l~  318 (336)
T 3g2f_A          317 MM  318 (336)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.2e-44  Score=332.57  Aligned_cols=242  Identities=17%  Similarity=0.194  Sum_probs=187.6

Q ss_pred             CCCCCC-ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHh-ccCCCCCccceeeeeec----CCc
Q 020027           61 DGFSHR-RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVPILGFSQA----PGE  133 (332)
Q Consensus        61 ~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~  133 (332)
                      ++|... +.||+|+||+||++. ..+|+.||+|.++..       ..+.+|+.++ +..+||||+++++++..    .+.
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            345554 689999999999999 458999999998632       2457788876 44589999999998865    567


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEccC
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCDY  210 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~df  210 (332)
                      .+++|||+++++|.+++.....  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.   ++.+||+||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            8999999999999999976432  2389999999999999999999998   9999999999999997   789999999


Q ss_pred             CccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH----HHHHhhhcccc
Q 020027          211 GLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW----ALPLIKEMRFS  281 (332)
Q Consensus       211 g~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~  281 (332)
                      |+++....     ...+|..|+|||.+..   ..++.++|||||||++|||++|+.||.+.....    ....+..+.+ 
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-  284 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-  284 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCC---CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-
Confidence            99976542     2357899999999865   678999999999999999999999997643221    1122222211 


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           .+..+.......++.+++.+||+.||++|||+.|+++
T Consensus       285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 1111111223347889999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.3e-44  Score=317.82  Aligned_cols=252  Identities=20%  Similarity=0.251  Sum_probs=199.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeee-ecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS-QAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+ ..+|+.||+|.+....    ....+.+|+.+++.++|+|++..+.++ ...+..+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            4679999999999999999999 4789999999986543    223578999999999998877776665 566778999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC---CCCceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN---EKFCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a~  214 (332)
                      |||+ +++|.+++.....   .+++..++.++.|++.||.|||++   +++||||||+||+++   +++.+||+|||++.
T Consensus        84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            9999 8999999975432   289999999999999999999999   999999999999994   78899999999986


Q ss_pred             cCCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH---HHHHHhhhc
Q 020027          215 LAPE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK---WALPLIKEM  278 (332)
Q Consensus       215 ~~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~---~~~~~~~~~  278 (332)
                      ....             ...++..|+|||.+..   ..++.++|||||||++|||+||+.||.+....   .....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            5432             2357899999999876   67899999999999999999999999763211   111111111


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ...... +...    ...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus       234 ~~~~~~-~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          234 KMSTPI-EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHSCH-HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCch-HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            110000 0000    0112368899999999999999999999999998763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.9e-45  Score=323.15  Aligned_cols=262  Identities=22%  Similarity=0.255  Sum_probs=186.1

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .....++|...+.||+|+||.||+|. ..+++.||+|.+...... .....+.+|+..++.++||||+++++++..++..
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            44567889999999999999999999 458899999998754322 2233578899999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccC----CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          135 IIVSEFINMASLDFYLHENN----DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      +++|||+++++|.+++....    .....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence            99999999999999986421    1123488999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCc-----------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc
Q 020027          211 GLSFLAPE-----------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR  279 (332)
Q Consensus       211 g~a~~~~~-----------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~  279 (332)
                      |++.....           ...++..|+|||.+...  ..++.++||||||+++|||+||+.||.+..............
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV--RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHH--HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccc--cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            98864322           22578899999988642  357899999999999999999999998754433322221111


Q ss_pred             cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....................+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11110000000111122346789999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.5e-44  Score=318.37  Aligned_cols=243  Identities=23%  Similarity=0.292  Sum_probs=202.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .+.|...+.||+|+||.||+|. ..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..+++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            4568889999999999999998 467899999999765432 23345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++++|.+++...     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999998642     278999999999999999999999   999999999999999999999999999865432


Q ss_pred             ------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCC
Q 020027          219 ------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC  292 (332)
Q Consensus       219 ------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (332)
                            ...++..|+|||.+..   ..++.++||||||+++|||++|+.||...........+.....     +...   
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~---  240 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-----PTLE---  240 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCCC---
T ss_pred             cccccCccCCCcCccCHHHHhc---CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-----CCCc---
Confidence                  2357889999999876   6788999999999999999999999987655544443333211     1111   


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          293 EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       293 ~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ......+.+++.+||+.||++|||+.++++
T Consensus       241 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          241 -GNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             -SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             112236789999999999999999999976

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-44  Score=342.38  Aligned_cols=243  Identities=22%  Similarity=0.261  Sum_probs=199.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            36788889999999999999995 579999999997654322 2233578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++.........+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999976543334589999999999999999999999   99999999999999999999999999997543


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh----HHHHHHHhhhcccccccCCc
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL----VKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~  287 (332)
                      .      ...||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+..    .......+....        
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--------  409 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLG---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--------  409 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--------
T ss_pred             CCCcccccccCCccccChhhhcC---CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--------
Confidence            2      2368999999999876   678999999999999999999999997642    222222222211        


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      ...+  ......+.+++.+||+.||++||++
T Consensus       410 ~~~p--~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 VTYP--DKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CCCC--TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             cCCC--cccCHHHHHHHHHhccCCHhHCCCC
Confidence            1111  1223467899999999999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.3e-44  Score=315.84  Aligned_cols=244  Identities=20%  Similarity=0.280  Sum_probs=199.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--------  130 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  130 (332)
                      .++|...+.||+|+||.||+|.. .+++.||+|.++...      ..+.+|+.+++.++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            45688899999999999999995 489999999987432      246899999999999999999998754        


Q ss_pred             --------CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC
Q 020027          131 --------PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK  202 (332)
Q Consensus       131 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  202 (332)
                              .+..+++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence                    3457999999999999999975422  2378999999999999999999999   99999999999999999


Q ss_pred             CceEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh
Q 020027          203 FCARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~  277 (332)
                      +.+||+|||++......     ..++..|+|||.+..   ..++.++||||||+++|||+||..|+....  .....+..
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~  233 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS---QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD  233 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC---SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhcc---CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc
Confidence            99999999998765432     357899999999876   678999999999999999999998875422  11122222


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      ..        +...    ....+.+++.+||+.||++|||+.|+++.|..+...
T Consensus       234 ~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          234 GI--------ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             TC--------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             cc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            11        1111    123577899999999999999999999999887654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.3e-45  Score=320.79  Aligned_cols=254  Identities=21%  Similarity=0.301  Sum_probs=187.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|+ ..+|+.||+|.++...........+.++...++.++||||+++++++..++..+++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            45678999999999999999999 46899999999976543333322344555568888999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||++ ++|.+++.........+++..++.++.|++.||.|||+++  +++||||||+||+++.++.+||+|||++....
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99997 5888777653222234899999999999999999999842  89999999999999999999999999987543


Q ss_pred             cc-----cCCcccccCccccccc-CCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-HHHHHHHhhhcccccccCCcCCC
Q 020027          218 EE-----KRGLAGYVDDDYWHEK-GGGNATRESDVYGFGVVLLEILSGRRCEEGLL-VKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       218 ~~-----~~~~~~~~~pe~~~~~-~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..     ..++..|+|||.+... .+..++.++|||||||++|||+||+.||.... .............     +..  
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~--  234 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-----PQL--  234 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-----CCC--
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-----CCc--
Confidence            32     2588999999997432 23678999999999999999999999997522 2222121111111     111  


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       ........+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          235 -PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             11122346889999999999999999999876

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.2e-46  Score=339.42  Aligned_cols=245  Identities=13%  Similarity=0.069  Sum_probs=186.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHH---HHhccCCCCCcccee-------ee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVI---KTLSLAQHPNIVPIL-------GF  127 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  127 (332)
                      .++|...+.||+|+||.||+|+ ..+|+.||+|.+....... .....+.+|+   ..++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4567788999999999999999 4689999999997543322 2233578999   555666899999998       55


Q ss_pred             eecCC-----------------ceeEEEeccCCCCHHHHhcccCCC---CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 020027          128 SQAPG-----------------ERIIVSEFINMASLDFYLHENNDG---ASLLDWNRRLRIATGAARGLEYLHQGVAPNI  187 (332)
Q Consensus       128 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i  187 (332)
                      +..++                 ..+++|||+ +|+|.+++......   ...+++..++.++.|++.||.|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 278999999 68999999764221   11244688889999999999999999   99


Q ss_pred             eecCCCCCCEEeCCCCceEEccCCccccCCcc---cCCcccccCccccccc--------CCCCCCchhhhHHHHHHHHHH
Q 020027          188 IHGCIKASNILLNEKFCARVCDYGLSFLAPEE---KRGLAGYVDDDYWHEK--------GGGNATRESDVYGFGVVLLEI  256 (332)
Q Consensus       188 vH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~--------~~~~~~~~~DiwS~G~il~el  256 (332)
                      +||||||+|||++.++.+||+|||+++.....   ..| ..|+|||.+...        ....++.++|||||||++|||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            99999999999999999999999999765432   356 899999998762        001689999999999999999


Q ss_pred             HhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          257 LSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       257 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +||+.||.+.........+..        ..      ......+.+++.+||+.||++|||+.|+++
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~--------~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFR--------SC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHSSCCC------CCSGGGGS--------SC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHCCCCCcccccccchhhhhh--------hc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999976543222111111        00      111236889999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-44  Score=330.13  Aligned_cols=253  Identities=21%  Similarity=0.257  Sum_probs=199.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||.||++.. .+++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            46788999999999999999994 5889999999976532 222335789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||+++++|.+++.....    +++..+..++.|++.||.|||+ +   +++||||||+||+++.++.+||+|||++....
T Consensus       111 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             ECCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999976543    7899999999999999999998 4   79999999999999999999999999986432


Q ss_pred             ----cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc---c----------
Q 020027          218 ----EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR---F----------  280 (332)
Q Consensus       218 ----~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~---~----------  280 (332)
                          ....++..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....   .          
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          184 DSMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             HHC----CCCCTTCCHHHHTT---CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             cccccCCCCCCCeECHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                23468999999999876   678999999999999999999999997654433322111000   0          


Q ss_pred             ---------------------ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 ---------------------SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ---------------------~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                           ...................+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                 0000000000111112346889999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.4e-44  Score=327.57  Aligned_cols=253  Identities=20%  Similarity=0.241  Sum_probs=204.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccccc------ccccHHHHHHHhccC-CCCCccceeeeee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSN------AGFGFASVIKTLSLA-QHPNIVPILGFSQ  129 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~  129 (332)
                      ...++|...+.||+|+||.||+|.. .+|+.||||.++.......      ....+.+|+.+++.+ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3446788889999999999999995 5899999999976542211      122467899999998 7999999999999


Q ss_pred             cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEcc
Q 020027          130 APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD  209 (332)
Q Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~d  209 (332)
                      ..+..+++|||+++++|.+++.....    +++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence            99999999999999999999976432    88999999999999999999998   999999999999999999999999


Q ss_pred             CCccccCCc-----ccCCcccccCccccccc---CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccc
Q 020027          210 YGLSFLAPE-----EKRGLAGYVDDDYWHEK---GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS  281 (332)
Q Consensus       210 fg~a~~~~~-----~~~~~~~~~~pe~~~~~---~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  281 (332)
                      ||++.....     ...||..|+|||.+...   ....++.++|||||||++|||+||+.||.+.........+..+...
T Consensus       244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            999865432     23588999999988642   1245789999999999999999999999876555554444443211


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..      .+........+.+++.+||+.||++|||+.|+++
T Consensus       324 ~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          324 FS------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CC------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00      0000011236789999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.3e-44  Score=323.03  Aligned_cols=250  Identities=22%  Similarity=0.241  Sum_probs=195.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc------ccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL------SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.+......      ......+.+|+.+++.++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            4578899999999999999999 457899999999754321      122235789999999999999999999987665


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc---eEEcc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC---ARVCD  209 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~d  209 (332)
                       .+++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             8999999999999999875432    78999999999999999999999   9999999999999987654   99999


Q ss_pred             CCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccccc
Q 020027          210 YGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFSEL  283 (332)
Q Consensus       210 fg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~  283 (332)
                      ||++......     ..++..|+|||.+.......++.++|||||||++|||++|..||.+.... .....+..+.... 
T Consensus       161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  239 (322)
T 2ycf_A          161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-  239 (322)
T ss_dssp             CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-
T ss_pred             CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-
Confidence            9999766543     25789999999986443467899999999999999999999999764322 1222222221110 


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .+..    .......+.+++.+||+.||++|||+.++++
T Consensus       240 -~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          240 -IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             0000    0012346889999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.7e-44  Score=326.79  Aligned_cols=251  Identities=19%  Similarity=0.207  Sum_probs=192.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  132 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.+............+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            4689999999999999999998 457899999999765433333345789999999999999999999987654      


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||++ ++|.+++...      +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhhc------cCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            6799999997 4787777521      78899999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccc---c---
Q 020027          213 SFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRF---S---  281 (332)
Q Consensus       213 a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~---  281 (332)
                      ++.....     ..+|..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....-   .   
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             ----------------CTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccccccCCceecCCccCHHHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9765432     357899999999876   6789999999999999999999999987655444333221100   0   


Q ss_pred             ccc----------CCc------------CCCCCC----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 ELL----------DPR------------LAIPCE----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~~~----------~~~------------~~~~~~----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+          .+.            ...+..    ......+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            000          000            001111    112457889999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.4e-44  Score=343.34  Aligned_cols=247  Identities=21%  Similarity=0.271  Sum_probs=202.1

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ..++|...+.||+|+||.||+|+. .+|+.||+|.+.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            346788899999999999999994 589999999997643322 223346899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++|+|.+++.....  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence            9999999999999876432  2388999999999999999999999   9999999999999999999999999999765


Q ss_pred             Cc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh----HHHHHHHhhhcccccccCCc
Q 020027          217 PE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL----VKWALPLIKEMRFSELLDPR  287 (332)
Q Consensus       217 ~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~  287 (332)
                      ..     ...||+.|+|||.+..   ..++.++|||||||++|||++|+.||.+..    .......+....        
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~---~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--------  405 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKN---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--------  405 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTT---CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--------
T ss_pred             ccCccccccCCCccccCHHHHcC---CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--------
Confidence            43     2368999999999876   578999999999999999999999998642    222222222211        


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ...+  ......+.+++.+||+.||++||     +++|+++
T Consensus       406 ~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 EEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            1111  12224788999999999999999     6788764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=317.50  Aligned_cols=246  Identities=22%  Similarity=0.287  Sum_probs=196.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ...++|...+.||+|+||.||+|.. .+|+.||+|.+....    ....+.+|+.+++.++||||+++++++...+..++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3456789999999999999999995 579999999987532    23357899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++++|.+++.....   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       102 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            9999999999999874322   278999999999999999999999   9999999999999999999999999998654


Q ss_pred             Cc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          217 PE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       217 ~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ..      ...++..|+|||.+..   ..++.++||||||+++|||++|+.||.+.........+.....     +..  
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~--  245 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQE---IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-----PTF--  245 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSS---SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCC--
T ss_pred             hhhccccCccCCCCCccChhhcCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----ccc--
Confidence            32      2357889999999876   5788999999999999999999999987654433332222211     111  


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+......+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            111122347889999999999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=314.96  Aligned_cols=247  Identities=20%  Similarity=0.207  Sum_probs=197.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc--cccccHHHHHHHhccCCCCCccceeeee--ecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLAQHPNIVPILGFS--QAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~  134 (332)
                      .++|...+.||+|+||.||++.. .+++.||+|.++......  .....+.+|+.+++.++||||+++++++  ...+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999994 688999999997543221  2234578999999999999999999998  445678


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||++++ +.+++.....  ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999876 7777765432  2388999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          215 LAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       215 ~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ....        ...++..|++||.+... ....+.++||||||+++|||++|+.||.+.........+.....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC------
Confidence            5432        22578999999988642 12347899999999999999999999988766555554444321      


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        ..+  ......+.+++.+||+.||++|||+.|+++
T Consensus       231 --~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 --AIP--GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             --CCC--SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --CCC--CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              111  122346789999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.2e-44  Score=332.90  Aligned_cols=193  Identities=23%  Similarity=0.300  Sum_probs=164.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      .++|...+.||+|+||.||+|+ ..+++.||+|++............+.+|+.+++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            5689999999999999999999 56788999999976544333344678999999999999999999998765     56


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||++ ++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~----l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIF----LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999996 699999976432    89999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCc----------------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCC
Q 020027          214 FLAPE----------------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC  262 (332)
Q Consensus       214 ~~~~~----------------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p  262 (332)
                      +....                            ...+|..|+|||.+...  ..++.++||||+||++|||++|..|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ--ENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC--CCCCcccccchHHHHHHHHHhcccc
Confidence            75432                            23578999999987442  5689999999999999999985443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.2e-44  Score=325.86  Aligned_cols=262  Identities=20%  Similarity=0.243  Sum_probs=198.7

Q ss_pred             hHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc---------cccHHHHHHHhccCCCCCccc
Q 020027           53 LTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA---------GFGFASVIKTLSLAQHPNIVP  123 (332)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~  123 (332)
                      ..++....++|...+.||+|+||.||+|...+|+.||+|.+.........         ...+.+|+.+++.++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45677888999999999999999999999878999999999754432221         135789999999999999999


Q ss_pred             eeeeeec-----CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEE
Q 020027          124 ILGFSQA-----PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNIL  198 (332)
Q Consensus       124 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  198 (332)
                      +++++..     ....+++|||++ ++|.+++....   ..+++..+..++.|++.||.|||++   +++||||||+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            9999843     346799999997 67877776432   2389999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH
Q 020027          199 LNEKFCARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP  273 (332)
Q Consensus       199 l~~~~~~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~  273 (332)
                      ++.++.+||+|||++......     ..++..|+|||.+...  ..++.++|||||||++|||+||+.||.+........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQF--KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             ECTTCCEEECCTTC---------------CGGGCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEEecCcccccccccccceecccceecCcHHhcCC--CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999754322     2578889999988653  568899999999999999999999998765444433


Q ss_pred             Hhhhcc---------------cccccCCcCC-CCC------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          274 LIKEMR---------------FSELLDPRLA-IPC------EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       274 ~~~~~~---------------~~~~~~~~~~-~~~------~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+....               ..+....... .+.      .......+.+++.+||+.||++|||+.|+++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            322100               0000000000 000      0111336789999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.4e-44  Score=320.90  Aligned_cols=247  Identities=20%  Similarity=0.243  Sum_probs=193.3

Q ss_pred             cCCCCCC-ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeE
Q 020027           60 TDGFSHR-RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        60 ~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  136 (332)
                      .+.|... +.||+|+||.||+|. ..+++.||+|.+....  ......+.+|+.++.++ +||||+++++++..++..++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            3456664 789999999999999 5689999999997543  22233578999999884 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc---eEEccCCcc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC---ARVCDYGLS  213 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~dfg~a  213 (332)
                      +|||+++++|.+++.....    +++..+..++.|++.||.|||++   +++||||||+||+++.++.   +||+|||++
T Consensus        89 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEcCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999976532    78999999999999999999999   9999999999999998766   999999998


Q ss_pred             ccCCc-------------ccCCcccccCcccccccC--CCCCCchhhhHHHHHHHHHHHhCCCCCCchhH----------
Q 020027          214 FLAPE-------------EKRGLAGYVDDDYWHEKG--GGNATRESDVYGFGVVLLEILSGRRCEEGLLV----------  268 (332)
Q Consensus       214 ~~~~~-------------~~~~~~~~~~pe~~~~~~--~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~----------  268 (332)
                      .....             ...||..|+|||.+....  ...++.++|||||||++|||+||+.||.+...          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            65421             124889999999886411  13468899999999999999999999976421          


Q ss_pred             -----HHHHHHhhhcccccccCCcCCCCCC--hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          269 -----KWALPLIKEMRFSELLDPRLAIPCE--IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       269 -----~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           ......+..+.        ...+..  ......+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          242 CPACQNMLFESIQEGK--------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CHHHHHHHHHHHHHCC--------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             chhHHHHHHHHHhccC--------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                 11222222221        111100  012236789999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.9e-44  Score=313.08  Aligned_cols=246  Identities=20%  Similarity=0.205  Sum_probs=197.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..+++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            35688899999999999999995 58899999998754322 22235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||.+.... 
T Consensus        85 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999987542    278999999999999999999999   99999999999999999999999999986532 


Q ss_pred             -------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH-HHHHhhhcccccccCCcCC
Q 020027          218 -------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW-ALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       218 -------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  289 (332)
                             ....++..|+|||.+...  ...+.++||||||+++|||+||+.||.+..... ....+....        ..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~  227 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------TY  227 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCS--SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--------TT
T ss_pred             CcchhcccCCccccCccChHHHhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--------cc
Confidence                   223578899999998752  234789999999999999999999997643221 111111110        00


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+........+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1111122346789999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-44  Score=319.43  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe--CCCC--EEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL--STGK--LVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~--~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|...+.||+|+||.||+|+.  .+++  .||+|.++...... .....+.+|+..++.++||||+++++++..++ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            46789999999999999999984  2333  68999987654322 22335789999999999999999999998765 8


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++++||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            899999999999999976422   378999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          215 LAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       215 ~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....         ..++..|+|||.+..   ..++.++||||||+++|||++ |+.||.+.........+.....    
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----  242 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKT---RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE----  242 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC----
T ss_pred             cccccccchhhhccCCCCceeeCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC----
Confidence            65322         245668999999876   567899999999999999999 9999987765555444433211    


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                          ..+.+......+.+++.+||+.||++|||+.++++.|+++..
T Consensus       243 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 ----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ----CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                111122333478899999999999999999999999998753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=326.40  Aligned_cols=255  Identities=18%  Similarity=0.270  Sum_probs=185.8

Q ss_pred             HHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeee----
Q 020027           56 IDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQ----  129 (332)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~----  129 (332)
                      ++....+|...+.||+|+||.||+|+ ..+++.||+|.+.....  .....+.+|+..+..+. ||||+++++++.    
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            33445678999999999999999999 46899999999864432  22235689999999995 999999999983    


Q ss_pred             ----cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeecCCCCCCEEeCCCC
Q 020027          130 ----APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN--IIHGCIKASNILLNEKF  203 (332)
Q Consensus       130 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~  203 (332)
                          .....+++|||+. |+|.+++..... ...+++..++.++.|++.||.|||++   +  ++||||||+|||++.++
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence                3345799999996 789888865221 12389999999999999999999998   7  99999999999999999


Q ss_pred             ceEEccCCccccCCc------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc
Q 020027          204 CARVCDYGLSFLAPE------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      .+||+|||++.....                  ...++..|+|||.+....+..++.++|||||||++|||+||+.||.+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            999999999976543                  22478899999998543446789999999999999999999999976


Q ss_pred             hhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      .......    ..        ....+........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       256 ~~~~~~~----~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          256 GAKLRIV----NG--------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHhh----cC--------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4332211    11        1111111111225778999999999999999999999998865

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.6e-44  Score=348.97  Aligned_cols=240  Identities=20%  Similarity=0.245  Sum_probs=202.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc-ccccccHHHHHHHhccC-CCCCccceeeeeecCCcee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  135 (332)
                      ..++|...+.||+|+||.||+|+ ..+++.||+|++++.... ......+..|..++..+ +||||+++++++...+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            45678889999999999999999 567889999999764322 22333567888999887 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +||||+++++|.+++.....    +++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       419 lV~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            99999999999999986543    89999999999999999999999   999999999999999999999999999875


Q ss_pred             CC------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          216 AP------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       216 ~~------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ..      ....||+.|+|||.+..   ..++.++|||||||++|||++|+.||.+....+....+....        +.
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------~~  560 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------VA  560 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTC---CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------CC
T ss_pred             cccCCcccccccCCCcccCHhhhcC---CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------CC
Confidence            32      22368999999999876   678999999999999999999999999887776666555432        11


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                      .+.  ....++.+++.+||+.||++||++
T Consensus       561 ~p~--~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          561 YPK--SMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             CCT--TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             CCc--cCCHHHHHHHHHHccCCHHHCCCC
Confidence            222  223478899999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.6e-44  Score=314.19  Aligned_cols=249  Identities=21%  Similarity=0.226  Sum_probs=205.1

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ...++|...+.||+|+||.||+|+. .+++.||+|.+............+.+|+.++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            3456799999999999999999995 488999999997655444444567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC---CceEEccCCcc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK---FCARVCDYGLS  213 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~dfg~a  213 (332)
                      ++||+++++|.+++.....    +++..++.++.|++.||.|||++   +++|+||||+||+++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999988875432    78999999999999999999999   99999999999999754   47999999998


Q ss_pred             ccCCccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          214 FLAPEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       214 ~~~~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      .......     .++..|+|||.+..    .++.++||||||+++|||++|+.||.+.........+..+.....     
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  242 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-----  242 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred             eeecCCCccccccCcccccChHHhcC----CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence            7654322     36788999998764    488999999999999999999999988766655555544332111     


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .+........+.+++.+||+.||++|||+.|+++
T Consensus       243 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 -LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence             1111112346889999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-43  Score=316.98  Aligned_cols=256  Identities=19%  Similarity=0.245  Sum_probs=200.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe--CCCCEEEEEEeccCcccccccccHHHHHHHhccC---CCCCccceeeeee----
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA---QHPNIVPILGFSQ----  129 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  129 (332)
                      ..++|...+.||+|+||.||+|+.  .+|+.||+|.++...........+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456899999999999999999995  4688999999976554444444567888777766   8999999999986    


Q ss_pred             -cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEc
Q 020027          130 -APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC  208 (332)
Q Consensus       130 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  208 (332)
                       ..+..+++|||++ ++|.+++......  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             4567899999997 6999998765432  378999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-----
Q 020027          209 DYGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-----  278 (332)
Q Consensus       209 dfg~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-----  278 (332)
                      |||++.....     ...++..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+...     
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            9999876543     2357889999999876   67899999999999999999999999876554443333211     


Q ss_pred             --ccccccC-Cc--C-------CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 --RFSELLD-PR--L-------AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 --~~~~~~~-~~--~-------~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .+..... +.  .       ...........+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000000 00  0       00001122346779999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.6e-44  Score=315.96  Aligned_cols=253  Identities=19%  Similarity=0.191  Sum_probs=205.4

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-------cccccHHHHHHHhccCC-CCCccceeeee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-------NAGFGFASVIKTLSLAQ-HPNIVPILGFS  128 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~~~~~~  128 (332)
                      ...++|...+.||+|+||.||+|.. .+|+.||+|.++......       .....+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3467899999999999999999995 578999999997653211       11224678999999995 99999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEc
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC  208 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  208 (332)
                      ..++..+++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence            999999999999999999999976432    78999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCcc-----cCCcccccCccccccc---CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccc
Q 020027          209 DYGLSFLAPEE-----KRGLAGYVDDDYWHEK---GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRF  280 (332)
Q Consensus       209 dfg~a~~~~~~-----~~~~~~~~~pe~~~~~---~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~  280 (332)
                      |||++......     ..++..|++||.+...   ....++.++||||||+++|||++|+.||.+.........+..+..
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (298)
T 1phk_A          167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  246 (298)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence            99998754322     3578899999988532   235678999999999999999999999987665555544444322


Q ss_pred             ccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 SELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .      ...+........+.+++.+||+.||++|||+.|+++
T Consensus       247 ~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          247 Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             c------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1      111111223447889999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.9e-44  Score=318.39  Aligned_cols=250  Identities=22%  Similarity=0.258  Sum_probs=198.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|.. .+++.||+|.+....  ......+.+|+.+++.++||||+++++++..++..+++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            356789999999999999999995 578999999987543  22234578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC-
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA-  216 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~-  216 (332)
                      |||+++++|.+++.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++... 
T Consensus        95 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999876432   278999999999999999999999   9999999999999999999999999987432 


Q ss_pred             -----CcccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          217 -----PEEKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       217 -----~~~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                           .....++..|+|||.+...  .+..++.++||||||+++|||+||..||...........+......       .
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~  241 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-------T  241 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------C
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-------c
Confidence                 1223688999999988421  2367889999999999999999999999876554443333222111       1


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...+......+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1112223347889999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=312.45  Aligned_cols=250  Identities=22%  Similarity=0.255  Sum_probs=196.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|.....||+|+||.||+|. ..+++.||+|.+.....  .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            4556777799999999999999 56889999999875432  22335789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccCCccccCC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDYGLSFLAP  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~  217 (332)
                      ||+++++|.+++..... ...+++..+..++.|++.||.|||++   +++|+||||+||+++. ++.+||+|||++....
T Consensus        99 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             ECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999976432 22367888999999999999999999   9999999999999987 8999999999987543


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .      ...++..|+|||.+.... ..++.++||||||+++|||+||+.||.+....... .......  ...+.+   
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~--~~~~~~---  247 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGP-RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFKVGMF--KVHPEI---  247 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGG-GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHHHHHH--CCCCCC---
T ss_pred             CCCCcccccCCCccccChhhhcCCC-CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHhhccc--cccccc---
Confidence            2      235788999999986521 23789999999999999999999999753221111 0111000  001111   


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       +......+.+++.+||+.||++|||+.++++
T Consensus       248 -~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 -PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1122347789999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=327.38  Aligned_cols=247  Identities=19%  Similarity=0.170  Sum_probs=196.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCccc--ccccccHHHHHHHhccC-CCCCccceeeeeecCC
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVL--SNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPG  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  132 (332)
                      .++|...+.||+|+||.||+++.    .+++.||+|.++.....  ......+.+|+.+++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46799999999999999999995    47899999999754321  12223457889999998 6999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++++|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            99999999999999999976543    78999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCc-------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH----HHHHHHhhhcccc
Q 020027          213 SFLAPE-------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV----KWALPLIKEMRFS  281 (332)
Q Consensus       213 a~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~  281 (332)
                      ++....       ...||..|+|||.+... ...++.++|||||||++|||+||+.||.....    ......+...   
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---  281 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---  281 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc---
Confidence            875422       12589999999998742 13468899999999999999999999964321    1111111111   


Q ss_pred             cccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 020027          282 ELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRP-----SIVQVATI  324 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~~  324 (332)
                           ....  +......+.+++.+||+.||++||     |+.|+++.
T Consensus       282 -----~~~~--~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 -----EPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -----CCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----CCCC--CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                 1111  122234677999999999999999     89988763

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=317.79  Aligned_cols=253  Identities=22%  Similarity=0.269  Sum_probs=198.6

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeec--
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQA--  130 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--  130 (332)
                      ++....++|...+.||+|+||.||+|+. .+|+.||+|.+....   .....+.+|+..++.+ +||||+++++++..  
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3344567899999999999999999994 689999999987542   2234578999999998 79999999999876  


Q ss_pred             ----CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          131 ----PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       131 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                          .+..+++|||+++++|.+++.....  ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence                4678999999999999999976431  2378999999999999999999999   999999999999999999999


Q ss_pred             EccCCccccCCc------ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc
Q 020027          207 VCDYGLSFLAPE------EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       207 l~dfg~a~~~~~------~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~  278 (332)
                      |+|||++.....      ...++..|+|||.+...  .+..++.++|||||||++|||+||..||.+.........+...
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  249 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  249 (326)
T ss_dssp             ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            999999876432      22578899999998632  1356889999999999999999999999876554443333332


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....     .   .......+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~-----~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 PAPRL-----K---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCCC-----S---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccC-----C---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            21111     1   1112236889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.5e-44  Score=322.54  Aligned_cols=257  Identities=15%  Similarity=0.191  Sum_probs=203.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccccc---------------ccHHHHHHHhccCCCCCccc
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAG---------------FGFASVIKTLSLAQHPNIVP  123 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~h~niv~  123 (332)
                      ..++|...+.||+|+||.||+|.. +|+.||+|.+..........               ..+.+|+.+++.++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999999999 89999999997654332211               45789999999999999999


Q ss_pred             eeeeeecCCceeEEEeccCCCCHHHH------hcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCC
Q 020027          124 ILGFSQAPGERIIVSEFINMASLDFY------LHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASN  196 (332)
Q Consensus       124 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~N  196 (332)
                      +++++..++..+++|||+++++|.++      +....  ...+++..++.++.|++.||.|||+ +   +++||||||+|
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN  182 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence            99999999999999999999999998      54321  2348999999999999999999998 8   99999999999


Q ss_pred             EEeCCCCceEEccCCccccCCc----ccCCcccccCcccccccCCCCCCc-hhhhHHHHHHHHHHHhCCCCCCchhH-HH
Q 020027          197 ILLNEKFCARVCDYGLSFLAPE----EKRGLAGYVDDDYWHEKGGGNATR-ESDVYGFGVVLLEILSGRRCEEGLLV-KW  270 (332)
Q Consensus       197 ill~~~~~~kl~dfg~a~~~~~----~~~~~~~~~~pe~~~~~~~~~~~~-~~DiwS~G~il~el~tg~~p~~~~~~-~~  270 (332)
                      |+++.++.+||+|||++.....    ...++..|+|||.+...  ..++. ++||||||+++|||++|+.||.+... ..
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNE--SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSC--CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCC--CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9999999999999999876432    23688999999998752  25555 99999999999999999999987544 44


Q ss_pred             HHHHhhhcccccccCCc-C-----C---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          271 ALPLIKEMRFSELLDPR-L-----A---IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~-~-----~---~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ....+.........+.. .     .   ..........+.+++.+||+.||++|||+.|+++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            44444333211100000 0     0   0000122347889999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.4e-44  Score=327.67  Aligned_cols=253  Identities=21%  Similarity=0.263  Sum_probs=183.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------C
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------G  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  132 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|++............+.+|+.+++.++||||+++++++...      +
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4789999999999999999998 56899999999976543333334578999999999999999999998654      5


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..++++|++ +++|.+++...     .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 68998888642     288999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c--------
Q 020027          213 SFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R--------  279 (332)
Q Consensus       213 a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~--------  279 (332)
                      ++.....   ..+|..|+|||.+...  ..++.++||||+||++|||+||+.||.+.........+...  .        
T Consensus       179 a~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTADEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             ------------CCCTTCCHHHHTTC--CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccccCCCcCcCcCccChHHHcCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9765432   3578999999988652  56889999999999999999999999876554443333210  0        


Q ss_pred             -----cccccCCcCCCC-CC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -----FSELLDPRLAIP-CE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -----~~~~~~~~~~~~-~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           .......-...+ .+     ......+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                 000000000000 00     011236789999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.5e-44  Score=348.54  Aligned_cols=253  Identities=22%  Similarity=0.301  Sum_probs=205.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE  133 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  133 (332)
                      ...++|...+.||+|+||.||+|...    .+..||+|.++.... ......+.+|+.+++.++||||+++++++. ++.
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            34456777889999999999999853    345799998865322 222235789999999999999999999985 456


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence            8999999999999999976432   278999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccC
Q 020027          214 FLAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       214 ~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      +.....       ..++..|+|||.+..   ..++.++|||||||++|||++ |..||.+.........+..+..     
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-----  610 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-----  610 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-----
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcC---CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            765432       235678999999876   678999999999999999997 9999988766655554444321     


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                          .+.+...+..+.+++.+||+.||++|||+.++++.|+++++
T Consensus       611 ----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          611 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                11122233478899999999999999999999999998864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2e-43  Score=329.05  Aligned_cols=253  Identities=19%  Similarity=0.163  Sum_probs=196.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccC------CCCCccceeeeeecC
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA------QHPNIVPILGFSQAP  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~  131 (332)
                      ...+|...+.||+|+||.||+|. ..+++.||+|.++....   ....+.+|+.+++.+      +|+||+++++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc---hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            34578899999999999999998 55789999999975421   122356677766655      678999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc--eEEcc
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC--ARVCD  209 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~d  209 (332)
                      +..+++|||+. ++|.+++......  .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.  +||+|
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             CeEEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence            99999999996 6899988765432  388999999999999999999999   9999999999999999887  99999


Q ss_pred             CCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc---cc---
Q 020027          210 YGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM---RF---  280 (332)
Q Consensus       210 fg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~~---  280 (332)
                      ||++......   ..+|..|+|||.+..   ..++.++|||||||++|||+||..||.+....+....+...   ..   
T Consensus       246 FG~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          246 FGSSCYEHQRVYTYIQSRFYRAPEVILG---ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             CTTCEETTCCCCSSCSCGGGCCHHHHHT---BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccceecCCcccccCCCCCccChHHHhC---CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9999665432   367899999999876   57899999999999999999999999876554443322210   00   


Q ss_pred             -------ccccCC---------------------------cCCC---CCCh------HHHHHHHHHHHHcccCCCCCCCC
Q 020027          281 -------SELLDP---------------------------RLAI---PCEI------KPLVRLAKVALACVGNSRKNRPS  317 (332)
Q Consensus       281 -------~~~~~~---------------------------~~~~---~~~~------~~~~~l~~l~~~c~~~dp~~RPs  317 (332)
                             ....+.                           ....   ....      .....+.+++.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                   000000                           0000   0000      01246789999999999999999


Q ss_pred             HHHHHH
Q 020027          318 IVQVAT  323 (332)
Q Consensus       318 ~~~i~~  323 (332)
                      +.|+++
T Consensus       403 a~e~L~  408 (429)
T 3kvw_A          403 PGQALR  408 (429)
T ss_dssp             HHHHHT
T ss_pred             HHHHhC
Confidence            999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-44  Score=330.90  Aligned_cols=254  Identities=9%  Similarity=-0.012  Sum_probs=179.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHH---HHHhccCCCCCcccee-------ee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASV---IKTLSLAQHPNIVPIL-------GF  127 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~niv~~~-------~~  127 (332)
                      ..+|...+.||+|+||.||+|. ..+|+.||+|.+....... .....+.+|   +..++. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            4458889999999999999999 4588999999998765322 222245666   455556 799988754       44


Q ss_pred             eecC-----------------CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHH------HHHHHHHHHHHHHhhcCCC
Q 020027          128 SQAP-----------------GERIIVSEFINMASLDFYLHENNDGASLLDWNRR------LRIATGAARGLEYLHQGVA  184 (332)
Q Consensus       128 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~Lh~~~~  184 (332)
                      +..+                 ...+++|||++ ++|.+++......   +++..+      +.++.|++.||+|||++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--  213 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV---YVFRGDEGILALHILTAQLIRLAANLQSK--  213 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc---cchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence            4333                 23799999998 8999999864221   344444      67789999999999999  


Q ss_pred             CCeeecCCCCCCEEeCCCCceEEccCCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCC
Q 020027          185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR  261 (332)
Q Consensus       185 ~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~  261 (332)
                       +|+||||||+|||++.++.+||+|||+++.....   ..++..|+|||.+... ...++.++|||||||++|||+||+.
T Consensus       214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNAS-TATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCS-EEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             -CCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCC-CCCcCccccHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999999866543   3567999999998531 1367999999999999999999999


Q ss_pred             CCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          262 CEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       262 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ||.+....... .................+........+.+++.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99875332110 00000001111112222222233457889999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-44  Score=321.82  Aligned_cols=258  Identities=18%  Similarity=0.244  Sum_probs=199.0

Q ss_pred             cCCChHHHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC--CCCccceee
Q 020027           49 FAYPLTEIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ--HPNIVPILG  126 (332)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~  126 (332)
                      ..+..+.+....++|...+.||+|+||.||++...+++.||+|.+............+.+|+.+++.++  |+||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            334444555667789999999999999999999888999999999765443333446789999999997  599999999


Q ss_pred             eeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceE
Q 020027          127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR  206 (332)
Q Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  206 (332)
                      ++..++..+++|| +.+++|.+++....    .+++..+..++.|++.||.|||++   +++||||||+||++++ +.+|
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEE
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEE
Confidence            9999999999999 55789999997653    278999999999999999999999   9999999999999964 8999


Q ss_pred             EccCCccccCCc--------ccCCcccccCccccccc--------CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-
Q 020027          207 VCDYGLSFLAPE--------EKRGLAGYVDDDYWHEK--------GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-  269 (332)
Q Consensus       207 l~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~--------~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-  269 (332)
                      |+|||++.....        ...++..|+|||.+...        ....++.++||||||+++|||++|+.||.+.... 
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  246 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence            999999876432        22578999999998642        1246889999999999999999999999764221 


Q ss_pred             HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          270 WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ........        +......+......+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          247 SKLHAIID--------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHHHC--------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHh--------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11111111        11111111112346889999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.3e-44  Score=327.87  Aligned_cols=252  Identities=18%  Similarity=0.213  Sum_probs=189.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------c
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------E  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  133 (332)
                      ..+|...+.||+|+||.||+|+...+..+|+|++.....      ...+|+.+++.++||||+++++++...+      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            456899999999999999999976666799998864321      1247999999999999999999985433      3


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC-CCCceEEccCCc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGL  212 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~dfg~  212 (332)
                      .+++|||++++.+....... .....+++..+..++.|++.||.|||++   +|+||||||+|||++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCccHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            78999999865444333211 1122388999999999999999999999   999999999999998 799999999999


Q ss_pred             cccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c-----c
Q 020027          213 SFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R-----F  280 (332)
Q Consensus       213 a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~-----~  280 (332)
                      ++....     ...+|..|+|||.+...  ..++.++||||+||++|||++|+.||.+....+....+...  .     +
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            975432     23578899999988652  46899999999999999999999999876544433222110  0     0


Q ss_pred             ----ccccCCcCCC--C------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 ----SELLDPRLAI--P------CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ----~~~~~~~~~~--~------~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          .......+..  +      .......++.+++.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                0000000000  0      01112347889999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-43  Score=329.97  Aligned_cols=251  Identities=20%  Similarity=0.217  Sum_probs=188.6

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------Cc
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------GE  133 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  133 (332)
                      .+|...+.||+|+||.||+|+. .+|+.||+|++....      ....+|+.+++.++||||+++++++...      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            3688889999999999999995 579999999986432      1235799999999999999999988432      23


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccCCc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYGL  212 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~  212 (332)
                      .+++|||+++ ++...+.........+++..+..++.|++.||.|||++   +|+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            6789999975 66665543211223389999999999999999999998   99999999999999954 6789999999


Q ss_pred             cccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc---------
Q 020027          213 SFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM---------  278 (332)
Q Consensus       213 a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~---------  278 (332)
                      ++....     ...+|..|+|||.+...  ..++.++|||||||++|||++|+.||.+....+....+...         
T Consensus       204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          204 AKQLVRGEPNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             CEECCTTCCCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhcccCCCceeeeeCCCcCCHHHHcCC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            975432     23578899999988652  46899999999999999999999999876543332222110         


Q ss_pred             -----ccccccCCcCCCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 -----RFSELLDPRLAIP-----CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 -----~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           .+.+..-+.+...     .......++.+++.+||+.||++|||+.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                 0000000110000     01112347889999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.2e-43  Score=320.19  Aligned_cols=261  Identities=21%  Similarity=0.208  Sum_probs=188.1

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      .......++|...+.||+|+||.||+|+. .+|+.||+|.+....   .......+++..++.++||||+++++++...+
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG   92 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence            55667788999999999999999999994 579999999986532   22234577888888899999999999986533


Q ss_pred             c-------eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhh--cCCCCCeeecCCCCCCEEeCC-C
Q 020027          133 E-------RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH--QGVAPNIIHGCIKASNILLNE-K  202 (332)
Q Consensus       133 ~-------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~~~~ivH~dlk~~Nill~~-~  202 (332)
                      .       .+++|||+++ ++...+.........+++..+..++.|++.|+.|||  ++   +|+||||||+|||++. +
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence            3       7899999986 554444322122234788999999999999999999  77   9999999999999996 8


Q ss_pred             CceEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh
Q 020027          203 FCARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~  277 (332)
                      +.+||+|||+++.....     ..+|..|+|||.+...  ..++.++|||||||++|||+||+.||.+.........+..
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN--QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            99999999999765432     2578899999988642  4589999999999999999999999987655544433322


Q ss_pred             cc------cccccCCc----------------CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 MR------FSELLDPR----------------LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 ~~------~~~~~~~~----------------~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..      .....++.                ............+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            10      00000000                000111223457889999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5e-43  Score=320.53  Aligned_cols=252  Identities=18%  Similarity=0.220  Sum_probs=195.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce----
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER----  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  134 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4688999999999999999999 56899999999976543333344678999999999999999999999876654    


Q ss_pred             --eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          135 --IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       135 --~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                        +++|||+. ++|.+++...      +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGME------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 6888877432      78999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc--c-cc----
Q 020027          213 SFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR--F-SE----  282 (332)
Q Consensus       213 a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~-~~----  282 (332)
                      ++.....   ..+|..|+|||.+...  ..++.++|||||||++|||+||+.||.+....+....+....  . .+    
T Consensus       191 a~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          191 ARHADAEMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             C--------CTTCCCTTSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccccCcCCcccCccccCHHHhcCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            9765433   3578999999988652  568899999999999999999999998765444333322100  0 00    


Q ss_pred             -----------ccCCcCCCC---CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 -----------LLDPRLAIP---CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 -----------~~~~~~~~~---~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                 .........   ........+.+++.+||+.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                       000000000   00112347889999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-43  Score=331.43  Aligned_cols=251  Identities=20%  Similarity=0.252  Sum_probs=199.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC-CCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH-PNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|. ..+++.||||.+.....    ...+..|+.+++.++| +++..+..++...+..+++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            4679999999999999999999 46899999998764432    2357899999999987 5555566666778888999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe---CCCCceEEccCCccc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL---NEKFCARVCDYGLSF  214 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~  214 (332)
                      |||+ +++|.+++.....   .+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus        82 me~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            9999 8999999975432   289999999999999999999999   99999999999999   588999999999986


Q ss_pred             cCCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH---HHHHHhhhc
Q 020027          215 LAPE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK---WALPLIKEM  278 (332)
Q Consensus       215 ~~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~---~~~~~~~~~  278 (332)
                      ....             ...||..|++||.+..   ..++.++|||||||++|||++|+.||.+....   .....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence            5432             2358899999999876   67899999999999999999999999864321   111222221


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ........ +..    ....++.+++.+||+.||++||++.++++.|+++.
T Consensus       232 ~~~~~~~~-l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          232 KVATSIEA-LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HHHSCHHH-HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cccccHHH-Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            11111000 000    11247889999999999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6e-43  Score=314.67  Aligned_cols=247  Identities=15%  Similarity=0.164  Sum_probs=192.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeec--CCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQA--PGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~  135 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.++...     ...+.+|+.+++.++ ||||+++++++..  ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            4678899999999999999998 5689999999986432     235789999999997 9999999999987  56789


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEccCCccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCDYGLSF  214 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~  214 (332)
                      ++|||+++++|.+++..       +++..+..++.|++.||.|||++   +++||||||+|||++.++ .+||+|||+++
T Consensus       110 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            99999999999998853       68889999999999999999999   999999999999999766 89999999997


Q ss_pred             cCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCch-hHHHHHHH-------------h
Q 020027          215 LAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGL-LVKWALPL-------------I  275 (332)
Q Consensus       215 ~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~-~~~~~~~~-------------~  275 (332)
                      ....     ...++..|+|||.+...  ..++.++|||||||++|||++|+.||... ........             +
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          180 FYHPGQEYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             ECCTTCCCCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             EcCCCCccccccccccccChhhhcCC--CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence            5432     23578889999998652  56889999999999999999999998432 11111111             0


Q ss_pred             hhccc------cc--------ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          276 KEMRF------SE--------LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       276 ~~~~~------~~--------~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .....      ..        .................+.+++.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000      00        00000001111112347889999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=319.60  Aligned_cols=251  Identities=15%  Similarity=0.137  Sum_probs=199.3

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEE------eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC---CCCccce
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAAL------LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPI  124 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~  124 (332)
                      .++....++|...+.||+|+||.||+|.      ..+++.||+|.++...     ...+..|+.+++.++   |+|++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            3444556778889999999999999993      5578999999986432     234577777777776   9999999


Q ss_pred             eeeeecCCceeEEEeccCCCCHHHHhcccCC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC--
Q 020027          125 LGFSQAPGERIIVSEFINMASLDFYLHENND-GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE--  201 (332)
Q Consensus       125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--  201 (332)
                      ++++..++..+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.  
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence            9999999999999999999999999975321 123489999999999999999999998   9999999999999998  


Q ss_pred             ---------CCceEEccCCccccCC--------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 020027          202 ---------KFCARVCDYGLSFLAP--------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE  264 (332)
Q Consensus       202 ---------~~~~kl~dfg~a~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~  264 (332)
                               ++.+||+|||+|+...        ....||..|+|||.+..   ..++.++|||||||++|||+||+.||.
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT---CCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC---CCCCccccHHHHHHHHHHHHhCCCccc
Confidence                     8999999999995432        12358999999999876   668999999999999999999999986


Q ss_pred             chhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhccc
Q 020027          265 GLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNR-PSIVQVATILNNLV  329 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~R-Ps~~~i~~~L~~~~  329 (332)
                      .....         ..  .....+....   ....+.+++..|++.+|.+| |++.++.+.|++.+
T Consensus       287 ~~~~~---------~~--~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          287 KNEGG---------EC--KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             EEETT---------EE--EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCCCC---------ce--eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            53211         00  0111111111   13356689999999999999 68888888888765

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.9e-43  Score=320.47  Aligned_cols=252  Identities=23%  Similarity=0.272  Sum_probs=196.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      .++|...+.||+|+||.||+|. ..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            4579999999999999999999 45788999999975322 22223578999999999999999999998654     36


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||++ ++|.+++....     +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~~-----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEcccC-cCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence            899999997 58999886532     78999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c-cc
Q 020027          214 FLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R-FS  281 (332)
Q Consensus       214 ~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~-~~  281 (332)
                      ......         ..||..|+|||.+...  ..++.++|||||||++|||+||+.||.+.........+...  . ..
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTB--CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCC--CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            755322         2678999999987542  55899999999999999999999999876544333322110  0 00


Q ss_pred             c----cc---------CCcCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          282 E----LL---------DPRLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       282 ~----~~---------~~~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +    ..         ........+     ......+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0    00         000000000     112346789999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.2e-43  Score=318.00  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=195.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      .++|...+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+|+.+++.++||||+++++++..+     +.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            56789999999999999999994 5789999999964321 22223567999999999999999999987654     67


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+. ++|.+++...     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            899999997 6899888753     278999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCcc----------------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhh
Q 020027          214 FLAPEE----------------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE  277 (332)
Q Consensus       214 ~~~~~~----------------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~  277 (332)
                      ......                ..||..|+|||.+...  ..++.++|||||||++|||++|+.||.+.........+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS--AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSC--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccC--CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            754321                2468889999987542  5689999999999999999999999987654433322211


Q ss_pred             c--ccc--------------cccCCcCCCCC-C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          278 M--RFS--------------ELLDPRLAIPC-E-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       278 ~--~~~--------------~~~~~~~~~~~-~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .  ...              +........+. .     ......+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0  000              00000000000 0     122346789999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=317.28  Aligned_cols=251  Identities=18%  Similarity=0.219  Sum_probs=195.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc-----
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE-----  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  133 (332)
                      .++|...+.||+|+||.||+|. ..+|+.||+|.+............+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4678899999999999999999 4689999999997654333333457899999999999999999999977654     


Q ss_pred             -eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          134 -RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       134 -~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                       .+++|||++ ++|.+++..      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 588777642      178999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--c--------
Q 020027          213 SFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--R--------  279 (332)
Q Consensus       213 a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~--------  279 (332)
                      +......   ..++..|+|||.+...  ..++.++|||||||++|||++|+.||.+.........+...  .        
T Consensus       173 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADAEMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC--------CCSBCCSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCCCccccccCcCcCCHHHHhCc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9765433   3578999999988652  56789999999999999999999999876544333222110  0        


Q ss_pred             ------------cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 ------------FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ------------~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                  ......+.+. .........+.+++.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                        0000000000 011123347889999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.5e-43  Score=309.74  Aligned_cols=244  Identities=19%  Similarity=0.245  Sum_probs=190.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--------  130 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  130 (332)
                      .++|...+.||+|+||.||+|+. .+++.||+|.+....   .....+.+|+.+++.++||||+++++++..        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            45688899999999999999994 589999999986421   222357899999999999999999998754        


Q ss_pred             -----CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCce
Q 020027          131 -----PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCA  205 (332)
Q Consensus       131 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  205 (332)
                           .+..+++|||+++++|.+++....   ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence                 356799999999999999997643   2368889999999999999999999   99999999999999999999


Q ss_pred             EEccCCccccCCc--------------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCc
Q 020027          206 RVCDYGLSFLAPE--------------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       206 kl~dfg~a~~~~~--------------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~  265 (332)
                      ||+|||++.....                    ...++..|+|||.+...  ..++.++|||||||++|||++   ||..
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSC--SCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC--CCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            9999999875431                    12478899999998752  468899999999999999998   5543


Q ss_pred             h-hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          266 L-LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       266 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      . ........+....      ..++...+......+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          231 GMERVNILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2 2222222222211      11111222233346789999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-43  Score=317.21  Aligned_cols=247  Identities=16%  Similarity=0.246  Sum_probs=198.1

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc----cccccHHHHHHHhccCC--CCCccce
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS----NAGFGFASVIKTLSLAQ--HPNIVPI  124 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~  124 (332)
                      +..+.+...++|...+.||+|+||.||+|. ..+++.||+|.+.......    .....+.+|+.+++.++  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            445556667889999999999999999998 5688999999997654332    12235678999999986  5999999


Q ss_pred             eeeeecCCceeEEEeccCC-CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC-CC
Q 020027          125 LGFSQAPGERIIVSEFINM-ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN-EK  202 (332)
Q Consensus       125 ~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~  202 (332)
                      ++++..++..++++|++.+ ++|.+++.....    +++..++.++.|++.||.|||+.   +|+||||||+||+++ ++
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence            9999999999999999976 899999976433    78999999999999999999999   999999999999999 78


Q ss_pred             CceEEccCCccccCCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc
Q 020027          203 FCARVCDYGLSFLAPEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM  278 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~  278 (332)
                      +.+||+|||++....+.    ..++..|+|||.+...  ...+.++||||||+++|||+||+.||......      ...
T Consensus       187 ~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~  258 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRG  258 (320)
T ss_dssp             TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHC
T ss_pred             CCEEEeeCccccccccccccCCCCCccCCChHHhccC--CCCCccchHHhHHHHHHHHHHCCCCCCChhhh------hcc
Confidence            99999999998765433    3578999999988762  33478899999999999999999999764311      111


Q ss_pred             ccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..        ..+  .....++.+++.+||+.||++|||++|+++
T Consensus       259 ~~--------~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          259 QV--------FFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CC--------CCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc--------ccc--ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10        011  111236789999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.6e-42  Score=312.44  Aligned_cols=253  Identities=18%  Similarity=0.208  Sum_probs=199.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe--CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCC------Cccceeeeeec
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL--STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP------NIVPILGFSQA  130 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~  130 (332)
                      ..++|...+.||+|+||.||+|..  .+++.||+|.++...   .....+.+|+.+++.++|+      +++++++++..
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            356899999999999999999984  478899999986432   1223467888888877654      59999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---------
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---------  201 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---------  201 (332)
                      .+..+++|||+ +++|.+++.....  ..+++..+..++.|++.||.|||++   +++||||||+||+++.         
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            99999999999 8899999976542  2378999999999999999999999   9999999999999987         


Q ss_pred             ----------CCceEEccCCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH
Q 020027          202 ----------KFCARVCDYGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV  268 (332)
Q Consensus       202 ----------~~~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~  268 (332)
                                ++.+||+|||++......   ..+|..|+|||.+..   ..++.++|||||||++|||+||..||.+...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA---LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTT---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      668999999999765433   367899999999876   6789999999999999999999999987654


Q ss_pred             HHHHHHhhhc--cccc-------------------------------ccCC-cCCCCCChHHHHHHHHHHHHcccCCCCC
Q 020027          269 KWALPLIKEM--RFSE-------------------------------LLDP-RLAIPCEIKPLVRLAKVALACVGNSRKN  314 (332)
Q Consensus       269 ~~~~~~~~~~--~~~~-------------------------------~~~~-~~~~~~~~~~~~~l~~l~~~c~~~dp~~  314 (332)
                      .+....+...  ....                               ...+ .............+.+++.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            4433322110  0000                               0000 0001122345668889999999999999


Q ss_pred             CCCHHHHHH
Q 020027          315 RPSIVQVAT  323 (332)
Q Consensus       315 RPs~~~i~~  323 (332)
                      |||+.|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-42  Score=318.93  Aligned_cols=262  Identities=19%  Similarity=0.183  Sum_probs=199.1

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CC-----Cccce
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HP-----NIVPI  124 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~  124 (332)
                      .....+...++|...+.||+|+||.||+|. ..+++.||+|.++....   ....+..|+.+++.++ |+     +++++
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA---FLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH---HHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH---HHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            334444557889999999999999999999 45788999999974321   1223567777777764 44     49999


Q ss_pred             eeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC--CC
Q 020027          125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN--EK  202 (332)
Q Consensus       125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~  202 (332)
                      ++++...+..+++|||++ ++|.+++......  .+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .+
T Consensus       122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~  197 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR  197 (382)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred             eeeeccCCceEEEEecCC-CCHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence            999999999999999996 5999998765322  378999999999999999999953 23899999999999995  47


Q ss_pred             CceEEccCCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc
Q 020027          203 FCARVCDYGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR  279 (332)
Q Consensus       203 ~~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~  279 (332)
                      +.+||+|||+++.....   ..+|..|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+....
T Consensus       198 ~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~  274 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLG---MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL  274 (382)
T ss_dssp             CCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             CcEEEEeccCceecccccccccCCccccChHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            88999999999765432   368899999999876   678999999999999999999999998765544433322100


Q ss_pred             -----------------cccccCC------------cCCC-------------------------CCChHHHHHHHHHHH
Q 020027          280 -----------------FSELLDP------------RLAI-------------------------PCEIKPLVRLAKVAL  305 (332)
Q Consensus       280 -----------------~~~~~~~------------~~~~-------------------------~~~~~~~~~l~~l~~  305 (332)
                                       +....+.            ....                         .....+...+.+++.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  354 (382)
T 2vx3_A          275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL  354 (382)
T ss_dssp             CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence                             0000000            0000                         011123357889999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 020027          306 ACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       306 ~c~~~dp~~RPs~~~i~~  323 (332)
                      +||+.||++|||+.|+++
T Consensus       355 ~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          355 RMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HhcCCChhhCCCHHHHhc
Confidence            999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-43  Score=311.42  Aligned_cols=244  Identities=21%  Similarity=0.311  Sum_probs=188.2

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc----cccccHHHHHHHhccC----CCCCcccee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS----NAGFGFASVIKTLSLA----QHPNIVPIL  125 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~~~  125 (332)
                      ..+...++|...+.||+|+||.||+|. ..+++.||+|.+.......    .....+.+|+..+.++    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            445567789999999999999999998 4688999999997554322    1223457788888887    899999999


Q ss_pred             eeeecCCceeEEEec-cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC-CCC
Q 020027          126 GFSQAPGERIIVSEF-INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN-EKF  203 (332)
Q Consensus       126 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~  203 (332)
                      +++...+..++++|+ +.+++|.+++.....    +++..++.++.|++.||.|||++   +++||||||+||+++ .++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence            999998999999999 789999999976542    78999999999999999999999   999999999999999 889


Q ss_pred             ceEEccCCccccCCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc
Q 020027          204 CARVCDYGLSFLAPEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR  279 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~  279 (332)
                      .+||+|||++......    ..++..|++||.+...  ...+.++||||||+++|||++|+.||.+...  .    ....
T Consensus       178 ~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~----~~~~  249 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRH--QYHALPATVWSLGILLYDMVCGDIPFERDQE--I----LEAE  249 (312)
T ss_dssp             EEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H----HHTC
T ss_pred             eEEEEEcchhhhcccCcccccCCcccccCceeeecC--CCCCccchHHHHHHHHHHHHHCCCCCCChHH--H----hhhc
Confidence            9999999998765432    3578899999988752  2334689999999999999999999976421  1    1111


Q ss_pred             cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                              ...+  ......+.+++.+||+.||++|||+.|+++
T Consensus       250 --------~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 --------LHFP--AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --------CCCC--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------cCCc--ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    1111  112236789999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-42  Score=313.59  Aligned_cols=248  Identities=18%  Similarity=0.192  Sum_probs=171.4

Q ss_pred             hcCCCCCC-ceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHH-HHHhccCCCCCccceeeeeec----C
Q 020027           59 ATDGFSHR-RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASV-IKTLSLAQHPNIVPILGFSQA----P  131 (332)
Q Consensus        59 ~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e-~~~l~~l~h~niv~~~~~~~~----~  131 (332)
                      ..++|... +.||+|+||.||+|+. .+|+.||+|.+....       ...+| ...++.++||||+++++++..    .
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            35678885 4699999999999994 589999999986431       12333 334566799999999999865    4


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEc
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVC  208 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~  208 (332)
                      +..+++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+||+++.   ++.+||+
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            458999999999999999986532  2389999999999999999999999   9999999999999976   4559999


Q ss_pred             cCCccccCCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          209 DYGLSFLAPEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       209 dfg~a~~~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      |||++......    ..+|..|+|||.+..   ..++.++|||||||++|||++|..||.+...............  ..
T Consensus       174 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~  248 (336)
T 3fhr_A          174 DFGFAKETTQNALQTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR--LG  248 (336)
T ss_dssp             CCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             ccccceeccccccccCCCCcCccChhhhCC---CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh--cc
Confidence            99999755432    357889999999865   6788999999999999999999999976544332111111000  00


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+........+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            011111111233447889999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=310.51  Aligned_cols=251  Identities=19%  Similarity=0.263  Sum_probs=181.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|...+.||+|+||.||+|.. .+|+.||+|.+............+.++...++.++||||+++++++..++..+++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            356788899999999999999995 5899999999976543322222334455567888999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |||+ ++.+..+......   .+++..+..++.|++.||.|||+ +   +++||||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 5566665543222   27899999999999999999998 5   8999999999999999999999999998654


Q ss_pred             Ccc-----cCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCch-hHHHHHHHhhhcccccccCCcC
Q 020027          217 PEE-----KRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGL-LVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       217 ~~~-----~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ...     ..++..|+|||.+...  ....++.++||||||+++|||+||+.||... ........+.....     +. 
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~~-  249 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-----PL-  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-----CC-
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-----CC-
Confidence            322     3578999999998532  1356889999999999999999999999763 22222222222211     11 


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .+........+.+++.+||+.||.+|||+.++++
T Consensus       250 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 -LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             1111122336889999999999999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=310.04  Aligned_cols=251  Identities=22%  Similarity=0.255  Sum_probs=188.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee---------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ---------  129 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---------  129 (332)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+....  ......+.+|+.+++.++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            46788999999999999999995 468999999987542  222335789999999999999999999873         


Q ss_pred             -----cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC-CCC
Q 020027          130 -----APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN-EKF  203 (332)
Q Consensus       130 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~  203 (332)
                           ..+..+++|||++ ++|.+++...     .+++..+..++.|++.||.|||++   +++||||||+||+++ +++
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                 3467899999997 6999998642     278899999999999999999999   999999999999997 567


Q ss_pred             ceEEccCCccccCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHH
Q 020027          204 CARVCDYGLSFLAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPL  274 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~  274 (332)
                      .+||+|||+++....         ...++..|+|||.+...  ..++.++|||||||++|||+||+.||.+.........
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL  236 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCc--ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999976432         12457889999987643  5689999999999999999999999987655443332


Q ss_pred             hhhcc-c------ccc-------cCCcCCCC-CC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          275 IKEMR-F------SEL-------LDPRLAIP-CE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       275 ~~~~~-~------~~~-------~~~~~~~~-~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +.... .      .+.       .......+ .+     ......+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            22110 0      000       00000000 00     112346889999999999999999999976

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-42  Score=312.79  Aligned_cols=257  Identities=21%  Similarity=0.267  Sum_probs=177.8

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHH-HhccCCCCCccceeeeeecCCcee
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIK-TLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ...++|...+.||+|+||.||+|.. .+|+.||+|.++...... ....+..|+. .++.++||||+++++++..++..+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            4467899999999999999999995 588999999997653222 2223455555 678889999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccC-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          136 IVSEFINMASLDFYLHENN-DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++|||+++ +|.+++.... .....+++..+..++.|++.||.|||++  .+++||||||+||+++.++.+||+|||+++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            99999975 7777765311 1122378999999999999999999984  289999999999999999999999999997


Q ss_pred             cCCcc-----cCCcccccCccccccc-CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-HHHHHhhhcccccccCCc
Q 020027          215 LAPEE-----KRGLAGYVDDDYWHEK-GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-WALPLIKEMRFSELLDPR  287 (332)
Q Consensus       215 ~~~~~-----~~~~~~~~~pe~~~~~-~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  287 (332)
                      .....     ..++..|+|||.+... .+..++.++|||||||++|||+||+.||.+.... .....+..+     ..+.
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~  249 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-----DPPQ  249 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-----CCCC
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-----CCCC
Confidence            65432     2578899999998432 2356889999999999999999999999764321 111111111     0111


Q ss_pred             CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       288 ~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +...........+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111111123347889999999999999999999865

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.7e-43  Score=322.35  Aligned_cols=254  Identities=19%  Similarity=0.190  Sum_probs=192.7

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC--------CCCccceeeeee
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ--------HPNIVPILGFSQ  129 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~  129 (332)
                      ..++|...+.||+|+||.||+|+ ..+++.||+|.++...   .....+.+|+.+++.++        |+||+++++++.
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            35789999999999999999998 5678999999987432   12234678999888875        788999999987


Q ss_pred             ----cCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC--
Q 020027          130 ----APGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF--  203 (332)
Q Consensus       130 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~--  203 (332)
                          .....+++|||+ ++++.+++.....  ..+++..++.++.|++.||.|||+++  +|+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence                456789999999 4566655544322  23899999999999999999999853  899999999999998775  


Q ss_pred             -----------------------------------------------ceEEccCCccccCCcc---cCCcccccCccccc
Q 020027          204 -----------------------------------------------CARVCDYGLSFLAPEE---KRGLAGYVDDDYWH  233 (332)
Q Consensus       204 -----------------------------------------------~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~  233 (332)
                                                                     .+||+|||++......   ..+|..|+|||.+.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc
Confidence                                                           7999999999765432   35799999999987


Q ss_pred             ccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH------HHHHHHhhh------------cccc-cccCC--c-----
Q 020027          234 EKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV------KWALPLIKE------------MRFS-ELLDP--R-----  287 (332)
Q Consensus       234 ~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~------~~~~~~~~~------------~~~~-~~~~~--~-----  287 (332)
                      .   ..++.++|||||||++|||+||+.||.+...      ......+..            +... .....  .     
T Consensus       267 ~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          267 G---SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             T---SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             C---CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            6   5689999999999999999999999975321      111111100            0000 00000  0     


Q ss_pred             ------------CCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          288 ------------LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       288 ------------~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                  .....+......+.+++.+||+.||++|||+.|+++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                        001223455667889999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.5e-43  Score=322.68  Aligned_cols=252  Identities=18%  Similarity=0.186  Sum_probs=178.4

Q ss_pred             CCCC-CceeeccCCeEEEEEEeC---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeee--cCCcee
Q 020027           62 GFSH-RRIIGQGRLGTVYAALLS---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQ--APGERI  135 (332)
Q Consensus        62 ~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  135 (332)
                      .|.. .+.||+|+||.||+|+..   +++.||+|.+....    ....+.+|+.+++.++||||+++++++.  .....+
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            3444 457999999999999954   67899999986432    2235689999999999999999999994  467889


Q ss_pred             EEEeccCCCCHHHHhcccC-----CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe----CCCCceE
Q 020027          136 IVSEFINMASLDFYLHENN-----DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL----NEKFCAR  206 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~k  206 (332)
                      ++|||++ ++|.+++....     .....+++..++.++.|++.||.|||++   +|+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999996 57877775321     1112388999999999999999999999   99999999999999    6788999


Q ss_pred             EccCCccccCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH--------
Q 020027          207 VCDYGLSFLAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK--------  269 (332)
Q Consensus       207 l~dfg~a~~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~--------  269 (332)
                      |+|||+++....         ...||..|+|||.+...  ..++.++|||||||++|||+||+.||.+...+        
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTC--CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCC--CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999976432         23578999999998752  45899999999999999999999999754321        


Q ss_pred             -HHHHHhhh-cc------cccc-------------cCCcCCCC--------CChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 020027          270 -WALPLIKE-MR------FSEL-------------LDPRLAIP--------CEIKPLVRLAKVALACVGNSRKNRPSIVQ  320 (332)
Q Consensus       270 -~~~~~~~~-~~------~~~~-------------~~~~~~~~--------~~~~~~~~l~~l~~~c~~~dp~~RPs~~~  320 (332)
                       .....+.. ..      +...             ........        ........+.+++.+||+.||.+|||++|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence             11111100 00      0000             00000000        00001236779999999999999999999


Q ss_pred             HHH
Q 020027          321 VAT  323 (332)
Q Consensus       321 i~~  323 (332)
                      +++
T Consensus       331 ~L~  333 (405)
T 3rgf_A          331 AMQ  333 (405)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=319.65  Aligned_cols=246  Identities=23%  Similarity=0.275  Sum_probs=188.2

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ...+|...+.||+|+||+|+.....+|+.||||++.....     ..+.+|+.+++.+ +||||+++++++...+..+++
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            3456888899999999997655566899999999865321     2357899999988 799999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-----CCceEEccCCc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-----KFCARVCDYGL  212 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~dfg~  212 (332)
                      |||+. ++|.+++......   .++..++.++.|++.||.|||++   +|+||||||+|||++.     +..+||+|||+
T Consensus        97 ~E~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EECCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99996 6999999765432   33345678999999999999999   9999999999999953     33688999999


Q ss_pred             cccCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccc
Q 020027          213 SFLAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       213 a~~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      ++.....         ..||..|+|||.+.......++.++|||||||++|||+| |..||.................  
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--  247 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL--  247 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC--
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc--
Confidence            8765422         358999999999875434677889999999999999999 8889866543332221111110  


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          . ...........+.+++.+||+.||++|||+.|+++
T Consensus       248 ----~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 ----D-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ----T-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----c-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                0 11112234446779999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.3e-42  Score=310.18  Aligned_cols=253  Identities=19%  Similarity=0.203  Sum_probs=195.5

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCC-CEEEEEEeccCcccccccccHHHHHHHhccCCCCC------ccceeeeeec
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STG-KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN------IVPILGFSQA  130 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~  130 (332)
                      ..++|...+.||+|+||.||+|.. .++ +.||+|.++...   .....+.+|+.+++.++|+|      ++.+.+++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            357899999999999999999994 344 689999986432   22234678888888887655      8999999999


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEe-----------
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILL-----------  199 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-----------  199 (332)
                      .+..+++|||+ ++++.+++.....  ..+++..+..++.|++.||.|||++   +|+||||||+|||+           
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence            99999999999 5667677665432  2388999999999999999999998   99999999999999           


Q ss_pred             --------CCCCceEEccCCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhH
Q 020027          200 --------NEKFCARVCDYGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLV  268 (332)
Q Consensus       200 --------~~~~~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~  268 (332)
                              +.++.+||+|||++......   ..+|..|+|||.+..   ..++.++|||||||++|||+||+.||.+...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeec---CCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                    56789999999999764432   368899999999876   6789999999999999999999999987654


Q ss_pred             HHHHHHhhhc--cccc-----------c--------------------cCC-cCCCCCChHHHHHHHHHHHHcccCCCCC
Q 020027          269 KWALPLIKEM--RFSE-----------L--------------------LDP-RLAIPCEIKPLVRLAKVALACVGNSRKN  314 (332)
Q Consensus       269 ~~~~~~~~~~--~~~~-----------~--------------------~~~-~~~~~~~~~~~~~l~~l~~~c~~~dp~~  314 (332)
                      ......+...  ....           .                    ..+ .............+.+++.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            4433222110  0000           0                    000 0001122344567889999999999999


Q ss_pred             CCCHHHHHH
Q 020027          315 RPSIVQVAT  323 (332)
Q Consensus       315 RPs~~~i~~  323 (332)
                      |||+.|+++
T Consensus       325 Rpt~~e~l~  333 (355)
T 2eu9_A          325 RITLAEALL  333 (355)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHhc
Confidence            999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.3e-42  Score=319.94  Aligned_cols=248  Identities=22%  Similarity=0.236  Sum_probs=186.3

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCceeEEEec
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .|...+.||+|+||+||.+...+|+.||||.+....     ...+.+|+.+++.+ +||||+++++++..++..+++|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            344567899999999987666689999999986432     12457899999876 899999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCc---CCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-------------Cc
Q 020027          141 INMASLDFYLHENNDGASL---LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-------------FC  204 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-------------~~  204 (332)
                      +. ++|.+++.........   .++..++.++.|++.||.|||++   +|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 6999999764332111   12334578999999999999999   99999999999999654             48


Q ss_pred             eEEccCCccccCCcc----------cCCcccccCccccccc----CCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHH
Q 020027          205 ARVCDYGLSFLAPEE----------KRGLAGYVDDDYWHEK----GGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVK  269 (332)
Q Consensus       205 ~kl~dfg~a~~~~~~----------~~~~~~~~~pe~~~~~----~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~  269 (332)
                      +||+|||++......          ..||..|+|||.+...    ....++.++|||||||++|||+| |+.||.+....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999998764332          2588999999998652    12568999999999999999999 89999765332


Q ss_pred             HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          270 WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..  .+..+...   .+......+.....++.+++.+||+.||++|||+.++++
T Consensus       247 ~~--~i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 ES--NIIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH--HHHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH--HHhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            21  11111110   011122233455668899999999999999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-41  Score=300.97  Aligned_cols=232  Identities=16%  Similarity=0.104  Sum_probs=183.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+....... .....+.+|+..++.++||||+++++++..++..+++
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            46799999999999999999995 568999999998654432 2224578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.++++..      ....++..++.|++.||.|||++   +|+||||||+|||++.++.+||+++|      
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999542      34557888999999999999999   99999999999999999999998553      


Q ss_pred             cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC--CCChH
Q 020027          218 EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI--PCEIK  295 (332)
Q Consensus       218 ~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  295 (332)
                              |+          ..++.++|||||||++|||+||+.||.+.........     ...........  .....
T Consensus       175 --------~~----------~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 --------TM----------PDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----AERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             --------CC----------TTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----CCBCTTSCBCCHHHHCTT
T ss_pred             --------cc----------CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----HHHHhccCCCChhhcccC
Confidence                    32          2468899999999999999999999987532211100     00000110000  00112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          296 PLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ....+.+++.+||+.||++| |+.|+++.|+++..
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            23468899999999999999 99999999998653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.4e-42  Score=312.56  Aligned_cols=253  Identities=17%  Similarity=0.181  Sum_probs=192.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-----------CCCccceeee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-----------HPNIVPILGF  127 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~  127 (332)
                      .++|...+.||+|+||.||+|+ ..+++.||+|.+.....   ....+.+|+.++++++           |+||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            4679999999999999999999 46889999999874321   2234678888888775           8999999999


Q ss_pred             eecCC----ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC---
Q 020027          128 SQAPG----ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN---  200 (332)
Q Consensus       128 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---  200 (332)
                      +...+    ..+++||++ +++|.+++......  .+++..+..++.|++.||.|||+++  +|+||||||+|||++   
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            87543    789999999 88999999764332  2789999999999999999999842  899999999999994   


Q ss_pred             ---CCCceEEccCCccccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH-----
Q 020027          201 ---EKFCARVCDYGLSFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK-----  269 (332)
Q Consensus       201 ---~~~~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~-----  269 (332)
                         ..+.+||+|||++......   ..+|..|+|||.+..   ..++.++|||||||++|||+||+.||.+....     
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT---CCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               4458999999999765432   368899999999876   67899999999999999999999999754311     


Q ss_pred             -HHHHHhhh--ccccc-----------------ccCC-------------cCCCCCChHHHHHHHHHHHHcccCCCCCCC
Q 020027          270 -WALPLIKE--MRFSE-----------------LLDP-------------RLAIPCEIKPLVRLAKVALACVGNSRKNRP  316 (332)
Q Consensus       270 -~~~~~~~~--~~~~~-----------------~~~~-------------~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP  316 (332)
                       .....+..  +....                 ....             ......+......+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence             11111100  00000                 0000             001123345667888999999999999999


Q ss_pred             CHHHHHH
Q 020027          317 SIVQVAT  323 (332)
Q Consensus       317 s~~~i~~  323 (332)
                      |+.|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.3e-41  Score=299.45  Aligned_cols=229  Identities=17%  Similarity=0.217  Sum_probs=177.6

Q ss_pred             cCCCCCC-ceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHh-ccCCCCCccceeeeeec----CC
Q 020027           60 TDGFSHR-RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL-SLAQHPNIVPILGFSQA----PG  132 (332)
Q Consensus        60 ~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~  132 (332)
                      .++|... +.||+|+||.||++. ..+++.||+|.++..       ..+.+|+..+ +..+||||+++++++..    .+
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            3456666 789999999999999 468899999998532       2457788877 56699999999999876    67


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEcc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCD  209 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~d  209 (332)
                      ..+++|||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +++||||||+||+++.   ++.+||+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             eEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence            78999999999999999987542  2388999999999999999999999   9999999999999998   78999999


Q ss_pred             CCccccCCcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          210 YGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       210 fg~a~~~~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      ||++.....                   ..++.++|||||||++|||+||+.||.+............    ........
T Consensus       164 fg~a~~~~~-------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----~~~~~~~~  220 (299)
T 3m2w_A          164 FGFAKETTG-------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYE  220 (299)
T ss_dssp             CTTCEECTT-------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC----SSCTTCCS
T ss_pred             ccccccccc-------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH----HHhhcccc
Confidence            999865331                   4567899999999999999999999977543322111111    11111111


Q ss_pred             CCCC--hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCE--IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~--~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.+  .....++.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1100  122347889999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-41  Score=325.79  Aligned_cols=263  Identities=19%  Similarity=0.224  Sum_probs=195.4

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec------C
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA------P  131 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~  131 (332)
                      ..++|...+.||+|+||.||+|.. .+|+.||+|.++.... ......+.+|+.+++.++||||+++++++..      .
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            347899999999999999999994 6789999999875432 2223357899999999999999999998755      6


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCc---eEEc
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFC---ARVC  208 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~  208 (332)
                      +..+++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   +||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            778999999999999999986443 22378888999999999999999998   9999999999999987664   9999


Q ss_pred             cCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHH-Hhhh-----
Q 020027          209 DYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALP-LIKE-----  277 (332)
Q Consensus       209 dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~-~~~~-----  277 (332)
                      |||++......     ..++..|+|||.+..   ..++.++|||||||++|||+||..||.+......+. .+..     
T Consensus       167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQ---KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH  243 (676)
T ss_dssp             SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC---SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred             ccccccccccccccccccCCcccCChHHhcc---CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence            99999765432     357899999999875   678999999999999999999999997642211110 0000     


Q ss_pred             cccccccC------CcCC--CCCChHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHhccc
Q 020027          278 MRFSELLD------PRLA--IPCEIKPLVRLAKVALACVGNSRKNRPSIVQ-----VATILNNLV  329 (332)
Q Consensus       278 ~~~~~~~~------~~~~--~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~-----i~~~L~~~~  329 (332)
                      ....+...      ....  ..........+.+++.+||+.||++|||+.+     ..+.+..++
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            00000001      1111  1122335568889999999999999999987     445554443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-40  Score=326.50  Aligned_cols=240  Identities=20%  Similarity=0.238  Sum_probs=190.8

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC--CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc---
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS--TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE---  133 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  133 (332)
                      ..++|...+.||+|+||.||+|...  +|+.||+|.+..... ......+.+|+.+++.++||||+++++++...+.   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            4578999999999999999999953  689999999865322 2222357899999999999999999999987655   


Q ss_pred             --eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          134 --RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       134 --~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                        .++||||+++++|.+++..      .+++..++.++.|++.||.|||++   +|+||||||+|||++.+ .+||+|||
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence              6999999999999887754      289999999999999999999999   99999999999999886 89999999


Q ss_pred             ccccCCc--ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCC
Q 020027          212 LSFLAPE--EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       212 ~a~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                      +++....  ...||+.|++||.+..    ..+.++|||||||++|||++|..||.+.....            .    ..
T Consensus       227 ~a~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~----~~  286 (681)
T 2pzi_A          227 AVSRINSFGYLYGTPGFQAPEIVRT----GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------L----PE  286 (681)
T ss_dssp             TCEETTCCSCCCCCTTTSCTTHHHH----CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------C----CT
T ss_pred             cchhcccCCccCCCccccCHHHHcC----CCCCceehhhhHHHHHHHHhCCCCCccccccc------------c----cc
Confidence            9976543  3368999999999865    24899999999999999999988876531100            0    00


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccc
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRP-SIVQVATILNNLV  329 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RP-s~~~i~~~L~~~~  329 (332)
                      ..........+.+++.+||+.||++|| +++++.+.|.+++
T Consensus       287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            000112234688999999999999999 5677777776653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-40  Score=308.72  Aligned_cols=243  Identities=14%  Similarity=0.067  Sum_probs=177.9

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCC-CCcccee---------eee
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQH-PNIVPIL---------GFS  128 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~---------~~~  128 (332)
                      .+|...+.||+|+||.||+|. ..+|+.||||+++...... .....+.+|+.+++.++| .|.....         +..
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            346677899999999999999 6689999999987443322 223457899999999877 3221111         111


Q ss_pred             ------------ec-----CCceeEEEeccCCCCHHHHhccc---CCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 020027          129 ------------QA-----PGERIIVSEFINMASLDFYLHEN---NDGASLLDWNRRLRIATGAARGLEYLHQGVAPNII  188 (332)
Q Consensus       129 ------------~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iv  188 (332)
                                  ..     ....+++|+++ +++|.+++...   ......+++..++.++.|++.||.|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                        11     12356777766 68999888521   11223477889999999999999999999   999


Q ss_pred             ecCCCCCCEEeCCCCceEEccCCccccCCcc---cCCcccccCccccccc-------CCCCCCchhhhHHHHHHHHHHHh
Q 020027          189 HGCIKASNILLNEKFCARVCDYGLSFLAPEE---KRGLAGYVDDDYWHEK-------GGGNATRESDVYGFGVVLLEILS  258 (332)
Q Consensus       189 H~dlk~~Nill~~~~~~kl~dfg~a~~~~~~---~~~~~~~~~pe~~~~~-------~~~~~~~~~DiwS~G~il~el~t  258 (332)
                      ||||||+|||++.++.+||+|||+++.....   ..| ..|+|||.+...       .+..++.++|||||||++|||+|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999999998765433   356 899999998422       23567889999999999999999


Q ss_pred             CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          259 GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       259 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                      |+.||.+.........+        ......      .+..+.+++.+||+.||++|||+.+++
T Consensus       313 g~~Pf~~~~~~~~~~~~--------~~~~~~------~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI--------FRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG--------GSSCCC------CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CCCCCCCcchhhhHHHH--------Hhhccc------CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999875433221111        111111      124688999999999999999977764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-39  Score=294.14  Aligned_cols=243  Identities=14%  Similarity=0.074  Sum_probs=179.9

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccc------ccccccHHHHHHHhccCC---------CCCccc
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVL------SNAGFGFASVIKTLSLAQ---------HPNIVP  123 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~---------h~niv~  123 (332)
                      ..++|...+.||+|+||.||+|+. +|+.||+|.+......      ......+.+|+.+++.++         |||+++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            346788999999999999999998 7899999999865432      111135788888888775         666665


Q ss_pred             eeee-----------------eec-------------CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHH
Q 020027          124 ILGF-----------------SQA-------------PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA  173 (332)
Q Consensus       124 ~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~  173 (332)
                      +.+.                 +..             .+..+++|||+++|++.+.+...     .+++..+..++.|++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHH
Confidence            5554                 332             67899999999999766555331     278999999999999


Q ss_pred             HHHHHhh-cCCCCCeeecCCCCCCEEeCCCC--------------------ceEEccCCccccCCcc-cCCcccccCccc
Q 020027          174 RGLEYLH-QGVAPNIIHGCIKASNILLNEKF--------------------CARVCDYGLSFLAPEE-KRGLAGYVDDDY  231 (332)
Q Consensus       174 ~~l~~Lh-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~dfg~a~~~~~~-~~~~~~~~~pe~  231 (332)
                      .||.||| ++   +|+||||||+|||++.++                    .+||+|||+|+..... ..||..|+|||.
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~  248 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGG
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhh
Confidence            9999999 88   999999999999999887                    8999999999876443 468999999999


Q ss_pred             ccccCCCCCCchhhhHHHHHH-HHHHHhCCCCCCchhH-HHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHccc
Q 020027          232 WHEKGGGNATRESDVYGFGVV-LLEILSGRRCEEGLLV-KWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVG  309 (332)
Q Consensus       232 ~~~~~~~~~~~~~DiwS~G~i-l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~  309 (332)
                      +..   .. +.++||||+++. .+++++|..||.+... ......+....   ........+.......++.+++.+||+
T Consensus       249 ~~g---~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~dli~~~L~  321 (336)
T 2vuw_A          249 FTG---DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQEFHRTMLN  321 (336)
T ss_dssp             GCC---CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred             hcC---CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHHHHHHHhc
Confidence            875   33 889999998777 7788889999855311 11111111100   001111111123456688999999999


Q ss_pred             CCCCCCCCHHHHH
Q 020027          310 NSRKNRPSIVQVA  322 (332)
Q Consensus       310 ~dp~~RPs~~~i~  322 (332)
                      .|     |+.|++
T Consensus       322 ~d-----sa~e~l  329 (336)
T 2vuw_A          322 FS-----SATDLL  329 (336)
T ss_dssp             SS-----SHHHHH
T ss_pred             cC-----CHHHHH
Confidence            76     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.1e-32  Score=261.23  Aligned_cols=179  Identities=15%  Similarity=0.099  Sum_probs=126.8

Q ss_pred             eeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc--------cccccHHHHHHHhccC-CCCCccceeeeeecCCceeEE
Q 020027           68 IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS--------NAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        68 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..+.|++|.+..++ .-.|+.+|+|.+.+.....        .....+.+|+.+|+++ +|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35677777776665 4578999999997653211        1122488999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||++|++|.+++.....    ++..   +|+.||+.||.|+|++   ||+||||||+|||+++++.+||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            999999999999986532    5554   5789999999999999   99999999999999999999999999998664


Q ss_pred             cc------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCC
Q 020027          218 EE------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR  260 (332)
Q Consensus       218 ~~------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~  260 (332)
                      ..      ..||+.|++||.+..    .+..++|+||+|++++++.++.
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~g----~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFAE----NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC---------------------CCCCTTH
T ss_pred             CCCccccCceechhhccHHHhCC----CCCCcccccccccchhhhcccc
Confidence            33      258999999999864    4677899999999988776553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3.2e-28  Score=232.13  Aligned_cols=181  Identities=17%  Similarity=0.140  Sum_probs=141.1

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc------cccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA------GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ...+.||+|+||.||+|.. .++.+++|...........      ...+.+|+.++++++||||+++..++...+..+++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999954 5788999987653322111      12368999999999999999776666677788999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++++|.+++..            ++.++.|+++||.|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999864            347899999999999999   9999999999999998  99999999998765


Q ss_pred             c-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          218 E-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       218 ~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                      +             ...||+.|++||.+.... ..|+..+|+||..+-..+-+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~-~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL-EGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH-HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHH-HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            4             225899999999997521 24677889999998888887776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2e-24  Score=189.53  Aligned_cols=150  Identities=12%  Similarity=0.060  Sum_probs=117.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCccccc----------------ccccHHHHHHHhccCCCCCc
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSN----------------AGFGFASVIKTLSLAQHPNI  121 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~ni  121 (332)
                      .....|...+.||+|+||.||+|...+|+.||+|.++.......                ....+.+|+.+++.++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            34455666699999999999999997899999999975432111                1224789999999998  5 


Q ss_pred             cceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC
Q 020027          122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE  201 (332)
Q Consensus       122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  201 (332)
                      +++.+++.. +..+++|||+++++|.+ +..          .....++.|++.||.|||+.   +|+||||||+|||++ 
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-  227 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-
Confidence            777775543 55699999999999988 421          11346899999999999999   999999999999999 


Q ss_pred             CCceEEccCCccccCCcccCCcccccCccccc
Q 020027          202 KFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH  233 (332)
Q Consensus       202 ~~~~kl~dfg~a~~~~~~~~~~~~~~~pe~~~  233 (332)
                      ++.+||+|||+|+..       ..+.+||++.
T Consensus       228 ~~~vkl~DFG~a~~~-------~~~~a~e~l~  252 (282)
T 1zar_A          228 EEGIWIIDFPQSVEV-------GEEGWREILE  252 (282)
T ss_dssp             TTEEEECCCTTCEET-------TSTTHHHHHH
T ss_pred             CCcEEEEECCCCeEC-------CCCCHHHHHH
Confidence            999999999999643       3467787764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=4.5e-21  Score=166.16  Aligned_cols=138  Identities=17%  Similarity=0.139  Sum_probs=104.1

Q ss_pred             CCCCceeeccCCeEEEEEEe-CCCCE--EEEEEeccCcccccc----------------------cccHHHHHHHhccCC
Q 020027           63 FSHRRIIGQGRLGTVYAALL-STGKL--VAVKRIHPRLVLSNA----------------------GFGFASVIKTLSLAQ  117 (332)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~  117 (332)
                      |...+.||+|+||.||+|.. .+|+.  ||+|.++........                      ...+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55678999999999999996 78989  999987654211110                      014678999999998


Q ss_pred             CCCc--cceeeeeecCCceeEEEeccCC-C----CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhh-cCCCCCeee
Q 020027          118 HPNI--VPILGFSQAPGERIIVSEFINM-A----SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH-QGVAPNIIH  189 (332)
Q Consensus       118 h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH  189 (332)
                      |+|+  ...+++    +..+++|||+.+ |    +|.++...       .++.....++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8764  333332    356899999942 3    66665432       123456788999999999999 88   9999


Q ss_pred             cCCCCCCEEeCCCCceEEccCCccccC
Q 020027          190 GCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       190 ~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999988  8999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=8.6e-19  Score=158.39  Aligned_cols=143  Identities=13%  Similarity=0.098  Sum_probs=97.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc------------cccHHHHHHHhccCCCCCccceeee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA------------GFGFASVIKTLSLAQHPNIVPILGF  127 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~~  127 (332)
                      ..-|...+.||+|+||.||+|...+|+.||||+++........            ......+.+......|+|+.+++..
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            3458889999999999999999889999999998754321100            0011222222222233444333322


Q ss_pred             eecC------CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC
Q 020027          128 SQAP------GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE  201 (332)
Q Consensus       128 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  201 (332)
                      ...-      ...+|+|||+++++|..+...          .....++.|++.+|.+||+.   |||||||||.|||+++
T Consensus       174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             TCSCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            1111      123699999998888654321          12346789999999999998   9999999999999987


Q ss_pred             CC----------ceEEccCCcccc
Q 020027          202 KF----------CARVCDYGLSFL  215 (332)
Q Consensus       202 ~~----------~~kl~dfg~a~~  215 (332)
                      ++          .+.|+||+-+..
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcccccccccceEEEEeCCccc
Confidence            76          388999997643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=3.1e-12  Score=110.45  Aligned_cols=145  Identities=12%  Similarity=0.066  Sum_probs=110.5

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERII  136 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  136 (332)
                      ...++|.....++.|+.+.||++... ++.+++|.......  .....+.+|...++.+. +.++.++++++...+..++
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            34456877778888889999999754 68999999865322  12235789999998884 6778889999988889999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG----------------------------------  182 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~----------------------------------  182 (332)
                      +||+++|.++.+....         ......++.+++++++.||+.                                  
T Consensus        88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999998876321         112336778899999999981                                  


Q ss_pred             ----------------------CCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          183 ----------------------VAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       183 ----------------------~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                                            ....++|+|++|.||+++++..+.++||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  01358999999999999876666799997663

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=2.8e-11  Score=103.98  Aligned_cols=135  Identities=15%  Similarity=0.043  Sum_probs=97.0

Q ss_pred             CCCCCceee-ccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCC--ccceeeeeecCCceeEEE
Q 020027           62 GFSHRRIIG-QGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN--IVPILGFSQAPGERIIVS  138 (332)
Q Consensus        62 ~~~~~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~  138 (332)
                      ++.. ..++ .|..+.||++...+|..+++|.....     ....+.+|+..++.+.+.+  +.+++++...++..+++|
T Consensus        21 ~~~~-~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDW-AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TCEE-EECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCce-EecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            3443 3344 55669999998777888999987543     1235688998888885444  456888888778889999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV-----------------------------------  183 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------  183 (332)
                      |+++|.++.  ...       .+.   ..++.+++..+..||+..                                   
T Consensus        95 e~i~G~~l~--~~~-------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           95 GEVPGQDLL--SSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             ECCSSEETT--TSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EecCCcccC--cCc-------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            999998874  211       121   245677777888888641                                   


Q ss_pred             --------------------CCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          184 --------------------APNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       184 --------------------~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                                          ...++|+|++|.||++++++.+.+.||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                1139999999999999877667799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=3.7e-10  Score=102.04  Aligned_cols=144  Identities=13%  Similarity=0.131  Sum_probs=104.6

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEec--cCcccccccccHHHHHHHhccCC--CCCccceeeeeecC---CceeE
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIH--PRLVLSNAGFGFASVIKTLSLAQ--HPNIVPILGFSQAP---GERII  136 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~l  136 (332)
                      ...+.++.|.++.||+....+ ..+++|...  .... ......+.+|..+++.+.  +..+.+++.++.+.   +..++
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            345789999999999988754 578888765  3221 112335788999998886  45678888888766   45899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV---------------------------------  183 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------  183 (332)
                      +||+++|..+.+...      ..++......++.+++..|+.||+..                                 
T Consensus       119 vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            999999877743111      12567778889999999999999720                                 


Q ss_pred             ----------------------CCCeeecCCCCCCEEeCCCCc--eEEccCCcccc
Q 020027          184 ----------------------APNIIHGCIKASNILLNEKFC--ARVCDYGLSFL  215 (332)
Q Consensus       184 ----------------------~~~ivH~dlk~~Nill~~~~~--~kl~dfg~a~~  215 (332)
                                            ...++|+|+++.||+++.++.  +.+.||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  247999999999999987653  68999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=4.7e-10  Score=98.93  Aligned_cols=185  Identities=15%  Similarity=0.087  Sum_probs=115.9

Q ss_pred             CCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCC--ccceeeeeecCC---ceeEEE
Q 020027           65 HRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPN--IVPILGFSQAPG---ERIIVS  138 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~  138 (332)
                      ..+.++.|..+.||+..    ..+++|.....    .....+.+|...++.+. +..  +.+++......+   ..+++|
T Consensus        24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           24 TIEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eeEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            34679999999999752    56888885432    12235688888887773 332  334444433332   458899


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG------------------------------------  182 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~------------------------------------  182 (332)
                      |+++|.++......      .++..+...++.+++..++.||+.                                    
T Consensus        96 ~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             ECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             cccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            99999887653321      145666667777777777777751                                    


Q ss_pred             -------------------CCCCeeecCCCCCCEEeCC--CCceEEccCCccccCCccc--CCcccc---cCcccccc--
Q 020027          183 -------------------VAPNIIHGCIKASNILLNE--KFCARVCDYGLSFLAPEEK--RGLAGY---VDDDYWHE--  234 (332)
Q Consensus       183 -------------------~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~~~~~~--~~~~~~---~~pe~~~~--  234 (332)
                                         ..+.++|+|++|.||++++  ...+.+.||+.+.......  ......   .+++.+..  
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence                               1235899999999999988  4567899999875432210  001111   12221110  


Q ss_pred             -cCCC--------CCCchhhhHHHHHHHHHHHhCCCCC
Q 020027          235 -KGGG--------NATRESDVYGFGVVLLEILSGRRCE  263 (332)
Q Consensus       235 -~~~~--------~~~~~~DiwS~G~il~el~tg~~p~  263 (332)
                       .-+.        ......+.|+++.++|.+.+|..+|
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             0000        0122368999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.35  E-value=2.9e-06  Score=73.01  Aligned_cols=134  Identities=17%  Similarity=0.123  Sum_probs=90.0

Q ss_pred             eeeccCCe-EEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCceeEEEeccCCC
Q 020027           68 IIGQGRLG-TVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        68 ~lg~G~~g-~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .+..|..| .||+... .++..+++|.-...     ....+.+|...++.+. +--+-++++++..++..+++||++++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            45555555 6898774 35667888876432     1234678888887664 334667788888889999999999998


Q ss_pred             CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 020027          145 SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV-----------------------------------------  183 (332)
Q Consensus       145 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------------  183 (332)
                      ++.+......        .....+..+++..++-||+.-                                         
T Consensus       106 ~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          106 TAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             cccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            8766543211        112234455555555555420                                         


Q ss_pred             --------------CCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          184 --------------APNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       184 --------------~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                                    .+.++|+|+.+.||++++++.+-|.||+.+.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                          1238999999999999987777799998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=3.8e-06  Score=73.90  Aligned_cols=137  Identities=16%  Similarity=0.107  Sum_probs=87.0

Q ss_pred             CCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCC---Cccceeeeee-cCCceeEEEec
Q 020027           65 HRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP---NIVPILGFSQ-APGERIIVSEF  140 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~  140 (332)
                      ..+.++.|....||+.    |..+++|.....    .....+.+|..+++.+.+.   .+.+++.++. ..+..+++||+
T Consensus        23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             CEEEEEECSSEEEEEE----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeeecCCCcceeEEEE----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            3457888999999987    567888874321    1223568999999888642   2445555553 45667899999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG--------------------------------------  182 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------------------------------------  182 (332)
                      ++|.++.......      ++......++.+++..|+-||+.                                      
T Consensus        95 i~G~~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           95 VQGQILGEDGMAV------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCSEECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             cCCeECchhhhhh------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            9998876521110      22222333333333333333321                                      


Q ss_pred             -------------------CCCCeeecCCCCCCEEeCC---CCc-eEEccCCcccc
Q 020027          183 -------------------VAPNIIHGCIKASNILLNE---KFC-ARVCDYGLSFL  215 (332)
Q Consensus       183 -------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~dfg~a~~  215 (332)
                                         ..+.++|+|+++.||+++.   ++. +.|.||+.+..
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               2346799999999999987   455 47999987754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=5.7e-06  Score=74.24  Aligned_cols=82  Identities=4%  Similarity=0.001  Sum_probs=54.4

Q ss_pred             Ccee-eccCCeEEEEEEeC-------CCCEEEEEEeccCcc-cccccccHHHHHHHhccCC-C--CCccceeeeeecC--
Q 020027           66 RRII-GQGRLGTVYAALLS-------TGKLVAVKRIHPRLV-LSNAGFGFASVIKTLSLAQ-H--PNIVPILGFSQAP--  131 (332)
Q Consensus        66 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--  131 (332)
                      .+.| +.|..+.+|+....       +++.+++|....... .......+.+|...++.+. +  -.+.+++.++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988754       266888887654321 0101235688888888774 2  3466777777654  


Q ss_pred             -CceeEEEeccCCCCHH
Q 020027          132 -GERIIVSEFINMASLD  147 (332)
Q Consensus       132 -~~~~lv~e~~~~~~L~  147 (332)
                       +..+++||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             4578999999887654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.87  E-value=6.8e-05  Score=66.47  Aligned_cols=31  Identities=29%  Similarity=0.265  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          184 APNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       184 ~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ...++|+|+.+.||+++.++.+.+.||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3489999999999999888889999998664

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.81  E-value=0.00012  Score=66.63  Aligned_cols=77  Identities=14%  Similarity=0.065  Sum_probs=47.3

Q ss_pred             CceeeccCCeEEEEEEeC-CCCEEEEEEeccCcc--cc---cccccHHHHHHHhccCCC--CC-ccceeeeeecCCceeE
Q 020027           66 RRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLV--LS---NAGFGFASVIKTLSLAQH--PN-IVPILGFSQAPGERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~l  136 (332)
                      .+.+|.|..+.||++... +++.+++|...+...  ..   .....+..|...++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999743 568899998754321  00   111235678887776632  33 3344443  3445689


Q ss_pred             EEeccCCC
Q 020027          137 VSEFINMA  144 (332)
Q Consensus       137 v~e~~~~~  144 (332)
                      +||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.75  E-value=6.6e-05  Score=68.94  Aligned_cols=74  Identities=12%  Similarity=0.173  Sum_probs=46.3

Q ss_pred             CCeeecCCCCCCEEeCCCCceEEccCCccccCCccc-C------CcccccCcccccccCCCCCCchhhhHHHHHHHHHHH
Q 020027          185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-R------GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEIL  257 (332)
Q Consensus       185 ~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~-~------~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~  257 (332)
                      +.++|+|+++.||+++.++ +++.||+.+...+... .      -...|.+|+......+.......++.+....+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4899999999999998776 9999999886543221 0      012344444433211112223455667777788777


Q ss_pred             hC
Q 020027          258 SG  259 (332)
Q Consensus       258 tg  259 (332)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.66  E-value=0.00072  Score=58.52  Aligned_cols=78  Identities=14%  Similarity=0.162  Sum_probs=53.3

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCC---CccceeeeeecCCceeEEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP---NIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~  138 (332)
                      .....+.+|.|..+.||+....+|+.+++|.......  .....+..|...|+.+.-.   -+.+++++    +..+++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~   89 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM   89 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence            3445678999999999999999999999997653321  1122467888888777422   23334443    2347899


Q ss_pred             eccCCCC
Q 020027          139 EFINMAS  145 (332)
Q Consensus       139 e~~~~~~  145 (332)
                      |+++++.
T Consensus        90 e~l~~~~   96 (288)
T 3f7w_A           90 EWVDERP   96 (288)
T ss_dssp             ECCCCCC
T ss_pred             EeecccC
Confidence            9987764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.57  E-value=0.00037  Score=61.23  Aligned_cols=141  Identities=18%  Similarity=0.235  Sum_probs=89.5

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC---CCCccceeeeeecCCceeEEEec
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ---HPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      ...+.|+.|..+.+|+... ++..+++|.....     ....+..|...++.+.   ...+.+++.++...+..+++||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            3456789999999999886 4678889876532     1234678888777763   35677888888877889999999


Q ss_pred             cCCCCHH--------HH---hcccCC-C-----------------CCcCCHHHHH---HHHH----------------HH
Q 020027          141 INMASLD--------FY---LHENND-G-----------------ASLLDWNRRL---RIAT----------------GA  172 (332)
Q Consensus       141 ~~~~~L~--------~~---l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~i  172 (332)
                      +++..+.        ..   ++.... .                 ...-+|....   ++..                .+
T Consensus       113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l  192 (312)
T 3jr1_A          113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI  192 (312)
T ss_dssp             CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred             ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence            9987542        11   222111 0                 0011354221   1111                11


Q ss_pred             HHHH-HHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          173 ARGL-EYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       173 ~~~l-~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      ...+ ..|.. ...+.++|+|+.+.|++++.++ +.+.|+.
T Consensus       193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1111 23421 2356899999999999999887 8899974

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.30  E-value=0.0023  Score=55.67  Aligned_cols=73  Identities=12%  Similarity=0.108  Sum_probs=45.3

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCceeEEEecc-
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERIIVSEFI-  141 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-  141 (332)
                      ...+.|+.|..+.+|+.     +.+++|......   ....+..+|...++.+...++ .+++++.  ++.-++++||+ 
T Consensus        21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CSCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             cceeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            33678999999999998     568888775432   112244678777776642233 3444443  33457899999 


Q ss_pred             CCCCH
Q 020027          142 NMASL  146 (332)
Q Consensus       142 ~~~~L  146 (332)
                      ++.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            65444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.14  E-value=0.0036  Score=55.19  Aligned_cols=33  Identities=21%  Similarity=0.172  Sum_probs=27.6

Q ss_pred             CCCeeecCCCCCCEEeCCC----CceEEccCCccccC
Q 020027          184 APNIIHGCIKASNILLNEK----FCARVCDYGLSFLA  216 (332)
Q Consensus       184 ~~~ivH~dlk~~Nill~~~----~~~kl~dfg~a~~~  216 (332)
                      ...++|+|+.+.||+++.+    +.+.+.||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3479999999999999874    67899999987543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.91  E-value=0.0046  Score=54.15  Aligned_cols=143  Identities=12%  Similarity=0.166  Sum_probs=75.5

Q ss_pred             ceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCC--ccceeee------eecCCceeEEE
Q 020027           67 RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN--IVPILGF------SQAPGERIIVS  138 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~  138 (332)
                      +.|+.|....+|+....+| .+++|......    ....+..|...+..+...+  +.+++..      ....+..++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4567788899999887655 67889876421    1123456666666553111  2233321      12235678999


Q ss_pred             eccCCCCHHH-----H---------hcccCCC---C-----CcCCHHHHHH------------HHHHHHHHHHHhhc---
Q 020027          139 EFINMASLDF-----Y---------LHENNDG---A-----SLLDWNRRLR------------IATGAARGLEYLHQ---  181 (332)
Q Consensus       139 e~~~~~~L~~-----~---------l~~~~~~---~-----~~l~~~~~~~------------i~~~i~~~l~~Lh~---  181 (332)
                      ++++|..+..     +         ++.....   .     ....|.....            +...+...+..+.+   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998765321     0         1111000   0     0011222110            00113334444442   


Q ss_pred             -CCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          182 -GVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       182 -~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                       ....+++|+|+.+.||+++++..+.+.||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             123479999999999999887666899998664

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.83  E-value=0.014  Score=47.94  Aligned_cols=101  Identities=12%  Similarity=0.061  Sum_probs=63.7

Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcccCCc
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGL  223 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~  223 (332)
                      -+|.+.+.....   ++++.+++.++.|.+.+|.-+-.+ ... ..+=..|..|++..+|.+...+ +.+.      ...
T Consensus        33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc------ccc
Confidence            478888876533   489999999999999998766211 001 1233456889999999988764 1111      112


Q ss_pred             ccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCC
Q 020027          224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR  260 (332)
Q Consensus       224 ~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~  260 (332)
                      ..+.+||...    ...+.+.=|||+|+++|.-+--.
T Consensus       101 ~~~~~pe~~~----~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          101 PPPVAGKLGY----SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------CCSS----SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             cCCCChhhcc----ccchHHHHHHHHHHHHHHHhhcC
Confidence            2455676543    34578889999999999988633

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.65  E-value=0.033  Score=48.73  Aligned_cols=76  Identities=11%  Similarity=-0.036  Sum_probs=46.6

Q ss_pred             CceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC--CCccceeee-----eecCCceeEEE
Q 020027           66 RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH--PNIVPILGF-----SQAPGERIIVS  138 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~-----~~~~~~~~lv~  138 (332)
                      ...++ |....||+....+|+.+++|...+...   ....+..|...++.+..  -.+.+++..     ....+..++++
T Consensus        31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             EEeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            34577 888899988776777899999864321   11234567666665531  123333332     12245667899


Q ss_pred             eccCCCC
Q 020027          139 EFINMAS  145 (332)
Q Consensus       139 e~~~~~~  145 (332)
                      |+++|..
T Consensus       107 ~~i~G~~  113 (328)
T 1zyl_A          107 PSVGGRQ  113 (328)
T ss_dssp             ECCCCEE
T ss_pred             EecCCCC
Confidence            9998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.53  E-value=0.0053  Score=56.36  Aligned_cols=72  Identities=13%  Similarity=0.112  Sum_probs=46.2

Q ss_pred             CceeeccCCeEEEEEEeCC--------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCceeE
Q 020027           66 RRIIGQGRLGTVYAALLST--------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l  136 (332)
                      .+.|+.|....+|+....+        ++.+++|+....    .....+..|..+++.+...++ .++++.+.+    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            4568888889999998643        578899887431    110234578887777643333 456665432    38


Q ss_pred             EEeccCCCC
Q 020027          137 VSEFINMAS  145 (332)
Q Consensus       137 v~e~~~~~~  145 (332)
                      ++||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            899997643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.38  E-value=0.02  Score=52.88  Aligned_cols=74  Identities=16%  Similarity=0.098  Sum_probs=46.6

Q ss_pred             CceeeccCCeEEEEEEeCC-CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCceeEEEeccCC
Q 020027           66 RRIIGQGRLGTVYAALLST-GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      .+.|+.|--..+|+....+ +..+++|......   ....+..+|..+++.+...++ .++++.+. .   ..++||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence            3568888889999998754 4678888764321   122234688888888764444 45666652 2   259999987


Q ss_pred             CCH
Q 020027          144 ASL  146 (332)
Q Consensus       144 ~~L  146 (332)
                      .++
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.29  E-value=0.0089  Score=53.51  Aligned_cols=74  Identities=12%  Similarity=0.071  Sum_probs=43.0

Q ss_pred             CceeeccCCeEEEEEEeCC---------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCcee
Q 020027           66 RRIIGQGRLGTVYAALLST---------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERI  135 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~  135 (332)
                      .+.++.|....+|+....+         +..+++|......   ....+...|...++.+...++ .++++..  +  -+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            3567788888999988643         2688888765432   111234677777777643333 3555443  2  36


Q ss_pred             EEEeccCCCCH
Q 020027          136 IVSEFINMASL  146 (332)
Q Consensus       136 lv~e~~~~~~L  146 (332)
                      +++||++|..+
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.24  E-value=0.012  Score=53.07  Aligned_cols=142  Identities=12%  Similarity=0.035  Sum_probs=77.6

Q ss_pred             CceeeccCCeEEEEEEeC--------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCC-ccceeeeeecCCceeE
Q 020027           66 RRIIGQGRLGTVYAALLS--------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPN-IVPILGFSQAPGERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l  136 (332)
                      .+.+..|.-..+|+....        +++.+.+|..-..   ........+|..+++.+.-.+ ..++++.+..    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            456777888899998864        3478899875321   112234568888887764222 3455665543    28


Q ss_pred             EEeccCCCCHHHH--------------h---cccCC-CCCcC--CHHHHHHHHHHHHH-------------------HHH
Q 020027          137 VSEFINMASLDFY--------------L---HENND-GASLL--DWNRRLRIATGAAR-------------------GLE  177 (332)
Q Consensus       137 v~e~~~~~~L~~~--------------l---~~~~~-~~~~l--~~~~~~~i~~~i~~-------------------~l~  177 (332)
                      ++||++|..+..-              +   +.... .....  -+.++.+...++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999987554310              1   11100 00111  23444444433321                   122


Q ss_pred             Hh----hc-CCCCCeeecCCCCCCEEeCCC----CceEEccCCccc
Q 020027          178 YL----HQ-GVAPNIIHGCIKASNILLNEK----FCARVCDYGLSF  214 (332)
Q Consensus       178 ~L----h~-~~~~~ivH~dlk~~Nill~~~----~~~kl~dfg~a~  214 (332)
                      .|    .. .....++|+|+.+.||+++.+    +.+.+.||..+.
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            22    21 123469999999999999876    689999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.03  E-value=0.071  Score=47.08  Aligned_cols=31  Identities=23%  Similarity=0.323  Sum_probs=27.1

Q ss_pred             CCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          185 PNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       185 ~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      ..++|+|+.+.||+++.++.+.+.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987644

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=93.96  E-value=0.17  Score=29.70  Aligned_cols=20  Identities=10%  Similarity=0.326  Sum_probs=8.7

Q ss_pred             HHHHHHHHHHHHHHHhhcCC
Q 020027           16 LSLFLIILAIVLIVLCKKKP   35 (332)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~   35 (332)
                      +++++++.+.++++++||+.
T Consensus        21 vll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           21 ILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHHHhheehhhh
Confidence            33444444444444444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.48  E-value=0.51  Score=38.45  Aligned_cols=115  Identities=9%  Similarity=0.082  Sum_probs=78.4

Q ss_pred             CCCCccceeeeeecCCceeEEEeccCCC-CHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCC
Q 020027          117 QHPNIVPILGFSQAPGERIIVSEFINMA-SLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       117 ~h~niv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  195 (332)
                      .||+.+.. .+-..++.+.+.++.-+.+ +... ++.       .+...+++++.+|+.-..+++.+     +|--+.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            57887766 5666667666666654422 2222 322       67888999999999888777654     78899999


Q ss_pred             CEEeCCCCceEEccCCccccCCcccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE  264 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~  264 (332)
                      |++++.++.+++.--|+....           +|.        ..+...=.-.+=|++..+++++..|.
T Consensus       109 NL~f~~~~~p~i~~RGik~~l-----------~P~--------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVV-----------DPL--------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTB-----------SCC--------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccCC-----------CCC--------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999877654322           221        12222223457788888999888764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.16  E-value=0.16  Score=29.90  Aligned_cols=18  Identities=28%  Similarity=0.327  Sum_probs=7.8

Q ss_pred             chHHHHHHHHHHHHHHHH
Q 020027            5 EHIAYDCLLAILSLFLII   22 (332)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~   22 (332)
                      -.|+..++++++++++++
T Consensus        11 ~~IA~gVVgGv~~~~ii~   28 (44)
T 2ks1_B           11 PSIATGMVGALLLLLVVA   28 (44)
T ss_dssp             SSSTHHHHHHHHHHHHHH
T ss_pred             ceEEeehhHHHHHHHHHH
Confidence            334444444444444333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.98  E-value=0.87  Score=41.42  Aligned_cols=74  Identities=14%  Similarity=0.125  Sum_probs=47.1

Q ss_pred             CceeeccCCeEEEEEEeCC--------CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCceeE
Q 020027           66 RRIIGQGRLGTVYAALLST--------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l  136 (332)
                      .+.+..|--..+|+....+        ++.+++|.....   .....+..+|..+++.+...++ .++++.+  .  -+.
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~---t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH---VGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC---C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC---cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            3567778888999998653        578898885432   1222345788888877742233 3445433  2  378


Q ss_pred             EEeccCCCCH
Q 020027          137 VSEFINMASL  146 (332)
Q Consensus       137 v~e~~~~~~L  146 (332)
                      ++||++|..+
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999988653

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.95  E-value=0.27  Score=28.85  Aligned_cols=6  Identities=17%  Similarity=0.418  Sum_probs=2.2

Q ss_pred             HHHhhc
Q 020027           28 IVLCKK   33 (332)
Q Consensus        28 ~~~~~~   33 (332)
                      +++++|
T Consensus        32 ~~~RRR   37 (44)
T 2l2t_A           32 VYVRRK   37 (44)
T ss_dssp             HHHHTT
T ss_pred             HHhhhh
Confidence            333333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.49  E-value=1.8  Score=35.39  Aligned_cols=115  Identities=11%  Similarity=0.046  Sum_probs=76.0

Q ss_pred             CCCCccceeeeeecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHH-HhhcCCCCCeeecCCCCC
Q 020027          117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE-YLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       117 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~Lh~~~~~~ivH~dlk~~  195 (332)
                      .||+.  -..+-..++.+.+.++.-+++.=...++.       .+...+++++.+++.-.. +++.     -+|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            56776  44455667777777776543322223322       678889998888887666 5554     488899999


Q ss_pred             CEEeCCCCceEEccCCccccCCcccCCcccccCcccccccCCCCCCchhh-hHHHHHHHHHHHhCCCCCCc
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESD-VYGFGVVLLEILSGRRCEEG  265 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~pe~~~~~~~~~~~~~~D-iwS~G~il~el~tg~~p~~~  265 (332)
                      |++++.++.+++.-.|+-..           ++|..        .+ ..| .-.+=|++..++.++..|..
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-----------lpP~e--------~~-ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-----------LPPDE--------WD-DERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-----------BSSCS--------CC-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-----------CCCCC--------CC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999999997775432           22321        12 233 33577778888888776643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.18  E-value=0.024  Score=52.50  Aligned_cols=62  Identities=13%  Similarity=-0.039  Sum_probs=17.7

Q ss_pred             CceeeccCCeEEEEEEeCC-CCEEEE------EEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec
Q 020027           66 RRIIGQGRLGTVYAALLST-GKLVAV------KRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA  130 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  130 (332)
                      .+.||   ||.||+|.+.. ..+||+      |..+...........+.+|..++..++|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            45566   99999999643 467888      7665444333334457888888888999999999988643

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=82.17  E-value=0.83  Score=25.25  Aligned_cols=19  Identities=32%  Similarity=0.565  Sum_probs=8.2

Q ss_pred             HHHHHHHHHHHHHHHHhhc
Q 020027           15 ILSLFLIILAIVLIVLCKK   33 (332)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~   33 (332)
                      .+++++++...+.++++||
T Consensus        16 glll~vii~l~~~~~iRRr   34 (35)
T 1iij_A           16 GVLLFLILVVVVGILIKRR   34 (35)
T ss_dssp             HHHHHHHHTTTTTHHHHHC
T ss_pred             HHHHHHHHHHHhheEEeec
Confidence            3333444444444444444

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=81.95  E-value=3.7  Score=25.14  Aligned_cols=14  Identities=29%  Similarity=0.505  Sum_probs=5.2

Q ss_pred             HHHHHHHHHHHHHH
Q 020027           17 SLFLIILAIVLIVL   30 (332)
Q Consensus        17 ~~~~~~~~~~~~~~   30 (332)
                      +++++.++++.++.
T Consensus        19 GLLLL~Lii~~LwK   32 (54)
T 2l8s_A           19 GLLLLMLLILALWK   32 (54)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHH
Confidence            33333333333333

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=80.62  E-value=1.2  Score=25.60  Aligned_cols=14  Identities=7%  Similarity=-0.045  Sum_probs=5.5

Q ss_pred             HHHHHHHHHHHHHH
Q 020027            9 YDCLLAILSLFLII   22 (332)
Q Consensus         9 ~~~~~~~~~~~~~~   22 (332)
                      .++..++.++++++
T Consensus        14 ~I~~~vv~Gv~ll~   27 (41)
T 2k9y_A           14 AVIGGVAVGVVLLL   27 (41)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             EEEeehhHHHHHHH
Confidence            33334444444433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	332
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-36
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-31
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-25
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-47
 Identities = 67/284 (23%), Positives = 123/284 (43%), Gaps = 27/284 (9%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS 114
           EI       +  + IG G  GTVY         VAVK ++           F + +  L 
Sbjct: 4   EIPD--GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
             +H NI+  +G+S AP +  IV+++   +SL  +LH      +  +  + + IA   A+
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQ 115

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK--------RGLAGY 226
           G++YLH     +IIH  +K++NI L+E    ++ D+GL+ +              G   +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLI--KEMRFSELL 284
           +  +    +     + +SDVY FG+VL E+++G+     +  +  +  +  +     +L 
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232

Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             R   P  +K      ++   C+   R  RP   Q+   +  L
Sbjct: 233 KVRSNCPKAMK------RLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 4e-45
 Identities = 56/282 (19%), Positives = 117/282 (41%), Gaps = 31/282 (10%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS 114
           E+    +       +G G+ G V+    +    VAVK +    +  +A   F +    + 
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMK 63

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
             QH  +V +           I++E++   SL  +L   +     L  N+ L +A   A 
Sbjct: 64  QLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAE 120

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------RGLAGYV 227
           G+ ++ +    N IH  ++A+NIL+++    ++ D+GL+ L  + +       +    + 
Sbjct: 121 GMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP 286
             +  +    G  T +SDV+ FG++L EI++ GR    G+     +  ++          
Sbjct: 178 APEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------GY 227

Query: 287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           R+  P        L ++   C     ++RP+   + ++L + 
Sbjct: 228 RMVRPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 57/266 (21%), Positives = 100/266 (37%), Gaps = 19/266 (7%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQ 117
              FS  R IG G  G VY A  +   ++VA+K++      SN  +      ++ L   +
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           HPN +   G         +V E+   ++ D            L       +  GA +GL 
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR--GLAGYVDDDYWHEK 235
           YLH     N+IH  +KA NILL+E    ++ D+G + +        G   ++  +     
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186

Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK 295
             G    + DV+  G+  +E+   +     +    AL  I +     L           +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH--WSEYFR 244

Query: 296 PLVRLAKVALACVGNSRKNRPSIVQV 321
             V       +C+    ++RP+   +
Sbjct: 245 NFVD------SCLQKIPQDRPTSEVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-43
 Identities = 55/297 (18%), Positives = 110/297 (37%), Gaps = 43/297 (14%)

Query: 66  RRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           +  IG+GR G V+      G+ VAVK    R       +   + I    + +H NI+  +
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI 63

Query: 126 GFSQAPG----ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
                      +  +VS++    SL  YL+        +     +++A   A GL +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 118

Query: 182 GVA-----PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----------GLAGY 226
            +      P I H  +K+ NIL+ +     + D GL+                  G   Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 227 VDDDYWHEK---GGGNATRESDVYGFGVVLLEILSGRR-----------CEEGLLVKWAL 272
           +  +   +        + + +D+Y  G+V  EI                  + +    ++
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 273 PLIKEMRFSELLDPRLAIPCEIKPLVR-LAKVALACVGNSRKNRPSIVQVATILNNL 328
             ++++   + L P +    +    +R +AK+   C   +   R + +++   L+ L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-43
 Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 21/264 (7%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
           + IG+G  G V       G  VAVK I            F +    ++  +H N+V +LG
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLG 67

Query: 127 -FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              +  G   IV+E++   SL  YL     G S+L  +  L+ +      +EYL      
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---N 122

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRESD 245
           N +H  + A N+L++E   A+V D+GL+  A   +      V             + +SD
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182

Query: 246 VYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVA 304
           V+ FG++L EI S GR     + +K  +P +++         ++  P    P   + +V 
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------GYKMDAPDGCPP--AVYEVM 233

Query: 305 LACVGNSRKNRPSIVQVATILNNL 328
             C       RPS +Q+   L ++
Sbjct: 234 KNCWHLDAAMRPSFLQLREQLEHI 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-42
 Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 36/294 (12%)

Query: 54  TEIDAATDGFSHRRIIGQGRLGTVYAALLSTG-----KLVAVKRIHPRLVLSNAGFGFAS 108
           TEI       + +++IG G  G VY  +L T        VA+K +            F  
Sbjct: 2   TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLG 58

Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRI 168
               +    H NI+ + G        +I++E++   +LD +L E +         + + +
Sbjct: 59  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGM 115

Query: 169 ATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------- 220
             G A G++YL      N +H  + A NIL+N     +V D+GLS +  ++         
Sbjct: 116 LRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 221 -RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEM 278
            +    +   +          T  SDV+ FG+V+ E+++ G R    L     +  I + 
Sbjct: 173 GKIPIRWTAPEAIS---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND- 228

Query: 279 RFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
                   RL  P +      + ++ + C    R  RP    + +IL+ L+  P
Sbjct: 229 ------GFRLPTPMDCPS--AIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 6e-42
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 15/211 (7%)

Query: 56  IDAATDGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS 114
           ++   D F     +G G  G V+      +G ++A K IH  +  +         ++ L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ-IIRELQVLH 59

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
               P IV   G   + GE  I  E ++  SLD  L +       +      +++    +
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIK 115

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDD 230
           GL YL +     I+H  +K SNIL+N +   ++CD+G+S    +       G   Y+  +
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                 G + + +SD++  G+ L+E+  GR 
Sbjct: 174 RLQ---GTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  145 bits (367), Expect = 6e-42
 Identities = 66/303 (21%), Positives = 121/303 (39%), Gaps = 44/303 (14%)

Query: 55  EIDAATDGFSHR---------RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSN 101
           + + A   F+           ++IG G  G V +  L         VA+K +        
Sbjct: 11  DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EK 69

Query: 102 AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLD 161
               F S    +    HPN++ + G        +I++EF+   SLD +L +N+   +   
Sbjct: 70  QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT--- 126

Query: 162 WNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK- 220
             + + +  G A G++YL      N +H  + A NIL+N     +V D+GLS    ++  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 221 ----------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVK 269
                     +    +   +          T  SDV+ +G+V+ E++S G R    +  +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 270 WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
             +  I++       D RL  P +      L ++ L C    R +RP   Q+   L+ ++
Sbjct: 241 DVINAIEQ-------DYRLPPPMDCPS--ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291

Query: 330 GDP 332
            +P
Sbjct: 292 RNP 294

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  145 bits (366), Expect = 6e-42
 Identities = 64/280 (22%), Positives = 112/280 (40%), Gaps = 25/280 (8%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTL 113
           E++      + +  +G G+ G VY  +       VAVK +    +       F      +
Sbjct: 13  EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVM 67

Query: 114 SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
              +HPN+V +LG         I++EF+   +L  YL E N     +     L +AT  +
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQIS 125

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDD 229
             +EYL +    N IH  + A N L+ E    +V D+GLS L   +      G    +  
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182

Query: 230 DYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-EEGLLVKWALPLIKEMRFSELLDPRL 288
                      + +SDV+ FGV+L EI +       G+ +     L+++       D R+
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------DYRM 235

Query: 289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             P       ++ ++  AC   +  +RPS  ++      +
Sbjct: 236 ERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 7e-42
 Identities = 54/275 (19%), Positives = 100/275 (36%), Gaps = 29/275 (10%)

Query: 63  FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +  + IG G+ G V+         VA+K I    +       F    + +    HP +V
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---FIEEAEVMMKLSHPKLV 63

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            + G         +V EF+    L  YL        L      L +      G+ YL + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE- 119

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------RGLAGYVDDDYWHEK 235
               +IH  + A N L+ E    +V D+G++    +++       +    +   + +   
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-- 175

Query: 236 GGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI 294
                + +SDV+ FGV++ E+ S G+   E       +  I       L  PRLA     
Sbjct: 176 -FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--RLYKPRLAST--- 229

Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
                + ++   C     ++RP+  ++   L  + 
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-41
 Identities = 62/307 (20%), Positives = 107/307 (34%), Gaps = 45/307 (14%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFAS 108
           E     +  S  + +G G  G V  A             VAVK + P   L+       S
Sbjct: 19  EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMS 75

Query: 109 VIKTLS-LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASL-------- 159
            +K LS L  H NIV +LG     G  ++++E+     L  +L    D            
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 160 ------LDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
                 LD    L  +   A+G+ +L      N IH  + A NILL      ++CD+GL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 214 FLAPEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEG 265
                +         R    ++  +          T ESDV+ +G+ L E+ S       
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGSS--- 246

Query: 266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL 325
                   +  + +F +++     +         +  +   C       RP+  Q+  ++
Sbjct: 247 ----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

Query: 326 NNLVGDP 332
              + + 
Sbjct: 303 EKQISES 309

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-41
 Identities = 50/274 (18%), Positives = 98/274 (35%), Gaps = 29/274 (10%)

Query: 63  FSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +  + +G G+ G V          VA+K I    +  +    F    K +    H  +V
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLSHEKLV 62

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            + G         I++E++    L  YL E           + L +       +EYL   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES- 118

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------RGLAGYVDDDYWHEK 235
                +H  + A N L+N++   +V D+GLS    +++       +    +   +     
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-- 174

Query: 236 GGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI 294
                + +SD++ FGV++ EI S G+   E          I +         RL  P   
Sbjct: 175 -YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-------GLRLYRPHLA 226

Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
               ++  +  +C       RP+   + + + ++
Sbjct: 227 SE--KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-40
 Identities = 70/287 (24%), Positives = 112/287 (39%), Gaps = 30/287 (10%)

Query: 61  DGFSHRRIIGQGRLGTVYAALLSTGKL---VAVKRIHPRLVLSNAGFGFASVIKTLS-LA 116
           +    + +IG+G  G V  A +    L    A+KR+       +    FA  ++ L  L 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLG 68

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHEN------------NDGASLLDWNR 164
            HPNI+ +LG  +  G   +  E+    +L  +L ++            N  AS L   +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 165 RLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLA 224
            L  A   ARG++YL Q      IH  + A NIL+ E + A++ D+GLS       +   
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185

Query: 225 GYVDDDY--WHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE 282
           G +   +           T  SDV+ +GV+L EI+S           +      E+    
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------TPYCGMTCAELYEKL 239

Query: 283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
               RL  P        +  +   C       RPS  Q+   LN ++
Sbjct: 240 PQGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-40
 Identities = 58/282 (20%), Positives = 111/282 (39%), Gaps = 31/282 (10%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS 114
           EI    +       +GQG  G V+    +    VA+K + P  +   A   F    + + 
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 67

Query: 115 LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAAR 174
             +H  +V +           IV+E+++  SL  +L             + + +A   A 
Sbjct: 68  KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIAS 124

Query: 175 GLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-------RGLAGYV 227
           G+ Y+ +    N +H  ++A+NIL+ E    +V D+GL+ L  + +       +    + 
Sbjct: 125 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181

Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP 286
             +       G  T +SDV+ FG++L E+ + GR    G++ +  L  ++          
Sbjct: 182 APEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------GY 231

Query: 287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           R+  P E      L  +   C     + RP+   +   L + 
Sbjct: 232 RMPCPPECPE--SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 6e-40
 Identities = 63/308 (20%), Positives = 104/308 (33%), Gaps = 45/308 (14%)

Query: 53  LTEIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGF 106
           L  ++   +   + R IG+G  G V+ A            +VAVK +            F
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-F 63

Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENN------------ 154
                 ++   +PNIV +LG         ++ E++    L+ +L   +            
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 155 --------DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCAR 206
                    G   L    +L IA   A G+ YL +      +H  +   N L+ E    +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 207 VCDYGLSFLAPEEKR-----GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
           + D+GLS               A  +             T ESDV+ +GVVL EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 262 -CEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQ 320
               G+  +  +  +++          LA P        L  +   C      +RPS   
Sbjct: 241 QPYYGMAHEEVIYYVRD-------GNILACPENCPL--ELYNLMRLCWSKLPADRPSFCS 291

Query: 321 VATILNNL 328
           +  IL  +
Sbjct: 292 IHRILQRM 299

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-39
 Identities = 49/269 (18%), Positives = 95/269 (35%), Gaps = 17/269 (6%)

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           + +     IG G  G        S GK++  K +    +         S +  L   +HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 120 NIVPILGFSQAPGERI--IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           NIV               IV E+     L   + +       LD    LR+ T     L+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 178 YLHQ--GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK 235
             H+       ++H  +K +N+ L+ K   ++ D+GL+ +   +      +V   Y+   
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 236 ---GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC 292
                 +   +SD++  G +L E+ +          K     I+E +F  +         
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---YSD 240

Query: 293 EIKPLVRLAKVALACVGNSRKNRPSIVQV 321
           E+  ++         +     +RPS+ ++
Sbjct: 241 ELNEIIT------RMLNLKDYHRPSVEEI 263

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 53/274 (19%), Positives = 103/274 (37%), Gaps = 33/274 (12%)

Query: 67  RIIGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVP 123
           + +G G  GTV           K VAVK +              +    +    +P IV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 124 ILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV 183
           ++G  +     ++V E   +  L+ YL +N      +     + +    + G++YL +  
Sbjct: 73  MIGICE-AESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE-- 125

Query: 184 APNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK---------RGLAGYVDDDYWHE 234
             N +H  + A N+LL  +  A++ D+GLS     ++         +    +   +  + 
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN- 183

Query: 235 KGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE 293
                 + +SDV+ FGV++ E  S G++   G+       ++++         R+  P  
Sbjct: 184 --YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------GERMGCPAG 234

Query: 294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNN 327
                 +  +   C     +NRP    V   L N
Sbjct: 235 CPR--EMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-39
 Identities = 57/271 (21%), Positives = 91/271 (33%), Gaps = 24/271 (8%)

Query: 60  TDGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
            D +     +G G  G VY A    T  L A K I  +         +   I  L+   H
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDH 68

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNIV +L          I+ EF    ++D  + E       L  ++   +       L Y
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNY 125

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH----- 233
           LH      IIH  +KA NIL       ++ D+G+S       +    ++   YW      
Sbjct: 126 LHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182

Query: 234 ---EKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI 290
                       ++DV+  G+ L+E+         L     L  I +     L  P    
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS-RW 241

Query: 291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
               K  ++       C+  +   R +  Q+
Sbjct: 242 SSNFKDFLK------KCLEKNVDARWTTSQL 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 6e-39
 Identities = 54/267 (20%), Positives = 101/267 (37%), Gaps = 26/267 (9%)

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQH 118
           + F   R +G+G+ G VY A    +  ++A+K +    +            ++  S  +H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNI+ + G+        ++ E+  + ++   L + +      D  R     T  A  L Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDDYWHE 234
            H      +IH  IK  N+LL      ++ D+G S  AP  +R    G   Y+  +    
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIE- 177

Query: 235 KGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI 294
             G     + D++  GV+  E L G+   E    +     I  + F+         P  +
Sbjct: 178 --GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------FPDFV 227

Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQV 321
                   +    + ++   RP + +V
Sbjct: 228 TE--GARDLISRLLKHNPSQRPMLREV 252

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 6e-38
 Identities = 58/276 (21%), Positives = 108/276 (39%), Gaps = 31/276 (11%)

Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
            +IG+G  G VY   L          AVK ++ R+        F +    +    HPN++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 123 PILGFS-QAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
            +LG   ++ G  ++V  ++    L  ++               +      A+G+++L  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-------KRGLAGYVDDDYWHE 234
                 +H  + A N +L+EKF  +V D+GL+    ++       K G    V       
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 235 KGGGNATRESDVYGFGVVLLEILSGRR--CEEGLLVKWALPLIKEMRFSELLDPRLAIPC 292
                 T +SDV+ FGV+L E+++       +       + L++  R   LL P      
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD- 261

Query: 293 EIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
                  L +V L C     + RPS  ++ + ++ +
Sbjct: 262 ------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-37
 Identities = 50/271 (18%), Positives = 102/271 (37%), Gaps = 33/271 (12%)

Query: 69  IGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           +G G  G+V   +         VA+K +      ++         + +    +P IV ++
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLI 75

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
           G  QA    ++V E      L  +L    +    +  +    +    + G++YL +    
Sbjct: 76  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE---K 128

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK---------RGLAGYVDDDYWHEKG 236
           N +H  + A N+LL  +  A++ D+GLS     +          +    +   +  +   
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--- 185

Query: 237 GGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK 295
               +  SDV+ +GV + E LS G++  + +     +  I++         R+  P E  
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GKRMECPPECP 238

Query: 296 PLVRLAKVALACVGNSRKNRPSIVQVATILN 326
           P   L  +   C     ++RP  + V   + 
Sbjct: 239 P--ELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-37
 Identities = 51/270 (18%), Positives = 94/270 (34%), Gaps = 26/270 (9%)

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           + +   + +G+G  G V  A    T + VAVK +  +  +          I    +  H 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHE 63

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           N+V   G  +    + +  E+ +   L   +  +      +      R       G+ YL
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYL 119

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR--------GLAGYVDDDY 231
           H      I H  IK  N+LL+E+   ++ D+GL+ +     R        G   YV  + 
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP 291
              K         DV+  G+VL  +L+G    +            + + +  L+P   I 
Sbjct: 177 L--KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKID 233

Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
                L+         +  +   R +I  +
Sbjct: 234 SAPLALLH------KILVENPSARITIPDI 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 5e-37
 Identities = 59/303 (19%), Positives = 104/303 (34%), Gaps = 44/303 (14%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFAS 108
           E     +     +++G G  G V  A             VAVK +  +   S      + 
Sbjct: 33  EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90

Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENN-------------- 154
           +     L  H NIV +LG     G   ++ E+     L  YL                  
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 155 -----DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCD 209
                +  ++L +   L  A   A+G+E+L      + +H  + A N+L+      ++CD
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 207

Query: 210 YGLSFLAPEEKR-----GLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCE 263
           +GL+     +            V          G  T +SDV+ +G++L EI S G    
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267

Query: 264 EGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT 323
            G+ V      + +  F      ++  P        +  +  +C     + RPS   + +
Sbjct: 268 PGIPVDANFYKLIQNGF------KMDQPFYATE--EIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 324 ILN 326
            L 
Sbjct: 320 FLG 322

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 7e-37
 Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 21/259 (8%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             IGQG  GTVY A+ ++TG+ VA+++++ +           + I  +   ++PNIV  L
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 83

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
                  E  +V E++   SL   + E        D  +   +     + LE+LH     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLHSN--- 135

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW---HEKGGGNATR 242
            +IH  IK+ NILL      ++ D+G       E+   +  V   YW             
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAK 302
           + D++  G++ +E++ G           AL LI      EL +P   +    +  +    
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE-KLSAIFRDFLN--- 251

Query: 303 VALACVGNSRKNRPSIVQV 321
               C+    + R S  ++
Sbjct: 252 ---RCLDMDVEKRGSAKEL 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  133 bits (336), Expect = 8e-37
 Identities = 54/248 (21%), Positives = 100/248 (40%), Gaps = 19/248 (7%)

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFA----SVIKTLSL 115
           + FS  RIIG+G  G VY      TGK+ A+K +  + +    G   A     ++  +S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
              P IV +      P +   + + +N   L ++L ++     +         A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK----RGLAGYVDDDY 231
           LE++H      +++  +K +NILL+E    R+ D GL+    ++K     G  GY+  + 
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 176

Query: 232 WHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP 291
                G      +D +  G +L ++L G         K    + +      +  P  +  
Sbjct: 177 LQ--KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD-SFS 233

Query: 292 CEIKPLVR 299
            E++ L+ 
Sbjct: 234 PELRSLLE 241

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 6e-36
 Identities = 56/270 (20%), Positives = 99/270 (36%), Gaps = 36/270 (13%)

Query: 67  RIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             IG+G   TVY  L   T   VA   +  R +  +    F    + L   QHPNIV   
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 126 GFSQAPGER----IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
              ++  +     ++V+E +   +L  YL        ++             +GL++LH 
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130

Query: 182 GVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKR----GLAGYVDDDYWHEKG 236
              P IIH  +K  NI +       ++ D GL+ L          G   ++  + + EK 
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK- 188

Query: 237 GGNATRESDVYGFGVVLLEILSGRR-----CEEGLLVKWALPLIKEMRFSELLDPRLAIP 291
                   DVY FG+ +LE+ +             + +     +K   F ++  P     
Sbjct: 189 ---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP----- 240

Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
                   + ++   C+  ++  R SI  +
Sbjct: 241 -------EVKEIIEGCIRQNKDERYSIKDL 263

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 9e-36
 Identities = 63/301 (20%), Positives = 105/301 (34%), Gaps = 40/301 (13%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL--------STGKLVAVKRIHPRLVLSNAGFGF 106
           E+    D     + +G+G  G V  A          +    VAVK +       +     
Sbjct: 9   ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66

Query: 107 ASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHEN------------N 154
           + +     + +H NI+ +LG     G   ++ E+ +  +L  YL               +
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 155 DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF 214
           +    L     +  A   ARG+EYL        IH  + A N+L+ E    ++ D+GL+ 
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 215 LAPEEKRGLAGYVDDDY-----WHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLV 268
                                          T +SDV+ FGV+L EI + G     G+ V
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243

Query: 269 KWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
           +    L+KE         R+  P        L  +   C       RP+  Q+   L+ +
Sbjct: 244 EELFKLLKE-------GHRMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

Query: 329 V 329
           V
Sbjct: 295 V 295

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  129 bits (324), Expect = 3e-35
 Identities = 49/269 (18%), Positives = 100/269 (37%), Gaps = 25/269 (9%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D +     +G G  G V+     +TG   A K +       +        I+T+S+ +HP
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            +V +    +   E +++ EF++   L   + + ++    +  +  +       +GL ++
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHM 140

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLSFLAPEEK-----RGLAGYVDDDYW 232
           H+    N +H  +K  NI+   K    +   D+GL+     ++      G A +   +  
Sbjct: 141 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197

Query: 233 HEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPC 292
               G      +D++  GV+   +LSG     G      L  +K   ++        I  
Sbjct: 198 E---GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 293 EIKPLVRLAKVALACVGNSRKNRPSIVQV 321
           + K  +R        +      R +I Q 
Sbjct: 255 DGKDFIR------KLLLADPNTRMTIHQA 277

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-34
 Identities = 58/296 (19%), Positives = 109/296 (36%), Gaps = 39/296 (13%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFAS 108
           E+    +  +  R +GQG  G VY  +            VA+K ++           F +
Sbjct: 16  EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLN 72

Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLH------ENNDGASLLDW 162
               +      ++V +LG        +++ E +    L  YL        NN   +    
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 163 NRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK-- 220
           ++ +++A   A G+ YL+       +H  + A N ++ E F  ++ D+G++    E    
Sbjct: 133 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189

Query: 221 ------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-EEGLLVKWALP 273
                      ++  +       G  T  SDV+ FGVVL EI +      +GL  +  L 
Sbjct: 190 RKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246

Query: 274 LIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV 329
            + E          L  P        L ++   C   + K RPS +++ + +   +
Sbjct: 247 FVME-------GGLLDKPDNCPD--MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  125 bits (316), Expect = 5e-34
 Identities = 45/266 (16%), Positives = 100/266 (37%), Gaps = 19/266 (7%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           D +     +G G  G V+  +  +TG++   K I+    L    +   + I  ++   HP
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHP 86

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            ++ +    +   E +++ EF++   L   +   +     +     +     A  GL+++
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHM 143

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARV--CDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
           H+    +I+H  IK  NI+   K  + V   D+GL+     ++         ++   +  
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK 295
                   +D++  GV+   +LSG     G      L  +K   +    D   ++  E K
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 296 PLVRLAKVALACVGNSRKNRPSIVQV 321
             ++        +    + R ++   
Sbjct: 261 DFIK------NLLQKEPRKRLTVHDA 280

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-34
 Identities = 67/304 (22%), Positives = 113/304 (37%), Gaps = 46/304 (15%)

Query: 55  EIDAATDGFSHRRIIGQGRLGTVYAAL------LSTGKLVAVKRIHPRLVLSNAGFGFAS 108
           E     D     + +G+G  G V  A        +T + VAVK +      S      + 
Sbjct: 9   EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66

Query: 109 VIKTLSLAQHPNIVPILGFSQAPGERI-IVSEFINMASLDFYLHENND------------ 155
           +   + +  H N+V +LG    PG  + ++ EF    +L  YL    +            
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 156 GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL 215
               L     +  +   A+G+E+L        IH  + A NILL+EK   ++CD+GL+  
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 216 APEEK--------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC--EEG 265
             ++         R    ++  +          T +SDV+ FGV+L EI S         
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 266 LLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL 325
            + +     +KE         R+  P    P   + +  L C       RP+  ++   L
Sbjct: 241 KIDEEFCRRLKE-------GTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 326 NNLV 329
            NL+
Sbjct: 292 GNLL 295

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 8e-34
 Identities = 46/282 (16%), Positives = 100/282 (35%), Gaps = 30/282 (10%)

Query: 63  FSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFG---FASVIKTLSLAQH 118
           F   +++G G  GTVY    +  G+ V +      L  + +             ++   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           P++  +LG       ++I         LD+     ++          L      A+G+ Y
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNY 126

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK--------RGLAGYVDDD 230
           L       ++H  + A N+L+      ++ D+GL+ L   E+        +    ++  +
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI 290
                     T +SDV+ +GV + E+++                I     S +L+    +
Sbjct: 184 SIL---HRIYTHQSDVWSYGVTVWELMTFGS--------KPYDGIPASEISSILEKGERL 232

Query: 291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP 332
           P      + +  + + C      +RP   ++    + +  DP
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 41/260 (15%), Positives = 94/260 (36%), Gaps = 20/260 (7%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G+G  G V+  +  S+ K    K +  +             I  L++A+H NI+ + 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHRNILHLH 67

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
              ++  E +++ EFI+   +   ++ +      L+    +         L++LH     
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---H 121

Query: 186 NIIHGCIKASNILLNEKFCARV--CDYGLSFLAPEEKRGLAGYVDDDYWH--EKGGGNAT 241
           NI H  I+  NI+   +  + +   ++G +            +   +Y+          +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 242 RESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLA 301
             +D++  G ++  +LSG         +  +  I    ++   +    I  E    V   
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD-- 239

Query: 302 KVALACVGNSRKNRPSIVQV 321
                 +   RK+R +  + 
Sbjct: 240 ----RLLVKERKSRMTASEA 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-33
 Identities = 55/274 (20%), Positives = 95/274 (34%), Gaps = 33/274 (12%)

Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNI 121
             +G G  G V              VAVK + P ++        F   +  +    H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 122 VPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ 181
           + + G    P  +++  E   + SL   L ++             R A   A G+ YL  
Sbjct: 74  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES 129

Query: 182 GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEK---------RGLAGYVDDDYW 232
                 IH  + A N+LL  +   ++ D+GL    P+           +    +   +  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 233 HEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP 291
                   +  SD + FGV L E+ + G+    GL     L  I +         RL  P
Sbjct: 187 K---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------GERLPRP 237

Query: 292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATIL 325
            +      +  V + C  +  ++RP+ V +   L
Sbjct: 238 EDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 6e-33
 Identities = 58/274 (21%), Positives = 98/274 (35%), Gaps = 26/274 (9%)

Query: 67  RIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIV 122
           R IG+G+ G V+  +     +    VA+K         +    F     T+    HP+IV
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            ++G         I+ E   +  L  +L         LD    +  A   +  L YL   
Sbjct: 72  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES- 126

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR----GLAGYVDDDYWHEKGGG 238
                +H  I A N+L++   C ++ D+GLS    +            +           
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 239 NATRESDVYGFGVVLLEIL-SGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL 297
             T  SDV+ FGV + EIL  G +  +G+     +  I+          RL +P    P 
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GERLPMPPNCPP- 236

Query: 298 VRLAKVALACVGNSRKNRPSIVQVATILNNLVGD 331
             L  +   C       RP   ++   L+ ++ +
Sbjct: 237 -TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-31
 Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 20/211 (9%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQH 118
           + F   +I+G+G   TV  A  L+T +  A+K +  R ++              +S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           P  V +    Q   +      +     L  Y+ +        D              LEY
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEY 123

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR--------GLAGYVDDD 230
           LH      IIH  +K  NILLNE    ++ D+G + +   E +        G A YV  +
Sbjct: 124 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 231 YWHEKGGGNATRESDVYGFGVVLLEILSGRR 261
                   +A + SD++  G ++ ++++G  
Sbjct: 181 LLT---EKSACKSSDLWALGCIIYQLVAGLP 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-31
 Identities = 55/266 (20%), Positives = 100/266 (37%), Gaps = 23/266 (8%)

Query: 61  DGFSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLA-Q 117
           + F   +++G+G  G V+ A    T +  A+K +   +VL +          + LSLA +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
           HP +  +    Q       V E++N   L +++   +      D +R    A     GL+
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH---E 234
           +LH      I++  +K  NILL++    ++ D+G+             +     +     
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174

Query: 235 KGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI 294
             G       D + FGV+L E+L G+    G   +    L   +R      PR  +  E 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFYPRW-LEKEA 230

Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQ 320
           K L+              + R  +  
Sbjct: 231 KDLLV------KLFVREPEKRLGVRG 250

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (294), Expect = 3e-31
 Identities = 50/268 (18%), Positives = 88/268 (32%), Gaps = 20/268 (7%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH 118
            D +  R ++G G    V  A    T KLVA+K I  + +    G    + I  L   +H
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKH 66

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           PNIV +    ++ G   ++ + ++   L   + E              R+       ++Y
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKY 122

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWH 233
           LH     +            L+E     + D+GLS +           G  GYV  +   
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 234 EKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE 293
           +K     ++  D +  GV+   +L G               I +  +         I   
Sbjct: 183 QKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 294 IKPLVRLAKVALACVGNSRKNRPSIVQV 321
            K  +R        +    + R +  Q 
Sbjct: 240 AKDFIR------HLMEKDPEKRFTCEQA 261

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (294), Expect = 3e-31
 Identities = 44/197 (22%), Positives = 78/197 (39%), Gaps = 9/197 (4%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQHPNIVPI 124
           R +G G  G V+       G+  A+K +   +V+              LS+  HP I+ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 125 LGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            G  Q   +  ++ ++I    L   L ++               A      LEYLH    
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNPVAKFYAAEVCLALEYLHS--- 122

Query: 185 PNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGGNATRES 244
            +II+  +K  NILL++    ++ D+G +   P+    L G  D             +  
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 245 DVYGFGVVLLEILSGRR 261
           D + FG+++ E+L+G  
Sbjct: 183 DWWSFGILIYEMLAGYT 199

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 7e-31
 Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 11/206 (5%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHP 119
           + F     IG+G  G VY A    TG++VA+K+I                I  L    HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           NIV +L       +  +V EF++     F       G   +             +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWH----EK 235
           H      ++H  +K  N+L+N +   ++ D+GL+       R     V   ++       
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 236 GGGNATRESDVYGFGVVLLEILSGRR 261
           G    +   D++  G +  E+++ R 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (285), Expect = 3e-30
 Identities = 50/278 (17%), Positives = 95/278 (34%), Gaps = 30/278 (10%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTL------ 113
           + +  + I+G+G    V   +   T K  AVK I      S +      + +        
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 114 --SLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATG 171
              ++ HPNI+ +    +      +V + +    L  YL E       L      +I   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118

Query: 172 AARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGY 226
               +  LH+    NI+H  +K  NILL++    ++ D+G S      ++     G   Y
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175

Query: 227 VDDDYWHEKGGGNA---TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSEL 283
           +  +        N     +E D++  GV++  +L+G            L +I    +   
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235

Query: 284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
                     +K LV         +    + R +  + 
Sbjct: 236 SPEWDDYSDTVKDLVS------RFLVVQPQKRYTAEEA 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  113 bits (284), Expect = 4e-30
 Identities = 55/276 (19%), Positives = 100/276 (36%), Gaps = 31/276 (11%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQ 117
           +D +    I+G G +  V+ A  L   + VAVK +   L    + +  F    +  +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 118 HPNIVPILGFSQAPGERI----IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
           HP IV +    +A         IV E+++  +L   +H        +   R + +   A 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GLA 224
           + L + HQ     IIH  +K +NI+++     +V D+G++    +            G A
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 225 GYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL 284
            Y+  +      G +    SDVY  G VL E+L+G     G                   
Sbjct: 179 QYLSPEQAR---GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235

Query: 285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQ 320
                +  ++  +V         +  + +NR     
Sbjct: 236 ARHEGLSADLDAVVL------KALAKNPENRYQTAA 265

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 3e-29
 Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 21/210 (10%)

Query: 63  FSHRRIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI 121
           ++  ++IG G  G VY A L  +G+LVA+K++       N        ++ +    H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 75

Query: 122 VPILGFSQAPGER------IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
           V +  F  + GE+       +V +++         H +    +L              R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-PVIYVKLYMYQLFRS 134

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYGLSFLAPEEKRGLAGYVDDDYWH- 233
           L Y+H      I H  IK  N+LL+      ++CD+G +      +  ++      Y   
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

Query: 234 --EKGGGNATRESDVYGFGVVLLEILSGRR 261
               G  + T   DV+  G VL E+L G+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (276), Expect = 9e-29
 Identities = 49/281 (17%), Positives = 90/281 (32%), Gaps = 36/281 (12%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           R IG G  G +Y    ++ G+ VA+K    +              K   + Q    +P +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTI 68

Query: 126 GFSQAPGER-IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
            +  A G+  ++V E +  +  D +   +            L +A      +EY+H    
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHS--- 121

Query: 185 PNIIHGCIKASNILLNEKFCARVC---DYGLSFLAPEEKRGLAGYVDDDYWHEKG----- 236
            N IH  +K  N L+       +    D+GL+    + +     +    Y   K      
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR----THQHIPYRENKNLTGTA 177

Query: 237 ---------GGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
                    G   +R  D+   G VL+    G    +GL         + +   ++  P 
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 288 LAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
             +          A     C      ++P    +  +  NL
Sbjct: 238 EVLCKGYPS--EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  110 bits (275), Expect = 1e-28
 Identities = 40/282 (14%), Positives = 81/282 (28%), Gaps = 36/282 (12%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           R IG+G  G ++    L   + VA+K    R              +T  L      +P +
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNV 66

Query: 126 -GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVA 184
             F Q     ++V + +  +  D                     A      ++ +H+   
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHE--- 119

Query: 185 PNIIHGCIKASNILLNEKFC-----ARVCDYGLSFLAPEEK-------------RGLAGY 226
            ++++  IK  N L+            V D+G+     +                G A Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 227 VDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP 286
           +  +    +     +R  D+   G V +  L G    +GL         + +   +   P
Sbjct: 180 MSINTHLGRE---QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236

Query: 287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL 328
              +           K        +    P    +  + + +
Sbjct: 237 LRELCAGFPE--EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  109 bits (274), Expect = 1e-28
 Identities = 37/198 (18%), Positives = 70/198 (35%), Gaps = 11/198 (5%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILG 126
             IG+G  G VY A  + G+  A+K+I                I  L   +H NIV +  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 127 FSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN 186
                   ++V E ++                 L+             G+ Y H      
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RR 120

Query: 187 IIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE----KGGGNATR 242
           ++H  +K  N+L+N +   ++ D+GL+       R     +   ++       G    + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 243 ESDVYGFGVVLLEILSGR 260
             D++  G +  E+++G 
Sbjct: 181 TIDIWSVGCIFAEMVNGT 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 3e-28
 Identities = 39/223 (17%), Positives = 78/223 (34%), Gaps = 18/223 (8%)

Query: 67  RIIGQGRLGTVYAA--LLSTGKLVAVKRIHPRLVLSNAGFGF---ASVIKTLSLAQHPNI 121
             IG+G  G V+ A  L + G+ VA+KR+  +              +V++ L   +HPN+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 122 VPILGFSQAPGERIIVSEFINMASL--DFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
           V +                +    +  D   + +      +       +     RGL++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWHE 234
           H      ++H  +K  NIL+      ++ D+GL+ +   +           Y   +    
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL- 188

Query: 235 KGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKE 277
               +     D++  G +  E+   +    G      L  I +
Sbjct: 189 --QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 4e-28
 Identities = 41/206 (19%), Positives = 83/206 (40%), Gaps = 12/206 (5%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQH 118
           + F + +++G+G  G V      +TG+  A+K +   ++++        +  + L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           P +  +    Q       V E+ N   L F+L        +    R           LEY
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYW---HEK 235
           LH     ++++  IK  N++L++    ++ D+GL      +   +  +     +      
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 236 GGGNATRESDVYGFGVVLLEILSGRR 261
              +  R  D +G GVV+ E++ GR 
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 5e-28
 Identities = 50/272 (18%), Positives = 89/272 (32%), Gaps = 24/272 (8%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG----FASVIKTLSL 115
           D +     +G G+   V      STG   A K I  R   S+            +  L  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 116 AQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARG 175
            QHPN++ +    +   + I++ E +    L  +L E       L              G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNG 125

Query: 176 LEYLHQGVAPNIIHGCIKASNILLNEKFCAR----VCDYGLSFLAPEEKRGLAGYVDDDY 231
           + YLH      I H  +K  NI+L ++   +    + D+GL+            +   ++
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 232 W--HEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLA 289
                        E+D++  GV+   +LSG     G   +  L  +  + +    +    
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQV 321
                K  +R        +    K R +I   
Sbjct: 243 TSALAKDFIR------RLLVKDPKKRMTIQDS 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 1e-26
 Identities = 45/266 (16%), Positives = 83/266 (31%), Gaps = 23/266 (8%)

Query: 66  RRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI 124
            +++G G  G V       T +  A+K +               V      +Q P+IV I
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRI 70

Query: 125 LGFSQAPGER----IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLH 180
           +   +         +IV E ++   L   + +  D A          I       ++YLH
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLH 128

Query: 181 QGVAPNIIHGCIKASNILLNEKFC---ARVCDYGLSFLAPEEKRGLAGYVDDDYWHEK-- 235
                NI H  +K  N+L   K      ++ D+G +                 Y   +  
Sbjct: 129 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 236 GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK 295
           G     +  D++  GV++  +L G             P +K        +       E+ 
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 296 PLVRLAKVALACVGNSRKNRPSIVQV 321
             V+   +    +      R +I + 
Sbjct: 246 EEVK--MLIRNLLKTEPTQRMTITEF 269

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-26
 Identities = 42/200 (21%), Positives = 77/200 (38%), Gaps = 12/200 (6%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             IG+G  GTV+ A    T ++VA+KR+                I  L   +H NIV + 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
               +  +  +V EF +     ++   N D     D            +GL + H     
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL----DPEIVKSFLFQLLKGLGFCHS---R 120

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHE----KGGGNAT 241
           N++H  +K  N+L+N     ++ ++GL+       R  +  V   ++       G    +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 242 RESDVYGFGVVLLEILSGRR 261
              D++  G +  E+ +  R
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-26
 Identities = 37/267 (13%), Positives = 87/267 (32%), Gaps = 36/267 (13%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG----FASVIKTLSLAQ--HP 119
            ++G G  G+VY+ + +S    VA+K +    +               +  L        
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 120 NIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
            ++ +L + + P   +++ E        F           L               + + 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 126

Query: 180 HQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLAPEEKR----GLAGYVDDDYWHE 234
           H      ++H  IK  NIL++  +   ++ D+G   L  +       G   Y   ++   
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI-- 181

Query: 235 KGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI 294
           +      R + V+  G++L +++ G    E                 E++  ++     +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--------------DEEIIRGQVFFRQRV 227

Query: 295 KPLVRLAKVALACVGNSRKNRPSIVQV 321
                   +   C+     +RP+  ++
Sbjct: 228 SS--ECQHLIRWCLALRPSDRPTFEEI 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (261), Expect = 3e-26
 Identities = 35/203 (17%), Positives = 71/203 (34%), Gaps = 9/203 (4%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG-FASVIKTLSLAQH 118
           D F   + +G G  G V       +G   A+K +  + V+         +  + L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 119 PNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEY 178
           P +V +    +      +V E++    +  +L                  A       EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156

Query: 179 LHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDDDYWHEKGGG 238
           LH     ++I+  +K  N+L++++   +V D+G +         L G  +          
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSK 213

Query: 239 NATRESDVYGFGVVLLEILSGRR 261
              +  D +  GV++ E+ +G  
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYP 236

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-25
 Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 19/204 (9%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASV---IKTLSLAQHPNIV 122
             +G+G+  TVY A   +T ++VA+K+I              +    IK L    HPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 123 PILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQG 182
            +L          +V +F+           +     +L  +          +GLEYLHQ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR------GLAGYVDDDYWHEKG 236
               I+H  +K +N+LL+E    ++ D+GL+       R          Y   +     G
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF--G 174

Query: 237 GGNATRESDVYGFGVVLLEILSGR 260
                   D++  G +L E+L   
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRV 198

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 8e-25
 Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 29/217 (13%)

Query: 60  TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFG--FASVIKTLSLA 116
              +++   IG+G  G V +A        VA+K+I P     +  +       IK L   
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRF 63

Query: 117 QHPNIVPILGFSQAPGERIIVSEFINMASLDF----YLHENNDGASLLDWNRRLRIATGA 172
           +H NI+ I    +AP    +   ++    +       L   +     L  +         
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQI 118

Query: 173 ARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR---------GL 223
            RGL+Y+H     N++H  +K SN+LLN     ++CD+GL+ +A  +             
Sbjct: 119 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 224 AGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             Y   +          T+  D++  G +L E+LS R
Sbjct: 176 RWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNR 210

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 2e-24
 Identities = 46/232 (19%), Positives = 84/232 (36%), Gaps = 24/232 (10%)

Query: 67  RIIGQGRLGTVYAA-LLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             IGQG  G V+ A    TG+ VA+K++                IK L L +H N+V ++
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 126 GFSQAPGERI--------IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLE 177
              +              +V +F          +           +   R+      GL 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLY 131

Query: 178 YLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAGYVDD-------- 229
           Y+H+     I+H  +KA+N+L+      ++ D+GL+      K        +        
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 230 DYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS 281
                 G  +     D++G G ++ E+ +     +G   +  L LI ++  S
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-24
 Identities = 43/218 (19%), Positives = 83/218 (38%), Gaps = 21/218 (9%)

Query: 55  EIDAATDGFSHR----RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASV 109
           E+              + +G G  G V +A+   TG  VA+K+++               
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 110 IKTLSLAQHPNIVPILGFSQAPGERIIVSEFI----NMASLDFYLHENNDGASLLDWNRR 165
           ++ L   +H N++ +L            ++F      M +    L ++      L  +R 
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRI 123

Query: 166 LRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLAG 225
             +     +GL Y+H      IIH  +K  N+ +NE    ++ D+GL+  A  E  G   
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 180

Query: 226 YVDDDYWHE---KGGGNATRESDVYGFGVVLLEILSGR 260
                Y            T+  D++  G ++ E+++G+
Sbjct: 181 TR--WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 5e-24
 Identities = 51/252 (20%), Positives = 95/252 (37%), Gaps = 20/252 (7%)

Query: 61  DGFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLSNAGFG--FASVIKTLS 114
           + F   +++G G  G V+         TGKL A+K +    ++  A       +  + L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 115 -LAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAA 173
            + Q P +V +    Q   +  ++ ++IN   L  +L +          +          
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIV 139

Query: 174 RGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGLA----GYVDD 229
             LE+LH+     II+  IK  NILL+      + D+GLS     ++   A    G ++ 
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 230 DYWHEKGGGNA--TRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPR 287
                  GG++   +  D +  GV++ E+L+G         K +   I            
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 288 LAIPCEIKPLVR 299
             +    K L++
Sbjct: 257 QEMSALAKDLIQ 268

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 1e-21
 Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 9/219 (4%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
             +G G  G+V AA    TG  VAVK++                ++ L   +H N++ +L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 126 GFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAP 185
                       ++   +  L      N      L  +    +     RGL+Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140

Query: 186 NIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKRGL---AGYVDDDYWHEKGGGNATR 242
           +IIH  +K SN+ +NE    ++ D+GL+    +E  G      Y   +        +  +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQ 198

Query: 243 ESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFS 281
             D++  G ++ E+L+GR    G      L LI  +  +
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 86.8 bits (214), Expect = 5e-20
 Identities = 37/209 (17%), Positives = 72/209 (34%), Gaps = 23/209 (11%)

Query: 61  DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS-LAQH 118
           D +   R +G+G+   V+ A+ ++  + V VK + P              IK L  L   
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGG 89

Query: 119 PNIVPILGFSQAPGER--IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGL 176
           PNI+ +    + P  R   +V E +N                 L             + L
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKAL 142

Query: 177 EYLHQGVAPNIIHGCIKASNILLNEKFC-ARVCDYGLSFLAPEEKRGLAGYVDDDYWH-- 233
           +Y H      I+H  +K  N++++ +    R+ D+GL+      +          +    
Sbjct: 143 DYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199

Query: 234 -EKGGGNATRESDVYGFGVVLLEILSGRR 261
                       D++  G +L  ++  + 
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.6 bits (195), Expect = 2e-17
 Identities = 41/245 (16%), Positives = 79/245 (32%), Gaps = 25/245 (10%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPIL 125
           + IG G  G V AA      + VA+K++                +  +    H NI+ +L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 126 GFSQAPG------ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYL 179
                        +  +V E ++         E        D  R   +      G+++L
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHL 135

Query: 180 HQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEEKR-----GLAGYVDDDYWHE 234
           H      IIH  +K SNI++      ++ D+GL+  A              Y   +    
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL- 191

Query: 235 KGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI 294
             G       D++  G ++ E++  +    G         + E   +   +    +   +
Sbjct: 192 --GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 295 KPLVR 299
           +  V 
Sbjct: 250 RNYVE 254

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 76.2 bits (186), Expect = 4e-16
 Identities = 33/213 (15%), Positives = 70/213 (32%), Gaps = 24/213 (11%)

Query: 67  RIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLS--------LAQ 117
           R +G G   TV+ A  +     VA+K +    V + A      +++ ++           
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 118 HPNIVPILGFSQAPGERIIVSEFINMASLDFYLH-ENNDGASLLDWNRRLRIATGAARGL 176
             +I+ +L      G   +    +     +  L          +      +I+     GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 177 EYLHQGVAPNIIHGCIKASNILLN-EKFCARVCDYGLSFLA--------PEEKRGLAGYV 227
           +Y+H+     IIH  IK  N+L+        +    ++ L                  Y 
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 228 DDDYWHEKGGGNATRESDVYGFGVVLLEILSGR 260
             +      G      +D++    ++ E+++G 
Sbjct: 197 SPEVLL---GAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 58.3 bits (140), Expect = 8e-11
 Identities = 18/163 (11%), Positives = 43/163 (26%), Gaps = 35/163 (21%)

Query: 67  RIIGQGRLGTVYAALLSTGKLVAVKRIHPRLV----------------LSNAGFGFASVI 110
           +++G+G+   V+           VK                          A     +  
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 111 KTLSLAQHPNIVPILGFSQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIAT 170
           + L   Q   +  +  +        ++ E I+                 +       +  
Sbjct: 66  RALQKLQGLAVPKVYAW----EGNAVLMELIDA-----------KELYRVRVENPDEVLD 110

Query: 171 GAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS 213
                +   +      I+HG +   N+L++E     + D+  S
Sbjct: 111 MILEEVAKFYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQS 149

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	332
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.46
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.93
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.63
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.71
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.39

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=404.51  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=209.3

Q ss_pred             HhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           58 AATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ...++|...+.||+|+||+||+|+.+  ..||||+++...........+.+|+.++++++|||||++++++.. +..+++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            34678999999999999999999864  369999998665545555578899999999999999999999865 568999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||||++|+|.+++.....   .+++..++.++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999999975432   289999999999999999999998   99999999999999999999999999997653


Q ss_pred             c--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHH-HHhhhcccccccCCcC
Q 020027          218 E--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWAL-PLIKEMRFSELLDPRL  288 (332)
Q Consensus       218 ~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  288 (332)
                      .        ...||+.|+|||.+.......++.++|||||||++|||+||+.||.+....... ..+..+..    .+..
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~p~~  231 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL----SPDL  231 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC----CCCG
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----CCcc
Confidence            2        225899999999987654467899999999999999999999999875433322 22222211    1111


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                       ...+..++.++.+++.+||+.||++||||+|+++.|+.+.+
T Consensus       232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             01112233478899999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-58  Score=405.53  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=204.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEeC-CCC---EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLS-TGK---LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ++|...+.||+|+||+||+|+.. +++   .||||.+..... ......+.+|+.++++++|||||+++|++..++..++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45667789999999999999953 333   589998865432 2223468999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +||||++|+|.+++.....   .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 v~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            9999999999998876432   389999999999999999999998   9999999999999999999999999999765


Q ss_pred             Ccc-----------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          217 PEE-----------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       217 ~~~-----------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .+.           ..+|..|+|||.+..   ..++.++|||||||++|||+| |+.||.+.........+..+.     
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~-----  250 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQY---RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY-----  250 (299)
T ss_dssp             -----------------CGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhc---CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            322           135788999999876   689999999999999999998 899998877666655554421     


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                          ..+.+..++..+.+++.+||+.||++|||++||++.|++++.+|
T Consensus       251 ----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                12223334457889999999999999999999999999998776

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-58  Score=397.92  Aligned_cols=250  Identities=20%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .++|+..+.||+|+||.||+|++.+++.||||+++....   ...++.+|+.++++++||||++++|++..++..+++||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            457888899999999999999988888999999975432   23458999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++|+|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        81 ~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             ecCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            9999999999875432   378999999999999999999999   9999999999999999999999999999764332


Q ss_pred             -------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          220 -------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       220 -------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                             ..||..|+|||.+..   ..++.++|||||||++|||+| |.+||...........+..+.         ..+
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------~~~  222 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------RLY  222 (263)
T ss_dssp             ----------CTTSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC---------CCC
T ss_pred             CceeecceecCcccCChHHhcC---CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC---------CCC
Confidence                   257889999999876   679999999999999999999 566666655555555444431         111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      .+..+..++.+++.+||+.||++||||+|+++.|+++.+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            122334478899999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-58  Score=400.93  Aligned_cols=258  Identities=23%  Similarity=0.329  Sum_probs=213.4

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG  132 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  132 (332)
                      ++++...++|...+.||+|+||+||+|.. .+|+.||||+++.+..   ....+.+|+.+++.++|||||+++|++..++
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            44556677888899999999999999995 5788999999875432   2335799999999999999999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+++|+|.+++.....  ..+++..++.++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             eeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence            99999999999999999976433  2389999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCccc-------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCC-CchhHHHHHHHhhhccccccc
Q 020027          213 SFLAPEEK-------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCE-EGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       213 a~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      |+......       .++..|+|||.+..   ..++.++|||||||++|||+||..|+ .+.........+..+      
T Consensus       162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~------  232 (287)
T d1opja_         162 SRLMTGDTYTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------  232 (287)
T ss_dssp             TTTCCSSSSEEETTEEECGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT------
T ss_pred             eeecCCCCceeeccccccccccChHHHcC---CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC------
Confidence            98764332       36778999999887   67899999999999999999966654 454444444444332      


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                         ...+.+...+.++.+++.+||+.||++|||++|+++.|+.+..+
T Consensus       233 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         233 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             ---CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence               11222223345788999999999999999999999999987653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-57  Score=391.69  Aligned_cols=243  Identities=21%  Similarity=0.319  Sum_probs=208.3

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||+||+|+. .+|+.||+|.+.+..... .....+.+|+.+++.++||||+++++++.+++..+++|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5688899999999999999994 689999999987544322 22335789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      |||++|+|.+++.....    +++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|.....
T Consensus        86 Ey~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999976543    89999999999999999999999   999999999999999999999999999976654


Q ss_pred             c----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCCh
Q 020027          219 E----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEI  294 (332)
Q Consensus       219 ~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      .    ..||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+....+....+.....        ..+.  
T Consensus       159 ~~~~~~~Gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--------~~p~--  225 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPEMIEG---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------TFPD--  225 (263)
T ss_dssp             CCCEETTEEGGGCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------CCCT--
T ss_pred             CcccccCCCCcccCHHHHcC---CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCCc--
Confidence            3    268999999999986   6789999999999999999999999998777666665544321        1111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          295 KPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       295 ~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+.++.+++.+||+.||++|||++|+++
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         226 FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            22346789999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-58  Score=397.07  Aligned_cols=252  Identities=19%  Similarity=0.237  Sum_probs=200.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--CCceeE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--PGERII  136 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  136 (332)
                      .++|+..+.||+|+||+||+|+ ..+|+.||+|.++...........+.+|++++++++||||+++++++.+  ++..++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            3678999999999999999999 5689999999998765444444467899999999999999999998854  466899


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV--APNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +||||++|+|.+++.........+++..++.++.|++.||.|||++.  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998754322334899999999999999999999861  1249999999999999999999999999997


Q ss_pred             cCCc------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcC
Q 020027          215 LAPE------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       215 ~~~~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ....      ...||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+....+....+..+.....     
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~-----  234 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNR---MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-----  234 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-----
T ss_pred             ecccCCCccccCCCCcccCCHHHHcC---CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence            6433      2368999999999876   6789999999999999999999999998777766666655433211     


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +...+.++.+++.+||+.||++|||++|+++
T Consensus       235 ----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 ----PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                1122347889999999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=386.24  Aligned_cols=248  Identities=19%  Similarity=0.283  Sum_probs=211.8

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .++|+..+.||+|+||+||+|+.++++.||||.++....   ...++.+|+.++++++||||++++|++..++..+++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            468999999999999999999998888999999986532   23468999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+++|++.+++.....   .+++..+.+++.|+++||.|||+.   +|+||||||+||++++++.+||+|||+++...+.
T Consensus        80 y~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          80 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             CCTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             ccCCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            9999999999765433   278999999999999999999998   9999999999999999999999999999754322


Q ss_pred             -------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          220 -------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       220 -------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                             ..+|..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+.       +  .+
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-------~--~~  221 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------R--LY  221 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------C--CC
T ss_pred             CceeecccCCCCCcCCcHHhcC---CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-------C--CC
Confidence                   247788999999887   678999999999999999998 899999887777666555431       1  11


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      .+...+.++.+++.+||+.||++|||++++++.|.++
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1222334788999999999999999999999998653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-57  Score=395.33  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=206.0

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      +...++|...+.||+|+||.||+|+.++++.||||+++...   .....+.+|+.++++++|||||+++|++.. +..++
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            34456788899999999999999998888899999997543   223358999999999999999999998865 55789


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++|+|.+++.....  ..+++..++.++.||++||.|||++   +|+||||||+|||+++++.+||+|||+|+..
T Consensus        85 v~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence            9999999999998764322  2389999999999999999999998   9999999999999999999999999999865


Q ss_pred             Ccc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCC-CCCchhHHHHHHHhhhcccccccCCcC
Q 020027          217 PEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR-CEEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       217 ~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      .+.       ..+|..|+|||.+..   ..++.++|||||||++|||+||.. |+......+....+..+.         
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~---------  227 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------  227 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred             cCCccccccccCCcccccChHHHhC---CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---------
Confidence            432       257789999999876   678999999999999999999654 555555555544444321         


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      ..+.+...+.++.+++.+||+.||++||||+||++.|+..
T Consensus       228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            1112223344788999999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=391.45  Aligned_cols=242  Identities=22%  Similarity=0.353  Sum_probs=200.5

Q ss_pred             ceeeccCCeEEEEEEeC---CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEeccCC
Q 020027           67 RIIGQGRLGTVYAALLS---TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEFINM  143 (332)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  143 (332)
                      +.||+|+||+||+|.++   +++.||||.++...........+.+|+.++++++|||||+++|++..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999843   456899999976544333344689999999999999999999999654 57899999999


Q ss_pred             CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc----
Q 020027          144 ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE----  219 (332)
Q Consensus       144 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~----  219 (332)
                      |+|.+++.....    +++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|++|||+|+.....    
T Consensus        92 g~L~~~l~~~~~----l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhccC----CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999986543    89999999999999999999998   9999999999999999999999999999754322    


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ..||+.|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+.       +  .+.+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~---~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-------~--~~~p  232 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------R--MGCP  232 (277)
T ss_dssp             EC----CCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------C--CCCC
T ss_pred             ccccccCCCceecCchhhcC---CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-------C--CCCC
Confidence                 257889999999876   678999999999999999998 899999877666665555432       1  1222


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                      ..++.++.+++.+||+.||++|||+++|.+.|+..
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            23345788999999999999999999999988764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=390.92  Aligned_cols=243  Identities=22%  Similarity=0.269  Sum_probs=205.0

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||+|+++.....  ....+.+|+.+++.++|||||++++++..++..+++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            479999999999999999999 568999999998755322  23357899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      ||++|+|.+++....     +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.... 
T Consensus        98 y~~gg~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          98 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             CCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            999999999886532     89999999999999999999999   999999999999999999999999999976432 


Q ss_pred             -----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                           ...||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+.....       ...+.+
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-------~~~~~~  239 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-------PELQNP  239 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSS---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-------CCCSSG
T ss_pred             cccccccccCCCccChhhhcC---CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------CCCCCc
Confidence                 2258999999999876   6789999999999999999999999987665554443333211       111122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            233457889999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=393.17  Aligned_cols=254  Identities=23%  Similarity=0.392  Sum_probs=204.6

Q ss_pred             cCCCCCCceeeccCCeEEEEEEeCC-C----CEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALLST-G----KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .+.|+..++||+|+||.||+|.+.+ +    ..||||.++..... .....+.+|+.++++++|||||+++|++...+..
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            3567888999999999999998543 2    36999999754332 2233588999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+.++++.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            999999999999988876433   289999999999999999999998   99999999999999999999999999997


Q ss_pred             cCCcc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCC-CCCchhHHHHHHHhhhccccccc
Q 020027          215 LAPEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRR-CEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       215 ~~~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....         ..||..|+|||.+..   ..++.++|||||||++|||+||.. |+.+.........+..+.     
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-----  230 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-----  230 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----
T ss_pred             cccCCCccceEeccCCCCccccCHHHHcc---CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-----
Confidence            64322         246888999999876   789999999999999999999655 455555555554444321     


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccCC
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGDP  332 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~~  332 (332)
                          ..+.+..++.++.+++.+||+.||++||||+||++.|++++..|
T Consensus       231 ----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         231 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                22223334457889999999999999999999999999887654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=388.27  Aligned_cols=246  Identities=20%  Similarity=0.206  Sum_probs=198.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||+||+|+ ..+|+.||+|.++..... .....+.+|+.++++++||||+++++++.+++..+++|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            3578899999999999999999 468999999999765432 22346899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC-
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP-  217 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~-  217 (332)
                      |||++|+|.+++....    .+++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+|+... 
T Consensus        83 Ey~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            9999999999997543    389999999999999999999999   99999999999999999999999999997542 


Q ss_pred             -------cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHH-HHHhhhcccccccCCcCC
Q 020027          218 -------EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWA-LPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       218 -------~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  289 (332)
                             ....||+.|+|||.+...  ..++.++||||+||++|||+||+.||.+...... ........        ..
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--------~~  225 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------TY  225 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCS--SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--------TT
T ss_pred             CCccccccceeeCcCccCHhHhcCC--CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--------CC
Confidence                   223689999999998762  2346789999999999999999999976432211 11111111        11


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+.......++.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111122346779999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-56  Score=390.03  Aligned_cols=248  Identities=21%  Similarity=0.227  Sum_probs=207.4

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      +.|+..+.||+|+||.||+|+ ..+|+.||+|.++....  .....+.+|+.+++.++|||||++++++..++..+++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            468888999999999999999 56899999999976532  233467999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc-
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE-  218 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~-  218 (332)
                      ||++|+|.+++.+...   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.... 
T Consensus        90 y~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999865432   289999999999999999999999   999999999999999999999999999865432 


Q ss_pred             -----ccCCcccccCccccccc--CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          219 -----EKRGLAGYVDDDYWHEK--GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       219 -----~~~~~~~~~~pe~~~~~--~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                           ...||+.|+|||.+...  .+..++.++|||||||++|||+||+.||.+.........+..+...       ...
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~-------~~~  236 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-------TLA  236 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-------CCS
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------CCC
Confidence                 34689999999998532  2356899999999999999999999999887666555544443211       112


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .+...+.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22233457889999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=390.71  Aligned_cols=248  Identities=20%  Similarity=0.297  Sum_probs=204.1

Q ss_pred             CCCCCCce-eeccCCeEEEEEEe---CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           61 DGFSHRRI-IGQGRLGTVYAALL---STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        61 ~~~~~~~~-lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      ++|...+. ||+|+||.||+|..   .++..||||.++.... ......+.+|+.++++++|||||+++|++..+ ..++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence            45555564 99999999999974   2455799999975532 22334689999999999999999999999754 5789


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      ||||+++|+|.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        86 vmE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999865432   389999999999999999999998   9999999999999999999999999999754


Q ss_pred             Ccc---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          217 PEE---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       217 ~~~---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ...         ..+|..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+..+..      
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~------  230 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------  230 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC------
T ss_pred             cccccccccccccccCccccChHHHhC---CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            322         246789999999876   678999999999999999998 8999988766666666655321      


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                       +  +.+..++.++.+++.+||+.||++||||.+|++.|+..
T Consensus       231 -~--~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 -M--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -C--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -C--CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             1  12223345788999999999999999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-56  Score=393.64  Aligned_cols=247  Identities=22%  Similarity=0.257  Sum_probs=205.7

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc-ccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN-AGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      .|+..+.||+|+||.||+|+ ..+|+.||||.++....... ....+.+|+.++++++|||||++++++.+++..+++||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            48889999999999999999 56889999999976543322 22357899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      ||++|++..++....    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|......
T Consensus        96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            999999987765443    289999999999999999999999   9999999999999999999999999999765433


Q ss_pred             --cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHH
Q 020027          220 --KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPL  297 (332)
Q Consensus       220 --~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (332)
                        ..||+.|+|||.+.......++.++|||||||++|||++|+.||.+.........+..+....        ..+...+
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------~~~~~~s  240 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------LQSGHWS  240 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------CSCTTSC
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------CCCCCCC
Confidence              469999999999875444678999999999999999999999998766555444443332111        1111223


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          298 VRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       298 ~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         241 EYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            47889999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-55  Score=378.91  Aligned_cols=241  Identities=21%  Similarity=0.303  Sum_probs=195.1

Q ss_pred             CCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec----CCceeEEE
Q 020027           64 SHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA----PGERIIVS  138 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  138 (332)
                      ...+.||+|+||+||+|+ ..+++.||+|.+............+.+|++++++++|||||++++++..    ++..+++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            344679999999999999 4578999999997665444444468899999999999999999999864    34679999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeecCCCCCCEEeC-CCCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPN--IIHGCIKASNILLN-EKFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~dfg~a~~  215 (332)
                      ||+++|+|.+++.+...    +++..+..++.||+.||.|||++   +  |+||||||+|||++ +++.+||+|||+|+.
T Consensus        92 E~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhcccc----ccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            99999999999976543    88999999999999999999998   6  99999999999997 578999999999976


Q ss_pred             CCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-HHHHHHHhhhcccccccCCcCCC
Q 020027          216 APEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL-VKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....    ..||+.|+|||.+..    .++.++|||||||++|||+||+.||.+.. .......+..+....    .+  
T Consensus       165 ~~~~~~~~~~GT~~Y~aPE~~~~----~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~----~~--  234 (270)
T d1t4ha_         165 KRASFAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----SF--  234 (270)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----GG--
T ss_pred             ccCCccCCcccCccccCHHHhCC----CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc----cc--
Confidence            4432    368999999998863    58999999999999999999999997643 333333333321111    11  


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        +.....++.+++.+||+.||++|||++|+++
T Consensus       235 --~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence              1111236789999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=392.93  Aligned_cols=255  Identities=23%  Similarity=0.362  Sum_probs=204.4

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEe-CCC-----CEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALL-STG-----KLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQ  129 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  129 (332)
                      +...++|+..+.||+|+||+||+|+. .++     ..||+|.+..... ......+.+|+.+++++ +|||||++++++.
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            34557889999999999999999984 233     2699999875432 23334678999999988 8999999999999


Q ss_pred             cCCceeEEEeccCCCCHHHHhcccCCC-------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeec
Q 020027          130 APGERIIVSEFINMASLDFYLHENNDG-------------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHG  190 (332)
Q Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~  190 (332)
                      .++..+++||||++|+|.++++.....                   ...+++..++.++.|+++||.|||++   +|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            999999999999999999999764321                   13478999999999999999999999   99999


Q ss_pred             CCCCCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCC
Q 020027          191 CIKASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRR  261 (332)
Q Consensus       191 dlk~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~  261 (332)
                      ||||+|||++.++.+||+|||+|+.....        ..+|+.|+|||.+..   ..++.++|||||||++|||+| |+.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC---CCCCcceeccchhHHHHHHHhCCCC
Confidence            99999999999999999999999764432        236889999999876   788999999999999999998 899


Q ss_pred             CCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 020027          262 CEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILN  326 (332)
Q Consensus       262 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~  326 (332)
                      ||.+.........+....        ...+.+..++.++.+++.+||+.||++|||++||++.|.
T Consensus       266 Pf~~~~~~~~~~~~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         266 PYPGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SSTTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcC--------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            998754433332222221        112223334457889999999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=386.56  Aligned_cols=242  Identities=21%  Similarity=0.267  Sum_probs=206.0

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.+++.... ......+.+|+.++++++||||+++++++.+++..+++|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999994 68999999999764432 223345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        88 Ey~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhccCC----CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999876543    89999999999999999999999   999999999999999999999999999976532


Q ss_pred             --------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          219 --------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       219 --------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                              ...||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+.....        ..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--------~~  229 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTE---KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--------DF  229 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--------CC
T ss_pred             CCcccccccccCCccccCceeecc---CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--------CC
Confidence                    2358999999999876   6789999999999999999999999998776666555544321        12


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVA  322 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~  322 (332)
                      +.  ....++.+++.+||+.||++|||++|++
T Consensus       230 p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         230 PE--KFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CT--TCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             Cc--cCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            21  1233678999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-55  Score=386.86  Aligned_cols=247  Identities=20%  Similarity=0.228  Sum_probs=195.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .+.|+..+.||+|+||+||+|+ ..+|+.||+|.+........ ...+.+|+.+++.++||||+++++++.+++..+++|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4668999999999999999999 46899999999976543322 235679999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC---CCCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN---EKFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a~~  215 (332)
                      |||++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+||++.   +++.+||+|||+|+.
T Consensus        87 E~~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHHTCSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhhcccC----CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999976432    89999999999999999999999   999999999999995   578999999999976


Q ss_pred             CCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          216 APEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       216 ~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      ....     ..||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+.....      .+..
T Consensus       160 ~~~~~~~~~~~GT~~y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------~~~~  230 (307)
T d1a06a_         160 EDPGSVLSTACGTPGYVAPEVLAQ---KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY------EFDS  230 (307)
T ss_dssp             -------------CTTSCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC------CCCT
T ss_pred             ccCCCeeeeeeeCccccCcHHHcC---CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC------CCCC
Confidence            5432     368999999999876   6789999999999999999999999988766666555544322      1111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      +.....+.++.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            222223347889999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=384.35  Aligned_cols=252  Identities=21%  Similarity=0.367  Sum_probs=206.0

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeE
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERII  136 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  136 (332)
                      +...++|...+.||+|+||.||+|+..+++.||||+++....   ....+.+|+.++++++|||||+++|++.. +..++
T Consensus        13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            344678999999999999999999988888899999975432   22358999999999999999999999854 56789


Q ss_pred             EEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          137 VSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      +|||+++|+|..++......  .++|..++.++.||+.||+|||++   +|+||||||+|||+++++++||+|||+|+..
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~--~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEEecCCCchhhhhhhcccc--cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence            99999999999988754322  289999999999999999999999   9999999999999999999999999999765


Q ss_pred             Ccc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCC-CCchhHHHHHHHhhhcccccccCCcC
Q 020027          217 PEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRC-EEGLLVKWALPLIKEMRFSELLDPRL  288 (332)
Q Consensus       217 ~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      .+.       ..+|..|+|||++..   ..++.++|||||||++|||+||..| +.+....+....+..+.         
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---------  231 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------  231 (285)
T ss_dssp             ------------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred             cCCCceeeccccccccccChHHHhC---CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---------
Confidence            322       257889999999987   7889999999999999999996554 55555555555544321         


Q ss_pred             CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          289 AIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       289 ~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ..+.+..++.++.+++.+||+.||++|||+++|++.|++..
T Consensus       232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            12222334457889999999999999999999999998865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=391.66  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             hcCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ..++|+..+.||+|+||+||+|+ ..+|+.||+|.++.... ......+.+|+.+++.++|||||++++++..++..++|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46789999999999999999999 56899999999976532 22233578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCCceEEccCCccccC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLA  216 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~  216 (332)
                      |||+++|+|.+++.+...    +++..+..++.|++.||.|||+ +   +|+||||||+|||+++++.+||+|||+|+..
T Consensus        83 mEy~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999976543    8999999999999999999996 5   8999999999999999999999999999754


Q ss_pred             C----cccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhh---hccccc-------
Q 020027          217 P----EEKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIK---EMRFSE-------  282 (332)
Q Consensus       217 ~----~~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~-------  282 (332)
                      .    ....||..|+|||.+..   ..++.++||||+||++|||+||+.||.+...........   .+....       
T Consensus       156 ~~~~~~~~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         156 IDSMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHHTC---CCSSCCCCHHHHHC---SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             CCCccccccCCccccCchHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            3    23479999999999987   689999999999999999999999997643222110000   000000       


Q ss_pred             ------------------------ccC-CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 ------------------------LLD-PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ------------------------~~~-~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                                              ... +....+ ......++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                    000 000000 0011246789999999999999999999976

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-55  Score=384.83  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=214.9

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFS  128 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  128 (332)
                      +++...++|+..+.||+|+||+||+|+..      +++.||||+++.... ......+.+|+.+++.++||||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            34445678999999999999999999842      457899999875432 22234689999999999999999999999


Q ss_pred             ecCCceeEEEeccCCCCHHHHhcccCC--------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 020027          129 QAPGERIIVSEFINMASLDFYLHENND--------------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNII  188 (332)
Q Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iv  188 (332)
                      ...+..+++|||+++|+|.+++.....                    ....+++..++.++.|++.||+|||++   +++
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            999999999999999999999965321                    122478999999999999999999999   999


Q ss_pred             ecCCCCCCEEeCCCCceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCC
Q 020027          189 HGCIKASNILLNEKFCARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR  260 (332)
Q Consensus       189 H~dlk~~Nill~~~~~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~  260 (332)
                      ||||||+|||++.++.+||+|||+|+...+        ...++..|+|||.+..   ..++.++|||||||++|||+||.
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc---CCCChhhhhccchhhHHHHHccC
Confidence            999999999999999999999999864422        1246788999999987   78999999999999999999985


Q ss_pred             -CCCCchhHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          261 -RCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       261 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                       +||.+....+....+.++...         +.+...+.++.+++.+||+.||++||||.||++.|+++.+
T Consensus       240 ~~p~~~~~~~e~~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         240 LQPYYGMAHEEVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             678887777776666554321         1122233478899999999999999999999999998863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=380.06  Aligned_cols=248  Identities=20%  Similarity=0.218  Sum_probs=207.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccc----cccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNA----GFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .+.|+..+.||+|+||+||+|+. .+|+.||+|.+++.......    ...+.+|+.++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46789999999999999999994 68999999999765443222    23578999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC----ceEEccC
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF----CARVCDY  210 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~df  210 (332)
                      +++||||++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+||+++.++    .+|++||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~----l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhccccc----cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            999999999999999976543    89999999999999999999999   999999999999998776    4999999


Q ss_pred             CccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          211 GLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       211 g~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      |+|......     ..+|+.|+|||.+..   ..++.++||||+||++|||+||+.||.+....+....+......    
T Consensus       162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~----  234 (293)
T d1jksa_         162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----  234 (293)
T ss_dssp             TTCEECTTSCBCSCCCCCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC----
T ss_pred             hhhhhcCCCccccccCCCCcccCHHHHcC---CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----
Confidence            999765432     367889999999876   67899999999999999999999999987776666555443211    


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        ...+.....+..+.+++.+||+.||++|||++|+++
T Consensus       235 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 --FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000112336789999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=377.94  Aligned_cols=249  Identities=26%  Similarity=0.363  Sum_probs=201.3

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec-CCceeEE
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA-PGERIIV  137 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  137 (332)
                      ..++|+..+.||+|+||.||+|+. +|+.||||+++.+.    ....+.+|+.++++++||||++++|++.. ++..+++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            345678889999999999999998 47899999996532    23457899999999999999999999854 4678999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+|++|||+++...
T Consensus        80 ~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            999999999999975421  2379999999999999999999998   99999999999999999999999999998654


Q ss_pred             cc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCCcCCCCCC
Q 020027          218 EE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCE  293 (332)
Q Consensus       218 ~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                      ..   ..++..|+|||.+..   ..+++++|||||||++|||+| |+.||.+.........+..+.       +  .+.+
T Consensus       155 ~~~~~~~~~~~y~aPE~l~~---~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-------~--~~~~  222 (262)
T d1byga_         155 STQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------K--MDAP  222 (262)
T ss_dssp             -------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------C--CCCC
T ss_pred             CCCccccccccCCChHHHhC---CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------C--CCCC
Confidence            33   357889999999887   678999999999999999999 788887766655555554432       1  1122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          294 IKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       294 ~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ...+.++.+++.+||+.||++||||.++++.|+++.
T Consensus       223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            223347889999999999999999999999998864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=384.91  Aligned_cols=251  Identities=19%  Similarity=0.354  Sum_probs=203.7

Q ss_pred             CCCCCCceeeccCCeEEEEEEe-CCCC----EEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCcee
Q 020027           61 DGFSHRRIIGQGRLGTVYAALL-STGK----LVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  135 (332)
                      ++|+..+.||+|+||+||+|.. .+|+    .||+|.++.... ......+.+|+.++++++|||||+++|++..+ ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            4689999999999999999984 4554    588888864432 23334689999999999999999999999865 467


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFL  215 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~  215 (332)
                      +++|++.+++|.+++.....   .+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence            88899999999988876533   389999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          216 APEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       216 ~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      ....        ..||..|+|||.+..   +.++.++|||||||++|||+| |..||.+.........+..+.       
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-------  230 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------  230 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-------
T ss_pred             cccccccccccccccCccccChHHHhc---CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            4322        247889999999887   678999999999999999999 788998776666555554432       


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                        ..+.+..++.++.+++.+||+.||++|||+.|+++.|..+..+
T Consensus       231 --~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         231 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence              1222233445788999999999999999999999999887654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-55  Score=380.64  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=201.6

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEeC----CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALLS----TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      ..++|+..+.||+|+||.||+|+..    .+..||+|.++.... ......+.+|+.++++++||||++++|++. ++..
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            3567888999999999999999843    234689998865432 222345889999999999999999999986 4678


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||+++|++.+++.....   .+++..++.++.|+++||.|||++   +++||||||+||++++++.+||+|||+|+
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence            999999999999998765432   279999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCcc-------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          215 LAPEE-------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       215 ~~~~~-------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      .....       ..+|+.|+|||.+..   ..++.++|||||||++|||+| |..||.+....+....+..+..      
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~---~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~------  227 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------  227 (273)
T ss_dssp             --------------CCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred             eccCCcceeccceecCcccchhhHhcc---CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------
Confidence            64322       246889999999987   688999999999999999998 8999988776666655554321      


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                         .+.+...+.++.+++.+||+.||++|||++||++.|+++++
T Consensus       228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               11222334578899999999999999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.3e-54  Score=385.54  Aligned_cols=247  Identities=17%  Similarity=0.211  Sum_probs=208.1

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||+|+ ..+|+.||+|.++.....  ....+.+|+.++++++|||||++++++..++..+++|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4579999999999999999999 568999999999765432  2235689999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC--CCCceEEccCCccccC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN--EKFCARVCDYGLSFLA  216 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~dfg~a~~~  216 (332)
                      |||++|+|.+++.....   .+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+|...
T Consensus       106 E~~~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         106 EFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             ECCCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCChHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence            99999999988765432   389999999999999999999999   999999999999998  5789999999999765


Q ss_pred             Ccc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 PEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ...     ..+|+.|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+..+...      +...
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------~~~~  250 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDR---EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE------FDED  250 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC------CCSS
T ss_pred             CCCCceeeccCcccccCHHHHcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------CCcc
Confidence            433     368999999999876   67899999999999999999999999987777666666554321      1111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .......++.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11222346789999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.7e-54  Score=386.33  Aligned_cols=247  Identities=18%  Similarity=0.188  Sum_probs=207.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|+..+.||+|+||.||+|+ ..+|+.||+|++......  ....+.+|+.+++.++|||||++++++.+++..+++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4579999999999999999999 468999999999765432  2235789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeC--CCCceEEccCCccccC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLN--EKFCARVCDYGLSFLA  216 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~dfg~a~~~  216 (332)
                      |||++|+|.+++.....   .+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+|+..
T Consensus       103 E~~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         103 EFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCCCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EcCCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            99999999999864332   289999999999999999999999   999999999999996  4678999999999765


Q ss_pred             Ccc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 PEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ...     ..||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+....+....+.......      ...
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~---~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------~~~  247 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEG---KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------DDS  247 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHT---CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------CCG
T ss_pred             ccccccceecCcccccCHHHHcC---CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------Ccc
Confidence            433     368999999999876   678999999999999999999999999877776666665543211      111


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .......++.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11122346789999999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-53  Score=371.00  Aligned_cols=250  Identities=19%  Similarity=0.196  Sum_probs=210.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-------cccHHHHHHHhccCC-CCCccceeeeeecC
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-------GFGFASVIKTLSLAQ-HPNIVPILGFSQAP  131 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  131 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||+|+++........       ...+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            678899999999999999999 468999999999865433221       124788999999997 99999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCC
Q 020027          132 GERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYG  211 (332)
Q Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg  211 (332)
                      +..+++|||+++|+|.+++.....    +++.++..++.||++||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            999999999999999999976543    89999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCcc-----cCCcccccCccccccc---CCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccc
Q 020027          212 LSFLAPEE-----KRGLAGYVDDDYWHEK---GGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSEL  283 (332)
Q Consensus       212 ~a~~~~~~-----~~~~~~~~~pe~~~~~---~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      +++.....     ..||..|++||.+...   ....++.++||||+||++|||+||+.||.+....+....+..+...  
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~--  233 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--  233 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC--
Confidence            99765432     3588999999998643   2345789999999999999999999999988777766666554321  


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 LDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          +..+.....+.++.+++.+||+.||++|||+.|+++
T Consensus       234 ----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 ----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                122222233457889999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=378.71  Aligned_cols=244  Identities=20%  Similarity=0.270  Sum_probs=208.0

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|+..+.||+|+||.||+|+ ..+|+.||+|++++..... .....+.+|+.+++.++||||+++++++.+++..+++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            4679999999999999999999 5689999999997654322 2334578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      ||||++|+|.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999987653    78999999999999999999999   99999999999999999999999999997643


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .      ...||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+..+..        ..+
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~---~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~--------~~p  225 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------RFP  225 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSS---SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCC
T ss_pred             cCCcccccceeCHHHhhhhhccC---CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC--------CCC
Confidence            2      2368999999999876   6789999999999999999999999998877766665555321        122


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      ..  ...++.+++.+||+.||++||+     ++|+++
T Consensus       226 ~~--~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 RT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             TT--SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cc--CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            22  2236789999999999999995     777765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-54  Score=374.54  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=197.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe--CCC--CEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL--STG--KLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~--~~~--~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|+..+.||+|+||.||+|+.  .++  ..||||++++....... ...+.+|+.++++++||||++++|++.++ ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            35688899999999999999984  233  37899998765543332 23689999999999999999999999764 67


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++|||++++++.+++.....   .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+|++|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            899999999999988765432   389999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCccc---------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCchhHHHHHHHhhhccccccc
Q 020027          215 LAPEEK---------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       215 ~~~~~~---------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      ......         .++..|+|||.+..   ..++.++|||||||++|||+| |+.||.+....+....+....     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-----  231 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKT---RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-----  231 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhC---CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC-----
Confidence            653321         36778999999987   678999999999999999998 899998877766655554322     


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNL  328 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~  328 (332)
                         ...+.+...+..+.+++.+||+.||++||||.||.+.|++.
T Consensus       232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               11122223334788999999999999999999999998864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.1e-53  Score=375.31  Aligned_cols=243  Identities=20%  Similarity=0.248  Sum_probs=206.5

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc-ccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL-SNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||+|++++.... ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            568899999999999999999 468999999999765432 223345789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+++|++..++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+...+
T Consensus        84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999998876543    68888899999999999999999   999999999999999999999999999977644


Q ss_pred             c---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 E---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                      .   ..||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+....+....+..+..        ..+.  .
T Consensus       157 ~~~~~~Gt~~Y~APE~l~~---~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------~~p~--~  223 (316)
T d1fota_         157 VTYTLCGTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------RFPP--F  223 (316)
T ss_dssp             CBCCCCSCTTTCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--------CCCT--T
T ss_pred             ccccccCcccccCHHHHcC---CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------CCCC--C
Confidence            3   468999999999876   6789999999999999999999999998777666655554321        1111  1


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ...++.+++.+||+.||.+||     |++++++
T Consensus       224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            223678999999999999996     8888875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.2e-53  Score=370.80  Aligned_cols=254  Identities=22%  Similarity=0.284  Sum_probs=204.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHHHHHHHhccCCCCCccceeeeeecCC----c
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFASVIKTLSLAQHPNIVPILGFSQAPG----E  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  133 (332)
                      .++|...+.||+|+||.||+|+ ..+|+.||+|.++........ ...+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            4679999999999999999999 568999999999866543322 235789999999999999999999987654    3


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+++++|.+++.....    +++.+++.++.|++.||.|||++   +|+||||||+|||++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            7899999999999999876543    89999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          214 FLAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       214 ~~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....         ...||+.|+|||.+..   ..+++++|||||||++|||+||+.||.+....+....+......   
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~---  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC---
T ss_pred             hhhccccccccccccccCcccccCHHHHcC---CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC---
Confidence            54322         2258999999999876   67899999999999999999999999887665554433322111   


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccc
Q 020027          285 DPRLAIPCEIKPLVRLAKVALACVGNSRKNRP-SIVQVATILNNLV  329 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RP-s~~~i~~~L~~~~  329 (332)
                         .........+.++.+++.+||+.||++|| |++++++.|.++.
T Consensus       233 ---~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 ---PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ---CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence               00111112234788999999999999999 8999999998764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=376.48  Aligned_cols=262  Identities=21%  Similarity=0.302  Sum_probs=216.3

Q ss_pred             HHHHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeee
Q 020027           54 TEIDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGF  127 (332)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  127 (332)
                      ++++...++|...+.||+|+||.||+|.+.      +++.||||+++.... ......+.+|+.++++++||||++++|+
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            345566788999999999999999999852      357899999975432 2333357899999999999999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccC------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENN------DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE  201 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  201 (332)
                      +..++..+++|||+++|+|.+++....      .....+++..+..++.|+++||.|||++   +|+||||||+|||+++
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  168 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence            999999999999999999999986432      1123368999999999999999999998   9999999999999999


Q ss_pred             CCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhC-CCCCCchhHHHHH
Q 020027          202 KFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSG-RRCEEGLLVKWAL  272 (332)
Q Consensus       202 ~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg-~~p~~~~~~~~~~  272 (332)
                      ++++||+|||+|+...+.        ..+|+.|++||.+..   ..++.++|||||||++|||+|| ..||.+.......
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~---~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~  245 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  245 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHcc---CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999755332        247889999999887   7889999999999999999997 4778887777776


Q ss_pred             HHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          273 PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      ..+.++...         +.+..++..+.+++.+||+.||++|||+++|++.|++.++.
T Consensus       246 ~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         246 RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            666554321         11122334788999999999999999999999999987653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=374.91  Aligned_cols=256  Identities=26%  Similarity=0.359  Sum_probs=208.3

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCC--EEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeeeeecCCcee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGK--LVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGFSQAPGERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  135 (332)
                      .++|+..+.||+|+||.||+|++ .+|.  .||||.++.... ......+.+|+.+++++ +|||||+++|++...+..+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            46788889999999999999995 4554  477888764332 22334689999999998 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHhcccC------------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC
Q 020027          136 IVSEFINMASLDFYLHENN------------DGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF  203 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  203 (332)
                      +||||+++|+|.+++....            .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence            9999999999999996541            1223489999999999999999999999   999999999999999999


Q ss_pred             ceEEccCCccccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCC-CCCCchhHHHHHHHhhh
Q 020027          204 CARVCDYGLSFLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-RCEEGLLVKWALPLIKE  277 (332)
Q Consensus       204 ~~kl~dfg~a~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~-~p~~~~~~~~~~~~~~~  277 (332)
                      .+||+|||+|+.....     ..+|..|++||.+..   ..++.++|||||||++|||++|. .||.+....+....+..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhcc---CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            9999999999765432     257889999999976   68899999999999999999965 56877766666555544


Q ss_pred             cccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          278 MRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      +.       +  .+.+...+.++.+++.+||+.||++||||+|+++.|++++++
T Consensus       242 ~~-------~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         242 GY-------R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             TC-------C--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cC-------C--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            31       1  122223345788999999999999999999999999988754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=375.69  Aligned_cols=262  Identities=26%  Similarity=0.360  Sum_probs=198.9

Q ss_pred             ChHHHHHhcCCCCCCceeeccCCeEEEEEEeC------CCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccce
Q 020027           52 PLTEIDAATDGFSHRRIIGQGRLGTVYAALLS------TGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPI  124 (332)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~  124 (332)
                      ..++++...++|+..+.||+|+||.||+|...      +++.||+|+++..... .....+.+|...+.++ +|+||+.+
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            34566677788999999999999999999832      4568999998754322 2233467777777766 68999999


Q ss_pred             eeeeecC-CceeEEEeccCCCCHHHHhcccCC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecC
Q 020027          125 LGFSQAP-GERIIVSEFINMASLDFYLHENND------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGC  191 (332)
Q Consensus       125 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  191 (332)
                      ++++..+ +..+++||||++|+|.+++.....            ....+++..++.++.||+.||.|||++   +|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence            9988654 568999999999999999975421            112378999999999999999999999   999999


Q ss_pred             CCCCCEEeCCCCceEEccCCccccCCc--------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCC-CC
Q 020027          192 IKASNILLNEKFCARVCDYGLSFLAPE--------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGR-RC  262 (332)
Q Consensus       192 lk~~Nill~~~~~~kl~dfg~a~~~~~--------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~-~p  262 (332)
                      |||+|||+++++.+||+|||+|+....        ...||+.|+|||.+..   ..++.++|||||||++|||+||. .|
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDiwS~Gvil~ellt~~~~p  236 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASP  236 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc---CCCCcccceeehHHHHHHHHhCCCCC
Confidence            999999999999999999999975432        1257899999999987   68899999999999999999964 57


Q ss_pred             CCchhHH-HHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          263 EEGLLVK-WALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       263 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      |.+.... .....+..+.       ++  +.+...+.++.+++.+||+.||++|||++|+++.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         237 YPGVKIDEEFCRRLKEGT-------RM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             STTCCCSHHHHHHHHHTC-------CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCC-------CC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            7664332 2333333321       11  112223347889999999999999999999999999886

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=369.92  Aligned_cols=246  Identities=21%  Similarity=0.299  Sum_probs=196.8

Q ss_pred             CceeeccCCeEEEEEEeCC----CCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec-CCceeEEEec
Q 020027           66 RRIIGQGRLGTVYAALLST----GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA-PGERIIVSEF  140 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  140 (332)
                      .++||+|+||+||+|++.+    ...||||.++... .......+.+|+.++++++||||++++|++.. ++..+++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            3679999999999999532    2368999986432 22333468999999999999999999999865 5688999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      |++++|.+++.....   .+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++..... 
T Consensus       111 ~~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         111 MKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             eecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999999875433   267888999999999999999998   9999999999999999999999999999764322 


Q ss_pred             ---------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchh-HHHHHHHhhhcccccccCCcCC
Q 020027          220 ---------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLL-VKWALPLIKEMRFSELLDPRLA  289 (332)
Q Consensus       220 ---------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  289 (332)
                               ..||..|+|||.+..   ..++.++||||||+++|||+||+.||.... .......+..+.       ++ 
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-------~~-  253 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------RL-  253 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-------CC-
T ss_pred             cccceecccccccccccChHHHhc---CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------CC-
Confidence                     247889999999887   688999999999999999999877775432 222233333322       11 


Q ss_pred             CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          290 IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       290 ~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                       ..+..+..++.+++.+||+.||++||||.||++.|++++.
T Consensus       254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             1122334578899999999999999999999999998764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=373.15  Aligned_cols=258  Identities=24%  Similarity=0.329  Sum_probs=207.7

Q ss_pred             HHhcCCCCCCceeeccCCeEEEEEEe-CC-------CCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeee
Q 020027           57 DAATDGFSHRRIIGQGRLGTVYAALL-ST-------GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGF  127 (332)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  127 (332)
                      +...++|...+.||+|+||.||+|+. .+       +..||||+++.+... .....+.+|...+.++ +|||||+++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-HHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            34567888999999999999999983 22       247999999765432 2234578888888877 89999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCC
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDG------------ASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKAS  195 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  195 (332)
                      +.+++..+++|||+++|+|.+++......            ...+++.+++.++.|++.||.|||++   +|+||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence            99999999999999999999999754321            13489999999999999999999999   9999999999


Q ss_pred             CEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCCch
Q 020027          196 NILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEEGL  266 (332)
Q Consensus       196 Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~~~  266 (332)
                      |||++.++.+||+|||+++...+.        ..++..|+|||.+..   +.++.++|||||||++|||+| |..||.+.
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~---~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC---CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence            999999999999999998765432        257889999999987   789999999999999999998 78889887


Q ss_pred             hHHHHHHHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          267 LVKWALPLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                      ........+..+.       +  .+.+...+.++.+++.+||+.||++|||+.||++.|+++++
T Consensus       242 ~~~~~~~~i~~~~-------~--~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         242 PVEELFKLLKEGH-------R--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             CHHHHHHHHHTTC-------C--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCC-------C--CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            7766665554432       1  11122233478899999999999999999999999998864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-52  Score=376.19  Aligned_cols=243  Identities=16%  Similarity=0.150  Sum_probs=207.4

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccc-cccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLS-NAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||+|+ ..+|+.||+|.+.+..... .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            579999999999999999999 4689999999997544322 23335789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE  218 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~  218 (332)
                      ||+.+|+|..++.....    +++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       121 e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999976543    89999999999999999999999   999999999999999999999999999986643


Q ss_pred             c---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCCCChH
Q 020027          219 E---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIPCEIK  295 (332)
Q Consensus       219 ~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (332)
                      .   ..||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+.....        ..+.  .
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------~~p~--~  260 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------RFPS--H  260 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCCT--T
T ss_pred             ccccccCccccCCHHHHcC---CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--------CCCc--c
Confidence            3   368999999999876   6789999999999999999999999998776666665554321        1111  2


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 020027          296 PLVRLAKVALACVGNSRKNRP-----SIVQVAT  323 (332)
Q Consensus       296 ~~~~l~~l~~~c~~~dp~~RP-----s~~~i~~  323 (332)
                      ...++.+++.+||+.||++|+     |++++++
T Consensus       261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            233688999999999999994     8898875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=375.78  Aligned_cols=261  Identities=25%  Similarity=0.384  Sum_probs=210.8

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEe------CCCCEEEEEEeccCcccccccccHHHHHHHhccC-CCCCccceeee
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALL------STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA-QHPNIVPILGF  127 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  127 (332)
                      +++...++|+..+.||+|+||.||+|++      .+++.||||+++.... ......+.+|+.+++.+ +|||||+++|+
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4555667899999999999999999984      3567899999976543 22333578999999998 69999999999


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCC--------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCC
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENND--------------GASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIK  193 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  193 (332)
                      +..++..+++||||++|+|.+++.....              ....+++..++.++.||+.||+|||++   +++|||||
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK  172 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccc
Confidence            9999999999999999999999976432              122488999999999999999999999   99999999


Q ss_pred             CCCEEeCCCCceEEccCCccccCCcc--------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 020027          194 ASNILLNEKFCARVCDYGLSFLAPEE--------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILS-GRRCEE  264 (332)
Q Consensus       194 ~~Nill~~~~~~kl~dfg~a~~~~~~--------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~t-g~~p~~  264 (332)
                      |+||+++.++.+|++|||+++...+.        ..+|+.|+|||.+..   ..++.++|||||||++|||+| |.+||.
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC---CCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            99999999999999999999865432        246889999999987   788999999999999999999 555565


Q ss_pred             chhHHHHH-HHhhhcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccccC
Q 020027          265 GLLVKWAL-PLIKEMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVGD  331 (332)
Q Consensus       265 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~~  331 (332)
                      +....... ..+..+         .....+...+.++.+++.+||+.||++||||+||++.|++.+++
T Consensus       250 ~~~~~~~~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         250 GMPVDSKFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             TCCSSHHHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            54433332 222222         11112222334788999999999999999999999999987653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.2e-52  Score=377.00  Aligned_cols=248  Identities=21%  Similarity=0.260  Sum_probs=198.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc-cccHH---HHHHHhccCCCCCccceeeeeecCCce
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA-GFGFA---SVIKTLSLAQHPNIVPILGFSQAPGER  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~  134 (332)
                      .++|+..+.||+|+||.||+|+ ..+|+.||+|.+.+....... ...+.   .++.+++.++|||||++++++..++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            4679999999999999999999 468999999998754332221 11233   446778888999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      ++||||+++|+|.+++.....    +++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhccc----ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            999999999999999987543    78899999999999999999999   99999999999999999999999999997


Q ss_pred             cCCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCC
Q 020027          215 LAPEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAI  290 (332)
Q Consensus       215 ~~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      .....    ..||+.|+|||.+...  ..++.++|||||||++|||+||+.||.+.............     .......
T Consensus       156 ~~~~~~~~~~~GT~~y~APE~~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-----~~~~~~~  228 (364)
T d1omwa3         156 DFSKKKPHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----LTMAVEL  228 (364)
T ss_dssp             ECSSSCCCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-----SSCCCCC
T ss_pred             ecCCCcccccccccccchhHHhhcC--CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----ccCCCCC
Confidence            65433    3689999999998642  56899999999999999999999999865433222211111     1111111


Q ss_pred             CCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          291 PCEIKPLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       291 ~~~~~~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      +.  ....++.+++.+||+.||++|||     ++|+++
T Consensus       229 ~~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         229 PD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CS--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CC--CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11  22336889999999999999999     677764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=372.88  Aligned_cols=242  Identities=20%  Similarity=0.268  Sum_probs=203.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccc-ccccccHHHHHHHhc-cCCCCCccceeeeeecCCceeEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVL-SNAGFGFASVIKTLS-LAQHPNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  137 (332)
                      ++|...+.||+|+||+||+|+ ..+|+.||+|++++.... ......+..|..++. .++||||+++++++..++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            578889999999999999999 468999999999764432 222234566766654 68999999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCC
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAP  217 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~  217 (332)
                      |||+++|+|.+++.....    +++..+..++.||+.||.|||++   +|+||||||+|||+++++.+|++|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            999999999999986543    78999999999999999999999   99999999999999999999999999997543


Q ss_pred             c------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          218 E------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       218 ~------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .      ...||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+.........+..+..        ..+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------~~p  223 (320)
T d1xjda_         155 LGDAKTNTFCGTPDYIAPEILLG---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------FYP  223 (320)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCC
T ss_pred             cccccccccCCCCCcCCHHHHcC---CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------CCC
Confidence            2      2368999999999986   6789999999999999999999999998877777666654321        112


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIV-QVA  322 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~-~i~  322 (332)
                      .  ....++.+++.+||+.||++|||+. |++
T Consensus       224 ~--~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         224 R--WLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             T--TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             c--cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            1  2234688999999999999999985 664

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=371.05  Aligned_cols=246  Identities=15%  Similarity=0.160  Sum_probs=205.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe-CCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL-STGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVS  138 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  138 (332)
                      .++|...+.||+|+||+||+|.. .+|+.||+|.++....   ....+.+|+.+++.++||||+++++++.+++..+++|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            46788999999999999999994 5889999999976532   2234689999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC--CCceEEccCCccccC
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE--KFCARVCDYGLSFLA  216 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~~  216 (332)
                      |||++++|.+++.....   .+++.++..++.||+.||.|||++   +|+||||||+|||++.  ...+||+|||+++..
T Consensus        81 E~~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          81 EFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999976432   289999999999999999999999   9999999999999985  458999999999765


Q ss_pred             Cccc-----CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCCcCCCC
Q 020027          217 PEEK-----RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDPRLAIP  291 (332)
Q Consensus       217 ~~~~-----~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ....     .+++.|++||....   ..++.++||||+||++|||++|+.||.+.........+......-      ..+
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~---~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------~~~  225 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQH---DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF------DEE  225 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTT---CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------CHH
T ss_pred             ccCCcccccccccccccchhccC---CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------Chh
Confidence            4332     57899999998776   678999999999999999999999999887777666665543210      000


Q ss_pred             CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          292 CEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       292 ~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      .......++.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00011236789999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-52  Score=365.54  Aligned_cols=250  Identities=21%  Similarity=0.173  Sum_probs=193.5

Q ss_pred             CCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccc---cccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           65 HRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNA---GFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        65 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      .++.||+|+||+||+|+ ..+|+.||+|+++........   ...+.+|+.+++.++|||||++++++..++..+++|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999999 568999999999765432221   23578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc-
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE-  219 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-  219 (332)
                      +.++++..+.....    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        82 ~~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            98887776654322    278888999999999999999999   9999999999999999999999999999765432 


Q ss_pred             -----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-------cccccCC-
Q 020027          220 -----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-------FSELLDP-  286 (332)
Q Consensus       220 -----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~-  286 (332)
                           ..+|+.|+|||.+...  ..++.++|||||||++|||+||..||.+....+....+....       +...... 
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             ccccceecChhhccHHHHccC--CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence                 2589999999988652  567999999999999999999999998876655544432210       0000000 


Q ss_pred             -----cCCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          287 -----RLAIPCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       287 -----~~~~~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                           ......+     ......+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                 0000001     012346889999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-52  Score=365.51  Aligned_cols=256  Identities=22%  Similarity=0.302  Sum_probs=195.3

Q ss_pred             CCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC----ceeEE
Q 020027           62 GFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG----ERIIV  137 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  137 (332)
                      +|...+.||+|+||.||+|+. +|+.||||+++.+.   .....+..|+..++.++||||+++++++..++    ..+++
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            455668899999999999997 68899999986432   12222345666667889999999999997653    57899


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV-----APNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      |||+++|+|.+++++..     ++|..++.++.|++.||.|||+..     .++|+||||||+|||++.++.+||+|||+
T Consensus        80 ~Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EecccCCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            99999999999998642     799999999999999999999731     24899999999999999999999999999


Q ss_pred             cccCCc----------ccCCcccccCcccccccCC---CCCCchhhhHHHHHHHHHHHhCCCCCCchh------------
Q 020027          213 SFLAPE----------EKRGLAGYVDDDYWHEKGG---GNATRESDVYGFGVVLLEILSGRRCEEGLL------------  267 (332)
Q Consensus       213 a~~~~~----------~~~~~~~~~~pe~~~~~~~---~~~~~~~DiwS~G~il~el~tg~~p~~~~~------------  267 (332)
                      ++....          ...||+.|+|||++.....   ..++.++|||||||++|||+||..|+....            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            865422          2358999999999875321   136789999999999999999987764211            


Q ss_pred             ---HHHHHHHhhhcccccccCCcCCC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccc
Q 020027          268 ---VKWALPLIKEMRFSELLDPRLAI-PCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLVG  330 (332)
Q Consensus       268 ---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~~  330 (332)
                         ..........    +..++.+.. ..+.+....+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       235 ~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         235 DPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             SCCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence               1111111111    112222211 1133455678899999999999999999999999998753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=362.10  Aligned_cols=256  Identities=19%  Similarity=0.191  Sum_probs=197.2

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||+|+++...........+.+|++++++++||||+++++++..++..+++||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            678999999999999999999 5789999999997654433344468899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      |+.++ +.+++.....  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++|||+|+.....
T Consensus        82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99754 4444433222  2389999999999999999999999   9999999999999999999999999998654322


Q ss_pred             ------cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--cccc--------c
Q 020027          220 ------KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--RFSE--------L  283 (332)
Q Consensus       220 ------~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~--------~  283 (332)
                            ..||+.|+|||.+...  ..++.++||||+||++|||++|+.||.+.........+...  ...+        .
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~--~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccceeecccceeeehhhhccc--cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence                  2689999999987663  45689999999999999999999999876554443322110  0000        0


Q ss_pred             cCCcCCC----CCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          284 LDPRLAI----PCE-----IKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       284 ~~~~~~~----~~~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                      .+.....    ..+     .....++.+++.+||+.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000000    000     0112467899999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.2e-51  Score=359.75  Aligned_cols=254  Identities=18%  Similarity=0.191  Sum_probs=201.8

Q ss_pred             CCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEec
Q 020027           61 DGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSEF  140 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  140 (332)
                      ++|...+.||+|+||+||+|+.++|+.||+|+++...........+.+|+.++++++||||+++++++..++..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57889999999999999999988999999999987655444455688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCc--
Q 020027          141 INMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPE--  218 (332)
Q Consensus       141 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~--  218 (332)
                      +.++++..+.....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.|.....  
T Consensus        82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            98777776665433    289999999999999999999998   999999999999999999999999999865432  


Q ss_pred             ----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-------c---ccc-
Q 020027          219 ----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-------F---SEL-  283 (332)
Q Consensus       219 ----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~---~~~-  283 (332)
                          ...+++.|++||.+...  ..++.++||||+||++|||++|+.||.+.........+....       +   ... 
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             -------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccceecccchhhhHHHHhCC--CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence                22578899999998653  567899999999999999999999998765444333221100       0   000 


Q ss_pred             -cCCcC----CC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          284 -LDPRL----AI---PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       284 -~~~~~----~~---~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .....    ..   .........+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000    00   001112336789999999999999999999974

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=368.34  Aligned_cols=245  Identities=17%  Similarity=0.193  Sum_probs=193.7

Q ss_pred             cCCCCCCc-eeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhcc-CCCCCccceeeeeec----CC
Q 020027           60 TDGFSHRR-IIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSL-AQHPNIVPILGFSQA----PG  132 (332)
Q Consensus        60 ~~~~~~~~-~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~  132 (332)
                      .++|.... .||+|+||+||+|+ ..+++.||+|+++..       ..+.+|+.++.+ .+|||||++++++.+    .+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            45787764 69999999999999 578999999998632       245789988655 489999999999865    46


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEcc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCD  209 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~d  209 (332)
                      ..+++||||++|+|.+++.....  ..+++..+..++.|++.||.|||++   +|+||||||+|||+++   ++.+||+|
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence            68999999999999999976432  2389999999999999999999999   9999999999999985   56799999


Q ss_pred             CCccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccccc
Q 020027          210 YGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELL  284 (332)
Q Consensus       210 fg~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      ||+|+....     ...||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+.........+..    ...
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~----~i~  230 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIR  230 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCG---GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCC
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcC---CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH----HHh
Confidence            999975433     2368999999999876   6789999999999999999999999977543332222211    111


Q ss_pred             CCcCCCCCC--hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          285 DPRLAIPCE--IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       285 ~~~~~~~~~--~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ......+.+  .....++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            122222222  233457889999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=356.34  Aligned_cols=239  Identities=16%  Similarity=0.244  Sum_probs=194.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCccccc----ccccHHHHHHHhccCC--CCCccceeeeeecCC
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSN----AGFGFASVIKTLSLAQ--HPNIVPILGFSQAPG  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  132 (332)
                      .++|...+.||+|+||.||+|+ ..+|+.||+|.+++......    ....+.+|+.++++++  ||||+++++++..++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            3578899999999999999999 56899999999976543221    1234678999999886  899999999999999


Q ss_pred             ceeEEEeccCC-CCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-CCceEEccC
Q 020027          133 ERIIVSEFINM-ASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-KFCARVCDY  210 (332)
Q Consensus       133 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~df  210 (332)
                      ..+++|||+.+ +++.+++.....    +++..+..++.|++.||.|||++   +|+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~----l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 578888866433    89999999999999999999999   9999999999999985 579999999


Q ss_pred             CccccCCcc----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccCC
Q 020027          211 GLSFLAPEE----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLDP  286 (332)
Q Consensus       211 g~a~~~~~~----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (332)
                      |+|......    ..||+.|+|||.+...  ..++.++||||+||++|||+||+.||.+...      +..+..      
T Consensus       156 G~a~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~~------  221 (273)
T d1xwsa_         156 GSGALLKDTVYTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQV------  221 (273)
T ss_dssp             TTCEECCSSCBCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC------
T ss_pred             ccceecccccccccccCCCcCCHHHHcCC--CCCCcccccccceeeehhHhhCCCCCCCchH------Hhhccc------
Confidence            999765432    3689999999998762  3346789999999999999999999987431      111111      


Q ss_pred             cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          287 RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       287 ~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        ..+.  ..+.++.+++.+||+.||++|||++|+++
T Consensus       222 --~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 --FFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --CCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCC--CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              1111  11236789999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=357.81  Aligned_cols=256  Identities=17%  Similarity=0.212  Sum_probs=198.1

Q ss_pred             hcCCCCCCceeeccCCeEEEEEEe-CC-CCEEEEEEeccCcccccccccHHHHHHHhccC---CCCCccceeeeeec---
Q 020027           59 ATDGFSHRRIIGQGRLGTVYAALL-ST-GKLVAVKRIHPRLVLSNAGFGFASVIKTLSLA---QHPNIVPILGFSQA---  130 (332)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---  130 (332)
                      ..++|+..+.||+|+||+||+|+. ++ ++.||+|+++...........+.+|+.+++.+   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            346899999999999999999994 44 56799999987655444455677888877665   79999999998853   


Q ss_pred             --CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEc
Q 020027          131 --PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVC  208 (332)
Q Consensus       131 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  208 (332)
                        ....+++||+++++++.........   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence              3467999999988776655443322   378999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc-----
Q 020027          209 DYGLSFLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM-----  278 (332)
Q Consensus       209 dfg~a~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~-----  278 (332)
                      |||+++....     ...||+.|+|||.+..   ..++.++||||+||++|||+||+.||.+....+....+...     
T Consensus       159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~---~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             chhhhhhhcccccCCCcccChhhcCcchhcC---CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            9999876543     2368999999999876   68899999999999999999999999887665554433221     


Q ss_pred             --ccccc-------cCCcCCC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 --RFSEL-------LDPRLAI---PCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 --~~~~~-------~~~~~~~---~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                        .+...       .......   .........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              00000       0000000   001112236778999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=349.60  Aligned_cols=255  Identities=19%  Similarity=0.223  Sum_probs=196.5

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec--------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA--------  130 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  130 (332)
                      .++|+..+.||+|+||+||+|+ ..+|+.||||++............+.+|+.+++.++|||++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            4689999999999999999999 4689999999997765555555568899999999999999999998754        


Q ss_pred             CCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccC
Q 020027          131 PGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDY  210 (332)
Q Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~df  210 (332)
                      .+..+++|||+.++++..+.....    .++...+..++.|++.||.|||++   +|+||||||+|||++.++.+|++||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            346799999998776665544322    278889999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCc----------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc-
Q 020027          211 GLSFLAPE----------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR-  279 (332)
Q Consensus       211 g~a~~~~~----------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-  279 (332)
                      |+++....          ...||..|+|||.+...  ..+++++||||+||++|||+||+.||.+....+....+.... 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCC--CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99864331          12589999999998653  468899999999999999999999998876655544433211 


Q ss_pred             -cccccCC-------------cCCCCCChH-------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          280 -FSELLDP-------------RLAIPCEIK-------PLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       280 -~~~~~~~-------------~~~~~~~~~-------~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                       .......             .........       ....+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence             0000000             000011111       1225678999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=353.44  Aligned_cols=253  Identities=19%  Similarity=0.220  Sum_probs=193.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCC------
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPG------  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  132 (332)
                      .++|...+.||+|+||+||+|. ..+|+.||||+++...........+.+|+.+|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            5679999999999999999999 568999999999865443333446789999999999999999999987654      


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+ +.+|..+.+...     +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            469999999 567877775432     89999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcc----------
Q 020027          213 SFLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMR----------  279 (332)
Q Consensus       213 a~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~----------  279 (332)
                      |+.....   ..+|+.|+|||.+...  ..++.++||||+||++|||++|+.||.+.........+....          
T Consensus       168 a~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADSEMTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCSSCCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCCccccccccccccCHHHHcCC--CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            9876543   3688999999988653  567899999999999999999999998765443332221100          


Q ss_pred             ------------cccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          280 ------------FSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       280 ------------~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                                  ..+....... .........+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                        0000000000 0001112367799999999999999999999873

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=351.79  Aligned_cols=250  Identities=20%  Similarity=0.217  Sum_probs=188.8

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC------Cce
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP------GER  134 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  134 (332)
                      +|...++||+|+||+||+|+ ..+|+.||||+++...      ....+|+.++++++||||+++++++...      ...
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            58888999999999999999 4689999999997542      1235799999999999999999998532      347


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCC-ceEEccCCcc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKF-CARVCDYGLS  213 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a  213 (332)
                      +++|||++++.+..+... ......+++..+..++.|++.||.|||++   +|+||||||+|||++.++ .+||+|||++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            899999986644433321 11122389999999999999999999998   999999999999999765 8999999998


Q ss_pred             ccCCc-----ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc----------
Q 020027          214 FLAPE-----EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM----------  278 (332)
Q Consensus       214 ~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~----------  278 (332)
                      .....     ...|+..|+|||.....  ..++.++||||+||++|||++|+.||.+....+....+...          
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         171 KQLVRGEPNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             EECCTTSCCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hhccCCcccccccccccccChHHhhcc--cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            76432     23688999999987642  57899999999999999999999999876544433322110          


Q ss_pred             ----ccccccCCcCC-----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          279 ----RFSELLDPRLA-----IPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       279 ----~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                          ......-+...     .........++.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000000000     0001122346789999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=341.09  Aligned_cols=254  Identities=20%  Similarity=0.159  Sum_probs=199.4

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCceeEEEe
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGERIIVSE  139 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  139 (332)
                      ++|+..+.||+|+||+||+|+ ..+|+.||||+++...........+.+|+.+++.++||||+++++++..++..++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            578899999999999999999 5689999999997665444444567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccccCCcc
Q 020027          140 FINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSFLAPEE  219 (332)
Q Consensus       140 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~  219 (332)
                      ++.++++..++.....    +++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.|+.....
T Consensus        82 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTTTC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccccc----cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999988887765433    78899999999999999999999   9999999999999999999999999999765432


Q ss_pred             c------CCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCC-chhHHHHHHHhhhccc----------cc
Q 020027          220 K------RGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEE-GLLVKWALPLIKEMRF----------SE  282 (332)
Q Consensus       220 ~------~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~-~~~~~~~~~~~~~~~~----------~~  282 (332)
                      .      .++..|++||.+...  ..++.++||||+||++|||++|+.||. +....+....+.....          ..
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CccceeeccccchhhhhHhccC--CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            2      456778889987653  457899999999999999999999864 3333332222211000          00


Q ss_pred             ccCC---------cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 LLDP---------RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 ~~~~---------~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ..+.         .............+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000         0000011122336778999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-48  Score=341.14  Aligned_cols=253  Identities=19%  Similarity=0.218  Sum_probs=190.7

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccce-eeeeecCCceeEEE
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPI-LGFSQAPGERIIVS  138 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~  138 (332)
                      ++|+..+.||+|+||.||+|+ ..+|+.||||.+....    ....+..|+.+++.++|+|++.. .++....+..+++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            468999999999999999999 5688999999987542    22357899999999987765555 55557778889999


Q ss_pred             eccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC---CCceEEccCCcccc
Q 020027          139 EFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE---KFCARVCDYGLSFL  215 (332)
Q Consensus       139 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a~~  215 (332)
                      ||+. +++...+.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..+|++|||+|+.
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          83 ELLG-PSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             ECCC-CBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEcC-CchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            9994 566666654332   289999999999999999999999   9999999999999863   55799999999975


Q ss_pred             CCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc
Q 020027          216 APE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE  282 (332)
Q Consensus       216 ~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  282 (332)
                      ..+             ...||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+.................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  232 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT---BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhC---CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence            432             2258999999999876   678999999999999999999999997654332221111100000


Q ss_pred             ccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          283 LLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ...+....  ....+.++.+++.+||+.||++||+++++.+.|+.+.
T Consensus       233 ~~~~~~~~--~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         233 MSTPIEVL--CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHSCHHHH--TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             CCCChhHh--ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            00000000  0112246889999999999999999999998888653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=346.89  Aligned_cols=254  Identities=24%  Similarity=0.253  Sum_probs=191.4

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecCCc----e
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAPGE----R  134 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~  134 (332)
                      .++|...+.||+|+||+||+|. ..+|+.||||++++... ......+.+|+.+|+.++||||+++++++..+..    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3568899999999999999998 57899999999975432 2222357899999999999999999999866532    3


Q ss_pred             eEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          135 IIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      +++++++.+++|.+++....     +++..+..++.|+++||.|||++   +|+||||||+|||+++++.+||+|||+|.
T Consensus        86 ~~l~~~~~~g~L~~~l~~~~-----l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCchhhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            44556667899999997532     89999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCc---------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhc--ccc-c
Q 020027          215 LAPE---------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEM--RFS-E  282 (332)
Q Consensus       215 ~~~~---------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-~  282 (332)
                      ....         ...||+.|+|||.+...  ..++.++||||+||++|||++|+.||.+.............  ... .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTB--CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcC--CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            5422         22578899999987553  56789999999999999999999999875443332222110  000 0


Q ss_pred             -------------ccCCcCCCCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 020027          283 -------------LLDPRLAIPCEI-----KPLVRLAKVALACVGNSRKNRPSIVQVATI  324 (332)
Q Consensus       283 -------------~~~~~~~~~~~~-----~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~  324 (332)
                                   ..........+.     ....++.+++.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                         000000000000     112367899999999999999999999863

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=347.07  Aligned_cols=250  Identities=19%  Similarity=0.181  Sum_probs=198.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEEe----CCCCEEEEEEeccCcccc--cccccHHHHHHHhccCCC-CCccceeeeeecCC
Q 020027           60 TDGFSHRRIIGQGRLGTVYAALL----STGKLVAVKRIHPRLVLS--NAGFGFASVIKTLSLAQH-PNIVPILGFSQAPG  132 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~  132 (332)
                      .++|+..+.||+|+||+||+|+.    .+|+.||+|.+++.....  .....+.+|+.++++++| |||+++++++.+.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            36799999999999999999983    368899999997654322  223356899999999976 89999999999999


Q ss_pred             ceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCc
Q 020027          133 ERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGL  212 (332)
Q Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~  212 (332)
                      ..+++|||+.+++|.+++.....    ++...+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence            99999999999999999987654    67888999999999999999999   999999999999999999999999999


Q ss_pred             cccCCc-------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhcccccccC
Q 020027          213 SFLAPE-------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSELLD  285 (332)
Q Consensus       213 a~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ++....       ...|++.|++||.+... ...++.++||||+||+||||+||+.||.+.........+......    
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~-~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~----  250 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----  250 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----
T ss_pred             hhhhcccccccccccccccccchhHHhhcC-CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc----
Confidence            865432       22578999999998652 135688999999999999999999999775443333333222111    


Q ss_pred             CcCCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 020027          286 PRLAIPCEIKPLVRLAKVALACVGNSRKNRPS-----IVQVAT  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs-----~~~i~~  323 (332)
                      ....  .+.....++.+++.+||++||++|||     ++|+++
T Consensus       251 ~~~~--~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 SEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCC--CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1111  12233447889999999999999994     788875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-47  Score=334.58  Aligned_cols=251  Identities=18%  Similarity=0.197  Sum_probs=198.9

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC-CCccceeeeeecCCceeEE
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH-PNIVPILGFSQAPGERIIV  137 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv  137 (332)
                      .++|...+.||+|+||+||+|+ ..+|+.||+|.+....    ....+.+|++.++.++| +|++.+++++...+..+++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            3578999999999999999999 5689999999886432    22346888999998865 8999999999999999999


Q ss_pred             EeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCC-----CCceEEccCCc
Q 020027          138 SEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNE-----KFCARVCDYGL  212 (332)
Q Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~dfg~  212 (332)
                      |||+ +++|.+++.....   .+++.++..++.|++.||.|||++   +|+||||||+|||++.     ++.+||+|||+
T Consensus        80 me~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            9999 6899998876543   278999999999999999999999   9999999999999974     57899999999


Q ss_pred             cccCCc-------------ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHH---HHHHHhh
Q 020027          213 SFLAPE-------------EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVK---WALPLIK  276 (332)
Q Consensus       213 a~~~~~-------------~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~---~~~~~~~  276 (332)
                      |+...+             ...||+.|+|||.+..   ..++.++|||||||++|||+||+.||.+....   .....+.
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~  229 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  229 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcC---CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence            975432             1258999999999876   67899999999999999999999999754221   1222222


Q ss_pred             hcccccccCCcCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 020027          277 EMRFSELLDPRLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVATILNNLV  329 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~~L~~~~  329 (332)
                      ........ +.+..    ..+.++.+++..||+.+|++||+++.+.+.|++++
T Consensus       230 ~~~~~~~~-~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         230 EKKQSTPL-RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHSCH-HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hccCCCCh-HHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11100000 00101    11236889999999999999999999998888765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.3e-47  Score=339.06  Aligned_cols=247  Identities=17%  Similarity=0.212  Sum_probs=190.2

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecC--Ccee
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAP--GERI  135 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~  135 (332)
                      .++|+..+.||+|+||+||+|+ ..+|+.||+|++++..     ...+.+|+.+|+.++ ||||+++++++...  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            3679999999999999999999 4689999999986432     235689999999995 99999999998743  5689


Q ss_pred             EEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCC-CceEEccCCccc
Q 020027          136 IVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEK-FCARVCDYGLSF  214 (332)
Q Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a~  214 (332)
                      ++|||+++++|..+.+       .+++..+..++.||+.||.|||++   +|+||||||+|||++.+ +.+|++|||+|+
T Consensus       109 ~v~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EEEECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             EEEeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence            9999999999876542       278999999999999999999999   99999999999999865 469999999997


Q ss_pred             cCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH-HHHHh-------------
Q 020027          215 LAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW-ALPLI-------------  275 (332)
Q Consensus       215 ~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~-~~~~~-------------  275 (332)
                      .....     ..+|..|+|||.+...  ..++.++||||+||++||+++|+.||....... ....+             
T Consensus       179 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         179 FYHPGQEYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             ECCTTCCCCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             eccCCCcccccccCccccCcccccCC--CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence            65432     2578899999988753  457899999999999999999999986432111 10000             


Q ss_pred             hhc------ccccccCC--------cCCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          276 KEM------RFSELLDP--------RLAIPCEIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       276 ~~~------~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                      ...      .+......        ............++.+++.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000      00000000        0001111122346789999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=342.64  Aligned_cols=250  Identities=17%  Similarity=0.155  Sum_probs=189.1

Q ss_pred             CCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeec------CCc
Q 020027           61 DGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQA------PGE  133 (332)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  133 (332)
                      ++|...+.||+|+||+||+|+ ..+|+.||||++............+.+|+.+++.++||||+++++++..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            679999999999999999999 4589999999998665444444457899999999999999999999854      367


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .+++|||+.++.+. .+..      .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHH-HHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHH-hhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            89999999765554 4432      178999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCcc-----cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccc--------
Q 020027          214 FLAPEE-----KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRF--------  280 (332)
Q Consensus       214 ~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------  280 (332)
                      +.....     ..+|..|+|||.+.+   ..+++++||||+||++|||++|+.||.+.........+.....        
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~l~~---~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTSFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             --------------CCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hccccccccccccccccccChhhhcC---CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            765433     258899999999876   6789999999999999999999999986544433322211000        


Q ss_pred             ------c---------------cccCCcCCCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          281 ------S---------------ELLDPRLAIPC---EIKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       281 ------~---------------~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                            .               ...........   .......+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  0               00000000001   1123456889999999999999999999984

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=344.89  Aligned_cols=254  Identities=20%  Similarity=0.234  Sum_probs=195.7

Q ss_pred             cCCCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCccceeeeeecC-----Cc
Q 020027           60 TDGFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNIVPILGFSQAP-----GE  133 (332)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  133 (332)
                      .++|+..+.||+|+||+||+|+ ..+|+.||||+++...........+.+|+.+++.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5679999999999999999999 56899999999986554333344578999999999999999999998543     33


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEEccCCcc
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARVCDYGLS  213 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a  213 (332)
                      .++++|++.+++|.+++...     .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            46667778899999999643     289999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCcc---cCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHHHHHHhhhccccc--------
Q 020027          214 FLAPEE---KRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKWALPLIKEMRFSE--------  282 (332)
Q Consensus       214 ~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  282 (332)
                      ......   ..|+..|+|||.....  ..++.++||||+||++|||++|+.||.+.........+.......        
T Consensus       169 ~~~~~~~~~~~g~~~y~apE~~~~~--~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         169 RHTDDEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             -CCTGGGSSSCHHHHTSCHHHHTTC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccCcccccccccccccCchhhcCC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            765443   3578899999987653  457899999999999999999999998765544433332211000        


Q ss_pred             -------ccCCcCCCCC-C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 020027          283 -------LLDPRLAIPC-E-----IKPLVRLAKVALACVGNSRKNRPSIVQVAT  323 (332)
Q Consensus       283 -------~~~~~~~~~~-~-----~~~~~~l~~l~~~c~~~dp~~RPs~~~i~~  323 (332)
                             ........+. .     ......+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                   0000000000 0     012236779999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-40  Score=300.19  Aligned_cols=251  Identities=16%  Similarity=0.160  Sum_probs=179.8

Q ss_pred             CCCCCceeeccCCeEEEEEE-eCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-----------CCCccceeeeee
Q 020027           62 GFSHRRIIGQGRLGTVYAAL-LSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-----------HPNIVPILGFSQ  129 (332)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  129 (332)
                      +|...+.||+|+||+||+|+ ..+|+.||||+++++...   ...+.+|+++++.++           |+||+++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~---~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc---hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            48999999999999999999 568999999999754321   124577888777664           578999998875


Q ss_pred             c--CCceeEEEeccCCCCH-HHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeecCCCCCCEEeCCCC--
Q 020027          130 A--PGERIIVSEFINMASL-DFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQ-GVAPNIIHGCIKASNILLNEKF--  203 (332)
Q Consensus       130 ~--~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~--  203 (332)
                      .  ....+++++++..... ........  ...+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++  
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred             eccccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence            4  3556666766654433 22222222  2237889999999999999999998 5   999999999999997654  


Q ss_pred             ----ceEEccCCccccCCc---ccCCcccccCcccccccCCCCCCchhhhHHHHHHHHHHHhCCCCCCchhHHH------
Q 020027          204 ----CARVCDYGLSFLAPE---EKRGLAGYVDDDYWHEKGGGNATRESDVYGFGVVLLEILSGRRCEEGLLVKW------  270 (332)
Q Consensus       204 ----~~kl~dfg~a~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~~~DiwS~G~il~el~tg~~p~~~~~~~~------  270 (332)
                          .++++|||.|.....   ...+|..|+|||.+..   ..++.++||||+||+++||++|+.||.......      
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT---CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cccceeeEeecccccccccccccccccccccChhhccc---cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                389999999865443   3368999999998886   678999999999999999999999986432110      


Q ss_pred             -HHHHhh-----------hccc-c---------cccCC----------cCCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 020027          271 -ALPLIK-----------EMRF-S---------ELLDP----------RLAIPCEIKPLVRLAKVALACVGNSRKNRPSI  318 (332)
Q Consensus       271 -~~~~~~-----------~~~~-~---------~~~~~----------~~~~~~~~~~~~~l~~l~~~c~~~dp~~RPs~  318 (332)
                       ....+.           .... .         .....          ............++.+++.+|++.||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence             000000           0000 0         00000          00111223455678899999999999999999


Q ss_pred             HHHHH
Q 020027          319 VQVAT  323 (332)
Q Consensus       319 ~~i~~  323 (332)
                      +|+++
T Consensus       323 ~e~L~  327 (362)
T d1q8ya_         323 GGLVN  327 (362)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=9.5e-27  Score=190.82  Aligned_cols=163  Identities=14%  Similarity=0.135  Sum_probs=116.2

Q ss_pred             CCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccc----------------cccHHHHHHHhccCCCCCccceeee
Q 020027           64 SHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNA----------------GFGFASVIKTLSLAQHPNIVPILGF  127 (332)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~niv~~~~~  127 (332)
                      ...+.||+|+||.||+|...+|+.||||.++........                ......|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            346789999999999999889999999988653221100                0113457778888999999888766


Q ss_pred             eecCCceeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeecCCCCCCEEeCCCCceEE
Q 020027          128 SQAPGERIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGVAPNIIHGCIKASNILLNEKFCARV  207 (332)
Q Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  207 (332)
                      ..    .+++|||+++..+..           ++......++.|++.++.|||++   +|+||||||+|||++++ .+++
T Consensus        83 ~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             cC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            32    379999998765432           23334567899999999999999   99999999999999865 5899


Q ss_pred             ccCCccccCCcccCCcccccC------cccccccCCCCCCchhhhHHHHH
Q 020027          208 CDYGLSFLAPEEKRGLAGYVD------DDYWHEKGGGNATRESDVYGFGV  251 (332)
Q Consensus       208 ~dfg~a~~~~~~~~~~~~~~~------pe~~~~~~~~~~~~~~DiwS~G~  251 (332)
                      +|||.|.........  .|..      .+.+.    ..++.++|+||..-
T Consensus       144 iDFG~a~~~~~~~~~--~~l~rd~~~~~~~f~----r~y~~~~d~~s~~~  187 (191)
T d1zara2         144 IDFPQSVEVGEEGWR--EILERDVRNIITYFS----RTYRTEKDINSAID  187 (191)
T ss_dssp             CCCTTCEETTSTTHH--HHHHHHHHHHHHHHH----HHHCCCCCHHHHHH
T ss_pred             EECCCcccCCCCCcH--HHHHHHHHHHHHHHc----CCCCCcccHHHHHH
Confidence            999998765432211  1111      11221    45678899999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.46  E-value=6.3e-07  Score=74.71  Aligned_cols=148  Identities=13%  Similarity=0.085  Sum_probs=94.5

Q ss_pred             HHHHhcCCCCCCceeeccCCeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCC-CCCccceeeeeecCCc
Q 020027           55 EIDAATDGFSHRRIIGQGRLGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQ-HPNIVPILGFSQAPGE  133 (332)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  133 (332)
                      ++.....+|...+..+-++.+.||+... +++.+.+|.......  .....+.+|...+..+. +--+-+++.+...++.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            4444455665554444444578998765 556678887754432  22334678888776653 4335667777888888


Q ss_pred             eeEEEeccCCCCHHHHhcccCCCCCcCCHHHHHHHHHHHHHHHHHhhcCC------------------------------
Q 020027          134 RIIVSEFINMASLDFYLHENNDGASLLDWNRRLRIATGAARGLEYLHQGV------------------------------  183 (332)
Q Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------  183 (332)
                      .+++|+++++.++.......      ..   ...++.++++.++-||+..                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            99999999988776543211      11   1223445555555555421                              


Q ss_pred             --------------------------CCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          184 --------------------------APNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       184 --------------------------~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                                                ...++|+|+.|.||++++++.+-+.||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      1238999999999999887667799997664

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.93  E-value=1.9e-05  Score=65.01  Aligned_cols=74  Identities=12%  Similarity=-0.001  Sum_probs=51.1

Q ss_pred             eeeccC-CeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCC--CCccceeeeeecCCceeEEEeccCCC
Q 020027           68 IIGQGR-LGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQH--PNIVPILGFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        68 ~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~  144 (332)
                      .+..|. -+.||+....++..+.+|.-....     ...+..|...++.+..  -.+.+++.+...++..+++|++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            344444 367899888778888888764332     2245777777776632  33566777778888899999999876


Q ss_pred             CH
Q 020027          145 SL  146 (332)
Q Consensus       145 ~L  146 (332)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            54

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.63  E-value=0.00022  Score=62.62  Aligned_cols=78  Identities=14%  Similarity=0.033  Sum_probs=46.0

Q ss_pred             CceeeccCCeEEEEEEeC-CCCEEEEEEeccCcc--cc---cccccHHHHHHHhccCC-C--CCccceeeeeecCCceeE
Q 020027           66 RRIIGQGRLGTVYAALLS-TGKLVAVKRIHPRLV--LS---NAGFGFASVIKTLSLAQ-H--PNIVPILGFSQAPGERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l  136 (332)
                      .+.||.|....||+.... +++.+++|.-.+...  ..   ........|...++.+. +  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            357899999999999854 467899997643211  11   11112345777766552 2  234445544  4455689


Q ss_pred             EEeccCCCC
Q 020027          137 VSEFINMAS  145 (332)
Q Consensus       137 v~e~~~~~~  145 (332)
                      +||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.71  E-value=0.004  Score=52.71  Aligned_cols=68  Identities=12%  Similarity=-0.043  Sum_probs=42.8

Q ss_pred             CeEEEEEEeCCCCEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-----ccee--eeeecCCceeEEEeccCCC
Q 020027           74 LGTVYAALLSTGKLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-----VPIL--GFSQAPGERIIVSEFINMA  144 (332)
Q Consensus        74 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~--~~~~~~~~~~lv~e~~~~~  144 (332)
                      -..||++..++|+.+++|..++....   ...+..|+..+..|...++     +..-  ......+..+.++++++|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            46899999999999999998765321   2235667776665532111     1111  1234456678889998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.49  E-value=0.048  Score=45.35  Aligned_cols=32  Identities=13%  Similarity=0.253  Sum_probs=27.4

Q ss_pred             CCCCeeecCCCCCCEEeCCCCceEEccCCccc
Q 020027          183 VAPNIIHGCIKASNILLNEKFCARVCDYGLSF  214 (332)
Q Consensus       183 ~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~  214 (332)
                      .+.+++|+|+.+.|++++.+...-+.||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence            34589999999999999988777899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.39  E-value=0.026  Score=48.86  Aligned_cols=73  Identities=14%  Similarity=0.132  Sum_probs=46.2

Q ss_pred             CceeeccCCeEEEEEEeCCC--------CEEEEEEeccCcccccccccHHHHHHHhccCCCCCc-cceeeeeecCCceeE
Q 020027           66 RRIIGQGRLGTVYAALLSTG--------KLVAVKRIHPRLVLSNAGFGFASVIKTLSLAQHPNI-VPILGFSQAPGERII  136 (332)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l  136 (332)
                      .+.|+-|--..+|++..+++        +.|.+++.- .   .....+..+|..+++.+.-.++ .++++++.+    ..
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            35788888899999985432        456666543 2   1122345678888877743344 466776643    67


Q ss_pred             EEeccCCCCH
Q 020027          137 VSEFINMASL  146 (332)
Q Consensus       137 v~e~~~~~~L  146 (332)
                      ++||+++..+
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999986533